Citrus Sinensis ID: 041487
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 218 | 2.2.26 [Sep-21-2011] | |||||||
| P34117 | 292 | Cyclin-dependent kinase 5 | yes | no | 0.711 | 0.530 | 0.394 | 2e-28 | |
| Q00526 | 305 | Cyclin-dependent kinase 3 | no | no | 0.711 | 0.508 | 0.392 | 2e-26 | |
| P23437 | 297 | Cyclin-dependent kinase 2 | N/A | no | 0.715 | 0.525 | 0.339 | 1e-23 | |
| Q80YP0 | 303 | Cyclin-dependent kinase 3 | yes | no | 0.706 | 0.508 | 0.350 | 9e-22 | |
| P00546 | 298 | Cyclin-dependent kinase 1 | yes | no | 0.655 | 0.479 | 0.344 | 1e-21 | |
| P24033 | 302 | Cyclin-dependent kinase 1 | N/A | no | 0.743 | 0.536 | 0.351 | 5e-21 | |
| P43063 | 317 | Cyclin-dependent kinase 1 | N/A | no | 0.729 | 0.501 | 0.328 | 6e-21 | |
| Q9DGD3 | 303 | Cyclin-dependent kinase 1 | N/A | no | 0.747 | 0.537 | 0.331 | 1e-20 | |
| Q9DGA2 | 303 | Cyclin-dependent kinase 1 | N/A | no | 0.747 | 0.537 | 0.331 | 1e-20 | |
| Q9DG98 | 303 | Cyclin-dependent kinase 1 | N/A | no | 0.747 | 0.537 | 0.331 | 1e-20 |
| >sp|P34117|CDK5_DICDI Cyclin-dependent kinase 5 homolog OS=Dictyostelium discoideum GN=cdk5 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 125 bits (314), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 84/213 (39%), Positives = 106/213 (49%), Gaps = 58/213 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EK+G+G +G VYK N ETG+ VA+K I + +E EGVP I +SLLKEL+H NI
Sbjct: 4 YSKIEKLGEGTYGIVYKAKNRETGEIVALKRIRLDSEDEGVPCTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL-------GSFIRKHTITS------------------ 137
VRL DV+ T R + LVFEYLD DL G I K TI S
Sbjct: 64 VRLHDVIHTERKLTLVFEYLDQDLKKYLDECGGEISKPTIKSFMYQLLKGVAFCHDHRVL 123
Query: 138 ---IRPH-----------------IKEVGSP------------YKAPESRIRSSVYSTPH 165
++P + G P Y+AP+ + S YSTP
Sbjct: 124 HRDLKPQNLLINRKGELKLADFGLARAFGIPVRTYSHEVVTLWYRAPDVLMGSRKYSTPI 183
Query: 166 DVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
D+W+ GCIFAEM SG+PLFP G D L I +
Sbjct: 184 DIWSAGCIFAEMASGRPLFPGSGTSDQLFRIFK 216
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q00526|CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 84/214 (39%), Positives = 109/214 (50%), Gaps = 59/214 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++ VEKIG+G +G VYK N ETG+ VA+K I + E EGVPS I +SLLKEL+H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKAKNRETGQLVALKKIRLDLEMEGVPSTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL--------GSFIRKHTITS----------------- 137
VRLLDV+ R +YLVFE+L DL GS + H I S
Sbjct: 64 VRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSELPLHLIKSYLFQLLQGVSFCHSHRV 123
Query: 138 ----IRPH---IKEVGS--------------P------------YKAPESRIRSSVYSTP 164
++P I E+G+ P Y+APE + S Y+T
Sbjct: 124 IHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGSKFYTTA 183
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
D+W++GCIFAEMV+ K LFP + D L I R
Sbjct: 184 VDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFR 217
|
Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P23437|CDK2_XENLA Cyclin-dependent kinase 2 OS=Xenopus laevis GN=cdk2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 109 bits (273), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 73/215 (33%), Positives = 100/215 (46%), Gaps = 59/215 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N ETG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNRETGEIVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSI----------------------- 138
IV+LLDV+ T +YLVFE+L+ DL F+ I+ I
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLNQDLKKFMDGSNISGISLALVKSYLFQLLQGLAFCHSHR 122
Query: 139 ------RPH-----------------IKEVGSPYKAPESRIRSSVYSTPH---------- 165
+P + G P + + + Y P
Sbjct: 123 VLHRDLKPQNLLINSDGAIKLADFGLARAFGVPVRTFTHEVVTLWYRAPEILLGCKFYST 182
Query: 166 --DVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
D+W++GCIFAEM++ + LFP + D L I R
Sbjct: 183 AVDIWSLGCIFAEMITRRALFPGDSEIDQLFRIFR 217
|
Involved in the control of the cell cycle. Interacts with cyclins A, B, D, or E. Activity of CDK2 is maximal during S phase and G2. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q80YP0|CDK3_MOUSE Cyclin-dependent kinase 3 OS=Mus musculus GN=Cdk3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 103 bits (257), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 75/214 (35%), Positives = 103/214 (48%), Gaps = 60/214 (28%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS + +SLLKEL+H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKVTGQLVALKKIRLDLEAEGVPSTAVREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLG---------------------------SFIRKHTI 135
++LLDV+ + +Y+VFE+L DL SF H +
Sbjct: 64 IKLLDVVHREKKLYMVFEFLTQDLKRHMDSSPTSELPLPVVKSYLAQLLEGVSFCHSHRV 123
Query: 136 --TSIRPH-----------------IKEVGSP------------YKAPESRIRSSVYSTP 164
++P + G P Y+APE + S YST
Sbjct: 124 IHRDLKPQNLLLDGLGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGSKFYSTA 183
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
D+ ++GCIFAEMV+GK LFP + D L I R
Sbjct: 184 VDI-SIGCIFAEMVTGKALFPGDSEIDQLFRIFR 216
|
Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P00546|CDK1_YEAST Cyclin-dependent kinase 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=CDC28 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 103 bits (256), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 71/206 (34%), Positives = 100/206 (48%), Gaps = 63/206 (30%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
NYK +EK+G+G +G VYK L+L G+ VA+K I +++E EGVPS I +SLLKEL+
Sbjct: 7 NYKRLEKVGEGTYGVVYKALDLRPGQGQRVVALKKIRLESEDEGVPSTAIREISLLKELK 66
Query: 99 HDNIVRLLDVLTTGRY-VYLVFEYLDLDLGSFIR-------------------------- 131
DNIVRL D++ + + +YLVFE+LDLDL ++
Sbjct: 67 DDNIVRLYDIVHSDAHKLYLVFEFLDLDLKRYMEGIPKDQPLGADIVKKFMMQLCKGIAY 126
Query: 132 --KHTI--TSIRPH-----------------IKEVGSPYKA------------PESRIRS 158
H I ++P + G P +A PE +
Sbjct: 127 CHSHRILHRDLKPQNLLINKDGNLKLGDFGLARAFGVPLRAYTHEIVTLWYRAPEVLLGG 186
Query: 159 SVYSTPHDVWAVGCIFAEMVSGKPLF 184
YST D W++GCIFAEM + KP+F
Sbjct: 187 KQYSTGVDTWSIGCIFAEMCNRKPIF 212
|
This protein is essential for the completion of the start, the controlling event, in the cell cycle. More than 200 substrates have been identified. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P24033|CDK1B_XENLA Cyclin-dependent kinase 1-B OS=Xenopus laevis GN=cdk1-b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 101 bits (251), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 78/222 (35%), Positives = 102/222 (45%), Gaps = 60/222 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EKIG+G +G VYK + TG+ VA+K I ++NE EGVPS I +SLLKEL+H NI
Sbjct: 4 YTKIEKIGEGTYGVVYKGRHKATGQVVAMKKIRLENEEEGVPSTAIREISLLKELQHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFE--------YLD-LDLGSFIRKHTITS---------------- 137
V LLDVL +YL+FE YLD + G +I + S
Sbjct: 64 VCLLDVLMQDSRLYLIFEFLSMDLKKYLDSIPSGQYIDTMLVKSYLYQILQGIVFCHSRR 123
Query: 138 -----IRPH-----------------IKEVGSP------------YKAPESRIRSSVYST 163
++P + G P Y+A E + S YST
Sbjct: 124 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRASEVLLGSVRYST 183
Query: 164 PHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALTN 204
P DVW+VG IFAE+ + KPLF + D L I R N
Sbjct: 184 PVDVWSVGTIFAEIATKKPLFHGDSEIDQLFRIFRSLGTPNN 225
|
Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P43063|CDK1_CANAL Cyclin-dependent kinase 1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CDC28 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (250), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 73/222 (32%), Positives = 107/222 (48%), Gaps = 63/222 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKV-AIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
+Y+ EK+G+G +G VYK L+ + +V A+K I +++E EGVPS I +SLLKE++ D
Sbjct: 6 DYQRQEKVGEGTYGVVYKALDTKHNNRVVALKKIRLESEDEGVPSTAIREISLLKEMKDD 65
Query: 101 NIVRLLDVLTTGRY-VYLVFEYLDLDLGSFIR------------------------KHTI 135
NIVRL D++ + + +YLVFE+LDLDL ++ KH
Sbjct: 66 NIVRLYDIIHSDSHKLYLVFEFLDLDLKKYMESIPQGVGLGANMIKRFMNQLIRGIKHCH 125
Query: 136 T------SIRPH-----------------IKEVGSPYKA------------PESRIRSSV 160
+ ++P + G P +A PE +
Sbjct: 126 SHRVLHRDLKPQNLLIDKEGNLKLADFGLARAFGVPLRAYTHEVVTLWYRAPEILLGGKQ 185
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL 202
YST D+W+VGCIFAEM + KPLFP + + I R F L
Sbjct: 186 YSTGVDMWSVGCIFAEMCNRKPLFPGDSE--IDEIFRIFRIL 225
|
This protein is essential for the completion of the start, the controlling event, in the cell cycle. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9DGD3|CDK1_ORYLA Cyclin-dependent kinase 1 OS=Oryzias latipes GN=cdk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (248), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 74/223 (33%), Positives = 104/223 (46%), Gaps = 60/223 (26%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EKIG+G +G VYK + TG+ VA+K I +++E EGVPS + VSLL+EL+H N
Sbjct: 3 DYVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPN 62
Query: 102 IVRLLDVLTTGRYVYLVF--------EYLD-LDLGSFIRKHTITS--------------- 137
+VRLLDVL +YL+F +YLD + G ++ + S
Sbjct: 63 VVRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRR 122
Query: 138 ------IRPH-----------------IKEVGSP------------YKAPESRIRSSVYS 162
++P + G P Y+APE + S YS
Sbjct: 123 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALTN 204
TP DVW+ G IFAE+ + KPLF + D L I R N
Sbjct: 183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNN 225
|
Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Catalytic component of MPF. Oryzias latipes (taxid: 8090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9DGA2|CDK1_ORYJA Cyclin-dependent kinase 1 OS=Oryzias javanicus GN=cdk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (248), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 74/223 (33%), Positives = 104/223 (46%), Gaps = 60/223 (26%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EKIG+G +G VYK + TG+ VA+K I +++E EGVPS + VSLL+EL+H N
Sbjct: 3 DYVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPN 62
Query: 102 IVRLLDVLTTGRYVYLVF--------EYLD-LDLGSFIRKHTITS--------------- 137
+VRLLDVL +YL+F +YLD + G ++ + S
Sbjct: 63 VVRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRR 122
Query: 138 ------IRPH-----------------IKEVGSP------------YKAPESRIRSSVYS 162
++P + G P Y+APE + S YS
Sbjct: 123 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALTN 204
TP DVW+ G IFAE+ + KPLF + D L I R N
Sbjct: 183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNN 225
|
Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Catalytic component of MPF. Oryzias javanicus (taxid: 123683) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9DG98|CDK1_ORYLU Cyclin-dependent kinase 1 OS=Oryzias luzonensis GN=cdk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (248), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 74/223 (33%), Positives = 104/223 (46%), Gaps = 60/223 (26%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EKIG+G +G VYK + TG+ VA+K I +++E EGVPS + VSLL+EL+H N
Sbjct: 3 DYVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPN 62
Query: 102 IVRLLDVLTTGRYVYLVF--------EYLD-LDLGSFIRKHTITS--------------- 137
+VRLLDVL +YL+F +YLD + G ++ + S
Sbjct: 63 VVRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRR 122
Query: 138 ------IRPH-----------------IKEVGSP------------YKAPESRIRSSVYS 162
++P + G P Y+APE + S YS
Sbjct: 123 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALTN 204
TP DVW+ G IFAE+ + KPLF + D L I R N
Sbjct: 183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNN 225
|
Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Catalytic component of MPF. Oryzias luzonensis (taxid: 104659) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 218 | ||||||
| 334323158 | 248 | PREDICTED: cyclin-dependent kinase 3-lik | 0.711 | 0.625 | 0.484 | 2e-30 | |
| 194037512 | 241 | PREDICTED: cyclin-dependent kinase 2 iso | 0.715 | 0.647 | 0.5 | 2e-30 | |
| 348508000 | 241 | PREDICTED: cyclin-dependent kinase 2-lik | 0.715 | 0.647 | 0.481 | 1e-29 | |
| 291235181 | 243 | PREDICTED: cell division cycle 2-like is | 0.655 | 0.588 | 0.482 | 9e-28 | |
| 403297079 | 351 | PREDICTED: cyclin-dependent kinase 2 [Sa | 0.715 | 0.444 | 0.448 | 7e-27 | |
| 330840804 | 292 | protein serine/threonine kinase [Dictyos | 0.711 | 0.530 | 0.394 | 9e-27 | |
| 340717613 | 241 | PREDICTED: cyclin-dependent kinase 1-lik | 0.715 | 0.647 | 0.446 | 1e-26 | |
| 327264997 | 325 | PREDICTED: cyclin-dependent kinase 3-lik | 0.834 | 0.56 | 0.366 | 1e-26 | |
| 380030750 | 241 | PREDICTED: cyclin-dependent kinase 1-lik | 0.743 | 0.672 | 0.436 | 1e-26 | |
| 66805759 | 292 | protein serine/threonine kinase [Dictyos | 0.711 | 0.530 | 0.394 | 1e-26 |
| >gi|334323158|ref|XP_003340355.1| PREDICTED: cyclin-dependent kinase 3-like isoform 2 [Monodelphis domestica] | Back alignment and taxonomy information |
|---|
Score = 138 bits (347), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 76/157 (48%), Positives = 103/157 (65%), Gaps = 2/157 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++ VEKIG+G +G VYK N +TG+ VA+K I + +E EGVPS I +SLLKEL+H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKQTGQLVALKKIRLDSETEGVPSTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPH-IKEVGSPYKAPESRIRSSVY 161
VRLLDV+ + + +YLVFE+L DL ++ T + H +K V Y+APE + Y
Sbjct: 64 VRLLDVVHSEKKLYLVFEFLSQDLKKYMDSAAATELPLHLVKVVTLWYRAPEILLGCKFY 123
Query: 162 STPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
ST DVW++GCIFAEMV+ + LFP + D L I R
Sbjct: 124 STAVDVWSIGCIFAEMVTRRALFPGDSEIDQLFRIFR 160
|
Source: Monodelphis domestica Species: Monodelphis domestica Genus: Monodelphis Family: Didelphidae Order: Didelphimorphia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|194037512|ref|XP_001929000.1| PREDICTED: cyclin-dependent kinase 2 isoform 2 [Sus scrofa] | Back alignment and taxonomy information |
|---|
Score = 138 bits (347), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 79/158 (50%), Positives = 101/158 (63%), Gaps = 2/158 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKVTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIKEVGSPYKAPESRIRSSV 160
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK V Y+APE +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKVVTLWYRAPEILLGCKY 122
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
YST D+W++GCIFAEMV+ + LFP + D L I R
Sbjct: 123 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 160
|
Source: Sus scrofa Species: Sus scrofa Genus: Sus Family: Suidae Order: Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|348508000|ref|XP_003441543.1| PREDICTED: cyclin-dependent kinase 2-like isoform 2 [Oreochromis niloticus] | Back alignment and taxonomy information |
|---|
Score = 135 bits (340), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/158 (48%), Positives = 101/158 (63%), Gaps = 2/158 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 SFQKVEKIGEGTYGVVYKAKNKVTGETVALKKIRLDTETEGVPSTAIREISLLKELSHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIKEVGSPYKAPESRIRSSV 160
IV+L DV+ T +YLVFE+L DL F+ ++T I P +K V Y+APE +
Sbjct: 63 IVKLRDVIHTENKLYLVFEFLHQDLKKFMDSSSVTGIPLPLVKVVTLWYRAPEILLGCKY 122
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
YST D+W++GCIFAEMV+ + LFP + D L I R
Sbjct: 123 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 160
|
Source: Oreochromis niloticus Species: Oreochromis niloticus Genus: Oreochromis Family: Cichlidae Order: Perciformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|291235181|ref|XP_002737516.1| PREDICTED: cell division cycle 2-like isoform 2 [Saccoglossus kowalevskii] | Back alignment and taxonomy information |
|---|
Score = 129 bits (324), Expect = 9e-28, Method: Compositional matrix adjust.
Identities = 70/145 (48%), Positives = 95/145 (65%), Gaps = 2/145 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EKIG+G +G VYK N +TGK VA+K I +++E EGVPS I +SLLKEL+H N
Sbjct: 3 DYVKIEKIGEGTYGVVYKGRNKKTGKLVALKKIRLESEEEGVPSTAIREISLLKELQHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPH--IKEVGSPYKAPESRIRSS 159
IV L DVL +YLVFE+L +DL ++ + +K V Y+APE + S
Sbjct: 63 IVSLQDVLMQEAKLYLVFEFLTMDLKKYMDNIPSGKLMDTGLVKVVTLWYRAPEVLLGSP 122
Query: 160 VYSTPHDVWAVGCIFAEMVSGKPLF 184
YSTP DVW++GCIF+EM + +PLF
Sbjct: 123 RYSTPVDVWSIGCIFSEMATKRPLF 147
|
Source: Saccoglossus kowalevskii Species: Saccoglossus kowalevskii Genus: Saccoglossus Family: Harrimaniidae Order: Class: Enteropneusta Phylum: Hemichordata Superkingdom: Eukaryota |
| >gi|403297079|ref|XP_003939416.1| PREDICTED: cyclin-dependent kinase 2 [Saimiri boliviensis boliviensis] | Back alignment and taxonomy information |
|---|
Score = 126 bits (316), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 79/176 (44%), Positives = 101/176 (57%), Gaps = 20/176 (11%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 95 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 154
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK----------------- 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 155 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKVMLLISSSLSWTCLGGL 214
Query: 144 -EVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
V Y+APE + YST D+W++GCIFAEMV+ + LFP + D L I R
Sbjct: 215 MVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 270
|
Source: Saimiri boliviensis boliviensis Species: Saimiri boliviensis Genus: Saimiri Family: Cebidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|330840804|ref|XP_003292399.1| protein serine/threonine kinase [Dictyostelium purpureum] gi|325077355|gb|EGC31073.1| protein serine/threonine kinase [Dictyostelium purpureum] | Back alignment and taxonomy information |
|---|
Score = 125 bits (315), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 84/213 (39%), Positives = 106/213 (49%), Gaps = 58/213 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EK+G+G +G VYK N ETG+ VA+K I + +E EGVP I +SLLKEL+H NI
Sbjct: 4 YAKIEKLGEGTYGIVYKAKNRETGEIVALKRIRLDSEDEGVPCTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL-------GSFIRKHTITS------------------ 137
VRL DV+ T R + LVFEYLD DL G I K TI S
Sbjct: 64 VRLHDVIHTERKLTLVFEYLDQDLKKYLDECGGEISKATIKSFMYQLLKGVAFCHDHRVL 123
Query: 138 ---IRPH-----------------IKEVGSP------------YKAPESRIRSSVYSTPH 165
++P + G P Y+AP+ + S YSTP
Sbjct: 124 HRDLKPQNLLINRKGELKLADFGLARAFGIPVRTYSHEVVTLWYRAPDVLMGSRKYSTPI 183
Query: 166 DVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
D+W+ GCIFAEM SG+PLFP G D L I +
Sbjct: 184 DIWSAGCIFAEMASGRPLFPGSGTSDQLFRIFK 216
|
Source: Dictyostelium purpureum Species: Dictyostelium purpureum Genus: Dictyostelium Family: Order: Dictyosteliida Class: Phylum: Superkingdom: Eukaryota |
| >gi|340717613|ref|XP_003397275.1| PREDICTED: cyclin-dependent kinase 1-like isoform 2 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 125 bits (314), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 71/159 (44%), Positives = 102/159 (64%), Gaps = 3/159 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N+ +EKIG+G +G VYK + +TG+ VA+K I ++++ EG+PS I +SLLKEL H N
Sbjct: 3 NFVKIEKIGEGTYGVVYKGKHKKTGEIVAMKKIRLESDDEGIPSTAIREISLLKELPHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK-HTITSIRPH-IKEVGSPYKAPESRIRSS 159
IVRL+DVL +YL+FEYL +DL ++ T + P +K V Y+APE + ++
Sbjct: 63 IVRLMDVLMEETRLYLIFEYLTMDLKKYMDTLGTGKLMEPKMVKVVTLWYRAPEILLGTN 122
Query: 160 VYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
YS D+W++GCIFAEM + KPLF + D L I R
Sbjct: 123 RYSCAIDIWSIGCIFAEMATKKPLFQGDSEIDQLFRIFR 161
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|327264997|ref|XP_003217295.1| PREDICTED: cyclin-dependent kinase 3-like [Anolis carolinensis] | Back alignment and taxonomy information |
|---|
Score = 125 bits (314), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 89/243 (36%), Positives = 121/243 (49%), Gaps = 61/243 (25%)
Query: 24 KVVKKTNGSEQ-MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG 82
KV+++ G Q M+ +D ++ VEKIG+G +G VYK N +TG+ VA+K I + +E EG
Sbjct: 6 KVIQQEEGRRQRMDTFQD-TFQKVEKIGEGTYGVVYKARNRQTGQLVALKKIRLDSETEG 64
Query: 83 VPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLG--------------- 127
VPS I +SLLKEL+H NIVRLLDV+ + + +YLVFEYL+ DL
Sbjct: 65 VPSTAIREISLLKELKHPNIVRLLDVIHSQKKLYLVFEYLNQDLKKYMDSSRTGELPMSL 124
Query: 128 ------------SFIRKHTI--TSIRPH---IKEVGS--------------P-------- 148
SF H + ++P I E G+ P
Sbjct: 125 IQSYLYQLLQGVSFCHSHRVIHRDLKPQNLLINETGAIKLADFGLARAFGVPLRTYTHEV 184
Query: 149 ----YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALT 203
Y+APE + YST D+W++GCIFAEMV+ K LFP + D L I R T
Sbjct: 185 VTLWYRAPEILLGCKYYSTAVDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFRTLGTPT 244
Query: 204 NYL 206
L
Sbjct: 245 ESL 247
|
Source: Anolis carolinensis Species: Anolis carolinensis Genus: Anolis Family: Iguanidae Order: Squamata Class: Phylum: Chordata Superkingdom: Eukaryota |
| >gi|380030750|ref|XP_003699005.1| PREDICTED: cyclin-dependent kinase 1-like isoform 2 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 125 bits (314), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 72/165 (43%), Positives = 103/165 (62%), Gaps = 3/165 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N+ +EKIG+G +G VYK + +TG+ VA+K I ++++ EG+PS I +SLLKEL H N
Sbjct: 3 NFVKIEKIGEGTYGVVYKGKHKKTGEIVAMKKIRLESDDEGIPSTAIREISLLKELPHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK-HTITSIRPH-IKEVGSPYKAPESRIRSS 159
IVRL+DVL +YL+FEYL +DL ++ T + P +K V Y+APE + ++
Sbjct: 63 IVRLMDVLMEETRLYLIFEYLTMDLKKYMDNLGTGKLMEPKMVKVVTLWYRAPEILLGAN 122
Query: 160 VYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALT 203
YS D+W++GCIFAEM + KPLF + D L I R T
Sbjct: 123 RYSCAIDIWSIGCIFAEMATKKPLFQGDSEIDQLFRIFRILRTPT 167
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|66805759|ref|XP_636601.1| protein serine/threonine kinase [Dictyostelium discoideum AX4] gi|161784321|sp|P34117.2|CDK5_DICDI RecName: Full=Cyclin-dependent kinase 5 homolog; AltName: Full=CDC2-like serine/threonine-protein kinase CRP; AltName: Full=Cell division protein kinase 5 gi|60464959|gb|EAL63070.1| protein serine/threonine kinase [Dictyostelium discoideum AX4] | Back alignment and taxonomy information |
|---|
Score = 125 bits (314), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 84/213 (39%), Positives = 106/213 (49%), Gaps = 58/213 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EK+G+G +G VYK N ETG+ VA+K I + +E EGVP I +SLLKEL+H NI
Sbjct: 4 YSKIEKLGEGTYGIVYKAKNRETGEIVALKRIRLDSEDEGVPCTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL-------GSFIRKHTITS------------------ 137
VRL DV+ T R + LVFEYLD DL G I K TI S
Sbjct: 64 VRLHDVIHTERKLTLVFEYLDQDLKKYLDECGGEISKPTIKSFMYQLLKGVAFCHDHRVL 123
Query: 138 ---IRPH-----------------IKEVGSP------------YKAPESRIRSSVYSTPH 165
++P + G P Y+AP+ + S YSTP
Sbjct: 124 HRDLKPQNLLINRKGELKLADFGLARAFGIPVRTYSHEVVTLWYRAPDVLMGSRKYSTPI 183
Query: 166 DVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
D+W+ GCIFAEM SG+PLFP G D L I +
Sbjct: 184 DIWSAGCIFAEMASGRPLFPGSGTSDQLFRIFK 216
|
Source: Dictyostelium discoideum AX4 Species: Dictyostelium discoideum Genus: Dictyostelium Family: Order: Dictyosteliida Class: Phylum: Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 218 | ||||||
| DICTYBASE|DDB_G0288677 | 292 | cdk5 "cyclin-dependent kinase | 0.463 | 0.345 | 0.504 | 3.8e-33 | |
| TAIR|locus:2099478 | 294 | CDC2 "cell division control 2" | 0.385 | 0.285 | 0.535 | 1.3e-32 | |
| UNIPROTKB|P29618 | 294 | CDKA-1 "Cyclin-dependent kinas | 0.403 | 0.299 | 0.511 | 4.3e-32 | |
| UNIPROTKB|P23437 | 297 | cdk2 "Cyclin-dependent kinase | 0.444 | 0.326 | 0.536 | 6.9e-32 | |
| UNIPROTKB|E2QW70 | 298 | CDK2 "Uncharacterized protein" | 0.467 | 0.342 | 0.524 | 6.9e-32 | |
| UNIPROTKB|F1SPH6 | 298 | CDK2 "Uncharacterized protein" | 0.467 | 0.342 | 0.524 | 6.9e-32 | |
| UNIPROTKB|O55076 | 298 | CDK2 "Cyclin-dependent kinase | 0.467 | 0.342 | 0.524 | 6.9e-32 | |
| UNIPROTKB|Q5E9Y0 | 298 | CDK2 "Cyclin-dependent kinase | 0.467 | 0.342 | 0.524 | 8.8e-32 | |
| UNIPROTKB|P24941 | 298 | CDK2 "Cyclin-dependent kinase | 0.467 | 0.342 | 0.524 | 8.8e-32 | |
| UNIPROTKB|A0MSV8 | 298 | cdk2 "Cyclin-dependent kinase | 0.467 | 0.342 | 0.524 | 8.8e-32 |
| DICTYBASE|DDB_G0288677 cdk5 "cyclin-dependent kinase 5" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 236 (88.1 bits), Expect = 3.8e-33, Sum P(2) = 3.8e-33
Identities = 51/101 (50%), Positives = 67/101 (66%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EK+G+G +G VYK N ETG+ VA+K I + +E EGVP I +SLLKEL+H NI
Sbjct: 4 YSKIEKLGEGTYGIVYKAKNRETGEIVALKRIRLDSEDEGVPCTAIREISLLKELKHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
VRL DV+ T R + LVFEYLD DL ++ + +P IK
Sbjct: 64 VRLHDVIHTERKLTLVFEYLDQDLKKYLDECGGEISKPTIK 104
|
|
| TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 231 (86.4 bits), Expect = 1.3e-32, Sum P(2) = 1.3e-32
Identities = 45/84 (53%), Positives = 62/84 (73%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ VEKIG+G +G VYK + T + +A+K I ++ E EGVPS I +SLLKE++H NI
Sbjct: 4 YEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHSNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL 126
V+L DV+ + + +YLVFEYLDLDL
Sbjct: 64 VKLQDVVHSEKRLYLVFEYLDLDL 87
|
|
| UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 229 (85.7 bits), Expect = 4.3e-32, Sum P(2) = 4.3e-32
Identities = 45/88 (51%), Positives = 62/88 (70%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ EKIG+G +G VY+ + T + +A+K I ++ E EGVPS I +SLLKE+ H NI
Sbjct: 4 YEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHHGNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFI 130
VRL DV+ + + +YLVFEYLDLDL F+
Sbjct: 64 VRLHDVIHSEKRIYLVFEYLDLDLKKFM 91
|
|
| UNIPROTKB|P23437 cdk2 "Cyclin-dependent kinase 2" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 250 (93.1 bits), Expect = 6.9e-32, Sum P(2) = 6.9e-32
Identities = 52/97 (53%), Positives = 67/97 (69%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N ETG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNRETGEIVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSI 138
IV+LLDV+ T +YLVFE+L+ DL F+ I+ I
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLNQDLKKFMDGSNISGI 99
|
|
| UNIPROTKB|E2QW70 CDK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 247 (92.0 bits), Expect = 6.9e-32, Sum P(2) = 6.9e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKVTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 105
|
|
| UNIPROTKB|F1SPH6 CDK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 247 (92.0 bits), Expect = 6.9e-32, Sum P(2) = 6.9e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKVTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 105
|
|
| UNIPROTKB|O55076 CDK2 "Cyclin-dependent kinase 2" [Cricetulus griseus (taxid:10029)] | Back alignment and assigned GO terms |
|---|
Score = 247 (92.0 bits), Expect = 6.9e-32, Sum P(2) = 6.9e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAVTGIPLPLIK 105
|
|
| UNIPROTKB|Q5E9Y0 CDK2 "Cyclin-dependent kinase 2" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 246 (91.7 bits), Expect = 8.8e-32, Sum P(2) = 8.8e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 105
|
|
| UNIPROTKB|P24941 CDK2 "Cyclin-dependent kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 246 (91.7 bits), Expect = 8.8e-32, Sum P(2) = 8.8e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 105
|
|
| UNIPROTKB|A0MSV8 cdk2 "Cyclin-dependent kinase 2" [Capra hircus (taxid:9925)] | Back alignment and assigned GO terms |
|---|
Score = 246 (91.7 bits), Expect = 8.8e-32, Sum P(2) = 8.8e-32
Identities = 54/103 (52%), Positives = 68/103 (66%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKAKNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIR-PHIK 143
IV+LLDV+ T +YLVFE+L DL F+ +T I P IK
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 105
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 218 | |||
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-45 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-37 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-24 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-23 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-23 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-05 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-05 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.001 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 0.001 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 0.001 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.001 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.001 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.002 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 0.002 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 0.003 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.003 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.003 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.004 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.004 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 76/215 (35%), Positives = 104/215 (48%), Gaps = 58/215 (26%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ +EK+G+G +G VYK + +TG+ VA+K I + NE EG+PS + +SLLKEL+H NI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK------------------- 143
V+LLDV+ T R +YLVFEY D+DL ++ K IK
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 144 --------------------------EVGSPYKA------------PESRIRSSVYSTPH 165
G P + PE + S YST
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV 180
Query: 166 DVWAVGCIFAEMVSGKPLFPC-GKKDHLSLIVRYF 199
D+W+VGCIFAEM++GKPLFP + D L I +
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-37
Identities = 74/214 (34%), Positives = 98/214 (45%), Gaps = 60/214 (28%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ + KIG+G +G VYK + TG+ VAIK I ++ E EG+P + + LLKEL H NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK------------------- 143
++LLDV +YLVFE++D DL I+ IK
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 144 --------------------------EVGSP------------YKAPESRIRSSVYSTPH 165
GSP Y+APE + YSTP
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 166 DVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
D+W+VGCIFAE++S +PLFP GK D L I R
Sbjct: 181 DIWSVGCIFAELLSRRPLFP-GKSEIDQLFKIFR 213
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-36
Identities = 75/202 (37%), Positives = 97/202 (48%), Gaps = 58/202 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFE--------YLDLDLGSFIRKHTITS---------------- 137
IV+LLDV+ T +YLVFE ++D S I I S
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 -----IRP---------HIK--------EVGSP------------YKAPESRIRSSVYST 163
++P IK G P Y+APE + YST
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 164 PHDVWAVGCIFAEMVSGKPLFP 185
D+W++GCIFAEMV+ + LFP
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 6e-35
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 59/209 (28%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+++EK+G+G FG+VY + +TGK VAIK+I + + ++ + +LK+L+H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 103 VRLLDVLTTGRYVYLVFEYLD-LDLGSFI-RKHTITS----------------------- 137
VRL DV +YLV EY + DL + ++ ++
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 138 ---IRP---------HIK------------------EVGSP-YKAPESRIRSSVYSTPHD 166
++P H+K VG+P Y APE + Y D
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE-VLLGKGYGKAVD 178
Query: 167 VWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195
+W++G I E+++GKP FP G L L
Sbjct: 179 IWSLGVILYELLTGKPPFP-GDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-34
Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 58/213 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+++ K+G G FG VYK + TGK VA+K++ ++E + +L+ L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 103 VRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKHTITSIR---------------------- 139
VRL+D ++YLV EY + DL ++ + S
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 --------------PHIK-------------------EVGSP-YKAPESRIRSSVYSTPH 165
+K VG+P Y APE + + Y
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 166 DVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
DVW++G I E+++GKP F D L LI R
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213
|
Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-34
Identities = 72/202 (35%), Positives = 98/202 (48%), Gaps = 59/202 (29%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EKIG+G +G VYK N +TG+ VA+K I +++E EGVPS I +SLLKEL+H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFE--------YLD-LDLGSFIRKHTITS--------------- 137
IV L DVL +YL+FE YLD L G ++ + S
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 138 ----------------------------------IRPHIKEVGSP-YKAPESRIRSSVYS 162
+R + EV + Y+APE + S YS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 163 TPHDVWAVGCIFAEMVSGKPLF 184
TP D+W++G IFAEM + KPLF
Sbjct: 181 TPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-32
Identities = 51/100 (51%), Positives = 69/100 (69%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ VEKIG+G +G VYK + TG+ VA+K I ++ E EGVPS I +SLLKEL H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHI 142
VRLLDV+ + +YLVFE+LDLDL ++ +T + P +
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL 100
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 56/204 (27%), Positives = 83/204 (40%), Gaps = 60/204 (29%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI---NIQNEPEGVPSYLIAGVSLLKELE 98
Y+ +K+G+G + VYK + ETG+ VAIK I + +G+ + + LL+EL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK--------------- 143
H NI+ LLDV + LVFE+++ DL I+ +I IK
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 144 ------------------------------EVGSP------------YKAPESRIRSSVY 161
GSP Y+APE + Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180
Query: 162 STPHDVWAVGCIFAEMVSGKPLFP 185
D+W+VGCIFAE++ P P
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-28
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 61/216 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+V+ +G+G +G V KC N TG+ VAIK + E V + V +L++L H+N
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 102 IVRLLDVLTTGRYVYLVFEYLD---LDL------G-----------------SFIRKHTI 135
IV L + +YLVFEY++ L+L G ++ H I
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 136 T--SIRPH---IKEVG------------------SPY---------KAPESRIRSSVYST 163
I+P + E G SP +APE + + Y
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 164 PHDVWAVGCIFAEMVSGKPLFPCGKKDH--LSLIVR 197
P DVWA+GCI AE++ G+PLFP G D L LI +
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQK 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-27
Identities = 48/91 (52%), Positives = 65/91 (71%), Gaps = 4/91 (4%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ VEKIG+G +G VYK + T + +A+K I ++ E EGVPS I +SLLKE++H NI
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
VRL DV+ + + +YLVFEYLDLDL +KH
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDL----KKH 90
|
Length = 294 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-25
Identities = 41/103 (39%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ + +IG+G +G+VYK N +TG+ VA+K I ++NE EG P I + LL++L H NI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 103 VRLLDVLT--TGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
VRL +++T +Y+VFEY+D DL + + IK
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK 103
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-24
Identities = 43/112 (38%), Positives = 67/112 (59%), Gaps = 9/112 (8%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---H 99
Y+ + +IG+G +G VYK +L TG+ VA+K + + EG+P + ++LLK+LE H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 100 DNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRKHTITSIRPH-IKEV 145
NIVRLLDV R + LVFE++D DL +++ K + P IK++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-24
Identities = 42/88 (47%), Positives = 60/88 (68%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ +EKIG+G +G V+K N ET + VA+K + + ++ EGVPS + + LLKEL+H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSF 129
IVRL DVL + + + LVFEY D DL +
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKY 88
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-24
Identities = 45/93 (48%), Positives = 63/93 (67%), Gaps = 1/93 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N+K +EK+G+G + VYK N TG+ VA+K I++ E EG PS I +SL+KEL+H+N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHEN 59
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHT 134
IVRL DV+ T + LVFEY+D DL ++ H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHG 92
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-24
Identities = 73/213 (34%), Positives = 100/213 (46%), Gaps = 59/213 (27%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y +EK+G+G + V+K + T VA+K I +++E EG P I VSLLK+L+H NI
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANI 66
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL-------GSFIRKHTIT------------------- 136
V L D++ T + + LVFEYLD DL G+ + H +
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 137 --SIRPH---IKEVGS--------------P------------YKAPESRIRSSVYSTPH 165
++P I E G P Y+ P+ + SS YST
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 166 DVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVR 197
D+W VGCIF EM SG+PLFP +D L LI R
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-23
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 62/217 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + +I +G +G VY+ + +TG+ VA+K + ++ E EG P + +++L +L+H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 102 IVRLLDVL--TTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK---------------- 143
IV + +V+ + +Y+V EY++ DL S + ++ +K
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 144 -----------------------------EVGSPYK------------APESRIRSSVYS 162
E GSP K APE + + YS
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
T D+W+VGCIFAE+++ KPLFP GK D L+ I +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFK 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-23
Identities = 67/200 (33%), Positives = 94/200 (47%), Gaps = 58/200 (29%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y ++K+G+G + VYK + T VA+K I +++E EG P I VSLLK+L+H NI
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANI 66
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDL-------GSFIRKHTIT------------------- 136
V L D++ T + + LVFEYLD DL G+ I H +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 137 --SIRPH---IKEVGS--------------P------------YKAPESRIRSSVYSTPH 165
++P I E G P Y+ P+ + S+ YST
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 166 DVWAVGCIFAEMVSGKPLFP 185
D+W VGCIF EM +G+PLFP
Sbjct: 187 DMWGVGCIFYEMSTGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 5e-23
Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 66/234 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ E +G+G FG VY L+ +TG+ +A+K + + + E L + +L L+H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 102 IVRLL----DVLTTGRYVYLVF--------------------------------EYL--- 122
IVR D ++L + YL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 123 -----DL----------------DLGSFIRKHTITSIRPHIKEVGSP-YKAPESRIRSSV 160
D+ D G R I + G+P + APE IR
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEE 179
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYL-VLPCFLS 213
Y D+W++GC EM +GKP + + ++ + Y + +P LS
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSE-LGNPMAAL--YKIGSSGEPPEIPEHLS 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-22
Identities = 47/188 (25%), Positives = 75/188 (39%), Gaps = 60/188 (31%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDV 108
+G+G FG VY + +TGKKVAIK+I ++ + L+ + +LK+L H NIV+L V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59
Query: 109 LTTGRYVYLVFEYLDL-DLGSFIRKHT--------------------------------- 134
++YLV EY + L ++++
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 135 -----ITSIRPHIK-------------------EVGSP-YKAPESRIRSSVYSTPHDVWA 169
+ S +K VG+P Y APE + YS D+W+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 170 VGCIFAEM 177
+G I E+
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-21
Identities = 47/126 (37%), Positives = 67/126 (53%), Gaps = 16/126 (12%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ +EKIG+G +G+VYK + TGK VA+K ++ + EG+P + +SLL+ L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 102 -IVRLLDVLTT----GR-YVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESR 155
IVRLLDV G+ +YLVFEYLD DL F+ + G P
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN----------GRGPGRPLPAKT 111
Query: 156 IRSSVY 161
I+S +Y
Sbjct: 112 IKSFMY 117
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-21
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 58/219 (26%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ + +G+G +G V KC + ETG+ VAIK + + V + + +LK+L H+N+
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 103 VRLLDVLTTGRYVYLVFEY-----LD--------LDLG-------------SFIRKHTIT 136
V L++V + +YLVFE+ LD LD F H I
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 137 --SIRPH-----------------IKEVGSP------------YKAPESRIRSSVYSTPH 165
I+P + + +P Y+APE + + Y
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV 182
Query: 166 DVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALT 203
D+WAVGC+ EM++G+PLFP D L I++ L
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-21
Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 63/203 (31%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIK-MINIQNEPEGVPSYLIAGVSLLKELE-HD 100
YK++ KIG+G F EV K + +TGK AIK M E V + + L+ L H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHP 58
Query: 101 NIVRLLDVL---TTGRYVYLVFEYLDLDLGSFIRKH-------TITS------------- 137
NI+RL++VL TGR + LVFE +D++L I+ + S
Sbjct: 59 NILRLIEVLFDRKTGR-LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 138 --------IRP--------HIK--EVGS--------PY---------KAPESRIRSSVYS 162
I+P +K + GS PY +APE + Y
Sbjct: 118 RNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 163 TPHDVWAVGCIFAEMVSGKPLFP 185
D+WAVGC+F E++S PLFP
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFP 200
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-21
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 61/214 (28%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y ++K+G+G + V+K + T VA+K I +++E EG P I VSLLK L+H NI
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANI 65
Query: 103 VRLLDVLTTGRYVYLVFE--------YLDLDLGSFIRKHTIT------------------ 136
V L D++ T R + LVFE YLD + G+ + H +
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 137 ---SIRPH---IKEVGS--------------P------------YKAPESRIRSSVYSTP 164
++P I E G P Y+ P+ + S+ YSTP
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVR 197
D+W VGCI EM +G+P+FP K+ L LI R
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-20
Identities = 31/91 (34%), Positives = 52/91 (57%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
YK++ +IG+G G V+K + ETG+ VA+K + ++ G+P+ + + L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
+V+LLDV G LV EY+ DL +R
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRD 91
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-20
Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 8/111 (7%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ + KIGQG FGEV+K + +T + VA+K + ++NE EG P + + +L+ L+H+N+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73
Query: 103 VRLLDVLTT-----GRY---VYLVFEYLDLDLGSFIRKHTITSIRPHIKEV 145
V L+++ T RY YLVFE+ + DL + + IK+V
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 9e-20
Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 8/110 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y+++ K+G+G FGEVYK ++TG+ VA+K I + NE +G P + + +LK+L+H N
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 102 IVRLLDV--------LTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
+V L+D+ VY+V Y+D DL + ++ IK
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-19
Identities = 31/81 (38%), Positives = 49/81 (60%), Gaps = 3/81 (3%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
YK +EKIG+G GEVYK + TGK+VAIK + ++ + +I + ++K+ +H NI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNI 77
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V D G +++V EY+D
Sbjct: 78 VDYYDSYLVGDELWVVMEYMD 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-19
Identities = 40/91 (43%), Positives = 59/91 (64%), Gaps = 1/91 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
YK ++K+G+G + VYK + TG+ VA+K I +++E EG P I SLLK+L+H NI
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANI 65
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
V L D++ T + + LVFEYLD DL ++
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC 96
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 34/80 (42%), Positives = 51/80 (63%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
NY++ + IG+G FG VYK LNLETG VAIK I+++ E ++ + LLK L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
IV+ + + T +Y++ EY
Sbjct: 61 IVKYIGSIETSDSLYIILEY 80
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-18
Identities = 69/218 (31%), Positives = 96/218 (44%), Gaps = 59/218 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y+ +EK+G+G + VYK + GK VA+K+I +Q E EG P I SLLK L+H N
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHAN 64
Query: 102 IVRLLDVLTTGRYVYLVFE--------YLDLDLG------------------SFIRKHTI 135
IV L D++ T + LVFE Y+D G S+I + I
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 136 --TSIRPH---IKEVGSP--------------------------YKAPESRIRSSVYSTP 164
++P I + G Y+ P+ + S+ YST
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL 202
D+W VGCIF EM+ G FP G KD + R F L
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFP-GMKDIQDQLERIFLVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-17
Identities = 41/98 (41%), Positives = 59/98 (60%), Gaps = 8/98 (8%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---H 99
Y+ V +IG G +G VYK + +G VA+K + +Q +G+P + V+LLK LE H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 100 DNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRK 132
NIVRL+DV T R V LVFE++D DL +++ K
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDK 99
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-17
Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 12/112 (10%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ ++ +IG+G +G+VYK + +TG+ VA+K + + NE EG P I + +L++L H NI
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 103 VRLLDVLT-----------TGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
V L +++T G + YLVFEY+D DL + + HIK
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAF-YLVFEYMDHDLMGLLESGLVHFSEDHIK 119
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 5e-17
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+V+E IG+G FG V K GK + K I+ N E L++ V++L+EL+H NI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 103 VRLLD--VLTTGRYVYLVFEYLDL-DLGSFIRK 132
VR D + + + +Y+V EY + DL I+K
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK 94
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 1e-16
Identities = 38/92 (41%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 47 EKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+K+G+G FGEVYK T KVA+K + E + S++K+L H NI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNI 63
Query: 103 VRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
VRLL V T G +Y+V EY+ DL F+RKH
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH 95
|
Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-16
Identities = 39/99 (39%), Positives = 62/99 (62%), Gaps = 9/99 (9%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSYLIAGVSLLKEL---E 98
Y+ V +IG+G +G+V+K +L+ G + VA+K + +Q EG+P I V++L+ L E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 99 HDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRK 132
H N+VRL DV T R + LVFE++D DL +++ K
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 101
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 4e-16
Identities = 42/127 (33%), Positives = 58/127 (45%), Gaps = 29/127 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ--------NEPEGVPSYLIAGVSLL 94
YKV++++G G FG VY N ETG+ VAIK + + N E V SL
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-V-------KSLR 52
Query: 95 KELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
K EH NIV+L +V +Y VFEY++ +L ++ ES
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPF-------------SES 99
Query: 155 RIRSSVY 161
IRS +Y
Sbjct: 100 VIRSIIY 106
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 33/95 (34%), Positives = 60/95 (63%), Gaps = 7/95 (7%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI--NIQNEPEGVPSYLIAGVSLLKEL-EH 99
Y++++K+G+G +G V+K ++ T + VA+K I +N + ++ + L+EL +H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 100 DNIVRLLDVL--TTGRYVYLVFEYLDLDLGSFIRK 132
NIV+LL+V+ + +YLVFEY++ DL + IR
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA 101
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-15
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 24/115 (20%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAG------VSLL 94
Y++++ IG G +G V ++ TG+KVAIK I+ + LI + LL
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--------LIDAKRILREIKLL 53
Query: 95 KELEHDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIR-KHTITSIRPHIK 143
+ L H+NI+ LLD+L VY+V E ++ DL I+ +T HI+
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD--HIQ 106
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-15
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+++++IG+G FG+VY GK +K I++ N E + V +LK+L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKE 144
I++ + + +V EY D DL I+K E
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQ--KKEGKPFPE 102
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-15
Identities = 38/92 (41%), Positives = 59/92 (64%), Gaps = 1/92 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y +EK+G+G + VYK ++ G+ VA+K+I+++ E EGVP I SLLK L+H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHAN 64
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
IV L D++ T + VFEY+ DL ++ +H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQH 96
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 8e-15
Identities = 31/92 (33%), Positives = 57/92 (61%), Gaps = 4/92 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++ + +IG+G +G VY+ + +G+ VA+K + + NE +G+P + ++LL L H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 102 IVRLLDVLTTGRY---VYLVFEYLDLDLGSFI 130
IV L +V+ G++ ++LV EY + DL S +
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLL 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 43 YKVVEKIGQGVFGEVYKC--LNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEH 99
Y++ IG+G +G VYK N + GK+ AIK E G+ ++LL+EL+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 100 DNIVRLLDVL--TTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHI 142
+N+V L++V + VYL+F+Y + DL I+ H + R I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHR-QAKRVSI 105
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 3e-14
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ +K+G+G FGEVYK +VA+K + + + + ++++L+H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDH 60
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NIV+LL V T + +V EY+ DL ++RK+
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN 95
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 4e-14
Identities = 32/95 (33%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ +K+G+G FGEVYK G K VA+K + ++ E + ++++L+H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASEQQIEEFLREARIMRKLDH 60
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
N+V+LL V T +Y+V EY++ DL S++RK+
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN 95
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 67/235 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI-QNEPEGVP--SYLIAGVSLLKELE 98
N++ + +GQG FG VY C +++TG+++A+K + + PE + L + LLK L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 99 HDNIVRLLDVLT-------------------------------TGRYVYLVFE---YL-- 122
H+ IV+ L T +Y + E YL
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 123 ------DL----------------DLGSFIRKHTITSIRPHIKEV-GSPY-KAPESRIRS 158
D+ D G+ R TI S +K V G+PY +PE I
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV-ISG 181
Query: 159 SVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLVLPCFLS 213
Y DVW+VGC EM++ KP P + + ++ I + T TN LP +S
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTNP-QLPSHVS 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-13
Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 14/121 (11%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ + KIG+G +G V+KC N ETG+ VAIK + + + + +LK+L+H N+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYS 162
V L++V R ++LVFEY D + + + K+ P PE I+ ++
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--------------PRGVPEHLIKKIIWQ 108
Query: 163 T 163
T
Sbjct: 109 T 109
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 4e-13
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 47 EKIGQGVFGEVYKCL---NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+K+G+G FGEVYK +VA+K + ++ E + ++K+L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGS 147
RLL V T +YLV EY++ DL ++RK P +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-13
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 64/210 (30%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ ++++G G +G V L+ TG KVAIK + + E + LLK ++H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 103 VRLLDVLTTG--------------------------------RYVYLVFEYL-------- 122
+ LLDV T R +LV++ L
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 123 ------DLDLGSF--------------IRKHTITSIRPHIKEVGSPYKAPESRIRSSVYS 162
DL G+ + + T + + ++ V Y+APE + Y+
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV--VTRWYRAPEVILNWMHYT 194
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192
D+W+VGCI AEM++GKPLF DHL
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFK--GHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-12
Identities = 25/37 (67%), Positives = 30/37 (81%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE + S YSTP D+W+VGCIFAEMV+ KPLFP
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205
|
Length = 294 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-12
Identities = 32/80 (40%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y EKIGQG G VY +++ TG++VAIK +N+Q +P+ +I + +++E +H NI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPNI 78
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V LD G +++V EYL
Sbjct: 79 VNYLDSYLVGDELWVVMEYL 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-12
Identities = 48/211 (22%), Positives = 76/211 (36%), Gaps = 61/211 (28%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+ V+ +GQG G VYK + TGK A+K I++ + E L+ + L+ E +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESPYVV 62
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH---------TITS---------------- 137
+ + +V EY+D L ++K I
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 138 ---IRPH---------IK-------------------EVGS-PYKAPESRIRSSVYSTPH 165
I+P +K VG+ Y +PE RI+ YS
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAA 181
Query: 166 DVWAVGCIFAEMVSGK-PLFPCGKKDHLSLI 195
D+W++G E GK P P G+ L+
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELM 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 23/37 (62%), Positives = 30/37 (81%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE + S YSTP D+W++GCIFAEMV+ +PLFP
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 25/49 (51%), Positives = 33/49 (67%), Gaps = 3/49 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLI 195
Y+APE + S Y+ D+W+VGCI AEM+S +PLFP GK L+LI
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP-GKDYLHQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-12
Identities = 28/81 (34%), Positives = 51/81 (62%), Gaps = 2/81 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++++EKIG+G FGEVYK + TGK+VAIK+I ++++ + +I + +LK+ +H NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKIINEIQILKKCKHPNI 59
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V+ +++V E+
Sbjct: 60 VKYYGSYLKKDELWIVMEFCS 80
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-12
Identities = 21/37 (56%), Positives = 30/37 (81%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE +RS+ YS+P D+WA+GCI AE+ + +PLFP
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-12
Identities = 27/50 (54%), Positives = 37/50 (74%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + SS Y+ D+W+VGCIFAE+++ KPLFP G+ D L+LIV
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP-GRDYIDQLNLIV 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-11
Identities = 23/37 (62%), Positives = 29/37 (78%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE + S+ YSTP D+W+VGCIFAEM +PLFP
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 69/204 (33%)
Query: 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQ-NEPEGVPSYLIAG-VSLLKELEHDNIV-- 103
KIG G FG+VY +NL+TG+ +A+K I IQ N+P+ + IA + +L+ L+H N+V
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE--IADEMKVLELLKHPNLVKY 64
Query: 104 -----------------------------RLLDVLTTGRYVYLVFEYLD----------- 123
R+LD Y + E L
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 124 -------------LDLGSF-----IRKHTITSIRPHIKE-VGSP-YKAPE--SRIRSSVY 161
+ LG F ++ +T T++ ++ G+P Y APE + + +
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNT-TTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 162 STPHDVWAVGCIFAEMVSGKPLFP 185
D+W++GC+ EM +GK +
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 2e-11
Identities = 31/80 (38%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y EKIGQG G VY +++ TG++VAIK +N+Q +P+ +I + +++E ++ NI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNI 78
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V LD G +++V EYL
Sbjct: 79 VNYLDSYLVGDELWVVMEYL 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-11
Identities = 26/88 (29%), Positives = 50/88 (56%), Gaps = 6/88 (6%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ ++EK+G+G +G VYK ++ ETG+ VAIK++ ++ + + +I +S+LK+ + I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE----IIKEISILKQCDSPYI 60
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFI 130
V+ +++V EY GS
Sbjct: 61 VKYYGSYFKNTDLWIVMEY--CGAGSVS 86
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI-NIQNEPEGVPSYLIAGVSLLKELEHD 100
YK +E IG G +G V ++ +GKKVAIK I + + P L + +L+ +HD
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHD 64
Query: 101 NIVRLLDVLTT----GRYVYLVFEYLDLDLGSFIR 131
NI+ + D+L + VY+V + ++ DL I
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH 99
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-11
Identities = 25/50 (50%), Positives = 34/50 (68%), Gaps = 1/50 (2%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
Y+AP+ + S YST D+W+VGCI AEM++G+PLFP +D L I R
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-11
Identities = 33/80 (41%), Positives = 51/80 (63%), Gaps = 2/80 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y EKIGQG G V+ +++ TG++VAIK IN+Q +P+ +I + ++KEL++ NI
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPNI 78
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V LD G +++V EYL
Sbjct: 79 VNFLDSFLVGDELFVVMEYL 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-11
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 63/216 (29%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ + +G G +G V + +TG +VA+K ++ Q+ +Y + LLK ++H+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 76
Query: 101 NIVRLLDVLTTGRY------VYLVFEYLDLDLGSFIRKHTIT------------------ 136
N++ LLDV T R VYLV + DL + ++ +T
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136
Query: 137 --------SIRP--------------------HIKEVGSPY------KAPESRIRSSVYS 162
++P H + + Y +APE + Y+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 163 TPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197
D+W+VGCI AE+++G+ LFP D L LI+R
Sbjct: 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 30/80 (37%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y EKIGQG G VY +++ TG++VAI+ +N+Q +P+ +I + +++E ++ NI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNI 79
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V LD G +++V EYL
Sbjct: 80 VNYLDSYLVGDELWVVMEYL 99
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 2/51 (3%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
Y+ P+ + S+ YST D+W VGCIF EM +G+PLFP +D L I R
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-10
Identities = 25/51 (49%), Positives = 36/51 (70%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE + + Y P DVWA+GC+FAE+++G+PL+P GK D L LI +
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVDQLYLIRK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 59.0 bits (141), Expect = 2e-10
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ-NEPEGVPSYLIAGVSLLKEL-EH 99
+Y+++ K+G+G FGEVY + K VA+K++ + + + +L L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
NIV+L D +YLV EY+D L ++K
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI 92
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-10
Identities = 52/232 (22%), Positives = 83/232 (35%), Gaps = 76/232 (32%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELEHDNIV 103
E +G G FG VY+ LNL+ G A+K +++ ++ + L ++LL +L+H NIV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 104 RLLDVLTTGRYVYLVFEYLDL--------DLGSF----IRK------------HTITSIR 139
+ L +Y+ E + GSF IR H ++
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 140 PHIK---------------EVGSPYKAPESRIRSSVYSTPH-----------------DV 167
IK + G + E S +P+ D+
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 168 WAVGCIFAEMVSGKP----------LFPCGKK-------DHLSLIVRYFTAL 202
W++GC EM +GKP +F G+ DHLS + F
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 27/52 (51%), Positives = 34/52 (65%), Gaps = 5/52 (9%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH---LSLIVR 197
Y+APE + S Y+T DVW+VGCIFAE++ KPLFP KD+ L LI
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP--GKDYVHQLKLITE 223
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-10
Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIK---MINIQNEPEGVPSY---------LIAGVSLLKE 96
+G+G +G+V K + TGK VAIK +I I N+ + + ++ E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
++H+NI+ L+DV G ++ LV + + DL + + + +K
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTE-SQVK 122
|
Length = 335 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-10
Identities = 24/48 (50%), Positives = 33/48 (68%), Gaps = 2/48 (4%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-CGKKDHLSLI 195
Y+APE ++SS Y+TP D+W+VGCIFAE+ +PLF + D L I
Sbjct: 172 YRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 20/37 (54%), Positives = 27/37 (72%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE + S+ Y+ D+W+VGCI EM+ GKPLFP
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-10
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 14/119 (11%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++V+ +G+G +G V KC + ET + VAIK E E V + + +L+ L+ +NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVY 161
V L + +YLVFEY++ ++ + + P P ++RS +Y
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEM--------------PNGVPPEKVRSYIY 107
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIV 196
Y+APE + Y+T D+W+VGCIFAEM+ + LFP GK L LI+
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP-GKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-10
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 20/88 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---------IQNEPEGVPSYLIAGVSL 93
Y+++++IG G +G+VYK ++ TG+ VAIK+I IQ E +S+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE-----------ISM 53
Query: 94 LKELEHDNIVRLLDVLTTGRYVYLVFEY 121
LKE H NIV +++V EY
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEY 81
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ + +G G +G+V + +TG+KVAIK ++ Q+ +Y + LLK ++H+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 101 NIVRLLDVLTTG------RYVYLVFEYLDLDLGSFIR 131
N++ LLDV T + VYLV + DL + ++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK 111
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINI-----QNEPE---GVPSYLIAGVSLLKELE 98
E IG+G +G VY LN+ TG+ +A+K + + + L + + LK+L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
H NIV+ L TT Y+ + EY+ +GS +R +
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY 102
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 24/42 (57%), Positives = 32/42 (76%), Gaps = 2/42 (4%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190
Y+APE ++S+ Y+TP D+W+VGCIFAEM KPLF CG +
Sbjct: 173 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF-CGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 27/76 (35%), Positives = 45/76 (59%), Gaps = 5/76 (6%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
IG+G FG+V L G+KVA+K + +++ ++L A S++ L H N+V+LL
Sbjct: 12 ATIGKGEFGDVM--LGDYRGQKVAVKCL--KDDSTAAQAFL-AEASVMTTLRHPNLVQLL 66
Query: 107 DVLTTGRYVYLVFEYL 122
V+ G +Y+V EY+
Sbjct: 67 GVVLQGNPLYIVTEYM 82
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYL--IAGVSLLKELEHD 100
Y ++ IG+G +G V N ET +KVAIK I N + + + LL+ L+H+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIA--NAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 101 NIVRLLDVLT-TGRY----VYLVFEYLDLDLGSFIR 131
N++ + D++ R VY+V+E +D DL IR
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR 100
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 28/61 (45%), Positives = 36/61 (59%), Gaps = 6/61 (9%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLVL 208
Y+APE + Y D+W+ GCIFAEM+ GKPLFP KDH V F+ +T+ L
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP--GKDH----VNQFSIITDLLGT 224
Query: 209 P 209
P
Sbjct: 225 P 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-09
Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 67/236 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVP--SYLIAGVSLLKELE 98
N+++ + +GQG FG VY C + +TG+++A+K + E PE + L + LLK L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 99 HDNIVRLLDVL---------------------------------TTGRYVYLVFE---YL 122
H+ IV+ L T +Y + E YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 123 ---------------------DLDLGSF---IRKHTITSIRPHIKEV-GSPYKAPESRIR 157
++ LG F R TI +K V G+PY I
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 158 SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLVLPCFLS 213
Y D+W+VGC EM++ KP P + + ++ I + T TN VLP +S
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTN-PVLPPHVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 5e-09
Identities = 26/64 (40%), Positives = 39/64 (60%), Gaps = 4/64 (6%)
Query: 139 RPHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD--HLSLI 195
R + +V + Y+APE + Y D+WAVGCIFAE+++G PLFP G+ D L+++
Sbjct: 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP-GENDIEQLAIV 213
Query: 196 VRYF 199
R
Sbjct: 214 FRTL 217
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-09
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI-QNEPEGVPSYLIAGVSLLKELEHD 100
N+K+ +KIG+G F VYK + L G+ VA+K + I + + + LLK+L+H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHT 134
N+++ L + +V E D DL I KH
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMI-KHF 96
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-08
Identities = 23/36 (63%), Positives = 29/36 (80%), Gaps = 1/36 (2%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
Y+APE ++SS Y+TP D+W+VGCIFAEM KPLF
Sbjct: 175 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VSLLKELE 98
Y+ + IG+G +G V + TG KVAIK I P ++ + +L+ +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRFK 61
Query: 99 HDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIR 131
H+NI+ +LD++ + VY+V E ++ DL I+
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK 99
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVY 161
I ++ D RY Y + + R+ +TS K V Y+APE + + Y
Sbjct: 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS-----KVVTLWYRAPELLMGAEKY 211
Query: 162 STPHDVWAVGCIFAEMVSGKPLFP 185
D+W+VGCIFAE+++GKPLFP
Sbjct: 212 HFAVDMWSVGCIFAELLTGKPLFP 235
|
Length = 335 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-08
Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
EKIG+G FG+VYK + L+ +VA+K P+ +L +LK+ +H NIV+L+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 107 DVLTTGRYVYLVFEYL-DLDLGSFIRK 132
V + +Y+V E + L +F+RK
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRK 85
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ + IG G FGEV + L L GKK VAIK + + + +L S++ + +H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKL-PGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDH 64
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NI+RL V+T R V ++ EY++ L F+R++
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN 99
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 24/50 (48%), Positives = 34/50 (68%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + + Y+T D+WAVGCI AE+++ KPL P GK + L LI+
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP-GKSEIEQLDLII 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 66/227 (29%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVP--SYLIAGVSLLKELE 98
N++ + +GQG FG VY C +++TG+++A K + E PE S L + LLK L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 99 HDNIVRLLDVL---------------------------------TTGRYVYLVFE---YL 122
H+ IV+ L T +Y + E YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 123 ---------------------DLDLGSF---IRKHTITSIRPHIKEV-GSPYKAPESRIR 157
++ LG F R TI I+ V G+PY I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 158 SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN 204
Y DVW++GC EM++ KP P + + ++ I + T TN
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP--PWAEYEAMAAIFKIATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 46 VEKIGQGVFGEVYK--CLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
++G+G FG+V+ C +LE VA+K + + + LL +H+
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-REAELLTNFQHE 68
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NIV+ V T G +VFEY++ DL F+R H
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH 102
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
YK+ E IG+G +G V ++ TG+KVAIK IN E + ++ + LL+ L H +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 103 VRLLDVL-----TTGRYVYLVFEYLDLDLGSFIR 131
V + ++ + +Y+VFE ++ DL I+
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK 95
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190
Y+APE + + Y+ D+WA+GCIFAE+++ +P+F +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 44/196 (22%), Positives = 76/196 (38%), Gaps = 58/196 (29%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ ++E IG+G FGEVYK ++ T + VAIK+I+++ + + + + L + I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPYI 61
Query: 103 VRLLDVLTTGRYVYLVFEYLD----LDL---GSFIRKHTITSIRP--------H------ 141
+ G ++++ EY LDL G + +R H
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIH 121
Query: 142 --IK----------EV----------------------GSPY-KAPESRIRSSVYSTPHD 166
IK +V G+P+ APE I+ S Y D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV-IKQSGYDEKAD 180
Query: 167 VWAVGCIFAEMVSGKP 182
+W++G E+ G+P
Sbjct: 181 IWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-08
Identities = 56/227 (24%), Positives = 85/227 (37%), Gaps = 66/227 (29%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ---NEPEGVPSYLIAGVSLLKELE 98
N+++ + +G+G FGEVY C + +TG+++A+K + E + L + LLK L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 99 HDNIVRLLDVL---------------------------------TTGRYVYLVFE---YL 122
HD IV+ L T RY + + YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 123 ---------------------DLDLGSF---IRKHTITSIRPHIKEV-GSPYKAPESRIR 157
++ LG F R TI IK V G+PY I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 158 SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN 204
Y DVW+V C EM++ KP P + + ++ I + T T
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKP--PWAEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 46/201 (22%), Positives = 76/201 (37%), Gaps = 64/201 (31%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ-----NEPEGVPSYLIAGVSLLKEL 97
++++ ++GQG +G+V+ +TG+ VA+K + NE +++ +L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE----VRHVLTERDILTTT 58
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEY---------------LDLDLGSFIRKHTITSI---- 138
+ + +V+LL Y+YL EY L D F ++
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 139 ---------RP---------HIK----------------EVGSP-YKAPESRIRSSVYST 163
+P HIK VGSP Y APE +R Y
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV-LRGKGYDF 177
Query: 164 PHDVWAVGCIFAEMVSGKPLF 184
D W++GC+ E + G P F
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-08
Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y ++++G G +G V ++ TG+KVAIK ++ + E ++LLK ++H+N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 103 VRLLDVLTTG------RYVYLVFEYLDLDL 126
+ LLDV T+ + YLV Y+ DL
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL 106
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193
Y+APE + Y+ D+W+VGCI AE+++GK LFP DH+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP--GSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-08
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVRY 198
Y+APE + Y+ DVW+VGCI AE++ KP+F GK D L+ I++
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK-GKDYVDQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-08
Identities = 26/82 (31%), Positives = 46/82 (56%), Gaps = 4/82 (4%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD-- 100
Y+ +E IG+G +G VY+ ++ TG+ VA+K+IN+ + V S + V+LL +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQP 61
Query: 101 -NIVRLLDVLTTGRYVYLVFEY 121
NI + G ++++ EY
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEY 83
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 8e-08
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+V++KIG G FGEV+ + T + K I+ + E S L+ V++++EL+H NI
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 103 VRLLDVL--TTGRYVYLVFEYLDL-DLGSFIRK 132
VR +D + +Y++ E+ D DL I+K
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK 107
|
Length = 1021 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 16/37 (43%), Positives = 24/37 (64%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+ PE + ++ Y D+W+VGCI AE+ GKP+F
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 45/202 (22%), Positives = 72/202 (35%), Gaps = 67/202 (33%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLD 107
I +G +G V+ TG AIK+I + + ++ +L + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 108 VLTTGRYVYLVFEYL---DL-----DLGSF------------------IRKHTIT--SIR 139
+ +YLV EYL DL ++GS + + I ++
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 140 P---------HIK---------------------------EVGSP-YKAPESRIRSSVYS 162
P H+K VG+P Y APE I +S
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV-ILGQGHS 179
Query: 163 TPHDVWAVGCIFAEMVSGKPLF 184
D W++GCI E + G P F
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-07
Identities = 26/79 (32%), Positives = 49/79 (62%), Gaps = 2/79 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++++ ++G G FG+VYK N ETG A K+I+ ++E E + Y++ + +L +H NI
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVE-IDILASCDHPNI 64
Query: 103 VRLLDVLTTGRYVYLVFEY 121
V+LLD ++++ E+
Sbjct: 65 VKLLDAFYYENNLWILIEF 83
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ--NEPEGVPSYLIAGVSLLKELEH 99
++K + IG+G F V ET K+ AIK+++ + + + V I L + H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 100 DNIVRLLDVLTTGRYVYLVFEYL-DLDLGSFIRKH 133
I++L +Y V EY + +L +IRK+
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY 96
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 15/83 (18%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMV-SGKPLFPCGK--KDHLSLIVRYF------ 199
Y+ P+ + +YST D+W+ GCIFAE+ +G+PLFP G D L I R
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQLKRIFRLLGTPTEE 223
Query: 200 -----TALTNYLVLPCFLSIMLL 217
+ L +Y P + + L
Sbjct: 224 SWPGVSKLPDYKPYPMYPATTSL 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 20/49 (40%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD--HLSLI 195
Y+ PE + Y+T D+W +GC+FAEM + +P+ GK D L LI
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ-GKSDIDQLHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 24/43 (55%), Positives = 33/43 (76%), Gaps = 6/43 (13%)
Query: 149 YKAPESRIRSSVYS--TPH-DVWAVGCIFAEMVSGKPLFPCGK 188
Y+APE + S +S TP D+W++GCIFAE+++GKPLFP GK
Sbjct: 172 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP-GK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-07
Identities = 36/118 (30%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 48 KIGQGVFGEVYKCLNLETG--KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
K+G+G +G VYK + K+ A+K I E G+ ++LL+EL+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 106 LDVLT--TGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVY 161
V + R V+L+F+Y + DL I+ H + K P + P S ++S +Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRAS------KANKKPMQLPRSMVKSLLY 115
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-07
Identities = 18/42 (42%), Positives = 31/42 (73%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190
Y+APE + + Y+ D+WA+GCIFAE+++ +P+F C ++D
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 18/37 (48%), Positives = 26/37 (70%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y++P + + Y+ D+WA GCIFAEM++GKPLF
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 18/106 (16%)
Query: 45 VVEKIGQGVFGEVYKCLNLETGKK----------------VAIKMINIQNEPEGVPSYLI 88
VEK+G+G FGEV+ C VA+K++ + + +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-PDASDNAREDFL 67
Query: 89 AGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
V +L L NI RLL V T + ++ EY++ DL F++KH
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH 113
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 1/80 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+++E IG G VY + L +KVAIK I+++ V L V + + H N+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNV 61
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V+ G ++LV YL
Sbjct: 62 VKYYTSFVVGDELWLVMPYL 81
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
K+ +G G FGE+ + CL L + ++ VAI + + +L A L + +H
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFL-AEALTLGQFDHS 66
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLD-LGSFIRKH 133
NIVRL V+T G + +V EY+ L SF+RKH
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH 100
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-07
Identities = 18/42 (42%), Positives = 31/42 (73%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190
Y+APE + + Y+ D+WA+GCIFAE+++ +P+F C ++D
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 17/36 (47%), Positives = 26/36 (72%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
Y+APE + S Y++ D+W+VGCIFAE++ + LF
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 23/67 (34%), Positives = 42/67 (62%), Gaps = 2/67 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++++ ++G G FG+VYK + ETG A K+I I++E E + +++ + +L E +H N
Sbjct: 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-LEDFMVE-IDILSECKHPN 63
Query: 102 IVRLLDV 108
IV L +
Sbjct: 64 IVGLYEA 70
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-07
Identities = 27/109 (24%), Positives = 55/109 (50%), Gaps = 16/109 (14%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y + +G G G V+ ++ + K+VA+K I + +P+ V + + +++ L+HDNI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-DPQSVKH-ALREIKIIRRLDHDNI 64
Query: 103 VRLLDVLTTG--------------RYVYLVFEYLDLDLGSFIRKHTITS 137
V++ +VL VY+V EY++ DL + + + ++
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 26/69 (37%), Positives = 34/69 (49%), Gaps = 5/69 (7%)
Query: 124 LDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPL 183
LD G T + P++ V Y+APE I Y D+W+VGCI EM+ G L
Sbjct: 160 LDFGLARTAGTSFMMTPYV--VTRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIRGTVL 216
Query: 184 FPCGKKDHL 192
FP DH+
Sbjct: 217 FP--GTDHI 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL 97
+ K ++++G+G FG+V C L TG++VA+K +N E + S + +L+ L
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ-HRSDFEREIEILRTL 63
Query: 98 EHDNIVRLLDVLT--TGRYVYLVFEYLDL-DLGSFIRKH 133
+H+NIV+ V GR + L+ EYL L ++++H
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH 102
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 9/83 (10%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV--PSYLIAGVSLLKELEH 99
K+V+K+G G FGEV+ KVAIK + +G P +A +L+K+L+H
Sbjct: 7 TLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLK-----QGSMSPEAFLAEANLMKQLQH 60
Query: 100 DNIVRLLDVLTTGRYVYLVFEYL 122
+VRL V+T +Y++ EY+
Sbjct: 61 PRLVRLYAVVTQ-EPIYIITEYM 82
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-07
Identities = 38/201 (18%), Positives = 72/201 (35%), Gaps = 58/201 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++KV++K+G+G +G VYK L + A+K +++ + + + + +L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRK---------------------------H 133
I+ + G + +V EY DL I K H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 134 TITSIRPHIKE----VGSPY----------KAPESRIRSSVYSTPH-------------- 165
+ +K + + K + + + TPH
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 166 --DVWAVGCIFAEMVSGKPLF 184
D+W++GC+ EM + P F
Sbjct: 181 KSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 19/102 (18%)
Query: 42 NYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMI------NIQNEPEGVPSYLIAG 90
N + V IGQG FG V++ L E VA+KM+ ++Q + +
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-------RE 58
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
+L+ E +H NIV+LL V G+ + L+FEY+ DL F+R
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 100
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-07
Identities = 25/80 (31%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y++++++G G +G+VYK NL TG+ A+K+I + EP S + + ++KE +H N
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCN 67
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
IV + +++ EY
Sbjct: 68 IVAYFGSYLSREKLWICMEY 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 49 IGQGVFGEVYK-----CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+GQG FG VY+ + E +VAIK +N +N + S++KE ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
RLL V++TG+ +V E + DL S++R
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSR 103
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
+ + K+G G FGEV++ L +VAIK++ +++ V LK L H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNR-VRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHK 62
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
+++ L V + G VY++ E ++ L +F+R
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLR 94
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-07
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 14/118 (11%)
Query: 48 KIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
K+G+G +G VYK + + A+K I E G+ ++LL+EL+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 106 LDVLTT--GRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVY 161
V + R V+L+F+Y + DL I+ H + K P + P ++S +Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRAS------KANKKPVQLPRGMVKSLLY 115
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-07
Identities = 24/79 (30%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++++ ++G G FG+VYK N ETG A K+I ++E E + Y++ + +L H I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVE-IEILATCNHPYI 71
Query: 103 VRLLDVLTTGRYVYLVFEY 121
V+LL ++++ E+
Sbjct: 72 VKLLGAFYWDGKLWIMIEF 90
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV--PSYLIAGVSLLKELEHDN 101
K+ K+G G FGEV+ T KVA+K + G P + ++K+L HD
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGT-TKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRHDK 62
Query: 102 IVRLLDVLTTGRYVYLVFEYL 122
+V+L V + +Y+V EY+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYM 83
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 48 KIGQGVFGEVY--KCLNL--ETGKK-VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++G+G FG+V+ +C NL E K VA+K + +E A LL L+H +I
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA--ELLTVLQHQHI 69
Query: 103 VRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
VR V T GR + +VFEY+ DL F+R H
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH 101
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 23/82 (28%), Positives = 39/82 (47%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y++++KIG+G FG++Y + IK I++ P V LL +++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
IV +++V EY D
Sbjct: 61 IVTFFASFQENGRLFIVMEYCD 82
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY-LIAGVSLLKELEHD 100
N+++ +KIG+G F EVY+ L K VA+K + I + + + LLK+L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
N+++ LD + +V E D DL I+
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK 94
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 20/125 (16%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSY--------LIAGVS 92
Y V+E +G G FG VYK G+ +A+K IN+ N G +++ V+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 93 LLKE-LEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKA 151
++KE L H NIVR +Y+V + ++ G+ + +H + +KE +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIE---GAPLGEHFNS-----LKEKKQRF-- 110
Query: 152 PESRI 156
E RI
Sbjct: 111 TEERI 115
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 49 IGQGVFGEVYKCLNLETG-----KKVAIKMINIQNEP--EGVPSYLIAGVSLLKELEHDN 101
IG G FG VY +N +G K+V + ++ ++ + L ++LLKEL+H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 102 IVRLLDVLTTGRYVYLVFEYL 122
IV+ L ++ + EY+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYV 88
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 19/80 (23%), Positives = 38/80 (47%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++++ KIG+G FG V+K + + A+K I++ I +L +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
I+R + + +V EY
Sbjct: 61 IIRYYESFLDKGKLNIVMEY 80
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-06
Identities = 21/80 (26%), Positives = 35/80 (43%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + +G+G FG V+ C K V IK I ++ + +LK L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
I+ + + + +V EY
Sbjct: 61 IIEYYENFLEDKALMIVMEY 80
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 30/87 (34%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
E +G+G FGEV+K L+ VA+K ++ P+ + ++ +LK+ +H NIV+L+
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 107 DVLTTGRYVYLVFEYLD-LDLGSFIRK 132
V T + +Y+V E + D SF+RK
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRK 85
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 66/204 (32%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ ++ IG G G V + G VA+K ++ QN+ +Y + LLK + H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHK 80
Query: 101 NIVRLLDVLTTGRY------VYLVFEYLDLDLG------------SFIRKHTITSIRPHI 142
NI+ LL+V T + VYLV E +D +L S++ + I+ H+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK-HL 139
Query: 143 KEVG------------------------------------SPY------KAPESRIRSSV 160
G +PY +APE I
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV-ILGMG 198
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLF 184
Y D+W+VGCI E+V G +F
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 78/235 (33%)
Query: 8 HDLFRTNMKKVKDCCYKVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK 67
H+ FR ++ V V + ++ N+ KIG+G G V + TG+
Sbjct: 1 HEQFRAALQLV-------VDPGDPRSYLD-----NFV---KIGEGSTGIVCIATDKSTGR 45
Query: 68 KVAIKMINI--QNEPEGVPSYLIAGVSLLKELEHDNIVR--------------------- 104
+VA+K +++ Q E L V ++++ +H NIV
Sbjct: 46 QVAVKKMDLRKQQRRE----LLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 105 -LLDVLTTGR-----------YVYLVFEYL--------DLDLGSFIRKHT---------- 134
L D++T R V +L D+ S +
Sbjct: 102 ALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF 161
Query: 135 ---ITSIRPHIKE-VGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
++ P K VG+PY APE I Y T D+W++G + EMV G+P +
Sbjct: 162 CAQVSKEVPRRKSLVGTPYWMAPEV-ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-06
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
K+ E IG G FGEV + GK+ VAIK + + +L + S++ + +H
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQFDHP 65
Query: 101 NIVRLLDVLTTGRYVYLVFEYLD-LDLGSFIR 131
NI+ L V+T R V ++ E+++ L SF+R
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLR 97
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 25/64 (39%), Positives = 37/64 (57%), Gaps = 6/64 (9%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI--QNEPEGVPSYLIAGVSLLKELEHD 100
+++VE IG+G +G+VYK + +TG+ VAIK+++I E E Y I L K H
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI----LRKYSNHP 63
Query: 101 NIVR 104
NI
Sbjct: 64 NIAT 67
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 17/36 (47%), Positives = 27/36 (75%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
Y+APE + ++ Y+T D+W++GCI AEM+ G P+F
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 46 VEKIGQGVFGEVYKCLNLETGK-KVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDNI 102
++++G G FG V+ L GK VAIKMI EG S I ++ +L H N+
Sbjct: 9 LKELGSGQFGVVH--LGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 103 VRLLDVLTTGRYVYLVFEYLDLD-LGSFIRKH 133
V+L V T R +++V EY+ L +++R+
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRER 93
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-06
Identities = 45/197 (22%), Positives = 67/197 (34%), Gaps = 56/197 (28%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEHDNIVRLL 106
I +G FG VY TG AIK++ + V + ++ + E + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 107 DVLTTGRYVYLVFEYLD-LDLGSFIRKHTITS---------------------------I 138
+ Y+YLV EYL+ D S I+ I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 139 RP---------HIKE---------------VGSP-YKAPESRIRSSVYSTPHDVWAVGCI 173
+P H+K VG+P Y APE+ I D W++GC+
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPET-ILGVGDDKMSDWWSLGCV 182
Query: 174 FAEMVSGKPLFPCGKKD 190
E + G P F D
Sbjct: 183 IFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-06
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 44 KVVEKIGQGVFGEVYK----CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ +E++G+ FG++YK ++ + VAIK + N P+ + SL+ EL H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ-QEASLMAELHH 66
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFI 130
NIV LL V+T + V ++FEYL+ DL F+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL 98
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-06
Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE + Y+ D+W+VGCI AEM++GK LF GK D L+ I++
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 18/37 (48%), Positives = 25/37 (67%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
Y+APE + Y+ D+W+VGCI AE++ GK LFP
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-05
Identities = 21/62 (33%), Positives = 41/62 (66%), Gaps = 2/62 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++++++IG G +G+VYK N+ TG+ AIK+I + EP + + + ++K+ +H N
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHSN 67
Query: 102 IV 103
IV
Sbjct: 68 IV 69
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-05
Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 56/192 (29%)
Query: 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
+E+IG+G FGEVYK ++ T + VAIK+I+++ E E + +++L + + I R
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 106 LDVLTTGRYVYLVFEYLD----LDL-----------GSFIRK--------HTITSIRPHI 142
G ++++ EYL LDL + +R+ H+ I I
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 143 KE--------------------------------VGSPYKAPESRIRSSVYSTPHDVWAV 170
K VG+P+ I+ S Y D+W++
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 171 GCIFAEMVSGKP 182
G E+ G+P
Sbjct: 188 GITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 13/102 (12%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPS---YLIAGVSLLKELEH 99
Y ++ +G G FG V + TG+ VAIK I +P P + LLK L H
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI---MKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 100 DNIVRLLDVLTTGRY-VYLVFEYLDLDLGSFIRKHTITSIRP 140
+NI+ L D+ + +Y V E L DL H + + RP
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDL------HRLLTSRP 104
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 38 VKDWNYKVVEKIGQGVFGEVY--KCLNL-ETGKKVAIKMINIQNEPEGVPSYLIAGVSLL 94
+K N + ++G+G FG+V+ +C NL K+ + + +++ + LL
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 95 KELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
L+H++IV+ V G + +VFEY+ DL F+R H
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH 101
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 28/79 (35%), Positives = 46/79 (58%), Gaps = 4/79 (5%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+V+K+G G FGEV+ KVA+K ++ V ++L +L+K L+HD +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVK--TLKPGTMSVQAFL-EEANLMKTLQHDKLV 64
Query: 104 RLLDVLTTGRYVYLVFEYL 122
RL V+T +Y++ EY+
Sbjct: 65 RLYAVVTKEEPIYIITEYM 83
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 58/196 (29%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVP------------------ 84
+ +EKIG+G FGEV+K ++ T K VAIK+I+++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 85 ----SYL-----------IAGVSLLKELEHD------------NIVRLLDVLTTGRYVY- 116
SYL + G S L LE I++ LD L + + ++
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 117 -------LVFEYLDLDLGSFIRKHTITSIRPHIKE---VGSPYKAPESRIRSSVYSTPHD 166
L+ E+ ++ L F +T + IK VG+P+ I+ S Y + D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 167 VWAVGCIFAEMVSGKP 182
+W++G E+ G+P
Sbjct: 184 IWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 9/79 (11%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQ-----NEPEGVPSYLIAGVSLLKELEHDNIV 103
+G+G FG+V +TGK A+K++ + E E + + ++L + H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE----HTLTERNILSRINHPFIV 56
Query: 104 RLLDVLTTGRYVYLVFEYL 122
+L T +YLV EY
Sbjct: 57 KLHYAFQTEEKLYLVLEYA 75
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-05
Identities = 27/80 (33%), Positives = 46/80 (57%), Gaps = 7/80 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+++ IG+G FG+V L G KVA+K I + + +A S++ +L H N+V
Sbjct: 9 KLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 104 RLLDVLTTGR-YVYLVFEYL 122
+LL V+ + +Y+V EY+
Sbjct: 63 QLLGVIVEEKGGLYIVTEYM 82
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 44 KVVEKIGQGVFGEV-YKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K+ + IG G FGEV L L GK+ VAIK + + +L + S++ + +H
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLP-GKREIPVAIKTLKAGYTEKQRRDFL-SEASIMGQFDH 64
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NI+ L V+T + V +V EY++ L +F+RKH
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH 99
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 48 KIGQGVFGEVY--KCLNLE-TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVR 104
++G+G FG+V+ +C NL T K+ + + +++ LL L+H++IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 105 LLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
V G + +VFEY+ DL F+R H
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 101
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 42 NYKVVEKIGQGVFGEVYK-----CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ +E++G+G FG+VYK + VAIK + EP+ V L+ +
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-VQQEFRQEAELMSD 64
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITS 137
L+H NIV LL V T + ++FEYL DL F+ +++ S
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHS 106
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 53/205 (25%), Positives = 79/205 (38%), Gaps = 66/205 (32%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ ++ IG G G V + + VAIK ++ QN+ +Y + L+K + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 76
Query: 101 NIVRLLDVLTTGRY------VYLVFEYLDLDLG------------SFIRKHTITSIRPHI 142
NI+ LL+V T + VYLV E +D +L S++ + I+ H+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK-HL 135
Query: 143 KEVG------------------------------------SPY------KAPESRIRSSV 160
G +PY +APE I
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMG 194
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFP 185
Y D+W+VGCI EMV K LFP
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFP 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-05
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 2/86 (2%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
E+IG+G FGEV+ VA+K P+ +L +LK+ H NIVRL+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEA-RILKQYSHPNIVRLI 59
Query: 107 DVLTTGRYVYLVFEYLD-LDLGSFIR 131
V T + +Y+V E + D +F+R
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLR 85
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-05
Identities = 27/88 (30%), Positives = 49/88 (55%), Gaps = 17/88 (19%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI----NIQNEPEGVPSYLIAGVSLLKEL- 97
++++E IG+G +G+V+K LN + G K A+K++ +I E E A ++LK L
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE-------AEYNILKALS 72
Query: 98 EHDNIVRLLDV-----LTTGRYVYLVFE 120
+H N+V+ + + G ++LV E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLE 100
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 3e-05
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 24/104 (23%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN------------IQNEPEGVPSYLIA 89
+++ ++ +G G FG V + +GK A+K+++ + NE
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE---------- 51
Query: 90 GVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRK 132
+L+ + H +V L +YLV EY+ +L S +RK
Sbjct: 52 -KRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK 94
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-05
Identities = 45/192 (23%), Positives = 78/192 (40%), Gaps = 56/192 (29%)
Query: 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
+E+IG+G FGEV+K ++ T + VAIK+I+++ E E + +++L + + + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 106 LDVLTTGRYVYLVFEYLD----LDL---GSF-----------IRK-----HTITSIRPHI 142
G ++++ EYL LDL G F I K H+ I I
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 143 KE--------------------------------VGSPYKAPESRIRSSVYSTPHDVWAV 170
K VG+P+ I+ S Y + D+W++
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187
Query: 171 GCIFAEMVSGKP 182
G E+ G+P
Sbjct: 188 GITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-05
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 48 KIGQGVFGEVYK-----CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
++GQG FG VY+ + E +VAIK +N +L S++KE ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 103 VRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
VRLL V++ G+ ++ E + DL S++R S+RP + +P +AP S
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLR-----SLRP--EMENNPVQAPPS 117
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-05
Identities = 23/75 (30%), Positives = 42/75 (56%), Gaps = 3/75 (4%)
Query: 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD 107
K+G G +GEVY+ + + VA+K + V +L +++KE++H N+V+LL
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFL-KEAAVMKEIKHPNLVQLLG 69
Query: 108 VLTTGRYVYLVFEYL 122
V T Y++ E++
Sbjct: 70 VCTREPPFYIITEFM 84
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 9e-05
Identities = 14/53 (26%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 145 VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
VG+PY ++ Y D+W++GC+ E+ + P P ++ L L +
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP--PFTARNQLQLASK 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 2/50 (4%)
Query: 134 TITSIRPHIKEVGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
++ + VG+PY APE I Y D+W++G E+ GKP
Sbjct: 147 QLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 19/103 (18%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLET--GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-- 97
Y++++++GQG +G V N ET + VAIK I V S I L+EL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT------NVFSKKILAKRALRELKL 54
Query: 98 -----EHDNIVRL--LDVLTTGRY--VYLVFEYLDLDLGSFIR 131
H NI L +D++ G + +YL E ++ DL IR
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR 97
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAI-KMINI-QNEPEGVPSYLIAGVSLLKELE------HD 100
IG G FG V+ + GK+VA+ KM N+ QN L++ + +EL+ HD
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN--------LVSCKRVFRELKMLCFFKHD 59
Query: 101 NIVRLLDVLTTG-----RYVYLVFEYLDLDLGSFI-RKHTITSIRPHIK 143
N++ LD+L +Y+V E + DL I ++S H+K
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS--DHVK 106
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 11 FRTNMKKVKDCCYKVVKKTNGSEQMEKVKD--------WNYKVVEKIGQGVFGEVYKCLN 62
F N KK+ + E EK+ D +YK+ IG G FG VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 63 LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111
++T +KVAIK + +Q+ P Y + ++K L H NI+ L D T
Sbjct: 88 IDTSEKVAIKKV-LQD-----PQYKNRELLIMKNLNHINIIFLKDYYYT 130
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 1e-04
Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ + +G G +G V + +KVA+K ++ Q+ +Y + LLK ++H+
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRLLKHMKHE 74
Query: 101 NIVRLLDVLTTG------RYVYLVFEYLDLDLGSFIRKHTIT 136
N++ LLDV T VYLV + DL + ++ ++
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS 116
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 44/200 (22%), Positives = 77/200 (38%), Gaps = 53/200 (26%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
E +G G G VYK +L T + +A+K+I + E + +++ + +L + + I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFY 65
Query: 107 DVLTTGRYVYLVFEYLD---LDLGSFIRKHTITSI------------------------- 138
+ + E++D LD+ I +H + I
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 139 -----RPHIK-----------------EVGS-PYKAPESRIRSSVYSTPHDVWAVGCIFA 175
R +K VG+ Y APE RI Y DVW++G F
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE-RISGEQYGIHSDVWSLGISFM 184
Query: 176 EMVSGKPLFPCGKKDHLSLI 195
E+ G+ +P +K+ SL+
Sbjct: 185 ELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+VV +G+G +G VY +L T ++AIK I ++ P L ++L L+H N
Sbjct: 11 GERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRN 66
Query: 102 IVRLLDVLTTGRYVYLVFE 120
IV+ L + + + E
Sbjct: 67 IVQYLGSDSENGFFKIFME 85
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG-VPSYLIAGVSLLKELEHD 100
N+++ +KIG+G F EVY+ L G VA+K + I + + + I + LLK+L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
N+++ + +V E D DL I+
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIK 94
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 22/78 (28%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
V +IG G G VYK ++ TG+ A+K+I N + V + + +L+++ H N+V+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKC 137
Query: 106 LDVLTTGRYVYLVFEYLD 123
D+ + ++ E++D
Sbjct: 138 HDMFDHNGEIQVLLEFMD 155
|
Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 53/212 (25%), Positives = 81/212 (38%), Gaps = 68/212 (32%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ ++ IG G G V + + VAIK ++ QN+ +Y + L+K + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 83
Query: 101 NIVRLLDVLTTGRY------VYLVFEY------------LDLDLGSFIRKHTITSIRPHI 142
NI+ LL+V T + VY+V E LD + S++ + I+ H+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK-HL 142
Query: 143 KEVG------------------------------------SP------YKAPESRIRSSV 160
G +P Y+APE I
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMG 201
Query: 161 YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192
Y D+W+VGCI EM+ G LFP DH+
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFP--GTDHI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 45 VVEKIGQGVFGEVYK-----CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-E 98
+ + +G+G FG+V K N VA+KM+ + E S L++ + ++K + +
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGK 74
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H NI+ LL V T +Y+V EY +L F+R
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR 110
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 26/91 (28%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 47 EKIGQGVFGEVYKCL--NLETGK-KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
IG+G FG+VY+ + + E K VA+K P +L ++++ +H +IV
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL-QEAYIMRQFDHPHIV 70
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L+ V+T V++V E L +L S+++ +
Sbjct: 71 KLIGVITENP-VWIVMELAPLGELRSYLQVN 100
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 22/56 (39%), Positives = 32/56 (57%), Gaps = 2/56 (3%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTALT 203
+ APE +R Y DVW+VGC+ EM + KP + K +HL+LI + +A T
Sbjct: 174 FMAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 21/51 (41%), Positives = 28/51 (54%), Gaps = 4/51 (7%)
Query: 146 GSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195
G+PY APE I S Y D+W++GC EM +GKP P D L+ +
Sbjct: 170 GTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMATGKP--PLASMDRLAAM 217
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 64/202 (31%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV----SLLKEL 97
+ + ++ +G G FG V+ + + A+K++ I PE + V +LKE+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI---PEVIRLKQEQHVHNEKRVLKEV 58
Query: 98 EHDNIVRLLDVLTTGRYVYLV---------FEYLDLDLGSF------------------I 130
H I+RL R++Y++ F YL + G F +
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYL 117
Query: 131 RKHTIT--SIRP---------HI--------KEV--------GSP-YKAPESRIRSSVYS 162
I ++P HI K++ G+P Y APE I+S ++
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEV-IQSKGHN 176
Query: 163 TPHDVWAVGCIFAEMVSGKPLF 184
D WA+G + EM+ G P F
Sbjct: 177 KAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 44 KVVEKIGQGVFGEV----YKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K + +G+G FG+V Y N TG+ VA+K + + + + +++LK L H
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW-KKEINILKTLYH 65
Query: 100 DNIVRLLDVLTT--GRYVYLVFEYLDL-DLGSFIRKHTI 135
+NIV+ + G+ + L+ EY+ L L ++ KH +
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL 104
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 49 IGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
IG G FGEV++ + G+K VAIK + + +L + S++ + H NI+RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHNIIRL 71
Query: 106 LDVLTTGRYVYLVFEYLDLD-LGSFIRKH 133
V+T + ++ EY++ L ++R H
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDH 100
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 4e-04
Identities = 23/70 (32%), Positives = 33/70 (47%), Gaps = 7/70 (10%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT 203
G+P Y APE + Y D W++G + EM++GKP F + + Y L
Sbjct: 154 CGTPEYLAPEV-LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-----YEKILK 207
Query: 204 NYLVLPCFLS 213
+ L P FLS
Sbjct: 208 DPLRFPEFLS 217
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
+V++IG G FG V+ LE +KVAIK I EG S I ++ +L H
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPK 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+L V T + LVFE+++
Sbjct: 61 LVQLYGVCTERSPICLVFEFME 82
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 16/103 (15%)
Query: 49 IGQGVFGEVYK-----CLNLETGK-KVAIKMIN----IQNEPEGVPSYLIAGVSLLKELE 98
+G G FGEVY+ L +G +VA+K + Q + E + L+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFN 57
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRP 140
H NIV+LL V Y++ E ++ DL S++R + P
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGP 100
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 24/72 (33%), Positives = 35/72 (48%), Gaps = 4/72 (5%)
Query: 123 DLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
DL LG F T + H VG+PY RI + Y+ D+W++GC+ EM + +
Sbjct: 149 DLGLGRFFSSKTTAA---H-SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
Query: 183 LFPCGKKDHLSL 194
F K + SL
Sbjct: 205 PFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 49 IGQGVFGEVYKCL---NLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+G+G FGEV+ E G + V +K + + E + S + + ++L H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVV 71
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
RLL + Y++ EY DL DL F+R
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLR 100
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 6e-04
Identities = 25/81 (30%), Positives = 40/81 (49%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y V+KIG+G FG+ + E GK+ IK INI V++L ++H NI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V+ + +Y+V +Y +
Sbjct: 62 VQYQESFEENGNLYIVMDYCE 82
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYL----VFEYLDLDLGSFIRKHTITSIRPHIKEVG 146
V L LEH + R++ V++ V + DL LG F T + H VG
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---H-SLVG 168
Query: 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194
+PY RI + Y+ D+W++GC+ EM + + F K + SL
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLL 106
E IG+G FG V + TG+KVA+K I + + +++ +L H N+VRLL
Sbjct: 12 EIIGEGEFGAVLQ--GEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLL 65
Query: 107 DV-LTTGRYVYLVFEYLDL-DLGSFIR 131
V L G +Y+V E + +L +F+R
Sbjct: 66 GVILHNG--LYIVMELMSKGNLVNFLR 90
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 7e-04
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 25/152 (16%)
Query: 23 YKVVKKTNGSE-------QMEKVKDW-----NYKVVEKIGQGVFGEVYKCLNLETGK--- 67
+K+++ G+ Q+ + W N + + +G G FG+V + GK
Sbjct: 8 WKIIEAAEGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDN 67
Query: 68 --KVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124
+VA+KM+ + + L++ + +L L +H NIV LL T G V ++ EY
Sbjct: 68 VLRVAVKMLKASAHTDEREA-LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 125 -DLGSFIRKHTITSIR-----PHIKEVGSPYK 150
DL +F+RK T + P I E S YK
Sbjct: 127 GDLLNFLRKKAETFLNFVMALPEISETSSDYK 158
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 17/57 (29%), Positives = 37/57 (64%), Gaps = 3/57 (5%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+++VE +G G +G+VYK +++TG+ AIK++++ + E + +++LK+ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSH 71
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 14/94 (14%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSY--LIAGVSLLKELE 98
Y+ ++ IG G G V + TG+ VAIK ++ QN +Y L+ L+K +
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVN 73
Query: 99 HDNIVRLLDVLT------TGRYVYLVFEYLDLDL 126
H NI+ LL+V T + VYLV E +D +L
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANL 107
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 8e-04
Identities = 19/69 (27%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI----NIQNEPEGVPSYLIAGVSLLKEL 97
+ +++G G F Y+ +++TG +A+K + N +E E V L + L+ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 98 EHDNIVRLL 106
H +I+R+L
Sbjct: 61 NHPHIIRML 69
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 8e-04
Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 8/90 (8%)
Query: 49 IGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKELEHDNIVR 104
+G G FG V + A+K + ++ G ++ + +L+E H IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVK 57
Query: 105 LLDVLTTGRYVYLVFEY-LDLDLGSFIRKH 133
L +Y+Y++ EY L +L + +R
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDR 87
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.001
Identities = 16/39 (41%), Positives = 23/39 (58%), Gaps = 2/39 (5%)
Query: 145 VGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
VG+PY APE I+ Y D+W++G + EM G+P
Sbjct: 177 VGTPYWMAPEV-IKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.001
Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 2/39 (5%)
Query: 145 VGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
VG+PY APE I S ST D+W++GC E+++G P
Sbjct: 160 VGTPYWMAPEV-IEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (91), Expect = 0.001
Identities = 14/41 (34%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
VG+P Y +PE ++ Y+ D+W++GC+ E+ + K F
Sbjct: 164 VGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPF 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 24/87 (27%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD 107
KIG+G G V TGK+VA+K ++++ + L V ++++ H+N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYN 86
Query: 108 VLTTGRYVYLVFEYLDLDLGSFIRKHT 134
G +++V E+L+ + I HT
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT 113
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.001
Identities = 23/75 (30%), Positives = 33/75 (44%), Gaps = 4/75 (5%)
Query: 113 RYVYLVFEYLDLDLGSFIRKHTITSIRPHIKE--VGSP-YKAPESRIRSSVYSTPHDVWA 169
R YL + L + + + R VG+P Y APE +R + Y D W+
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV-LRGTPYGLECDWWS 215
Query: 170 VGCIFAEMVSGKPLF 184
+G I EM+ G P F
Sbjct: 216 LGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 26/82 (31%), Positives = 47/82 (57%), Gaps = 9/82 (10%)
Query: 44 KVVEKIGQGVFGEVYKCL-NLETGKKVAIKMINIQNEPEGV-PSYLIAGVSLLKELEHDN 101
++++K+G G FGEV+ N T KVA+K + +P + P + ++K+L HD
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNT--KVAVKTL----KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+L V++ +Y+V EY+
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMS 83
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 18/106 (16%)
Query: 47 EKIGQGVFGEVYKC--------------LNLETGKK--VAIKMINIQNEPEGVPSYLIAG 90
EK+G+G FGEV+ C N+ G+ VA+K++ + + + +
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARNDFLKE 69
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI 135
V +L L+ NI+RLL V + ++ EY++ DL F+ H +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHL 115
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 19/56 (33%), Positives = 28/56 (50%), Gaps = 7/56 (12%)
Query: 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPCGKK-----DHLSLIV 196
S Y APE RI+ + YS D+W++G E+ +G+ P P + L IV
Sbjct: 163 SSYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 14/36 (38%), Positives = 20/36 (55%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
Y+ PE + Y DVW+ GCI E+ + KP+F
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 38.2 bits (87), Expect = 0.002
Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 5/70 (7%)
Query: 121 YLDLDLGSFIRKHTITSIRPHIK--EVGSP-YKAPE--SRIRSSVYSTPHDVWAVGCIFA 175
+D L + TS P + VG+P Y APE + + S+ D+W++G
Sbjct: 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 176 EMVSGKPLFP 185
E+++G P F
Sbjct: 203 ELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.002
Identities = 16/41 (39%), Positives = 24/41 (58%), Gaps = 2/41 (4%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
VG+ Y +PE + D+WA+GCI +M++GKP F
Sbjct: 183 VGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 26/132 (19%)
Query: 23 YKVVKKTNGSE-------QMEKVKDW-----NYKVVEKIGQGVFGEVYKCLNLETGK--- 67
+KV++ NG+E Q+ W N + +G G FG+V + K
Sbjct: 5 WKVIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDA 64
Query: 68 --KVAIKMINIQNEPEGVPSYLIAGVSLLKEL----EHDNIVRLLDVLTTGRYVYLVFEY 121
KVA+KM+ +P S A +S LK + H+NIV LL T G + ++ EY
Sbjct: 65 VMKVAVKML----KPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEY 120
Query: 122 LDL-DLGSFIRK 132
DL +F+R+
Sbjct: 121 CCYGDLLNFLRR 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 21/62 (33%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 64 ETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDNIVRLLDVLTTG-RYVYLVFE 120
TG +VAIK++ + PE +L L H NIV LLD ++ VFE
Sbjct: 1 MTGHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 121 YL 122
Y+
Sbjct: 60 YV 61
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV-PSYLIAGVSLLKELEHDNIVRLL 106
K+GQG FGEV+ +VAIK + +P + P + ++K+L H+ +V+L
Sbjct: 13 KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 107 DVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIR-PHIKEVGS 147
V++ +Y+V EY+ L F++ +R P + ++ +
Sbjct: 68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.002
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 47 EKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+++G G FG V K + L K VA+K + ++ G +L S++ +L+H IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIV 59
Query: 104 RLLDVLTTGRYVYLVFEYLDLD-LGSFIRKHTITS 137
RL+ V G + LV E L L +++K
Sbjct: 60 RLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIP 93
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 47 EKIGQGVFGEVYKC------------LNLETGKK--VAIKMINIQNEPEGVPSYLIAGVS 92
EK+G+G FGEV+ C G+ VA+KM+ +L +
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69
Query: 93 LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITS 137
++ L++ NI+RLL V + + ++ EY++ DL F+ + I S
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES 115
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.003
Identities = 20/60 (33%), Positives = 34/60 (56%), Gaps = 6/60 (10%)
Query: 139 RPHIKEVGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
RP ++ GS + APE ++ + Y+ D+W++GC+ EM++GK FP L I +
Sbjct: 169 RPSLQ--GSVFWMAPEV-VKQTSYTRKADIWSLGCLVVEMLTGKHPFP--DCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 2/39 (5%)
Query: 145 VGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
VG+PY APE I + Y T D+W++G + EMV G+P
Sbjct: 178 VGTPYWMAPEV-ISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 20/106 (18%)
Query: 43 YKVVEKIGQGVFGEVYKC-LNLETGKKVAIKMINIQNEPEGVP----------------- 84
++V++ + G FG+++ C L T + A + +N N+ G P
Sbjct: 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQ--GKPKCERLIAKRVKAGSRAA 207
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFI 130
L + L L H+NI+++ ++L + Y++ + D DL SF+
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
|
Length = 501 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 29/108 (26%), Positives = 55/108 (50%), Gaps = 19/108 (17%)
Query: 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIAGVSL 93
+K+ + ++ +G G FG VYK + + G+K VAIK++ + P+ A +
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-------ANKEI 56
Query: 94 LKE------LEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHT 134
L E ++H ++VRLL + + + V L+ + + L L ++R H
Sbjct: 57 LDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHK 103
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEH 99
+++ ++ IG+G FGEV +TG A+K + E E V +++ A +L E ++
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQV-AHVRAERDILAEADN 60
Query: 100 DNIVRLLDVLTTGRYVYLVFEYL---DLDLGSFIRKHTIT 136
+V+L Y+YL+ EYL D+ + ++K T T
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDM-MTLLMKKDTFT 99
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 37.4 bits (86), Expect = 0.003
Identities = 17/57 (29%), Positives = 37/57 (64%), Gaps = 3/57 (5%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+++VE +G G +G+VYK +++TG+ AIK++++ + E + +++LK+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSH 61
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.003
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 49 IGQGVFGEVYKCLNLETGKK-----VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+G+G FG+V K + VA+KM+ + L++ +LLK++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131
+L + + L+ EY L SF+R
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLR 95
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.003
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 22/107 (20%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV-------PS 85
+ E V Y V++ + G G V+ VA K +P+ V +
Sbjct: 58 KAREVVASLGYTVIKTLTPGSEGRVF----------VATK----PGQPDPVVLKIGQKGT 103
Query: 86 YLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
LI + LL+ + H +++R+ D L +G +V + DL +++ K
Sbjct: 104 TLIEAM-LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK 149
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.004
Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 9/85 (10%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
++++E IG+G +G+VYK N + G A+K+++ ++ V + A ++L+ L H
Sbjct: 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHP 79
Query: 101 NIVRLLDVL-----TTGRYVYLVFE 120
N+V+ + G ++LV E
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLE 104
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.004
Identities = 25/79 (31%), Positives = 44/79 (55%), Gaps = 8/79 (10%)
Query: 44 KVVEKIGQGVFGEVYKCL-NLETGKKVAIKMINIQNEPEGV-PSYLIAGVSLLKELEHDN 101
+++ K+G G FGEV++ L N T VA+K + +P + P +A ++K+L H
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPK 62
Query: 102 IVRLLDVLTTGRYVYLVFE 120
+++L V T +Y+V E
Sbjct: 63 LIQLYAVCTLEEPIYIVTE 81
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.004
Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 5/43 (11%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191
Y APE ++ YS P D +A+GC EMV+G+ F KDH
Sbjct: 160 YMAPEI-LKEEPYSYPVDWFAMGCSIYEMVAGRTPF----KDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 218 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.91 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.89 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.88 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.88 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.88 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.88 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.88 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.88 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.87 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.87 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.87 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.87 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.87 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.87 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.87 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.87 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.87 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.87 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.86 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.86 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.86 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.86 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.86 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.86 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.86 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.85 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.85 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.85 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.85 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.85 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.85 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.85 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.85 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.85 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.84 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.84 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.84 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.84 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.84 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.84 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.83 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.83 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.83 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.82 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.81 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.81 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.81 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.8 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.79 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.79 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.78 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.78 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.77 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.77 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.75 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.74 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.74 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.71 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.69 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.68 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.67 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.64 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.6 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.59 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.58 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.54 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.52 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.5 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.43 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.41 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.36 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.28 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.17 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.16 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.1 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.05 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 98.96 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.68 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.64 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.6 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.49 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.42 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.4 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.37 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.3 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.17 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.17 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.1 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.99 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.99 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.97 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.93 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.76 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.49 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.08 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 96.93 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 96.92 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 96.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.03 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 94.98 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 94.72 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 94.66 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 94.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 94.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 93.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 93.41 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 92.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 92.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 90.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 89.97 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 89.86 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 89.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 85.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 85.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 85.29 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 85.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 83.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 82.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 80.05 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=230.29 Aligned_cols=159 Identities=35% Similarity=0.629 Sum_probs=136.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|.+.+.||+|+||+||+|+++.++..||||.+.+........+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999999999999999999877666677888999999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccc-----------------cccccCCc------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRP-----------------HIKEVGSP------ 148 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------------~~~~~g~~------ 148 (218)
|||++ +|.+|+..++.. |.+| ++++||.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99996 999999987543 3333 34455443
Q ss_pred -----------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 041487 149 -----------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF 199 (218)
Q Consensus 149 -----------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~ 199 (218)
|||||+ .....|+.++|+||+|+++|++++|+.||+..+...+...++..
T Consensus 169 ~~a~tlcGSplYMAPEV-~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEV-IMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred hHHHHhhCCccccCHHH-HHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 999995 44556999999999999999999999999987777777766654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=209.52 Aligned_cols=164 Identities=35% Similarity=0.625 Sum_probs=141.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.|+.+..+|+|+||.|++|+++++|+.||||.+.....+....+...+|+.+|+.++|+|+|.++++|+....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57888999999999999999999999999999997665666777889999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Ccccccc-----------ccCC--------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHIK-----------EVGS-------------- 147 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~~-----------~~g~-------------- 147 (218)
||+.++.+-+...+.. +++|.+. +||.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 9997776665544332 6666542 1222
Q ss_pred ----cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc
Q 041487 148 ----PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN 204 (218)
Q Consensus 148 ----~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~ 204 (218)
.|.|||.+..+..|+.++||||+||++.||++|++.|++. +.+.+..+++.+|..++
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 2999999898899999999999999999999999999998 89999999999887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=214.13 Aligned_cols=170 Identities=36% Similarity=0.704 Sum_probs=146.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVY 116 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 116 (218)
..+.|+-+++||+|.||.||+|++..+|..||+|.++.......-.....+|+.+|++++||||+++.++.... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 45568889999999999999999999999999999997777777788999999999999999999999998655 7999
Q ss_pred EEEecCCCChHHHhhhcccC----------------------------Ccc-----------ccccccCCc---------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT----------------------------SIR-----------PHIKEVGSP--------- 148 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~----------------------------~~~-----------~~~~~~g~~--------- 148 (218)
+|+|||+.+|..++...... |++ .++.+||.+
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 99999998888777654332 222 233455543
Q ss_pred ----------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcccchh
Q 041487 149 ----------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 149 ----------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
|.|||.+.+...|++.+|+||+||+|.||++|++.|.+. +.+++..|.+.+|.|.... |+
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~-W~ 345 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY-WP 345 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc-cc
Confidence 999998888888999999999999999999999999998 8999999999999998766 44
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=213.41 Aligned_cols=176 Identities=22% Similarity=0.416 Sum_probs=139.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..|...+.||+|+|+.||.+++..+|+.||+|++++.. .+....+.+.+|+++++.++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 66999999999999999999999999999999998765 45677889999999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC--------------------------------------Cccccccc----------------
Q 041487 120 EYLDL-DLGSFIRKHTIT--------------------------------------SIRPHIKE---------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~--------------------------------------~~~~~~~~---------------- 144 (218)
|+|.. +|..+.+..... ....++.+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99986 777776643221 22223333
Q ss_pred -cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh-cccCc--ccchhhhhhhccc
Q 041487 145 -VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF-TALTN--YLVLPCFLSIMLL 217 (218)
Q Consensus 145 -~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~ 217 (218)
+|++ |.|||++...+ .+..+||||+||++|-|++|++||...+.......++.. ...|. +....+.+..||+
T Consensus 178 lCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 4544 99999777444 899999999999999999999999988555555555443 33333 4444567777765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=218.80 Aligned_cols=172 Identities=30% Similarity=0.467 Sum_probs=139.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+...+.+.+|++++++++||||++++++|.....+|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999999999999999998877777778899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC---------------------------Ccccccc-----------c-----------------c
Q 041487 121 YLDLDLGSFIRKHTIT---------------------------SIRPHIK-----------E-----------------V 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~---------------------------~~~~~~~-----------~-----------------~ 145 (218)
||.++|..++...+.. +++|.+. + -
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsik 161 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIK 161 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeecc
Confidence 9988887777554332 4444331 1 1
Q ss_pred CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCcccchhhhhh
Q 041487 146 GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLVLPCFLS 213 (218)
Q Consensus 146 g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (218)
|++ ||||| +..+++|+..+|.||+||++||+++|++||.......+.+.+..-...+++...++|.+
T Consensus 162 GtPlYmAPE-lv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 162 GTPLYMAPE-LVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN 229 (808)
T ss_pred CcccccCHH-HHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence 333 99999 56688899999999999999999999999988766666666554333344444444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=202.80 Aligned_cols=163 Identities=26% Similarity=0.435 Sum_probs=132.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
....++|+++++||+|+||+|++++.+++++.+|+|++++... .....++...|..++.+++||+||.++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 4668999999999999999999999999999999999987763 345678899999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-------------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------------------- 142 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------------------- 142 (218)
|+|+||+.| .|.-.+...+.- +.+|.+
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999987 555444432221 333332
Q ss_pred ---cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhc
Q 041487 143 ---KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFT 200 (218)
Q Consensus 143 ---~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~ 200 (218)
..+|++ |||||.+... .|+..+|.||||+++|+|++|.+||.+.+...+...+....
T Consensus 181 ~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred ccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 334544 9999966655 59999999999999999999999999987666655555433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=205.67 Aligned_cols=164 Identities=32% Similarity=0.484 Sum_probs=135.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeee-eEEeCCE-E
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD-VLTTGRY-V 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~ 115 (218)
....+|+++++||+|+||.||++.+..+|..+|.|.+.-...+....+.+..|+.+|+.++|||||++++ .|.++.. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3456799999999999999999999999999999999866677777889999999999999999999999 5666555 9
Q ss_pred EEEEecCCC-ChHHHhhhcccC-----------------------------------Ccccccc----------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT-----------------------------------SIRPHIK---------------- 143 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~-----------------------------------~~~~~~~---------------- 143 (218)
+|+||+|+. +|++.++..... +++|.+.
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999986 888877542211 4444331
Q ss_pred ------------ccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc
Q 041487 144 ------------EVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 144 ------------~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
..|+| ||+|| ++....|+.++||||+||++|||+.-++||.+.+-..+...+....-+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE-~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPE-RIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP 246 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHH-HHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence 13444 89999 566666999999999999999999999999999888888888875443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=191.40 Aligned_cols=170 Identities=39% Similarity=0.674 Sum_probs=145.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.|..++.+|+|.||.||+|++..+|+.||||.++.....+.......+|+..|+.++|+||+.++++|-..+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788899999999999999999999999999998776666666788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccccc-----------cccCCc-------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVGSP------------- 148 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~~------------- 148 (218)
|++.+|...++..... |++|.+ .+||.+
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence 9998888887765432 444432 344332
Q ss_pred -----ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcccchhhh
Q 041487 149 -----YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNYLVLPCF 211 (218)
Q Consensus 149 -----y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 211 (218)
|.|||.+++.+.|+..+|+||.||++.||+.|.+-|++. +.+++..+.+.+|.|.+. .||++
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~-~WP~~ 229 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD-QWPEM 229 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc-cCccc
Confidence 999999999999999999999999999999999999998 899999999998887543 44443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=205.40 Aligned_cols=159 Identities=27% Similarity=0.498 Sum_probs=127.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|.+++.||+|+||.||+|+.+.+|..+|+|++++.. ....+.++...|-.+|...++|+||+++..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456789999999999999999999999999999999998776 4567789999999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-------------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------------------- 142 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------------------- 142 (218)
|+||||++| ++.-.+...... +++|.+
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999964 443333322211 111110
Q ss_pred --------------------------------------------------cccCCc-ccCcccccCCCCCCCcchHHHHH
Q 041487 143 --------------------------------------------------KEVGSP-YKAPESRIRSSVYSTPHDVWAVG 171 (218)
Q Consensus 143 --------------------------------------------------~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG 171 (218)
+.+|+| |+|||++...+ |+..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHH
Confidence 123444 99999666555 99999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 172 CIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 172 ~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
|++|||+.|.+||.+.++....+.+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI 400 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKI 400 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999998655544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=201.49 Aligned_cols=169 Identities=30% Similarity=0.494 Sum_probs=132.2
Q ss_pred CCChhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-----CCchHHHHHHHHHHhhCCCCCee
Q 041487 29 TNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-----EGVPSYLIAGVSLLKELEHDNIV 103 (218)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv 103 (218)
.+++-..++...+.|.+.+.||.|+||.|-+|..+.+++.||||++.+.... ........+|+++|++++|||||
T Consensus 160 ~d~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV 239 (475)
T KOG0615|consen 160 RDSSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIV 239 (475)
T ss_pred chhccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEE
Confidence 3334445566788899999999999999999999999999999999764321 12334567999999999999999
Q ss_pred eeeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-------------
Q 041487 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------- 142 (218)
Q Consensus 104 ~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------- 142 (218)
+++++|......|+||||+++ .|-+++..+... +++|.+
T Consensus 240 ~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 240 RIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred EEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence 999999999999999999987 888887665432 444433
Q ss_pred -ccc----------------CCc-ccCcccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcch-HHHHHH
Q 041487 143 -KEV----------------GSP-YKAPESRIRSSV--YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH-LSLIVR 197 (218)
Q Consensus 143 -~~~----------------g~~-y~aPE~~~~~~~--~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~-~~~~~~ 197 (218)
.+| |++ |.|||++...+. +..++|+||+||+||-+++|.+||+....+. +...+.
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 333 433 999998877644 4458999999999999999999999873333 444443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=208.35 Aligned_cols=174 Identities=24% Similarity=0.387 Sum_probs=137.5
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....+....++.++.||+|.||.||.|..+ ....||+|.++.... ..+.|.+|+.+|++++|++||++++++..+.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 344466677888999999999999999972 345899999985433 3367889999999999999999999999988
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------------------CccccccccCCc----
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------------------SIRPHIKEVGSP---- 148 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------------~~~~~~~~~g~~---- 148 (218)
.++|||||+.. +|.+|++..... +...++++||.+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999986 999999973222 233355667765
Q ss_pred ---------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhhhh
Q 041487 149 ---------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPCFL 212 (218)
Q Consensus 149 ---------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (218)
|+|||.+..++ ++.++|||||||+|||++| |+.||++.........+.....++.+...|+.+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~v 433 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEV 433 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHH
Confidence 99999665555 9999999999999999999 999999995555555555556665555555544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=209.07 Aligned_cols=177 Identities=28% Similarity=0.385 Sum_probs=144.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecC-CCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ-NEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.+-|++.+.||.|+-|.|.+|+++.+|+.+|||++.+. ...+.+...+.+|+.+|+-+.|||++++|++|.++..+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46689999999999999999999999999999999876 46677788999999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccc-----------cccccCCc-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEVGSP----------- 148 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~g~~----------- 148 (218)
.||+++ .|-+|+..++.. +.+| ++++||.+
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 999987 888988776554 2222 23444443
Q ss_pred ------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhhcc
Q 041487 149 ------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSIML 216 (218)
Q Consensus 149 ------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 216 (218)
|.|||.+.+..+-+.++||||+||+||.|+||++||++.+...+...++......+ +....+.|..||
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 99999666556667889999999999999999999999998888888887443333 223334444444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=194.31 Aligned_cols=150 Identities=25% Similarity=0.428 Sum_probs=125.3
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-E
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-Y 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~ 114 (218)
..+..++.+.++.||+|+.|+|+++.++.++..+|+|.+. ...+....+.+.+|+++++.++||+||++|+.|.... .
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3455668888999999999999999999999999999994 3345566788999999999999999999999999888 5
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
++++||||++ +|++++...+.. |++|.+ .+||
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998 999988753221 445533 2232
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..||||| .+++..|+.++||||||++++|+++|+.||...
T Consensus 233 ~a~tfvGT~~YMsPE-Ri~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPE-RISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hcccccccccccChh-hhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 2399999 567777999999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=188.56 Aligned_cols=160 Identities=26% Similarity=0.411 Sum_probs=132.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++++.||.|+||.|.+++++.++..+|+|++.+.. ..-.+.++..+|..+|+.+.||+++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999998654 34466889999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc-------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE------------- 144 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~------------- 144 (218)
+||||+++ -|-.++++.+.- +.+|++ .+
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T 200 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT 200 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence 99999987 666666653321 333332 22
Q ss_pred -cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 -VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 -~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+|++ |+||| +++.+.|+.++|.|||||++|||+.|.+||...+...+...+..
T Consensus 201 lCGTPeYLAPE-ii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 201 LCGTPEYLAPE-IIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred ecCCccccChH-HhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 4544 99999 56677799999999999999999999999998866666555543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=204.16 Aligned_cols=161 Identities=22% Similarity=0.384 Sum_probs=129.7
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
.+..++|.++++||+|+||+|+++..+.+++.+|||.+++.. ..++..+....|..++... +||+++.++.+|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 567889999999999999999999999999999999999876 5567788899999998888 59999999999999999
Q ss_pred EEEEEecCCC-ChHHHhh------------------------hcccC--Cc----------------------------c
Q 041487 115 VYLVFEYLDL-DLGSFIR------------------------KHTIT--SI----------------------------R 139 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~------------------------~~~~~--~~----------------------------~ 139 (218)
+|+||||+.| ++..+.. .++.. |. .
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9999999965 3222221 11110 11 1
Q ss_pred ccccccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 140 PHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 140 ~~~~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.....+|++ |+|||. ..+..|+.++|.|||||++|||+.|+.||++.+-+.+..-+..
T Consensus 524 ~TsTfCGTpey~aPEi-l~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEV-LTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred ccccccCChhhcChhh-hccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 112344555 999995 5555699999999999999999999999999987777776664
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=205.22 Aligned_cols=210 Identities=20% Similarity=0.263 Sum_probs=168.7
Q ss_pred hHHHHHHHHhhhhhhhhcccc-ccCCChhhhhhhhccceeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecC-CC
Q 041487 6 QIHDLFRTNMKKVKDCCYKVV-KKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQ-NE 79 (218)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~-~~ 79 (218)
.+.+++..++.....+..... ...+-..+..++.+++-.+.++||+|+||.||+|..+..+ ..||+|..+.. ..
T Consensus 121 si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 121 TISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred cHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 346677777777776666555 5666668889999999999999999999999999976542 23899998753 35
Q ss_pred CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC----------------------
Q 041487 80 PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------- 136 (218)
Q Consensus 80 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------- 136 (218)
.......+.+|+++++.++|||||++||+...+..+++|||+|.+ +|.+|+++....
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 667788999999999999999999999999999999999999998 999999987631
Q ss_pred -----------------CccccccccCCc------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-C
Q 041487 137 -----------------SIRPHIKEVGSP------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-G 180 (218)
Q Consensus 137 -----------------~~~~~~~~~g~~------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g 180 (218)
...+++++||.. |+|||.+..+ .|+.++|||||||++||+++ |
T Consensus 281 k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccC
Confidence 122355666543 9999965555 79999999999999999999 8
Q ss_pred CCCCCCCCcchHHHHH-HHhcccCcccchhhhhhhcc
Q 041487 181 KPLFPCGKKDHLSLIV-RYFTALTNYLVLPCFLSIML 216 (218)
Q Consensus 181 ~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 216 (218)
..||.+.....+...+ ....+.+.+...|..+..++
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVM 396 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHH
Confidence 9999999666666666 65667777777777776554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=198.61 Aligned_cols=179 Identities=25% Similarity=0.422 Sum_probs=140.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
.....+|.+.+.||+|+|++|++|+++.++..+|||++.+.. ..+...+...+|-.+|..+ .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 556788999999999999999999999999999999998765 3445567788899999999 89999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV---------- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~---------- 145 (218)
+|+|+||++. +|.++|.+.+.- |++|+ +.+|
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999986 899988876543 33332 2333
Q ss_pred --------------------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh-cccC
Q 041487 146 --------------------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF-TALT 203 (218)
Q Consensus 146 --------------------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~-~~~~ 203 (218)
|++ |.+|| +..++..++.+|||+|||++|.|+.|++||-..+...+.+.+..+ ...+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPE-lL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPE-LLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHH-HhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 332 99999 566666899999999999999999999999988666655555543 3333
Q ss_pred c--ccchhhhhhhcc
Q 041487 204 N--YLVLPCFLSIML 216 (218)
Q Consensus 204 ~--~~~~~~~~~~~l 216 (218)
+ +....+.+.++|
T Consensus 308 ~~fp~~a~dLv~KLL 322 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLL 322 (604)
T ss_pred CCCCHHHHHHHHHHH
Confidence 3 233344444444
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=188.45 Aligned_cols=165 Identities=32% Similarity=0.622 Sum_probs=137.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 118 (218)
+.|+.++.|++|+||.||+|+++.+++.||+|.++.........-.-.+|+.+|.+++|||||.+-++.. .-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4588899999999999999999999999999999866555555667889999999999999999999875 34569999
Q ss_pred EecCCCChHHHhhhcccC----------------------------Cccc-----------cccccCCc-----------
Q 041487 119 FEYLDLDLGSFIRKHTIT----------------------------SIRP-----------HIKEVGSP----------- 148 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~----------------------------~~~~-----------~~~~~g~~----------- 148 (218)
||||+.+|...+..-... |.++ ++.+||.+
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T 235 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYT 235 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCc
Confidence 999987776665442211 2222 23445543
Q ss_pred -------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 149 -------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 -------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
|.|||.+.....|+.+.|+||+||++.|++++++.|++. +.+.+.++.+.+|.|...
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999998888888999999999999999999999999998 899999999998887654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=201.67 Aligned_cols=168 Identities=35% Similarity=0.603 Sum_probs=144.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCC-EE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGR-YV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~ 115 (218)
+..++|+++++||.|.||.||+|+.+.++..||||.+++..-.. ..-.-.||+..|++++ ||||+++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45688999999999999999999999999999999998665443 2234568999999998 999999999999888 99
Q ss_pred EEEEecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccCCc--------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVGSP-------- 148 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g~~-------- 148 (218)
|+|||||+..|.+.++.+... |.+|+ +++||.+
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999999999988776332 44443 3556654
Q ss_pred ---------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCccc
Q 041487 149 ---------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNYL 206 (218)
Q Consensus 149 ---------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~ 206 (218)
|.|||++.+...|+.+.|+|++||+++|+++-++.|+|. +.+.+.++.+.+|.|....
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 999999999999999999999999999999999999999 8999999999999886643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=200.58 Aligned_cols=162 Identities=33% Similarity=0.613 Sum_probs=135.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-C-----CCeeeeeeeEEeCC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-H-----DNIVRLLDVLTTGR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~ 113 (218)
..+|.+.+.||+|+||+|.+|.+..+++.||||+++. ..........|+.+|..++ | -|+|+++++|..++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3468999999999999999999999999999999973 3334455667888888875 3 37999999999999
Q ss_pred EEEEEEecCCCChHHHhhhcccC-----------------------------Cccc-------------cccccCCc---
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRP-------------HIKEVGSP--- 148 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~-------------~~~~~g~~--- 148 (218)
++|||.|..+-+|.+|++...-. |.+| ++.+||++
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999999999999875443 3333 34567765
Q ss_pred ------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 149 ------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 ------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
|.|||++ -+.+|+.+.|+|||||+++||++|.+.|++. +.+.+..+++.+|.|++.
T Consensus 342 ~q~vytYiQSRfYRAPEVI-LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVI-LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred CCcceeeeeccccccchhh-ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999954 4666999999999999999999999999998 889999999999977653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=183.11 Aligned_cols=159 Identities=40% Similarity=0.706 Sum_probs=125.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|.+.+.||+|+||.||+|.++.++..||+|.++... .......+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 3578999999999999999999999999999999987543 223345678999999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC-------------
Q 041487 119 FEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
|||++++|.+++...... +++|. +.++|
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 999999998887653221 22221 12222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHH
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRY 198 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~ 198 (218)
..|+|||.+.+...++.++||||+||++|+|++|+.||.+.+. +.+..+.+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 2399999766666689999999999999999999999987743 333344333
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=189.01 Aligned_cols=181 Identities=28% Similarity=0.449 Sum_probs=137.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTG 112 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 112 (218)
....++|.+.+.||+|+||+|+.|.+..++..||+|++.+.... ....+.+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35678999999999999999999999999999999987764221 245677889999999998 99999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccc------------ccccc-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP------------HIKEV------- 145 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~------------~~~~~------- 145 (218)
..+++|||||.+ .|.+++...+.. |+++ ++.+|
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999997 999999874332 1221 12222
Q ss_pred ----------CC-cccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh-cccCc---ccchh
Q 041487 146 ----------GS-PYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF-TALTN---YLVLP 209 (218)
Q Consensus 146 ----------g~-~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~-~~~~~---~~~~~ 209 (218)
|+ +|+|||.+.... +-+.++||||+||+||.|++|+.||+..+...+...+... ...+. +...-
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence 32 399999666555 4558899999999999999999999987666666654432 22222 33445
Q ss_pred hhhhhccc
Q 041487 210 CFLSIMLL 217 (218)
Q Consensus 210 ~~~~~~l~ 217 (218)
++++.||.
T Consensus 253 ~Li~~mL~ 260 (370)
T KOG0583|consen 253 SLIEKMLV 260 (370)
T ss_pred HHHHHHcC
Confidence 55666654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=188.40 Aligned_cols=182 Identities=22% Similarity=0.267 Sum_probs=135.1
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
...+..++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+.+|+.++++++||||+++++++...+
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34456788999999999999999999999999999999997543 23344677899999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------- 146 (218)
..+++|||+.+ +|.+++...... +++|. +.++|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999987 888887654321 22222 12222
Q ss_pred ------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc-C--cccchhhhhhhcc
Q 041487 147 ------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL-T--NYLVLPCFLSIML 216 (218)
Q Consensus 147 ------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l 216 (218)
+ .|+|||.+ .+..++.++|||||||++|+|++|+.||...+.......+...... + .+..+.+++..||
T Consensus 172 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred cceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHh
Confidence 2 39999954 4555899999999999999999999999876554444443322111 1 1223445666665
Q ss_pred c
Q 041487 217 L 217 (218)
Q Consensus 217 ~ 217 (218)
+
T Consensus 251 ~ 251 (329)
T PTZ00263 251 Q 251 (329)
T ss_pred h
Confidence 3
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=185.57 Aligned_cols=176 Identities=23% Similarity=0.326 Sum_probs=131.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.++.+++.+|+|.+..... .....+.+.+|+.+++.++||||+++++.+.+...++++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999998999999999875432 2234567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+++ +|.+++...... +++|. +.++|
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g 160 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence 99987 898887654321 22221 12222
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc---Ccccchhhhhhhccc
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL---TNYLVLPCFLSIMLL 217 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 217 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||...+...+...+...... ..+..+-+++..||+
T Consensus 161 t~~y~aPE~-~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 161 TPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ChhhcCHHH-HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 23999995 45555899999999999999999999999887555444443332111 113344456666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=188.79 Aligned_cols=184 Identities=20% Similarity=0.291 Sum_probs=136.0
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCC-cEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETG-KKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
.....+..++|++.+.||+|+||.||+|.++..+ ..||+|.+.+.. ......+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 4445577889999999999999999999876554 689999987543 23345677889999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC-----
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG----- 146 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g----- 146 (218)
.....++||||+.+ +|.+++...... +++|. +.++|
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999976 888888654321 22221 12222
Q ss_pred ---------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhc---ccCcccchhhhhh
Q 041487 147 ---------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFT---ALTNYLVLPCFLS 213 (218)
Q Consensus 147 ---------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 213 (218)
+ .|+|||.+ .+..++.++|||||||++|+|++|+.||...+.......+.... +...+....++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 260 (340)
T PTZ00426 182 DTRTYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260 (340)
T ss_pred CCCcceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 2 39999965 45558899999999999999999999999876554444433221 1112334456666
Q ss_pred hccc
Q 041487 214 IMLL 217 (218)
Q Consensus 214 ~~l~ 217 (218)
.||+
T Consensus 261 ~~l~ 264 (340)
T PTZ00426 261 KLLS 264 (340)
T ss_pred HHcc
Confidence 6664
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=207.06 Aligned_cols=164 Identities=28% Similarity=0.467 Sum_probs=127.8
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD 107 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (218)
.....+...+....+.||+|+||.||+|+.- .....||||.++.. .+....+.|.+|++++..++|||||++++
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3344466677888999999999999999854 24567999998743 23335789999999999999999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC--------------------------------------------------
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------------- 136 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------------- 136 (218)
+|..++.+++|+|||.. +|.+|+..+...
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 99999999999999986 999999765432
Q ss_pred --CccccccccCCc--------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 041487 137 --SIRPHIKEVGSP--------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLS 193 (218)
Q Consensus 137 --~~~~~~~~~g~~--------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~ 193 (218)
....+++++|.. ||+||.+. .+.++..+|||||||+|||+++ |+.||.+...+..-
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 111122334332 99999655 4559999999999999999999 99999998444444
Q ss_pred HHHHH
Q 041487 194 LIVRY 198 (218)
Q Consensus 194 ~~~~~ 198 (218)
..++.
T Consensus 716 e~i~~ 720 (774)
T KOG1026|consen 716 ECIRA 720 (774)
T ss_pred HHHHc
Confidence 44443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=181.82 Aligned_cols=147 Identities=41% Similarity=0.696 Sum_probs=119.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.++..||+|.++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 5789999999999999999999988999999999875432 223456778999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+.++|.+++...... +++|. +.++|
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 99998988887654211 22221 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++||||+||++|+|++|+.||.+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23999997666666889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=185.54 Aligned_cols=159 Identities=36% Similarity=0.639 Sum_probs=131.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RYV 115 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 115 (218)
=.|...+++|.|+||.||+|....+++.+|||..-.. . +.-.+|+++|+.++|||||++..+|... -++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d---~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD---K---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC---C---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3588899999999999999999999999999986422 1 2344799999999999999999888522 257
Q ss_pred EEEEecCCCChHHHhhhc-----ccC--------------------------Cccccc------------cccCCc----
Q 041487 116 YLVFEYLDLDLGSFIRKH-----TIT--------------------------SIRPHI------------KEVGSP---- 148 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~-----~~~--------------------------~~~~~~------------~~~g~~---- 148 (218)
.+||||++.+|.++++.. ... |++|.+ .+||++
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 899999999999988742 111 555543 456665
Q ss_pred -------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 149 -------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 -------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
|.|||.+++...|+.+.||||.||++.||+-|++.|+|. ..+++..+++.+|.|+..
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999998888888999999999999999999999999998 788999999999988753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=180.18 Aligned_cols=146 Identities=32% Similarity=0.623 Sum_probs=117.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||+|+++.+++.+|+|.+..........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999999999999999998655445556788899999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~---------------- 145 (218)
|+++++.+.+...... +++|. +.++
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 9988655544332110 11111 1111
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+. +..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 161 YVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 1 2399999654 455899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=187.57 Aligned_cols=153 Identities=25% Similarity=0.431 Sum_probs=121.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.++.+++.||+|++++.. ........+.+|+.++..++|++|+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997543 23344567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccc----------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKE---------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~---------------- 144 (218)
||+++ +|.+++...... +++|. +.+
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99987 888887654321 11111 111
Q ss_pred ------------------------------------cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 ------------------------------------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 ------------------------------------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+ .|+|||.+. +..++.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 222 399999654 555899999999999999999999999877
Q ss_pred CcchHHH
Q 041487 188 KKDHLSL 194 (218)
Q Consensus 188 ~~~~~~~ 194 (218)
+......
T Consensus 240 ~~~~~~~ 246 (363)
T cd05628 240 TPQETYK 246 (363)
T ss_pred CHHHHHH
Confidence 5544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=190.94 Aligned_cols=150 Identities=29% Similarity=0.441 Sum_probs=119.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++++.||+|+||.||++.+..+++.||+|.+.+.. ......+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986543 23345677889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccc----------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKE---------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~---------------- 144 (218)
||+++ +|.+++...... +++|. +.+
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99976 888877543221 22221 111
Q ss_pred ------------------------------------------------cCC-cccCcccccCCCCCCCcchHHHHHHHHH
Q 041487 145 ------------------------------------------------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFA 175 (218)
Q Consensus 145 ------------------------------------------------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~ 175 (218)
.|+ .|+|||.+ .+..++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEecchhhh
Confidence 132 39999954 4555899999999999999
Q ss_pred HHHhCCCCCCCCCcch
Q 041487 176 EMVSGKPLFPCGKKDH 191 (218)
Q Consensus 176 ~l~tg~~Pf~~~~~~~ 191 (218)
+|++|+.||...+...
T Consensus 240 elltG~~Pf~~~~~~~ 255 (377)
T cd05629 240 ECLIGWPPFCSENSHE 255 (377)
T ss_pred hhhcCCCCCCCCCHHH
Confidence 9999999998765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=189.11 Aligned_cols=149 Identities=25% Similarity=0.456 Sum_probs=120.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|++++.||+|+||.||+|.+..+++.||+|++++.. ......+.+.+|+.+++.++|+||+++++++.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5899999999999999999999999999999997643 334456788999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~---------------- 145 (218)
|+++ +|.+++...... +++|. +.++
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9976 888877553321 12111 1122
Q ss_pred ------------------------------------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHH
Q 041487 146 ------------------------------------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAE 176 (218)
Q Consensus 146 ------------------------------------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~ 176 (218)
| ..|+|||.+. +..++.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHHHH
Confidence 2 2499999654 4558999999999999999
Q ss_pred HHhCCCCCCCCCcch
Q 041487 177 MVSGKPLFPCGKKDH 191 (218)
Q Consensus 177 l~tg~~Pf~~~~~~~ 191 (218)
|++|+.||...+...
T Consensus 241 lltG~~Pf~~~~~~~ 255 (381)
T cd05626 241 MLVGQPPFLAPTPTE 255 (381)
T ss_pred HHhCCCCCcCCCHHH
Confidence 999999998765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=184.79 Aligned_cols=152 Identities=23% Similarity=0.487 Sum_probs=122.1
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.+..+++.||+|++++... .......+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 469999999999999999999999999999999975432 2244567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+++ +|.+++...... ++++. +.++|
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 99987 999888654321 22221 12222
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
..|+|||.+. +..++.++|||||||++|+|++|+.||...+.....
T Consensus 161 t~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 161 SPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred CccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 2399999554 446899999999999999999999999887554443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=186.77 Aligned_cols=179 Identities=25% Similarity=0.303 Sum_probs=132.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcE-EEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
....++.....+.+.||.|+||+||+|.. .|.. ||+|++..........+.|.+|+.++.+++|||||++++++...
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34556677778888899999999999988 5555 99999986554444478999999999999999999999999877
Q ss_pred C-EEEEEEecCCC-ChHHHhhhc--ccC----------------------C------c------------cccccccCC-
Q 041487 113 R-YVYLVFEYLDL-DLGSFIRKH--TIT----------------------S------I------------RPHIKEVGS- 147 (218)
Q Consensus 113 ~-~~~lv~E~~~~-~L~~~~~~~--~~~----------------------~------~------------~~~~~~~g~- 147 (218)
. .+++||||+++ +|.+++... ... . . ..++.+||.
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 79999999987 999988662 111 0 0 112233332
Q ss_pred -----------------cccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH-HHHHHhcccCcccch
Q 041487 148 -----------------PYKAPESRIR-SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS-LIVRYFTALTNYLVL 208 (218)
Q Consensus 148 -----------------~y~aPE~~~~-~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~ 208 (218)
.|||||.+.+ ...|+.++||||||+++|||+||+.||......... .++.....++.+...
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 3999996554 467999999999999999999999999988553333 333333444434434
Q ss_pred hhhhhh
Q 041487 209 PCFLSI 214 (218)
Q Consensus 209 ~~~~~~ 214 (218)
|..+..
T Consensus 272 ~~~l~~ 277 (362)
T KOG0192|consen 272 PPHLSS 277 (362)
T ss_pred CHHHHH
Confidence 444433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=189.81 Aligned_cols=151 Identities=26% Similarity=0.438 Sum_probs=121.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++++.||+|+||.||+|++..+++.||+|++.+.. ......+.+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986533 22344677889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~--------------- 145 (218)
||+++ +|.+++...... +++|. +.++
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99986 888887654321 22221 1222
Q ss_pred ---------------------------------------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHh
Q 041487 146 ---------------------------------------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS 179 (218)
Q Consensus 146 ---------------------------------------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t 179 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeeehhh
Confidence 22 49999954 45558999999999999999999
Q ss_pred CCCCCCCCCcchH
Q 041487 180 GKPLFPCGKKDHL 192 (218)
Q Consensus 180 g~~Pf~~~~~~~~ 192 (218)
|+.||...+....
T Consensus 240 G~~Pf~~~~~~~~ 252 (376)
T cd05598 240 GQPPFLADTPAET 252 (376)
T ss_pred CCCCCCCCCHHHH
Confidence 9999988754433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=187.20 Aligned_cols=160 Identities=23% Similarity=0.405 Sum_probs=132.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
...+|.+.+.||+|.||.|-+|.....|+.||||.+++.... ..+.-++.+|+++|..++||||+.+|++|.+.+.++|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456799999999999999999999899999999999876643 4557789999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC--------------------------------------Cccccccc--------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT--------------------------------------SIRPHIKE-------------- 144 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~--------------------------------------~~~~~~~~-------------- 144 (218)
||||..+ .|+||+...+.. ....++.+
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 9999987 999999876553 11112233
Q ss_pred --cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 --VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 --~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+|++ |.+||.+.+..+-++.+|-||||++||-++-|..||++.+...+.+.+..
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~ 267 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR 267 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc
Confidence 3444 77788444444456789999999999999999999999988887776664
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=187.28 Aligned_cols=150 Identities=27% Similarity=0.462 Sum_probs=120.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++++.||+|+||.||+|++..+++.||+|++++.. ........+.+|+.+++.++||||+++++.+.....+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997543 23345567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~--------------- 145 (218)
||+.+ +|.+++...... +++|.+ .++
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99976 888887654321 222211 111
Q ss_pred ----------------------------------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 041487 146 ----------------------------------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184 (218)
Q Consensus 146 ----------------------------------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf 184 (218)
|+ .|+|||.+ ....++.++|||||||++|+|++|+.||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 22 49999955 4555899999999999999999999999
Q ss_pred CCCCcch
Q 041487 185 PCGKKDH 191 (218)
Q Consensus 185 ~~~~~~~ 191 (218)
...+...
T Consensus 240 ~~~~~~~ 246 (364)
T cd05599 240 CSDNPQE 246 (364)
T ss_pred CCCCHHH
Confidence 8765433
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=181.72 Aligned_cols=165 Identities=38% Similarity=0.630 Sum_probs=137.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-----CCE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-----GRY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 114 (218)
...|..++.||+|+||.|+.|.++.+|..||||.+..........++..+|+.+++.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445666899999999999999999999999999887555566678899999999999999999999999875 346
Q ss_pred EEEEEecCCCChHHHhhhccc-C--------------------------Ccccc-----------ccccCC---------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTI-T--------------------------SIRPH-----------IKEVGS--------- 147 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~-~--------------------------~~~~~-----------~~~~g~--------- 147 (218)
+|+|+|+|+.+|.+.++.... . +.+|. +-+||.
T Consensus 101 vYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred eEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 999999999888888877652 2 22332 223332
Q ss_pred -----------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc
Q 041487 148 -----------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN 204 (218)
Q Consensus 148 -----------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~ 204 (218)
.|.|||.+.....|+...||||+||++.||++|++.|+|. ..+++..+...+|.|++
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 2999998888888999999999999999999999999998 67788888888777754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=186.87 Aligned_cols=149 Identities=26% Similarity=0.441 Sum_probs=119.6
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|.+++.||+|+||.||+|.+..+++.+|+|.+.+.. ......+.+.+|+.+++.++|+||+++++.+.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5899999999999999999999999999999987543 233446788899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~---------------- 145 (218)
|+++ +|.+++...... +++|. +.++
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9987 888877553221 11211 1222
Q ss_pred ------------------------------------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHH
Q 041487 146 ------------------------------------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAE 176 (218)
Q Consensus 146 ------------------------------------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~ 176 (218)
| ..|+|||.+ .+..++.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEechHHHHH
Confidence 2 239999955 45558999999999999999
Q ss_pred HHhCCCCCCCCCcch
Q 041487 177 MVSGKPLFPCGKKDH 191 (218)
Q Consensus 177 l~tg~~Pf~~~~~~~ 191 (218)
|++|+.||...+...
T Consensus 241 lltG~~Pf~~~~~~~ 255 (382)
T cd05625 241 MLVGQPPFLAQTPLE 255 (382)
T ss_pred HHhCCCCCCCCCHHH
Confidence 999999998775443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=177.69 Aligned_cols=165 Identities=45% Similarity=0.762 Sum_probs=140.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC-eeeeeeeEEeCC-----
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN-IVRLLDVLTTGR----- 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 113 (218)
...|..++.||+|.||.||+|+.+.+|+.||+|.++.....+.......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677788899999999999999999999999999866554567788899999999999999 999999998766
Q ss_pred -EEEEEEecCCCChHHHhhhccc---C----------------------------Cccccc-----------cccCCc--
Q 041487 114 -YVYLVFEYLDLDLGSFIRKHTI---T----------------------------SIRPHI-----------KEVGSP-- 148 (218)
Q Consensus 114 -~~~lv~E~~~~~L~~~~~~~~~---~----------------------------~~~~~~-----------~~~g~~-- 148 (218)
.+++|+||++.+|.+|+..... . |.+|++ ++||.+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 8999999999999999877552 1 444443 444433
Q ss_pred ----------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc
Q 041487 149 ----------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN 204 (218)
Q Consensus 149 ----------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~ 204 (218)
|.|||++.+...|+..+||||+||+++||+++++.|++. +.+.+..+.+.++.|..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 999999999888999999999999999999999999998 78888888888777644
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=176.68 Aligned_cols=158 Identities=43% Similarity=0.706 Sum_probs=123.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|.+.+.||+|+||.||+|.++.++..+|+|.++.... ......+.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 34779999999999999999999988999999999875432 23345677899999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 119 FEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
|||++++|.+++...... +++|. +.++
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 999998888877543221 22221 1222
Q ss_pred ----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHH
Q 041487 146 ----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197 (218)
Q Consensus 146 ----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~ 197 (218)
+..|+|||.+.....++.++|||||||++|+|+||+.||...+. +.+..+.+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22399999776666689999999999999999999999987743 33333333
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=199.83 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=141.1
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCC-----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETG-----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
.+.+....-+....||+|.||.||.|...+.. ..||+|.+++. .+......|.+|+.+|+.++|||||++++++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 34455777889999999999999999986543 34899988743 3445678899999999999999999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------------------------Ccccccc
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------------SIRPHIK 143 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------------~~~~~~~ 143 (218)
.+....+|++|||.+ +|..|++..... +...++.
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 999999999999998 999999886332 2233445
Q ss_pred ccCCc--------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhccc
Q 041487 144 EVGSP--------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 144 ~~g~~--------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
+||.+ |||||.+.. +.++.++|||||||++||++| |..||...+...+...+...+..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 56554 999997766 449999999999999999999 99999998666666656666677
Q ss_pred Ccccchhhhh
Q 041487 203 TNYLVLPCFL 212 (218)
Q Consensus 203 ~~~~~~~~~~ 212 (218)
+++...|+-+
T Consensus 924 ~~P~~CP~~l 933 (1025)
T KOG1095|consen 924 DPPSYCPEKL 933 (1025)
T ss_pred CCCCCCChHH
Confidence 6666666544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=184.88 Aligned_cols=160 Identities=24% Similarity=0.406 Sum_probs=124.9
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+..++|++.+.||+|+||.||+|.++.+++.+|+|++.+.. ......+.+.+|+.+++.++||||+++++.+..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4456689999999999999999999999999999999987533 233445678889999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC--------------------------Cccccc-----------ccc-----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEV----------- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~----------- 145 (218)
+++||||+++ +|.+++...... +++|.+ .++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999986 888887654321 222211 111
Q ss_pred -------C-CcccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 146 -------G-SPYKAPESRIRS---SVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 146 -------g-~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
| ..|+|||.+... ..++.++|||||||++|+|++|+.||...+.......
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~ 258 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2 239999976543 2378899999999999999999999988755444333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=185.00 Aligned_cols=155 Identities=26% Similarity=0.429 Sum_probs=123.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++++.||+|+||.||+|.++.++..||+|+++... ........+.+|+.++..++|++++++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997543 33455678889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~--------------- 145 (218)
||+++ +|.+++...... +++|. +.++
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99987 888887654321 11111 1111
Q ss_pred -------------------------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -------------------------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -------------------------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 2 239999954 4556899999999999999999999999887
Q ss_pred CcchHHHHH
Q 041487 188 KKDHLSLIV 196 (218)
Q Consensus 188 ~~~~~~~~~ 196 (218)
+.......+
T Consensus 240 ~~~~~~~~i 248 (360)
T cd05627 240 TPQETYRKV 248 (360)
T ss_pred CHHHHHHHH
Confidence 655544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=183.82 Aligned_cols=156 Identities=23% Similarity=0.441 Sum_probs=123.0
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|.+..++..+|+|.+++.. ......+.+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356688999999999999999999999999999999997543 2334456688899999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC--------------------------Ccccc-----------cccc------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEV------------ 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~------------ 145 (218)
++||||+++ +|.+++...... +++|. +.++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999976 888877553221 12221 1111
Q ss_pred ------C-CcccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 146 ------G-SPYKAPESRIRS---SVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 146 ------g-~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
| ..|+|||.+... ..++.++|||||||++|+|++|+.||...+....
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 2 239999966542 3478899999999999999999999988754433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-25 Score=178.18 Aligned_cols=155 Identities=23% Similarity=0.335 Sum_probs=126.6
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
....-....+|++..+||.|..++||+|.....+..||||++..+....+ .+.+.+|+..++.++||||++++..|..+
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 33444678899999999999999999999999999999999986554443 78999999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cc-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KE------- 144 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~------- 144 (218)
..+|+||+||.+ ++.+.++..... ++++.+ .+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999986 777777654332 222221 11
Q ss_pred --------------cC-CcccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 145 --------------VG-SPYKAPESRIR-SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 145 --------------~g-~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
.| ..|||||++.+ ..-|+.++||||||++..|+++|..||....
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 22 34999998555 3449999999999999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-24 Score=173.76 Aligned_cols=146 Identities=26% Similarity=0.431 Sum_probs=115.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|+..+.||+|+||.||+|.+..++..||+|.+.+.... ......+.+|+.+++.++|++++++++.+..++..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 488999999999999999999999999999998754322 2334567889999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccC-------------
Q 041487 121 YLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g------------- 146 (218)
|+++ +|.+++...... +++|. +.++|
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9987 887766432110 22221 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+
T Consensus 161 ~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 161 RVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 249999955 45568999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=178.01 Aligned_cols=147 Identities=36% Similarity=0.647 Sum_probs=115.2
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RYVY 116 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 116 (218)
+|++.+.||+|+||.||+|.++.++..||+|.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58999999999999999999999999999999875433344456788999999999999999999987532 3589
Q ss_pred EEEecCCCChHHHhhhcccC---------------------------Ccccc-----------cccc-------------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~------------- 145 (218)
++|||++++|.+++...... +++|. +.++
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999998988887653221 22221 1122
Q ss_pred -------C-CcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -------G-SPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -------g-~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||.+... ..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1 238999965442 558899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=170.53 Aligned_cols=169 Identities=22% Similarity=0.369 Sum_probs=136.4
Q ss_pred CCChhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeee
Q 041487 29 TNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLD 107 (218)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (218)
.+.+.....+..++|.+.+.||+|.||.||+|+.+.++-.||+|++-+.+ ........+.+|+++...++||||+++|+
T Consensus 10 ~~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~ 89 (281)
T KOG0580|consen 10 PFGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG 89 (281)
T ss_pred CcccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence 34445567788899999999999999999999999999999999997765 34456678899999999999999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g 146 (218)
+|.+...+|+++||... .+.+.+...... +++|.+ +++|
T Consensus 90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 99999999999999975 777776632221 344432 2222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|.+|| ..++..++..+|+|++|++.||++.|.+||.....+...+.++.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pE-mv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPE-MVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred ceeecCCCCceeeecccccCCHh-hcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 2399999 66777799999999999999999999999998855555554444
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=178.06 Aligned_cols=155 Identities=21% Similarity=0.401 Sum_probs=123.5
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++++.||+|+||.||++++..++..+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45688999999999999999999999999999999987532 22345679999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG----------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g----------- 146 (218)
+|||+++ +|.+++...... ++++. +.++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 160 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence 9999987 888887543211 22221 12222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+..
T Consensus 161 ~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 161 SFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred cCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 249999954 45568999999999999999999999998765544433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=180.20 Aligned_cols=102 Identities=22% Similarity=0.268 Sum_probs=87.9
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+...+..++|++++.||.|.-|+||+|+.+.+++.+|+|++.+... ......+...|.+||+.++||.++++|..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3455677889999999999999999999999999999999987763 356678899999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI 135 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~ 135 (218)
...|++||||+| +|.-..+++..
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~ 173 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPG 173 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCC
Confidence 999999999976 66555555433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=173.58 Aligned_cols=150 Identities=40% Similarity=0.687 Sum_probs=120.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|.+.+.||+|+||.||+|.++.++..||+|.++... .......+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 3578999999999999999999998899999999987443 223345677899999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 119 FEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
|||++++|.+++...... ++++. +.++
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 999998888877653211 11111 1122
Q ss_pred ----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 ----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 ----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
+..|+|||.+.....++.++|||||||++|+|++|++||...+.
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22389999766666688899999999999999999999987644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=180.79 Aligned_cols=170 Identities=21% Similarity=0.317 Sum_probs=125.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
+.||+|+||.||+|.++.+++.||+|++++... .......+.+|+.++++++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975432 334456788899999999999999999999999999999999987
Q ss_pred ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------Cc
Q 041487 125 DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------SP 148 (218)
Q Consensus 125 ~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~~ 148 (218)
+|.+++...... +++|. +.++| ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 887777553321 22221 12222 23
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc---Ccccchhhhhhhccc
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL---TNYLVLPCFLSIMLL 217 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 217 (218)
|+|||. ..+..++.++|||||||++|+|++|+.||...+...+...+...... ..+..+.+++..||.
T Consensus 161 y~aPE~-~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 161 YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccChhh-hcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 999995 45556899999999999999999999999877665555544322111 123344555665553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-26 Score=188.50 Aligned_cols=148 Identities=29% Similarity=0.490 Sum_probs=122.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
...|+.++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++..++++||.++|+.+..+..+|++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 345777899999999999999999999999999998543 3345678899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc----------------------------cc
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH----------------------------IK 143 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~----------------------------~~ 143 (218)
|||.+ ++.+.+...... ++++. ..
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 99987 777777665441 22221 13
Q ss_pred ccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 144 EVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 144 ~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.+|++ |||||++. ...|+.++||||||++++||++|.+||....+
T Consensus 171 fvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 34555 89999655 55699999999999999999999999987644
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=185.05 Aligned_cols=158 Identities=28% Similarity=0.491 Sum_probs=132.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE-EEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY-VYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 118 (218)
.++|..++++|+|+||.+++++++..+..+++|.+..........+...+|+.+++++.|||||.+.+.|..++. ++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999999999999999998777777777789999999999999999999999998887 9999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Cccc-----------cc---------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRP-----------HI--------------- 142 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~-----------~~--------------- 142 (218)
|+||++ ++++.+.++... +++. ..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999998 999998876521 1111 11
Q ss_pred --cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 143 --KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 --~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
...|++ |+.|| +..+.+|+.++|||||||++|||++-+++|...+...+...+..
T Consensus 163 a~tvvGTp~YmcPE-il~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~ 220 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPE-ILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR 220 (426)
T ss_pred hheecCCCcccCHH-HhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence 123444 77788 77788899999999999999999999999998866655554444
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=182.41 Aligned_cols=154 Identities=24% Similarity=0.429 Sum_probs=122.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++.+.||+|+||.||++.++.+++.+|+|++.+.. ......+.+.+|+.+++.++||||+++++.+..+..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999987532 23344567889999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC--------------------------Cccccc-----------ccc-------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEV------------- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~------------- 145 (218)
+||||+++ +|.+++...... +++|.+ .++
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999986 888887654321 222211 111
Q ss_pred -----C-CcccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 146 -----G-SPYKAPESRIRS---SVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 146 -----g-~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
| ..|+|||.+... ..++.++||||+||++|+|++|+.||...+...
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~ 254 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH
Confidence 2 239999976543 237889999999999999999999998775433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=173.22 Aligned_cols=158 Identities=27% Similarity=0.396 Sum_probs=120.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+...+|++.+.||+|+||.||+|..+ ..+..+|+|.++... .......+.+|+.+++.++||||+++++++..++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999765 356789999987432 22334678899999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
.++||||+++ +|.+++...... +++|.+ .++|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999987 888887653211 222211 1111
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|++++ |+.||.......+...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222 (266)
T ss_pred chhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 248999954 45668999999999999999876 999998775544444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=176.45 Aligned_cols=153 Identities=24% Similarity=0.415 Sum_probs=116.1
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHH---hhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLL---KELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
|++++.||+|+||.||+|.++.+++.||+|.+++.. ......+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 688999999999999999999999999999997543 2233456677776654 566899999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC--------------------------Ccccc-----------ccccC--------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g-------------- 146 (218)
|||+++ +|..++...... ++++. +.++|
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccc
Confidence 999987 777666442211 12211 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 161 ~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 161 FCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred cccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 239999954 4556899999999999999999999999887554444433
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=177.41 Aligned_cols=149 Identities=21% Similarity=0.361 Sum_probs=116.2
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
+.||+|+||.||++.++.++..||+|.++.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975432 234456778899999999999999999999999999999999987
Q ss_pred ChHHHhhhcccC---------------------------Cccccc-----------ccc-----------------C-Cc
Q 041487 125 DLGSFIRKHTIT---------------------------SIRPHI-----------KEV-----------------G-SP 148 (218)
Q Consensus 125 ~L~~~~~~~~~~---------------------------~~~~~~-----------~~~-----------------g-~~ 148 (218)
+|.+++...... +++|.+ .++ | ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 887776543221 222211 111 2 24
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
|+|||.+ .+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 161 y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 161 YLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred cCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999955 4556899999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=182.51 Aligned_cols=157 Identities=31% Similarity=0.596 Sum_probs=118.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------- 111 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 111 (218)
...+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999999999999999987532 1234579999999999999999888643
Q ss_pred -CCEEEEEEecCCCChHHHhhhccc----C---------------------------Cccc------------cccccC-
Q 041487 112 -GRYVYLVFEYLDLDLGSFIRKHTI----T---------------------------SIRP------------HIKEVG- 146 (218)
Q Consensus 112 -~~~~~lv~E~~~~~L~~~~~~~~~----~---------------------------~~~~------------~~~~~g- 146 (218)
...+++||||+++++.+++..... . +++| ++.++|
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 235789999999988776643110 0 2222 222333
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcc
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTA 201 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~ 201 (218)
..|+|||.+.....++.++|||||||++|+|++|++||.+. ..+.+..+++.++.
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 22899997666666899999999999999999999999876 44555666555443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=177.77 Aligned_cols=149 Identities=24% Similarity=0.381 Sum_probs=118.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||++.++.+++.||+|++.+.. ......+.+.+|..++..++|++|+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997532 23344567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
||+++ +|.+++...... ++++. +.++
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99976 998888653211 11111 1111
Q ss_pred ----C-CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 ----G-SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 ----g-~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
| ..|+|||.+.. ...++.++|||||||++|+|++|+.||...+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 2 24999997653 24478899999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-26 Score=179.07 Aligned_cols=163 Identities=25% Similarity=0.401 Sum_probs=130.6
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
...+..++|..+++||+|.||+|-+++.+.+++.+|+|++++.. ...+...+-..|-++|+..+||.+..+...|+.++
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34457788999999999999999999999999999999999876 33455678888999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHh-------------------------hhcccC--Ccc-----------ccc------------
Q 041487 114 YVYLVFEYLDL-DLGSFI-------------------------RKHTIT--SIR-----------PHI------------ 142 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~-------------------------~~~~~~--~~~-----------~~~------------ 142 (218)
.+|+||||++| .|.-.+ ..+... +.+ -++
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999964 222111 111100 111 111
Q ss_pred -----cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 143 -----KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 -----~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..+|++ |+||| +.++..|+.++|.|.+||++|||++|++||...+++.+..++..
T Consensus 322 g~t~kTFCGTPEYLAPE-VleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPE-VLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM 382 (516)
T ss_pred cceeccccCChhhcCch-hhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence 334555 99999 56677799999999999999999999999999999999888764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=174.75 Aligned_cols=153 Identities=24% Similarity=0.366 Sum_probs=118.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCC-CCeeeeeeeEEeCCEEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEH-DNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 119 (218)
+|++++.||+|+||.||+|.+..+++.||+|++++... .....+.+..|..++..++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999975432 33456678889999999976 46889999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+++ +|.+++...... +++|. +.++|
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99986 888777543221 22221 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
..|+|||.+ .+..++.++||||+||++|+|+||+.||.+.+...+...
T Consensus 161 ~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 161 FCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred ecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 239999954 455689999999999999999999999987754444433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=174.59 Aligned_cols=155 Identities=23% Similarity=0.348 Sum_probs=119.5
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
+|++.+.||+|+||.||+|.++.++..||+|.+++... .....+.+..|..++..+ .|++++++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999986432 233445667788888777 5899999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~--------------- 145 (218)
||+++ +|.+++...... +++|. +.++
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99986 888777543221 22221 1222
Q ss_pred --CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 --GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 --g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|+||+.||...+...+...+.
T Consensus 161 ~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 161 FCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred CCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22 39999954 55668999999999999999999999999876555544443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=180.59 Aligned_cols=147 Identities=31% Similarity=0.515 Sum_probs=117.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----EEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-----YVY 116 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 116 (218)
+|++++.||+|+||.||++.+..++..||+|.+..........+++.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998654333334567889999999999999999999998766 799
Q ss_pred EEEecCCCChHHHhhhcccC---------------------------Ccccc-----------ccccC------------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------ 146 (218)
+||||+.++|.+++...... +++|. +.++|
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~ 160 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence 99999988887776543221 22221 11222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++||||+||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 238999976665668999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=176.52 Aligned_cols=149 Identities=31% Similarity=0.498 Sum_probs=117.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++.+.||+|+||.||++.+..++..+|+|.+............+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45889999999999999999999999999999999976544445567788999999999999999999998644
Q ss_pred CEEEEEEecCCCChHHHhhhcccC-------------------------Ccccc-----------ccccC----------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~-----------~~~~g---------- 146 (218)
...|++|||+++++.+++...... +++|. +.++|
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 178 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM 178 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCcc
Confidence 357999999998877655321110 22222 22222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+
T Consensus 179 ~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 179 MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 239999955 45568999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=182.62 Aligned_cols=179 Identities=28% Similarity=0.429 Sum_probs=145.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+=|.+.+.||+|-|+.|-+|++--+|..||||++.+.-.+.....++.+|+.+|+-++|||||++|++...+..+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 35668999999999999999999888999999999998777776677899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Cccccc------------ccc------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPHI------------KEV------------ 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~------------~~~------------ 145 (218)
+|.-++ +|.|||.++... +.+|.+ .+|
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 999998 999999887554 334432 222
Q ss_pred ----C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc--ccchhhhhhhccc
Q 041487 146 ----G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN--YLVLPCFLSIMLL 217 (218)
Q Consensus 146 ----g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 217 (218)
| .+|-|||.+.++.+-.+++|||||||+||-+++|++||.-. +.+.+..+.......|- +-..-+.+..||.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 2 35999998888886678899999999999999999999876 67777777665444432 3344455555553
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=175.86 Aligned_cols=145 Identities=23% Similarity=0.394 Sum_probs=114.5
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||+|+||.||+|.+..++..||+|.++... ........+.+|+.+++.++||||+++++.+...+..++||||+++ +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999987543 2334456788999999999999999999999999999999999987 88
Q ss_pred HHHhhhcccC---------------------------Ccccc-----------cccc-----------------C-Cccc
Q 041487 127 GSFIRKHTIT---------------------------SIRPH-----------IKEV-----------------G-SPYK 150 (218)
Q Consensus 127 ~~~~~~~~~~---------------------------~~~~~-----------~~~~-----------------g-~~y~ 150 (218)
.+++...... +++|. +.++ | ..|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 8887654321 22221 1122 2 2399
Q ss_pred CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 151 APESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 151 aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
|||.+ .+..++.++|||||||++|+|++|+.||...+...+..
T Consensus 161 aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~ 203 (312)
T cd05585 161 APELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR 203 (312)
T ss_pred CHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence 99954 45568999999999999999999999998765444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=179.18 Aligned_cols=150 Identities=29% Similarity=0.491 Sum_probs=120.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.+..+++.||+|++++... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 469999999999999999999998999999999976542 3355678889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc----------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE---------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~---------------- 144 (218)
||+.+ +|.+++...... +++|.+ .+
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99976 888887664221 111110 11
Q ss_pred ------------------------------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 145 ------------------------------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 145 ------------------------------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
.| ..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHH-cCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12 249999954 45568999999999999999999999998775433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=184.26 Aligned_cols=159 Identities=29% Similarity=0.552 Sum_probs=124.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..|....+||+|+.|.||.|....+++.||||.+....... .+.+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 44788899999999999999999999999999997544333 4678999999999999999999999998999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccc-----------ccc-----------------cc
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRP-----------HIK-----------------EV 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~-----------~~~-----------------~~ 145 (218)
|+++ +|.|.+...... +++. ++. .+
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmV 430 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMV 430 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccccc
Confidence 9998 888877654322 1111 112 23
Q ss_pred CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc
Q 041487 146 GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 146 g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
|++ |||||+ ...+.|++++||||||++++||+-|++||-..++-.-...+...+.|
T Consensus 431 GTPYWMAPEV-vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P 487 (550)
T KOG0578|consen 431 GTPYWMAPEV-VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 487 (550)
T ss_pred CCCCccchhh-hhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC
Confidence 444 899995 45555999999999999999999999999865444444444443433
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=168.53 Aligned_cols=146 Identities=46% Similarity=0.783 Sum_probs=118.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||+|++..++..||+|.++...........+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58899999999999999999988999999999876544445567788999999999999999999999999999999999
Q ss_pred CCCChHHHhhhccc----C--------------------------Ccccc-----------cccc---------------
Q 041487 122 LDLDLGSFIRKHTI----T--------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~~----~--------------------------~~~~~-----------~~~~--------------- 145 (218)
+.++|.+++..... . ++++. +.++
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 99888888754221 0 11111 1122
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++|||||||++|+|+||+.||.+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 224899997665566789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=177.17 Aligned_cols=150 Identities=24% Similarity=0.375 Sum_probs=118.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||++.++.+++.+|+|++.+.. ........+.+|..++..++|++|+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987532 23334566888999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
||+.+ +|.+++...... ++++. +.++
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99986 898888653211 12221 1122
Q ss_pred ----C-CcccCcccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 146 ----G-SPYKAPESRIRS----SVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 146 ----g-~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
| ..|+|||.+... +.++.++|||||||++|+|++|+.||...+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 2 249999965432 45788999999999999999999999876443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=175.19 Aligned_cols=148 Identities=22% Similarity=0.378 Sum_probs=115.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
+.||+|+||.||++.++.++..||+|++.+.. ........+.+|+.+++.++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997543 2334456788999999999999999999999999999999999987
Q ss_pred ChHHHhhhcccC---------------------------Ccccc-----------cccc-----------------C-Cc
Q 041487 125 DLGSFIRKHTIT---------------------------SIRPH-----------IKEV-----------------G-SP 148 (218)
Q Consensus 125 ~L~~~~~~~~~~---------------------------~~~~~-----------~~~~-----------------g-~~ 148 (218)
+|.+++...... +++|. +.++ | ..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 787776543221 22221 1122 2 24
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...
T Consensus 161 y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 161 YLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred ccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999954 455589999999999999999999999987655544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=182.82 Aligned_cols=160 Identities=29% Similarity=0.440 Sum_probs=132.4
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...-....|.+++.||+|.|+.|.+|++..++..||||++.+........+.+-+|+.+++.++|||||+++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 33445677999999999999999999999999999999999888777777779999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC--------------------------------------Ccccccccc----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT--------------------------------------SIRPHIKEV---------- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~--------------------------------------~~~~~~~~~---------- 145 (218)
+|+||||+.+ .+.+|+.+++.. +..-++.+|
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999977 888888776543 111122333
Q ss_pred ------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 146 ------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 146 ------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
|+ +|.|||.+.+.++.++.+|+||+|+++|.++.|.+||++.+-..+..
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 22 39999966666667789999999999999999999999885444433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=169.28 Aligned_cols=157 Identities=47% Similarity=0.793 Sum_probs=122.3
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++++.||.|++|.||+|++..++..+|+|.++.........+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999988999999999876554445557889999999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC-----------------------------Ccccc-----------cccc----------------
Q 041487 122 LDLDLGSFIRKHTIT-----------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~---------------- 145 (218)
+.++|.+++...... ++.+. ..++
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 988888776542211 11111 1111
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHH
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRY 198 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~ 198 (218)
...|+|||.+.....++.++||||||+++|+|+||+.||...+ .+...+..+.
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 216 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 1238999976665657889999999999999999999998763 3334444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=168.56 Aligned_cols=158 Identities=41% Similarity=0.721 Sum_probs=117.3
Q ss_pred cceeEEEEeeecCceEEEEEEEcc-CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEE-----e
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLE-TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLT-----T 111 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 111 (218)
.+|++.+.||+|+||.||+|.+.. .+..||+|.++...........+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 467899999876544444445666777777665 6999999999885 3
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC-----------------------------Ccccc-----------ccccC-----
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPH-----------IKEVG----- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g----- 146 (218)
...++++|||++++|.+++...... +++|. +.++|
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4569999999999998887643211 22221 12222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHh
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYF 199 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~ 199 (218)
..|+|||.+ .+..++.++|||||||++|+|++|++||.+. +.+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred cCCcccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 238999965 4455899999999999999999999999877 344555555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=176.40 Aligned_cols=149 Identities=31% Similarity=0.501 Sum_probs=117.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++.+.||+|+||.||+|.+...++.+|+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 46789999999999999999999999999999999876544455567788999999999999999999987543
Q ss_pred CEEEEEEecCCCChHHHhhhcccC-------------------------Ccccc-----------ccccC----------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~-----------~~~~g---------- 146 (218)
..+|+||||++++|.+++...... +++|. +.++|
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 181 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc
Confidence 358999999998887766432110 22222 12222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+
T Consensus 182 ~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 182 MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 238999954 45568999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=175.62 Aligned_cols=152 Identities=23% Similarity=0.357 Sum_probs=119.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||++..+.++..+|+|++.+.. ......+.+.+|+.++..++|++|+++++.+.....+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986532 23334556888999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
||+.+ +|.+++...... ++++. +.++
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99976 899888653211 12221 1122
Q ss_pred ----C-CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 146 ----G-SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 146 ----g-~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
| ..|+|||.+.. ...++.++|||||||++|+|++|+.||...+....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~ 216 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH
Confidence 2 24999996642 34578999999999999999999999987644333
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=168.78 Aligned_cols=147 Identities=27% Similarity=0.444 Sum_probs=115.6
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+.+++.++||+|+++++.+..+..++++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999999889999999998754322 2234567789999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC-----------------------------Ccccc-----------cccc--------------
Q 041487 121 YLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~-------------- 145 (218)
|+.+ +|.+++...... ++++. +.++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9986 887776442211 11111 1122
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
| ..|+|||.+ .+..++.++||||+||++|++++|+.||.+.+.
T Consensus 161 ~~~~~~y~aPE~~-~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 161 RVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ccCCCCccCcHHh-cCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1 249999955 455689999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=165.62 Aligned_cols=149 Identities=24% Similarity=0.457 Sum_probs=120.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|.+.+.||+|++|.||+|..+.++..|++|.+..........+.+.+|+.+++.++|||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58899999999999999999999999999999876544555677889999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC--------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG-------------- 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g-------------- 146 (218)
+++ +|.+++...... ++++.+ .++|
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 976 999988664211 111111 1111
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.. ....++.++|+|||||++|+|++|+.||...+...
T Consensus 161 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 161 IVGTPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred cccCccccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 238899954 44558899999999999999999999998775443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=172.31 Aligned_cols=170 Identities=23% Similarity=0.304 Sum_probs=122.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.+..++..||+|.++.... .....+....|..++... +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 223345566777777765 999999999999999999999999986
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 888887653221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+....+.. .+..+.+++..||.
T Consensus 161 ~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 161 DYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred cccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhc
Confidence 39999954 45568999999999999999999999998876655555544322211 12233456666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=172.25 Aligned_cols=154 Identities=25% Similarity=0.389 Sum_probs=118.8
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 119 (218)
+|+..+.||+|+||.||+|.++.++..||+|++++... .....+.+..|..++..+. |++++++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999975432 2344567788888888885 577888999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~--------------- 145 (218)
||+++ +|.+++...... +++|. +.++
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99986 888887653321 22221 1222
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
| ..|+|||. ..+..++.++|||||||++|+|++|+.||...+...+...+
T Consensus 161 ~~gt~~y~aPE~-~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 161 FCGTPDYIAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred ccCCccccCHHH-HcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 24999995 45566899999999999999999999999887555444433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=177.81 Aligned_cols=151 Identities=26% Similarity=0.406 Sum_probs=120.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.++.++..+|+|.++.... .....+.+.+|+.+++.++|++|+++++.+.....+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 469999999999999999999999999999999986432 3345677889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
||+++ +|.+++...... +++|. +.++|
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99976 999888664211 22221 11222
Q ss_pred ------CcccCcccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 ------SPYKAPESRIR-----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 ------~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||.......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 216 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH
Confidence 23999996542 4457889999999999999999999998764433
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-26 Score=180.20 Aligned_cols=142 Identities=24% Similarity=0.474 Sum_probs=117.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+-|.++++||+|+||.||+|.++.+|+.+|||.++ -+.+.+.+..|+.+++.++.|++|++|+.+.....+|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34889999999999999999999999999999876 34567889999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC----------------------------Cccccc-----------cc----------------
Q 041487 121 YLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KE---------------- 144 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~---------------- 144 (218)
||.. ++.|.++..... +++..+ .+
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 9975 787777644322 222221 22
Q ss_pred -cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 -VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 -~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|++ |||||++.+-+ |+..+||||||++..||+.|++||...
T Consensus 189 VIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccc
Confidence 3444 89999655555 899999999999999999999999865
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=173.53 Aligned_cols=152 Identities=22% Similarity=0.422 Sum_probs=121.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|+||.||++.+..++..+|+|.+.... .....+.+.+|+.+++.++|+||+++++++..++.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 45688999999999999999999999899999999887532 23345678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG----------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g----------- 146 (218)
+|||+.+ +|.+++...... ++++. ..++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 160 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence 9999987 898887543221 12221 12222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+ .+..++.++|||||||++|++++|+.||.......
T Consensus 161 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 161 SFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred cCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 249999954 55568999999999999999999999998654433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=189.78 Aligned_cols=153 Identities=33% Similarity=0.573 Sum_probs=120.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--C
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--G 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 112 (218)
......++|++++.||+|+||.||+|.+..++..+|+|.+............+..|+.+++.++||||++++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34456789999999999999999999999999999999997655555566788999999999999999999998854 4
Q ss_pred CEEEEEEecCCC-ChHHHhhhcc-----cC---------------------------------Cccc-------------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHT-----IT---------------------------------SIRP------------- 140 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~-----~~---------------------------------~~~~------------- 140 (218)
..+|+||||+++ +|.+++.... .. +++|
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 679999999986 8877764310 00 1111
Q ss_pred ---------------cccccC-----------------CcccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 141 ---------------HIKEVG-----------------SPYKAPESRIR-SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 141 ---------------~~~~~g-----------------~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
++.+|| ..|+|||.+.. ...++.++|||||||++|+|+||+.||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 122232 23999997654 345889999999999999999999999765
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=181.26 Aligned_cols=161 Identities=23% Similarity=0.356 Sum_probs=123.5
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+.......++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++..++|++++++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 34444566899999999999999999999999999999999976555555567788999999999999999998877532
Q ss_pred C--------EEEEEEecCCC-ChHHHhhhcccC-------------------------------Ccccc-----------
Q 041487 113 R--------YVYLVFEYLDL-DLGSFIRKHTIT-------------------------------SIRPH----------- 141 (218)
Q Consensus 113 ~--------~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------~~~~~----------- 141 (218)
. .+++||||+++ +|.+++...... +++|.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 47899999987 898887542110 22221
Q ss_pred ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 142 IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 142 ~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
+.+|| ..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~ 255 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 12222 239999954 55668999999999999999999999998765444333
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=174.31 Aligned_cols=149 Identities=24% Similarity=0.391 Sum_probs=114.6
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|+++.+++.||+|++++... .....+.+..|..++..+ +||+|+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999999999999999975432 234456677888888866 899999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 887776543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 161 ~y~aPE~-~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i 208 (321)
T cd05591 161 DYIAPEI-LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208 (321)
T ss_pred cccCHHH-HcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 3999995 44556899999999999999999999999887555444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=172.94 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=123.4
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.++..||+|++++.. ......+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999997543 2334456777888888776 799999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 888877654321 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+....... .+..+.++++.||+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 161 DYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred cccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 39999954 55568999999999999999999999998876555444443211111 12334455666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=171.74 Aligned_cols=149 Identities=25% Similarity=0.360 Sum_probs=112.7
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.+..++..||+|.++... ......+.+..|..++... +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997543 2233345556666666654 899999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 888877553321 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 161 DYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred cccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 39999954 4556899999999999999999999999887655544443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=169.41 Aligned_cols=148 Identities=17% Similarity=0.225 Sum_probs=113.2
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEe----CCEEEEEEec
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTT----GRYVYLVFEY 121 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~E~ 121 (218)
..|++|+++.||+|.. ++..||+|.++...... ...+.+.+|+.++++++||||+++++++.+ ...++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 78999999987543222 235778899999999999999999999876 4579999999
Q ss_pred CCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC---------------
Q 041487 122 LDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG--------------- 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g--------------- 146 (218)
+++ +|.+++...... ++++. +.++|
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 997 888887653221 12221 11222
Q ss_pred CcccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 SPYKAPESRIR-SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||...+...+...+
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 34999996544 256899999999999999999999999987655544443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=174.84 Aligned_cols=146 Identities=27% Similarity=0.483 Sum_probs=117.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC--EEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR--YVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 117 (218)
..++...+.||+|+||.||++.+.+++..+|+|.+....... .+.+.+|+.+|++++||+||++++...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 456788899999999999999998889999999987653222 677999999999999999999999854443 7999
Q ss_pred EEecCCC-ChHHHhhhccc--C--------------------------Ccc------------ccccccCC---------
Q 041487 118 VFEYLDL-DLGSFIRKHTI--T--------------------------SIR------------PHIKEVGS--------- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~--~--------------------------~~~------------~~~~~~g~--------- 147 (218)
.|||+++ +|.+++...+. . +++ .++.+||.
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999997 99999987652 1 222 22334442
Q ss_pred ------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 ------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 ------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|||||++..+...+..+|||||||++.||+||+.||...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 2999997665433446999999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-26 Score=175.03 Aligned_cols=160 Identities=31% Similarity=0.484 Sum_probs=126.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..+.|.+-++||+|.|+.|+++.++.+|+.+|+|++..........+.+.+|+.+.+.++||||+++++.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34567899999999999999999999999999999998766677788999999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhc----------cc-----------------CCccccc---------------------------
Q 041487 118 VFEYLDL-DLGSFIRKH----------TI-----------------TSIRPHI--------------------------- 142 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~----------~~-----------------~~~~~~~--------------------------- 142 (218)
|+|+++| .|-.-|-.. .. .+.+|++
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 9999986 443222110 00 1333332
Q ss_pred ---cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH-HHHHH
Q 041487 143 ---KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS-LIVRY 198 (218)
Q Consensus 143 ---~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~-~~~~~ 198 (218)
...|++ |+||| +....+|+.++|||++||+||-++.|++||.+.+...+. ++.+.
T Consensus 168 ~~~G~~GtP~fmaPE-vvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred ccccccCCCcccCHH-HhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 112333 99999 556666999999999999999999999999995444444 44443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=168.15 Aligned_cols=144 Identities=39% Similarity=0.702 Sum_probs=116.3
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||+|.++.+|..+++|.++...........+.+|+.++++++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 48899999999999999999999999999999976544444556778899999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Ccccc-----------cccc-----------------
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV----------------- 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~----------------- 145 (218)
++++|.+++...... ++++. +.++
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 999988887643211 11111 1111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
...|+|||.+.....++.++|||||||++|+|+||+.||.
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1248999976666668999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=176.76 Aligned_cols=160 Identities=26% Similarity=0.398 Sum_probs=125.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
-+...+|.++.+||+|+||.|.+|..+.+.+.+|||++++... ..++.+.-..|..+|.-. +-|.++.++.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4677889999999999999999999999999999999987753 234456666777777766 57899999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhccc----C-----------------------Cccc-----------cc-------------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI----T-----------------------SIRP-----------HI------------- 142 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~----~-----------------------~~~~-----------~~------------- 142 (218)
+|+||||+.+ +|--.++..+. . +.+. ++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 9999999986 55433332111 0 0100 11
Q ss_pred ----cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 143 ----KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 143 ----~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..+|++ |+||| ++.+.+|+.++|.||+||+||||+.|++||++.+.+.+.+.+.
T Consensus 505 ~TTkTFCGTPdYiAPE-Ii~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred cceeeecCCCcccccc-eEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 234544 99999 7778889999999999999999999999999997777766544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=157.70 Aligned_cols=164 Identities=41% Similarity=0.745 Sum_probs=137.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|.-.++||+|.||+||+|+.+.+++.||+|.++....++.+.....+|+.+++.++|.|||+++++...++.+-+|.||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556789999999999999999999999999998777888889999999999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Cccccc-----------cccCC------c--------
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS------P-------- 148 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~------~-------- 148 (218)
|+.+|..|..+.... +.+|++ .++|. +
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaev 162 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV 162 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee
Confidence 998887777654321 233322 22332 2
Q ss_pred ----ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 149 ----YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 ----y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
|.+|.++++.+-|+.+.|+||-||++.|+.. |++.|+++ ..+.+.++.+.+|.|...
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 7777778888889999999999999999998 89999998 567888888888877653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-23 Score=165.01 Aligned_cols=155 Identities=42% Similarity=0.721 Sum_probs=115.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEEe-----CC
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLTT-----GR 113 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 113 (218)
+|++.+.||+|+||.||+|.++.+++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58899999999999999999999999999999876543443344566777777665 79999999998753 35
Q ss_pred EEEEEEecCCCChHHHhhhcccC-----------------------------Ccccc-----------cccc--------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPH-----------IKEV-------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~-------- 145 (218)
.++++||++.++|.+++...... +++|. ..++
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998888887653211 22221 1122
Q ss_pred ---------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHH
Q 041487 146 ---------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVR 197 (218)
Q Consensus 146 ---------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~ 197 (218)
...|+|||.+. +..++.++||||+||++|+|++|++||.... .+.+..+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred cccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 12399999654 4558999999999999999999999998763 333444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=170.09 Aligned_cols=151 Identities=23% Similarity=0.346 Sum_probs=115.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.++..||+|.+++... .....+.+..|..++... +||+|+++++.+...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975432 233455667777777765 899999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 888777654221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+..
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~ 210 (316)
T cd05620 161 DYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210 (316)
T ss_pred CccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 39999954 455689999999999999999999999988766555555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=174.51 Aligned_cols=150 Identities=31% Similarity=0.574 Sum_probs=118.3
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++++.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 35789999999999999999999999999999999875433334456678899999999999999999987533
Q ss_pred CEEEEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------ccccC---------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEVG--------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g--------- 146 (218)
...++++|++.++|.+++...... +++|. +.++|
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 172 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM 172 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCc
Confidence 457999999988888776543221 22222 22222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||...+
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 238999977665678999999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=174.60 Aligned_cols=140 Identities=19% Similarity=0.366 Sum_probs=113.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+...+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 45578999999999999999999999999999999643 2346789999999999999999999999999999
Q ss_pred EEecCCCChHHHhhhcccC---------------------------Cccccc-----------cccC-------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------------- 146 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------------- 146 (218)
++|++.++|..++...... +++|.+ .++|
T Consensus 161 v~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 9999988888776543221 222221 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||..
T Consensus 241 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 241 YGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 238899954 455689999999999999999999987753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=173.47 Aligned_cols=149 Identities=32% Similarity=0.500 Sum_probs=117.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++.+.||+|+||.||+|.+...++.+|+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999999988999999999875544445567788999999999999999999998643
Q ss_pred CEEEEEEecCCCChHHHhhhcccC-------------------------Ccccc-----------ccccC----------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~-----------~~~~g---------- 146 (218)
...+++|||+++++.+++...... +++|. +.++|
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 174 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc
Confidence 357999999998887765432110 22222 12222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+
T Consensus 175 ~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 175 MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 239999954 45568999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-23 Score=165.94 Aligned_cols=153 Identities=26% Similarity=0.434 Sum_probs=121.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|++|.||++.+..+++.+|+|.++.... .....+.+.+|+.++++++||||+++++++.....++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999998999999999875432 3345678899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccc-----------ccccc--------------C
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEV--------------G 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~--------------g 146 (218)
||+++ +|.+++...... ++.+ .+.++ +
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence 99965 898887654321 1111 11111 1
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+. +...+.++||||||+++|+|++|+.||...+......
T Consensus 161 ~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred CccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2399999654 4457889999999999999999999998765444333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-23 Score=166.70 Aligned_cols=150 Identities=33% Similarity=0.649 Sum_probs=118.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 117 (218)
.++|++.+.||+|+||.||+|.++.++..||+|.++...........+.+|+.++++++|+|++++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 5789999999999999999999999999999999976544444444567899999999999999999998654 57999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc-------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~------------- 145 (218)
||||+.++|.+++...... ++++. +.++
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence 9999998888776643111 11111 1111
Q ss_pred -----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 -----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 -----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
...|+|||.+.....++.++|||||||++|+|++|++||...+.
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12399999766666689999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=170.29 Aligned_cols=149 Identities=23% Similarity=0.371 Sum_probs=115.3
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.++..||+|.+++.. ........+.+|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998643 2234456677888888888 799999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 888777654221 11111 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 161 DYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred cccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 39999954 5556899999999999999999999999877655544433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=171.97 Aligned_cols=170 Identities=22% Similarity=0.336 Sum_probs=119.5
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHH-HHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVS-LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.+..+++.+|+|++.+... .......+..|.. +++.++||||+++++.+...+.+++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999975432 2222334444443 56778999999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 887777543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh-c--ccCcccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF-T--ALTNYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+... . .+..+..+.+++..||+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 161 EYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcc
Confidence 39999954 4566899999999999999999999999876544443333221 1 11223445556666664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=174.64 Aligned_cols=170 Identities=21% Similarity=0.291 Sum_probs=124.4
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
+.||+|+||.||++.++.++..||+|++++... .......+.+|+.+++.++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999986432 233456778899999999999999999999999999999999987
Q ss_pred ChHHHhhhcccC----------------------------Cccccc-----------cccC------------------C
Q 041487 125 DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------------------S 147 (218)
Q Consensus 125 ~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------------------~ 147 (218)
+|.+++...... +++|.+ .++| .
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 777666443211 222221 2222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc---Ccccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL---TNYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+.+.+...+...... ..+..+.+++..||+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 161 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred ccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence 39999954 4556899999999999999999999999877665555444321111 123344555555553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-22 Score=163.54 Aligned_cols=147 Identities=35% Similarity=0.673 Sum_probs=115.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|++|.||+|.++.+++.+|+|.+..........+.+.+|+.+++.++|+|++++++.+......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999998899999999987544334445678899999999999999999999999999999999
Q ss_pred cCCCChHH-HhhhcccC---------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDLDLGS-FIRKHTIT---------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~~L~~-~~~~~~~~---------------------------~~~~~-----------~~~~---------------- 145 (218)
|+++++.+ +....... ++++. +.++
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99874433 33221111 11111 1111
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++||||||+++|+|++|+.||.+.
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 123899997655566889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=171.33 Aligned_cols=145 Identities=26% Similarity=0.503 Sum_probs=112.2
Q ss_pred EEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCC--CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 46 VEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNE--PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++.||+|+||.||++... ..++.||+|+++.... .......+.+|+.+++.++||||+++++.+..++.+|++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999863 4688999999975432 22345677889999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Cccc-----------cccccC---------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEVG--------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~g--------------- 146 (218)
|+++ +|.+++...... ++++ .+.++|
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 9987 888877544321 1222 112222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...
T Consensus 161 ~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 161 CGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred CCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 239999955 44557899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-23 Score=170.75 Aligned_cols=139 Identities=22% Similarity=0.380 Sum_probs=110.7
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.+++.||+|++++... .....+.+.+|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999999999999999999986542 234456788899999988 799999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 888777543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.|+|||.+ .+..++.++|+|||||++|+|++|+.||+.
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 161 NYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 39999954 455689999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-23 Score=177.30 Aligned_cols=152 Identities=20% Similarity=0.326 Sum_probs=116.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccC-CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLET-GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
...|.+.+.||+|++|.||+|....+ +..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 34599999999999999999998777 788999976432 233345778899999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcc----cC---------------------------Cccccc-----------ccc----------
Q 041487 119 FEYLDL-DLGSFIRKHT----IT---------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~----~~---------------------------~~~~~~-----------~~~---------- 145 (218)
|||+++ +|.+++.... .. +++|.+ .++
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999986 8987764311 00 222211 111
Q ss_pred ---------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 146 ---------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 146 ---------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~ 281 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ 281 (478)
T ss_pred ccccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 22 39999954 45568999999999999999999999998765444333
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=172.65 Aligned_cols=170 Identities=24% Similarity=0.373 Sum_probs=120.4
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHH-HHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVS-LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.+++.+|+|++.+... .......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999975432 2333445555554 46778999999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 777776543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhc---ccCcccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFT---ALTNYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+.... .+..+..+.+++..||.
T Consensus 161 ~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 161 EYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232 (325)
T ss_pred hhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhc
Confidence 39999954 45568999999999999999999999998875555444333211 11223344456666653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=171.37 Aligned_cols=149 Identities=26% Similarity=0.448 Sum_probs=111.6
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHH-HHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVS-LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|++..+++.+|+|++.+... .......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975432 2233345555554 67888999999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 787766543211 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (321)
T cd05603 161 EYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208 (321)
T ss_pred ccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 39999954 4556899999999999999999999999887654444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=171.07 Aligned_cols=161 Identities=31% Similarity=0.483 Sum_probs=129.7
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 114 (218)
.-....|.+.+.||+|.||.||.|+.+.+|..+|+|++++.... ......+.+|+.+|+.+. ||||+.+++.|.....
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34566799999999999999999999999999999999876543 234678999999999997 9999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhc-ccC-------------------------Cccc---------------ccccc-------
Q 041487 115 VYLVFEYLDL-DLGSFIRKH-TIT-------------------------SIRP---------------HIKEV------- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~-~~~-------------------------~~~~---------------~~~~~------- 145 (218)
+++|||+|.+ .|.+.+... -.. +.+| +..+|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999997 888888775 111 2222 12233
Q ss_pred ---------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 ---------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 ---------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
|++ |+|||+ .....|+..+|+||+|+++|.|++|.+||.+.........+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEv-l~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEV-LGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred CCceEeeecCCccccCchh-hcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 322 999995 4445699999999999999999999999998865555554444
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=163.61 Aligned_cols=146 Identities=36% Similarity=0.678 Sum_probs=119.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||+|.+..++..+++|.+............+.+|+.++++++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999988999999999986554455567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Cccccc-----------cc------------------
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIRPHI-----------KE------------------ 144 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~------------------ 144 (218)
+.++|.+++...... ++++.+ .+
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 966998887543211 111111 11
Q ss_pred -cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 -VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 -~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
....|+|||.+.....++.++||||+||++|+|++|++||.+.
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 1224899997766666789999999999999999999999766
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=171.33 Aligned_cols=170 Identities=24% Similarity=0.372 Sum_probs=119.8
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHH-HHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVS-LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.+++.||+|++.+... .......+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999975432 2233344555554 56778999999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... ++++. +.++| .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 887777543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhc---ccCcccchhhhhhhccc
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFT---ALTNYLVLPCFLSIMLL 217 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~ 217 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+.... ++..+..+.+++..||+
T Consensus 161 ~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 161 EYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred hhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 39999954 45568999999999999999999999998875544443332211 11123344455555553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=169.83 Aligned_cols=146 Identities=19% Similarity=0.365 Sum_probs=114.6
Q ss_pred ceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCC--CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
+|++.+.||+|+||.||+++.. .++..+|+|++.+.. ......+.+.+|+.+++.+ +|++|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 468899999997543 2234456788899999999 599999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g---------- 146 (218)
+++|||+++ +|.+++...... ++++. +.++|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999987 888887553321 22221 12222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|+|+||+.||...
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 23999997655455788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=165.01 Aligned_cols=147 Identities=50% Similarity=0.838 Sum_probs=118.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|++|.||+|.++.+++.+|+|.+..........+.+.+|+.++++++|||++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999998899999999987554444555678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC-----------------------------Cccc------------cccccC-------------
Q 041487 121 YLDLDLGSFIRKHTIT-----------------------------SIRP------------HIKEVG------------- 146 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~-----------------------------~~~~------------~~~~~g------------- 146 (218)
|++++|.+++...... ++++ .+.++|
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 9988887776432211 1111 111221
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|+|+||+.||...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23899997655566889999999999999999999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=163.94 Aligned_cols=156 Identities=24% Similarity=0.441 Sum_probs=123.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+...+|.+.+.||+|++|.||+|..+.++..+++|.+... ......+.+|+.++++++|++++++++++..++.+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 4567799999999999999999999989999999998632 2234678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||+++ +|.+++...... +++|.+ .++|
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999976 899888653211 222221 1211
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||. ..+..++.++|||||||++|+|++ |..||++.+.+.....+.
T Consensus 160 ~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 219 (263)
T cd05052 160 TAHAGAKFPIKWTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219 (263)
T ss_pred eccCCCCCccccCCHHH-hccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23999995 455668999999999999999999 999998876666555544
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=160.43 Aligned_cols=153 Identities=22% Similarity=0.357 Sum_probs=122.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|+..+.||+|+||.|+.+.+..++..+++|.+..........+.+.+|+.++++++|+|++++++++.....++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999999999999999999876555555667888999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Ccccc-----------cccc---------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~--------------- 145 (218)
+++ +|.+++...... ++++. +.++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 986 999888654111 11111 1111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
...|.|||.+. +..++.++|+||||+++|+|++|+.||...+.......
T Consensus 161 ~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 161 VVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred cCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 22388999554 44478899999999999999999999987654444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=163.69 Aligned_cols=147 Identities=27% Similarity=0.418 Sum_probs=119.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+|++.+.||.|+||.||+|.+..++..+++|.+...... ....+.+.+|+.++++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 589999999999999999999888999999999765432 2557789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~---------------- 145 (218)
|+.+ +|.+++...... ++.+. ..++
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 9987 888888665221 11111 1111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
...|+|||.+ ....++.++|+||||+++|++++|+.||...+.
T Consensus 161 ~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 161 GTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 1238999954 444489999999999999999999999997753
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=162.21 Aligned_cols=147 Identities=27% Similarity=0.515 Sum_probs=116.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC---CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE---GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
++|++.+.||+|++|.||+|.+..++..+++|.++...... ...+.+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999998899999999987543222 234578899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------ 146 (218)
++||+++ +|.+++...... ++.+. +.++|
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999987 888877643221 11111 11111
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++||||||+++|++++|+.||...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccccCCCcCccccCccee-ccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 248999954 44558999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=163.76 Aligned_cols=148 Identities=42% Similarity=0.729 Sum_probs=118.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|++|.||+|.++.++..||+|.+..... ......+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 5789999999999999999999988899999999875432 223345678999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Cccc-----------cccccC--------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRP-----------HIKEVG-------------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~-----------~~~~~g-------------- 146 (218)
||+.++|.+++...... ++++ ...++|
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 99999998887653221 1111 112222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++||||+|+++|+|++|+.||....
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 238999976655668899999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=172.61 Aligned_cols=150 Identities=25% Similarity=0.442 Sum_probs=113.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
...++|+.++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++...+.+++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 34567899999999999999999999899999999986432 23345678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhh---------------------hccc--CCccc-----------ccccc-----------------
Q 041487 118 VFEYLDL-DLGSFIR---------------------KHTI--TSIRP-----------HIKEV----------------- 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~---------------------~~~~--~~~~~-----------~~~~~----------------- 145 (218)
||||+++ +|.+... ..+. .++++ ++.++
T Consensus 150 v~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 229 (353)
T PLN00034 150 LLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229 (353)
T ss_pred EEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence 9999976 5533211 0000 01111 11222
Q ss_pred C-CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 G-SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 g-~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||.+.. +...+.++|||||||++|+|++|+.||....
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 24999996532 3345678999999999999999999998543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=161.35 Aligned_cols=146 Identities=27% Similarity=0.502 Sum_probs=115.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (218)
.+|++.+.||+|+||.||.+.+..++..|++|.+...... ....+.+.+|+.+++++.||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999998643322 1235678899999999999999999998865 4578
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccc-----------cccccC----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEVG---------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~g---------- 146 (218)
+++|||+++ +|.+++...... ++++ .+.++|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999986 899887654321 1111 112222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. +..++.++|||||||++|++++|+.||...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 2399999654 455889999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=164.71 Aligned_cols=156 Identities=26% Similarity=0.417 Sum_probs=122.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||++.++.+++.|++|.+..... .....+.+.+|+.+++.++||||+++++.+..++.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 2334567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+++ +|.+++...... +++|. ..++|
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99987 888887653321 11111 11222
Q ss_pred -------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+.. ..++.++|+|||||++|++++|+.||.+.....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 13899996544 458999999999999999999999998775555444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=159.48 Aligned_cols=154 Identities=27% Similarity=0.464 Sum_probs=122.7
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58999999999999999999989999999999986554555567899999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Cccc------------ccccc--------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRP------------HIKEV-------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~------------~~~~~-------------- 145 (218)
+++ +|.+++...... ++++ ...++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 987 898888653211 1111 11111
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
+ ..|+|||.+ .+..++.++||||||+++|++++|+.||...+.......+
T Consensus 161 ~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 161 VVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred cccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 1 239999955 4455789999999999999999999999877554444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=163.79 Aligned_cols=145 Identities=27% Similarity=0.453 Sum_probs=115.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|+..+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.++++++|++++.+++.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3788899999999999999999999999999987543322 234567789999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC-----------------------------Ccccc-----------cccc--------------
Q 041487 121 YLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~-------------- 145 (218)
|+.+ +|.+++...... ++++. +.++
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9986 888877433211 12221 1122
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 161 RVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred CCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 248999954 4556899999999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=163.00 Aligned_cols=149 Identities=23% Similarity=0.435 Sum_probs=118.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||+|.+..++..+++|.+.... .......+.+|+.+++.++|+|++++++.+..+..+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36888999999999999999999899999999987543 23445678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Ccccc-----------ccccC----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEVG---------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g---------------- 146 (218)
|+.+ +|.+++...... ++++. ..++|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9987 888887764221 11111 11111
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+.. ..++.++||||||+++|+|+||+.||...+...
T Consensus 160 ~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 160 GTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred CCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 13899996554 448999999999999999999999998764333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=161.44 Aligned_cols=146 Identities=29% Similarity=0.529 Sum_probs=116.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|....++..||+|.++... ........+.+|+.+++.++|||++++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999998899999999887543 23344567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhccc----C---------------------------Ccccc-----------ccccC----------
Q 041487 120 EYLDL-DLGSFIRKHTI----T---------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~----~---------------------------~~~~~-----------~~~~g---------- 146 (218)
||+++ +|.+++..... . ++++. +.++|
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99997 88877643111 0 11111 11222
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. +..++.++|+||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 162 AAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred HHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 2389999654 445789999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-22 Score=164.05 Aligned_cols=153 Identities=33% Similarity=0.645 Sum_probs=118.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999999999999999999875544444445667899999999999999999998654
Q ss_pred --CEEEEEEecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC-----
Q 041487 113 --RYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG----- 146 (218)
Q Consensus 113 --~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g----- 146 (218)
...+++|||+.++|.+++...... ++++. +.++|
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 346999999998888776543211 11111 11111
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+.....++.++||||||+++|+|++|+.||.+.+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 238999976655557889999999999999999999998775443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=161.84 Aligned_cols=153 Identities=25% Similarity=0.385 Sum_probs=116.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+.++|++.+.||+|+||.||++..+ .+..+|+|.+.... ...+.+.+|+.++++++||||+++++++......+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3467999999999999999999864 45689999876332 2246788899999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------ 146 (218)
|||+++ +|.+++...... ++++. +.++|
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999986 888887643211 11111 11211
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|++++ |+.||...+.......+
T Consensus 158 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 158 SSGAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred cCCCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 248999954 45568899999999999999999 99999877544443333
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-22 Score=161.98 Aligned_cols=147 Identities=38% Similarity=0.712 Sum_probs=117.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||+|+||.||+|.+..++..+++|.++.... ......+.+|+.+++.++|+||+++++++......+++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4689999999999999999999988999999999875432 233446778999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+.+++.+++...... ++++. ..++|
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 99988887776542211 12111 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|++++|+.||...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 23899997655555788999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=169.27 Aligned_cols=138 Identities=22% Similarity=0.400 Sum_probs=109.2
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.++.+++.+|+|++++... .....+.+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999986532 334456778888888777 899999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 887776543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||.
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 161 NYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 38999954 45668999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=160.29 Aligned_cols=150 Identities=27% Similarity=0.447 Sum_probs=117.6
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE-eCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-TGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~E 120 (218)
+|++.+.||+|++|.||++.++.+++.+|+|.+..........+.+.+|+.++++++|+|++++++.+. .+..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999999888999999998765444455677889999999999999999999876 4557899999
Q ss_pred cCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc--------------
Q 041487 121 YLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV-------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~-------------- 145 (218)
|+++ +|.+++...... ++++.+ .++
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9986 888887652110 222211 111
Q ss_pred ---C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 146 ---G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 146 ---g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
+ ..|+|||. ..+..++.++||||||+++|++++|+.||...+....
T Consensus 161 ~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 210 (257)
T cd08223 161 TLIGTPYYMSPEL-FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210 (257)
T ss_pred cccCCcCccChhH-hcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 1 23899995 4555688999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=165.32 Aligned_cols=150 Identities=24% Similarity=0.424 Sum_probs=118.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||++....++..+++|.+... .....+.+.+|+.++++++|+|++++++.+..+...++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5699999999999999999999888999999998643 33345678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------
Q 041487 121 YLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------- 146 (218)
|+++ +|.+++...... ++++. +.++|
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 9988 888877553211 12221 11222
Q ss_pred ----CcccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 147 ----SPYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 147 ----~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
..|++||.+. ....++.++|+||||+++|+|++|+.||...+....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~ 216 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV 216 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence 2389999654 234578899999999999999999999987654443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=165.95 Aligned_cols=157 Identities=24% Similarity=0.422 Sum_probs=121.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
...+|.+.+.||+|+||.||+|.... .+..+|+|.++... .....+.+.+|+.+++.++|+|++++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 45679999999999999999998743 35789999986432 2234578999999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-----------------------------------------Cccccc---------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-----------------------------------------SIRPHI--------- 142 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------------------~~~~~~--------- 142 (218)
..+++|||+++ +|.+++...... +++|.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999987 998888653210 112211
Q ss_pred --cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 143 --KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 143 --~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
.++| ..|+|||.+ .+..++.++|||||||++|+|++ |..||...+.......+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 1111 238999954 45568999999999999999999 999998775555555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=163.51 Aligned_cols=138 Identities=26% Similarity=0.370 Sum_probs=107.9
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||+|+||.||++.++.+++.+|+|.+...... ....+.+..|+.+++.++|++++++.+++......+++|||+++ +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998754322 23345678899999999999999999999999999999999987 88
Q ss_pred HHHhhhcc-----cC--------------------------Ccccc-----------cccc-----------------C-
Q 041487 127 GSFIRKHT-----IT--------------------------SIRPH-----------IKEV-----------------G- 146 (218)
Q Consensus 127 ~~~~~~~~-----~~--------------------------~~~~~-----------~~~~-----------------g- 146 (218)
.+++.... .. ++++. +.++ |
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 77653211 00 22221 1112 2
Q ss_pred CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 161 PGFMAPELL-QGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCccCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 249999955 4556899999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-22 Score=161.90 Aligned_cols=146 Identities=27% Similarity=0.448 Sum_probs=115.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|+..+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++|++++.+++.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3788899999999999999999999999999987543322 234567889999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC-----------------------------Cccc-----------cccccC-------------
Q 041487 121 YLDL-DLGSFIRKHTIT-----------------------------SIRP-----------HIKEVG------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~g------------- 146 (218)
|+.+ +|.+++...... ++++ .+.++|
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9987 787776432210 1111 112222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|+|||||++|++++|+.||....
T Consensus 161 ~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 161 RVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred CCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 349999965 45568999999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=164.42 Aligned_cols=158 Identities=26% Similarity=0.454 Sum_probs=121.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|++.+.||+|++|.||+|.+.. .+..|++|.++.. ........+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345779999999999999999999876 6788999987633 2222345688899999999999999999999988
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccc--------------ccc
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRP--------------HIK 143 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~--------------~~~ 143 (218)
...+++|||+.+ +|.+++...... ++++ ...
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 899999999976 999887654210 1111 112
Q ss_pred ccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 144 EVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 144 ~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
++| ..|+|||.+. +..++.++|||||||++|+|++ |..||+..+...+...+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 222 1389999654 4558999999999999999997 999998876555555444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=160.68 Aligned_cols=153 Identities=27% Similarity=0.457 Sum_probs=119.5
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|+||.||++++..++..+++|.++... .....+.+.+|+.+++.++|+|++++++.+..+..++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5889999999999999999999999999999986432 233456788899999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc---------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV--------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~--------------- 145 (218)
+++ +|.+++...... ++++.+ .++
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 986 888877542211 222211 111
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
| ..|+|||. ..+..++.++|+||||+++|+|++|+.||...+.......+
T Consensus 160 ~~~~~~~~aPE~-~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 212 (255)
T cd08219 160 YVGTPYYVPPEI-WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212 (255)
T ss_pred ccCCccccCHHH-HccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence 1 12899995 45555899999999999999999999999876544443333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=171.80 Aligned_cols=144 Identities=24% Similarity=0.415 Sum_probs=112.0
Q ss_pred EEeeecCceEEEEEEE---ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 47 EKIGQGVFGEVYKCLN---LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
+.||+|+||.||++.+ +.++..+|+|+++...........+.+|+.++++++||||+++++.+...+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999876 3578999999998654333445667889999999999999999999999999999999998
Q ss_pred C-ChHHHhhhcccC---------------------------Ccccc-----------cccc-----------------C-
Q 041487 124 L-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV-----------------G- 146 (218)
Q Consensus 124 ~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~-----------------g- 146 (218)
+ +|.+++...... ++++. +.++ |
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~ 161 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence 6 888887553221 11111 1122 2
Q ss_pred CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...
T Consensus 162 ~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 162 VEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred hhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCHHH
Confidence 239999954 44557899999999999999999999998765433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=162.48 Aligned_cols=155 Identities=26% Similarity=0.469 Sum_probs=119.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|++|.||+|.. ..+..+++|.+... ....+.+.+|+.++++++|+|++++++.+......++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 5678899999999999999999986 45678999987632 2235788999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV----------- 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~----------- 145 (218)
+|||+.+ +|.+++...... +++|.+ .++
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999976 998887653211 122211 111
Q ss_pred --------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 146 --------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 --------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
...|+|||.+ ....++.++|||||||++|+|+| |+.||...........+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05072 159 TAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218 (261)
T ss_pred eccCCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 1249999954 45558889999999999999999 999998765444444333
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-22 Score=162.07 Aligned_cols=147 Identities=37% Similarity=0.682 Sum_probs=117.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|++|.||+|.++.+++.|++|.++.........+.+.+|+.++++++|+|++++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46999999999999999999999899999999987655555566789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccc-----------ccccc----------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRP-----------HIKEV---------------- 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~-----------~~~~~---------------- 145 (218)
|+++++.+.+...... ++.+ .+.++
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 9998665543332111 1111 01111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++||||||+++|++++|++||...
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123899997665546899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=163.62 Aligned_cols=149 Identities=22% Similarity=0.404 Sum_probs=116.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.+.|++++.||.|+||.||+|++..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 46799999999999999999999999999999998643 3334677888999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
||+++ +|..++...... ++++. +.++|
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99987 666665432110 22221 12222
Q ss_pred -----CcccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 -----SPYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 -----~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||.+. ....++.++|||||||++|+|++|.+||...+..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 2389999654 2344788999999999999999999999876433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=182.31 Aligned_cols=148 Identities=24% Similarity=0.403 Sum_probs=118.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+++.+|+.++++++|||++++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6799999999999999999999999999999998754322 234567899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhccc--------------------------------------CCccccc-----------cc-----
Q 041487 120 EYLDL-DLGSFIRKHTI--------------------------------------TSIRPHI-----------KE----- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~--------------------------------------~~~~~~~-----------~~----- 144 (218)
||+++ +|.+++..... .+++|.+ .+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99987 88887653100 0222211 01
Q ss_pred ------------------------------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 145 ------------------------------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 145 ------------------------------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.| ..|+|||. ..+..++.++|||||||++|+|+||+.||...+.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~-l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER-LLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHH-hcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 12 24999995 4555689999999999999999999999987543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=182.67 Aligned_cols=146 Identities=30% Similarity=0.497 Sum_probs=119.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------CE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------RY 114 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 114 (218)
..+..-+.||+|+||.||+++++.+|+.||||.++... .....++.-+|++++++++|+|||+++++-.+. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 33455678999999999999999999999999997543 445678899999999999999999999997644 36
Q ss_pred EEEEEecCCC-ChHHHhhhcccC------------------------------Cccccc---------------ccc---
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT------------------------------SIRPHI---------------KEV--- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~~~---------------~~~--- 145 (218)
..++||||.+ +|...+.+.... |++|.+ .++
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 8999999987 888888765443 455543 122
Q ss_pred -------------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -------------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -------------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+. |++||...+.++|+.-+|.|||||++|+++||..||-..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 222 999996555688999999999999999999999999755
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-24 Score=182.05 Aligned_cols=139 Identities=29% Similarity=0.502 Sum_probs=115.0
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-C
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-D 125 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~ 125 (218)
-+||+|.||+||.|+++.+....|||.++.. ..+..+-+..|+.++++++|.|||++.+.+-.++.+-|.||-++| +
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 4699999999999999999999999999743 445567899999999999999999999999999999999999988 9
Q ss_pred hHHHhhhc-ccC-----------------------------Cc------------cccccccCCc---------------
Q 041487 126 LGSFIRKH-TIT-----------------------------SI------------RPHIKEVGSP--------------- 148 (218)
Q Consensus 126 L~~~~~~~-~~~-----------------------------~~------------~~~~~~~g~~--------------- 148 (218)
|...+... +.. ++ -.++++||+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 98887653 221 11 1123455543
Q ss_pred ---ccCcccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 149 ---YKAPESRIRSSV-YSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 149 ---y~aPE~~~~~~~-~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|||||.+-++.. |+.++|||||||++.||+||++||.-.
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 999996555533 999999999999999999999999754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=162.27 Aligned_cols=138 Identities=27% Similarity=0.374 Sum_probs=107.6
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||+|+||.||++..+.+++.+|+|.+....... .....+..|++++++++||||+++++.+..+...+++|||+++ +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999987543322 2234556799999999999999999999999999999999986 88
Q ss_pred HHHhhhcccC-----------------------------Cccccc-----------ccc-----------------CCcc
Q 041487 127 GSFIRKHTIT-----------------------------SIRPHI-----------KEV-----------------GSPY 149 (218)
Q Consensus 127 ~~~~~~~~~~-----------------------------~~~~~~-----------~~~-----------------g~~y 149 (218)
.+++...... +++|.+ .++ ...|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 7776432211 222211 111 2349
Q ss_pred cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 150 KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 150 ~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+|||.+. +..++.++||||+||++|+|++|+.||...
T Consensus 161 ~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 161 MAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999654 445899999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-22 Score=159.02 Aligned_cols=147 Identities=30% Similarity=0.540 Sum_probs=117.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|++|.||+|....+++.+++|.++... ......+.+.+|+.++++++|++++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999998899999999987543 23344678999999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC-------------------------------Cccccc-----------ccc-----------
Q 041487 120 EYLDL-DLGSFIRKHTIT-------------------------------SIRPHI-----------KEV----------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~-------------------------------~~~~~~-----------~~~----------- 145 (218)
||+++ +|.+++...... ++.|.+ .++
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99987 998887532110 111111 111
Q ss_pred ------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+ ..|.|||.+ .+..++.++|+|||||++|++++|+.||....
T Consensus 162 ~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 162 AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 1 238899955 45558899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=163.25 Aligned_cols=151 Identities=23% Similarity=0.428 Sum_probs=118.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..|+.++.||.|+||.||+|.+..++..+|+|.++... .....+.+.+|+.+++.++|+|++++++.+......++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35778899999999999999998899999999987542 23345788899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG---------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g---------------- 146 (218)
|+++ +|.+++...... ++.+.+ .++|
T Consensus 83 ~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06640 83 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence 9987 888887653321 111111 1111
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
..|.|||.+ .+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 163 ~~~~y~apE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06640 163 GTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210 (277)
T ss_pred CcccccCHhHh-ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh
Confidence 238999954 4555899999999999999999999999876544333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=167.29 Aligned_cols=139 Identities=22% Similarity=0.383 Sum_probs=110.2
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|.+..+++.+|+|++++... .....+.+.+|+.++.++ .||+|+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999986542 234466788999998888 699999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------cccc-----------------C-C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEV-----------------G-S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~-----------------g-~ 147 (218)
+|.+++...... +++|. +.++ | .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 887776543221 22221 1122 2 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||..
T Consensus 161 ~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 161 NYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 38999954 456689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=162.73 Aligned_cols=145 Identities=50% Similarity=0.866 Sum_probs=118.3
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|++.+.||.|++|.||+|.++.++..||+|.+............+.+|+.+++.++|+|++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999889999999999765544455567889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcc--c-C--------------------------Ccccc-----------cccc-----------------
Q 041487 123 DLDLGSFIRKHT--I-T--------------------------SIRPH-----------IKEV----------------- 145 (218)
Q Consensus 123 ~~~L~~~~~~~~--~-~--------------------------~~~~~-----------~~~~----------------- 145 (218)
+++|.+++.... . . ++.+. ..++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 160 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence 889998876544 1 0 11111 1111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++|+||||+++|+|++|+.||...
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223899997666566789999999999999999999999866
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=167.74 Aligned_cols=143 Identities=20% Similarity=0.325 Sum_probs=114.3
Q ss_pred EEEEeeec--CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 45 VVEKIGQG--VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 45 ~~~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
++++||+| +|++||++.++.+++.||+|.++.........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999999999999999998765444455667888999999999999999999999999999999999
Q ss_pred CC-ChHHHhhhcccC-----------------------------Cccccc-----------cc-----------------
Q 041487 123 DL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KE----------------- 144 (218)
Q Consensus 123 ~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~----------------- 144 (218)
++ +|.+++..+... ++++.+ .+
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 86 888887543211 222211 00
Q ss_pred --------cCCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 --------VGSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 --------~g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
....|+|||.+... ..++.++|||||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 11238999976543 45889999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=159.06 Aligned_cols=150 Identities=30% Similarity=0.506 Sum_probs=118.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|+||.+|++.+..+++.+++|.+............+.+|+.++++++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58999999999999999999988999999999875444444456788999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Cccc-----------ccccc---------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRP-----------HIKEV--------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~--------------- 145 (218)
+.+ +|.+++...... ++++ .+.++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 986 888887653210 1111 11111
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
| ..|+|||.+ .+..++.++|+|||||+++++++|+.||...+....
T Consensus 161 ~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08218 161 CIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209 (256)
T ss_pred ccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence 1 238899954 455588899999999999999999999986644333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-22 Score=158.26 Aligned_cols=146 Identities=27% Similarity=0.442 Sum_probs=117.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||+|.+..++..+++|.+..... ...+.+.+|+.+++.++|||++++++.+.....++++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 679999999999999999999988899999999975432 246789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhc-ccC---------------------------Ccccc-----------ccccC--------------
Q 041487 121 YLDL-DLGSFIRKH-TIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~-~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
|+++ +|.+++... ... ++++. +.++|
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 9987 888877654 111 12221 12221
Q ss_pred ----CcccCcccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRS--SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+... ..++.++|+||||+++|+|++|+.||....
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 138999965433 257889999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=164.52 Aligned_cols=159 Identities=26% Similarity=0.451 Sum_probs=121.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCC-----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETG-----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|++.+.||+|+||.||+|.....+ ..+++|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 34568999999999999999999876544 67999988633 2233456788999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Ccccc-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPH------- 141 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~------- 141 (218)
...+++|||+++ +|.+++...... +++|.
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999986 998888653110 22221
Q ss_pred ----ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 142 ----IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 142 ----~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
+.++| ..|+|||.+. +..++.++|||||||++|+|++ |..||.+.....+...+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 12222 2399999654 4458999999999999999998 99999887655555544
Q ss_pred HH
Q 041487 197 RY 198 (218)
Q Consensus 197 ~~ 198 (218)
..
T Consensus 240 ~~ 241 (283)
T cd05048 240 RS 241 (283)
T ss_pred Hc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=168.95 Aligned_cols=94 Identities=22% Similarity=0.408 Sum_probs=76.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 111 (218)
+..++|++.+.||+|+||.||+|.+. ..+..||+|.++.. ......+.+.+|+.++..+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 44578999999999999999999752 34568999998643 2233456788999999999 89999999998864
Q ss_pred -CCEEEEEEecCCC-ChHHHhhh
Q 041487 112 -GRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 112 -~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
...++++|||+++ +|.+++..
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~ 105 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRA 105 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHh
Confidence 4568999999987 99888764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=184.18 Aligned_cols=181 Identities=25% Similarity=0.397 Sum_probs=141.9
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCC---cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETG---KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
-..+++..+.+|.++||.|.||.|++|+.+..+ ..||||.++.. ..+.+...|+.|+.+|.+++||||+++.++-.
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 345678888999999999999999999987555 57999999854 34556788999999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC---------------------------------------CccccccccCC---
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------SIRPHIKEVGS--- 147 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------~~~~~~~~~g~--- 147 (218)
....+.||+|||+. +|+.|++.+-.. ...-++++||.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999976 999998875332 11112344443
Q ss_pred ------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC-CCcchHHHHHHHhcccCcccc
Q 041487 148 ------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPC-GKKDHLSLIVRYFTALTNYLV 207 (218)
Q Consensus 148 ------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~-~~~~~~~~~~~~~~~~~~~~~ 207 (218)
.|.|||. +....++.++||||+|+++||.++ |..||=. .+.+.+..+.+...-|++-.=
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEA-Ia~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEA-IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhH-hhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence 2999995 556669999999999999999999 9888754 488888888887665555444
Q ss_pred hhhhhhhcc
Q 041487 208 LPCFLSIML 216 (218)
Q Consensus 208 ~~~~~~~~l 216 (218)
+......||
T Consensus 860 P~aL~qLMl 868 (996)
T KOG0196|consen 860 PAALYQLML 868 (996)
T ss_pred cHHHHHHHH
Confidence 444455554
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-22 Score=160.30 Aligned_cols=147 Identities=29% Similarity=0.565 Sum_probs=117.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||+|++|.||+|.+..++..+++|.+..... ...+.+.+|+.+++.+.|+|++++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 4579999999999999999999988999999999875432 23467889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC--------------------------Cccc-----------cccccC---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT--------------------------SIRP-----------HIKEVG--------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~--------------------------~~~~-----------~~~~~g--------------- 146 (218)
||+++ +|.+++...... +++| .+.++|
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 99987 898887643211 1111 112222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+.
T Consensus 177 ~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 177 VGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 248999954 455578999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=162.71 Aligned_cols=159 Identities=28% Similarity=0.432 Sum_probs=120.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+..++|++.+.||+|+||.||+|... ..+..+++|.++... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 34578999999999999999999853 356789999987432 2333467889999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhccc--------------------------------------------CCcccc-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTI--------------------------------------------TSIRPH------- 141 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~--------------------------------------------~~~~~~------- 141 (218)
..|++|||+++ +|.+++..... .+++|.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999987 89888742210 012221
Q ss_pred ----ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 142 ----IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 142 ----~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..++| ..|+|||.+. +..++.++|||||||++|+|++ |..||.+.....+...+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 12222 1399999554 4558999999999999999999 99999876555555544
Q ss_pred HH
Q 041487 197 RY 198 (218)
Q Consensus 197 ~~ 198 (218)
..
T Consensus 240 ~~ 241 (283)
T cd05090 240 RK 241 (283)
T ss_pred Hc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=178.18 Aligned_cols=155 Identities=21% Similarity=0.356 Sum_probs=128.6
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
...+++..+...+...||+|+||+||+|.+ ...||||.+.......+..+.|..|+.++++-+|.||+-+-+++...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 356667777888999999999999999985 56799999998877778899999999999999999999999999877
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------------------CccccccccCCc----
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------SIRPHIKEVGSP---- 148 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------~~~~~~~~~g~~---- 148 (218)
.. .||+-+|++ +|+.++.-.... +.+.++.+||..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 66 999999998 898887654332 244455666654
Q ss_pred ----------------ccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 149 ----------------YKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 149 ----------------y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
|||||++.. ..+|+..+||||||+++|||+||.+||.....+.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 999996433 4669999999999999999999999999664443
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=160.94 Aligned_cols=145 Identities=36% Similarity=0.619 Sum_probs=113.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC--CEEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG--RYVYLVF 119 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~ 119 (218)
|++.+.||+|+||.||+|++..++..+|+|.++....... .....+|+.+++++ +|+|++++++++.+. +.++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 6789999999999999999998999999999875432222 23345788888888 599999999999877 8999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Ccccc----------cccc----------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPH----------IKEV---------------- 145 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~----------~~~~---------------- 145 (218)
||+++++.+++...... ++++. +.++
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~ 159 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYI 159 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCC
Confidence 99998888887653211 11111 1111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+..++.++.++|||||||++|+|++|+.||++.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 1238999976666668899999999999999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=163.38 Aligned_cols=149 Identities=22% Similarity=0.419 Sum_probs=118.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++++.||+|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++.+......++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 44678999999999999999999998899999999987432 33446788999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC----------------------------Cccc-----------ccccc------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT----------------------------SIRP-----------HIKEV------------ 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~----------------------------~~~~-----------~~~~~------------ 145 (218)
||||+++ +|.+++...... ++++ .+.++
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 9999987 887776543211 1111 11122
Q ss_pred ----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+. +..++.++|||||||++|++++|+.||....
T Consensus 161 ~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 161 TFVGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred ccccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 22489999654 4468899999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=163.24 Aligned_cols=149 Identities=21% Similarity=0.413 Sum_probs=118.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.++++++||||+++++.+..++.++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46999999999999999999999999999999986432 22344568899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC----------------------------Cccc-----------cccccC--------------
Q 041487 121 YLDL-DLGSFIRKHTIT----------------------------SIRP-----------HIKEVG-------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~----------------------------~~~~-----------~~~~~g-------------- 146 (218)
|+++ +|.+++...... ++++ .+.++|
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 9987 898887543211 1111 112222
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||. ..+..++.++|+|||||++|++++|+.||...+...
T Consensus 160 ~~~~~~aPE~-~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 160 GTRSYMSPER-LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred CCcCccChhH-hcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 24999995 455568899999999999999999999997654333
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=166.97 Aligned_cols=183 Identities=20% Similarity=0.320 Sum_probs=137.2
Q ss_pred CChhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeee
Q 041487 30 NGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLD 107 (218)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (218)
++......+...+|.++.+||+|+|++|.++..+++.+.+|+|+++++. ...++.+....|..+.... +||.+|.++.
T Consensus 239 ~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 239 DGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred cccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 3334556677889999999999999999999999999999999999876 4556678888888888887 7999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC--------------------------------------------------
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------------- 136 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------------- 136 (218)
+|+....+++|.||+++ +|--.++.+...
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence 99999999999999975 443333322111
Q ss_pred -----CccccccccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CcchHHHHHHHhcccCcccc
Q 041487 137 -----SIRPHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG---KKDHLSLIVRYFTALTNYLV 207 (218)
Q Consensus 137 -----~~~~~~~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~---~~~~~~~~~~~~~~~~~~~~ 207 (218)
........+|++ |.||| +.++..|+.++|.|+||++++||+.|+.||+-. +++...............++
T Consensus 399 ke~l~~gd~tstfcgtpnyiape-ilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred hcCCCCCcccccccCCCcccchh-hhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 111112345655 99999 677878999999999999999999999999732 44444333333333344555
Q ss_pred hhhhhh
Q 041487 208 LPCFLS 213 (218)
Q Consensus 208 ~~~~~~ 213 (218)
+|+.+|
T Consensus 478 iprsls 483 (593)
T KOG0695|consen 478 IPRSLS 483 (593)
T ss_pred ccceee
Confidence 555544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=163.56 Aligned_cols=149 Identities=24% Similarity=0.384 Sum_probs=117.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..|.+.+.||+|+||.||+|+...+++.|++|.+.... ......+.+.+|+.+++.++|||++++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45899999999999999999998899999999986433 22334467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+.+++.+++...... ++.+. +.++|
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCC
Confidence 99998887776532111 12221 12222
Q ss_pred CcccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 SPYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 ~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+.. ...++.++||||||+++|++++|+.||...+.
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 23899996642 35588899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-24 Score=177.74 Aligned_cols=138 Identities=22% Similarity=0.352 Sum_probs=107.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+-.+...-++=||.|+-|.||+|+. .++.||||.++ +.-..++.-|++++||||+.+.++|.....+||
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 3334444567799999999999986 88999999764 222356777999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC--------------------------------------CccccccccCC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT--------------------------------------SIRPHIKEVGS----------- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~--------------------------------------~~~~~~~~~g~----------- 147 (218)
|||||.. .|...++..... +-..++.+||+
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence 9999975 666666553322 11122344444
Q ss_pred ------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 ------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 ------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+||||| ++.+.+.+.++||||||||||||+||..||-..
T Consensus 270 SFaGTVaWMAPE-vIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 270 SFAGTVAWMAPE-VIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhhhhHhhhCHH-HhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 399999 788888999999999999999999999999643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=176.25 Aligned_cols=172 Identities=22% Similarity=0.353 Sum_probs=139.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
..++++..+.....+||-|-||.||.|..++....||||.++. +....+.|+.|+.+|+.++|||+|+++++|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4556777778889999999999999999999999999999873 4455789999999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccCC----------------------------------------ccccccccCCc----
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTITS----------------------------------------IRPHIKEVGSP---- 148 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~~----------------------------------------~~~~~~~~g~~---- 148 (218)
.+|||+|||.- .|.||++.+.... .-.++.+||..
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999975 9999998765431 11122344432
Q ss_pred ---------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 149 ---------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 149 ---------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
|.|||-+. .+.++.++|||+|||+|||++| |--||++.+......+.+....+..+-..|
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred CCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 99999654 5558999999999999999999 999999988777777666655554444443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=160.09 Aligned_cols=147 Identities=25% Similarity=0.444 Sum_probs=115.3
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|++..++..+|+|.+.... ......+.+|+.+++.++|||++++++.+......+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3467999999999999999999998899999999986432 23345688999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccc-----------ccccc--------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEV-------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~-------------- 145 (218)
|||+++ +|.+++...... ++++ .+.++
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 999987 888877543221 1111 11111
Q ss_pred ---C-CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---G-SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---g-~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+. ....++.++|+|||||++|+|++|+.||...
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1 2389999653 2344778999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-22 Score=159.03 Aligned_cols=146 Identities=46% Similarity=0.821 Sum_probs=118.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||.|++|.||+|++..++..||+|.++.... ....+.+.+|+.+++.++|+|++++++.+...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999988999999999875432 23346677899999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC------------------------------Cccccc-----------ccc---------------
Q 041487 122 LDLDLGSFIRKHTIT------------------------------SIRPHI-----------KEV--------------- 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~------------------------------~~~~~~-----------~~~--------------- 145 (218)
++++|.+++...... ++++.+ .++
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 999998887654310 111111 111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|++||.+.....++.++|||||||++|++++|+.||...+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1238999976666667899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=161.04 Aligned_cols=145 Identities=35% Similarity=0.645 Sum_probs=117.9
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|++.+.||+|+||.||++.+..+++.+|+|.+..............+|+.++++++||||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999865433333344556999999999999999999999999999999999
Q ss_pred CC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------------
Q 041487 123 DL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------------- 146 (218)
Q Consensus 123 ~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------------- 146 (218)
.+ +|.+++...... +++|.+ .++|
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99 999988733221 233322 1122
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|.|||.+..+..++.++||||+|+++|+|++|..||...
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc
Confidence 12899996543677899999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=159.24 Aligned_cols=155 Identities=24% Similarity=0.432 Sum_probs=119.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|++|.||+|... .+..||+|.++... ...+.+.+|+.++++++|+|++++++++...+..++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 45678999999999999999999864 45789999986432 234678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||+.+ +|.+++...... ++++.+ .++|
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999965 999988654310 222221 1211
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||. ..+..++.++||||||+++|+++| |+.||.+.+...+...+.
T Consensus 159 ~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05068 159 EAREGAKFPIKWTAPEA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218 (261)
T ss_pred cccCCCcCceeccCccc-cccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 13899994 455668999999999999999999 999998875554444433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=160.87 Aligned_cols=147 Identities=46% Similarity=0.790 Sum_probs=116.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE-----
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY----- 114 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----- 114 (218)
++|++.+.||+|+||.||+|.+..++..||+|.++...........+.+|+.+++.+ .|+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 469999999999999999999999999999999876544444556788899999999 46999999999876555
Q ss_pred EEEEEecCCCChHHHhhhccc------C--------------------------Cccc------------cccccC----
Q 041487 115 VYLVFEYLDLDLGSFIRKHTI------T--------------------------SIRP------------HIKEVG---- 146 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~------~--------------------------~~~~------------~~~~~g---- 146 (218)
.|++|||++++|.+++..... . ++++ ...++|
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999999888754311 0 1111 112222
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++||||||+++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 23899997766566889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=160.28 Aligned_cols=149 Identities=28% Similarity=0.470 Sum_probs=114.5
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-C
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-D 125 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~ 125 (218)
+.||+|+||.||+|.++.++..+|+|.+... ........+.+|+.+++.++||||+++++++......++||||+.+ +
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999999889999999987643 2333456789999999999999999999999999999999999977 8
Q ss_pred hHHHhhhcccC----------------------------Ccccc-----------ccccC--------------------
Q 041487 126 LGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------------- 146 (218)
Q Consensus 126 L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------------- 146 (218)
|.+++...... +++|. ..++|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 98887653211 12221 12222
Q ss_pred CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|++++ |..||...........+.
T Consensus 160 ~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~ 210 (252)
T cd05084 160 VKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210 (252)
T ss_pred eeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence 138999954 55558999999999999999998 899997665444444333
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=164.54 Aligned_cols=157 Identities=29% Similarity=0.414 Sum_probs=119.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcE--EEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGR 113 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (218)
.+..++|++.+.||+|+||.||+|.++.++.. +++|.++.. ........+.+|+.++.++ +|+||+++++++..++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45678899999999999999999998777654 566765422 2333456788899999999 8999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Ccccc--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPH-------- 141 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~-------- 141 (218)
.++++|||+++ +|.+++...... +++|.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 99999999976 898888643210 12221
Q ss_pred ---ccccC-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 142 ---IKEVG-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 142 ---~~~~g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
+.++| ..|+|||.+ .+..++.++|||||||++|+++| |..||...+.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 235 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 12222 239999954 55568899999999999999998 9999987655544443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=162.79 Aligned_cols=147 Identities=34% Similarity=0.643 Sum_probs=115.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..........+.+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46899999999999999999998889999999987554444456678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~---------------- 145 (218)
|+++ .|.++....... ++.+. ..++
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 9987 444443322110 11111 1111
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++||||||+++|+|++|++||+..
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 123899997765556788999999999999999999999765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-21 Score=158.90 Aligned_cols=146 Identities=32% Similarity=0.592 Sum_probs=116.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.+|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 56999999999999999999998999999999987432 2335678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Ccccc-----------ccccC----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEVG---------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g---------------- 146 (218)
|+++ +|.+++...... ++++. +.++|
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06655 97 YLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (296)
T ss_pred ecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence 9987 887776553221 11111 11221
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+ ....++.++|||||||++|++++|+.||...+.
T Consensus 177 ~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 177 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred CCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 238999954 445588999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=161.23 Aligned_cols=159 Identities=25% Similarity=0.442 Sum_probs=119.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|++.+.||+|+||.||+|.++. .+..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999998642 35679999875322 222345688999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-------------------------------------Ccccc-----------cc
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------SIRPH-----------IK 143 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------~~~~~-----------~~ 143 (218)
...+++|||+++ +|.+++...... +++|. ..
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 999999999987 898887642110 11111 12
Q ss_pred ccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 144 EVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 144 ~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
++| ..|+|||.+ .+..++.++|||||||++|+|++ |..||...........+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 222 139999954 45568999999999999999999 7899987765555444433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=160.97 Aligned_cols=157 Identities=26% Similarity=0.400 Sum_probs=119.3
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
...+|++.+.||+|+||.||+|..+.++. .|++|.+.... .......+..|+.+++.++||||+++++++..+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 34679999999999999999999876554 69999986432 233456889999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------- 146 (218)
+++|||+++ +|.+++...... ++++.+ .++|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999987 888887653211 122211 1111
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++||+++ |..||...+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred cccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 138999954 45568999999999999999987 999998765444444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=160.68 Aligned_cols=146 Identities=24% Similarity=0.455 Sum_probs=110.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHH-HhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSL-LKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||++.++.++..||+|.++....... ...+..|+.+ ++..+|||++++++.+..++.++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 479999999999999999999999999999999875433332 3345555554 66679999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC--------------------------------Ccccc-----------ccccC----------
Q 041487 120 EYLDLDLGSFIRKHTIT--------------------------------SIRPH-----------IKEVG---------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~--------------------------------~~~~~-----------~~~~g---------- 146 (218)
||++++|.+++...... ++++. +.++|
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99998887776542100 11111 11221
Q ss_pred -------CcccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -------SPYKAPESRIRS---SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -------~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+... ..++.++|+|||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 238999965432 34688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=161.82 Aligned_cols=150 Identities=34% Similarity=0.693 Sum_probs=116.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-------- 111 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 111 (218)
.++|++.+.||+|++|.||+|.++.+++.+++|.+............+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999997654444444567789999999999999999998753
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc-------
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV------- 145 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~------- 145 (218)
...++++|||+..++.+++...... ++++. ..++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 3357999999988777665432111 11111 1111
Q ss_pred ----------------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 ----------------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 ----------------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
...|+|||.+.....++.++|||||||++|+|++|++||.+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 11289999766666689999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=159.04 Aligned_cols=156 Identities=24% Similarity=0.392 Sum_probs=118.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
..++|++.+.||+|+||.||+|..+.. ...+|+|.++... .......+.+|+.+++.++||||+++++.+......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 457899999999999999999987643 4579999886432 233456788899999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------- 146 (218)
+++|||+++ +|.+++...... +++|.+ .++|
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999987 899887653211 222211 1111
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|++++ |..||.......+...+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred cceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 238999954 45558999999999999999998 99999766544444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-22 Score=157.68 Aligned_cols=152 Identities=25% Similarity=0.454 Sum_probs=118.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|++|.||+|... .+..+++|.+.... ...+.+.+|+.+++.++|+|++++++++......++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 56788999999999999999999864 56789999886432 234678899999999999999999999998899999
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||+++ +|.+++...... ++++.+ .++|
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999987 898888653211 122211 1221
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+ .+..++.++|+||||+++|++++ |+.||.+.+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05034 159 TAREGAKFPIKWTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE 215 (261)
T ss_pred hhhhccCCCccccCHHHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 248999954 45568999999999999999999 999998775444333
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-22 Score=160.96 Aligned_cols=150 Identities=33% Similarity=0.663 Sum_probs=117.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR----- 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 113 (218)
..++|++.+.||+|++|.||+|.++.++..||+|.++...........+.+|+.++++++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999989999999999765444445567788999999999999999999986544
Q ss_pred -----EEEEEEecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc----
Q 041487 114 -----YVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV---- 145 (218)
Q Consensus 114 -----~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~---- 145 (218)
.+++++||+++++.+++...... ++++. +.++
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 79999999998877776543110 11111 1111
Q ss_pred ---------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|+|++|++||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1238999966555557899999999999999999999998663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=160.59 Aligned_cols=152 Identities=27% Similarity=0.439 Sum_probs=116.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCC---cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETG---KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
..++|++.+.||+|+||.||+|..+.++ ..+|+|.++... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4578999999999999999999876443 379999886432 223356788999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g--------- 146 (218)
+++|||+++ +|.+++...... +++|. ..++|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999986 898888654211 11111 11111
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
..|+|||.+ .+..++.++|+|||||++|++++ |..||........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred ceeeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 138999954 45558999999999999999887 9999987644433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=162.72 Aligned_cols=166 Identities=23% Similarity=0.391 Sum_probs=118.0
Q ss_pred eEEEEeeecCceEEEEEEEc----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 44 KVVEKIGQGVFGEVYKCLNL----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++.+.||.|+||.||+|... ..+..|+||.++.. ......+.+.+|+..+++++||||+++++++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 34678999998532 22234678999999999999999999999999888899999
Q ss_pred ecCCC-ChHHHhhhcccC-----------------------------Cc-----------ccccccc-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT-----------------------------SI-----------RPHIKEV------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~-----------------------------~~-----------~~~~~~~------------- 145 (218)
||++. +|.+++...... ++ ..++.++
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99986 999999886111 11 1111111
Q ss_pred -------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhhh
Q 041487 146 -------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPCF 211 (218)
Q Consensus 146 -------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (218)
...|+|||.+. +..++.++||||||+++||+++ |+.||...+...+...+.....++.+...|..
T Consensus 161 ~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKD 233 (259)
T ss_dssp ESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHH
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccceeccchhHH
Confidence 12399999544 4448999999999999999999 78999877555544444443443333333333
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=159.73 Aligned_cols=147 Identities=28% Similarity=0.545 Sum_probs=116.8
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC---CCCeeeeeeeEEeCCEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---HDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 118 (218)
.|++.+.||+|+||.||+|.+..++..+++|.++... .....+.+.+|+.+++.+. |||++++++++......+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4788899999999999999998899999999987432 3334567888999999986 99999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC--------------------------Ccccc-----------cccc---------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~--------------- 145 (218)
|||+++ +|.+++...... ++.+. ..++
T Consensus 81 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 81 MEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred EecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 999987 888887654321 11111 1112
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
| ..|+|||.+..+..++.++|+|||||++|+|++|+.||...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 1389999776666678999999999999999999999986643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=159.37 Aligned_cols=158 Identities=23% Similarity=0.427 Sum_probs=119.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+..++|+..+.||+|++|.||+|....++. .+++|.++... .....+.+.+|+.+++.++|+|++++.+++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 446789999999999999999999865544 78999886432 22335678899999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------- 146 (218)
.+++|||+++ +|.+++...... ++++. ..++|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999987 888887653211 11111 11221
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ ....++.++|||||||++|++++ |+.||...+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~ 224 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224 (268)
T ss_pred cccceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 138999954 44558999999999999999998 999998765544444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-22 Score=158.76 Aligned_cols=147 Identities=38% Similarity=0.744 Sum_probs=118.4
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEEEEEe
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVYLVFE 120 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~E 120 (218)
|++.+.||.|++|.||+|....++..+|+|.++.........+.+.+|+.+++.++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6789999999999999999988899999999986654445567788999999999999999999999877 89999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Ccccc-----------ccc-----------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKE----------------- 144 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~----------------- 144 (218)
|++++|.+++...... ++++. +.+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 9998888877554111 11111 111
Q ss_pred --cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 145 --VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 145 --~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
....|+|||.+.....++.++||||||+++|+|++|+.||...+.
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 123389999766555688999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=158.96 Aligned_cols=149 Identities=27% Similarity=0.409 Sum_probs=114.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
...+|++.+.||+|+||.||.+... .+..+|+|.++.... ..+.+.+|+.++++++||||+++++++......+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3567999999999999999999764 345699998764322 246788999999999999999999999988899999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------ 146 (218)
|||+.+ +|.+++...... ++++. +.++|
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999976 888887653211 11111 11111
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
..|++||.+ .+..++.++|||||||++|+|++ |+.||...+....
T Consensus 158 ~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 158 SVGSKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred cCCCccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 238999954 44558899999999999999999 9999987654433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-22 Score=158.51 Aligned_cols=151 Identities=23% Similarity=0.436 Sum_probs=116.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
-|++.+.||.|+||.||+|.+..++..+|+|.+.... .....+.+.+|+.++++++|||++++++.+..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4788899999999999999988889999999876432 223456788999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC--------------------------Ccccc-----------cccc-----------------C
Q 041487 122 LDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEV-----------------G 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~-----------------g 146 (218)
+++ +|.+++...... ++++. +.++ +
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccC
Confidence 987 888877543221 11111 1122 1
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+. ...++.++|+|||||++|++++|..||..........
T Consensus 164 ~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 211 (277)
T cd06641 164 TPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211 (277)
T ss_pred CccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence 2378999544 4557889999999999999999999998765443333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=159.02 Aligned_cols=152 Identities=26% Similarity=0.372 Sum_probs=116.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||+|+||.||++.++ .+..+|+|.+..... ....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 456899999999999999999875 567899998864322 2356888999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
||+++ +|.+++...... +++|. +.++|
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99976 899887643211 11111 11221
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|++++ |+.||...+.......+
T Consensus 159 ~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 159 QGTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCCCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 139999954 45558999999999999999999 89999876544444433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=160.43 Aligned_cols=159 Identities=27% Similarity=0.445 Sum_probs=121.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|++.+.||+|+||.||+|..+.. +..+|+|.+.... .......+.+|+.+++.++|+|++++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 5567899999999999999999987643 4789999975332 223345788999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-------------------------------------Cccccc-----------c
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------SIRPHI-----------K 143 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------~~~~~~-----------~ 143 (218)
...+++|||+++ +|.+++...... +++|.+ .
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 999999999975 998887542110 122211 1
Q ss_pred ccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 144 EVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 144 ~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
++| ..|+|||.+. ...++.++|||||||++|+++| |+.||...+.......+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 222 2389999654 4458999999999999999998 9999987766665555553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=159.66 Aligned_cols=146 Identities=24% Similarity=0.422 Sum_probs=115.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|++..++..+|+|.++... ......+.+|+.+++.++|||++++++.+...+..+++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 457899999999999999999998899999999987542 223456788999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+++ +|.+++...... ++++. +.++|
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 99987 888877543321 11111 11222
Q ss_pred ----CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. ....++.++|+|||||++|+|++|+.||...
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 2389999653 2445788999999999999999999999655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=179.18 Aligned_cols=179 Identities=23% Similarity=0.321 Sum_probs=131.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee-EE----
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV-LT---- 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~---- 110 (218)
.+...+.++.+.|.+|+|+.||+|++...+..+|+|.+-.. +....+.+.+|+++|+.| .|+|||.+++. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 35566788999999999999999999888899999987643 566788999999999999 49999999993 22
Q ss_pred -e-CCEEEEEEecCCC-ChHHHhhhcccC-------------------------------Cccccc-----------ccc
Q 041487 111 -T-GRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------SIRPHI-----------KEV 145 (218)
Q Consensus 111 -~-~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------~~~~~~-----------~~~ 145 (218)
. ..++.|+||||.+ +|.||+...... |++.++ =+|
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 2 3579999999995 999999754222 111111 123
Q ss_pred CCc---------------------------ccCccc--ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHH
Q 041487 146 GSP---------------------------YKAPES--RIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLI 195 (218)
Q Consensus 146 g~~---------------------------y~aPE~--~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~ 195 (218)
|++ |.|||. +..+...+.++|||+|||+||.|+-...||+.. ....+.-.
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 322 999995 344677999999999999999999999999876 33333333
Q ss_pred HHHhcccCcccchhhhhhhccc
Q 041487 196 VRYFTALTNYLVLPCFLSIMLL 217 (218)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~l~ 217 (218)
......+..+-.+-+++..||.
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQ 292 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhc
Confidence 3322223334555555666653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-22 Score=160.53 Aligned_cols=147 Identities=35% Similarity=0.657 Sum_probs=118.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+|++.+.||+|++|.||+|.+..+++.|++|.++..... ......+..|+.++++++|+|++++++++.....+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999888999999999765433 33456677899999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcc-cC---------------------------Cccccc-----------ccc--------------
Q 041487 119 FEYLDLDLGSFIRKHT-IT---------------------------SIRPHI-----------KEV-------------- 145 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~-~~---------------------------~~~~~~-----------~~~-------------- 145 (218)
|||+.++|.+++.... .. ++++.+ .++
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence 9999769999886654 11 122111 111
Q ss_pred ----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|++++|.+||....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 1238999976555668899999999999999999988888663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-22 Score=171.05 Aligned_cols=160 Identities=20% Similarity=0.399 Sum_probs=116.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC------CCeeeeeeeEEe-
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH------DNIVRLLDVLTT- 111 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~- 111 (218)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ........|+.++..+.| .+++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3578999999999999999999999999999999986321 223345567766666644 458888888864
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC----------------------------Cccc-----------------------
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRP----------------------- 140 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~----------------------- 140 (218)
....++|||++.++|.+++...... +++|
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 4579999999988888776543211 1221
Q ss_pred ----cccccC---------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhc
Q 041487 141 ----HIKEVG---------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFT 200 (218)
Q Consensus 141 ----~~~~~g---------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~ 200 (218)
++.++| ..|+|||.+ .+..++.++|||||||++|||++|++||.+.+ .+.+..+.+.++
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHh-hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 223333 249999965 45568999999999999999999999998763 344455555444
Q ss_pred cc
Q 041487 201 AL 202 (218)
Q Consensus 201 ~~ 202 (218)
.+
T Consensus 363 ~~ 364 (467)
T PTZ00284 363 RL 364 (467)
T ss_pred CC
Confidence 43
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-22 Score=165.02 Aligned_cols=149 Identities=32% Similarity=0.505 Sum_probs=116.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
...+|++.+.||+|+||.||+|.+..++..+|+|.+............+.+|+.++++++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 46789999999999999999999999999999999875444444556778899999999999999999988643
Q ss_pred CEEEEEEecCCCChHHHhhhcccC-------------------------Ccccc-----------cccc-----------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPH-----------IKEV----------- 145 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~-----------~~~~----------- 145 (218)
...|+||||+.++|.+++...... +++|. ..++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 173 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC
Confidence 357999999998888776432110 22221 1111
Q ss_pred ------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+ .+..++.++|||||||++|+|++|+.||...+
T Consensus 174 ~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 174 MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 1238999954 45568999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=155.92 Aligned_cols=148 Identities=26% Similarity=0.411 Sum_probs=118.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||+|....++..+++|.+....... ..+.+.+|+.+++.++|+|++++++.+......+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999988889999999986543333 56789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhccc----C--------------------------Ccccc-----------ccc--------------
Q 041487 121 YLDL-DLGSFIRKHTI----T--------------------------SIRPH-----------IKE-------------- 144 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~----~--------------------------~~~~~-----------~~~-------------- 144 (218)
++++ +|.+++..... . ++.+. ..+
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9987 88888765322 0 11111 011
Q ss_pred -------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 145 -------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 145 -------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.| ..|+|||.+.....++.++|+|||||++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 12 2389999766655689999999999999999999999986643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-22 Score=161.86 Aligned_cols=149 Identities=23% Similarity=0.413 Sum_probs=118.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.+|++.+.||+|++|.||+|.+..++..+|+|.+....... ...+.+.+|+.+++.++|++|+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999998899999999997654332 35667889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cc--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KE-------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~-------------- 144 (218)
||+.+ +|.+++...... ++++.+ .+
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99987 888887643211 122111 11
Q ss_pred --------------------------------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 145 --------------------------------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 145 --------------------------------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
.| ..|+|||.+. +..++.++||||||+++|+|++|+.||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 11 2389999654 455789999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-21 Score=155.95 Aligned_cols=146 Identities=27% Similarity=0.517 Sum_probs=113.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC---CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (218)
.+|++.+.||+|++|.||+|.+..++..+++|.+..... .......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998864321 22345678899999999999999999999865 4578
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccc-----------ccccc-----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEV----------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~----------- 145 (218)
++++||+++ +|.+++...... ++++ .+.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999986 888887653221 1111 11111
Q ss_pred ---------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+ ..|+|||.+. +..++.++|+|||||++|++++|+.||...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1 2389999544 455789999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-22 Score=156.91 Aligned_cols=147 Identities=27% Similarity=0.507 Sum_probs=117.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|+||.||++..+.++..+|+|.+..........+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58899999999999999999999999999999976544444556788999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC-----------------------------Cccc------------ccccc--------------
Q 041487 122 LDL-DLGSFIRKHTIT-----------------------------SIRP------------HIKEV-------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~-----------------------------~~~~------------~~~~~-------------- 145 (218)
+++ +|.+++...... ++++ ...++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 977 888887543211 1111 11111
Q ss_pred ---C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 146 ---G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 146 ---g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
| ..|+|||.+ ....++.++|+||||+++|++++|+.||...+.
T Consensus 161 ~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 161 TCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred ccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 1 138899954 444588999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-22 Score=161.86 Aligned_cols=150 Identities=34% Similarity=0.580 Sum_probs=119.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-CCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-GRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 117 (218)
..++|++.+.||+|+||.||+|.+..++..+|+|.+.+........+.+.+|+.+++.++|||++++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4678999999999999999999999999999999987554444556778899999999999999999999865 567999
Q ss_pred EEecCCCChHHHhhhcccC--------------------------Ccccc-----------ccccC--------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g-------------- 146 (218)
++||++++|.+++...... ++++. ..++|
T Consensus 88 v~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 167 (328)
T cd07856 88 VTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS 167 (328)
T ss_pred EeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCcc
Confidence 9999988887776542211 11111 11111
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|++++|+.||...+
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 238999976555668999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=163.81 Aligned_cols=149 Identities=25% Similarity=0.450 Sum_probs=115.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+-|+..+.||+|+||.||+|.+..++..||+|.++... .....+.+.+|+.++++++|||++++++.+..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34677788999999999999998889999999986442 22345678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Ccccc-----------cccc-----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEV----------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~----------------- 145 (218)
|+++ +|.+++...... ++.+. ..++
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 83 YLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred ccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 9987 887776543221 11111 1111
Q ss_pred C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 146 G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 146 g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
+ ..|+|||.+ .+..++.++|+|||||++|++++|+.||.......
T Consensus 163 ~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 163 GTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred CcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 1 238999954 45558899999999999999999999997654333
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-22 Score=160.50 Aligned_cols=148 Identities=34% Similarity=0.652 Sum_probs=118.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 117 (218)
.++|++.+.||.|++|.||+|.++.++..+++|.++...........+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 3579999999999999999999988999999999986544444455677899999999999999999998877 89999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc-------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~------------- 145 (218)
+|||++++|.+++...... ++++. ..++
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 9999998888877653221 11111 1111
Q ss_pred -----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+..|+|||.+.....++.++|+||||+++|+|++|..||...
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223899997665555789999999999999999999999866
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-22 Score=157.81 Aligned_cols=146 Identities=27% Similarity=0.527 Sum_probs=114.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (218)
.+|+..+.||+|+||.||+|.+..++..+++|.++..... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999889999999998754322 2334578889999999999999999998865 4679
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccc-----------cccccC----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEVG---------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~g---------- 146 (218)
++++||+++ +|.+++...... ++++ ...++|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999986 888887653221 1111 111221
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|++++|+.||...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 238999955 4555889999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=167.25 Aligned_cols=159 Identities=25% Similarity=0.361 Sum_probs=119.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------------CCCchHHHHHHHHHHhhCCCCCeeeee
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------------PEGVPSYLIAGVSLLKELEHDNIVRLL 106 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 106 (218)
..+.|++++.||+|.||.|-+|.+..++..||||++.+... ...-.+...+|+.+|+++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45779999999999999999999999999999999975421 112246889999999999999999999
Q ss_pred eeEEe--CCEEEEEEecCCCCh--------------------------HHHhhhccc--CCccccc-----------ccc
Q 041487 107 DVLTT--GRYVYLVFEYLDLDL--------------------------GSFIRKHTI--TSIRPHI-----------KEV 145 (218)
Q Consensus 107 ~~~~~--~~~~~lv~E~~~~~L--------------------------~~~~~~~~~--~~~~~~~-----------~~~ 145 (218)
++..+ ...+|+|+|||...- ..|+..++. .+|+|.+ .+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99864 467999999995211 122233322 2444432 222
Q ss_pred ----------------------C-CcccCcccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 ----------------------G-SPYKAPESRIRSS---VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ----------------------g-~~y~aPE~~~~~~---~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
| .+|+|||.+..+. ..+.+.||||+||+||-++-|+.||.+.....++..+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 3 2399999777633 35678999999999999999999999875555555444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=168.99 Aligned_cols=95 Identities=31% Similarity=0.460 Sum_probs=79.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (218)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|.++... .....+.+.+|+.+++.+ +|+||+++++.+.
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4567789999999999999999998643 34579999987543 223456788999999999 8999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhh
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
..+..+++|||+++ +|.+++..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~ 135 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRK 135 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHh
Confidence 99999999999987 88888753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-22 Score=160.20 Aligned_cols=146 Identities=31% Similarity=0.573 Sum_probs=117.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||+|++|.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++.+......++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 477999999999999999999998899999999987433 233467889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC--------------------------Cccc-----------cccccC---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT--------------------------SIRP-----------HIKEVG--------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~--------------------------~~~~-----------~~~~~g--------------- 146 (218)
||+++ +|.+++...... ++++ .+.++|
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence 99987 888887543211 1111 112222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+. +..++.++|+|||||++|++++|+.||...+
T Consensus 176 ~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 176 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred cCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2388999554 4557899999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=168.11 Aligned_cols=95 Identities=27% Similarity=0.388 Sum_probs=78.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEE-----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLN-----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (218)
.+..++|++.+.||+|+||.||+|+. ..++..||+|+++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 34456899999999999999999974 2456789999986432 223356788999999999 8999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhh
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
..+..++||||+++ +|.+++..
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~ 132 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRR 132 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHh
Confidence 99999999999987 88888754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=160.30 Aligned_cols=154 Identities=26% Similarity=0.468 Sum_probs=120.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||.|+||.||+|.... +..+++|.+.... ......+..|+.+++.++|+|++++++++......+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 4569999999999999999999876 8999999987432 223567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccC------------
Q 041487 120 EYLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g------------ 146 (218)
||+++ +|.+++...... ++++. +.++|
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99987 999988653211 22221 11222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|++||.. ....++.++||||||+++|++++ |+.||...+.......+.
T Consensus 162 ~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 162 SDKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred cCCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 138999954 45568899999999999999999 899998775544444443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=159.47 Aligned_cols=145 Identities=23% Similarity=0.425 Sum_probs=112.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++++.||+|+||.||+|.+..++..+|+|.+.... .....+.+.+|+.++++++|||++++++.+......+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 36889999999999999999998999999999987542 23334678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhh---------------------ccc--CCcccc-----------ccccC----------------Ccc
Q 041487 121 YLDL-DLGSFIRK---------------------HTI--TSIRPH-----------IKEVG----------------SPY 149 (218)
Q Consensus 121 ~~~~-~L~~~~~~---------------------~~~--~~~~~~-----------~~~~g----------------~~y 149 (218)
|+++ +|..+... .+. .++++. +.++| ..|
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y 159 (279)
T cd06619 80 FMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAY 159 (279)
T ss_pred cCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhh
Confidence 9987 55433211 000 022221 12222 248
Q ss_pred cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 150 KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 150 ~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+|||.+ .+..++.++|+|||||++|+|++|+.||...
T Consensus 160 ~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 160 MAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred cCceee-cCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 999954 4556899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=158.47 Aligned_cols=151 Identities=25% Similarity=0.450 Sum_probs=113.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|++..+ ..||+|.++... ...+.+.+|+.++++++|+|++++++.+. ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 456799999999999999999987544 469999987432 23467889999999999999999998874 4558999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g----------- 146 (218)
|||+++ +|.+++...... +++|.+ .++|
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999987 999988653210 222211 1111
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
..|+|||.. .+..++.++|||||||++|+++| |..||.......+...
T Consensus 159 ~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~ 215 (262)
T cd05071 159 ARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 215 (262)
T ss_pred cccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Confidence 239999954 45558999999999999999999 8899987754444333
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=163.04 Aligned_cols=157 Identities=24% Similarity=0.435 Sum_probs=118.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+...+|++.+.||+|+||.||+|....++. .||+|.++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 456789999999999999999998765554 4899998632 2334467788999999999999999999998764
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------- 146 (218)
..++++||+.+ +|.+++...... ++++. +.++|
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 46789999876 888887654321 22221 11221
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ ....++.++|||||||++|++++ |+.||.+.....+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~ 225 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225 (316)
T ss_pred CCcceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 239999955 44558999999999999999998 999998765555554444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=169.27 Aligned_cols=148 Identities=25% Similarity=0.401 Sum_probs=110.9
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC---CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
||+|+||.||+|+++.++..||+|++.+... ..........|..++... +||+|+++++.+.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999865432 222334455566666655 699999999999999999999999986
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC------------------C
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG------------------S 147 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g------------------~ 147 (218)
+|.+++...... +++|. +.++| .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 887776543221 22221 12222 2
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+.....++.++|||||||++|+|++|+.||...+...+...+
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 3999997766666899999999999999999999999887655544433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=155.95 Aligned_cols=145 Identities=28% Similarity=0.535 Sum_probs=114.3
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-------CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-------GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+|.+.+.||.|++|.||+|.+..++..+|+|.+....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999998889999999887543222 123568889999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccccC---------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG--------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g--------- 146 (218)
.+++|||+++ +|.+++...... ++.|. +.++|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999987 888887654321 11111 11111
Q ss_pred ---------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|+|||||++|++++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 248899954 4455788999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=156.91 Aligned_cols=153 Identities=28% Similarity=0.493 Sum_probs=115.5
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|+||.||+|.. .++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4567899999999999999999985 467889999986432 23467889999999999999999998874 456899
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV----------- 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~----------- 145 (218)
+|||+.+ +|.+++...... +++|.+ .++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999976 898887543211 111111 111
Q ss_pred --------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 146 --------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 146 --------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
...|+|||.+ ....++.++||||||+++|++++ |+.||.+.+........
T Consensus 158 ~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05067 158 TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216 (260)
T ss_pred ccccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 1249999954 45558899999999999999999 99999877554444433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=157.84 Aligned_cols=150 Identities=23% Similarity=0.370 Sum_probs=120.0
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe----
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT---- 111 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 111 (218)
-.+...+|++.+.+|+|+|+.|++++...++..+|+|.+.+.. .+..+...+|++..++++|||+++++++...
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3467889999999999999999999988999999999987643 5567889999999999999999999998642
Q ss_pred -CCEEEEEEecCCC-ChHHHhhhcccC---------------------------------Cccccc-----------cc-
Q 041487 112 -GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------SIRPHI-----------KE- 144 (218)
Q Consensus 112 -~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------~~~~~~-----------~~- 144 (218)
....|++.+|... +|.|.+...... |++|.+ .+
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3459999999865 798888653322 334432 12
Q ss_pred --------------------------cCCcccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 --------------------------VGSPYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 --------------------------~g~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
++.+|.|||.+.- +...+.++|||||||+||+|+-|.-||+..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 3445999995432 233778999999999999999999999743
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-25 Score=168.05 Aligned_cols=160 Identities=25% Similarity=0.378 Sum_probs=125.8
Q ss_pred ccCCChhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeee
Q 041487 27 KKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRL 105 (218)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (218)
...++......+..++.+-++.||+|+||+|++-.++++|+..|||.++.... ....+++..|.++..+- +.|+||++
T Consensus 50 l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 50 LKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred eecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 34455566777888888889999999999999999999999999999986544 34467788888765554 78999999
Q ss_pred eeeEEeCCEEEEEEecCCCChHHHhhhc------cc---------------------------CCcccccc---------
Q 041487 106 LDVLTTGRYVYLVFEYLDLDLGSFIRKH------TI---------------------------TSIRPHIK--------- 143 (218)
Q Consensus 106 ~~~~~~~~~~~lv~E~~~~~L~~~~~~~------~~---------------------------~~~~~~~~--------- 143 (218)
|+.+...+-.|+-||.|+.+|..+.+.- .. .+++|.+.
T Consensus 129 yGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence 9999999999999999987776655431 00 04444331
Q ss_pred -------------------ccCCcccCcccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 144 -------------------EVGSPYKAPESRIRSSV-YSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 144 -------------------~~g~~y~aPE~~~~~~~-~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
....+|||||.+..... |+.++||||||++|||++||+.||..-
T Consensus 209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 11245999997665544 999999999999999999999999865
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-21 Score=154.17 Aligned_cols=146 Identities=27% Similarity=0.421 Sum_probs=117.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|++|.||+|++..++..+++|.+...... ...+.+.+|+..+.+++|+|++++++.+......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3689999999999999999999989999999998754332 456789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC----------------------------Ccccc-----------cccc---------------
Q 041487 121 YLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~--------------- 145 (218)
|+++ +|.+++...... ++++. ..++
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9995 898887652211 11111 0111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+ ....++.++|+||||+++|++++|+.||....
T Consensus 160 ~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 160 FVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred eeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1238899954 45568899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=160.11 Aligned_cols=152 Identities=27% Similarity=0.490 Sum_probs=117.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|.+.+.||+|+||.||++... .++..+|+|.+... .....+.+.+|+.++++++||+++++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45678999999999999999999853 24566899987632 233456789999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc--------------C--------------------------Cccccc---------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI--------------T--------------------------SIRPHI--------- 142 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~--------------~--------------------------~~~~~~--------- 142 (218)
+..+++|||+++ +|.+++..... . +++|.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 999999999986 99888864421 0 222211
Q ss_pred --cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 143 --KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 143 --~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
.++| ..|+|||. ..+..++.++|||||||++|+|++ |..||........
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES-IMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHH-hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 1111 14999995 455668999999999999999999 9999987654433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=163.18 Aligned_cols=149 Identities=37% Similarity=0.639 Sum_probs=117.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (218)
..+|.+.+.||+|+||.||+|++..++..||+|.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4579999999999999999999999999999999875443444456778899999999999999999987643 35
Q ss_pred EEEEEecCCCChHHHhhhcccC---------------------------Ccccc-----------cccc-----------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEV----------- 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~----------- 145 (218)
.++++||+.++|.+++...... ++++. +.++
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 8999999998888877553321 11111 1111
Q ss_pred -------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|+|++|+.||.+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 2238999976665568999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=167.59 Aligned_cols=96 Identities=26% Similarity=0.354 Sum_probs=79.3
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVL 109 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 109 (218)
.....++|.+.+.||+|+||.||+|++... +..||+|.++.. ......+.+.+|+.+++++. ||||+++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 345577899999999999999999986433 346999998643 23334568899999999995 99999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhh
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
......++|||||++ +|.+++..
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~ 134 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHK 134 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHH
Confidence 999999999999987 88887754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=155.73 Aligned_cols=153 Identities=28% Similarity=0.475 Sum_probs=120.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+...+|++.+.||.|++|.||+|.. .++.+|+|.++.... ..+.+.+|+.++++++|+|++++++++......++
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3467899999999999999999986 588999999874322 46789999999999999999999999998999999
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||+++ +|.+++...... +++|.+ .++|
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999986 999988654310 222221 2222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|.|||.+. ...++.++||||||+++|++++ |+.||.......+...+
T Consensus 158 ~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05039 158 SGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212 (256)
T ss_pred cCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2389999654 4558899999999999999998 99999877555544433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=157.74 Aligned_cols=149 Identities=23% Similarity=0.435 Sum_probs=112.6
Q ss_pred EeeecCceEEEEEEE--ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 48 KIGQGVFGEVYKCLN--LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
.||+|+||.||+|.. ..++..+|+|+++.........+.+.+|+.+++.++||||+++++++. ....+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 356789999998754444445678899999999999999999999875 4467899999986
Q ss_pred ChHHHhhhcccC---------------------------Cccccc-----------ccc---------------------
Q 041487 125 DLGSFIRKHTIT---------------------------SIRPHI-----------KEV--------------------- 145 (218)
Q Consensus 125 ~L~~~~~~~~~~---------------------------~~~~~~-----------~~~--------------------- 145 (218)
+|.+++...... +++|.+ .++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 898888653221 122211 111
Q ss_pred CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 146 GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
...|+|||.+ ....++.++|+|||||++|++++ |+.||...+...+...++.
T Consensus 161 ~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred CccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 1358999954 45568899999999999999998 9999987755555555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=157.64 Aligned_cols=152 Identities=22% Similarity=0.389 Sum_probs=113.6
Q ss_pred eeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC------
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR------ 113 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (218)
|++.+.||+|+||.||+|....+ +..+|+|.++...........+.+|+.+++.++|||++++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987643 478999998754444445567899999999999999999999876544
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------------Cccccc-----------cccC--
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------------SIRPHI-----------KEVG-- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------~~~~~~-----------~~~g-- 146 (218)
..++++||+.+ +|..++...... +++|.+ .++|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 38999999986 887776432110 222211 1221
Q ss_pred ------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 147 ------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 147 ------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
..|+|||.+ .+..++.++|||||||++|+|++ |..||...+...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227 (273)
T ss_pred eeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 248999954 55668999999999999999999 8999987655444433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=163.51 Aligned_cols=148 Identities=34% Similarity=0.618 Sum_probs=117.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE----eCCEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT----TGRYVY 116 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~ 116 (218)
++|++.+.||+|++|.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 7899999999999999999999999999999998765444455677888999999999999999999875 345789
Q ss_pred EEEecCCCChHHHhhhcccC---------------------------Ccccc-----------cccc-------------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~------------- 145 (218)
+||||+.++|.+++...... ++++. +.++
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 99999988888877543221 11111 1111
Q ss_pred ---------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|+|++|+.||...+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 1238899976665668999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=160.72 Aligned_cols=153 Identities=30% Similarity=0.470 Sum_probs=116.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCc--EEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGK--KVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
++|++.+.||+|+||.||+|....++. .+++|.++.. ......+.+.+|+.++.++ .||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 579999999999999999999876664 4688877632 2333456788999999999 79999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC-------------------------------------------Ccccc-----------c
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPH-----------I 142 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~-----------~ 142 (218)
+|||+++ +|.+++...... +++|. +
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 9999986 999888653210 22222 1
Q ss_pred cccC-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 143 KEVG-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 143 ~~~g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
.++| ..|+|||. ..+..++.++|||||||++|+|++ |..||...........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIES-LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchh-hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2222 13999995 445558999999999999999998 9999987755544443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=155.29 Aligned_cols=147 Identities=28% Similarity=0.523 Sum_probs=116.5
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC---CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+|+..+.||+|++|.||+|..+.++..+++|.+..... ..+..+.+.+|+.+++.++|+|++++++.+......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46778899999999999999988899999999875432 234567889999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc--------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~-------------- 145 (218)
+||+++ +|.+++...... ++++. +.++
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 999987 898888654321 11111 1111
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+ ..|++||.+.....++.++|+||||+++|++++|+.||....
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 238899965444448899999999999999999999997653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=164.18 Aligned_cols=150 Identities=32% Similarity=0.607 Sum_probs=118.3
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE----
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY---- 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 114 (218)
..++|++.+.||+|++|.||+|.+..++..||+|.+..........+.+.+|+.+++.++|+|++++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999998899999999987544344455677889999999999999999998865554
Q ss_pred --EEEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------cccc----------
Q 041487 115 --VYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEV---------- 145 (218)
Q Consensus 115 --~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~---------- 145 (218)
.++++||++.+|.+++...... ++++. +.++
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccccc
Confidence 9999999988888877553221 12221 1111
Q ss_pred -----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|++++|+.||...+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1238999976555568899999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=158.89 Aligned_cols=150 Identities=25% Similarity=0.424 Sum_probs=113.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc----------------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE----------------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 101 (218)
+..++|.+.+.||+|+||.||+|.... ++..||+|.+.... .......+.+|+.++.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 345789999999999999999997532 34579999986432 2333567889999999999999
Q ss_pred eeeeeeeEEeCCEEEEEEecCCC-ChHHHhhhccc---------------------------------------------
Q 041487 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI--------------------------------------------- 135 (218)
Q Consensus 102 iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~--------------------------------------------- 135 (218)
|+++++++...+..+++|||+.+ +|.+++.....
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999999999999999999977 88887754210
Q ss_pred -CCcccc-----------ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh--CC
Q 041487 136 -TSIRPH-----------IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS--GK 181 (218)
Q Consensus 136 -~~~~~~-----------~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t--g~ 181 (218)
.+++|. +.++| ..|+|||.+. .+.++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCC
Confidence 022221 12222 1389999654 4558999999999999999987 56
Q ss_pred CCCCCCCc
Q 041487 182 PLFPCGKK 189 (218)
Q Consensus 182 ~Pf~~~~~ 189 (218)
.||...+.
T Consensus 240 ~p~~~~~~ 247 (304)
T cd05096 240 QPYGELTD 247 (304)
T ss_pred CCCCcCCH
Confidence 78876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=159.56 Aligned_cols=150 Identities=27% Similarity=0.486 Sum_probs=116.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++++.||+|+||.||++.+..++..+|+|.++.. ........+.+|+.++++++|+||+++++.+...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688999999999999999999889999999988643 233334678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcc----cC---------------------------Cccc-----------cccccC-----------
Q 041487 121 YLDL-DLGSFIRKHT----IT---------------------------SIRP-----------HIKEVG----------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~----~~---------------------------~~~~-----------~~~~~g----------- 146 (218)
|+++ +|..++.... .. +++| .+.++|
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 9987 8877765521 10 1111 112222
Q ss_pred -----CcccCcccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 -----SPYKAPESRIRSS-----VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 -----~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+.... .++.++|+|||||++|++++|+.||.......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 2489999654332 35789999999999999999999997654333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=159.90 Aligned_cols=148 Identities=24% Similarity=0.384 Sum_probs=115.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..|...+.||+|+||.||++.+..++..+|+|.+..... ..+....+.+|+.+++.++|+|++++++++......+++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 337889999999999999999988999999999875432 2234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------- 146 (218)
||+.+++.+++...... ++.+. +.++|
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccCC
Confidence 99998887776432211 11111 12222
Q ss_pred CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+. ..+.++.++|||||||++|+|++|+.||...+
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 2389999654 34558899999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-21 Score=154.01 Aligned_cols=145 Identities=28% Similarity=0.517 Sum_probs=113.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC----CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP----EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+|++.+.||.|+||.||+|.. .++..+|+|.++..... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999975 57889999998754322 1234568899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc-------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~------------- 145 (218)
++||+++ +|.+++...... ++++. ..++
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999987 898888654321 11111 1111
Q ss_pred ----------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||. ..+..++.++|+|||||++|++++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~-~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred cccccccccCCCccccChhh-hcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 1 23888995 445558899999999999999999999998653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=159.14 Aligned_cols=147 Identities=29% Similarity=0.541 Sum_probs=116.1
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|++|.||++....++..+++|.+.... ......+.+.+|+.+++.++|+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999998899999999886543 22334567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhccc-----C--------------------------Ccccc-----------cccc-----------
Q 041487 120 EYLDL-DLGSFIRKHTI-----T--------------------------SIRPH-----------IKEV----------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~-----~--------------------------~~~~~-----------~~~~----------- 145 (218)
||+++ +|.+++..... . ++++. ..++
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99987 88887753111 0 11111 1111
Q ss_pred ------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+ ..|+|||.+ .+..++.++|+||||+++|+|++|..||.+..
T Consensus 162 ~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 162 AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1 238899954 45558899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-21 Score=152.58 Aligned_cols=146 Identities=29% Similarity=0.522 Sum_probs=118.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||+|....++..+++|.++.........+.+.+|+.++++++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 58899999999999999999988999999999986654445678899999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc-----------------
Q 041487 122 LDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV----------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~----------------- 145 (218)
+++ +|.+++...... ++++. +.++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 986 888887654221 11111 1111
Q ss_pred -----CCcccCcccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -----GSPYKAPESRIRSS--VYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -----g~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|++||.+.... .++.++||||||+++|++++|+.||...
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 12489999654432 2788999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=160.72 Aligned_cols=161 Identities=32% Similarity=0.582 Sum_probs=119.9
Q ss_pred cccee-EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC------------chHHHHHHHHHHhhCCCCCeeeee
Q 041487 40 DWNYK-VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG------------VPSYLIAGVSLLKELEHDNIVRLL 106 (218)
Q Consensus 40 ~~~~~-~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~ 106 (218)
.++|. +.+.||.|+||.||+|.++..++.||+|.++....... ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45665 45779999999999999988999999999875432210 112577899999999999999999
Q ss_pred eeEEeCCEEEEEEecCCCChHHHhhhcccC---------------------------Ccccc-----------cccc---
Q 041487 107 DVLTTGRYVYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEV--- 145 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~--- 145 (218)
+++......+++|||++++|.+++...... ++.+. ..++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 999999999999999998888887543221 11111 1111
Q ss_pred -----------------------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHH
Q 041487 146 -----------------------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLI 195 (218)
Q Consensus 146 -----------------------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~ 195 (218)
...|+|||.+.+...++.++|||||||++|+|++|+.||...+ .+.+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1238999977665667899999999999999999999998763 3334444
Q ss_pred HHHhc
Q 041487 196 VRYFT 200 (218)
Q Consensus 196 ~~~~~ 200 (218)
...++
T Consensus 247 ~~~~~ 251 (335)
T PTZ00024 247 FELLG 251 (335)
T ss_pred HHHhC
Confidence 44333
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=156.49 Aligned_cols=154 Identities=25% Similarity=0.484 Sum_probs=115.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+..++|++.+.||+|++|.||+|... .+..+|+|.+..... ..+.+.+|+.++++++|++++++++++. ....++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 44578999999999999999999764 567799999864322 3467899999999999999999999875 456899
Q ss_pred EEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||+++ +|.+++...... ++++.+ .++|
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999987 898887643211 122211 1111
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ ....++.++||||||+++|++++ |..||...+.......+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05070 158 TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217 (260)
T ss_pred ccccCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 249999954 45558899999999999999999 899998765544444433
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=159.34 Aligned_cols=161 Identities=25% Similarity=0.431 Sum_probs=122.1
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEcc-------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLE-------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV 108 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (218)
.+..++|.+.+.||+|+||.||++.+.. ....+|+|.+.... .....+.+.+|+.+++.+ +|+||++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4556789999999999999999998643 23579999987532 233456788899999999 79999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhccc----------------C---------------------------Cccccc--
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTI----------------T---------------------------SIRPHI-- 142 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~----------------~---------------------------~~~~~~-- 142 (218)
+...+..+++|||+++ +|.+++..... . +++|.+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 9999999999999987 99988865321 0 111111
Q ss_pred ---------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 143 ---------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 143 ---------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
.++| ..|+|||.+ .+..++.++|||||||++|+|++ |..||.....+.+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh-ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 1111 249999955 44558999999999999999998 8999988766666
Q ss_pred HHHHHHh
Q 041487 193 SLIVRYF 199 (218)
Q Consensus 193 ~~~~~~~ 199 (218)
...+...
T Consensus 252 ~~~~~~~ 258 (307)
T cd05098 252 FKLLKEG 258 (307)
T ss_pred HHHHHcC
Confidence 6555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=160.45 Aligned_cols=148 Identities=34% Similarity=0.619 Sum_probs=115.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (218)
.++|++.+.||+|++|.||+|.+..++..||+|.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46899999999999999999999999999999998642 2233456788899999999999999999987543 35
Q ss_pred EEEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------cccc------------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEV------------ 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~------------ 145 (218)
.++++||+.+++.+++...... ++++. +.++
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 8999999988877765543211 11111 1111
Q ss_pred ---------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++||||+||++|+|++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1238999976666668999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-21 Score=157.14 Aligned_cols=146 Identities=25% Similarity=0.402 Sum_probs=114.8
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
|...+.||+|+||.||+|++..++..+++|.+..... .....+.+.+|+.+++.++|||++++++++..+...|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 6778889999999999999988999999999875432 233446788899999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------Cc
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG--------------SP 148 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g--------------~~ 148 (218)
+.+++.+++...... ++.+. ..++| ..
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 182 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY 182 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccccc
Confidence 988887776543211 11111 12221 24
Q ss_pred ccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 149 YKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 149 y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
|+|||.+. ....++.++|||||||++|+|++|..||...+
T Consensus 183 y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 89999653 24558889999999999999999999997764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-21 Score=157.56 Aligned_cols=147 Identities=35% Similarity=0.686 Sum_probs=116.2
Q ss_pred ceeEEEEeeecCceEEEEEEEcc--CCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLE--TGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVY 116 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 116 (218)
+|++.+.||+|++|.||+|.+.. .+..+|+|.+.... ......+.+.+|+.+++.++|||++++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999987 78999999997543 2234456788999999999999999999999877 8899
Q ss_pred EEEecCCCChHHHhhhcccC--------------------------------Cccc---------------cccccC---
Q 041487 117 LVFEYLDLDLGSFIRKHTIT--------------------------------SIRP---------------HIKEVG--- 146 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~--------------------------------~~~~---------------~~~~~g--- 146 (218)
+||||++.++.+++...... ++++ .+.++|
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999988777665432110 1111 111222
Q ss_pred ------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|+|++|++||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 238999976665668899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=157.73 Aligned_cols=157 Identities=25% Similarity=0.429 Sum_probs=117.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+..++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.++++++|+|++++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456889999999999999999997653 34579999876332 222344677899999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-------------------------------------Cccccc-----------c
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------SIRPHI-----------K 143 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------~~~~~~-----------~ 143 (218)
...+++|||+++ +|.+++...... +++|.+ .
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999986 999988642110 122211 1
Q ss_pred ccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 144 EVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 144 ~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
++| ..|+|||.+. +..++.++|||||||++|++++ |..||.+.........+
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 222 2399999544 4558999999999999999999 78999877555444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=157.45 Aligned_cols=158 Identities=22% Similarity=0.406 Sum_probs=121.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+...+|++.+.||+|+||.||+|..+.++. .+|+|.++... .......+.+|+.++++++|+|++++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 456789999999999999999999876654 58999876432 23345678899999999999999999999877 7
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------- 146 (218)
..+++|||+++ +|.+++...... ++++.+ .++|
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999986 898887653211 222211 1221
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ ....++.++|+||||+++|++++ |+.||.......+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226 (279)
T ss_pred cccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence 248999955 45558899999999999999999 9999998766666655554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=154.43 Aligned_cols=156 Identities=31% Similarity=0.546 Sum_probs=119.7
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYVYLVF 119 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 119 (218)
+|++.+.||.|+||.||++.+..++..+|+|.+..........+.+..|+.+++.++|+|++++++.+. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999999999999999998765555555678889999999999999999999875 456789999
Q ss_pred ecCCC-ChHHHhhhccc----C--------------------------------Cccccc-----------cc-------
Q 041487 120 EYLDL-DLGSFIRKHTI----T--------------------------------SIRPHI-----------KE------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~----~--------------------------------~~~~~~-----------~~------- 144 (218)
||+++ +|.+++..... . ++++.+ .+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99986 88877754210 0 011100 01
Q ss_pred -----------cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 -----------VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 -----------~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
....|+|||.+ .+..++.++|+||||+++|+|++|+.||...+...+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred cCCcccccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 11238899954 445588999999999999999999999998765555555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=155.27 Aligned_cols=143 Identities=27% Similarity=0.509 Sum_probs=115.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||+|..+.++..+++|.++.... .+.+.+|+.+++.++|+|++++++.+......|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 579999999999999999999988899999999864321 6789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC----------------------------Ccccc-----------cccc---------------
Q 041487 121 YLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEV--------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~--------------- 145 (218)
|+++ +|.+++...... ++.+. ..++
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9987 888887542211 11111 1111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+ .+..++.++||||||+++|+|++|+.||....
T Consensus 159 ~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 159 VIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred ccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1248999954 45568899999999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-21 Score=155.17 Aligned_cols=145 Identities=25% Similarity=0.400 Sum_probs=113.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 118 (218)
++|...+.||.|++|.||++.+..++..+|+|.+..... ......+.+|++++++++||||+++++++.. .+.++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468999999999999999999988999999999875422 2445778999999999999999999998864 4579999
Q ss_pred EecCCC-ChHHHhhhccc-----C--------------------------Cccc-----------cccccC---------
Q 041487 119 FEYLDL-DLGSFIRKHTI-----T--------------------------SIRP-----------HIKEVG--------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~-----~--------------------------~~~~-----------~~~~~g--------- 146 (218)
|||+++ +|.+++..... . ++.+ .+.++|
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999987 88777543110 0 1111 111221
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 160 AGTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 238899954 4556899999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=159.08 Aligned_cols=138 Identities=35% Similarity=0.704 Sum_probs=105.8
Q ss_pred EEEeeecCceEEEEEEEc--cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEEEEEEec
Q 041487 46 VEKIGQGVFGEVYKCLNL--ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYVYLVFEY 121 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~E~ 121 (218)
.+.||+|+||.||+|.++ .++..+|+|.+... .....+.+|+.++++++||||+++++++. .+...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 36789999988633 22345778999999999999999999985 45679999999
Q ss_pred CCCChHHHhhhcccC------------------------------------Ccccc---------------ccccC----
Q 041487 122 LDLDLGSFIRKHTIT------------------------------------SIRPH---------------IKEVG---- 146 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~------------------------------------~~~~~---------------~~~~g---- 146 (218)
++++|.+++...... +++|. +.++|
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 988887776432100 22221 12222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++||||+||++|+|++|++||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 23999997766666899999999999999999999999765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-21 Score=160.43 Aligned_cols=152 Identities=31% Similarity=0.585 Sum_probs=117.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG----- 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 112 (218)
...++|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 346889999999999999999999988999999999875433334456788899999999999999999988543
Q ss_pred -CEEEEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------ccccC--------
Q 041487 113 -RYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEVG-------- 146 (218)
Q Consensus 113 -~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g-------- 146 (218)
...+++++++.++|.+++...... ++++. +.++|
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred cccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 347899999877887765443211 22221 11221
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||...+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2389999765545688999999999999999999999986643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-21 Score=153.91 Aligned_cols=146 Identities=25% Similarity=0.482 Sum_probs=116.1
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
+|+..+.||+|++|.||++.+..++..+|+|.++...... ...+.+.+|+.++++++|+|++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999998999999999987543221 235678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccc------------ccccc------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRP------------HIKEV------------ 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~------------~~~~~------------ 145 (218)
++||+.+ +|.+++...... ++.+ ...++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999987 888887653321 1111 11111
Q ss_pred ----------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+ .+..++.++|+||+|+++|++++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred CCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1248999965 44558899999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=162.69 Aligned_cols=142 Identities=20% Similarity=0.358 Sum_probs=111.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
+...+|.+++.||+|+||.||+|.... .+..|++|.+... ....+|+.+++.++||||+++++.+......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 345579999999999999999997643 4678999987532 2356899999999999999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC---------------------------Ccccc-----------ccccC-----------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEVG----------- 146 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g----------- 146 (218)
+++||++.++|.+++...... ++++. +.++|
T Consensus 162 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 162 CMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 999999998888887543221 22221 12222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||.+.
T Consensus 242 ~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 242 PQCYGWSGTLETNSPEL-LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccCccCHhH-hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 23899995 45556899999999999999999999999765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=155.31 Aligned_cols=156 Identities=26% Similarity=0.503 Sum_probs=122.8
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||++.++.++..+++|.+............+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999999988999999999976554455567788999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhccc-----C--------------------------Cccccc-----------ccc-------------
Q 041487 122 LDL-DLGSFIRKHTI-----T--------------------------SIRPHI-----------KEV------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~-----~--------------------------~~~~~~-----------~~~------------- 145 (218)
+++ +|.+++..... . ++.+.+ .++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 977 88888755211 0 111111 111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
...|++||.+ .+..++.++|+||||+++|++++|+.||...+...+...+..
T Consensus 161 ~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 161 QIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred ccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 1238889954 455588899999999999999999999988766555444443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=153.17 Aligned_cols=152 Identities=29% Similarity=0.519 Sum_probs=116.5
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE-eCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-TGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 116 (218)
+...+|++.+.||+|+||.||++.. .+..+++|.++. ....+.+.+|+.++++++|++++++++++. .....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4557899999999999999999976 578899998753 223567889999999999999999999764 556799
Q ss_pred EEEecCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccC---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVG--------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g--------- 146 (218)
++|||+++ +|.+++...... +++|. ..++|
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999986 999988654321 22222 12222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||. ..+..++.++|||||||++|+|++ |+.||...+...+...+
T Consensus 157 ~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05082 157 DTGKLPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212 (256)
T ss_pred CCCccceeecCHHH-HccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 13999995 455568899999999999999998 99999876554444433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=154.20 Aligned_cols=149 Identities=25% Similarity=0.385 Sum_probs=112.2
Q ss_pred EEeeecCceEEEEEEEccCC---cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 47 EKIGQGVFGEVYKCLNLETG---KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
+.||+|+||.||+|.....+ ..+|+|.+...... ...+.+.+|+.+++.++|+|++++++++. ....+++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999876544 78999998754332 35567889999999999999999999875 456899999998
Q ss_pred C-ChHHHhhhcccC---------------------------Cccccc-----------ccc-------------------
Q 041487 124 L-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------------------- 145 (218)
Q Consensus 124 ~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------------------- 145 (218)
+ +|.+++...... ++++.+ .++
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 6 899988764421 222211 111
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
...|+|||.+ .+..++.++||||||+++|++++ |++||...+...+...+..
T Consensus 159 ~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 159 RWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred cccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 1248999955 55558999999999999999998 9999987655555444443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=160.09 Aligned_cols=147 Identities=31% Similarity=0.630 Sum_probs=114.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------- 112 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 112 (218)
..+|.+.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 368999999999999999999999999999999986543 24456788999999999999999999876543
Q ss_pred -------CEEEEEEecCCCChHHHhhhcccC--------------------------Ccccc------------cccc--
Q 041487 113 -------RYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH------------IKEV-- 145 (218)
Q Consensus 113 -------~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~------------~~~~-- 145 (218)
...+++|||++++|.+++...... ++++. ..++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 368999999988887776432211 11111 1111
Q ss_pred -------------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -------------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -------------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|||||||++|+|++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1248999976666668899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=156.81 Aligned_cols=146 Identities=32% Similarity=0.580 Sum_probs=116.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|.+.+.||+|+||.||++....++..+++|.+... .....+.+.+|+.+++.++|||++++++.+......++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36899999999999999999998888999999998643 2233567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC--------------------------Cccc-----------cccccC---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT--------------------------SIRP-----------HIKEVG--------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~--------------------------~~~~-----------~~~~~g--------------- 146 (218)
||+++ +|.+++...... ++++ .+.++|
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred ecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 99987 888887653221 1111 112222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|++||.+. ...++.++|+||||+++|++++|+.||...+
T Consensus 176 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 176 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred cCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1389999654 4457899999999999999999999998663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=156.67 Aligned_cols=151 Identities=28% Similarity=0.478 Sum_probs=115.5
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+...+|...+.||+|+||.||++... .++..+++|.++.. .....+.+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 34577899999999999999999743 24567899987632 334456789999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc----------------C--------------------------Cccc---------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI----------------T--------------------------SIRP--------- 140 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~----------------~--------------------------~~~~--------- 140 (218)
...+++|||+++ +|.+++..... . +++|
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999986 88888765321 0 1111
Q ss_pred --cccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcch
Q 041487 141 --HIKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDH 191 (218)
Q Consensus 141 --~~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~ 191 (218)
...++| ..|+|||.+ .+..++.++|||||||++|+|++ |.+||.......
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 112222 238999954 45558999999999999999999 999997654333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=153.48 Aligned_cols=152 Identities=24% Similarity=0.446 Sum_probs=116.1
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
++..++|++.+.||+|+||.||++... .+..+++|.+... ....+.+.+|+.++++++|+|++++++.+.. ...+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 356788999999999999999999854 4567999987632 2234678899999999999999999999877 7789
Q ss_pred EEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~---------- 145 (218)
++|||+++ +|.+++...... ++++.+ .++
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999986 999998653211 112211 111
Q ss_pred ---------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 146 ---------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 146 ---------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
...|+|||.+ ....++.++|+|||||++|+++| |+.||...+...+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred cccccCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 1238999954 45568899999999999999999 999998765444443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=157.81 Aligned_cols=161 Identities=27% Similarity=0.454 Sum_probs=121.7
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
..+..++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.+++++ +|+||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 446678899999999999999999987643 3689999987432 223346688999999999 899999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc--------------C-----------------------------Ccccc----
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI--------------T-----------------------------SIRPH---- 141 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~--------------~-----------------------------~~~~~---- 141 (218)
...+.++++|||+.+ +|.+++..... . +++|.
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999976 88888754210 0 11111
Q ss_pred -------ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 041487 142 -------IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLS 193 (218)
Q Consensus 142 -------~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~ 193 (218)
..++| ..|+|||.+ .+..++.++|||||||++|++++ |..||.........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 11221 238999954 45558999999999999999998 99999877655555
Q ss_pred HHHHH
Q 041487 194 LIVRY 198 (218)
Q Consensus 194 ~~~~~ 198 (218)
.....
T Consensus 245 ~~~~~ 249 (293)
T cd05053 245 KLLKE 249 (293)
T ss_pred HHHHc
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-23 Score=175.14 Aligned_cols=156 Identities=25% Similarity=0.407 Sum_probs=120.3
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
|.=+..||.|+||.||-|.+..+.+.||||.+.-.- ...+..+.+..|+..|+++.|||++.+.++|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555678999999999999999999999999875322 2335578899999999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Ccc------------------------ccccccCCc-
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIR------------------------PHIKEVGSP- 148 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~------------------------~~~~~~g~~- 148 (218)
|-|+-.|.+.-+... +++ |.+++.|+|
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPy 187 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPY 187 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCCcc
Confidence 977666555332211 222 223445655
Q ss_pred ccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHH
Q 041487 149 YKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRY 198 (218)
Q Consensus 149 y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~ 198 (218)
|||||++.. .+.|+-++||||||++..|++..++|+-.+ -...+..|-+.
T Consensus 188 wMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN 240 (948)
T KOG0577|consen 188 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 240 (948)
T ss_pred ccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc
Confidence 799997543 466999999999999999999999886544 44444554443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=153.21 Aligned_cols=148 Identities=28% Similarity=0.494 Sum_probs=114.0
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-C
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-D 125 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~ 125 (218)
+.||+|++|.||++.+.. +..|++|.++..... .....+.+|+.+++.++|+||+++++++......+++|||+.+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999877 999999988754332 3456789999999999999999999999999999999999976 8
Q ss_pred hHHHhhhcccC----------------------------Cccccc-----------cccC--------------------
Q 041487 126 LGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------------------- 146 (218)
Q Consensus 126 L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------------------- 146 (218)
|.+++...... +++|.+ .++|
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 88887543211 122211 1111
Q ss_pred CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|+|||||++|+++| |..||...........+.
T Consensus 159 ~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~ 209 (251)
T cd05041 159 IKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209 (251)
T ss_pred eccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh
Confidence 128999954 45568999999999999999999 899998776555555444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=157.13 Aligned_cols=153 Identities=25% Similarity=0.424 Sum_probs=116.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
...+|.+.+.||+|+||.||+|.... ++..+++|.+... .....+.+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45679999999999999999998543 3456888887532 2233467889999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Cccccc-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPHI------- 142 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~~------- 142 (218)
..++||||+++ +|.+++..+... +++|.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999976 999998654210 222221
Q ss_pred ----cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 143 ----KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 143 ----~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
.++| ..|+|||.+ .+..++.++|||||||++|+|+| |+.||..........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1222 238999954 45568899999999999999999 999997765444433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=152.32 Aligned_cols=151 Identities=27% Similarity=0.434 Sum_probs=115.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
...+|++.+.||+|+||.||++... .+..+++|.++.... ....+.+|+.+++.++||+++++++++......+++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 3568999999999999999999874 477899998764322 235688999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------------ 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------------ 146 (218)
|||+.+ +|.+++...... ++++.+ .++|
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999987 888887543211 111111 1111
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+ .++.++.++||||||+++|++++ |+.||.......+..
T Consensus 158 ~~~~~~~~~~~aPe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05112 158 STGTKFPVKWSSPEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212 (256)
T ss_pred cCCCccchhhcCHhHh-ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 248999954 45558899999999999999998 999998665444333
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-23 Score=160.20 Aligned_cols=167 Identities=33% Similarity=0.634 Sum_probs=133.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-C
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-G 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 112 (218)
-....|+.++.||+|.||.||+|..+.++ ..+|||.++............-+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44578999999999999999999765443 378999998655555667788899999999999999999999876 8
Q ss_pred CEEEEEEecCCCChHHHhhhcccC--------------------------------Ccc---------------cccccc
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT--------------------------------SIR---------------PHIKEV 145 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~--------------------------------~~~---------------~~~~~~ 145 (218)
..++++.||.+.+|.+.|+-+... +.+ .++.++
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 899999999999998888765432 222 223333
Q ss_pred CCc---------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----------CcchHHH
Q 041487 146 GSP---------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG----------KKDHLSL 194 (218)
Q Consensus 146 g~~---------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~----------~~~~~~~ 194 (218)
|.+ |.|||.+.+...|+.+.|||+.||++.||+|-++.|.+. ..+.+.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 332 999999888888999999999999999999999999765 2345667
Q ss_pred HHHHhcccCc
Q 041487 195 IVRYFTALTN 204 (218)
Q Consensus 195 ~~~~~~~~~~ 204 (218)
+.+.+|.|+.
T Consensus 261 If~vLG~Pt~ 270 (438)
T KOG0666|consen 261 IFEVLGTPTD 270 (438)
T ss_pred HHHHcCCCcc
Confidence 7777666643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=155.80 Aligned_cols=145 Identities=26% Similarity=0.458 Sum_probs=113.1
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|++.+.||.|+||.||++.+..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+..+...++++||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 67889999999999999999888999999998532 2234567888999999999999999999999999999999999
Q ss_pred CC-ChHHHhhhccc--C--------------------------Cccccc-----------cccC----------------
Q 041487 123 DL-DLGSFIRKHTI--T--------------------------SIRPHI-----------KEVG---------------- 146 (218)
Q Consensus 123 ~~-~L~~~~~~~~~--~--------------------------~~~~~~-----------~~~g---------------- 146 (218)
++ +|..++..... . ++++.+ .++|
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 87 76666543111 0 222211 1221
Q ss_pred --CcccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 --SPYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 --~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+. ....++.++|||||||++|+|++|++||...+.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 2399999653 344578899999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-21 Score=154.09 Aligned_cols=149 Identities=31% Similarity=0.533 Sum_probs=119.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
....|.+.+.||+|++|.||++.+..++..+++|.++.... ..+.+.+|+.+++.++|+|++++++.+......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34568899999999999999999988899999999875432 456788999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcc-cC---------------------------Ccccc-----------cccc-------------
Q 041487 119 FEYLDL-DLGSFIRKHT-IT---------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~-~~---------------------------~~~~~-----------~~~~------------- 145 (218)
+||+++ +|.+++.... .. ++++. +.++
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 999995 9999988764 11 11111 1111
Q ss_pred ----C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 146 ----G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 146 ----g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
+ ..|++||.+ .+..++.++|+||||+++|++++|+.||...+...
T Consensus 174 ~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 174 NSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred ccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 238999954 45568999999999999999999999998764443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=158.41 Aligned_cols=151 Identities=34% Similarity=0.637 Sum_probs=117.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC----
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR---- 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 113 (218)
-..++|++.+.||+|++|.||++.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3578899999999999999999999989999999998654333444567889999999999999999999987543
Q ss_pred --EEEEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------ccccC--------
Q 041487 114 --YVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEVG-------- 146 (218)
Q Consensus 114 --~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g-------- 146 (218)
..++||||+..+|.+++...... +++|. ..++|
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred cceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 46999999977887776542211 12211 12222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|+||||+++|++++|+.||...+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 238999976654558899999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-21 Score=153.06 Aligned_cols=140 Identities=24% Similarity=0.436 Sum_probs=104.7
Q ss_pred EeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHh---hCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLK---ELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
.||+|+||.||++.+..++..+|+|.+.+..... .......+|..+++ ...||+++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999998899999999987554322 22233444544333 3479999999999999999999999998
Q ss_pred C-ChHHHhhhcccC---------------------------Ccccc-----------cccc----------------CCc
Q 041487 124 L-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV----------------GSP 148 (218)
Q Consensus 124 ~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~----------------g~~ 148 (218)
+ +|.+++..+... ++++. ..++ ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 160 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence 7 888887654321 22221 1222 224
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+|||.+..+..++.++||||+||++|+|++|..||...
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 999997655566889999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=156.84 Aligned_cols=152 Identities=28% Similarity=0.427 Sum_probs=117.0
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
..+..++|.+.+.||+|+||.||++... ..+..+|+|.++... .....+.+.+|+.+++++ +|+||+++++.+
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3466778999999999999999999752 345689999886432 233356789999999999 799999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc---C--------------------------Cccccc-----------ccc---
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPHI-----------KEV--- 145 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~~-----------~~~--- 145 (218)
...+..+++|||+.+ +|.+++..... . +++|.+ .++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999986 89888865321 0 122211 111
Q ss_pred -----------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 041487 146 -----------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKK 189 (218)
Q Consensus 146 -----------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~ 189 (218)
...|+|||.+ .+..++.++||||+||++|++++ |..||.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 1238999955 44558999999999999999998 9999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=159.21 Aligned_cols=149 Identities=34% Similarity=0.620 Sum_probs=115.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------C
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------R 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (218)
..+|.+.+.||+|+||.||+|.+..++..+|+|.+.+..........+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 5689999999999999999999988999999999876544444456788999999999999999999998643 3
Q ss_pred EEEEEEecCCCChHHHhhhccc-------------------------CCcccc-----------ccccC-----------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTI-------------------------TSIRPH-----------IKEVG----------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~-------------------------~~~~~~-----------~~~~g----------- 146 (218)
..++++||+..+|.++...... .++++. ..++|
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~ 173 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 173 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCC
Confidence 5699999997766654321100 022221 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred ceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 238999976655668899999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=154.34 Aligned_cols=145 Identities=24% Similarity=0.457 Sum_probs=111.7
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe------CC
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT------GR 113 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~ 113 (218)
+.|++.+.||+|+||.||+|....++..+|+|.+... ......+.+|+.+++++ +|+|++++++.+.. ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4588889999999999999999999999999998743 23346788999999998 79999999999864 35
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccc-----------cccccC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRP-----------HIKEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~g------ 146 (218)
.++++|||+.+ +|.+++...... ++.+ .+.++|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 68999999987 888877653211 1111 112222
Q ss_pred ------------CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------------SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------------~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||....
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 13899996642 3347889999999999999999999997653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=158.18 Aligned_cols=159 Identities=23% Similarity=0.396 Sum_probs=118.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
+...+|++.+.||+|+||.||+|+... .+..||+|.++... .....+.+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345678899999999999999998753 35789999987432 223356788999999999999999999999998
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc-------------------------------------------CCcccc-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI-------------------------------------------TSIRPH------- 141 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~-------------------------------------------~~~~~~------- 141 (218)
...++++||+.+ +|.+++..... .+++|.
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999986 88877642100 012221
Q ss_pred ----ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 142 ----IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 142 ----~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..++| ..|+|||.+. ...++.++|||||||++|+|++ |..||.+.....+...+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 12222 2499999654 4448999999999999999998 88999877555555444
Q ss_pred HH
Q 041487 197 RY 198 (218)
Q Consensus 197 ~~ 198 (218)
..
T Consensus 240 ~~ 241 (283)
T cd05091 240 RN 241 (283)
T ss_pred Hc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=154.64 Aligned_cols=147 Identities=25% Similarity=0.492 Sum_probs=111.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE-----eC
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT-----TG 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~ 112 (218)
..++|++.+.||+|+||.||+|.+..++..+|+|.+... ......+.+|+.+++++ +|+|++++++++. .+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 457899999999999999999999989999999987532 22235678899999999 7999999999873 45
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc----C---------------------------Ccccc-----------cccc----
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI----T---------------------------SIRPH-----------IKEV---- 145 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~----~---------------------------~~~~~-----------~~~~---- 145 (218)
..++++|||+++ +|.+++..... . ++++. ..++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 679999999987 88877642110 0 11111 1122
Q ss_pred -------------C-CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -------------G-SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -------------g-~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||.+.. ...++.++|||||||++|+|++|+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 1 23999996542 2447889999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=154.67 Aligned_cols=146 Identities=24% Similarity=0.461 Sum_probs=112.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE------eC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT------TG 112 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~ 112 (218)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+... ......+..|+.+++++ +|+|++++++++. ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 46799999999999999999999999999999998643 22335678889999998 7999999999985 35
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccc-----------cccccC-----
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRP-----------HIKEVG----- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~g----- 146 (218)
..++++|||+++ +|.+++...... ++++ .+.++|
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 679999999987 888877543211 1111 111221
Q ss_pred -------------CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------------SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------------~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 23899996542 3447889999999999999999999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=158.98 Aligned_cols=148 Identities=36% Similarity=0.634 Sum_probs=117.7
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----EEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-----YVY 116 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 116 (218)
+|++.+.||+|++|.||+|++..++..+++|.+..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999888999999998765443455678999999999999999999999987664 799
Q ss_pred EEEecCCCChHHHhhhcccC---------------------------Cccccc-----------cc--------------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KE-------------- 144 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~-------------- 144 (218)
++|||+..+|.+++...... ++++.+ .+
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999998888777553221 111111 11
Q ss_pred ------c-CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 145 ------V-GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 145 ------~-g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
. ...|+|||.+.....++.++|+||||+++|+|++|+.||.+.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 1 12389999665554689999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=152.61 Aligned_cols=150 Identities=27% Similarity=0.467 Sum_probs=112.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|.+...||+|++|.||+|..... ..+++|.+... ....+.+.+|+.++++++|++++++++++. ....+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 346799999999999999999987543 46999987532 233467889999999999999999998875 4568999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g----------- 146 (218)
|||+.+ +|.+++...... ++++.+ .++|
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999987 899988653211 111111 1111
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++||||||+++|+++| |+.||..........
T Consensus 159 ~~~~~~~~~~y~~Pe~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05069 159 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214 (260)
T ss_pred ccCCCccchhhCCHHH-hccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 23999994 445568999999999999999999 999998775444333
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=154.29 Aligned_cols=159 Identities=20% Similarity=0.398 Sum_probs=119.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-C
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-G 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 112 (218)
+..++|++.+.||+|+||.||+|.+.. .+..|++|.+... ......+.+.+|+.++++++|+|++++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456789999999999999999999865 2578999987632 233446778899999999999999999998764 5
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc---------C--------------------------Ccccc-----------cccc
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI---------T--------------------------SIRPH-----------IKEV 145 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~---------~--------------------------~~~~~-----------~~~~ 145 (218)
...++++||+++ +|.+++..... . ++++. +.++
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 779999999985 99888765311 0 11111 1111
Q ss_pred C--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 146 G--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
| ..|+|||.+ .+..++.++|||||||++|++++ |+.||...+...+...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 1 238999955 45558999999999999999999 9999987765555554443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=153.98 Aligned_cols=152 Identities=25% Similarity=0.465 Sum_probs=114.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+...+|++.+.||+|+||.||+|.+... ...+++|...... .....+.+.+|+.++++++|+|++++++++.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3456799999999999999999987543 3568999876432 23345688999999999999999999998875 45
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
.+++|||+++ +|.+++...... ++++.+ .++|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999986 899988653321 111111 1111
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
..|+|||. .....++.++||||||+++|++++ |..||........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~ 217 (270)
T cd05056 161 SYYKASKGKLPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217 (270)
T ss_pred cceecCCCCccccccChhh-hccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 24999995 455568999999999999999997 9999987644433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=160.16 Aligned_cols=149 Identities=36% Similarity=0.673 Sum_probs=116.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe--CCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 115 (218)
..++|++.+.||+|+||.||+|.+..++..+|+|.+............+.+|+.+++++ +|+||+++++++.. ...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35779999999999999999999988899999998864433333445677899999999 99999999999864 4478
Q ss_pred EEEEecCCCChHHHhhhcccC--------------------------Ccccc-----------cccc-------------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~-----------~~~~------------- 145 (218)
++||||++++|.+++...... ++++. ..++
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 999999998888877553211 11111 1111
Q ss_pred ---------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+.....++.++||||||+++|+|++|+.||.+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 13899997766666889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=156.43 Aligned_cols=157 Identities=31% Similarity=0.508 Sum_probs=118.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+.+|+.++++++|||++++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 45779999999999999999998743 56789999986432 2233467889999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-------------------------------------------------Cccc---
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------------SIRP--- 140 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------------~~~~--- 140 (218)
..+++|||+++ +|.+++...... ++++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999987 898887642110 1111
Q ss_pred --------cccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcch
Q 041487 141 --------HIKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDH 191 (218)
Q Consensus 141 --------~~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~ 191 (218)
.+.++| ..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 112222 139999954 45568999999999999999998 888997765554
Q ss_pred HHHHHH
Q 041487 192 LSLIVR 197 (218)
Q Consensus 192 ~~~~~~ 197 (218)
....+.
T Consensus 241 ~~~~~~ 246 (288)
T cd05050 241 VIYYVR 246 (288)
T ss_pred HHHHHh
Confidence 444333
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-21 Score=152.38 Aligned_cols=145 Identities=26% Similarity=0.444 Sum_probs=112.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------ 112 (218)
.++|++.+.||.|++|.||+|.++.+++.+++|.+.... ...+.+.+|+.+++++ +|+|++++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999998889999999987432 2346788999999999 799999999999654
Q ss_pred CEEEEEEecCCC-ChHHHhhhcc----cC---------------------------Ccccc-----------ccccC---
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHT----IT---------------------------SIRPH-----------IKEVG--- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~----~~---------------------------~~~~~-----------~~~~g--- 146 (218)
..++++|||+++ +|.+++.... .. ++.+. ..++|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 459999999997 8888765422 10 11111 11121
Q ss_pred ---------------CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------------SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------------~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.. ...++.++|||||||++|++++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 13899996543 234678999999999999999999999765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-21 Score=152.59 Aligned_cols=140 Identities=29% Similarity=0.435 Sum_probs=109.9
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||+|+||.||+|.++.++..+++|.+...... ....+.+..|+.+++.++||+++++++.+...+..|++|||+++ +|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999889999999998754322 23455677899999999999999999999999999999999986 89
Q ss_pred HHHhhhcccC-----------------------------Ccccc-----------ccccC-----------------Ccc
Q 041487 127 GSFIRKHTIT-----------------------------SIRPH-----------IKEVG-----------------SPY 149 (218)
Q Consensus 127 ~~~~~~~~~~-----------------------------~~~~~-----------~~~~g-----------------~~y 149 (218)
.+++...... ++.+. ..++| ..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 8887654311 11111 11221 248
Q ss_pred cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 150 KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 150 ~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
+|||.+. +..++.++|+||||+++|+|++|+.||.....
T Consensus 161 ~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 161 MAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999654 44488999999999999999999999977643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-21 Score=150.90 Aligned_cols=139 Identities=24% Similarity=0.468 Sum_probs=111.5
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||.|++|.||+|++..++..+++|.+.+... .....+.+.+|+.+++.++||||+++++.+..+...++++||+++ +|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999988899999999976543 234567899999999999999999999999999999999999986 99
Q ss_pred HHHhhhcccC---------------------------Cccccc-----------ccc-----------------CCcccC
Q 041487 127 GSFIRKHTIT---------------------------SIRPHI-----------KEV-----------------GSPYKA 151 (218)
Q Consensus 127 ~~~~~~~~~~---------------------------~~~~~~-----------~~~-----------------g~~y~a 151 (218)
.+++...... ++++.+ .++ ...|++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 9888654321 111111 111 223899
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 152 PESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 152 PE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
||. ..+..++.++|+||+|+++|++++|..||...+
T Consensus 161 PE~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 161 PEI-ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred hhH-hcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 995 445558999999999999999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=153.74 Aligned_cols=155 Identities=23% Similarity=0.397 Sum_probs=113.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCc--EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------CCE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGK--KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------GRY 114 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 114 (218)
+.+.+.||+|+||.||+|+....+. .+|+|.++.........+.+.+|+.+++.++|+||+++++.+.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876665 68999987654445556788899999999999999999998642 235
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------------Ccccc-----------ccccC---
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------------SIRPH-----------IKEVG--- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------------~~~~~-----------~~~~g--- 146 (218)
.+++|||+.+ +|.+++...... +++|. +.++|
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999986 888776421100 12221 12222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|++||.. .+..++.++|||||||++|++++ |+.||.......+...++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 138889954 44558999999999999999999 8999987655554444443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=151.63 Aligned_cols=147 Identities=31% Similarity=0.492 Sum_probs=111.1
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-C
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-D 125 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~ 125 (218)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++|||++++++++......+++|||+++ +
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 3689999999999985 468899999876432 223345688999999999999999999999999999999999986 8
Q ss_pred hHHHhhhcccC----------------------------Ccccc-----------ccccC-------------------C
Q 041487 126 LGSFIRKHTIT----------------------------SIRPH-----------IKEVG-------------------S 147 (218)
Q Consensus 126 L~~~~~~~~~~----------------------------~~~~~-----------~~~~g-------------------~ 147 (218)
|.+++...... ++++. ..++| .
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 88887543211 12221 12222 1
Q ss_pred cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+ ....++.++||||||+++|++++ |..||...........+
T Consensus 159 ~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 159 KWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred cccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 39999955 45558899999999999999999 99999876544443333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-21 Score=153.83 Aligned_cols=160 Identities=21% Similarity=0.338 Sum_probs=120.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.+...+|++++.||+|+||.||+|....++. .||+|.++.. ......+.+.+|+.+++.+.|+|++++++++..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 4567889999999999999999999776665 4899988643 233345678899999999999999999999865
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------ 146 (218)
...++++||+++ +|.+++...... +++|.+ .++|
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 457789999986 888887653221 222221 2222
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYF 199 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~ 199 (218)
..|+|||... +..++.++|||||||++||+++ |..||.......+...+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227 (279)
T ss_pred cccceeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 2389999654 4458999999999999999999 99999877666665555543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-20 Score=148.29 Aligned_cols=146 Identities=35% Similarity=0.576 Sum_probs=118.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||++++..++..+++|.+..........+.+.+|+.++++++|++++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 48899999999999999999988999999999986654445667899999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc-----------------
Q 041487 122 LDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV----------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~----------------- 145 (218)
+++ +|.+++...... ++++.+ .++
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 987 888887654221 111111 111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.. ..++.++||||+|+++|++++|+.||...+
T Consensus 161 ~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 161 GTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 123899996544 448899999999999999999999997653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-21 Score=156.36 Aligned_cols=138 Identities=36% Similarity=0.710 Sum_probs=105.4
Q ss_pred EEEeeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEEEEEEec
Q 041487 46 VEKIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYVYLVFEY 121 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~E~ 121 (218)
...||+|+||.||+|..+. ++..+|+|.+... .....+.+|+.+++.++||||+++++++. .+..++++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999999654 5678999987632 22345788999999999999999999985 45689999999
Q ss_pred CCCChHHHhhhcccC------------------------------------Ccccc---------------ccccC----
Q 041487 122 LDLDLGSFIRKHTIT------------------------------------SIRPH---------------IKEVG---- 146 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~------------------------------------~~~~~---------------~~~~g---- 146 (218)
+.++|.+++...... +++|. +.++|
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 998887776422100 12221 12222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|+|+||++||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 12899997666566899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-20 Score=151.16 Aligned_cols=140 Identities=25% Similarity=0.458 Sum_probs=104.0
Q ss_pred EeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCc-hHHHHHHH---HHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV-PSYLIAGV---SLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
.||+|+||.||+|.+..+++.||+|.+.+....... ...+..|. ..++...||+++++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999889999999998765432211 22233333 33445689999999999999999999999998
Q ss_pred C-ChHHHhhhcccC---------------------------Cccc-----------cccccC----------------Cc
Q 041487 124 L-DLGSFIRKHTIT---------------------------SIRP-----------HIKEVG----------------SP 148 (218)
Q Consensus 124 ~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~g----------------~~ 148 (218)
+ +|.+++...... ++++ .+.++| ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 7 787777543221 1222 112222 23
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+|||.+..+..++.++||||+||++|+|++|+.||...
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 899997665556889999999999999999999999866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-21 Score=152.42 Aligned_cols=145 Identities=24% Similarity=0.464 Sum_probs=116.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||.|++|.||++.++.+++.+++|.+..... ....+.+.+|+.++++++||||+++++.+......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 367888999999999999999998999999999875432 2445678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcc-cC----------------------------Ccccc-----------ccccC-------------
Q 041487 121 YLDL-DLGSFIRKHT-IT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~-~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
|+++ +|.+++.... .. ++++. ..++|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 9995 9988886531 10 11111 11221
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++||||||+++|++++|+.||...
T Consensus 160 ~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 160 VGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 239999954 4556899999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=151.96 Aligned_cols=153 Identities=25% Similarity=0.458 Sum_probs=116.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
.|.-.+.||+|++|.||++.+..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 355568999999999999999889999999987532 233356688999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC--------------------------Ccccc-----------cccc-----------------C
Q 041487 122 LDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEV-----------------G 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~-----------------g 146 (218)
+.+ +|.+++...... ++.|. ..++ |
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 98 LEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 976 888887553211 11111 1111 1
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||...+.......+.
T Consensus 178 ~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 178 TPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred CccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 138999954 45558899999999999999999999998765444443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=148.76 Aligned_cols=152 Identities=30% Similarity=0.544 Sum_probs=120.8
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|++.+.||+|++|.||++.+..++..+++|.+..........+.+.+|+++++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58899999999999999999988899999999976555555667889999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcc----cC---------------------------Ccccc-----------cccc-------------
Q 041487 122 LDL-DLGSFIRKHT----IT---------------------------SIRPH-----------IKEV------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~----~~---------------------------~~~~~-----------~~~~------------- 145 (218)
+++ +|.+++.... .. ++.+. +.++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 987 8988886642 10 11111 1111
Q ss_pred ----C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 146 ----G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 146 ----g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
| ..|+|||.+ ....++.++|+||+|++++++++|+.||...+...+..
T Consensus 161 ~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 161 KTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred cceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 1 238899954 44558899999999999999999999998765444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=154.35 Aligned_cols=158 Identities=27% Similarity=0.387 Sum_probs=115.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+..++|++.+.||+|+||.||+|....++. .+++|.+... ........+..|+.++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 445789999999999999999999876666 4677776421 12233456777888889999999999999875 45
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------- 146 (218)
..++++||+++ +|.+++...... ++++. ..++|
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57889999875 999988653221 22221 12221
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .++.++.++|||||||++||+++ |+.||.+.....+..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226 (279)
T ss_pred CCcccccCCCCCcccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 148999955 44558999999999999999998 9999988766665555543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=171.94 Aligned_cols=169 Identities=23% Similarity=0.299 Sum_probs=125.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccC-C--cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLET-G--KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
|-.+..++.++||+|+||.|++|..... | ..||||+++...... ....|.+|+.+|.+++|+|++++|++-.+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 3344567788999999999999987643 2 468999997543332 56789999999999999999999999877 66
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------------------CccccccccCC------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------------------SIRPHIKEVGS------ 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------------------~~~~~~~~~g~------ 147 (218)
+-+|+|.+++ +|.+.+.+-... .-..++.+||.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 7899999987 888888772111 11123344443
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
+|.|||.+... .++.++|||+|||++|||+| |+.||.+.....+.+.+......+.+...|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence 39999965544 49999999999999999999 899999986666655555444444443333
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-23 Score=184.57 Aligned_cols=152 Identities=27% Similarity=0.452 Sum_probs=128.4
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
-.+..++|.++++||+|+||.|.+++++.+++.||+|++.+.. ..+.....|..|-.+|...+.+.|+.++..|++..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3457889999999999999999999999999999999998754 456677899999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhccc-C--------------------------Cccccc-----------cc-----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI-T--------------------------SIRPHI-----------KE----------- 144 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~-~--------------------------~~~~~~-----------~~----------- 144 (218)
+|+||||++| +|...+.+... . +++|.+ ++
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999987 88877776651 1 555543 22
Q ss_pred -------cCCc-ccCcccccC---C-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 -------VGSP-YKAPESRIR---S-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 -------~g~~-y~aPE~~~~---~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+| |.+||++.. + +.|+..+|.||+||.+|||+.|..||+..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 2333 999997533 3 66999999999999999999999999865
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=151.31 Aligned_cols=146 Identities=23% Similarity=0.437 Sum_probs=111.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC-----C
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG-----R 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~ 113 (218)
.++|++.+.||+|+||.||++....+++.+|+|.+... ......+.+|+.+++++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999899999999998642 22345677899999998 899999999998643 4
Q ss_pred EEEEEEecCCC-ChHHHhhhcc----c-C--------------------------Cccc-----------cccccC----
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHT----I-T--------------------------SIRP-----------HIKEVG---- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~----~-~--------------------------~~~~-----------~~~~~g---- 146 (218)
..+++|||+++ +|.+++.... . . ++++ ...++|
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 68999999987 8888765311 0 0 1111 112221
Q ss_pred --------------CcccCcccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 --------------SPYKAPESRIRSS----VYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~----~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.... .++.++|||||||++|+|++|+.||...+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 2399999654332 26789999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=156.12 Aligned_cols=145 Identities=24% Similarity=0.499 Sum_probs=112.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..|.....||+|+||.||++.+..++..+|+|.+.... ....+.+.+|+.+++.++|||++++++.+..++..++++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 44555668999999999999998899999999986432 2335678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccc-----------cccccC----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRP-----------HIKEVG---------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~-----------~~~~~g---------------- 146 (218)
|+++ +|.+++...... ++++ .+.++|
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 9987 777766443211 1111 112221
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+
T Consensus 179 ~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 179 GTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 238999955 44558999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=151.03 Aligned_cols=149 Identities=30% Similarity=0.518 Sum_probs=116.1
Q ss_pred EEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 47 EKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
+.||+|+||.||+|..... +..+++|.+....... ..+.+.+|+.+++.++|+|++++++++......+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999998765 8899999987543333 46788999999999999999999999999999999999996
Q ss_pred C-ChHHHhhhc---------ccC---------------------------Cccccc-----------ccc----------
Q 041487 124 L-DLGSFIRKH---------TIT---------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 124 ~-~L~~~~~~~---------~~~---------------------------~~~~~~-----------~~~---------- 145 (218)
+ +|.+++... ... +++|.+ .++
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 5 999998764 111 222221 111
Q ss_pred ----------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 146 ----------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ----------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
...|+|||.+.. ..++.++||||||+++|+|++ |..||.......+...+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred ccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 123899995544 468999999999999999999 699998875555555444
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=152.45 Aligned_cols=155 Identities=25% Similarity=0.419 Sum_probs=117.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
.++|++++.||+|+||.||+|+.+. ....+++|.+... ......+.+.+|+.++++++|+|++++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4789999999999999999999653 3467999987532 122345779999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcc---------cC---------------------------Cccccc-----------cccC
Q 041487 115 VYLVFEYLDL-DLGSFIRKHT---------IT---------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~---------~~---------------------------~~~~~~-----------~~~g 146 (218)
.+++|||+++ +|.+++.... .. +++|.+ ..+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999986 9999886544 11 222221 1111
Q ss_pred -------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 -------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+. +..++.++||||||+++|++++ |..||............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~ 231 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence 1299999544 4457889999999999999999 88999766444433333
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=153.75 Aligned_cols=146 Identities=44% Similarity=0.788 Sum_probs=117.4
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|++.+.||.|++|.||+|.+..+++.+++|.++...........+.+|+.++++++|++++++++.+..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67789999999999999999889999999998765444445678889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccC----------------------------Cccc-----------ccccc-----------------C
Q 041487 123 DLDLGSFIRKHTIT----------------------------SIRP-----------HIKEV-----------------G 146 (218)
Q Consensus 123 ~~~L~~~~~~~~~~----------------------------~~~~-----------~~~~~-----------------g 146 (218)
++++.+++...... ++.+ .+.++ +
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence 98888887664211 1111 11111 1
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|.|||.+.....++.++|+||||+++|+++||+.||+..+
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 238899966555468999999999999999999999998764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=154.24 Aligned_cols=146 Identities=49% Similarity=0.881 Sum_probs=119.4
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|+..+.||+|.+|.||+|+...+++.+++|.+..........+.+..|+.+++.++|++++++++++......++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56788999999999999999989999999999866544555677889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcc-cC---------------------------Ccccc-----------cccc------------------
Q 041487 123 DLDLGSFIRKHT-IT---------------------------SIRPH-----------IKEV------------------ 145 (218)
Q Consensus 123 ~~~L~~~~~~~~-~~---------------------------~~~~~-----------~~~~------------------ 145 (218)
+++|.+++.... .. ++++. +.++
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence 999999887652 11 11211 1111
Q ss_pred CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+.....++.++|+|||||++|++++|+.||...+
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 1238999976666578999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=157.36 Aligned_cols=162 Identities=23% Similarity=0.421 Sum_probs=121.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccC-------CcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLET-------GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRL 105 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (218)
....+...+|++.+.||+|+||.||+|.+... +..+|+|.++.. ......+.+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 34456667899999999999999999986432 236899987643 2333456788999999999 89999999
Q ss_pred eeeEEeCCEEEEEEecCCC-ChHHHhhhccc-------------------------------------------CCcccc
Q 041487 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI-------------------------------------------TSIRPH 141 (218)
Q Consensus 106 ~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~-------------------------------------------~~~~~~ 141 (218)
++.+...+.+++++||+++ +|.+++..... .+++|.
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 9999999999999999987 99988764311 011221
Q ss_pred c-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 041487 142 I-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKK 189 (218)
Q Consensus 142 ~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~ 189 (218)
+ .++| ..|+|||.+ .+..++.++||||||+++|+|++ |..||...+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 1 1111 239999955 44558899999999999999999 8999988766
Q ss_pred chHHHHHH
Q 041487 190 DHLSLIVR 197 (218)
Q Consensus 190 ~~~~~~~~ 197 (218)
+.....+.
T Consensus 243 ~~~~~~~~ 250 (334)
T cd05100 243 EELFKLLK 250 (334)
T ss_pred HHHHHHHH
Confidence 66555544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=166.44 Aligned_cols=160 Identities=26% Similarity=0.429 Sum_probs=127.8
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.+.+++-.+...+.+.||+|.||.|.+|.- ..+..||+|+++... .......|.+|+.+|.+++||||+++.++|..+
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 455666677788999999999999999986 336899999998543 333467899999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccCC----------------------------------------ccccccccCC----
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTITS----------------------------------------IRPHIKEVGS---- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~~----------------------------------------~~~~~~~~g~---- 147 (218)
+.+++++||++. +|.+|+.++.... ...++.++|.
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 999999999986 9999999884321 1112233332
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcchHHHH
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS--GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t--g~~Pf~~~~~~~~~~~ 195 (218)
.|||||.+..++ ++.++|+|+||+++||+++ .+.||+....+.....
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 299999777666 8999999999999999877 6799988755554443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=155.08 Aligned_cols=160 Identities=24% Similarity=0.440 Sum_probs=121.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEc-------cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeee
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNL-------ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLD 107 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (218)
..+..++|++.+.||+|+||.||+|+.. ..+..+|+|.+... ......+.+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3467888999999999999999999753 23457999988643 2233456788999999999 8999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Cccccc-
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPHI- 142 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~~- 142 (218)
.+......+++|||+.+ +|.+++...... ++++.+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 99999999999999987 998887653110 222211
Q ss_pred ----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcch
Q 041487 143 ----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDH 191 (218)
Q Consensus 143 ----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~ 191 (218)
.++| ..|+|||.+ .+..++.++||||||+++|++++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 1111 239999955 44558999999999999999999 889998776555
Q ss_pred HHHHHH
Q 041487 192 LSLIVR 197 (218)
Q Consensus 192 ~~~~~~ 197 (218)
+...+.
T Consensus 248 ~~~~~~ 253 (304)
T cd05101 248 LFKLLK 253 (304)
T ss_pred HHHHHH
Confidence 555444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=151.32 Aligned_cols=148 Identities=23% Similarity=0.361 Sum_probs=109.3
Q ss_pred EeeecCceEEEEEEEc--cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 48 KIGQGVFGEVYKCLNL--ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
.||+|+||.||+|..+ ..+..||+|.+... ......+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 34567999998643 23344567899999999999999999999875 4578999999987
Q ss_pred ChHHHhhhcccC----------------------------Cccccc-----------cccC-------------------
Q 041487 125 DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------------------- 146 (218)
Q Consensus 125 ~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------------------- 146 (218)
+|.+++...... +++|.+ .++|
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 898887542211 222211 1221
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ ....++.++|||||||++|++++ |+.||...........+..
T Consensus 160 ~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 160 WPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred CCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 249999954 45558899999999999999997 9999987755554444443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-21 Score=151.73 Aligned_cols=146 Identities=29% Similarity=0.506 Sum_probs=113.2
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC--------CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP--------EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+|.+.+.||.|++|.||+|....+++.+|+|.++..... ....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999889999999988643211 112456788999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc---------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV--------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~--------- 145 (218)
..++||||+++ +|.+++...... ++.+.+ .++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999977 888877654221 111111 111
Q ss_pred -----------CCcccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -----------GSPYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -----------g~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.... .++.++|+||||+++|++++|..||...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 12389999655443 4788999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=167.68 Aligned_cols=178 Identities=22% Similarity=0.375 Sum_probs=133.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccC----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLET----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
...+..+..+....||+|-||.||+|..... ..-||||+++... ..+..+.|.+|+.+++.++||||++++++|.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3445555566678899999999999987533 3458999998543 3344899999999999999999999999996
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccc-----------cccccCCc--
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRP-----------HIKEVGSP-- 148 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~-----------~~~~~g~~-- 148 (218)
+. ..|||||.++. -|..|+...... ++.. +..+||..
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 54 58999999986 777777665443 1111 12334432
Q ss_pred -----------------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC-CcchHHHHHHHhcccCcccchh
Q 041487 149 -----------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCG-KKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 149 -----------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
||||| -++...++.++|||=|||.+||+++ |..||.+- +.+.+-.+.+.-..|-++.=+|
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPE-SINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp 619 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPE-SINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPP 619 (974)
T ss_pred ccccchhhccccccceeecCcc-ccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCCh
Confidence 99999 5677789999999999999999999 99999988 7777777666555555555555
Q ss_pred hhhhhc
Q 041487 210 CFLSIM 215 (218)
Q Consensus 210 ~~~~~~ 215 (218)
...+.|
T Consensus 620 ~LYslm 625 (974)
T KOG4257|consen 620 ALYSLM 625 (974)
T ss_pred HHHHHH
Confidence 555544
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=161.34 Aligned_cols=97 Identities=27% Similarity=0.431 Sum_probs=80.7
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDV 108 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~ 108 (218)
...+..++|.+.+.||+|+||.||+|.++ ..+..||+|.++... .....+.+.+|+.++.++. ||||+++++.
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 35566778999999999999999999864 345689999997532 2233457889999999997 9999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhh
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
+...+..++||||+.+ +|.+++..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~ 134 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHR 134 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHh
Confidence 9999999999999987 99888754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=153.59 Aligned_cols=144 Identities=38% Similarity=0.681 Sum_probs=114.5
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEEEec
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
|++.+.||+|++|.||+|+...+++.+++|.+...... .......+|+..++++. |+|++++++.+..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999999888999999998754332 22334567889999998 99999999999999999999999
Q ss_pred CCCChHHHhhhcc--c-C--------------------------Cccccc-----------ccc----------------
Q 041487 122 LDLDLGSFIRKHT--I-T--------------------------SIRPHI-----------KEV---------------- 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~--~-~--------------------------~~~~~~-----------~~~---------------- 145 (218)
+.++|.+++.... . . ++.+.+ .++
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 9889988876643 1 1 111111 111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.....++.++|+||||+++|++++|++||+..
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 123899997766666889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=149.68 Aligned_cols=149 Identities=27% Similarity=0.455 Sum_probs=109.2
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHH-HhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSL-LKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||.|++|.||+|.+..+++.+|+|.+++.... ......+..|..+ ....+|+|++++++.+...+.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999889999999998754321 2222334444444 4445899999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Ccccc-----------ccccC--------------CcccC
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPH-----------IKEVG--------------SPYKA 151 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g--------------~~y~a 151 (218)
+|.+++...... ++++. ..++| ..|+|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~ 161 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLA 161 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCccC
Confidence 888887653321 11111 12222 23899
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 152 PESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 152 PE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
||.+. +..++.++||||||+++|++++|..||...+...+...+
T Consensus 162 pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 162 PETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred hhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99654 444889999999999999999999999877555544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=150.65 Aligned_cols=151 Identities=28% Similarity=0.495 Sum_probs=115.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
...+|++.+.||+|+||.||++.. ++..+|+|.++.. ...+.+.+|+.++++++|||++++++.+... ..+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 346799999999999999999864 7889999988632 2346788999999999999999999998654 47999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccC-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVG----------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g----------- 146 (218)
|||+.+ +|.+++...... +++|. ..++|
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~ 156 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence 999986 999888654321 22221 12222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|+|||||++|+|++ |+.||...+.......+.
T Consensus 157 ~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 211 (254)
T cd05083 157 SKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211 (254)
T ss_pred CCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 238999954 45568899999999999999998 999998775554444443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-21 Score=154.81 Aligned_cols=159 Identities=26% Similarity=0.448 Sum_probs=119.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
+..++|.+.+.||+|+||.||+|++.. ....+|+|.++... .......+.+|+.+++.+ +||||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 445789999999999999999997632 34579999876432 233456788999999999 699999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc-----------------C--------------------------Cccccc---
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI-----------------T--------------------------SIRPHI--- 142 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------------~--------------------------~~~~~~--- 142 (218)
......+++|||+++ +|.+++..... . ++++.+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 999999999999987 99988865321 0 111111
Q ss_pred --------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 041487 143 --------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLS 193 (218)
Q Consensus 143 --------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~ 193 (218)
.++| ..|+|||.+. +..++.++|||||||++|++++ |..||.......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 1111 2499999554 4568999999999999999999 89999877655555
Q ss_pred HHHHH
Q 041487 194 LIVRY 198 (218)
Q Consensus 194 ~~~~~ 198 (218)
..+..
T Consensus 247 ~~~~~ 251 (314)
T cd05099 247 KLLRE 251 (314)
T ss_pred HHHHc
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=154.51 Aligned_cols=148 Identities=26% Similarity=0.428 Sum_probs=112.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 118 (218)
.++|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35677788999999999999999999999999998754322 34567888999999995 99999999999988999999
Q ss_pred EecCCCChHHHhhh---cc---c---------------------------CCcccc-----------cccc---------
Q 041487 119 FEYLDLDLGSFIRK---HT---I---------------------------TSIRPH-----------IKEV--------- 145 (218)
Q Consensus 119 ~E~~~~~L~~~~~~---~~---~---------------------------~~~~~~-----------~~~~--------- 145 (218)
|||+..++.++... .. . .++++. +.++
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99998766543211 00 0 011111 1122
Q ss_pred --------CCcccCcccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 --------GSPYKAPESRIRS--SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 --------g~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
...|+|||.+... ..++.++|||||||++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 1249999976554 368899999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=152.17 Aligned_cols=147 Identities=31% Similarity=0.444 Sum_probs=110.9
Q ss_pred EEeeecCceEEEEEEEccCCc--EEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGK--KVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
+.||+|+||.||+|+...++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.++++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999877765 4688877632 2334456788999999999 89999999999999999999999998
Q ss_pred C-ChHHHhhhcccC-------------------------------------------Ccccc-----------ccccCC-
Q 041487 124 L-DLGSFIRKHTIT-------------------------------------------SIRPH-----------IKEVGS- 147 (218)
Q Consensus 124 ~-~L~~~~~~~~~~-------------------------------------------~~~~~-----------~~~~g~- 147 (218)
+ +|.+++...... +++|. ..++|.
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 6 998888643210 22221 122332
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
.|+|||.+ ....++.++|||||||++|+|++ |..||...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred cccchhhhccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 29999954 55568999999999999999997 9999987654444433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-21 Score=153.49 Aligned_cols=154 Identities=26% Similarity=0.468 Sum_probs=116.5
Q ss_pred ceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+|++.+.||+|+||.||+|+... ....+++|.+.... .....+.+.+|+.+++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998643 23568888876432 2233467889999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------------------------------Ccccc---
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------------------------------SIRPH--- 141 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------------------------------~~~~~--- 141 (218)
+++||+.+ +|.+++...... +++|.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 99999986 898887542100 11111
Q ss_pred --------ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 142 --------IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 142 --------~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
+.++| ..|+|||.+ .+..++.++||||||+++|+|++ |+.||++.....+
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 11121 248999954 45558999999999999999999 9999988766665
Q ss_pred HHHHH
Q 041487 193 SLIVR 197 (218)
Q Consensus 193 ~~~~~ 197 (218)
.....
T Consensus 239 ~~~~~ 243 (290)
T cd05045 239 FNLLK 243 (290)
T ss_pred HHHHh
Confidence 55544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-22 Score=156.80 Aligned_cols=140 Identities=32% Similarity=0.535 Sum_probs=113.4
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
.+.||+|+++.|-.|....++.++|||++.+. ......+..+|++++..+ .|+||+.++++|.++..+|+|||-+.+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 46799999999999999999999999999865 455578899999999999 699999999999999999999999987
Q ss_pred -ChHHHhhhcccC---------------------------Cccccccc--------------------------------
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPHIKE-------------------------------- 144 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~~~~-------------------------------- 144 (218)
.|...|.++..- +.+|.+..
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 777766553221 33332211
Q ss_pred ------cCCc-ccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 ------VGSP-YKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 ------~g~~-y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+|++ |||||++.- .-.|+.+.|.||||+++|-|++|.+||.+.
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1222 999996422 244899999999999999999999999865
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=154.89 Aligned_cols=147 Identities=24% Similarity=0.466 Sum_probs=113.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.|.....||+|+||.||++.+..++..+|+|.+... .....+.+.+|+.+++.++|+|++++++.+...+..+++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3455567899999999999999889999999988642 23345678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Ccccc-----------ccccC----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPH-----------IKEVG---------------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~-----------~~~~g---------------- 146 (218)
|+++ +|.+++...... ++++. ..++|
T Consensus 100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 9987 787776443211 11111 11221
Q ss_pred --CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 --SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 --~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||.+ .+..++.++||||||+++|++++|+.||...+..
T Consensus 180 ~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 180 GTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred cCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 239999954 4555889999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-20 Score=150.08 Aligned_cols=144 Identities=43% Similarity=0.758 Sum_probs=111.5
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEEeCCE-----
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLTTGRY----- 114 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 114 (218)
|++.+.||+|++|.||+|+++.++..+|+|.++...........+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999988899999999975544444445666787777665 69999999999987766
Q ss_pred EEEEEecCCCChHHHhhhcccC-----------------------------Cccc-----------ccccc---------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRP-----------HIKEV--------- 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~--------- 145 (218)
.+++|||++++|.+++...... ++++ .+.++
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 9999999998888877653221 1111 11111
Q ss_pred --------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+ .+..++.++|+|||||++|+|++|++||...
T Consensus 161 ~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 161 MALTSVVVTLWYRAPEVL-LQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred cccccccccccccChHHh-ccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 1238999965 4455889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=154.93 Aligned_cols=147 Identities=23% Similarity=0.394 Sum_probs=114.2
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|+..+.||+|++|.||+|.++.++..+++|.+.... ......+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3777889999999999999998899999999986432 223345678889999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC--------------C
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG--------------S 147 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g--------------~ 147 (218)
|+.+++.+++...... ++++. ..++| .
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccCCc
Confidence 9988887776432211 11111 12222 2
Q ss_pred cccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 148 PYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 148 ~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
.|+|||.+. ....++.++|||||||++|+|++|+.||...+
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 389999654 23457889999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=158.27 Aligned_cols=145 Identities=26% Similarity=0.419 Sum_probs=114.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-EEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-YVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 117 (218)
..++|.-...||+|+||.||+|... ++..||||.+....... ...|.+|+.++.+++|||+|+++|+|.+.+ ..++
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 4578888999999999999999863 44899999776433221 455999999999999999999999999888 5999
Q ss_pred EEecCCC-ChHHHhhhccc----C---------------------------------------Ccccccccc--------
Q 041487 118 VFEYLDL-DLGSFIRKHTI----T---------------------------------------SIRPHIKEV-------- 145 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~----~---------------------------------------~~~~~~~~~-------- 145 (218)
|.||++. +|.+++..... + +..+++.+|
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999985 99888766542 1 222222332
Q ss_pred ----------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ----------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ----------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.... +..+.++||||||+++.|++||+.|.+..
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 2 24899996544 55899999999999999999999988864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=152.16 Aligned_cols=176 Identities=24% Similarity=0.372 Sum_probs=127.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 118 (218)
++|.+.+.||.|++|.||+|+.+.++..+++|++.+... .....+.+.+|..+++++. |+||+++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999998999999999875432 2233467888999999998 99999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc---------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE--------------- 144 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~--------------- 144 (218)
||++.+ +|.+++...... ++++.+ .+
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999955 898888665321 111110 00
Q ss_pred -----------------------cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh-c
Q 041487 145 -----------------------VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF-T 200 (218)
Q Consensus 145 -----------------------~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~-~ 200 (218)
....|+|||... ...++.++|+||||++++++++|+.||...........+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 113489999544 445888999999999999999999999876433332222211 1
Q ss_pred ccC--cccchhhhhhhccc
Q 041487 201 ALT--NYLVLPCFLSIMLL 217 (218)
Q Consensus 201 ~~~--~~~~~~~~~~~~l~ 217 (218)
..+ .+..+.+++..||+
T Consensus 240 ~~~~~~~~~~~~li~~~l~ 258 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLV 258 (280)
T ss_pred CCCCccCHHHHHHHHHHhc
Confidence 111 12345566666654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-20 Score=145.47 Aligned_cols=146 Identities=28% Similarity=0.501 Sum_probs=117.7
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CEEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RYVYLVF 119 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 119 (218)
+|+..+.||+|++|.||+|.+..++..+++|.+..........+.+.+|+.++++++|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999988999999999876554445678899999999999999999999999888 8999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc-----------ccc----------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKE---------------- 144 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~---------------- 144 (218)
|++++ +|.+++...... ++.+. +.+
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99965 998887665321 11111 011
Q ss_pred ----cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 145 ----VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 145 ----~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
....|++||.+ .....+.++||||||+++|++++|+.||...+
T Consensus 161 ~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 161 GSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11238999954 44448999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=156.97 Aligned_cols=140 Identities=22% Similarity=0.427 Sum_probs=109.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
....+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.++++++|+||+++++++......++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4556799999999999999999999889999999975321 23468899999999999999999999999999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------Ccccc-----------ccccC------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------ 146 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------ 146 (218)
|||++.++|.+++...... ++++. +.++|
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9999998998887653221 22221 12222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCC
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPC 186 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~~ 186 (218)
..|+|||.+ .+..++.++|||||||++|+|+++. .+|..
T Consensus 215 ~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 215 GLAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccCCeec-CCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 238999955 4455899999999999999999954 45543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-21 Score=155.63 Aligned_cols=142 Identities=23% Similarity=0.350 Sum_probs=110.8
Q ss_pred EEeeec--CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQG--VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
..||+| +||+||++.+..++..||+|++..........+.+.+|+.+++.++||||++++++|..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 999999999999999999999875543444457888999999999999999999999999999999999986
Q ss_pred -ChHHHhhhcccC-----------------------------Ccccccc-------------------------------
Q 041487 125 -DLGSFIRKHTIT-----------------------------SIRPHIK------------------------------- 143 (218)
Q Consensus 125 -~L~~~~~~~~~~-----------------------------~~~~~~~------------------------------- 143 (218)
++.+++...... +++|.+.
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 888877643211 2222110
Q ss_pred -----ccCCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 144 -----EVGSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 144 -----~~g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
....+|+|||.+... ..++.++|||||||++|++++|+.||....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 011249999976543 347899999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-20 Score=149.69 Aligned_cols=146 Identities=18% Similarity=0.362 Sum_probs=113.7
Q ss_pred ceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCC--CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNE--PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
+|++.+.||.|+||.||.|... .++..||+|.++.... .....+++.+|+.+++++ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5889999999999999999874 4788999999875432 233457788999999999 699999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccc-----------ccccc-----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HIKEV----------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~~~~----------- 145 (218)
+++|||+++ +|.+++...... ++++ .+.++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999987 888887654321 1111 11122
Q ss_pred --------CCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --------GSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --------g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+... ..++.++||||||+++|++++|+.||...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 1238999976543 34678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=153.91 Aligned_cols=143 Identities=22% Similarity=0.444 Sum_probs=107.4
Q ss_pred EEeeecCceEEEEEEEccCCc-------EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 47 EKIGQGVFGEVYKCLNLETGK-------KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
+.||+|+||.||+|..+..+. .+++|.+... .....+.+.+|+.+++.++|||++++++.+......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999998765443 4888876532 2334567888999999999999999999999989999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-------------------ccccC-----
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-------------------IKEVG----- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-------------------~~~~g----- 146 (218)
||+++ +|.+++...... ++++. ..++|
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 99987 888888654321 22221 11111
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcch
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCGKKDH 191 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~~~~~ 191 (218)
..|+|||.+.....++.++|||||||++|++++| ..||...+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred CCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 2399999766556688999999999999999998 57776654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-20 Score=148.27 Aligned_cols=140 Identities=26% Similarity=0.368 Sum_probs=105.4
Q ss_pred cceeEEEEe--eecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 41 WNYKVVEKI--GQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 41 ~~~~~~~~i--g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
++|.+.+.+ |+|+||.||+++++.++..+|+|.+....... .|+.+...+ +|||++++++.+...+..++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 567776666 99999999999999999999999987543221 122222222 79999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccc------------cccccC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRP------------HIKEVG----------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~------------~~~~~g----------- 146 (218)
||||+++ +|.+++...... ++++ .+.++|
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 166 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccC
Confidence 9999986 999988765321 1111 112222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||....
T Consensus 167 ~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 167 DGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 249999965 44558899999999999999999999998653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-22 Score=165.32 Aligned_cols=149 Identities=32% Similarity=0.568 Sum_probs=116.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
.+....|+++++||+|+.+.||++.. ...+.+|+|.+.-...+....+-+.+|+..|.++ .|.+|++++++-..++.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34556699999999999999999985 3445666666554456666788999999999999 699999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC----------------------------Ccccc----------cccc------------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH----------IKEV------------ 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~----------~~~~------------ 145 (218)
|+|||+-+.+|...+...... +.+|. ..+|
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccc
Confidence 999999998998888765443 22221 1222
Q ss_pred -------CC-cccCcccccCCCC----------CCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 146 -------GS-PYKAPESRIRSSV----------YSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 146 -------g~-~y~aPE~~~~~~~----------~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
|+ .||+||.+..... .+.++|||||||+||+|+-|+.||..
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 32 3999997644221 56789999999999999999999964
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=164.68 Aligned_cols=154 Identities=30% Similarity=0.436 Sum_probs=125.9
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCCC
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLD 125 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~~ 125 (218)
-++||.|-||+||-|.++++|+.||||++.+.+.+....+.+.+|+.+|+.+.||.||.+-.+|...+.+++|||-+.++
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999999999999999999998888888899999999999999999999999999999999999999988
Q ss_pred hHHHhhhcccC-----------------------------Cccccc------------------------------cccC
Q 041487 126 LGSFIRKHTIT-----------------------------SIRPHI------------------------------KEVG 146 (218)
Q Consensus 126 L~~~~~~~~~~-----------------------------~~~~~~------------------------------~~~g 146 (218)
+.+.|.+.... +.+|.+ +..|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 87777654332 333322 1123
Q ss_pred C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc
Q 041487 147 S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 ~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
+ +|+|||++.+.+ |...-|+||+||++|--++|.+||+-. +.+...++....+
T Consensus 729 TPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFM 782 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFM 782 (888)
T ss_pred CccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccc
Confidence 3 399999665555 899999999999999999999999754 4444444443333
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=151.26 Aligned_cols=146 Identities=18% Similarity=0.288 Sum_probs=107.8
Q ss_pred EeeecCceEEEEEEEcc------------------------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCee
Q 041487 48 KIGQGVFGEVYKCLNLE------------------------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 103 (218)
.||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 68999999999997432 1235888887532 223345788889999999999999
Q ss_pred eeeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-------------
Q 041487 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH------------- 141 (218)
Q Consensus 104 ~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~------------- 141 (218)
++++++......++||||+++ +|.+++...... ++++.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999987 777776542111 22221
Q ss_pred -----cccc--------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcchHHHH
Q 041487 142 -----IKEV--------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMV-SGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 142 -----~~~~--------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~-tg~~Pf~~~~~~~~~~~ 195 (218)
..++ ..+|+|||.+.....++.++|||||||++|+++ +|+.||...........
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 1122 234999997766666899999999999999985 69999987655444443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=152.07 Aligned_cols=145 Identities=24% Similarity=0.460 Sum_probs=111.4
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
....||+|+||.||++..+.++..+|+|.+... .......+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 346899999999999999899999999987532 233456788999999999999999999999999999999999987
Q ss_pred -ChHHHhhhcccC--------------------------Cccc-----------cccccC------------------Cc
Q 041487 125 -DLGSFIRKHTIT--------------------------SIRP-----------HIKEVG------------------SP 148 (218)
Q Consensus 125 -~L~~~~~~~~~~--------------------------~~~~-----------~~~~~g------------------~~ 148 (218)
+|.+++...... ++.+ .+.++| ..
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 777765432211 1111 111221 23
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
|+|||.+ ....++.++|+||+|+++|++++|+.||.+......
T Consensus 182 y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~ 224 (292)
T cd06657 182 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224 (292)
T ss_pred ccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8999954 455578999999999999999999999987644433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=152.07 Aligned_cols=148 Identities=26% Similarity=0.492 Sum_probs=110.7
Q ss_pred EeeecCceEEEEEEEccCC------cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 48 KIGQGVFGEVYKCLNLETG------KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
.||+|+||.||+|+..... +.+++|.+.... .......+.+|+.+++.++||||+++++++......+++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 6899999999999876443 689999886432 223456788999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC----------------------------------Ccc----------------ccccccC----
Q 041487 122 LDL-DLGSFIRKHTIT----------------------------------SIR----------------PHIKEVG---- 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~----------------------------------~~~----------------~~~~~~g---- 146 (218)
+++ +|.+++...... +++ ....++|
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 986 888887542100 111 1112222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+. +..++.++|||||||++|+|++ |+.||...+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred cccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 3489999654 4558999999999999999998 999998765444444433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=152.76 Aligned_cols=149 Identities=26% Similarity=0.450 Sum_probs=112.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccC--------------CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeee
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLET--------------GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVR 104 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 104 (218)
...+|++.+.||+|+||.||+|.+... ...||+|.++.. ......+.+.+|+.++++++|+|+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 346899999999999999999986532 235899998643 22333467889999999999999999
Q ss_pred eeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------------------Ccccc---
Q 041487 105 LLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------SIRPH--- 141 (218)
Q Consensus 105 ~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------~~~~~--- 141 (218)
+++++......+++|||+.+ +|.+++...... +++|.
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999987 888887542100 11111
Q ss_pred --------ccccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCc
Q 041487 142 --------IKEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS--GKPLFPCGKK 189 (218)
Q Consensus 142 --------~~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t--g~~Pf~~~~~ 189 (218)
..++| ..|+|||.+. .+.++.++|||||||++|+|++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 11111 2499999654 4458999999999999999998 6678876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=151.47 Aligned_cols=148 Identities=28% Similarity=0.440 Sum_probs=114.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCC----------------cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCe
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETG----------------KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 102 (218)
...+|++.+.||+|+||.||+|.+...+ ..+|+|.+..... ....+.+.+|+.++++++|||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 3468999999999999999999875433 4689998864432 2345678899999999999999
Q ss_pred eeeeeeEEeCCEEEEEEecCCC-ChHHHhhhccc-----------C---------------------------Cccccc-
Q 041487 103 VRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------T---------------------------SIRPHI- 142 (218)
Q Consensus 103 v~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------~---------------------------~~~~~~- 142 (218)
+++++++..+...+++||++.+ +|.+++..... . +++|.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999986 88888765431 0 222221
Q ss_pred ----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 041487 143 ----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS--GKPLFPCGK 188 (218)
Q Consensus 143 ----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t--g~~Pf~~~~ 188 (218)
.++| ..|+|||.+. ...++.++|||||||++|++++ |..||...+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 1222 1399999554 4458999999999999999998 778887653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=148.10 Aligned_cols=147 Identities=27% Similarity=0.426 Sum_probs=114.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+++.....||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344555667999999999999999888999999987643 223456789999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcc--c--C--------------------------Ccccc------------cccc----------
Q 041487 119 FEYLDL-DLGSFIRKHT--I--T--------------------------SIRPH------------IKEV---------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~--~--~--------------------------~~~~~------------~~~~---------- 145 (218)
+||+++ +|.+++.... . . ++++. ..++
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999986 9998876531 1 0 11111 1111
Q ss_pred --------CCcccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --------GSPYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --------g~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.... .++.++|+||||+++|++++|+.||...
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 12489999764432 3788999999999999999999999765
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=150.06 Aligned_cols=143 Identities=25% Similarity=0.399 Sum_probs=108.3
Q ss_pred eeEEEEeeecCceEEEEEEE----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLN----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYVY 116 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 116 (218)
|++++.||+|+||.||++.. ..++..||+|.++... .......+.+|+.++++++|||++++++++.. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48999999999999988653 3467899999987442 22345678899999999999999999998764 45689
Q ss_pred EEEecCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG------------ 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g------------ 146 (218)
++|||+++ +|.+++...... +++|.+ .++|
T Consensus 85 lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred EEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence 99999987 888887653221 222221 1121
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ ....++.++||||||+++|+|+||+.||...
T Consensus 165 ~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 165 RVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 128899954 4455899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-20 Score=152.54 Aligned_cols=147 Identities=32% Similarity=0.521 Sum_probs=113.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccC--CcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe----CCE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLET--GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT----GRY 114 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 114 (218)
+|++.+.||+|+||.||++.+... +..+|+|.++.........+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999999877 88999999875443444466788999999999 69999999987542 246
Q ss_pred EEEEEecCCCChHHHhhhcccC---------------------------Ccccc-----------cccc-----------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-----------IKEV----------- 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-----------~~~~----------- 145 (218)
.++++|++..+|.+++...... +++|. +.++
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 8999999988888777543221 11211 1111
Q ss_pred ----------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||.+.....++.++||||+||++|++++|++||...+
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 1 248999976655568999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=147.05 Aligned_cols=153 Identities=26% Similarity=0.488 Sum_probs=118.0
Q ss_pred eeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+++.+.||+|+||.||+++....+ ..+|+|.++... .....+.+..|+.+++.++|+|++++++.+...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467889999999999999987766 899999986432 222567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhccc---C--------------------------Cccccc-----------cc-------------
Q 041487 119 FEYLDL-DLGSFIRKHTI---T--------------------------SIRPHI-----------KE------------- 144 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~~-----------~~------------- 144 (218)
|||+++ +|.+++..... . ++++.+ .+
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999987 89888765332 1 122211 11
Q ss_pred ------cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 145 ------VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 145 ------~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
....|+|||.+ ....++.++||||+|+++|+|++ |++||...+...+...+.
T Consensus 160 ~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~ 218 (258)
T smart00219 160 KKKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK 218 (258)
T ss_pred ccccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 11348999955 55668999999999999999999 899998765554444444
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=159.83 Aligned_cols=138 Identities=20% Similarity=0.330 Sum_probs=109.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
...+|.+.+.||+|+||.||+|.+...++.||+|... ...+.+|+.++++++|+||+++++++...+..+++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4557999999999999999999999999999999532 12356899999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcccC----------------------------Ccccc-----------cccc--------------
Q 041487 119 FEYLDLDLGSFIRKHTIT----------------------------SIRPH-----------IKEV-------------- 145 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~----------------------------~~~~~-----------~~~~-------------- 145 (218)
||++.++|.+++...... ++++. +.+|
T Consensus 239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999988888887643211 22221 1112
Q ss_pred -----C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 146 -----G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 146 -----g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
| ..|+|||.+ .+..++.++|||||||++|||++|..|+.
T Consensus 319 ~~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 319 HYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2 249999965 45568999999999999999999876543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=150.97 Aligned_cols=151 Identities=20% Similarity=0.359 Sum_probs=112.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
..+..++|++.+.||+|++|.||+|.+..++..+|+|.++..... .....+.+|+.++.+. .|+||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 346678899999999999999999999888999999998754322 2344566677666666 59999999999999999
Q ss_pred EEEEEecCCCChHHHhhhcccC-----------------------------Cccc-----------cccccC--------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRP-----------HIKEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~-----------~~~~~g-------- 146 (218)
.+++|||+.+.+.++....... ++++ .+.++|
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9999999986665544331100 1111 112221
Q ss_pred ---------CcccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRS---SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+... ..++.++||||||+++|+|++|+.||...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 248999965433 33788999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=149.57 Aligned_cols=145 Identities=26% Similarity=0.429 Sum_probs=111.0
Q ss_pred EEeeecCceEEEEEEEcc-CC--cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 47 EKIGQGVFGEVYKCLNLE-TG--KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
+.||+|++|.||+|.+.. .+ ..+|+|.++..... ...+.+.+|+.++++++||||+++++.+.. ...+++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998755 33 36999998754433 556789999999999999999999999988 89999999997
Q ss_pred C-ChHHHhhhccc--C---------------------------Cccccc-----------cccC----------------
Q 041487 124 L-DLGSFIRKHTI--T---------------------------SIRPHI-----------KEVG---------------- 146 (218)
Q Consensus 124 ~-~L~~~~~~~~~--~---------------------------~~~~~~-----------~~~g---------------- 146 (218)
+ +|.+++..... . +++|.+ .++|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 6 99988866431 0 122211 1221
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++|||||||++|+|++ |+.||...+...+..
T Consensus 159 ~~~~~~~y~~pE~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 211 (257)
T cd05040 159 HLKVPFAWCAPES-LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211 (257)
T ss_pred CCCCCceecCHHH-hcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 24899995 445558999999999999999999 999997664444433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=150.08 Aligned_cols=140 Identities=21% Similarity=0.350 Sum_probs=104.7
Q ss_pred EeeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 48 KIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++.+......+++|||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 68999999999996532 3457888877532 2233345678899999999999999999999999999999999987
Q ss_pred ChHHHhhhcccC--------------------------------Ccccc-----------ccccC---------------
Q 041487 125 DLGSFIRKHTIT--------------------------------SIRPH-----------IKEVG--------------- 146 (218)
Q Consensus 125 ~L~~~~~~~~~~--------------------------------~~~~~-----------~~~~g--------------- 146 (218)
+|.+++...... +++|. +.++|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 998887653210 12221 12222
Q ss_pred -----CcccCcccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 147 -----SPYKAPESRIR------SSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 147 -----~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
..|+|||.+.. ...++.++|||||||++|+|++ |..||....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 13999996532 2346789999999999999999 789998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-19 Score=142.54 Aligned_cols=143 Identities=29% Similarity=0.518 Sum_probs=115.4
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
+|.+.+.||+|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++|++++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 47889999999999999999988899999999875433 3567899999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcc-c-C--------------------------Cccccc-----------ccc----------------
Q 041487 122 LDL-DLGSFIRKHT-I-T--------------------------SIRPHI-----------KEV---------------- 145 (218)
Q Consensus 122 ~~~-~L~~~~~~~~-~-~--------------------------~~~~~~-----------~~~---------------- 145 (218)
+++ +|.+++.... . . ++.+.+ .++
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 995 9998876651 1 1 111111 111
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|++||.+ .+..++.++|+||||+++|++++|+.||...
T Consensus 159 ~~~~~~~PE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 159 GTPYWMAPEVI-NGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cCCcccCHHHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1238999954 4445889999999999999999999999866
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=148.07 Aligned_cols=149 Identities=30% Similarity=0.542 Sum_probs=111.5
Q ss_pred ceeEEEEeeecCceEEEEEEEcc-CCcEEEEEEeecCCC--------CCCchHHHHHHHHHHhh-CCCCCeeeeeeeEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLE-TGKKVAIKMINIQNE--------PEGVPSYLIAGVSLLKE-LEHDNIVRLLDVLTT 111 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 111 (218)
+|++.+.||+|+||.||+|.+.. .+..+|+|.+..... .......+.+|+.++.+ ++|+|++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 678999998864321 12234567778887765 699999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhc---cc-C----------------------------Ccccc-----------ccccC-
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKH---TI-T----------------------------SIRPH-----------IKEVG- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~---~~-~----------------------------~~~~~-----------~~~~g- 146 (218)
++..+++|||+++ +|.+++... .. . ++.+. ..++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999986 887776321 00 0 11111 11221
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|++||.+. +..++.++|+||||+++|++++|+.||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred eeecccccccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 2389999654 4558999999999999999999999997664433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=150.17 Aligned_cols=146 Identities=27% Similarity=0.460 Sum_probs=113.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEc----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNL----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 113 (218)
...|++.+.||+|+||.||+|... .++..+|+|.++..... ...+.+.+|+.+++.++|+|++++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888999999999999999864 34789999998754332 346789999999999999999999999876 66
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~-------- 145 (218)
..+++|||+++ +|.+++...... ++++.+ .++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 89999999976 999888654411 122111 111
Q ss_pred -------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|++||.+. ...++.++||||||+++|+|+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 12388999654 445889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=150.17 Aligned_cols=147 Identities=25% Similarity=0.427 Sum_probs=111.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEcc----------------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCee
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLE----------------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 103 (218)
.++|++.+.||+|+||.||++.+.. +...+|+|.+... ......+.+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4579999999999999999985432 3456899988643 2233456788999999999999999
Q ss_pred eeeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC--------------------------------------Cccccc--
Q 041487 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT--------------------------------------SIRPHI-- 142 (218)
Q Consensus 104 ~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~--------------------------------------~~~~~~-- 142 (218)
++++++...+..+++|||+++ +|.+++...... +++|.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999986 898887653210 222221
Q ss_pred ---------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 041487 143 ---------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS--GKPLFPCGK 188 (218)
Q Consensus 143 ---------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t--g~~Pf~~~~ 188 (218)
.++| ..|++||... .+.++.++|||||||++|+|++ |..||...+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 1111 2488999654 4458999999999999999998 778987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-22 Score=161.23 Aligned_cols=165 Identities=27% Similarity=0.578 Sum_probs=132.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC--C----CeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH--D----NIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~ 111 (218)
....+|.+...+|+|.||.|..+.++.++..||+|+++. -....+....|+.+++++.+ | -++.+.++|.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 346789999999999999999999999999999999873 23445667789999999932 2 27788888999
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc--------------------
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI-------------------- 142 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~-------------------- 142 (218)
.+..|+|.|.++.++.||++..... +.+|.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999999999999885443 222221
Q ss_pred -----------cccCCc---------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHH
Q 041487 143 -----------KEVGSP---------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLI 195 (218)
Q Consensus 143 -----------~~~g~~---------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~ 195 (218)
.+||++ |.|||++. +-.++.++||||+||+|+|++||...|+.. +.++++.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 234443 99999655 445999999999999999999999999988 77888888
Q ss_pred HHHhcccCccc
Q 041487 196 VRYFTALTNYL 206 (218)
Q Consensus 196 ~~~~~~~~~~~ 206 (218)
.+.+|++|..+
T Consensus 322 erIlGp~P~~m 332 (415)
T KOG0671|consen 322 ERILGPIPSRM 332 (415)
T ss_pred HHhhCCCcHHH
Confidence 88888665543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-22 Score=168.75 Aligned_cols=173 Identities=22% Similarity=0.348 Sum_probs=128.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
.+.|++.||-|+||.||+|..+.++...|-|++... ..+..+.+.-|+++|..++||+||++++.|...+.+|++.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 468899999999999999999989999999998633 445577888999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC----------------------------Ccccc----------------------------ccc
Q 041487 122 LDL-DLGSFIRKHTIT----------------------------SIRPH----------------------------IKE 144 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~----------------------------~~~~~----------------------------~~~ 144 (218)
|.| .+...+...+.. +.+.. -..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 976 333333322111 11111 123
Q ss_pred cCCc-ccCcccc----cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC--cccchhhhhhhcc
Q 041487 145 VGSP-YKAPESR----IRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT--NYLVLPCFLSIML 216 (218)
Q Consensus 145 ~g~~-y~aPE~~----~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 216 (218)
+|++ |||||++ +.+.+|+.++||||||++|.+|+-+.+|-...++......+..-.+|+ .+..|++..++.|
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 4555 7999964 446789999999999999999999999988776666555555444442 2455555555443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=151.33 Aligned_cols=158 Identities=22% Similarity=0.359 Sum_probs=116.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+...+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 456789999999999999999999877665 46888875332 222234678899999999999999999998654
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~-------- 145 (218)
..++++||+++ +|.+++...... +++|.+ .++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 46789999986 888887654211 222211 111
Q ss_pred ------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 146 ------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 ------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
...|+|||.+ .+..++.++|||||||++|++++ |+.||.+.........++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226 (303)
T ss_pred cccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 1249999954 55668999999999999999998 9999987655555554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=148.48 Aligned_cols=154 Identities=22% Similarity=0.385 Sum_probs=112.4
Q ss_pred eeEEEEeeecCceEEEEEEEcc---CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------C
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLE---TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------R 113 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (218)
|++.+.||+|+||.||+|..+. +++.+|+|.+..........+.+.+|+.++++++|||++++++++... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998643 578999999976554555567788999999999999999999987532 2
Q ss_pred EEEEEEecCCC-ChHHHhhhccc------C---------------------------Cccccc-----------cccC--
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTI------T---------------------------SIRPHI-----------KEVG-- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~------~---------------------------~~~~~~-----------~~~g-- 146 (218)
..++++||+.+ +|.+++..... . +++|.+ .++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 35788999876 88777532110 0 111111 1111
Q ss_pred ------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|++||.+ .+..++.++|||||||++|++++ |++||...+...+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 237889954 45557889999999999999999 899998776555544443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=154.78 Aligned_cols=95 Identities=24% Similarity=0.441 Sum_probs=76.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (218)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|.++... .......+.+|+.++.++ .|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 345678999999999999999999853 356789999987432 233356788999999999 6899999999875
Q ss_pred -eCCEEEEEEecCCC-ChHHHhhh
Q 041487 111 -TGRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 111 -~~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
.+..++++|||+++ +|.+++..
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~ 105 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRS 105 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHh
Confidence 45578999999987 88888754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=147.37 Aligned_cols=148 Identities=24% Similarity=0.441 Sum_probs=105.9
Q ss_pred EEeeecCceEEEEEEEcc---CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE-eCCEEEEEEecC
Q 041487 47 EKIGQGVFGEVYKCLNLE---TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-TGRYVYLVFEYL 122 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~E~~ 122 (218)
+.||+|+||.||+|.... ....+|+|.+... ......+.+.+|+.+++.++|||++++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998653 3457999987532 22234567888999999999999999999765 566789999999
Q ss_pred CC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC----------------
Q 041487 123 DL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG---------------- 146 (218)
Q Consensus 123 ~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g---------------- 146 (218)
.+ +|.+++...... ++++. ..++|
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 86 898887543211 11111 11222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+. ...++.++|||||||++|+|++ |.+||...+...+...+
T Consensus 160 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 160 TGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 1389999554 4558899999999999999999 56778765544444333
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-20 Score=147.84 Aligned_cols=144 Identities=30% Similarity=0.472 Sum_probs=109.3
Q ss_pred ccceeEEEEeeecCceEEEEEEE----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLN----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 113 (218)
..+|++++.||+|+||.||.+.. ..++..|++|.+... .....+.+.+|+.+++.++|||++++++++. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 35799999999999999999974 356789999997632 3334567889999999999999999999875 345
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------- 146 (218)
.++++|||+++ +|.+++...... ++++. +.++|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999976 999988653211 11111 11111
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+ .+..++.++|||||||++|+|++|..|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 238999955 455588999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-22 Score=152.62 Aligned_cols=163 Identities=17% Similarity=0.304 Sum_probs=122.4
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
+.+..+.++.++++.||.|+.|.||+++.+.+|...|||.+++.. ..+..++++..+.++... +.|+||+.+++|..+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 344456677888999999999999999999999999999998653 334467788888766655 689999999999999
Q ss_pred CEEEEEEecCCC--------------------------ChHHHhhhccc---CCcccccc--------------------
Q 041487 113 RYVYLVFEYLDL--------------------------DLGSFIRKHTI---TSIRPHIK-------------------- 143 (218)
Q Consensus 113 ~~~~lv~E~~~~--------------------------~L~~~~~~~~~---~~~~~~~~-------------------- 143 (218)
..+++.||.|.- +-.+|++.+.. .+.+|.+.
T Consensus 164 ~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 164 TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 999999998741 11233332211 13444331
Q ss_pred -------cc-CCcccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcchHHHHHH
Q 041487 144 -------EV-GSPYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG--KKDHLSLIVR 197 (218)
Q Consensus 144 -------~~-g~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~--~~~~~~~~~~ 197 (218)
.. ..+|||||.+-- ...|+.++||||||++++|++||+.||.+. +.+.+..+..
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 11 234999996533 344999999999999999999999999985 7777777766
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=154.06 Aligned_cols=93 Identities=25% Similarity=0.446 Sum_probs=74.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE-e
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT-T 111 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~ 111 (218)
-.++|++.+.||+|+||.||+|.... ++..||+|.++... .....+.+.+|+.+++++ +|+||+++++++. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34679999999999999999997433 45789999986432 223345678899999999 8999999999886 4
Q ss_pred CCEEEEEEecCCC-ChHHHhhh
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
+..++++|||+++ +|.+++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~ 105 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRS 105 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHh
Confidence 5678999999987 88888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-20 Score=146.64 Aligned_cols=144 Identities=20% Similarity=0.328 Sum_probs=106.4
Q ss_pred EEeeecCceEEEEEEEcc------------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 47 EKIGQGVFGEVYKCLNLE------------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+.||+|+||.||+|.... ....+++|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997432 2235888886532 23345678889999999999999999999998889
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc------------------cccC-
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI------------------KEVG- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~------------------~~~g- 146 (218)
.+++|||+++ +|..++...... +++|.+ .++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999987 777766543211 222211 1222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcchH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMV-SGKPLFPCGKKDHL 192 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~-tg~~Pf~~~~~~~~ 192 (218)
.+|+|||.+..+..++.++|||||||++|+|+ +|..||........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 159 PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 24999997665677899999999999999997 58999987644433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=153.40 Aligned_cols=91 Identities=26% Similarity=0.445 Sum_probs=73.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-----C---CCeeeeeeeEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-----H---DNIVRLLDVLT 110 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~ 110 (218)
...+|.+.++||+|-|++||+|-+....+.||+|+.+. .+...+....|+.+|+++. | .+||++++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 44779999999999999999999999999999999874 3455677888999998872 2 36999999996
Q ss_pred ----eCCEEEEEEecCCCChHHHhhh
Q 041487 111 ----TGRYVYLVFEYLDLDLGSFIRK 132 (218)
Q Consensus 111 ----~~~~~~lv~E~~~~~L~~~~~~ 132 (218)
.+.++|+|+|+....|..+|..
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~ 178 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKY 178 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHH
Confidence 5668999999985455444443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=145.93 Aligned_cols=148 Identities=25% Similarity=0.441 Sum_probs=114.6
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||.|+||.||++.+..+++.+++|.++.... .....+.+.+|+.++++++|+|++++++.+......++++||+.+ +|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988899999999875432 234567888999999999999999999999999999999999986 88
Q ss_pred HHHhhhcccC---------------------------Ccccc-----------cccc-----------------------
Q 041487 127 GSFIRKHTIT---------------------------SIRPH-----------IKEV----------------------- 145 (218)
Q Consensus 127 ~~~~~~~~~~---------------------------~~~~~-----------~~~~----------------------- 145 (218)
.+++...... ++.+. ..++
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 8887654321 11111 1111
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
...|++||.... ...+.++|+||||+++|++++|+.||.............
T Consensus 161 ~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 161 IVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred cccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 123899996544 447889999999999999999999998776555444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=146.67 Aligned_cols=143 Identities=22% Similarity=0.320 Sum_probs=105.8
Q ss_pred EEeeecCceEEEEEEEc--cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNL--ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.||+|+||.||+|... .++..+++|.++.... ......+.+|+.++++++|||++++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999754 3456799998764432 22345788899999999999999999999988899999999986
Q ss_pred -ChHHHhhhcccC--------------------------------Ccccc-----------ccccC--------------
Q 041487 125 -DLGSFIRKHTIT--------------------------------SIRPH-----------IKEVG-------------- 146 (218)
Q Consensus 125 -~L~~~~~~~~~~--------------------------------~~~~~-----------~~~~g-------------- 146 (218)
+|.+++...... ++++. ..++|
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 898887542110 11111 11222
Q ss_pred ------CcccCcccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 041487 147 ------SPYKAPESRIRS------SVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKD 190 (218)
Q Consensus 147 ------~~y~aPE~~~~~------~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~ 190 (218)
..|+|||.+... ..++.++||||||+++|+|++ |+.||...+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 239999965432 135789999999999999997 99999865433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=172.42 Aligned_cols=140 Identities=26% Similarity=0.432 Sum_probs=108.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..++..+.||+|+||.||+|..+.++..||+|.++.... ....|+.++++++||||+++++++......++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 457778899999999999999988999999998863221 12345788999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhccc---------------------------CCcccccc-----------------------c-cCCc
Q 041487 121 YLDL-DLGSFIRKHTI---------------------------TSIRPHIK-----------------------E-VGSP 148 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~---------------------------~~~~~~~~-----------------------~-~g~~ 148 (218)
|+++ +|.+++..... .++++.+. . ....
T Consensus 764 y~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~ 843 (968)
T PLN00113 764 YIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA 843 (968)
T ss_pred CCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCcccccc
Confidence 9986 88887743110 02222110 0 0135
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+|||.+ .+..++.++|||||||++|||+||+.||+..
T Consensus 844 y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 844 YVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 9999954 4556899999999999999999999999643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=144.25 Aligned_cols=147 Identities=27% Similarity=0.427 Sum_probs=113.9
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-Ch
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DL 126 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L 126 (218)
||+|++|.||++.+..++..+++|.++..... ......+..|+.+++.++|+|++++++.+..+...+++||++.+ +|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998765432 23566889999999999999999999999999999999999954 99
Q ss_pred HHHhhhcccC---------------------------Cccccc-----------ccc------------------CCccc
Q 041487 127 GSFIRKHTIT---------------------------SIRPHI-----------KEV------------------GSPYK 150 (218)
Q Consensus 127 ~~~~~~~~~~---------------------------~~~~~~-----------~~~------------------g~~y~ 150 (218)
.+++...... ++.+.+ .++ ...|.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 8888654321 111111 111 22489
Q ss_pred CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 151 APESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 151 aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
+||.. .+...+.++|+||||+++|++++|+.||...+...+...+
T Consensus 161 ~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 161 APEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred ChHHh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99954 4444788999999999999999999999876544443333
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=162.00 Aligned_cols=145 Identities=25% Similarity=0.461 Sum_probs=113.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE-----eCC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT-----TGR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~ 113 (218)
.+-|.+.++||.|.+|.||+++.+++++.+|+|+.... .+..+.+..|..+++.+ .|||+++++++|. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 35689999999999999999999999999999997643 33346677888889888 7999999999985 467
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-----------------------------Ccccc----------------------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPH---------------------- 141 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~---------------------- 141 (218)
.+|+|||||.+ +..|.++..... +++-.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999987 888887654321 11100
Q ss_pred ------ccccCCc-ccCcccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 142 ------IKEVGSP-YKAPESRIRS----SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 142 ------~~~~g~~-y~aPE~~~~~----~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+...|++ |||||++.-. ..|+.++|+||||++..||.-|.+|+-.+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 1223444 8999976543 33778999999999999999999999654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.9e-20 Score=145.05 Aligned_cols=147 Identities=22% Similarity=0.391 Sum_probs=109.9
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC---CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN---EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+|.+.+.||+|+||.||++.+...+..+++|.++... ........+..|+.+++.++|||++++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999987777666666654322 2233445677888999999999999999999988899999
Q ss_pred EecCCC-ChHHHhhhccc----C---------------------------Ccccc----------ccccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTI----T---------------------------SIRPH----------IKEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~----~---------------------------~~~~~----------~~~~g---------- 146 (218)
+||+.+ +|.+++..... . ++++. ..++|
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 999987 88777643110 0 11111 11111
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+ .+..++.++|+||||+++|++++|..||.....
T Consensus 161 ~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 161 LATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred cccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 238899954 455578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=147.69 Aligned_cols=143 Identities=24% Similarity=0.401 Sum_probs=109.3
Q ss_pred cceeEEEEeeecCceEEEEEEE----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLN----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RY 114 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 114 (218)
.-|++++.||+|+||.||++.. +.++..+|+|.++... .......+.+|+.+++.++|||++++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999974 3567899999986432 233456789999999999999999999998764 67
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
.+++|||+++ +|.+++...... +++|.+ .++|
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999999986 999988653211 222211 1111
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
..|+|||.+. +..++.++|||||||++|++++++.|+.
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 1389999654 4558899999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-22 Score=178.09 Aligned_cols=146 Identities=32% Similarity=0.560 Sum_probs=119.1
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
++-...||.|.||.||.|.+..+|...|+|.++...........+.+|+.++..++|||+|++|++-..+...+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 34467799999999999999999999999999877766777888999999999999999999999999999999999999
Q ss_pred CC-ChHHHhhhcccC---------------------------Ccccccc-----------cc------------------
Q 041487 123 DL-DLGSFIRKHTIT---------------------------SIRPHIK-----------EV------------------ 145 (218)
Q Consensus 123 ~~-~L~~~~~~~~~~---------------------------~~~~~~~-----------~~------------------ 145 (218)
.+ +|++...-.+.. ++++.+. +|
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 87 887765543222 3444321 22
Q ss_pred ---CCc-ccCcccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ---GSP-YKAPESRIRSS--VYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ---g~~-y~aPE~~~~~~--~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
|++ |||||.+.+.+ ..+.+.||||+|||+.||+||+.||...+
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 332 99999765533 35678999999999999999999998653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=157.46 Aligned_cols=147 Identities=22% Similarity=0.399 Sum_probs=103.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCc-EEEEEE--------------eec-CCCCCCchHHHHHHHHHHhhCCCCCee
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGK-KVAIKM--------------INI-QNEPEGVPSYLIAGVSLLKELEHDNIV 103 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~vaiK~--------------~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv 103 (218)
.++|++++.||+|+||.||+|..+.... ..+.|. +.+ ..........+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987654322 222221 111 112223456788999999999999999
Q ss_pred eeeeeEEeCCEEEEEEecCCCChHHHhhhccc--------------------------------CCcccc----------
Q 041487 104 RLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTI--------------------------------TSIRPH---------- 141 (218)
Q Consensus 104 ~~~~~~~~~~~~~lv~E~~~~~L~~~~~~~~~--------------------------------~~~~~~---------- 141 (218)
++++++...+..|+++|++..+|.+++..... .+++|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999998777776532211 022221
Q ss_pred -cccc------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCC
Q 041487 142 -IKEV------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP-LFPCG 187 (218)
Q Consensus 142 -~~~~------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~-Pf~~~ 187 (218)
+.+| | ..|+|||.+ .+..++.++|||||||++|+|++|.. ||...
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 1122 2 238999955 45558999999999999999999875 55433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-21 Score=164.68 Aligned_cols=160 Identities=26% Similarity=0.379 Sum_probs=125.3
Q ss_pred eeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.+-.++||.|+||+||+|..-..+ .+||||++... ......+.+..|+.+|.+++|||++++++++.... +-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 455789999999999999875544 57999988643 33445678999999999999999999999997665 8899
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------C-----------ccccccccCCc----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------S-----------IRPHIKEVGSP---------- 148 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~-----------~~~~~~~~g~~---------- 148 (218)
++++++ .|.||++.+... + -..++.++|.+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999997 999999876543 0 01112333332
Q ss_pred ----------ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcc
Q 041487 149 ----------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 ----------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 205 (218)
|+|-| .+....|+.++|||||||++||++| |..|+.+...+.+..+.+.....+.+
T Consensus 856 ~~~~gK~pikwmale-~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALE-SIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP 922 (1177)
T ss_pred cccccccCcHHHHHH-HhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence 67777 5666779999999999999999999 99999999888888887765554443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-21 Score=161.51 Aligned_cols=164 Identities=23% Similarity=0.360 Sum_probs=129.9
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
...++...+++.+..||-|+||.|=++..+.....+|+|++++.. .++.+.+++-.|-.+|..+.+|+||++|..|+++
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 445567788999999999999999999876666679999998765 5667788999999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc---------------------------CCccccc----------------------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI---------------------------TSIRPHI---------------------- 142 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~---------------------------~~~~~~~---------------------- 142 (218)
.++|++||-|-| .|.-.++..+. .+.+|.+
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999843 33333332221 1333332
Q ss_pred -----cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 143 -----KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 -----~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..+|++ |.|||.+.+.+ .+.++|.||||+++||+++|.+||++.++......+..
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred CCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 345655 99999666555 79999999999999999999999999877766665543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-21 Score=159.09 Aligned_cols=153 Identities=27% Similarity=0.471 Sum_probs=119.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-----CCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-----EGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
..-..+++|-++..||+|+|+.||+|.+....+.||+|+-...-.+ ....++.-+|-.+++.++||-||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3345678899999999999999999999989999999986433222 24467788999999999999999999999
Q ss_pred E-eCCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc--------------cc
Q 041487 110 T-TGRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI--------------KE 144 (218)
Q Consensus 110 ~-~~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~--------------~~ 144 (218)
. +.+.+|-|+|||+| +|.-|++.+... +.+|.+ .+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 6 66789999999999 887777765443 222211 22
Q ss_pred cC------------------------Cc-ccCcccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 VG------------------------SP-YKAPESRIRSSV---YSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 ~g------------------------~~-y~aPE~~~~~~~---~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|| +. |++||.++-++. .+.++||||+||++|.++-|+.||..+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 22 22 788887766632 678999999999999999999999754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=159.66 Aligned_cols=179 Identities=28% Similarity=0.439 Sum_probs=132.2
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEcc-------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLE-------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLL 106 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (218)
..++..++.++.+.+|+|.||.|++|.... ....||||..+..... ...+.+..|+.+++.+ .|+|++.+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 556667777888899999999999997531 1467999999865544 6678999999999999 699999999
Q ss_pred eeEEeCCEEEEEEecCCC-ChHHHhhhcc-----------------cC--------------------------------
Q 041487 107 DVLTTGRYVYLVFEYLDL-DLGSFIRKHT-----------------IT-------------------------------- 136 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~~~~-~L~~~~~~~~-----------------~~-------------------------------- 136 (218)
+.+...+.+++++||+.. +|.+|++... ..
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 999999999999999986 9999998877 11
Q ss_pred -----CccccccccC-------------------Cc--ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-
Q 041487 137 -----SIRPHIKEVG-------------------SP--YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK- 188 (218)
Q Consensus 137 -----~~~~~~~~~g-------------------~~--y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~- 188 (218)
.-..++.+|| .+ |||||.+.. ..|+.++||||||++|||++| |..||++..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 0000111221 23 999996655 669999999999999999999 999999853
Q ss_pred cchHHHHHHHhcccCcccc-hhhhhhhc
Q 041487 189 KDHLSLIVRYFTALTNYLV-LPCFLSIM 215 (218)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 215 (218)
...+.+.++....+..+.. .+.+...|
T Consensus 528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM 555 (609)
T KOG0200|consen 528 TEELLEFLKEGNRMEQPEHCSDEIYDLM 555 (609)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3333334444344333332 44444444
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=146.69 Aligned_cols=135 Identities=19% Similarity=0.269 Sum_probs=104.4
Q ss_pred CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChHHHhh
Q 041487 53 VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131 (218)
Q Consensus 53 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~~ 131 (218)
+++.|++++...++..||+|.+..........+.+.+|+.+++.++|+||+++++++......+++|||+++ +|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 455667777777999999999986544555678899999999999999999999999999999999999986 7888776
Q ss_pred hcccC-----------------------------Cccccc-----------ccc-------------------------C
Q 041487 132 KHTIT-----------------------------SIRPHI-----------KEV-------------------------G 146 (218)
Q Consensus 132 ~~~~~-----------------------------~~~~~~-----------~~~-------------------------g 146 (218)
..... ++++.+ .++ .
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 43111 122111 111 1
Q ss_pred CcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 SPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+... ..++.++|+|||||++|+|++|+.||...
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 138999965543 34788999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=140.54 Aligned_cols=139 Identities=22% Similarity=0.382 Sum_probs=105.6
Q ss_pred EEeeecCceEEEEEEEccCC----------cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 47 EKIGQGVFGEVYKCLNLETG----------KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++|||++++++.+.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999987665 357778765332 115788899999999999999999999887 7789
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc------------------ccc----
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI------------------KEV---- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~------------------~~~---- 145 (218)
++|||+++ +|.+++...... +++|.+ .++
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999987 888887654411 222221 122
Q ss_pred ----------CCcccCcccccCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 041487 146 ----------GSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKK 189 (218)
Q Consensus 146 ----------g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~ 189 (218)
..+|+|||.+... ..++.++||||||+++|++++ |..||...+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred ccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 2349999965544 368899999999999999999 6888876643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-19 Score=142.13 Aligned_cols=146 Identities=19% Similarity=0.358 Sum_probs=111.6
Q ss_pred ceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCC--CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
+|++.+.||+|++|.||+++.. .++..+|+|.+++.. ......+.+.+|+.++.++ +|++++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 357889999987543 2234456788999999999 699999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Ccccc-----------cccc-----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH-----------IKEV----------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~-----------~~~~----------- 145 (218)
++||||+.+ +|.+++...... ++++. ..++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999986 888877543221 11111 1111
Q ss_pred --------CCcccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 --------GSPYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 --------g~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.... ..+.++||||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22489999654432 2678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-20 Score=154.96 Aligned_cols=152 Identities=29% Similarity=0.477 Sum_probs=120.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
+++.+-|.-++.||-|+||.|.++...++...+|.|.+++.. ..+.+..+...|-.+|...+++.||++|..|++.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 345677999999999999999999988899999999998765 5566778899999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhccc---------------------------CCccccc-------------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTI---------------------------TSIRPHI------------------------- 142 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~---------------------------~~~~~~~------------------------- 142 (218)
|+||+|++| ++-..+-+.+. .+++|.+
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999964 43322222111 0333322
Q ss_pred ---------------------------------------------cccCCc-ccCcccccCCCCCCCcchHHHHHHHHHH
Q 041487 143 ---------------------------------------------KEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAE 176 (218)
Q Consensus 143 ---------------------------------------------~~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~ 176 (218)
...|++ |+|||++...+ |+..+|.||.||+|||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHH
Confidence 112322 99999777666 8999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 041487 177 MVSGKPLFPCGKK 189 (218)
Q Consensus 177 l~tg~~Pf~~~~~ 189 (218)
|+.|+.||-...+
T Consensus 864 m~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 864 MLVGQPPFLADTP 876 (1034)
T ss_pred HhhCCCCccCCCC
Confidence 9999999976633
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-18 Score=134.70 Aligned_cols=155 Identities=30% Similarity=0.533 Sum_probs=120.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
|.+.+.||.|++|.||++....++..+++|.+...... ...+.+.+|+.++++++|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 56789999999999999999888999999998754332 24678899999999999999999999999989999999999
Q ss_pred CC-ChHHHhhhccc-C---------------------------Ccccc-----------cc-------------------
Q 041487 123 DL-DLGSFIRKHTI-T---------------------------SIRPH-----------IK------------------- 143 (218)
Q Consensus 123 ~~-~L~~~~~~~~~-~---------------------------~~~~~-----------~~------------------- 143 (218)
++ +|.+++..... . ++.+. +.
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 98 99998866432 1 11110 01
Q ss_pred ccCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-C-CcchHHHHHHH
Q 041487 144 EVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC-G-KKDHLSLIVRY 198 (218)
Q Consensus 144 ~~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~-~-~~~~~~~~~~~ 198 (218)
.....|++||.+.....++.++|+|+||++++++++|+.||+. . +...+...+..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 1122388999653455577899999999999999999999987 3 44355555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-20 Score=138.50 Aligned_cols=157 Identities=24% Similarity=0.373 Sum_probs=118.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
..+...-+..||+|++|.|-+.++..+|...|+|.++.... ....+++.+|+.+..+. ..|++|++|+.......+|+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 34445557889999999999999999999999999986544 34456788888865555 89999999999999999999
Q ss_pred EEecCCCChHHHhhhc---ccC-----------------------------Cccccc-----------cccC--------
Q 041487 118 VFEYLDLDLGSFIRKH---TIT-----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~---~~~-----------------------------~~~~~~-----------~~~g-------- 146 (218)
.||.|+.+|..|.+.- +.. +.+|.+ =+||
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9999998888776541 110 344432 1222
Q ss_pred ---------CcccCcccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcchHHHHH
Q 041487 147 ---------SPYKAPESRIR---SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG--KKDHLSLIV 196 (218)
Q Consensus 147 ---------~~y~aPE~~~~---~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~--~~~~~~~~~ 196 (218)
-+|+|||.+.. .+.|+.++||||||+++.||++++.||+.- ..+.+.+++
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 34999995432 234899999999999999999999999865 444444443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=156.44 Aligned_cols=157 Identities=29% Similarity=0.482 Sum_probs=122.7
Q ss_pred ccce-eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC--CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--CE
Q 041487 40 DWNY-KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--RY 114 (218)
Q Consensus 40 ~~~~-~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 114 (218)
.++| +...+||+|+|-+||+|.+-.+|..||+-.++... ......++|..|+.+|+.|+||||+++|++|.+. .+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3445 67889999999999999998899999986665333 3345569999999999999999999999999754 45
Q ss_pred EEEEEecCCC-ChHHHhhhcccCCccc-----------------------------------------ccc---------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTITSIRP-----------------------------------------HIK--------- 143 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~~~~~-----------------------------------------~~~--------- 143 (218)
+.+|+|.+.. +|..|.+++...+++. ++.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999976 9999998876542111 111
Q ss_pred ------ccCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcchHHHHHHH
Q 041487 144 ------EVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVRY 198 (218)
Q Consensus 144 ------~~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~-~~~~~~~~~~~~~ 198 (218)
..|+| |||||.. + ..|+..+||||||+.+.||+|+.-||+ |.+...+.+.+-.
T Consensus 198 ~s~aksvIGTPEFMAPEmY-E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMY-E-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred ccccceeccCccccChHHH-h-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 13554 9999943 3 449999999999999999999999997 4466666665544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=155.19 Aligned_cols=164 Identities=32% Similarity=0.517 Sum_probs=129.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC------CCeeeeeeeEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH------DNIVRLLDVLT 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~ 110 (218)
++....|.+....|+|-||.|..|.+...++.||||+++... ...+.=++|+++|++|+. -|+++++..|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345567899999999999999999999899999999997433 233456689999999852 37999999999
Q ss_pred eCCEEEEEEecCCCChHHHhhhcccC------------------------------Ccccccc------------ccCCc
Q 041487 111 TGRYVYLVFEYLDLDLGSFIRKHTIT------------------------------SIRPHIK------------EVGSP 148 (218)
Q Consensus 111 ~~~~~~lv~E~~~~~L~~~~~~~~~~------------------------------~~~~~~~------------~~g~~ 148 (218)
..+++|+|+|-....|.+.+++.+.. +|+|.+. +||++
T Consensus 505 hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999999988888877765442 5566542 24443
Q ss_pred ----------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc
Q 041487 149 ----------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN 204 (218)
Q Consensus 149 ----------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~ 204 (218)
|.||| ++-+.+|+...|+||+||+|||++||+..|++. +..++.......|+.|.
T Consensus 585 ~~~~eneitPYLVSRFYRaPE-IiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPE-IILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccccHHHHHHhccCcc-eeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99999 666777999999999999999999999999999 55555555555555554
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-18 Score=138.44 Aligned_cols=140 Identities=23% Similarity=0.347 Sum_probs=102.2
Q ss_pred EeeecCceEEEEEEEccC--CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 48 KIGQGVFGEVYKCLNLET--GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++|||++++++.+......+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 689999999999975332 2356677765432 223456889999999999999999999999999999999999986
Q ss_pred ChHHHhhhcccC-------------------------------Cccccc-----------cccC----------------
Q 041487 125 DLGSFIRKHTIT-------------------------------SIRPHI-----------KEVG---------------- 146 (218)
Q Consensus 125 ~L~~~~~~~~~~-------------------------------~~~~~~-----------~~~g---------------- 146 (218)
+|.+++...... ++++.+ .++|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 998887643110 222211 2222
Q ss_pred ----CcccCcccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 147 ----SPYKAPESRIR------SSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
..|+|||.+.. ...++.++|||||||++|+|++ |..||...+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 24899996542 1235678999999999999997 578987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-18 Score=138.07 Aligned_cols=152 Identities=18% Similarity=0.241 Sum_probs=101.3
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCc---------hHHHHHHHHHHhhCCCCCe
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGV---------PSYLIAGVSLLKELEHDNI 102 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i 102 (218)
...+...+|++.+.||+|+||.||+|....+ +..+++|........... ......+...+..++|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3446667899999999999999999998776 567787764322111000 0112233344566789999
Q ss_pred eeeeeeEEeCC----EEEEEEecCCCChHHHhhhccc---------------------------CCcccc----------
Q 041487 103 VRLLDVLTTGR----YVYLVFEYLDLDLGSFIRKHTI---------------------------TSIRPH---------- 141 (218)
Q Consensus 103 v~~~~~~~~~~----~~~lv~E~~~~~L~~~~~~~~~---------------------------~~~~~~---------- 141 (218)
+++++++.... ..++++|++..++.+.+..... .+++|.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99998765432 4678888876555444332210 022221
Q ss_pred -cccc------------------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 142 -IKEV------------------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 142 -~~~~------------------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+.+| |+ .|+||| ...+..++.++|||||||++|+|++|+.||.+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape-~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD-AHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHH-HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 1122 22 377888 555666899999999999999999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-20 Score=149.77 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=119.7
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..+.|..-.+||+|+||.|+-++.+.+|.-+|.|.+.+.+... .-......|..++.+++.++||.+-..|...+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345677999999999999999999999999999999997766443 3345677899999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI----------------------- 142 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~----------------------- 142 (218)
++|+..|+| +|.-.+-..+.. +.+|.+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999986 664444333321 333322
Q ss_pred ----cccCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 143 ----KEVGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 143 ----~~~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+ .|||||++.... |+.+.|.|||||++|+|+.|+-||-..
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhh
Confidence 22333 499999665555 999999999999999999999999765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.9e-21 Score=145.94 Aligned_cols=167 Identities=32% Similarity=0.628 Sum_probs=132.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-------- 110 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------- 110 (218)
..++|.-...||+|.||.||+|+.+.+++.||+|..--+...........+|+.++..++|+|++.++++|.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345677778999999999999999999999999876544445566677899999999999999999999875
Q ss_pred eCCEEEEEEecCCCChHHHhhhcccC----------------------------Cccc-----------ccccc------
Q 041487 111 TGRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRP-----------HIKEV------ 145 (218)
Q Consensus 111 ~~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~-----------~~~~~------ 145 (218)
....+|+|+.+|+.+|...+...... ++++ +.++|
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 34569999999987776655432111 1211 11223
Q ss_pred ----------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 146 ----------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 146 ----------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
+..|.+||.+.+.+.|+++.|||+-||++.||.||.+-+.++ +...++.+.+.+|.+.+.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 334999998898999999999999999999999999999998 777888888888887664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-19 Score=150.40 Aligned_cols=149 Identities=28% Similarity=0.444 Sum_probs=118.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------CCCchHHHHHHHHHHhhCC---CCCeeeeeee
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------PEGVPSYLIAGVSLLKELE---HDNIVRLLDV 108 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~ 108 (218)
-...+|..++.+|+|+||.|++|.++...-.|+||.+.+++. .....-..-.|+.+|.+++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345679999999999999999999999999999999987641 1222334667999999997 9999999999
Q ss_pred EEeCCEEEEEEecCCC--ChHHHhhhcccC---------------------------Ccccc-----------ccccCC-
Q 041487 109 LTTGRYVYLVFEYLDL--DLGSFIRKHTIT---------------------------SIRPH-----------IKEVGS- 147 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~--~L~~~~~~~~~~---------------------------~~~~~-----------~~~~g~- 147 (218)
|.++++.|++||--.. +|-+||..++.. +++.. ..+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 9999999999997643 778888765543 22221 123333
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.|.|||++-+.++.+...|||++|++||-+.-..-||..
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 399999766667777889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-19 Score=145.90 Aligned_cols=145 Identities=23% Similarity=0.324 Sum_probs=108.2
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh--CCCCCeeeeeeeEE
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE--LEHDNIVRLLDVLT 110 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~ 110 (218)
...+.......++.+.||+|.||.||+|+. +++.||||+++.. ..+.+..|..+... ++|+||+++++.-.
T Consensus 202 ~sspl~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 202 PSSPLLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCcccccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 334455677889999999999999999987 7799999998632 34567777777655 48999999999876
Q ss_pred eCC----EEEEEEecCCC-ChHHHhhhcccC----------------------------------------------Ccc
Q 041487 111 TGR----YVYLVFEYLDL-DLGSFIRKHTIT----------------------------------------------SIR 139 (218)
Q Consensus 111 ~~~----~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------------------~~~ 139 (218)
... .+++|+||-+. +|.+|++.+... +..
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence 554 89999999876 999999887664 111
Q ss_pred ccccccCC--------------------cccCcccccCCCCCC-----CcchHHHHHHHHHHHHhCCCCC
Q 041487 140 PHIKEVGS--------------------PYKAPESRIRSSVYS-----TPHDVWAVGCIFAEMVSGKPLF 184 (218)
Q Consensus 140 ~~~~~~g~--------------------~y~aPE~~~~~~~~~-----~~~DiwSlG~~l~~l~tg~~Pf 184 (218)
..+.+||. .|||||++...-.+. .+.||||+|.+|||++++..-+
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 12233433 399999654322222 3699999999999999976433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-19 Score=140.20 Aligned_cols=142 Identities=26% Similarity=0.451 Sum_probs=111.4
Q ss_pred hhccceeE-EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE----e
Q 041487 38 VKDWNYKV-VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT----T 111 (218)
Q Consensus 38 ~~~~~~~~-~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~----~ 111 (218)
-..++|.+ .++||-|-.|.|..|.++.+++.+|+|++.. .....+|++.+-.. .|||||.++++|. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 35667776 5779999999999999999999999998752 24567899887776 7999999999985 4
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc--------------cccCC
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI--------------KEVGS 147 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~--------------~~~g~ 147 (218)
..++.+|||+++| .|...+..++.. +.+|.+ .+||.
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 5789999999987 777777765542 233322 22222
Q ss_pred ----------------c-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 ----------------P-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 ----------------~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+ |.||| +.+...|+...|+||+||++|-|++|.+||.++
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPe-vlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ccccCCCccccCCcccccccCHH-HhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 2 67777 555555999999999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=133.84 Aligned_cols=128 Identities=23% Similarity=0.305 Sum_probs=97.8
Q ss_pred cCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChHHHh
Q 041487 52 GVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFI 130 (218)
Q Consensus 52 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~ 130 (218)
|.+|.||++.++.+++.+|+|.++... ...+|...+....|||++++++++......+++|||+++ +|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999999999999999987532 123344455566799999999999999999999999987 898887
Q ss_pred hhcccC---------------------------Cccccc-----------cccC---------------CcccCcccccC
Q 041487 131 RKHTIT---------------------------SIRPHI-----------KEVG---------------SPYKAPESRIR 157 (218)
Q Consensus 131 ~~~~~~---------------------------~~~~~~-----------~~~g---------------~~y~aPE~~~~ 157 (218)
...... +++|.+ .++| ..|+|||.. .
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~-~ 155 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG-G 155 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCccc-C
Confidence 654221 222221 1222 239999954 4
Q ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 158 SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 158 ~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...++.++|+||+|+++|++++|+.|+...
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 555789999999999999999999988654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=147.39 Aligned_cols=168 Identities=26% Similarity=0.372 Sum_probs=120.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 118 (218)
.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+... ...+|+.++... +|||++++++.+.++...|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 5678888899999999999999999999999999975521 123566555555 899999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC--------------------------Ccccccccc--------------------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT--------------------------SIRPHIKEV-------------------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~~~~-------------------------- 145 (218)
||.+.+ -+.+.+...... |.+|.+..+
T Consensus 395 ~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~ 474 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPA 474 (612)
T ss_pred ehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccc
Confidence 999987 333433332211 333333222
Q ss_pred -CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc----ccchhhhhhhcc
Q 041487 146 -GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN----YLVLPCFLSIML 216 (218)
Q Consensus 146 -g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 216 (218)
+..|.|||.+. ...|+.++||||||++||+|++|+.||.....+ ..+....+.++. +...-+.++.||
T Consensus 475 ~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 475 LTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFSECVSDEAKDLLQQLL 547 (612)
T ss_pred hhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccccccCHHHHHHHHHhc
Confidence 22399999665 555999999999999999999999999988555 222333333322 333444555555
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=134.90 Aligned_cols=159 Identities=28% Similarity=0.497 Sum_probs=121.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC------CCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP------EGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
..+|.-.+.+|+|..+.|.++.++.++.++|+|++...... .+..+.-.+|+.+|+++ .||+|+.+.++|+..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677888999999999999999999999999999754321 13345566789999998 899999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc---------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE--------- 144 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~--------- 144 (218)
..+++|.|.|+. -|-||+.+.... +.+|.+ ++
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 999999999986 888888764332 333322 22
Q ss_pred -------cCCc-ccCccccc----C-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 -------VGSP-YKAPESRI----R-SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 -------~g~~-y~aPE~~~----~-~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+|++ |+|||.+- + ...|+..+|+|++|+++|-++.|++||--.....+.+.+..
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 3443 99999541 1 23378889999999999999999999986644444444443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-18 Score=138.22 Aligned_cols=92 Identities=24% Similarity=0.417 Sum_probs=74.0
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh--CCCCCeeeeeeeEEeC---
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE--LEHDNIVRLLDVLTTG--- 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~--- 112 (218)
......++.+.||+|.||.||+|.. .|+.||||+|.. .+.+...+|.++.+. ++|+||+.+++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 4566789999999999999999988 799999999852 223556677777666 4999999999886533
Q ss_pred -CEEEEEEecCCC-ChHHHhhhcccC
Q 041487 113 -RYVYLVFEYLDL-DLGSFIRKHTIT 136 (218)
Q Consensus 113 -~~~~lv~E~~~~-~L~~~~~~~~~~ 136 (218)
..+|+|++|=+. +|.||+......
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~ 306 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVT 306 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCC
Confidence 269999999876 999999885543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-19 Score=133.51 Aligned_cols=158 Identities=27% Similarity=0.568 Sum_probs=122.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEe--CCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 115 (218)
..++|++.+.+|+|.++.||.|....+++.++||++++. ..+.+.+|+.+|+.+. ||||++++++..+ ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 457799999999999999999998889999999998642 2366999999999995 9999999999864 4568
Q ss_pred EEEEecCCC-ChH----------------------HHhhhccc--CCccccc------------cccCCc----------
Q 041487 116 YLVFEYLDL-DLG----------------------SFIRKHTI--TSIRPHI------------KEVGSP---------- 148 (218)
Q Consensus 116 ~lv~E~~~~-~L~----------------------~~~~~~~~--~~~~~~~------------~~~g~~---------- 148 (218)
.++.||++. +.. ||..+.+. .+.+|++ .++|.+
T Consensus 111 aLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 999999862 221 11122221 1444443 223332
Q ss_pred -------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcchHHHHHHHhcc
Q 041487 149 -------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG--KKDHLSLIVRYFTA 201 (218)
Q Consensus 149 -------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~--~~~~~~~~~~~~~~ 201 (218)
|-.||.+.....|+.+-|+|||||++..|+..+.||-.. +.+.+.++.+.+|.
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 778998999999999999999999999999999888644 77888887776654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=123.96 Aligned_cols=141 Identities=36% Similarity=0.581 Sum_probs=107.9
Q ss_pred CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChHHHhh
Q 041487 53 VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIR 131 (218)
Q Consensus 53 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~~ 131 (218)
+||.||+|+...++..+++|.+........ .+.+.+|+..+++++|++++++++.+......++++|++++ +|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999875432221 67899999999999999999999999999999999999998 9988876
Q ss_pred hcccC---------------------------Cccccc-----------ccc-----------------CCcccCccccc
Q 041487 132 KHTIT---------------------------SIRPHI-----------KEV-----------------GSPYKAPESRI 156 (218)
Q Consensus 132 ~~~~~---------------------------~~~~~~-----------~~~-----------------g~~y~aPE~~~ 156 (218)
..... ++.+.+ .++ ...|++||.+.
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 54311 111111 111 12389999554
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcchHHHH
Q 041487 157 RSSVYSTPHDVWAVGCIFAEMVSGKPLFPC-GKKDHLSLI 195 (218)
Q Consensus 157 ~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~-~~~~~~~~~ 195 (218)
...++.++||||||++++++++|..||.. .+...+...
T Consensus 160 -~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~ 198 (244)
T smart00220 160 -GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK 198 (244)
T ss_pred -cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 45578899999999999999999999987 344444433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-18 Score=152.56 Aligned_cols=71 Identities=31% Similarity=0.455 Sum_probs=63.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
...+|..+..||+|+||.|++++.+-+|+.||||.++... .......+.+|+.++.+++|||+|+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 4567899999999999999999999999999999998665 6677889999999999999999999998664
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.9e-19 Score=135.66 Aligned_cols=160 Identities=29% Similarity=0.525 Sum_probs=124.2
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----EEEEEEe
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-----YVYLVFE 120 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~E 120 (218)
-+-||-|+||.||.+++..+|+.|++|.++.-...-...+++-+|+.++...+|.|++...++.+... ++|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999999999999999988643333334578889999999999999999998876443 4788888
Q ss_pred cCCCChHHHhhhccc---------------------------CCccccc-----------cccCCc--------------
Q 041487 121 YLDLDLGSFIRKHTI---------------------------TSIRPHI-----------KEVGSP-------------- 148 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~---------------------------~~~~~~~-----------~~~g~~-------------- 148 (218)
.+..+|...+-+... .+++|.+ -+||.+
T Consensus 138 LmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqE 217 (449)
T KOG0664|consen 138 LMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHE 217 (449)
T ss_pred HHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHH
Confidence 876554443322111 1555543 234443
Q ss_pred -----ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCcc
Q 041487 149 -----YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 149 -----y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~ 205 (218)
|.|||.+.+...|+.+.||||+||++.|++-.+..|.-. ..+.+..+...+|.|+..
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 999999888888999999999999999999999999866 667888888888887653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.2e-17 Score=131.04 Aligned_cols=176 Identities=19% Similarity=0.288 Sum_probs=135.5
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
-.+..++++....+-+|.||.||.|..++. .+.|-+|.++. ..++-+...+.+|...+..+.|||+..+.+++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 345667788899999999999999976643 24567777753 345566788999999999999999999999875
Q ss_pred -eCCEEEEEEecCCC-ChHHHhhhcccCC-----------------------------------ccc-----------cc
Q 041487 111 -TGRYVYLVFEYLDL-DLGSFIRKHTITS-----------------------------------IRP-----------HI 142 (218)
Q Consensus 111 -~~~~~~lv~E~~~~-~L~~~~~~~~~~~-----------------------------------~~~-----------~~ 142 (218)
+...++++.++.+. .|..|+..+...+ +.. +.
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 55678899999886 8888887443210 000 00
Q ss_pred cc--------------cC------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcc
Q 041487 143 KE--------------VG------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTA 201 (218)
Q Consensus 143 ~~--------------~g------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~ 201 (218)
.+ .| ..||+||.+. ...|+.++|+||||+++|||+| |+.||-..++..+.-.++....
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 00 01 1299999654 5559999999999999999999 9999999999999999998888
Q ss_pred cCcccchhhhhh
Q 041487 202 LTNYLVLPCFLS 213 (218)
Q Consensus 202 ~~~~~~~~~~~~ 213 (218)
..++...|+.|=
T Consensus 517 laQP~NCPDeLf 528 (563)
T KOG1024|consen 517 LAQPFNCPDELF 528 (563)
T ss_pred ecCCCCCcHHHH
Confidence 888888887653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.8e-18 Score=130.11 Aligned_cols=159 Identities=19% Similarity=0.306 Sum_probs=116.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee-EEeCCEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV-LTTGRYVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~l 117 (218)
.+.|.+.+.+|+|.||.+.+|.++.++..+++|.++... .....|.+|..---.+ -|.||+..|++ |+..+..++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 466999999999999999999999999999999987543 3357788988776666 58999998886 788889999
Q ss_pred EEecCCC-ChHHHhhhcccC--------------------------Ccccc-------------ccccCC----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT--------------------------SIRPH-------------IKEVGS---------- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~--------------------------~~~~~-------------~~~~g~---------- 147 (218)
+|||++. +|..-+...+.. +++.. .-+||.
T Consensus 100 ~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred eeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999975 665444333222 22221 122332
Q ss_pred -----cccCcccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcchHHHHHHHhcc
Q 041487 148 -----PYKAPESRIRS----SVYSTPHDVWAVGCIFAEMVSGKPLFPCG--KKDHLSLIVRYFTA 201 (218)
Q Consensus 148 -----~y~aPE~~~~~----~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~--~~~~~~~~~~~~~~ 201 (218)
+|-+||++... -...+.+|+|.||+++|.++||++||... .........+..+.
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 38999964332 22667899999999999999999999854 44444444554443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=125.81 Aligned_cols=164 Identities=29% Similarity=0.471 Sum_probs=128.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR----- 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 113 (218)
...+|.-+..+|.|.- .|..+.+.-.+++||+|........+.-.++..+|..++..++|+|+++++.+|..+.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4566788888999988 7778888888999999987655544555678899999999999999999999997654
Q ss_pred -EEEEEEecCCCChHHHhhhccc-------------------------CCccccc-----------cccCCc--------
Q 041487 114 -YVYLVFEYLDLDLGSFIRKHTI-------------------------TSIRPHI-----------KEVGSP-------- 148 (218)
Q Consensus 114 -~~~lv~E~~~~~L~~~~~~~~~-------------------------~~~~~~~-----------~~~g~~-------- 148 (218)
.+|+|||+++.+|.+.+.-... .+.+|++ -++|.+
T Consensus 94 ~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~ 173 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFM 173 (369)
T ss_pred HhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccc
Confidence 4899999999887776652100 0344433 222221
Q ss_pred ---------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccCc
Q 041487 149 ---------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALTN 204 (218)
Q Consensus 149 ---------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~~ 204 (218)
|.|||.+.+-+ +...+||||+||++.||++|+..|++. ..+...++++.+|.|-+
T Consensus 174 mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 89999877766 899999999999999999999999987 66777788887777654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.2e-17 Score=140.64 Aligned_cols=134 Identities=24% Similarity=0.468 Sum_probs=105.6
Q ss_pred EEEeeecCceE-EEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 46 VEKIGQGVFGE-VYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 46 ~~~ig~G~~g~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
-+.+|.|+.|+ ||+|.. .++.||||.+-. +......+|+..|+.- +||||||+|+.-.++...||..|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45688888774 788987 888999997642 3346688999999998 79999999999999999999999999
Q ss_pred CChHHHhhhcccC-------------------------------Cccccc----------------cccC----------
Q 041487 124 LDLGSFIRKHTIT-------------------------------SIRPHI----------------KEVG---------- 146 (218)
Q Consensus 124 ~~L~~~~~~~~~~-------------------------------~~~~~~----------------~~~g---------- 146 (218)
.+|.|++...... +.+|++ +++|
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999998774111 233322 2332
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCC
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCG 187 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~ 187 (218)
..|.|||.+.... ...++||+|+||++|+.++| ..||...
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch
Confidence 2399999766555 57799999999999999995 8999654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.2e-17 Score=137.18 Aligned_cols=144 Identities=24% Similarity=0.461 Sum_probs=112.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|..+..+|.|.+|.||+++++.++.+.|+|+++.. ..++.+-+.+|+.+++.++||||+.+++.+...+.+|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46799999999999999999999999999999999743 4455677889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccc-----------cc-----------------c
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRP-----------HI-----------------K 143 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~-----------~~-----------------~ 143 (218)
|||++ +|.+...--+.. +++- +. +
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99976 665433211110 1111 01 2
Q ss_pred ccCCc-ccCcccc--cCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 144 EVGSP-YKAPESR--IRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 144 ~~g~~-y~aPE~~--~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
..|++ |||||+. ...+.|...+|||++|++..|+..-++|..
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 23444 7999963 334558999999999999999988777654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9e-16 Score=124.92 Aligned_cols=159 Identities=30% Similarity=0.520 Sum_probs=120.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEcc---CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLE---TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
...|...+.||+|.|+.||++++.. .+..||+|.+... ....++..|+++|..+ .+.||+.+.+.++.++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 5668999999999999999999876 6788999988633 3456799999999999 799999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC------------------------Ccccc-----------------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT------------------------SIRPH----------------------------- 141 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~------------------------~~~~~----------------------------- 141 (218)
.+|+||.+. ...++....... |++|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred EEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999999842 111111110000 00000
Q ss_pred --------------------------------------------ccccCC-cccCcccccCCCCCCCcchHHHHHHHHHH
Q 041487 142 --------------------------------------------IKEVGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAE 176 (218)
Q Consensus 142 --------------------------------------------~~~~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~ 176 (218)
-...|+ .|.|||++.....-++++||||.|+++..
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 012233 38999999888878999999999999999
Q ss_pred HHhCCCCCCCC--CcchHHHHHHHhccc
Q 041487 177 MVSGKPLFPCG--KKDHLSLIVRYFTAL 202 (218)
Q Consensus 177 l~tg~~Pf~~~--~~~~~~~~~~~~~~~ 202 (218)
+++++.||-.. +.+.+..+.-.+|.-
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~ 298 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSA 298 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChH
Confidence 99999999765 666677766655543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=123.59 Aligned_cols=94 Identities=20% Similarity=0.400 Sum_probs=64.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc----------------cCCcEEEEEEeecCCCC------------CCchHHHHH
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL----------------ETGKKVAIKMINIQNEP------------EGVPSYLIA 89 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~------------~~~~~~~~~ 89 (218)
+..++|.+.++||+|+||.||+|... ..++.||||.+...... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 56889999999999999999999642 23567999998642211 011223445
Q ss_pred HHHHHhhCCCCCe-----eeeeeeEE--------eCCEEEEEEecCCC-ChHHHhh
Q 041487 90 GVSLLKELEHDNI-----VRLLDVLT--------TGRYVYLVFEYLDL-DLGSFIR 131 (218)
Q Consensus 90 e~~~l~~l~h~~i-----v~~~~~~~--------~~~~~~lv~E~~~~-~L~~~~~ 131 (218)
|+.++.++.|.++ ++++++|. ..+..++|+||++. +|.+++.
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~ 277 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALD 277 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHh
Confidence 6666777765543 56666654 23568999999987 8877765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-14 Score=123.79 Aligned_cols=90 Identities=17% Similarity=0.249 Sum_probs=58.6
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccC----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeee---
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLET----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDV--- 108 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~--- 108 (218)
..+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+....+ .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 345678999999999999999999999888 8999999875321 11111111 1222222222222211
Q ss_pred ---EEeCCEEEEEEecCCC-ChHHHhh
Q 041487 109 ---LTTGRYVYLVFEYLDL-DLGSFIR 131 (218)
Q Consensus 109 ---~~~~~~~~lv~E~~~~-~L~~~~~ 131 (218)
.......++|+||+++ +|.+++.
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~ 227 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQ 227 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHH
Confidence 2356679999999987 7777664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.8e-13 Score=100.65 Aligned_cols=128 Identities=34% Similarity=0.642 Sum_probs=99.6
Q ss_pred eeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChH
Q 041487 49 IGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLG 127 (218)
Q Consensus 49 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~ 127 (218)
||+|.+|.||++....++..+++|.+....... ..+.+.+|+.+++.+.|++++++++++......++++|++++ +|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999997779999999987543221 357899999999999999999999999998999999999994 999
Q ss_pred HHhhhc--ccC--------------------------Cccccc------------cc------------------cCCcc
Q 041487 128 SFIRKH--TIT--------------------------SIRPHI------------KE------------------VGSPY 149 (218)
Q Consensus 128 ~~~~~~--~~~--------------------------~~~~~~------------~~------------------~g~~y 149 (218)
+++... ... ++.+.+ .+ ....|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 988764 111 111111 11 11238
Q ss_pred cCcccccCCCCCCCcchHHHHHHHHHHH
Q 041487 150 KAPESRIRSSVYSTPHDVWAVGCIFAEM 177 (218)
Q Consensus 150 ~aPE~~~~~~~~~~~~DiwSlG~~l~~l 177 (218)
++||.......++.+.|+|++|++++++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 8899654443688999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=122.40 Aligned_cols=94 Identities=27% Similarity=0.323 Sum_probs=81.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.++|++++.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++..++|+||+++++.+.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4789999999999999999999988999999999975432 233456788999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhc
Q 041487 119 FEYLDL-DLGSFIRKH 133 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~ 133 (218)
|||+.+ +|.+++...
T Consensus 83 mEy~~g~~L~~li~~~ 98 (669)
T cd05610 83 MEYLIGGDVKSLLHIY 98 (669)
T ss_pred EeCCCCCCHHHHHHhc
Confidence 999976 888887643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.1e-14 Score=110.85 Aligned_cols=160 Identities=13% Similarity=0.261 Sum_probs=119.0
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+......++.+|.+...|..|+|+. .|-.++.|++.......+..+.|..|.-.++-+.||||+.+++.|.....
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3445566677888999999999999987 45556777776555555666778888888999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC------------------------------------------Ccccc----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT------------------------------------------SIRPH---------- 141 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~------------------------------------------~~~~~---------- 141 (218)
+.++..|++. +|.+.+.....- +....
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 9999999986 888777654332 00000
Q ss_pred ---ccccCCcccCcccccCCCCC--CCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 142 ---IKEVGSPYKAPESRIRSSVY--STPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 142 ---~~~~g~~y~aPE~~~~~~~~--~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
...+..+|++||.+.....- -.++|+|||++++||+-|...||....+..+-..+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 01223459999977665432 24799999999999999999999876444443333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=104.35 Aligned_cols=170 Identities=21% Similarity=0.217 Sum_probs=127.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGR 113 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (218)
...+.--+|++.++||+|+||.++.|+..-++++||||.=+.. ...-.+.-|-...+.+ ..++|..+|.+...+.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 4446667899999999999999999999999999999985432 1222366677777777 5799999998889999
Q ss_pred EEEEEEecCCCChHHHhhhcccC----------------------------Ccccccc----------------ccCCc-
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHIK----------------EVGSP- 148 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~~----------------~~g~~- 148 (218)
+-.+|||....+|.|...-+... +++|.+- +||.+
T Consensus 98 ~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 98 YNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99999999988888877654432 5555442 23322
Q ss_pred ------------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc
Q 041487 149 ------------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN 204 (218)
Q Consensus 149 ------------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 204 (218)
||+.-. .-++.-+.+.|+-|||-++++.+-|.+||.+...+.+.+..+..+.-..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINT-HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeec-cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 555442 2244467789999999999999999999999988888887777766555
Q ss_pred ccchh
Q 041487 205 YLVLP 209 (218)
Q Consensus 205 ~~~~~ 209 (218)
...+.
T Consensus 257 ~T~i~ 261 (449)
T KOG1165|consen 257 STPIE 261 (449)
T ss_pred cCCHH
Confidence 44433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.8e-12 Score=98.40 Aligned_cols=157 Identities=22% Similarity=0.285 Sum_probs=114.5
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC-CCeeeeeeeEEe
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-DNIVRLLDVLTT 111 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~ 111 (218)
.....+..++|.+++.||.|+||.+|+|....+|..||||.-.... ..-.+..|..+-+.+++ ..|+.+..+..+
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 3345577899999999999999999999999999999999854322 12347778888888854 678888888889
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC----------------------------Ccccccc--------------ccCCc-
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHIK--------------EVGSP- 148 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~~--------------~~g~~- 148 (218)
...-++||+....+|.+...-+... +++|.+- +||.+
T Consensus 83 ~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 83 KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999999988887776543322 6666542 23322
Q ss_pred ------------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 149 ------------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 149 ------------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
|.+-- ..-+..-+.+.|+-|+|.+|.++--|.+||.+.....-++
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASin-Ah~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASIN-AHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhh-hhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 22211 1112224568999999999999999999999884444333
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.2e-12 Score=97.31 Aligned_cols=96 Identities=11% Similarity=0.085 Sum_probs=76.5
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHH------HHHHHHHHhhCCCCCeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSY------LIAGVSLLKELEHDNIVRL 105 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~------~~~e~~~l~~l~h~~iv~~ 105 (218)
+-..++..++|++++.+|.|+||.||++.. ++..+|+|.+....... ...++ +.+|+..+.++.|++|..+
T Consensus 23 ~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 23 EIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 456667889999999999999999999755 57789999997554332 22233 6789999999999999999
Q ss_pred eeeEEeC--------CEEEEEEecCCC-ChHHHh
Q 041487 106 LDVLTTG--------RYVYLVFEYLDL-DLGSFI 130 (218)
Q Consensus 106 ~~~~~~~--------~~~~lv~E~~~~-~L~~~~ 130 (218)
.+++... +..+++|||++| +|.++.
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~ 134 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP 134 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh
Confidence 9886532 458999999998 887763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-09 Score=89.68 Aligned_cols=144 Identities=23% Similarity=0.328 Sum_probs=106.0
Q ss_pred ceeEEEEeeecCceEEEEEEEccCC-cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC----CCeeeeeeeE-EeCCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETG-KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH----DNIVRLLDVL-TTGRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~ 115 (218)
+|++.+.||+|+||.||.+.+...+ ..+|+|.-........ ..+..|..++..+.. +++.++++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987664 6789998764322221 257788888888862 6899999999 478899
Q ss_pred EEEEecCCCChHHHhhhcccC-----------------------------Cccccc----------------ccc-----
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI----------------KEV----- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~----------------~~~----- 145 (218)
|+||+.+..+|.+........ +++|.+ .++
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999988888876544321 111111 011
Q ss_pred ----------------------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------------------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------------------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
|+. |.++. ...+...+.+.|+||++.++.++..|..||....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~-~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASIN-VHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHH-HhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 222 44444 4455667889999999999999999999997763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-09 Score=86.85 Aligned_cols=143 Identities=32% Similarity=0.599 Sum_probs=111.8
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC-chHHHHHHHHHHhhCCCC-CeeeeeeeEEeCCEEEEEEe
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG-VPSYLIAGVSLLKELEHD-NIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~E 120 (218)
|.+...||.|+|+.||.+.+. ..+++|.+........ ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999975 8899999876554443 578899999999999888 79999999988888999999
Q ss_pred cCCC-ChHHHhhhcc---cC---------------------------Cccc------------cccccC-----------
Q 041487 121 YLDL-DLGSFIRKHT---IT---------------------------SIRP------------HIKEVG----------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~---~~---------------------------~~~~------------~~~~~g----------- 146 (218)
++.+ ++.+++.... .. +++| ...++|
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9987 7776665442 11 1111 111121
Q ss_pred -------------CcccCcccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------------SPYKAPESRIRS--SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------------~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|++||.+... ..+....|+||+|++++++++|..||....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 239999966553 568899999999999999999999987764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-10 Score=86.38 Aligned_cols=42 Identities=19% Similarity=0.329 Sum_probs=35.9
Q ss_pred cCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 ~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.+..|+|||.+ .+..++.++|||||||++|+|+||+.||...
T Consensus 66 g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 66 VDPYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred CcccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 44669999955 5556899999999999999999999999765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.2e-11 Score=102.51 Aligned_cols=144 Identities=22% Similarity=0.327 Sum_probs=102.2
Q ss_pred EeeecCceEEEEEEE---ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 48 KIGQGVFGEVYKCLN---LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
++|+|+||.|+++.. .+.+..+|+|+.++.........+...|..++...+ ||.+++++..++.....+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999988753 346778999998876654444447777888888885 9999999999999999999999985
Q ss_pred C-ChHHHhhhcccC---------------------------Cccccc-----------c-------------ccC-Cccc
Q 041487 124 L-DLGSFIRKHTIT---------------------------SIRPHI-----------K-------------EVG-SPYK 150 (218)
Q Consensus 124 ~-~L~~~~~~~~~~---------------------------~~~~~~-----------~-------------~~g-~~y~ 150 (218)
+ .+--.+...... +.++++ . .+| .-||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eym 160 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYR 160 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhhh
Confidence 4 221111110000 111111 1 133 3399
Q ss_pred CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 151 APESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 151 aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
|||... ....++|.||||+++++++||..||.. +.+.++.+
T Consensus 161 ApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il~ 201 (612)
T KOG0603|consen 161 APEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRILK 201 (612)
T ss_pred hhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHHhh
Confidence 999543 368899999999999999999999987 56666555
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-10 Score=104.47 Aligned_cols=145 Identities=26% Similarity=0.378 Sum_probs=92.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE----eCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT----TGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~ 114 (218)
..++|..++.|..|++|.||.+.++.+.+++|+|+-+... +.+. ++....+|.+| +-|. .-+.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv---gDc~tllk~~g~ 147 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV---GDCATLLKNIGP 147 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee---chhhhhcccCCC
Confidence 3567999999999999999999999999999996533211 1111 34445566554 1111 0000
Q ss_pred ----EEEEEecC--------------------C-CChHHHhhhcccC----------Ccccc------ccccCCc-ccCc
Q 041487 115 ----VYLVFEYL--------------------D-LDLGSFIRKHTIT----------SIRPH------IKEVGSP-YKAP 152 (218)
Q Consensus 115 ----~~lv~E~~--------------------~-~~L~~~~~~~~~~----------~~~~~------~~~~g~~-y~aP 152 (218)
.++..||. . .+|.||...+... .|... -..+|++ |.||
T Consensus 148 lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 148 LPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred CcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 11222332 1 2556665443221 11111 1225655 8999
Q ss_pred ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 153 ESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 153 E~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
|++...+ |+..+|+|++|+++|+.+.|+.||.+..++.+.-.+-
T Consensus 228 eVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 228 EVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 9666555 8999999999999999999999999997777665443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=90.93 Aligned_cols=87 Identities=15% Similarity=0.053 Sum_probs=68.0
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEcc-CCcEEEEEEeecCCC---CCCchHHHHHHHHHHhhCCCCCeee-eeeeEEe
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLE-TGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELEHDNIVR-LLDVLTT 111 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~ 111 (218)
....++|.+.+.||+|+||.||+|.++. +++.+|||....... .....+.+.+|+.+++.++|++++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 3457889999999999999999998876 677789998653321 2233567999999999999999885 443
Q ss_pred CCEEEEEEecCCC-ChH
Q 041487 112 GRYVYLVFEYLDL-DLG 127 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~ 127 (218)
.+..|+||||+++ +|.
T Consensus 90 ~~~~~LVmE~~~G~~L~ 106 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLH 106 (365)
T ss_pred cCCcEEEEEccCCCCHH
Confidence 2458999999987 564
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-10 Score=103.93 Aligned_cols=37 Identities=22% Similarity=0.316 Sum_probs=32.2
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
|+|||.+. +..++.++|||||||++|||++|.+|+..
T Consensus 181 Y~APE~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 181 YTSPEEDN-GSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred eEChhhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999654 45589999999999999999999998864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-10 Score=104.77 Aligned_cols=141 Identities=22% Similarity=0.375 Sum_probs=100.5
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHH---HHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIA---GVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.+...+.||.+.|=+|.+|++ +...|+||++-+....-. .+.+.+ |+. ....++||.+.+.-+...+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~--~eG~vVvKVFvk~~p~~s-L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD--REGLVVVKVFVKQDPTIS-LRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC--CCceEEEEEEeccCCCCC-chHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 688999999999999999976 555699999975542221 222222 333 4555899999998887788888999
Q ss_pred EecCCCChHHHhhhcccC---------------------------Ccccccc---------------------------c
Q 041487 119 FEYLDLDLGSFIRKHTIT---------------------------SIRPHIK---------------------------E 144 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~---------------------------~~~~~~~---------------------------~ 144 (218)
-+|+..+|.|.+..++-. |++.++. +
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999987887776543332 3333321 0
Q ss_pred ----cC-----CcccCcccccCC---------CC-CCCcchHHHHHHHHHHHHh-CCCCCCC
Q 041487 145 ----VG-----SPYKAPESRIRS---------SV-YSTPHDVWAVGCIFAEMVS-GKPLFPC 186 (218)
Q Consensus 145 ----~g-----~~y~aPE~~~~~---------~~-~~~~~DiwSlG~~l~~l~t-g~~Pf~~ 186 (218)
|. +.|.|||.+... +. .+++.||||+||++.|+++ |++||..
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 11 239999977552 22 5678999999999999999 8999973
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-10 Score=103.00 Aligned_cols=144 Identities=22% Similarity=0.321 Sum_probs=99.6
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEee----cCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.....+|.|++|.|+.+........++.|.++ ...........+..|..+-..+.|+|++.....+.......-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 46788999999988888877666666666554 12222222333667888888899999998888877666655669
Q ss_pred ecCCCChHHHhhhc-ccC--------------------------Ccccc-----------cccc----------------
Q 041487 120 EYLDLDLGSFIRKH-TIT--------------------------SIRPH-----------IKEV---------------- 145 (218)
Q Consensus 120 E~~~~~L~~~~~~~-~~~--------------------------~~~~~-----------~~~~---------------- 145 (218)
|||+.+|..++... ... ++++. +.++
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 99988776666553 111 22221 1122
Q ss_pred ------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..+|+|||++....+-....||||.|++++.|.+|+.||-..
T Consensus 481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 235999996555553445699999999999999999999765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=9e-09 Score=82.49 Aligned_cols=146 Identities=21% Similarity=0.333 Sum_probs=89.2
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCC----------CCCeeeeeeeEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELE----------HDNIVRLLDVLT 110 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~ 110 (218)
.+.....||.|+++.||.+++-.+++.+|+|++.... ......+.+.+|......+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3566789999999999999999999999999997544 33455777777776554432 222333333321
Q ss_pred ---------eCC--------EEEEEEecCCCChHHHhhh---c-ccC------------------------------Ccc
Q 041487 111 ---------TGR--------YVYLVFEYLDLDLGSFIRK---H-TIT------------------------------SIR 139 (218)
Q Consensus 111 ---------~~~--------~~~lv~E~~~~~L~~~~~~---~-~~~------------------------------~~~ 139 (218)
... ..+++|+-+..+|.+++.. . ... +++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111 2477888887777776542 1 000 223
Q ss_pred ccc--------------------------cccCCcccCcccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 140 PHI--------------------------KEVGSPYKAPESRIRS-------SVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 140 ~~~--------------------------~~~g~~y~aPE~~~~~-------~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
+.+ ..+...|.+||..... -.++.+.|.|+||+++|.|.++..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 322 1223336666633221 2378899999999999999999999987
Q ss_pred C
Q 041487 187 G 187 (218)
Q Consensus 187 ~ 187 (218)
.
T Consensus 253 ~ 253 (288)
T PF14531_consen 253 S 253 (288)
T ss_dssp C
T ss_pred C
Confidence 6
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-08 Score=92.69 Aligned_cols=142 Identities=21% Similarity=0.317 Sum_probs=103.0
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC---CCCeeeeeeeE
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---HDNIVRLLDVL 109 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~ 109 (218)
...-++....|.|.+.||+|+||+||.|...+ +..||+|+-+....++ |-.-.+++.+|+ -+.|..+....
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHH
Confidence 34445677889999999999999999999876 9999999876554443 112233445554 34566666666
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc------------------c
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------------K 143 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------------~ 143 (218)
...+.-++|+||.+. +|.|++...... |++|.+ .
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 667778899999986 999988743332 444432 2
Q ss_pred ccCCc--------------------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 041487 144 EVGSP--------------------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK 181 (218)
Q Consensus 144 ~~g~~--------------------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~ 181 (218)
+||.+ +-.+| ...++++++..|.|.++.+++-|+.|+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~E-M~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIE-MREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHH-HhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 23222 66788 677888999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=74.23 Aligned_cols=84 Identities=17% Similarity=0.296 Sum_probs=64.5
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-----CCCCeeeeeeeEEeCC---E-E
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-----EHDNIVRLLDVLTTGR---Y-V 115 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~ 115 (218)
-.+.||+|++|.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++++++.++. . +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 357899999999995 5556555 689886532 22356789999999999 6799999999998763 4 3
Q ss_pred EEEEecCC--C-ChHHHhhhc
Q 041487 116 YLVFEYLD--L-DLGSFIRKH 133 (218)
Q Consensus 116 ~lv~E~~~--~-~L~~~~~~~ 133 (218)
.+|+||+. + +|.+++...
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~ 101 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC 101 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc
Confidence 47899954 4 999998653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.9e-08 Score=74.79 Aligned_cols=77 Identities=22% Similarity=0.182 Sum_probs=54.8
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCc------------------------hHHHHHHHHHHhhCCCCC
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV------------------------PSYLIAGVSLLKELEHDN 101 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~ 101 (218)
.+.||+|++|.||+|.+. +|+.||+|+++........ .....+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999764321111 122345889999998777
Q ss_pred eeeeeeeEEeCCEEEEEEecCCCC
Q 041487 102 IVRLLDVLTTGRYVYLVFEYLDLD 125 (218)
Q Consensus 102 iv~~~~~~~~~~~~~lv~E~~~~~ 125 (218)
+.......... .++||||++++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~ 102 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDD 102 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCC
Confidence 65443332222 38999999973
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.9e-08 Score=88.43 Aligned_cols=48 Identities=25% Similarity=0.396 Sum_probs=38.6
Q ss_pred CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 146 GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 146 g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
+..|+|||.+. +..++.++|||||||++|||++|+.||.+.....+..
T Consensus 543 T~~Y~APE~l~-~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~ 590 (669)
T cd05610 543 TPDYLAPELLL-GKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQ 590 (669)
T ss_pred CccccCHHHcC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 34599999665 4558999999999999999999999998765444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-07 Score=71.05 Aligned_cols=77 Identities=19% Similarity=0.166 Sum_probs=56.8
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCc------------------------hHHHHHHHHHHhhCCCCC
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV------------------------PSYLIAGVSLLKELEHDN 101 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~ 101 (218)
.+.||+|++|.||+|.+. +|+.||+|+++........ ...+..|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999976 8999999999865321100 223457888999999988
Q ss_pred eeeeeeeEEeCCEEEEEEecCCCC
Q 041487 102 IVRLLDVLTTGRYVYLVFEYLDLD 125 (218)
Q Consensus 102 iv~~~~~~~~~~~~~lv~E~~~~~ 125 (218)
+.....+.... .++||||+++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~ 102 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDD 102 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCC
Confidence 75554444333 48999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.1e-07 Score=69.00 Aligned_cols=84 Identities=15% Similarity=0.113 Sum_probs=66.0
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC------chHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG------VPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.||+|++|.||+|.. .+..+++|.......... ...++.+|+.++..+.|++++....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999986 778899998654322111 12467789999999999998887777777778899999
Q ss_pred cCCC-ChHHHhhh
Q 041487 121 YLDL-DLGSFIRK 132 (218)
Q Consensus 121 ~~~~-~L~~~~~~ 132 (218)
|+++ +|.+++..
T Consensus 80 ~~~G~~L~~~~~~ 92 (211)
T PRK14879 80 YIEGEPLKDLINS 92 (211)
T ss_pred EeCCcCHHHHHHh
Confidence 9988 88877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=66.11 Aligned_cols=81 Identities=16% Similarity=0.013 Sum_probs=59.1
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC--CCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP--EGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 119 (218)
+.+...|++|.||.|+.+.. .+..++.+.+...... .-....+.+|+++++++. |+++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997754 7788887776532211 111236889999999995 5889999875 3469999
Q ss_pred ecCCC-ChHHH
Q 041487 120 EYLDL-DLGSF 129 (218)
Q Consensus 120 E~~~~-~L~~~ 129 (218)
||+.+ +|.+.
T Consensus 78 eyI~G~~L~~~ 88 (218)
T PRK12274 78 SYLAGAAMYQR 88 (218)
T ss_pred eeecCccHHhh
Confidence 99987 66543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.7e-07 Score=76.86 Aligned_cols=94 Identities=20% Similarity=0.370 Sum_probs=69.1
Q ss_pred HhhCCCCCeeeeeeeEEeCCEEEEEEecCCC-ChHHHhhhcccC------------------------------------
Q 041487 94 LKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT------------------------------------ 136 (218)
Q Consensus 94 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~------------------------------------ 136 (218)
|+.+.|.|+.++++.+.++...++|.+||.. +|.|.+......
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4567899999999999999999999999986 888877663221
Q ss_pred ----CccccccccCC--------------------cccCcccccCC--CC----CCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 137 ----SIRPHIKEVGS--------------------PYKAPESRIRS--SV----YSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 137 ----~~~~~~~~~g~--------------------~y~aPE~~~~~--~~----~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
....+++++|. -|.|||.+... .. .+.++||||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 00011112221 18999955442 11 46679999999999999999999987
Q ss_pred C
Q 041487 187 G 187 (218)
Q Consensus 187 ~ 187 (218)
.
T Consensus 161 ~ 161 (484)
T KOG1023|consen 161 R 161 (484)
T ss_pred c
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-06 Score=65.91 Aligned_cols=83 Identities=17% Similarity=0.080 Sum_probs=61.2
Q ss_pred EeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC------chHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG------VPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 48 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
.||+|++|.||++.. .+..+++|.......... ...++.+|+.++..+.|+++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 678899998653321111 135677899999999888766555555566667899999
Q ss_pred CCC-ChHHHhhh
Q 041487 122 LDL-DLGSFIRK 132 (218)
Q Consensus 122 ~~~-~L~~~~~~ 132 (218)
+++ +|.+++..
T Consensus 79 ~~g~~l~~~~~~ 90 (199)
T TIGR03724 79 IEGKPLKDVIEE 90 (199)
T ss_pred ECCccHHHHHhh
Confidence 987 88776544
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=68.35 Aligned_cols=83 Identities=19% Similarity=0.143 Sum_probs=59.7
Q ss_pred eeEEEEeeecCceEEEEEE-EccCCcEEEEEEeecCCCCCC----------------------chHHHHHHHHHHhhCCC
Q 041487 43 YKVVEKIGQGVFGEVYKCL-NLETGKKVAIKMINIQNEPEG----------------------VPSYLIAGVSLLKELEH 99 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~-~~~~~~~vaiK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h 99 (218)
|.+.+.||+|++|.||+|. +..+|+.||+|+++....... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999998 667899999999975431100 11245689999999965
Q ss_pred C--CeeeeeeeEEeCCEEEEEEecCCC-ChHHH
Q 041487 100 D--NIVRLLDVLTTGRYVYLVFEYLDL-DLGSF 129 (218)
Q Consensus 100 ~--~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~ 129 (218)
. .++++++. . ..++||||+++ ++..+
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~ 138 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAP 138 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCccccc
Confidence 3 33444432 2 35899999998 55544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.9e-06 Score=71.52 Aligned_cols=87 Identities=20% Similarity=0.132 Sum_probs=63.8
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CC-----CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EP-----EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
|...+.||+|+||.||++... +..+++|...... .. ....+++.+|+.+++.++|++++....++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 456789999999999999863 3344444322111 11 112357889999999999999988877777777789
Q ss_pred EEEecCCC-ChHHHhh
Q 041487 117 LVFEYLDL-DLGSFIR 131 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~ 131 (218)
+||||+++ +|.+++.
T Consensus 413 lv~E~~~g~~L~~~l~ 428 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE 428 (535)
T ss_pred EEEEecCCCcHHHHHH
Confidence 99999988 8888763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3e-07 Score=81.37 Aligned_cols=148 Identities=25% Similarity=0.388 Sum_probs=107.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEc-cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNL-ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 117 (218)
...|.+.+.||+|+|+.|-..... .....+|.|.+...........++..|..+-..+. |.|++++++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 566888999999999999888753 34556777776544433445566677888777786 9999999999999999999
Q ss_pred EEecCCC-ChHHHh-hhcccC-----------------------------Cccccc------------------------
Q 041487 118 VFEYLDL-DLGSFI-RKHTIT-----------------------------SIRPHI------------------------ 142 (218)
Q Consensus 118 v~E~~~~-~L~~~~-~~~~~~-----------------------------~~~~~~------------------------ 142 (218)
.+++..+ ++.+.+ ...... ++.|.+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999754 333333 111100 111111
Q ss_pred --------ccc--CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 143 --------KEV--GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 143 --------~~~--g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..+ +.+|.|||...+.++.+...|+||+|+++..+++|..||...
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 112 345999997776677889999999999999999999999866
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.5e-06 Score=68.52 Aligned_cols=32 Identities=25% Similarity=0.250 Sum_probs=26.8
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEc
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL 63 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~ 63 (218)
.....++..++|.+..-||+|....||.+...
T Consensus 148 ~r~dskFtiddyeiG~~igkGC~AaVY~A~~~ 179 (598)
T KOG4158|consen 148 NRIDSKFTIDDYEIGEFIGKGCNAAVYSARLA 179 (598)
T ss_pred chhhcccchhhhcccchhhccchhhhhhhhcC
Confidence 34566678899999999999999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-05 Score=61.74 Aligned_cols=82 Identities=23% Similarity=0.257 Sum_probs=58.0
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC--------------------CchHHHHHHHHHHhhCCCC--
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE--------------------GVPSYLIAGVSLLKELEHD-- 100 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~-- 100 (218)
|.+.+.||+|+||.||++.. .+++.+|+|+++...... ........|..++..+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 77889999999999999986 479999999976432110 0112356788888888766
Q ss_pred CeeeeeeeEEeCCEEEEEEecCCC-ChHHH
Q 041487 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSF 129 (218)
Q Consensus 101 ~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~ 129 (218)
.++..++ ....+++|||+++ +|.+.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~ 121 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRV 121 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhc
Confidence 3444443 2446899999998 66544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.8e-06 Score=71.07 Aligned_cols=160 Identities=20% Similarity=0.262 Sum_probs=112.9
Q ss_pred hhhhhccceeEEEEeee--cCceEEEEEEE--ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQ--GVFGEVYKCLN--LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~--G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
........+.+.+.+|. |.+|.+|.+.. +.++..+|+|.-+..........+-.+|+.....+ .|++.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 33445566888999999 99999999988 78889999998654443334445556777777777 699999999999
Q ss_pred EeCCEEEEEEecCCCChHHHhhhcccC--------------------------------Cccccc---------------
Q 041487 110 TTGRYVYLVFEYLDLDLGSFIRKHTIT--------------------------------SIRPHI--------------- 142 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~~L~~~~~~~~~~--------------------------------~~~~~~--------------- 142 (218)
...+..++-+|.|+.+|..+......- +.++..
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 999999999999986666654432110 000000
Q ss_pred -------------------c-ccCCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 143 -------------------K-EVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 143 -------------------~-~~g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
+ ..+..|++||. .++. ++...||+|+|.+..+..++..+........+.++.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhh-hccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 0 12334999994 4443 799999999999999999987666555344444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.99 E-value=2e-05 Score=56.47 Aligned_cols=77 Identities=16% Similarity=0.244 Sum_probs=62.2
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC--CCeeeeeeeEEeCCEEEEEEecC
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH--DNIVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~E~~ 122 (218)
+.+.||.|.++.||++.. .+..+++|....... ...+.+|+..++.+.+ .++++++.....++..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 457899999999999987 347899998764322 4678899999999966 58999988888878899999999
Q ss_pred CC-ChH
Q 041487 123 DL-DLG 127 (218)
Q Consensus 123 ~~-~L~ 127 (218)
.+ .+.
T Consensus 76 ~g~~~~ 81 (155)
T cd05120 76 EGETLD 81 (155)
T ss_pred CCeecc
Confidence 87 443
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3e-05 Score=67.92 Aligned_cols=63 Identities=27% Similarity=0.296 Sum_probs=52.1
Q ss_pred EEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 59 KCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 59 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
.|..+.++.+|.+...+.... ...+...+-+.-++.++||||+++++.+...+.+|+|+|.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 466678899999998874332 445567777788999999999999999999999999999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.7e-06 Score=72.21 Aligned_cols=30 Identities=43% Similarity=0.778 Sum_probs=26.9
Q ss_pred ccCcccccCCCCCCCcchHHHHHHHHHHHHh
Q 041487 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS 179 (218)
Q Consensus 149 y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t 179 (218)
||+||+ +.+..|+.++||||||++|+|++.
T Consensus 428 YmsPEQ-i~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 428 YMSPEQ-IRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cCCHHH-HhhhhhhhhcchhhHHHHHHHHHH
Confidence 999995 556669999999999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.76 E-value=7e-05 Score=56.33 Aligned_cols=74 Identities=23% Similarity=0.256 Sum_probs=48.0
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHH----------------------HHHHHHHHhhCCCCC--
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY----------------------LIAGVSLLKELEHDN-- 101 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~~-- 101 (218)
.+.||+|+||.||+|.+. +++.||+|+++........... ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999875 7999999998754322111111 134555555554332
Q ss_pred eeeeeeeEEeCCEEEEEEecCCC
Q 041487 102 IVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 102 iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
+.+.++. ...+++|||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g 99 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGG 99 (187)
T ss_pred CCceEec----CCCEEEEEEeCC
Confidence 4444432 235899999987
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=1.7e-05 Score=69.27 Aligned_cols=36 Identities=11% Similarity=0.280 Sum_probs=31.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecC
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ 77 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~ 77 (218)
..|.. +.||.|++|+||+|+.+++|+.||||+.++.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~ 155 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPD 155 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence 34666 7899999999999999878999999999754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=3.2e-05 Score=70.87 Aligned_cols=157 Identities=17% Similarity=0.200 Sum_probs=98.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...+.+.+.+-+-+|+++.++.+.-...+-..++|...... ......+...++-.++-...+|.+++....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45677888999999999999998766666555555443222 11112333334434444445678887776666777899
Q ss_pred EEEecCCC-ChHHHhhhcccC-----------------------------------------------------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------------------------------------- 136 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------------------------------------- 136 (218)
++++|.++ +|..-+...+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99998842 222221111100
Q ss_pred ---------------------------CccccccccC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 137 ---------------------------SIRPHIKEVG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 137 ---------------------------~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+.+.+....| ..|.+||... +...+..+|+|++|+++++.++|.+||+...
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0000011122 3399999544 5557899999999999999999999999876
Q ss_pred cchHHHH
Q 041487 189 KDHLSLI 195 (218)
Q Consensus 189 ~~~~~~~ 195 (218)
+....+-
T Consensus 1040 pq~~f~n 1046 (1205)
T KOG0606|consen 1040 PQQIFEN 1046 (1205)
T ss_pred hhhhhhc
Confidence 6666543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0017 Score=49.84 Aligned_cols=82 Identities=12% Similarity=0.112 Sum_probs=59.4
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCC--CeeeeeeeEEeC---CEEEEEEec
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD--NIVRLLDVLTTG---RYVYLVFEY 121 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~E~ 121 (218)
+.|+.|..+.+|++... .|..+++|........ .....+.+|..+++.+.+. .+++++.+.... +..+++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 57899999999999863 3589999997643321 2345688999999998653 456777766543 367899999
Q ss_pred CCC-ChHHHh
Q 041487 122 LDL-DLGSFI 130 (218)
Q Consensus 122 ~~~-~L~~~~ 130 (218)
+++ ++.+.+
T Consensus 82 i~G~~l~~~~ 91 (223)
T cd05154 82 VDGRVLRDRL 91 (223)
T ss_pred eCCEecCCCC
Confidence 998 665543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0019 Score=55.50 Aligned_cols=30 Identities=20% Similarity=0.311 Sum_probs=25.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQ 77 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~ 77 (218)
+.||.|++|+||+|+. .+|+.||||+.++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~ 152 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPG 152 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCC
Confidence 5699999999999986 47899999998643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.00058 Score=59.02 Aligned_cols=148 Identities=17% Similarity=0.125 Sum_probs=102.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc-cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL-ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
....+|..+..||.|.|+.|+.+..+ ..+..+++|.+............-..|+.+...+ .|.++++....|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 44567899999999999999998866 6788999999876554433334445666666666 689999998888877778
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc------------ccc----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------KEV---------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------~~~---------- 145 (218)
|+-.|||++ ++.......... +..+.+ ..+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 899999965 444333211000 122211 111
Q ss_pred -----CCccc-CcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCC
Q 041487 146 -----GSPYK-APESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFP 185 (218)
Q Consensus 146 -----g~~y~-aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~ 185 (218)
+..++ .+|.+.....+..+.|++|||..+.+.+++. .+.+
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 11255 3666777777889999999999999999886 3444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.006 Score=48.06 Aligned_cols=84 Identities=13% Similarity=0.128 Sum_probs=58.0
Q ss_pred EEee-ecCceEEEEEEEccCCcEEEEEEeecCCC-----------CCCchHHHHHHHHHHhhCCCCCe--eeeeeeEEe-
Q 041487 47 EKIG-QGVFGEVYKCLNLETGKKVAIKMINIQNE-----------PEGVPSYLIAGVSLLKELEHDNI--VRLLDVLTT- 111 (218)
Q Consensus 47 ~~ig-~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~- 111 (218)
..|| .|+.|+||.+.. .+..+++|.+..... ......++.+|+.++..+.|+++ ++.++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 778888888876 478899998853210 11234678899999999988775 666666432
Q ss_pred CC---EEEEEEecCCC--ChHHHhhh
Q 041487 112 GR---YVYLVFEYLDL--DLGSFIRK 132 (218)
Q Consensus 112 ~~---~~~lv~E~~~~--~L~~~~~~ 132 (218)
.. ..++|||++++ +|.+++..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~ 140 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE 140 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc
Confidence 22 24699999985 78777654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0083 Score=52.03 Aligned_cols=102 Identities=22% Similarity=0.303 Sum_probs=66.8
Q ss_pred HHHHHHHHHHhhCCCCCeeeeeeeEEe-CCEEEEEEecCCCChHHHhhhcccCCccccc---cccCCcccCcccccCC--
Q 041487 85 SYLIAGVSLLKELEHDNIVRLLDVLTT-GRYVYLVFEYLDLDLGSFIRKHTITSIRPHI---KEVGSPYKAPESRIRS-- 158 (218)
Q Consensus 85 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~~L~~~~~~~~~~~~~~~~---~~~g~~y~aPE~~~~~-- 158 (218)
..+.-....++.+.|+++..+.++-+. ..+..+|||+++.++.|+...+...+..-.. ...+.-|.+-. +..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~~s~~~~~~~~~~~~~~td~-~~t~~~ 105 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKDESLLAHGVLHLNIIYITDH-FLTKYP 105 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccchhhhcccccceehhhhcccc-ccccCC
Confidence 445556778999999999999988763 3458999999999999998776532111100 00000011110 1111
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 159 SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 159 ~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
-..++++||||+|.++.++..|...+...
T Consensus 106 ~~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 106 SPIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 11346999999999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.011 Score=43.35 Aligned_cols=75 Identities=13% Similarity=0.079 Sum_probs=51.8
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC-eeeeeeeEEeCCEEEEEEecCCC
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN-IVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
++.++.|..+.||++.. .+..+++|....... ....+..|+.+++.+.+.+ +++++.... ...++|||++++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46789999999999986 478899998753321 1223577888888875433 445555433 235799999987
Q ss_pred -ChH
Q 041487 125 -DLG 127 (218)
Q Consensus 125 -~L~ 127 (218)
++.
T Consensus 76 ~~l~ 79 (170)
T cd05151 76 SELL 79 (170)
T ss_pred Cccc
Confidence 554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.014 Score=43.73 Aligned_cols=78 Identities=21% Similarity=0.264 Sum_probs=55.6
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCe-eeeeeeEEeCCEEEEEEecC
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI-VRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~E~~ 122 (218)
+..+.|++|.+|.||++.. .+..+|+|+=+ .++-...+..|++++..+.-.++ .+++.+-. .++.|||.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 4567899999999999987 67799999743 22334678899999988865443 44544332 23559999
Q ss_pred CC-ChHHHhh
Q 041487 123 DL-DLGSFIR 131 (218)
Q Consensus 123 ~~-~L~~~~~ 131 (218)
+| .|.+...
T Consensus 95 ~G~~L~~~~~ 104 (201)
T COG2112 95 DGRPLGKLEI 104 (201)
T ss_pred cCcchhhhhh
Confidence 98 7766544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.019 Score=46.98 Aligned_cols=40 Identities=28% Similarity=0.471 Sum_probs=31.6
Q ss_pred HHhhCCCCCeeeeeeeEEe-----CCEEEEEEecCCC-ChHHHhhh
Q 041487 93 LLKELEHDNIVRLLDVLTT-----GRYVYLVFEYLDL-DLGSFIRK 132 (218)
Q Consensus 93 ~l~~l~h~~iv~~~~~~~~-----~~~~~lv~E~~~~-~L~~~~~~ 132 (218)
-+..+.|.||++++.++.+ ..+..+++||+.. ++..|+++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkr 165 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKR 165 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHH
Confidence 4556689999999999864 3468999999976 88887765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.19 Score=38.08 Aligned_cols=89 Identities=17% Similarity=0.043 Sum_probs=63.0
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecC-C----CCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ-N----EPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~-~----~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.+..+.+|+-+.|+.+.. .|+.++||.=... . .+. -..++..+|+..+.++.--.|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678899999999999976 7888888753221 1 111 1246788899998888655555444455555666799
Q ss_pred EecCCC--ChHHHhhhccc
Q 041487 119 FEYLDL--DLGSFIRKHTI 135 (218)
Q Consensus 119 ~E~~~~--~L~~~~~~~~~ 135 (218)
|||+++ ++.+|+.....
T Consensus 89 ME~~~g~~~vk~~i~~~~~ 107 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME 107 (229)
T ss_pred EEeccchhHHHHHHHHHcc
Confidence 999998 88999877544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.14 Score=39.14 Aligned_cols=75 Identities=13% Similarity=0.069 Sum_probs=50.9
Q ss_pred EEEeeecCceEEEEEEEcc------CCcEEEEEEeecCCC-----------C---------CCchHHHH----HHHHHHh
Q 041487 46 VEKIGQGVFGEVYKCLNLE------TGKKVAIKMINIQNE-----------P---------EGVPSYLI----AGVSLLK 95 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~ 95 (218)
...||.|.-+.||.|...+ .+..+|+|+.+.... + ..-.+.+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 357999999973211 0 01122233 7888888
Q ss_pred hCCC--CCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 96 ELEH--DNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 96 ~l~h--~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
++.. -.+++++++ ...++||||+++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~ 108 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGD 108 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCC
Confidence 8843 456666653 457799999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.26 Score=37.28 Aligned_cols=85 Identities=13% Similarity=0.045 Sum_probs=57.6
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCC-----chHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEG-----VPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..+++|+-+.++.+.. -|.++++|.=.++. ...+ -..+..+|+.++.++.-..+....-++.+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578899999998865 45557776533222 1111 14567789999998866666655555566777789999
Q ss_pred cCCC-ChHHHhhhc
Q 041487 121 YLDL-DLGSFIRKH 133 (218)
Q Consensus 121 ~~~~-~L~~~~~~~ 133 (218)
|+++ .|.+++...
T Consensus 80 ~I~G~~lkd~l~~~ 93 (204)
T COG3642 80 YIEGELLKDALEEA 93 (204)
T ss_pred EeCChhHHHHHHhc
Confidence 9999 667677655
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.22 Score=46.48 Aligned_cols=80 Identities=15% Similarity=0.208 Sum_probs=56.3
Q ss_pred EEEEeeecCceEEEEEEEccCC--cEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCe--eeeeeeEEeC---CEEE
Q 041487 45 VVEKIGQGVFGEVYKCLNLETG--KKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNI--VRLLDVLTTG---RYVY 116 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~ 116 (218)
-+..++.|..+.+|+......+ ..+++|..+.... ......+.+|..+++.+. |+++ ++++.++.+. +..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998764332 4677777653221 112346889999999985 6664 7777777653 4688
Q ss_pred EEEecCCCC
Q 041487 117 LVFEYLDLD 125 (218)
Q Consensus 117 lv~E~~~~~ 125 (218)
+||||+++.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999983
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.2 Score=43.68 Aligned_cols=77 Identities=19% Similarity=0.206 Sum_probs=56.4
Q ss_pred CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE----eCCEEEEEEecCCC--Ch
Q 041487 53 VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT----TGRYVYLVFEYLDL--DL 126 (218)
Q Consensus 53 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~E~~~~--~L 126 (218)
.-.+.|++....+|-.|++|.+...+.-. .-....-++..+++.|+|+|.+.++|. .+..+++|.+|.++ +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 44578999999999999999984322111 111233456789999999999999986 45679999999986 77
Q ss_pred HHHhh
Q 041487 127 GSFIR 131 (218)
Q Consensus 127 ~~~~~ 131 (218)
.++.-
T Consensus 366 ~d~~F 370 (655)
T KOG3741|consen 366 YDLYF 370 (655)
T ss_pred HHHHc
Confidence 76653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.54 Score=40.02 Aligned_cols=77 Identities=19% Similarity=0.135 Sum_probs=54.6
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCC---C--CCchHHHHHHHHHHhhCC---CCCeeeeeeeEEeCCEEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---P--EGVPSYLIAGVSLLKELE---HDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 117 (218)
.+.||.|.++.||++.....++.++||.-..... . .-..++...|.+.|+.+. -..+++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4689999999999999754335899998642211 1 234577888888888762 24577777663 345789
Q ss_pred EEecCCC
Q 041487 118 VFEYLDL 124 (218)
Q Consensus 118 v~E~~~~ 124 (218)
|||+++.
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.017 Score=51.28 Aligned_cols=134 Identities=15% Similarity=0.148 Sum_probs=83.2
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC-eeeeeeeEEeCCEEEEEEecC
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN-IVRLLDVLTTGRYVYLVFEYL 122 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~E~~ 122 (218)
.....+++++++++++.+...+...+ .+++... ....-++++|.+++||| .++.++.+..+...++.|+++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 44556789999999988654443333 5554322 22334567899999999 777777888888999999998
Q ss_pred CCC-------------hHHHhhh----cccC------Cc------------------------------cccccccCCcc
Q 041487 123 DLD-------------LGSFIRK----HTIT------SI------------------------------RPHIKEVGSPY 149 (218)
Q Consensus 123 ~~~-------------L~~~~~~----~~~~------~~------------------------------~~~~~~~g~~y 149 (218)
... +.++.-. .... .. .+........+
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~ 396 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEP 396 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCcccccccCCCCCCC
Confidence 521 1111000 0000 00 00011112238
Q ss_pred cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 150 KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 150 ~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
+|||+ ...+.+..+.|.|++|+-..++.-|-+|-..
T Consensus 397 ~~pev-~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 397 LAPEV-IQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCchh-hcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 99994 5555589999999999877777777766543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.45 Score=38.77 Aligned_cols=79 Identities=15% Similarity=0.105 Sum_probs=56.2
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC---CCeeeeeeeEEe---CCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH---DNIVRLLDVLTT---GRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~ 115 (218)
...-.+.||.|..+.||.... .+..+.+|..+. . .....+..|+..++.+.- ..++++++++.. .+..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 345567899999999999864 333577787432 1 122468899999988842 367888877653 3668
Q ss_pred EEEEecCCC-Ch
Q 041487 116 YLVFEYLDL-DL 126 (218)
Q Consensus 116 ~lv~E~~~~-~L 126 (218)
++|||++++ ++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999997 54
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.59 Score=35.73 Aligned_cols=77 Identities=18% Similarity=0.336 Sum_probs=54.7
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCC--CeeeeeeeE---EeCCEEEEEEe
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD--NIVRLLDVL---TTGRYVYLVFE 120 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~E 120 (218)
++.++.|..+.||...... ..+++|..... .....+.+|..+++.+... .+++++... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5689999999999998743 69999986532 3456778888888887432 356666643 34456899999
Q ss_pred cCCC-ChHH
Q 041487 121 YLDL-DLGS 128 (218)
Q Consensus 121 ~~~~-~L~~ 128 (218)
++++ .+..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 9998 5555
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.33 Score=37.89 Aligned_cols=70 Identities=17% Similarity=0.176 Sum_probs=52.9
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC--eeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN--IVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
..|+.|..+.||+. .+..+++|..+... ......+|.++++.+.... +++++++....+...++||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 67899999999974 25567889875321 2345788999998885433 57778887777788899999998
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.02 Score=49.22 Aligned_cols=74 Identities=28% Similarity=0.393 Sum_probs=59.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
.-..++|.....+|.|+||+|+.+....++..+|||.+.... ......+..+|...+..+.|+++++++..|..
T Consensus 45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn-~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN-REESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhhhccccccccccccCccccCCccccccchhhHHHHhcccc-hhhhhhhhhccccchhhhcccchhhheeceec
Confidence 345678999999999999999999988778899999986432 23345667788888999999999999877753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.49 E-value=0.35 Score=38.89 Aligned_cols=77 Identities=21% Similarity=0.250 Sum_probs=55.4
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------------------CCCc--hHHHHHHHHHHhhCCCC--
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------------------PEGV--PSYLIAGVSLLKELEHD-- 100 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------------------~~~~--~~~~~~e~~~l~~l~h~-- 100 (218)
..+...||.|.-|.||.|.+ +.|.++|+|+=+.... ++-. .....+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35678999999999999986 4789999998652211 1111 23456788889988644
Q ss_pred CeeeeeeeEEeCCEEEEEEecCCC
Q 041487 101 NIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 101 ~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
.+++.+ +.+..++|||++++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG 191 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEG 191 (304)
T ss_pred CCCCcc----ccccceeeeehccc
Confidence 666665 45567899999987
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=92.26 E-value=0.69 Score=36.18 Aligned_cols=74 Identities=12% Similarity=0.095 Sum_probs=51.5
Q ss_pred EeeecCc-eEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEEecCCC-
Q 041487 48 KIGQGVF-GEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL- 124 (218)
Q Consensus 48 ~ig~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~- 124 (218)
.|..|.. +.||+... .+..+.+|..+... ...+.+|+.+++.+ .+--++++++.....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 4555555 78888864 34688889875332 23467788888887 344566777777766778999999998
Q ss_pred ChHH
Q 041487 125 DLGS 128 (218)
Q Consensus 125 ~L~~ 128 (218)
++..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 5653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=90.20 E-value=2.4 Score=32.39 Aligned_cols=86 Identities=19% Similarity=0.254 Sum_probs=61.0
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCC--------------CCCCchHHHHHHHHHHhhCC------CCCeeee
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--------------EPEGVPSYLIAGVSLLKELE------HDNIVRL 105 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~ 105 (218)
...||+|+.-.||.- +.+...+||+..... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899998888854 456778889887554 11223455666666544444 8899999
Q ss_pred eeeEEeCCEEEEEEecCC-------CChHHHhhhcc
Q 041487 106 LDVLTTGRYVYLVFEYLD-------LDLGSFIRKHT 134 (218)
Q Consensus 106 ~~~~~~~~~~~lv~E~~~-------~~L~~~~~~~~ 134 (218)
+|...++--+.+|+|.+. .+|.+++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~ 118 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG 118 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC
Confidence 999999888899999862 37888875543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=89.97 E-value=1.8 Score=33.27 Aligned_cols=68 Identities=18% Similarity=0.266 Sum_probs=48.6
Q ss_pred cceeEEEEeeecCc-eEEEEEEEccCCcEEEEEEeecCC---C-------CC---------CchHHHHHHHHHHhhCC--
Q 041487 41 WNYKVVEKIGQGVF-GEVYKCLNLETGKKVAIKMINIQN---E-------PE---------GVPSYLIAGVSLLKELE-- 98 (218)
Q Consensus 41 ~~~~~~~~ig~G~~-g~v~~~~~~~~~~~vaiK~~~~~~---~-------~~---------~~~~~~~~e~~~l~~l~-- 98 (218)
.+++.++.||.|.- |.||++.. .|..+|+|.++.-. . .. ...+-|..|-++..+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999987 78899999943210 0 00 22345777777766664
Q ss_pred -CCCe--eeeeeeEE
Q 041487 99 -HDNI--VRLLDVLT 110 (218)
Q Consensus 99 -h~~i--v~~~~~~~ 110 (218)
+.++ ++++++..
T Consensus 115 ~~e~~~Avkc~Gyl~ 129 (207)
T PF13095_consen 115 GREGLWAVKCHGYLL 129 (207)
T ss_pred cccCceEEEeeEEEE
Confidence 3344 88887763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=89.86 E-value=1.7 Score=37.09 Aligned_cols=76 Identities=16% Similarity=0.156 Sum_probs=53.0
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-----CCCchHHHHHHHHHHhhCC---CCCeeeeeeeEEeCCEEE
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-----PEGVPSYLIAGVSLLKELE---HDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 116 (218)
..+.||-|....||+... .+..++||.-..... ......+...|...|+.+. ...+++++.++.+. .+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence 477899999999999886 355799998762221 1124556666677776653 24788888777644 67
Q ss_pred EEEecCCC
Q 041487 117 LVFEYLDL 124 (218)
Q Consensus 117 lv~E~~~~ 124 (218)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999965
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=89.80 E-value=0.15 Score=35.59 Aligned_cols=44 Identities=18% Similarity=0.297 Sum_probs=31.3
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~ 96 (218)
.-|+.|+.|+||+|+.+ +|+.||||+.++. ..+.+...+.+++.
T Consensus 17 ~PlasASiaQVh~a~l~-~g~~VaVKV~rP~-----i~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLK-DGEEVAVKVQRPG-----IEEQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeec-ccchhhhhhcchH-----HHHHHHHHHHHHHH
Confidence 46999999999999864 4999999986532 23444455544443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.44 E-value=0.91 Score=38.95 Aligned_cols=38 Identities=13% Similarity=0.273 Sum_probs=29.9
Q ss_pred ccCcccccC-----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCC
Q 041487 149 YKAPESRIR-----SSVYSTPHDVWAVGCIFAEMVSG-KPLFPCG 187 (218)
Q Consensus 149 y~aPE~~~~-----~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~ 187 (218)
|.+|| +.. +-.-+...|-|.||+++++++.| +.||++.
T Consensus 182 ftPPE-lQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 182 FTPPE-LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCHH-HhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 88888 333 22245679999999999999985 9999876
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.41 E-value=1.1 Score=39.56 Aligned_cols=28 Identities=25% Similarity=0.362 Sum_probs=24.6
Q ss_pred EEeeecCceEEEEEEEccCCcEEEEEEee
Q 041487 47 EKIGQGVFGEVYKCLNLETGKKVAIKMIN 75 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~ 75 (218)
+.||..+.|+|++|+.+. |+.||||+=+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~ 194 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQH 194 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecC
Confidence 579999999999999765 9999999865
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=85.29 E-value=6.5 Score=31.95 Aligned_cols=76 Identities=16% Similarity=0.233 Sum_probs=47.6
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEEeCCEEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.+-.+.++.|..+.+|+.. .++..+-+|+-.. .....+..|+.-|+.+ ..-.+++++.+...++..+++|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 3456788999999999886 5788999998652 2234577788777776 3456888888887777779999
Q ss_pred ecCCCC
Q 041487 120 EYLDLD 125 (218)
Q Consensus 120 E~~~~~ 125 (218)
||.+..
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.07 E-value=2.5 Score=35.88 Aligned_cols=77 Identities=26% Similarity=0.349 Sum_probs=49.8
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-----------------------CCCC-chHHHHHHHHHHhhCCC
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-----------------------EPEG-VPSYLIAGVSLLKELEH 99 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~-~~~~~~~e~~~l~~l~h 99 (218)
.+.+.|..|.-+-||.|+. .+|..+|||+++..- .++. ..-....|+.=|.++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4567788899999999974 678889999997321 1111 12233456666777776
Q ss_pred CCeeeeeeeEEeCCEEEEEEecCC
Q 041487 100 DNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 100 ~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
..|+-.-.+.... .++||+|+.
T Consensus 226 aGIP~PePIlLk~--hVLVM~FlG 247 (520)
T KOG2270|consen 226 AGIPCPEPILLKN--HVLVMEFLG 247 (520)
T ss_pred cCCCCCCceeeec--ceEeeeecc
Confidence 6654433333333 679999985
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=83.97 E-value=6.5 Score=30.34 Aligned_cols=74 Identities=18% Similarity=0.241 Sum_probs=46.0
Q ss_pred EEEeeecCceEEEEEEEcc-CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEEEecCC
Q 041487 46 VEKIGQGVFGEVYKCLNLE-TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLVFEYLD 123 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~ 123 (218)
++.|..|-.+.+|++.... .+..+++|+.... .... -...+|+.+++.+. +.-.++++..+. . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~--~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK--TELI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC--ccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 4667888888999987533 3578889976532 1111 12246777788774 333455554432 2 37999998
Q ss_pred C-Ch
Q 041487 124 L-DL 126 (218)
Q Consensus 124 ~-~L 126 (218)
+ ++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8 44
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=82.69 E-value=14 Score=28.93 Aligned_cols=94 Identities=18% Similarity=0.100 Sum_probs=55.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchH------HHHHHHHHHhhCC---CCCee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPS------YLIAGVSLLKELE---HDNIV 103 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~------~~~~e~~~l~~l~---h~~iv 103 (218)
-...+...+|.+.+++.......|.+-.. ++..+++|..+..... +.... ...+.+..+.++. -....
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 34567888999999999988877776654 7899999988643211 11011 1122233333332 22333
Q ss_pred eeeeeE-----EeCCEEEEEEecCCC-ChHHH
Q 041487 104 RLLDVL-----TTGRYVYLVFEYLDL-DLGSF 129 (218)
Q Consensus 104 ~~~~~~-----~~~~~~~lv~E~~~~-~L~~~ 129 (218)
.++.+. .-....+++|||++| .|.++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~ 133 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDI 133 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccc
Confidence 323222 223456789999998 66553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=80.05 E-value=0.18 Score=45.11 Aligned_cols=50 Identities=18% Similarity=0.290 Sum_probs=36.4
Q ss_pred CcccCcccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcchHHHHHH
Q 041487 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMV-SGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~-tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|.|||.+.. ...+.++|++|+|+.+|.+. .|+.-+..........+..
T Consensus 173 ~~f~apE~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~ 223 (700)
T KOG2137|consen 173 LNFLAPEYLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR 223 (700)
T ss_pred cccccchhhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh
Confidence 34999996655 55788999999999999999 4777676554444444433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 218 | ||||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-04 |
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 218 | |||
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-50 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-48 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-46 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-45 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-43 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-43 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-38 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-37 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-34 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-12 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-33 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-13 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-33 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-31 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-29 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-28 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-23 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-22 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-10 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-21 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-14 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-20 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-05 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-20 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-19 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-19 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-05 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-19 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-19 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-05 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-18 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-13 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 6e-13 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-17 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-17 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-17 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-17 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-17 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-17 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-17 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-17 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-04 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-17 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-04 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-17 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-17 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-17 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-17 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-16 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-16 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-04 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-16 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-16 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-09 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-16 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-16 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-16 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-12 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-16 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-16 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-13 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-16 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-16 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-16 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-16 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-15 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-15 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-15 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-15 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-15 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-15 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-15 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-15 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-12 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-12 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-15 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-15 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-15 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-15 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-11 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-14 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-14 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-14 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-14 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-04 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-14 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-14 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-14 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-14 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-14 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-14 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-14 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-12 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-13 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-13 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-13 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-13 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-08 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-13 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-13 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-13 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-13 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-13 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-13 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-13 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-12 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-12 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-12 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-12 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-12 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-12 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-08 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-11 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-11 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-04 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-11 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-11 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-11 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-11 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-11 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-11 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-11 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-10 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-10 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-10 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-10 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-10 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-10 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-10 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-05 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-09 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-09 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-09 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-09 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 6e-09 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 9e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-08 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-08 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-06 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-07 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-06 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-04 |
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-50
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 60/215 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + KIG+G +G V+KC N +TG+ VAIK + + + + +LK+L+H N
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK------------------ 143
+V LL+V R ++LVFEY D + + ++ +K
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 144 ---------------------------EVGSP------------YKAPESRIRSSVYSTP 164
+ P Y++PE + + Y P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
DVWA+GC+FAE++SG PL+P GK D L LI +
Sbjct: 184 VDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-48
Identities = 55/226 (24%), Positives = 87/226 (38%), Gaps = 65/226 (28%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG 90
+ MEK Y+ + +G+G +G V KC N +TG+ VAIK ++ + V +
Sbjct: 20 YFQSMEK-----YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE 74
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK------- 143
+ LLK+L H+N+V LL+V + YLVFE++D + + ++
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 144 --------------------------------------EVGSPYKA------------PE 153
+ +P + PE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 154 SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
+ Y DVWA+GC+ EM G+PLFP G D L I+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMM 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-46
Identities = 66/230 (28%), Positives = 97/230 (42%), Gaps = 69/230 (30%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG 90
+ ++ Y+ + K+G+G +GEVYK ++ T + VAIK I +++E EGVP I
Sbjct: 29 SATSID-----RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD------LDLGSFIRKHTITSI------ 138
VSLLKEL+H NI+ L V+ ++L+FEY + +D + I S
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 139 -----------------------------RPHIK--------EVGSP------------Y 149
P +K G P Y
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 150 KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
+ PE + S YST D+W++ CI+AEM+ PLFP G D L I
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP-GDSEIDQLFKIFE 252
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-45
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 63/218 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELE 98
Y+ ++ +G+G F VYK + T + VAIK I + + +G+ + + LL+EL
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK--------------- 143
H NI+ LLD + LVF++++ DL I+ +++ HIK
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 144 ------------------------------EVGSPYK------------APESRIRSSVY 161
GSP + APE + +Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 190
Query: 162 STPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
D+WAVGCI AE++ P P G D L+ I
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFE 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 61/215 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y ++K+G+G + VYK + T VA+K I +++E EG P I VSLLK+L+H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHAN 61
Query: 102 IVRLLDVLTTGRYVYLVFEYL--DL-----DLGSFIRKHTITSI---------------- 138
IV L D++ T + + LVFEYL DL D G+ I H +
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 139 --------------RPHIK--------EVGSP------------YKAPESRIRSSVYSTP 164
R +K P Y+ P+ + S+ YST
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
D+W VGCIF EM +G+PLFP G ++ L I R
Sbjct: 182 IDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFR 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-43
Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 61/216 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ +EKIG+G +G V+K N ET + VA+K + + ++ EGVPS + + LLKEL+H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYL--DL-----DLGSFIRKHTITSI---------------- 138
IVRL DVL + + + LVFE+ DL + + S
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 139 --------------RPHIK--------EVGSP------------YKAPESRIRSSVYSTP 164
+K G P Y+ P+ + +YST
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 165 HDVWAVGCIFAEMVS-GKPLFPCGK--KDHLSLIVR 197
D+W+ GCIFAE+ + G+PLFP G D L I R
Sbjct: 183 IDMWSAGCIFAELANAGRPLFP-GNDVDDQLKRIFR 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-38
Identities = 68/244 (27%), Positives = 96/244 (39%), Gaps = 83/244 (34%)
Query: 26 VKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-ETGKKVAIKMINIQNEPEGVP 84
++K + Y+ V +IG+G +G+V+K +L G+ VA+K + +Q EG+P
Sbjct: 1 MEKDGLCRADQ-----QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP 55
Query: 85 SYLIAGVSLLKEL---EHDNIVRLLDVLTTGRY-----VYLVFEY--------LDLDLGS 128
I V++L+ L EH N+VRL DV T R + LVFE+ LD
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 115
Query: 129 FIRKHTITSI------------------------------RPHIK--------EVGSP-- 148
+ TI + IK
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 149 ---------YKAPE----SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLS 193
Y+APE S Y+TP D+W+VGCIFAEM KPLF G D L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLG 229
Query: 194 LIVR 197
I+
Sbjct: 230 KILD 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-37
Identities = 68/241 (28%), Positives = 90/241 (37%), Gaps = 85/241 (35%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG---VPSYL 87
GS Y+ V +IG G +G VYK + +G VA+K + + N G +P
Sbjct: 4 GSMATS-----RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58
Query: 88 IAGVSLLKEL---EHDNIVRLLDVLTTGRY-----VYLVFEY--------LDLDLGSFIR 131
+ V+LL+ L EH N+VRL+DV T R V LVFE+ LD +
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 118
Query: 132 KHTITSI------------------------------RPHIK--------EVGSP----- 148
TI + +K
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 149 ------YKAPE----SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE S Y+TP D+W+VGCIFAEM KPLF G D L I
Sbjct: 179 VVVTLWYRAPEVLLQST-----YATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIF 232
Query: 197 R 197
Sbjct: 233 D 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-34
Identities = 43/102 (42%), Positives = 60/102 (58%), Gaps = 1/102 (0%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y +EKIG+G +G VYK N G+ A+K I ++ E EG+PS I +S+LKEL+H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
IV+L DV+ T + + LVFE+LD DL + K
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK 103
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-12
Identities = 28/51 (54%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
Y+AP+ + S YST D+W+VGCIFAEMV+G PLFP G D L I R
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLMRIFR 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-33
Identities = 43/103 (41%), Positives = 65/103 (63%), Gaps = 1/103 (0%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+K +EK+G G + VYK LN TG VA+K + + +E EG PS I +SL+KEL+H+N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHEN 64
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKE 144
IVRL DV+ T + LVFE++D DL ++ T+ + ++
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
Y+AP+ + S YST D+W+ GCI AEM++GKPLFP G ++ L LI
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP-GTNDEEQLKLIFD 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 42/102 (41%), Positives = 63/102 (61%), Gaps = 1/102 (0%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ +EK+G+G +G VYK + G+ VA+K I + E EG+PS I +SLLKEL H N
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
IV L+DV+ + R + LVFE+++ DL + ++ IK
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIK 122
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-13
Identities = 26/51 (50%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
Y+AP+ + S YST D+W++GCIFAEM++GKPLFP G D L I
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP-GVTDDDQLPKIFS 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 37/110 (33%), Positives = 63/110 (57%), Gaps = 8/110 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + KIGQG FGEV+K + +TG+KVA+K + ++NE EG P + + +L+ L+H+N
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 102 IVRLLDVLTTGRY--------VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
+V L+++ T +YLVF++ + DL + + IK
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-11
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
Y+ PE + Y P D+W GCI AEM + P+ G + L+LI +
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQLALISQ 243
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 66/216 (30%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
+Y++V K+G+G + EV++ +N+ +KV +K++ + + + + +L+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 91
Query: 101 NIVRLLDVLT--TGRYVYLVFEYLDL-DLGSFIRKHTITSIR------------------ 139
NI+ L D++ R LVFE+++ D + T IR
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGI 151
Query: 140 ------PH----------IK-------EVGSP------------YKAPESRIRSSVYSTP 164
PH ++ E P +K PE + +Y
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 211
Query: 165 HDVWAVGCIFAEMVSGK-PLFPCGK--KDHLSLIVR 197
D+W++GC+ A M+ K P F G D L I +
Sbjct: 212 LDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAK 246
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-29
Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 70/224 (31%)
Query: 30 NGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIA 89
N Q VK Y ++++IG G +V++ LN E + AIK +N++
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 90 GVSLLKELEH--DNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH---TITSIRPHIKE 144
++ L +L+ D I+RL D T +Y+Y+V E ++DL S+++K + + K
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 145 -----------------------------------------------------VGSP-YK 150
VG+ Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 151 APE----------SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
PE + S S DVW++GCI M GK F
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 47/217 (21%), Positives = 78/217 (35%), Gaps = 70/217 (32%)
Query: 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
VK Y ++++IG G +V++ LN E + AIK +N++ ++ L +
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 97 LEH--DNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH---TITSIRPHIKEV------ 145
L+ D I+RL D T +Y+Y+V E ++DL S+++K + + K +
Sbjct: 64 LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 146 -----------------------------------------------GSP-YKAPE---- 153
G+ Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 154 ------SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
+ S S DVW++GCI M GK F
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 70/227 (30%)
Query: 27 KKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY 86
K ++ + + VK Y ++++IG G +V++ LN E + AIK +N++
Sbjct: 42 KASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDS 100
Query: 87 LIAGVSLLKELEH--DNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH---TITSIRPH 141
++ L +L+ D I+RL D T +Y+Y+V E ++DL S+++K + +
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSY 160
Query: 142 IKEV-----------------------------------------------------GSP 148
K + G+
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 149 -YKAPE----------SRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
Y PE + S S DVW++GCI M GK F
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 28 KTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPS 85
K S + E+V+D K+G+G +G VYK + K A+K I E G+
Sbjct: 8 KVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISM 63
Query: 86 YLIAGVSLLKELEHDNIVRLLDVLT--TGRYVYLVFEYLDLDLGSFIRKH 133
++LL+EL+H N++ L V R V+L+F+Y + DL I+ H
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH 113
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 4e-12
Identities = 17/38 (44%), Positives = 28/38 (73%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186
Y+APE + + Y+ D+WA+GCIFAE+++ +P+F C
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-23
Identities = 50/233 (21%), Positives = 94/233 (40%), Gaps = 76/233 (32%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VSLLKEL-E 98
Y+V++ IG+G FG+V K + + + VA+KM+ + + +L+ L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRK 152
Query: 99 HD-----NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH-----TITSIR--------- 139
D N++ +L+ T ++ + FE L ++L I+K+ ++ +R
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 140 --------------------------PHIK-----------EVGSPY------KAPESRI 156
IK + Y +APE I
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEV-I 271
Query: 157 RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVRYFTALTNYLV 207
+ Y P D+W++GCI AE+++G PL P G+ D L+ ++ + L+
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGYPLLP-GEDEGDQLACMIELLGMPSQKLL 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-22
Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 6/107 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y++ IG G +G V + + + VAIK I E ++ +++L L HD+
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 102 IVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
+V++LD++ +Y+V E D D R + HIK
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-HIK 159
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-10
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 11/48 (22%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-----------GKPLFP 185
Y+APE + Y+ DVW++GCIFAE+++ PLFP
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP 296
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 29/127 (22%), Positives = 53/127 (41%), Gaps = 16/127 (12%)
Query: 26 VKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPS 85
V T G + +Y + IG G FG VY+ ++G+ VAIK + +
Sbjct: 40 VVATPGQGPDRPQ-EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE- 97
Query: 86 YLIAGVSLLKELEHDNIVRLLDVLTTGR------YVYLVFEYLDLDLGSFIRKHTITSIR 139
+ ++++L+H NIVRL + Y+ LV +Y+ + R ++
Sbjct: 98 -----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 152
Query: 140 ---PHIK 143
++K
Sbjct: 153 LPVIYVK 159
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-14
Identities = 20/51 (39%), Positives = 33/51 (64%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE ++ Y++ DVW+ GC+ AE++ G+P+FP G D L I++
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP-GDSGVDQLVEIIK 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 1/93 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y ++KIG+G FG+ + E G++ IK INI V++L ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
IV+ + +Y+V +Y + DL I
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 14/41 (34%), Positives = 24/41 (58%), Gaps = 2/41 (4%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
+G+P Y +PE + Y+ D+WA+GC+ E+ + K F
Sbjct: 186 IGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAF 225
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-20
Identities = 26/129 (20%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 24 KVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV 83
KV+K + + ++ Y + IG G FG V++ +E+ +VAIK + +
Sbjct: 23 KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR 81
Query: 84 PSYLIAGVSLLKELEHDNIVRLLDVLTTG------RYVYLVFEYLDLDLGSFIRKHTITS 137
+ +++ ++H N+V L + ++ LV EY+ + R +
Sbjct: 82 E------LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 138 IR---PHIK 143
IK
Sbjct: 136 QTMPMLLIK 144
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-14
Identities = 21/51 (41%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE ++ Y+T D+W+ GC+ AE++ G+PLFP G+ D L I++
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP-GESGIDQLVEIIK 256
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-19
Identities = 37/200 (18%), Positives = 65/200 (32%), Gaps = 60/200 (30%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
K +IG+G F VYK L+ ET +VA + + + +LK L+H NI
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 103 VRLL----DVLTTGRYVYLVFEYLDL-DLGSFIRKH---TITSIRPHIKEV--GSPY--- 149
VR + + + LV E + L +++++ I +R +++ G +
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 150 --------------------------------KAPESRIRSSVYSTPH------------ 165
+ +V TP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYD 207
Query: 166 ---DVWAVGCIFAEMVSGKP 182
DV+A G EM + +
Sbjct: 208 ESVDVYAFGMCMLEMATSEY 227
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-19
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLL 94
M + +Y+V+ IG G +G K GK + K ++ + E L++ V+LL
Sbjct: 1 MPSRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 95 KELEHDNIVRLLD--VLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+EL+H NIVR D + T +Y+V EY + DL S I K
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 101
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-05
Identities = 14/41 (34%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
VG+P Y +PE ++ Y+ D+W++GC+ E+ + P F
Sbjct: 177 VGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-19
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 7/110 (6%)
Query: 26 VKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVP 84
++ G + +++ +KIG+G F EVY+ L G VA+K + I +
Sbjct: 22 LRPDMGYNTLAN-----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR 76
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ I + LLK+L H N+++ + +V E D DL I+
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF 126
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-08
Identities = 19/54 (35%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 145 VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
VG+P Y +PE RI + Y+ D+W++GC+ EM + + F K + SL +
Sbjct: 197 VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-19
Identities = 44/250 (17%), Positives = 84/250 (33%), Gaps = 92/250 (36%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VS 92
E KD Y +V K+G G F V+ ++ VA+K++ G Y A +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV------RGDKVYTEAAEDEIK 67
Query: 93 LLKEL-----------EHDNIVRLLDVLT----TGRYVYLVFEYLDLDLGSFIRKH---- 133
LL+ + ++I++LLD G +V +VFE L +L + I+K+
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 127
Query: 134 -TITSIRP-------------------H-------IKEVGSPYKAPESRIR-----SSVY 161
+ ++ H + +I+ ++ +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 162 STPH-------------------------DVWAVGCIFAEMVSGKPLFPCGK-------K 189
H D+W+ C+ E+++G LF +
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 190 DHLSLIVRYF 199
DH++ I+
Sbjct: 248 DHIAQIIELL 257
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-18
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
+ + + + + +GQG V++ + +TG AIK+ N + V + +LK
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLK 62
Query: 96 ELEHDNIVRLLDVL--TTGRYVYLVFEYLDL-DLGSFIRKH 133
+L H NIV+L + TT R+ L+ E+ L + + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-18
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 12/98 (12%)
Query: 27 KKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP--EGVP 84
K + + W ++G+G FGEV++ + +TG + A+K + ++ E
Sbjct: 45 KLKPVDYEYREEVHW-MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--- 100
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
+ L IV L + G +V + E L
Sbjct: 101 ------LVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 9/39 (23%), Positives = 16/39 (41%), Gaps = 2/39 (5%)
Query: 145 VGSPY-KAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
G+ APE + D+W+ C+ M++G
Sbjct: 217 PGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-18
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
+ + + + + +GQG V++ + +TG AIK+ N + V + +LK
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLK 62
Query: 96 ELEHDNIVRLLDVL--TTGRYVYLVFEYLDL-DLGSFIRKH 133
+L H NIV+L + TT R+ L+ E+ L + + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-18
Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 21/99 (21%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---------IQNEPEG 82
S Q ++ + +E +G G F EV+ TGK A+K I ++NE
Sbjct: 1 SMQTTNIRK-TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE--- 56
Query: 83 VPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+++LK+++H+NIV L D+ + + YLV +
Sbjct: 57 --------IAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-18
Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 20/133 (15%)
Query: 24 KVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV 83
+ E+ K D ++V GQG FG V TG VAIK + IQ+
Sbjct: 7 SLNAAAAADERSRKEMD-RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQD----- 59
Query: 84 PSYLIAGVSLLKEL---EHDNIVRLLDVLTTGR-------YVYLVFEYLDLDLGSFIRKH 133
P + + ++++L H NIV+L T Y+ +V EY+ L R +
Sbjct: 60 PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 134 TITSIR---PHIK 143
+ IK
Sbjct: 120 YRRQVAPPPILIK 132
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-13
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE + Y+T D+W+VGCIFAEM+ G+P+F G L IVR
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR-GDNSAGQLHEIVR 246
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-18
Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 24/114 (21%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI-QNEP-------EGVPSYLIAGVSLL 94
+++ +G+G +G V + TG+ VAIK I E + +L
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE---------IKIL 63
Query: 95 KELEHDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
K +H+NI+ + ++ + VY++ E + DL I ++ HI+
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQ 115
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-13
Identities = 22/50 (44%), Positives = 31/50 (62%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + S+ YS DVW+ GCI AE+ +P+FP G+ + L LI
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP-GRDYRHQLLLIF 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-18
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGV 91
+ +++ Y + IGQG +G V + +T AIK++N I+ + V
Sbjct: 21 LLELQK-KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
L+K+L H NI RL +V +Y+ LV E
Sbjct: 80 RLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-18
Identities = 28/84 (33%), Positives = 50/84 (59%), Gaps = 3/84 (3%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELEH 99
Y++ E IG+G F V +C+N ETG++ A+K+++ + P L S+ L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLD 123
+IV LL+ ++ +Y+VFE++D
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMD 109
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-17
Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 1/86 (1%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
K D NY V E++G+G F V +C++ TG + A K+IN + L + +
Sbjct: 2 TKFSD-NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 96 ELEHDNIVRLLDVLTTGRYVYLVFEY 121
+L+H NIVRL D + + YLVF+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDL 86
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 27/122 (22%), Positives = 54/122 (44%), Gaps = 32/122 (26%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-------EGVPSYLIAGVSLLK 95
Y ++ +G G G V+ ++ + K+VAIK I + + E + +++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE---------IKIIR 63
Query: 96 ELEHDNIVRLLDVLT--------------TGRYVYLVFEYLDLDLGSFIRKHTITSIRPH 141
L+HDNIV++ ++L VY+V EY++ DL + + + + H
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--H 121
Query: 142 IK 143
+
Sbjct: 122 AR 123
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-13
Identities = 20/50 (40%), Positives = 31/50 (62%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y++P + + Y+ D+WA GCIFAEM++GK LF G + + LI+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLIL 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 23/90 (25%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV 91
+ + + Y++ E++G+G F V +C+ + G++ A +IN + L
Sbjct: 3 TITCTRFTE-EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ + L+H NIVRL D ++ + YL+F+
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDL 91
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 1/90 (1%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV 91
+ + + + Y+ V+K+G G +GEV C + T + AIK+I + S L+ V
Sbjct: 29 TSKKGHLSE-MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
++LK L+H NI++L D R YLV E
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 2e-17
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 8/99 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++ E++G G FG V + ++ +TG++VAIK + P+ + ++K+L H N
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPN 73
Query: 102 IVRLLDV------LTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V +V L L EY + DL ++ +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-17
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV 91
+ + +KV+D Y + E++G G F V KC TG + A K I + +
Sbjct: 4 TFKQQKVED-FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 92 ----SLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
S+L+++ H NI+ L DV V L+ E +
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 34/219 (15%), Positives = 63/219 (28%), Gaps = 81/219 (36%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---------IQNEPEGVP 84
+ + V D +Y + E++G G FG V++ TG A K + ++ E
Sbjct: 151 KHDHVLD-HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE----- 204
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV---------FEYLDLDLGSFIRKHTI 135
+ + L H +V L D + ++ FE + + +
Sbjct: 205 ------IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 258
Query: 136 TSIR-------------------------------PHIK------------------EVG 146
+R +K G
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 147 SP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
+ + APE D+W+VG + ++SG F
Sbjct: 319 TAEFAAPEV-AEGKPVGYYTDMWSVGVLSYILLSGLSPF 356
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 1/89 (1%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVS 92
K D NY V E++G+G F V +C++ TG + A K+IN + L
Sbjct: 22 NASTKFSD-NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 80
Query: 93 LLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ ++L+H NIVRL D + + YLVF+
Sbjct: 81 ICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-17
Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y +V +G+G FGEV KC + T ++ A+K+IN + S ++ V LLK+L+H N
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 102 IVRLLDVLTTGRYVYLVFEYL 122
I++L ++L Y+V E
Sbjct: 83 IMKLFEILEDSSSFYIVGELY 103
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-17
Identities = 19/81 (23%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
KIG+G G V +G++VA+KM++++ + L V ++++ +H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNV 104
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V + G ++++ E+L
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQ 125
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-17
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
+ +EKIG G FG V+KC+ G AIK + V L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++VR ++ + EY + L I ++
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN 105
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 9/45 (20%), Positives = 16/45 (35%), Gaps = 1/45 (2%)
Query: 144 EVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187
E G + A E + + D++A+ +PL G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-17
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIA 89
GS+ +VK +Y + + +G G FG+V + TG KVA+K++N Q V +
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 90 GVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ LK H +I++L V++T ++V EY
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-17
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI-------QNEPEGV 83
GS + NY+ E +G+GV V +C++ T K+ A+K+I++ E + +
Sbjct: 8 GSHSTHGFYE-NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 84 PSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEY 121
+ V +L+++ H NI++L D T + +LVF+
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-17
Identities = 21/93 (22%), Positives = 39/93 (41%), Gaps = 1/93 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
+++ + ++G G +GEV+K + E G+ A+K + +A V +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
VRL G +YL E L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAW 150
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 14/49 (28%), Positives = 21/49 (42%), Gaps = 3/49 (6%)
Query: 144 EVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191
+ G P Y APE + Y T DV+++G E+ L G+
Sbjct: 216 QEGDPRYMAPE--LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ 262
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-17
Identities = 25/108 (23%), Positives = 46/108 (42%), Gaps = 21/108 (19%)
Query: 23 YKVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN------- 75
+K + V D Y ++E++G G FG V++C+ TG+ K IN
Sbjct: 34 WKKYVPQPVEVKQGSVYD-YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92
Query: 76 --IQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
++NE +S++ +L H ++ L D + L+ E+
Sbjct: 93 YTVKNE-----------ISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-17
Identities = 30/81 (37%), Positives = 50/81 (61%), Gaps = 2/81 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y EKIGQG G VY +++ TG++VAI+ +N+Q +P+ +I + +++E ++ NI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNI 79
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V LD G +++V EYL
Sbjct: 80 VNYLDSYLVGDELWVVMEYLA 100
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-17
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV---- 91
+KV+D Y + E++G G F V KC TG + A K I + +
Sbjct: 8 QKVED-FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
S+L+++ H N++ L DV V L+ E
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILEL 96
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-17
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 27 KKTNGSEQMEKVKDWN--YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVP 84
++G E + + Y +V +G+G FGEV KC + T ++ A+K+IN +
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
S ++ V LLK+L+H NI++L ++L Y+V E
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-17
Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+++V ++G G FG+VYK N ETG A K+I ++E E I + +L +H I
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDHPYI 78
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
V+LL ++++ E+
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCP 99
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-16
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 5/93 (5%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV-- 91
+ E V D Y E++G G F V KC TG + A K I + +
Sbjct: 5 RQENVDD-YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 92 --SLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
S+LKE++H N++ L +V V L+ E +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELV 96
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-16
Identities = 24/101 (23%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 26 VKKTNGSEQMEKVKDWNYKVVEK-----IGQGVFGEVYKCLNLETGKKVAIKMINIQNEP 80
++ T + + +++Y+ E +G+G +G VY +L ++AIK I ++
Sbjct: 2 MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR 61
Query: 81 EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
P L ++L K L+H NIV+ L + ++ + E
Sbjct: 62 YSQP--LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 15/41 (36%), Positives = 20/41 (48%), Gaps = 4/41 (9%)
Query: 145 VGSPY-KAPESRIRSSV--YSTPHDVWAVGCIFAEMVSGKP 182
G+ APE I Y D+W++GC EM +GKP
Sbjct: 184 TGTLQYMAPEI-IDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-16
Identities = 19/94 (20%), Positives = 42/94 (44%), Gaps = 20/94 (21%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--------IQNEPEGVPSYL 87
+++ + Y + E +G+G FG V++C+ + K K + ++ E
Sbjct: 1 KELYE-KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE-------- 51
Query: 88 IAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+S+L H NI+ L + + + ++FE+
Sbjct: 52 ---ISILNIARHRNILHLHESFESMEELVMIFEF 82
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-16
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV----SLLKEL 97
+Y++ E++G G F V KC TGK+ A K I + + ++L+E+
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEY 121
H NI+ L D+ V L+ E
Sbjct: 66 RHPNIITLHDIFENKTDVVLILEL 89
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-16
Identities = 21/81 (25%), Positives = 35/81 (43%), Gaps = 1/81 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG-VSLLKELEHDN 101
+ + +IG G FG VY ++ + VAIK ++ + I V L++L H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 102 IVRLLDVLTTGRYVYLVFEYL 122
++ +LV EY
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC 136
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 24/115 (20%), Positives = 49/115 (42%), Gaps = 24/115 (20%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN-IQNEP-------EGVPSYLIAGVSL 93
Y + IG+G +G V + +VAIK I+ +++ E + +
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE---------IKI 78
Query: 94 LKELEHDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
L H+NI+ + D++ VY+V + ++ DL ++ +++ HI
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HIC 131
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-13
Identities = 24/50 (48%), Positives = 34/50 (68%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + S Y+ D+W+VGCI AEM+S +P+FP GK D L+ I+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-GKHYLDQLNHIL 245
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 23/105 (21%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVS 92
NY + IG+G +G VY + T K VAIK +N ++ E ++
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE---------IT 77
Query: 93 LLKELEHDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRK 132
+L L+ D I+RL D++ +Y+V E D DL +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-09
Identities = 17/48 (35%), Positives = 25/48 (52%), Gaps = 11/48 (22%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-----------KPLFP 185
Y+APE + Y+ D+W+ GCIFAE+++ PLFP
Sbjct: 217 YRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-16
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++ +V+ +G+G +GEV +N T + VA+K+++++ + P + + + K L H+N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHEN 66
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
+V+ G YL EY
Sbjct: 67 VVKFYGHRREGNIQYLFLEY 86
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-16
Identities = 26/100 (26%), Positives = 39/100 (39%), Gaps = 8/100 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV----SLLKEL 97
Y+V +G G FG VY + + VAIK + + V LLK++
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 98 EHD--NIVRLLDVLTTGRYVYLVFEYLDL--DLGSFIRKH 133
++RLLD L+ E + DL FI +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 35 MEKVKDW--NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGV 91
M K Y + E +G+G FG+V + +T +KVA+K I+ Q + + + +
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
S LK L H +I++L DV+TT + +V EY +L +I +
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK 102
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++ +V+ +G+G +GEV +N T + VA+K+++++ + P + + + K L H+N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHEN 66
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
+V+ G YL EY
Sbjct: 67 VVKFYGHRREGNIQYLFLEY 86
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG-V 91
D YK +G+G FGEV C + TG++ A+K+I+ + + + V
Sbjct: 19 HSTAIFSD-RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
LLK+L+H NI++L + Y YLV E
Sbjct: 78 QLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-16
Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 23/120 (19%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG 90
G+ ++K ++K +E IG G FG+V+K + GK IK + NE
Sbjct: 1 GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAERE 54
Query: 91 VSLLKELEHDNIVRLLD----------------VLTTGRYVYLVFEYLDL-DLGSFIRKH 133
V L +L+H NIV + + +++ E+ D L +I K
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-16
Identities = 21/87 (24%), Positives = 44/87 (50%), Gaps = 7/87 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI------QNEPEGVPSYLIAGVSLLK 95
Y + IG+GV V +C++ TG + A+K++ + + E V +L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 96 EL-EHDNIVRLLDVLTTGRYVYLVFEY 121
++ H +I+ L+D + +++LVF+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDL 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-16
Identities = 25/137 (18%), Positives = 50/137 (36%), Gaps = 44/137 (32%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
+ Y + + +G G FG V + ++E+GK+ A+K + P Y + ++K
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMK 55
Query: 96 ELEHDNIVRLLDVLTTG--------------------------------------RYVYL 117
L+H NI++L+D T +Y+ +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 118 VFEYLDLDLGSFIRKHT 134
+ EY+ L ++
Sbjct: 116 IMEYVPDTLHKVLKSFI 132
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-12
Identities = 20/51 (39%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK--DHLSLIVR 197
Y+APE + ++ Y+ D+W++GC+F E++ GKPLF G+ D L I++
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS-GETSIDQLVRIIQ 256
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-16
Identities = 17/83 (20%), Positives = 36/83 (43%), Gaps = 2/83 (2%)
Query: 43 YKVVEKIGQGV--FGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
Y+++ IG+G V TG+ V ++ IN++ + ++L + + K H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 101 NIVRLLDVLTTGRYVYLVFEYLD 123
NIV +++V ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMA 109
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-16
Identities = 22/82 (26%), Positives = 49/82 (59%), Gaps = 4/82 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ V+EK+G+G +G VYK ++ ETG+ VAIK + ++++ + + I +S++++ + +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSPH 85
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+ +++V EY
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCG 107
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-16
Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 8/105 (7%)
Query: 23 YKVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG 82
+ + + S + ++D Y + + +G G GEV +T KKVAI++I+ + G
Sbjct: 118 FFDLTVDDQSVYPKALRD-EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 83 VPSYLIAG------VSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ +LK+L H I+++ + Y+V E
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLEL 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-16
Identities = 21/81 (25%), Positives = 45/81 (55%), Gaps = 1/81 (1%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ +EKIG+G FGEV+K ++ T K VAIK+I+++ + + + +++L + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 82
Query: 103 VRLLDVLTTGRYVYLVFEYLD 123
+ ++++ EYL
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLG 103
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-16
Identities = 29/80 (36%), Positives = 49/80 (61%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
NY++++ IG+G F +V ++ TG++VAIK+I+ L V ++K L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 102 IVRLLDVLTTGRYVYLVFEY 121
IV+L +V+ T + +YL+ EY
Sbjct: 76 IVKLFEVIETEKTLYLIMEY 95
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-16
Identities = 25/103 (24%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K + +G+G FG+V N TG+ VA+K + + S + +L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYH 92
Query: 100 DNIVRLLDVLTTGRY--VYLVFEYLDL-DLGSFIRKHTITSIR 139
++I++ + LV EY+ L L ++ +H+I +
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ 135
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-16
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 3/97 (3%)
Query: 27 KKTNGSEQMEKVKDWN--YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVP 84
++G E + + + K+G G FG+V+ +G + IK IN +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 85 SYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ A + +LK L+H NI+++ +V +Y+V E
Sbjct: 66 Q-IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 23/113 (20%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVSL 93
Y++V+K+G+G +G V+K ++ TG+ VA+K I QN E + +
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE---------IMI 61
Query: 94 LKEL-EHDNIVRLLDVLTTGRY--VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
L EL H+NIV LL+VL VYLVF+Y++ DL + IR + + + H +
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV--HKQ 112
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 20/50 (40%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + S+ Y+ D+W++GCI E++ GKP+FP G + L I+
Sbjct: 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP-GSSTMNQLERII 244
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-16
Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 15/122 (12%)
Query: 16 KKVKDCCYKVVKKTNGS---EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIK 72
++ ++ + G ++ K+ + +Y V K+G G +GEV C + AIK
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGE-SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 73 MIN---IQNEPEGVPSYLIAG--------VSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+I + I +SLLK L+H NI++L DV +Y YLV E+
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 122 LD 123
+
Sbjct: 128 YE 129
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-16
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAG---VSLLK 95
Y + +G G FG V+ ++ E K+V +K I + + L +++L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 96 ELEHDNIVRLLDVLTTGRYVYLVFEYLD--LDLGSFIRKH 133
+EH NI+++LD+ + LV E LDL +FI +H
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-16
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 8/96 (8%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN------IQNEPEGVPS 85
S + ++D Y + + +G G GEV +T KKVAIK+I+
Sbjct: 2 SVYPKALRD-EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 86 YLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ + +LK+L H I+++ + Y+V E
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLEL 95
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-16
Identities = 19/102 (18%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ + +Y ++K+G+G F V L G A+K I + + + +
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRL 82
Query: 97 LEHDNIVRLLDV----LTTGRYVYLVFEYLDL-DLGSFIRKH 133
H NI+RL+ +L+ + L + I +
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-16
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 10/102 (9%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV----SLLKEL 97
Y++ +G+G FG V+ L +VAIK+I P +LL ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 98 ----EHDNIVRLLDVLTTGRYVYLVFEYLD--LDLGSFIRKH 133
H ++RLLD T LV E DL +I +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-16
Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 21/96 (21%)
Query: 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---------IQNEPEGVPS 85
+ Y + IG+G +GEV + T + A K I + E
Sbjct: 4 KGDINQ-YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQE------ 56
Query: 86 YLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ ++K L+H NI+RL + +YLV E
Sbjct: 57 -----IEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-16
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 16/95 (16%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN-----IQNEPEGVPSYL 87
+ D Y+V E IG G + +C++ T + A+K+I+ E E
Sbjct: 15 RNSIQFTD-GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE------ 67
Query: 88 IAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
LL+ +H NI+ L DV G+YVY+V E +
Sbjct: 68 ----ILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-15
Identities = 25/106 (23%), Positives = 41/106 (38%), Gaps = 17/106 (16%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++ + +GQG FG+V K N + AIK I E S +++ V LL L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQY 63
Query: 102 IVRLLDV-------------LTTGRYVYLVFEYLD-LDLGSFIRKH 133
+VR + +++ EY + L I
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-15
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ IG G FGEVYK L +GK VAIK + E + ++ + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSH 105
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NI+RL V++ + + ++ EY++ L F+R+
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-15
Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSL 93
+ + D ++V ++G+G VY+C T K A+K++ + + V + + +
Sbjct: 47 NRDALSD-FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGV 101
Query: 94 LKELEHDNIVRLLDVLTTGRYVYLVFEY 121
L L H NI++L ++ T + LV E
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLEL 129
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-15
Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
+Y + + +G G FG+V + TG KVA+K++N Q V + + LK H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 101 NIVRLLDVLTTGRYVYLVFEY 121
+I++L V++T +++V EY
Sbjct: 77 HIIKLYQVISTPSDIFMVMEY 97
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-15
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 19/88 (21%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--------IQNEPEGVPSYLIAGVSL 93
Y V+ IG G FG + T + VA+K I +Q E +
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE-----------IIN 69
Query: 94 LKELEHDNIVRLLDVLTTGRYVYLVFEY 121
+ L H NIVR +V+ T ++ ++ EY
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEY 97
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-15
Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 13/119 (10%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ ++G+G FG+V+ NL + VA+K + +E LL L+
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTMLQ 101
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPESRI 156
H +IVR V T GR + +VFEY+ DL F+R H P K + +
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-----GPDAKLLAGGEDVAPGPL 155
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-15
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 23/103 (22%)
Query: 32 SEQMEKVKDWNYKV--VEKIGQGVFGEVYKCLNLETGKKVAIKMIN---------IQNEP 80
+ + V Y V E +G G FG+V+KC TG K+A K+I ++NE
Sbjct: 79 TAKQGAVNS-FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE- 136
Query: 81 EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123
+S++ +L+H N+++L D + + LV EY+D
Sbjct: 137 ----------ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-15
Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y++ E IG G V +KVAIK IN++ + L+ + + + H N
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPN 74
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
IV ++LV + L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLS 96
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-15
Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ ++G+G FG+V+ NL K VA+K + LL L+
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQ 75
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H++IV+ V G + +VFEY+ DL F+R H
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-15
Identities = 25/85 (29%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELE 98
Y + + +G+G +G+V + L+ ET + A+K++ ++ P G + + + LL+ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLR 64
Query: 99 HDNIVRLLDVLT--TGRYVYLVFEY 121
H N+++L+DVL + +Y+V EY
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEY 89
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-15
Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K + +G+G FG+V C TG++VA+K + + L + +L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYH 82
Query: 100 DNIVRLLDVLTT--GRYVYLVFEYLDL-DLGSFIRKH 133
+NIV+ + T G + L+ E+L L ++ K+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-15
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
+ + +G G FGEV L L + K+ VAIK + + + +L S++ + +H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHP 106
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NI+RL V+T + V +V EY++ L SF+RKH
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-15
Identities = 24/93 (25%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
+ K+G G +GEVY+ + + VA+K + E + +++KE++H N
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V+LL V T Y++ E++ +L ++R+
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-15
Identities = 29/115 (25%), Positives = 39/115 (33%), Gaps = 15/115 (13%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVS---------L 93
Y V I G +G V ++ G VAIK + + L L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 94 LKELEHDNIVRLLDVLTTGRY-----VYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
L H NI+ L D+ +YLV E + DL I I HI+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-12
Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE ++ ++ D+W+ GC+ AEM + K LF G + L+ IV
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR-GSTFYNQLNKIV 247
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-15
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 18/87 (20%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN------IQNEPEGVPSYLIAGVSLLKE 96
+ +G+G F KC++ ++ + A+K+I+ Q E ++ LK
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE-----------ITALKL 61
Query: 97 L-EHDNIVRLLDVLTTGRYVYLVFEYL 122
H NIV+L +V + +LV E L
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELL 88
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-15
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 24/106 (22%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVS 92
Y +G G +G V ++ +G+KVAIK ++ Q+E E +
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE---------LL 75
Query: 93 LLKELEHDNIVRLLDVLT------TGRYVYLVFEYLDLDLGSFIRK 132
LLK ++H+N++ LLDV T YLV ++ DL +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-12
Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + Y+ D+W+VGCI AEM++GK LF GK D L+ I+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQIL 237
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-15
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
V++IG G FG V+ KVAIK I EG S I ++ +L H
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V+L V + LV E+++ L ++R
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ 97
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-15
Identities = 18/92 (19%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 33 EQMEKVKDWNYKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV 91
+ ME + Y + +++G+G F V +C++ TG++ A K + + + + ++ +
Sbjct: 21 QSMENFNN-FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 92 SLLKELEHD-NIVRLLDVLTTGRYVYLVFEYL 122
++L+ + ++ L +V + L+ EY
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYA 111
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-15
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
+ + IG G GEV G+ VAIK + +L + S++ + +H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHP 110
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
NI+RL V+T GR +V EY++ L +F+R H
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-15
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 9/93 (9%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
++++G G FG V VAIKMI EG S I ++ L H+
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V+L V T R ++++ EY+ L +++R+
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 7e-15
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 24/106 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVSL 93
Y+ ++ IG G G V + + VAIK ++ QN+ E + L
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE---------LVL 114
Query: 94 LKELEHDNIVRLLDVLT------TGRYVYLVFEYLDLDLGSFIRKH 133
+K + H NI+ LL+V T + VYLV E +D +L I+
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 21/50 (42%), Positives = 28/50 (56%), Gaps = 4/50 (8%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE I Y D+W+VGCI EMV K LFP G+ D + ++
Sbjct: 229 YRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHKILFP-GRDYIDQWNKVI 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-15
Identities = 24/93 (25%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
+ K+G G +GEVY+ + + VA+K + E + +++KE++H N
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPN 277
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V+LL V T Y++ E++ +L ++R+
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K + ++G+G FG V C L TG VA+K +Q+ + +LK L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHS 83
Query: 100 DNIVRLLDV--LTTGRYVYLVFEYLDL-DLGSFIRKH 133
D IV+ V + + LV EYL L F+++H
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-15
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 24/106 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVSL 93
Y+ ++ IG G G V + + VAIK ++ QN+ E + L
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE---------LVL 77
Query: 94 LKELEHDNIVRLLDVLT------TGRYVYLVFEYLDLDLGSFIRKH 133
+K + H NI+ LL+V T + VY+V E +D +L I+
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 123
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-11
Identities = 20/50 (40%), Positives = 27/50 (54%), Gaps = 4/50 (8%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE I Y D+W+VGCI EM+ G LFP G D + ++
Sbjct: 192 YRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGGVLFP-GTDHIDQWNKVI 239
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 4/82 (4%)
Query: 43 YKVVEK-IGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HD 100
Y++ E +G+G V C+NL T ++ A+K+I Q P + S + V +L + + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHR 71
Query: 101 NIVRLLDVLTTGRYVYLVFEYL 122
N++ L++ YLVFE +
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKM 93
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 12/109 (11%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELEHD 100
Y+ ++ +G G +G V ++ TG KVAIK + Q+E +Y + LLK + H+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 101 NIVRLLDVLT------TGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
N++ LLDV T YLV ++ DLG ++ + I+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED--RIQ 131
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-12
Identities = 22/50 (44%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + Y+ D+W+VGCI AEM++GK LF G D L I+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK-GSDHLDQLKEIM 239
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 35/127 (27%), Positives = 55/127 (43%), Gaps = 12/127 (9%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ V IG+G FG V++ L + VA+KM+ + + + +L+ E +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFD 108
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPESRIR 157
+ NIV+LL V G+ + L+FEY+ DL F+R PH S
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM-----SPHTVCSLSHSDLSTRARV 163
Query: 158 SSVYSTP 164
SS P
Sbjct: 164 SSPGPPP 170
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-14
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
K ++++G+G FG V C L TG+ VA+K +Q+ E + +LK L+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQH 101
Query: 100 DNIVRLLDVLTTGRY--VYLVFEYLDL-DLGSFIRKH 133
DNIV+ V + + L+ EYL L +++KH
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 138
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-14
Identities = 22/91 (24%), Positives = 43/91 (47%), Gaps = 3/91 (3%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
E +G+G FG+ K + ETG+ + +K + E + V +++ LEH N++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ + VL + + + EY+ L I+
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSM 101
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-14
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 44 KVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ ++GQG FG VY+ + E +VAIK +N + + S++KE
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFN 86
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++VRLL V++ G+ ++ E + DL S++R
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-14
Identities = 14/83 (16%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELE 98
Y +G+G F + ++ + +T + A K++ + + +S+ + L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLA 73
Query: 99 HDNIVRLLDVLTTGRYVYLVFEY 121
H ++V +V++V E
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLEL 96
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 19/114 (16%)
Query: 27 KKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN------IQNEP 80
+ + V ++ + +G G G + + + VA+K I E
Sbjct: 10 DDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADRE- 67
Query: 81 EGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
V LL+E EH N++R ++ Y+ E L ++ +
Sbjct: 68 ----------VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQK 111
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 6e-04
Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 13/67 (19%)
Query: 122 LDLDLGSFIRKHTITSIRPHIKEVGSP-YKAPE--SRIRSSVYSTPHDVWAVGCIFAEMV 178
L + SF R+ + G+ + APE S + D+++ GC+F ++
Sbjct: 173 LAVGRHSFSRRSGV---------PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223
Query: 179 S-GKPLF 184
S G F
Sbjct: 224 SEGSHPF 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 44 KVVEKIGQGVFGEVYKC----LNLETGKKVAIKMINIQNEPEGVPSY---LIAGVSLLKE 96
K ++++G+G FG V C L TG+ VA+K + + + +LK
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKS 67
Query: 97 LEHDNIVRLLDVLTTGRY--VYLVFEYLDL-DLGSFIRKH 133
L+HDNIV+ V + + L+ EYL L +++KH
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 107
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 2/91 (2%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+ E+IG+G FGEV+ VA+K P+ +L +LK+ H NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIV 175
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
RL+ V T + +Y+V E + D +F+R
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-14
Identities = 23/117 (19%), Positives = 47/117 (40%), Gaps = 15/117 (12%)
Query: 32 SEQMEKVKDW-----NYKVVEKIGQGVFGEVYKCL---NLETGKKVAIKMINIQNEPEGV 83
E EK++D + + +G+G FG V + + KVA+KM+
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 84 PSYLIAGVSLLKELEHDNIVRLLDVLTTGR------YVYLVFEYLDL-DLGSFIRKH 133
+ + +KE +H ++ +L+ V R ++ ++ DL +F+
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-14
Identities = 23/116 (19%), Positives = 48/116 (41%), Gaps = 14/116 (12%)
Query: 32 SEQMEKVKDW-----NYKVVEKIGQGVFGEVYKCL---NLETGKKVAIKMINIQNEPEGV 83
E K++D + + +G+G FG V + T KVA+K + + N +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 84 PSYLIAGVSLLKELEHDNIVRLLDVLTTGR-----YVYLVFEYLDL-DLGSFIRKH 133
++ + +K+ H N++RLL V ++ ++ DL +++
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-14
Identities = 24/93 (25%), Positives = 42/93 (45%), Gaps = 9/93 (9%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY--LIAGVSLLKELEHDN 101
+++++G G FG V + VA+KMI EG S + +L H
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+V+ V + +Y+V EY+ L +++R H
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH 97
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 14/83 (16%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELE 98
Y +G+G F + ++ + +T + A K++ + + +S+ + L
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLA 99
Query: 99 HDNIVRLLDVLTTGRYVYLVFEY 121
H ++V +V++V E
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLEL 122
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-14
Identities = 23/112 (20%), Positives = 44/112 (39%), Gaps = 14/112 (12%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++ ++ +G+G FG V++ N AIK I + N ++ V L +LEH
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPG 64
Query: 102 IVRLLDV------------LTTGRYVYLVFEYLD-LDLGSFIRKHTITSIRP 140
IVR + + Y+Y+ + +L ++ R
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 38.5 bits (90), Expect = 8e-04
Identities = 15/58 (25%), Positives = 28/58 (48%), Gaps = 7/58 (12%)
Query: 141 HIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
H +VG+ Y +PE +I + YS D++++G I E+ L+P + +
Sbjct: 187 HTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLT 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-14
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 12/107 (11%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
++ +G G FGEVY+ + +VA+K + + E + ++ +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN 91
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKE 144
H NIVR + V +++ E + DL SF+R+ RP +
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-----RPRPSQ 133
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-14
Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ +E++G+ FG+VYK G+ VAIK + + L L+
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQ 70
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H N+V LL V+T + + ++F Y DL F+
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR 106
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 4e-14
Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 1/81 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
++KV +G+G F VY+ ++ TG +VAIKMI+ + G+ + V + +L+H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 101 NIVRLLDVLTTGRYVYLVFEY 121
+I+ L + YVYLV E
Sbjct: 72 SILELYNYFEDSNYVYLVLEM 92
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-14
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 12/107 (11%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
++ +G G FGEVY+ + +VA+K + + E + ++ +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN 132
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKE 144
H NIVR + V +++ E + DL SF+R+ RP +
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-----RPRPSQ 174
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-14
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 32 SEQMEKVKDW-------NYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPE 81
S + +VKD IG+G FG VY ++ + + AIK ++ +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEM 63
Query: 82 GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-YVYLVFEYLDL-DLGSFIRKH 133
+ L++ L H N++ L+ ++ +++ Y+ DL FIR
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-14
Identities = 30/116 (25%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEP-------EGVPSYLIAGVSL 93
Y+ + +G G +G V + +TG +VA+K ++ Q+ E + L
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE---------LRL 81
Query: 94 LKELEHDNIVRLLDVLT------TGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIK 143
LK ++H+N++ LLDV T VYLV + DL + ++ +T H++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD--HVQ 135
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 22/50 (44%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIV 196
Y+APE + Y+ D+W+VGCI AE+++G+ LFP G D L LI+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLIL 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-14
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+++ IG+G FG+V G KVA+K I + +A S++ +L H N+V
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 77
Query: 104 RLLDVLTTGR-YVYLVFEYLDL-DLGSFIRKH 133
+LL V+ + +Y+V EY+ L ++R
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 109
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-14
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 21/92 (22%)
Query: 42 NYKVVEK-IGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKE 96
+YKV + +G G+ G+V + N T +K A+KM+ + E V L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----------VELHWR 110
Query: 97 L-EHDNIVRLLDV----LTTGRYVYLVFEYLD 123
+ +IVR++DV + + +V E LD
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-14
Identities = 22/88 (25%), Positives = 45/88 (51%), Gaps = 10/88 (11%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDN 101
+++VE +G G +G+VYK +++TG+ AIK++++ + E + +++LK+ H N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 102 IVRLLD------VLTTGRYVYLVFEYLD 123
I ++LV E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCG 110
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 26/106 (24%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN-----------IQNEPEGVPSYLIAG 90
Y + ++IG+G +G V N A+K+++ + P G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 91 -------------VSLLKELEHDNIVRLLDVLT--TGRYVYLVFEY 121
+++LK+L+H N+V+L++VL ++Y+VFE
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-13
Identities = 22/96 (22%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 44 KVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
+ + +G+G FG+V K VA+KM+ +N L++ ++LK++
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVN 84
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H ++++L + + L+ EY L F+R+
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-13
Identities = 21/98 (21%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGK-------KVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
E +GQG F +++K + E G +V +K+++ S++ +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSESFFEAASMMSK 68
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
L H ++V V G LV E++ L ++++K+
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-13
Identities = 20/90 (22%), Positives = 41/90 (45%), Gaps = 19/90 (21%)
Query: 43 YKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKEL 97
Y++ + +G GV G+V +C + TG+K A+K++ + E + +
Sbjct: 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD----------HHWQAS 79
Query: 98 EHDNIVRLLDV----LTTGRYVYLVFEYLD 123
+IV +LDV R + ++ E ++
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECME 109
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 25/105 (23%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIA 89
+ +K+ +K ++ +G G FG VYK L + G+K VAIK + + ++
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILD 66
Query: 90 GVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++ +++ ++ RLL + T V L+ + + L ++R+H
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 7/92 (7%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDN 101
+ +G G G V G+ VA+K + I + + LL E +H N
Sbjct: 17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPN 70
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
++R TT R++Y+ E +L+L +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESK 102
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 24/99 (24%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VSLLKEL-E 98
+ V+ K+G G FG V C +++ K A+K++ + Y + +LK++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR------NIKKYTRSAKIEADILKKIQN 90
Query: 99 HD----NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
D NIV+ ++ L+FE L L I ++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRN 129
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-08
Identities = 16/66 (24%), Positives = 30/66 (45%), Gaps = 14/66 (21%)
Query: 149 YKAPESRIRSSV-----YSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVRYFTA 201
Y+APE V + D+W+ GC+ AE+ +G LF +HL+++
Sbjct: 225 YRAPE------VILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEHMEHLAMMESIIQP 277
Query: 202 LTNYLV 207
+ ++
Sbjct: 278 IPKNML 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-13
Identities = 24/81 (29%), Positives = 39/81 (48%), Gaps = 1/81 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
++++ +G+G FG VY ++ +A+K++ E GV L V + L H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 101 NIVRLLDVLTTGRYVYLVFEY 121
NI+RL VYL+ EY
Sbjct: 70 NILRLYGYFHDATRVYLILEY 90
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VSLLKEL-E 98
Y++ IG+G FG+V K + + VAIK+I ++L V LL+ + +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK------NKKAFLNQAQIEVRLLELMNK 109
Query: 99 HD-----NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
HD IV L ++ LVFE L +L +R
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 149
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 18/60 (30%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC-GKKDHLSLIVRYFTALTNYLV 207
Y++PE + Y D+W++GCI EM +G+PLF + D ++ IV +++
Sbjct: 224 YRSPEV-LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 32 SEQMEKVKDW-------NYKVVEKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPE 81
E ++ V+ E IG+G FG VY L+ K A+K +N +
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDI 67
Query: 82 GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-YVYLVFEYLDL-DLGSFIRKH 133
G S + ++K+ H N++ LL + +V Y+ DL +FIR
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 29/109 (26%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 44 KVVEKIGQGVFGEVYKCL--NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
K + IG+G FG+V K AIK + + + + +L +L H
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHP 86
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSP 148
NI+ LL Y+YL EY +L F+RK + P S
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-13
Identities = 21/94 (22%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
+ +G+G FGEVY+ G+K VA+K ++ ++ ++K L+H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+IV+L+ ++ +++ E +LG ++ ++
Sbjct: 74 HIVKLIGIIEEEP-TWIIMELYPYGELGHYLERN 106
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-13
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGK--KVAIKMINIQN-EPEGVPSYLIAGVSLLKELEH 99
+++EK+G G FG V + + +GK VA+K + I V+ + L+H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
N++RL V + +V E L L +RKH
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKH 114
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-13
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+++ IG+G FG+V G KVA+K I + +A S++ +L H N+V
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLV 249
Query: 104 RLLDVLTTGR-YVYLVFEYLDL-DLGSFIRKH 133
+LL V+ + +Y+V EY+ L ++R
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-13
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 20/89 (22%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKEL- 97
+ +G G+ G+V + N T +K A+KM+ + E V L
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----------VELHWRAS 68
Query: 98 EHDNIVRLLDV----LTTGRYVYLVFEYL 122
+ +IVR++DV + + +V E L
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECL 97
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-13
Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
+V + +G F VY+ ++ +G++ A+K + E + +I V +K+L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHP 86
Query: 101 NIVRLLD-------VLTTGRYVYLVFEYL 122
NIV+ TG+ +L+ L
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTEL 115
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-13
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 32 SEQMEKVKDW-------NYKVVEKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPE 81
E ++ V+ E IG+G FG VY L+ K A+K +N +
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDI 131
Query: 82 GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY-VYLVFEYLDL-DLGSFIRKH 133
G S + ++K+ H N++ LL + +V Y+ DL +FIR
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-13
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEH 99
+ ++ +G GVFG V+K + + G+ V IK+I + + + L+H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDH 74
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+IVRLL + + LV +YL L L +R+H
Sbjct: 75 AHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQH 108
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 14/95 (14%), Positives = 37/95 (38%), Gaps = 17/95 (17%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN-----------IQNEPEGVPSYLIAG 90
+Y+++ + QG F ++ L + K A+K N +
Sbjct: 32 DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 91 V----SLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121
++ +++++ + ++T VY+++EY
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-12
Identities = 27/101 (26%), Positives = 54/101 (53%), Gaps = 16/101 (15%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSYLIAG---VSLLKEL- 97
Y++V+ +G+G FG+V +C++ + G + VA+K++ + V Y A + +L+ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV------KNVDRYCEAARSEIQVLEHLN 69
Query: 98 EHD-----NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
D V++L+ ++ +VFE L L FI+++
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKEN 110
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 14/66 (21%)
Query: 149 YKAPESRIRSSV-----YSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVRYFTA 201
Y+APE V +S P DVW++GCI E G +FP K+HL+++ R
Sbjct: 200 YRAPE------VILALGWSQPCDVWSIGCILIEYYLGFTVFP-THDSKEHLAMMERILGP 252
Query: 202 LTNYLV 207
L +++
Sbjct: 253 LPKHMI 258
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 25/105 (23%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIA 89
+ +K+ +K ++ +G G FG VYK L + G+K VAIK + + ++
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILD 66
Query: 90 GVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++ +++ ++ RLL + T V L+ + + L ++R+H
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-12
Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 1/81 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
++ + +G+G FG VY + +A+K++ E EGV L + + L H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 101 NIVRLLDVLTTGRYVYLVFEY 121
NI+R+ + + +YL+ E+
Sbjct: 75 NILRMYNYFHDRKRIYLMLEF 95
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-12
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 8/97 (8%)
Query: 44 KVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL- 97
+ +G G FG+V + + + VA+KM+ + L++ + +L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLG 84
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H NIV LL T G ++ EY DL +F+R+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-12
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 48 KIGQGVFGEVYK-CLNLETGK-KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
++G G FG V + + + VAIK++ Q + ++ ++ +L++ IVRL
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ V + LV E L F+
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGK 103
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-12
Identities = 24/106 (22%), Positives = 47/106 (44%), Gaps = 11/106 (10%)
Query: 37 KVKDW-----NYKVVEKIGQGVFGEVYK-CLNLETGK--KVAIKMINIQNEPEGVPSYLI 88
+D+ ++ IG+G FG+V++ VAIK +L
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL- 64
Query: 89 AGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+++ +H +IV+L+ V+T V+++ E L +L SF++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVR 109
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-12
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+VE++G G FGEV+ KVA+K + + P +A +L+K+L+H +V
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLV 71
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
RL V T +Y++ EY++ L F++
Sbjct: 72 RLYAV-VTQEPIYIITEYMENGSLVDFLKTP 101
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-12
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
++ K+GQG FGEV+ +VAIK + + ++K+L H+ +V
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 325
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L V+ + +Y+V EY+ L F++
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE 355
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-12
Identities = 27/121 (22%), Positives = 50/121 (41%), Gaps = 15/121 (12%)
Query: 44 KVVEKIGQGVFGEVYKCL-------NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ + +G+G FG+V + VA+KM+ + E S L++ + ++K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKM 142
Query: 97 L-EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
+ +H NI+ LL T +Y++ EY +L ++R RP E
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-----RPPGMEYSYDINRVPE 197
Query: 155 R 155
Sbjct: 198 E 198
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-12
Identities = 27/121 (22%), Positives = 50/121 (41%), Gaps = 15/121 (12%)
Query: 44 KVVEKIGQGVFGEVYKCL-------NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ + +G+G FG+V + VA+KM+ + E S L++ + ++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKM 96
Query: 97 L-EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
+ +H NI+ LL T +Y++ EY +L ++R RP E
Sbjct: 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-----RPPGMEYSYDINRVPE 151
Query: 155 R 155
Sbjct: 152 E 152
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-12
Identities = 28/118 (23%), Positives = 52/118 (44%), Gaps = 13/118 (11%)
Query: 44 KVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL- 97
+ + +G G FG+V + + KVA+KM+ L++ + ++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLG 107
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
+H+NIV LL T G V ++ EY DL +F+R+ ++ + A +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK-----SRVLETDPAFAIANST 160
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-12
Identities = 19/102 (18%), Positives = 42/102 (41%)
Query: 31 GSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG 90
EQ + K + +IG+G +G V K ++ +G+ +A+K I + + L+
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
+++ + IV+ L ++ E + F +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY 113
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSYLIAG---VSLLKEL- 97
Y++V +G+G FG+V +CL+ GK VA+K+I V Y A +++LK++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII------RNVGKYREAARLEINVLKKIK 74
Query: 98 EHD-----NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
E D V + D ++ + FE L + F++++
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN 115
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 4/61 (6%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVRYFTALTNYL 206
Y+ PE I ++ P DVW++GCI E G LF ++HL ++ + + +++
Sbjct: 205 YRPPEV-ILELGWAQPCDVWSIGCILFEYYRGFTLFQ-THENREHLVMMEKILGPIPSHM 262
Query: 207 V 207
+
Sbjct: 263 I 263
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
++ K+GQG FGEV+ +VAIK + + ++K+L H+ +V
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 242
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L V+ + +Y+V EY+ L F++
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-11
Identities = 24/124 (19%), Positives = 45/124 (36%), Gaps = 1/124 (0%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+++ ++ +G+G FG V++ N AIK I + N + V L +LEH
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHPG 65
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVY 161
IVR + E ++ L ++S P + +++V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 162 STPH 165
Sbjct: 126 QLQP 129
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-11
Identities = 23/179 (12%), Positives = 56/179 (31%), Gaps = 44/179 (24%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ-NEPEGVPSYLIAGVSLLKELEHDN 101
Y+++ G + ++ L+ ++VA+ ++ Q P+ V ++ L ++
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 102 IVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH-------TITS---------------- 137
+ R+LDV+ T +V E++ L
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 138 --IRP---------HIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
P + + P P++ + D+ +G ++ + P
Sbjct: 153 SIDHPSRVRVSIDGDVV-LAYPATMPDANPQD-------DIRGIGASLYALLVNRWPLP 203
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-11
Identities = 20/89 (22%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 48 KIGQGVFGEVYK-CLNLETGK-KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
++G G FG V K ++ VA+K++ + + L+A +++++L++ IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ + LV E +L L +++++
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQN 111
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 25/99 (25%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 44 KVVEKIGQGVFGEVYKCL-------NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ + +G+G FG+V KVA+KM+ + E S LI+ + ++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKM 130
Query: 97 L-EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ +H NI+ LL T +Y++ EY +L +++
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 3e-11
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 48 KIGQGVFGEVYK-CLNLETGK-KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
++G G FG V + + + VAIK++ E + ++ +L++ IVRL
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ V + LV E L F+
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGK 429
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-11
Identities = 21/102 (20%), Positives = 47/102 (46%), Gaps = 14/102 (13%)
Query: 29 TNGSEQMEKVKDWNY-----KVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEP 80
S+ +++W+ ++ E IG+G FG+VY G+ +VAI++I+I+ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYH------GRWHGEVAIRLIDIERDN 69
Query: 81 EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYL 122
E V ++ H+N+V + + ++ ++
Sbjct: 70 EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 3e-11
Identities = 19/92 (20%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV 91
+++ ++KD +++ + ++G G G V+K + +G +A K+I+++ +P + + +I +
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIREL 82
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123
+L E IV + + + E++D
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 2/42 (4%)
Query: 145 VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
VG Y +PE R++ + YS D+W++G EM G+ P
Sbjct: 191 VGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 3e-11
Identities = 23/94 (24%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGK--KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
++ IG+G FG+V++ VAIK +L +++ +H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHP 451
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+IV+L+ V+T V+++ E L +L SF++
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFLQVR 484
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-11
Identities = 23/98 (23%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 44 KVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL- 97
K+ + +G+G FG+V + T + VA+KM+ + L++ + +L +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIG 88
Query: 98 EHDNIVRLLDVLTT-GRYVYLVFEYLDL-DLGSFIRKH 133
H N+V LL T G + ++ E+ +L +++R
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 126
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-11
Identities = 25/91 (27%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
K+ +K+G G FGEV+ KVA+K + +A +++K L+HD +V
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 104 RLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L V T +Y++ E++ L F++
Sbjct: 247 KLHAV-VTKEPIYIITEFMAKGSLLDFLKSD 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-11
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 44 KVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL- 97
+ + +G G FG+V +VA+KM+ + L++ + ++ +L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLG 106
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
H+NIV LL T +YL+FEY DL +++R
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG-----VSLLKELE 98
+ ++IG+G FG V+K ++ VAIK + + + V ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 99 HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI 135
H NIV+L ++ +V E++ DL +
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH 117
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-11
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 44 KVVEKIGQGVFGEVYKCL-NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ EKIG G FG V++ + G VA+K++ Q+ + + V+++K L H NI
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 103 VRLLDVLTTGRYVYLVFEYL 122
V + +T + +V EYL
Sbjct: 97 VLFMGAVTQPPNLSIVTEYL 116
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-11
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 7/97 (7%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKKVAIKMINI--QNEPEGVPSYLIAGVSLLKELEHD 100
+ E IG G FG+VY+ G +VA+K + + L L+H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT 136
NI+ L V + LV E+ L + I
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP 103
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 9e-11
Identities = 16/88 (18%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 42 NYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGV-SLLK 95
V +G+G F +VY+ + + +K +K+ N E Y+ + LK
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLK 122
Query: 96 ELEHDNIVRLLDVLTTGRYVYLVFEYLD 123
++ LV E
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYS 150
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 18/90 (20%), Positives = 37/90 (41%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ + ++G G G+V+K +TG +A+K + E L+ +LK + I
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
V+ T V++ E + ++
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKR 116
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-10
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 10/82 (12%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD 100
V ++IG G FG VYK GK VA+KM+N+ V +L++ H
Sbjct: 27 TVGQRIGSGSFGTVYK------GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 101 NIVRLLDVLTTGRYVYLVFEYL 122
NI+ + T + +V ++
Sbjct: 81 NILLFMGYSTAPQL-AIVTQWC 101
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-10
Identities = 37/210 (17%), Positives = 59/210 (28%), Gaps = 83/210 (39%)
Query: 43 YKVVEKIGQGVFGEVYKC--LNLETGKKVAIKMINIQNEPEGVPSYL-----IAGVSLLK 95
Y+V I G G +Y N+ G+ V +K + + E + +A
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLA------ 134
Query: 96 ELEHDNIVRLLDV-----LTTGRYVYLVFEYLD-LDLGSFIR-----KHTITSIRP---- 140
E+ H +IV++ + Y+V EY+ L I +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPA 194
Query: 141 ----H--------IKEVGSPYKAPE-----------------SRI--RSSVYSTPH---- 165
H +K PE SRI +Y TP
Sbjct: 195 LSYLHSIGLVYNDLK--------PENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAP 246
Query: 166 -----------DVWAVGCIFAEMVSGKPLF 184
D++ VG A + P
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTR 276
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 17/90 (18%), Positives = 40/90 (44%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ + ++G+G +G V K ++ +G+ +A+K I + L+ ++ ++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 103 VRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
V L V++ E +D L F ++
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQ 98
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 5e-10
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 5/99 (5%)
Query: 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLL 94
ME +++ KIG G FGE+Y N++T ++VAIK+ N++ + L+ +
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIY 56
Query: 95 KELE-HDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
+ L+ I + G Y LV + L L
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF 95
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-10
Identities = 24/106 (22%), Positives = 47/106 (44%), Gaps = 22/106 (20%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ------NEPEGVPSYLIAGVSLLK 95
+++E +G FG V+K + VA+K+ IQ NE E V L
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE---------VYSLP 73
Query: 96 ELEHDNIVRLLDVLTTGRYV----YLVFEYLDL-DLGSFIRKHTIT 136
++H+NI++ + G V +L+ + + L F++ + ++
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS 119
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-10
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 12/99 (12%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLI-AGVSLLKELEHDNI 102
+ E IG+G FGEV++ G++VA+K+ + + E S+ A + L H+NI
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENI 98
Query: 103 VRLLDVLTTGRYV----YLVFEYLDL-DLGSFIRKHTIT 136
+ + +LV +Y + L ++ ++T+T
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 137
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-10
Identities = 22/99 (22%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLI-AGVSLLKELEHDNI 102
++E +G+G +GEV++ G+ VA+K+ + ++E S+ + L H+NI
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE----KSWFRETELYNTVMLRHENI 64
Query: 103 VRLLDVLTTGRY----VYLVFEYLDL-DLGSFIRKHTIT 136
+ + T R+ ++L+ Y ++ L +++ T+
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD 103
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 16/147 (10%), Positives = 40/147 (27%), Gaps = 5/147 (3%)
Query: 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSY-LIAGVSLLKEL 97
+ K+VE + G V+ ++E + A+K+ + E L L
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHI----KEVGSPYKAPE 153
++ D V ++ ++
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 154 SRIRSSVYSTPHDVWAVGCIFAEMVSG 180
+ V+ + A+ + A+++
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRL 206
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-05
Identities = 7/55 (12%), Positives = 14/55 (25%), Gaps = 2/55 (3%)
Query: 145 VGSPYKAPESRIRSS--VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
AP + +S ++ + W +G + F R
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-09
Identities = 23/104 (22%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ------NEPEGVPSYLIAGVSLLKEL 97
++V++IG+G +GEV+ G+KVA+K+ E E + +
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETE---------IYQTVLM 88
Query: 98 EHDNIVRLLDVLTTGRY----VYLVFEYLDL-DLGSFIRKHTIT 136
H+NI+ + G +YL+ +Y + L +++ T+
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD 132
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-09
Identities = 13/102 (12%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 44 KVVEKIGQGVFGEVYK-CLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
+ K+ + GE++K G + +K++ +++ L+ H N+
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 103 VRLLDVLTT--GRYVYLVFEYLDL-DLGSFIRKHTITSIRPH 141
+ +L + + L+ ++ L + + + T +
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS 111
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-09
Identities = 32/102 (31%), Positives = 42/102 (41%), Gaps = 20/102 (19%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK------- 95
YK+V+K+G G VY + KVAIK I I LK
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP---------PREKEETLKRFEREVH 63
Query: 96 ---ELEHDNIVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
+L H NIV ++DV YLV EY++ L +I H
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH 105
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-09
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 15/103 (14%)
Query: 42 NYKVVEKIGQGVFGEVYKC-LNLETGKKVAIKMINIQNEPEGVPSYLI-AGVSLLKELEH 99
N K++E IG+G +G VYK L+ + VA+K+ + N +++ + + +EH
Sbjct: 14 NLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFSFANR----QNFINEKNIYRVPLMEH 66
Query: 100 DNIVRLL-----DVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT 136
DNI R + LV EY L ++ HT
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD 109
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-09
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-D 100
Y++ KIG G FG++Y ++ G++VAIK+ ++ + L + K ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGV 65
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
I + G Y +V E L L
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF 97
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-09
Identities = 27/79 (34%), Positives = 36/79 (45%), Gaps = 8/79 (10%)
Query: 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+V E +G+G FG V K K VAIK I ++E + I + L + H NIV
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIV 64
Query: 104 RLLDVLTTGRYVYLVFEYL 122
+L V LV EY
Sbjct: 65 KLYGACL--NPVCLVMEYA 81
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 23/92 (25%), Positives = 38/92 (41%), Gaps = 5/92 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-D 100
+YKV +IG+G FG +++ NL ++VAIK +++ L K L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCT 66
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK 132
I + G + LV + L L +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL 98
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 1e-08
Identities = 24/238 (10%), Positives = 51/238 (21%), Gaps = 97/238 (40%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPS---------------- 85
+GQ + + ETG+ + + P
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 86 ----------YLIAGVSLLKELEHDNIVRLLDVLTTG--RYVYLVFEYLDLDLG------ 127
I L+K+ + ++R+ + ++ + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 128 -SFIRKHTITS---------------------------IRP---------HIK------- 143
S H +RP +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 144 --------EVGSP-YKAPE----------SRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
S ++ PE R R ++ + D WA+G + +
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-D 100
N++V +KIG G FGE+ NL T + VAIK+ +++ L K+L D
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGD 65
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLDL 126
I ++ G+Y +V E L L
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSL 91
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-08
Identities = 20/127 (15%), Positives = 45/127 (35%), Gaps = 16/127 (12%)
Query: 23 YKVVKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG 82
Y + ++ ++ + + +KIG G FG +Y +K A ++ ++ + G
Sbjct: 19 YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG 78
Query: 83 VPSY------LIAGVSLLKELEHDNIVRLLDV----------LTTGRYVYLVFEYLDLDL 126
+A +K+ + L + Y ++V E L +DL
Sbjct: 79 PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL 138
Query: 127 GSFIRKH 133
++
Sbjct: 139 QKISGQN 145
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-08
Identities = 17/99 (17%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI--NIQNEPEGVP-----SYLIAGVSLLK 95
Y++ +G+G G+VY+ + + VA+K++ + ++P +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR----- 90
Query: 96 ELEHDNIVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
L+ ++V + D +Y+ ++ +DL + +R+
Sbjct: 91 -LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ 128
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-07
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 14/82 (17%)
Query: 123 DLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP 182
DL ++ KH I+ Y++ E I S Y+TP D+W+ C+ E+ +G
Sbjct: 239 DLGNACWVHKHFTEDIQTR------QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDY 291
Query: 183 LFPC-------GKKDHLSLIVR 197
LF +DH++LI+
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIE 313
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 21/105 (20%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAG---VSLLKELE- 98
Y V+ K+G G F V+ +++ K VA+K++ Y + LLK +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK------SAEHYTETALDEIRLLKSVRN 92
Query: 99 -------HDNIVRLLDVLT----TGRYVYLVFEYLDLDLGSFIRK 132
+ +V+LLD G ++ +VFE L L +I K
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK 137
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-07
Identities = 24/103 (23%), Positives = 42/103 (40%), Gaps = 18/103 (17%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI--NIQNEPEGVP-----SYLIAGVSLLK 95
Y++ E +G G EV+ +L + VA+K++ ++ +P + A
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----- 68
Query: 96 ELEHDNIVRLLDV----LTTGRYVYLVFEYLD-LDLGSFIRKH 133
L H IV + D G Y+V EY+D + L +
Sbjct: 69 -LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE 110
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-07
Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 17/82 (20%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINI------QNEPEGVPSYLIAGVSLLK 95
+ EKIG+GVFGEV++ + VAIK+I I + ++ + + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 96 ELE---------HDNIVRLLDV 108
EL + + L V
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSV 100
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-07
Identities = 22/97 (22%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 44 KVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE 98
K+ + +G+G FG+V + T + VA+KM+ + + L+
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 99 HDNIVRLLDVLTT-GRYVYLVFEYLDL-DLGSFIRKH 133
H N+V LL T G + ++ E+ +L +++R
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 22/75 (29%), Positives = 34/75 (45%), Gaps = 2/75 (2%)
Query: 48 KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD 107
+G+G FG+VYK L G VA+K + + G V ++ H N++RL
Sbjct: 37 ILGRGGFGKVYKG-RLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 108 VLTTGRYVYLVFEYL 122
T LV+ Y+
Sbjct: 95 FCMTPTERLLVYPYM 109
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-06
Identities = 10/117 (8%), Positives = 29/117 (24%), Gaps = 28/117 (23%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG-------------------- 82
+GQ + + ETG+ + + P
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 83 VPSYLIAGVSLLKE---LEHDNIVRLLDVLTTGR-----YVYLVFEYLDLDLGSFIR 131
+ + ++ +++ V R + ++ + +L +F
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-06
Identities = 24/83 (28%), Positives = 35/83 (42%), Gaps = 9/83 (10%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELE 98
N+ IG GVFG+VYK L G KVA+K Q E + L
Sbjct: 40 NFDHKFLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEE-----FETEIETLSFCR 93
Query: 99 HDNIVRLLDVLTTGRYVYLVFEY 121
H ++V L+ + L+++Y
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKY 116
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 6/78 (7%)
Query: 48 KIGQGVFGEVYK-CLNLETGKKVAIKMINIQNEPEGVPSYL--IAGVSLLKELEHDNIVR 104
K+G+G FG VYK +N VA+K + + + ++ + +H+N+V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 105 LLDVLTTGRYVYLVFEYL 122
LL + G + LV+ Y+
Sbjct: 95 LLGFSSDGDDLCLVYVYM 112
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 15/108 (13%), Positives = 32/108 (29%), Gaps = 17/108 (15%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETG--------KKVAIKM--INIQNEPE------GVPS 85
+K+ + G +Y+ T +K ++K+ + + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 86 YLIAGVSLLKELEHDNIVRLLDV-LTTGRYVYLVFEYLDLDLGSFIRK 132
+ L I + + +Y +LV L L S +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV 150
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 18/110 (16%)
Query: 42 NYKVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEP---------EGVPSYL 87
+KV IGQG FG +Y ++ + +K+ N P
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 88 IAGVSLLKELEHDNIVRL----LDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
I ++L++ + + L Y +++ + DL +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN 145
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 218 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.94 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.92 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.92 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.91 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.91 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.9 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.9 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.9 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.89 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.89 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.88 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.87 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.86 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.86 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.86 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.86 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.81 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.53 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.32 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.88 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.07 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.63 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 95.87 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 93.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 92.52 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 87.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 85.54 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 85.52 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=248.55 Aligned_cols=177 Identities=26% Similarity=0.403 Sum_probs=134.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++++.||+|+||.||+|+++.+++.||||++.+........+.+.+|+.++++++|||||++++++.+.+.+|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999999987665555678899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~------------ 145 (218)
||||++ +|.+++...... |++|.+ .+|
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 999987 999998654221 444443 233
Q ss_pred -----CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCcccc----hhhhhhhc
Q 041487 146 -----GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLV----LPCFLSIM 215 (218)
Q Consensus 146 -----g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 215 (218)
|+ .|+|||. +.+..|+.++|||||||++|+|+||+.||.+.+...+...+.....++.+.. +-+++..|
T Consensus 182 ~~~~~GT~~YmAPE~-l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEI-CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHH-HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence 32 3999995 5566799999999999999999999999998765555554444333333322 33455555
Q ss_pred c
Q 041487 216 L 216 (218)
Q Consensus 216 l 216 (218)
|
T Consensus 261 L 261 (350)
T 4b9d_A 261 F 261 (350)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=234.48 Aligned_cols=178 Identities=26% Similarity=0.362 Sum_probs=133.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999986553 345567899999999999999999999999999999999
Q ss_pred EecCCCChHHHhhhcccC---------------------------Cccccc-----------cccC--------------
Q 041487 119 FEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KEVG-------------- 146 (218)
Q Consensus 119 ~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g-------------- 146 (218)
||||+++|.+++...... |++|.+ .+||
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 999988999998765432 444443 2333
Q ss_pred --C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhhccc
Q 041487 147 --S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSIMLL 217 (218)
Q Consensus 147 --~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 217 (218)
+ .|+|||.+....+++.++||||+||++|+|+||+.||.+.+...+...+.......+ +..+-+++..||.
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 2 299999665555567899999999999999999999998766666665554322211 2233445555553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.33 Aligned_cols=179 Identities=22% Similarity=0.407 Sum_probs=139.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++++.||+|+||.||+|+++.+++.||+|++.+.. ......+.+.+|+.++++++|||||+++++|.+.+.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44678999999999999999999999999999999997643 23455788999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc-------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE------------- 144 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~------------- 144 (218)
+|||||++ +|.+++...+.. |++|.+ .+
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999998 999998765432 444432 12
Q ss_pred ------cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhh
Q 041487 145 ------VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSI 214 (218)
Q Consensus 145 ------~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 214 (218)
+|++ |+|||. +.+..|+.++||||+||++|+|+||++||.+.+...+...+.......+ +...-+++..
T Consensus 189 ~~~~~~~GTp~YmAPEv-l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPEL-LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHH-HHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHH-HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 2433 999995 4556689999999999999999999999998766555555444222111 2233355666
Q ss_pred ccc
Q 041487 215 MLL 217 (218)
Q Consensus 215 ~l~ 217 (218)
||.
T Consensus 268 lL~ 270 (311)
T 4aw0_A 268 LLV 270 (311)
T ss_dssp HSC
T ss_pred Hcc
Confidence 653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=236.30 Aligned_cols=155 Identities=25% Similarity=0.462 Sum_probs=128.0
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++|||||+++++|.+.+.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999999999999999997543 2335678999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccccc-----------ccc-----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEV----------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~----------------- 145 (218)
||++ +|.+++...... |++|.+ .+|
T Consensus 152 y~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 9998 899888764332 444433 233
Q ss_pred CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
|++ |+|||. +.+..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 232 GTp~YmAPEv-l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 232 GTPYWMAPEL-ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp SCGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cCcCcCCHHH-HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 332 999995 5566699999999999999999999999998765555555544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=237.48 Aligned_cols=174 Identities=24% Similarity=0.391 Sum_probs=136.1
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
..|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|...+.+|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 56999999999999999999999999999999997543 3345779999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccCC---------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVGS--------------- 147 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g~--------------- 147 (218)
||++ +|.+++...... |+++.+ .+||.
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 308 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 308 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence 9998 899888654332 444432 33332
Q ss_pred ---cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc------ccchhhhhhhccc
Q 041487 148 ---PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN------YLVLPCFLSIMLL 217 (218)
Q Consensus 148 ---~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~ 217 (218)
.|+|||. +.+..|+.++|||||||++|||++|++||.+.+...+...+.....+.. +..+-+++..||.
T Consensus 309 GTp~YmAPEv-l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 309 GTPYWMAPEL-ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp ECTTTCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred cCcCcCCHHH-HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 2999995 5566699999999999999999999999988765555555544322211 2233456666653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=236.76 Aligned_cols=161 Identities=22% Similarity=0.381 Sum_probs=124.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....++|++++.||+|+||.||+|++. .+++.||+|++++.........++.+|+.++++++|||||++++++.+.+
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 455678999999999999999999874 46789999999765433334456889999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc----------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE---------- 144 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~---------- 144 (218)
.+|+|||||++ +|.+++...... |++|.+ .+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999997 999998765432 444433 11
Q ss_pred -------cCCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 -------VGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 -------~g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+|++ |+|||. ..+..|+.++|||||||++|+|+||+.||.+.+...+...+..
T Consensus 180 ~~~~~~~~GT~~YmAPE~-~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp -CCCCSCCCCGGGCCHHH-HHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccccccCcccCCHHH-hccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 2333 999995 5566699999999999999999999999998866555555443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=231.63 Aligned_cols=172 Identities=25% Similarity=0.426 Sum_probs=130.7
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
+.+..++|.+.+.||+|+||.||+|++. .++..||||.++.. .....+.|.+|+.++++++|||||++++++.
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4567789999999999999999999865 35788999998642 3344678999999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhccc--------------C--------------------------Ccccc--------
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTI--------------T--------------------------SIRPH-------- 141 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~--------------~--------------------------~~~~~-------- 141 (218)
+.+.+++|||||++ +|.+++..+.. . |+++.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 99999999999987 99999876421 0 33332
Q ss_pred ---ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 142 ---IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 142 ---~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
+.+||. .|+|||.+ .+..|+.++|||||||++|||+| |+.||.+.+...+...+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 233332 39999955 45569999999999999999999 899999886666655555
Q ss_pred HhcccCcccchhh
Q 041487 198 YFTALTNYLVLPC 210 (218)
Q Consensus 198 ~~~~~~~~~~~~~ 210 (218)
....++.+...|.
T Consensus 245 ~~~~~~~p~~~~~ 257 (299)
T 4asz_A 245 QGRVLQRPRTCPQ 257 (299)
T ss_dssp HTCCCCCCTTCCH
T ss_pred cCCCCCCCccchH
Confidence 5443433333343
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=236.87 Aligned_cols=163 Identities=31% Similarity=0.536 Sum_probs=132.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------CCE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------GRY 114 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 114 (218)
++|++++.||+|+||.||+|.++.+|+.||||+++.........+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999997655444556788999999999999999999998763 367
Q ss_pred EEEEEecCCCChHHHhhhcccC---------------------------Cccccc-----------cc------------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KE------------ 144 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~------------ 144 (218)
+|+|||||+++|.+++...... |++|.+ .+
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 9999999999999988764332 444432 12
Q ss_pred ---------cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 145 ---------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 145 ---------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
+|+ .|+|||.+.+..+++.++||||+||++|+|++|++||.+. ..+.+..+.+..+.++
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 233 3999997776677899999999999999999999999987 4555666666666554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.19 Aligned_cols=177 Identities=23% Similarity=0.374 Sum_probs=133.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
..++..+++++++.||+|+||.||+|... .+++.||||.++.. ......+.|.+|+.++++++|||||++++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 34566788999999999999999999853 35789999999743 3445567899999999999999999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Cccc-----
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRP----- 140 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~----- 140 (218)
...+.+++|||||++ +|.+++...... |+++
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 999999999999987 999998543210 2222
Q ss_pred ------cccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 041487 141 ------HIKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLS 193 (218)
Q Consensus 141 ------~~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~ 193 (218)
++.+||. .|+|||.+. ++.|+.++|||||||++|||+| |+.||.+.+...+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2233332 399999654 5569999999999999999999 89999988666666
Q ss_pred HHHHHhcccCcccchhhhhh
Q 041487 194 LIVRYFTALTNYLVLPCFLS 213 (218)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~ 213 (218)
..+.....++.+...|..+.
T Consensus 258 ~~i~~~~~~~~p~~~~~~~~ 277 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCPAWVY 277 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHH
T ss_pred HHHHcCCCCCCcccchHHHH
Confidence 66655444444444444443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=223.09 Aligned_cols=155 Identities=25% Similarity=0.375 Sum_probs=122.8
Q ss_pred cce-eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe----CCEE
Q 041487 41 WNY-KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT----GRYV 115 (218)
Q Consensus 41 ~~~-~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 115 (218)
++| ++.++||+|+||.||+|.++.++..||+|.+..........+.+.+|+.++++++|||||+++++|.. ...+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 78889999999999999999999999999998665555567789999999999999999999999864 4569
Q ss_pred EEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc------------cccC-------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI------------KEVG------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~------------~~~g------- 146 (218)
|+|||||++ +|.+++...... |++|.+ .+||
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999987 999988764332 333332 2333
Q ss_pred --------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHH
Q 041487 147 --------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVR 197 (218)
Q Consensus 147 --------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~ 197 (218)
+ .|+|||.+ .+ .|+.++|||||||++|+|+||+.||... +...+...+.
T Consensus 185 ~~~~~~~GTp~YmAPE~~-~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMY-EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp TSBEESCSSCCCCCGGGG-GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CccCCcccCccccCHHHc-CC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 2 29999955 44 4899999999999999999999999765 3344444333
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=226.46 Aligned_cols=151 Identities=21% Similarity=0.362 Sum_probs=123.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+.|++.+.||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999999999999999975422 24799999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc------------ccc-------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI------------KEV------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~------------~~~------------- 145 (218)
||||++ +|.+++...... |++|.+ .+|
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999997 999998765432 333322 222
Q ss_pred ---------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 ---------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ---------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
|+ .|+|||. +.+..|+.++|||||||++|+|+||++||.+.+...+...+.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~-~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 269 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269 (336)
T ss_dssp -----CCCCCCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred ceecCCccccCccccCHHH-HCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 33 3999995 556679999999999999999999999999875554444444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=228.78 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=130.9
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
..+..++|.+.++||+|+||.||+|+.+ .++..||||.++.. .....+.|.+|+.++++++|||||+++++|.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3466788999999999999999999865 35789999998632 3344678999999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC------------------------------------------Ccccc------
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT------------------------------------------SIRPH------ 141 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~------------------------------------------~~~~~------ 141 (218)
+...+++|||||++ +|.+++..+... |+++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 99999999999997 999998654210 23332
Q ss_pred -----ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 041487 142 -----IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLI 195 (218)
Q Consensus 142 -----~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~ 195 (218)
+.+||. .|+|||. ..+..++.++|||||||++|||+| |+.||...+...+...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~-~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES-ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHH-HTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhh-hcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 233332 3999995 556669999999999999999999 8999998765555555
Q ss_pred HHHhcccCcccchhh
Q 041487 196 VRYFTALTNYLVLPC 210 (218)
Q Consensus 196 ~~~~~~~~~~~~~~~ 210 (218)
+.....++.+...|.
T Consensus 273 i~~g~~~~~p~~~~~ 287 (329)
T 4aoj_A 273 ITQGRELERPRACPP 287 (329)
T ss_dssp HHHTCCCCCCTTCCH
T ss_pred HHcCCCCCCcccccH
Confidence 544333433333333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=222.84 Aligned_cols=159 Identities=20% Similarity=0.341 Sum_probs=123.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
.+++..+++++.+.||+|+||.||+|+.+ ..||||+++.........+.|.+|+.++++++|||||++++++.. +.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 34677889999999999999999999753 469999997655555567889999999999999999999998754 56
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccCC-------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVGS------- 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g~------- 147 (218)
+++|||||++ +|.+++...... |++|. +.+||.
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 8999999997 999998654321 33332 233332
Q ss_pred -------------cccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHH
Q 041487 148 -------------PYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVR 197 (218)
Q Consensus 148 -------------~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~ 197 (218)
.|+|||.+.. ...|+.++|||||||++|||+||+.||.+.+. ..+...+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 3999997643 34589999999999999999999999987643 34444433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=217.91 Aligned_cols=166 Identities=23% Similarity=0.422 Sum_probs=125.5
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC-CCeeeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-DNIVRLLDV 108 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~ 108 (218)
..++..++|++.+.||+|+||.||+|.+... ++.||||.+.... .....+.+.+|+.++.+++| ||||+++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3457788999999999999999999997654 3579999986432 23345679999999999976 899999999
Q ss_pred EEe-CCEEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Ccccc--
Q 041487 109 LTT-GRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPH-- 141 (218)
Q Consensus 109 ~~~-~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~-- 141 (218)
|.. +..+++|||||++ +|.+++...... |+++.
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 5679999999997 999998653210 22222
Q ss_pred ---------ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-cc
Q 041487 142 ---------IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK-KD 190 (218)
Q Consensus 142 ---------~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~-~~ 190 (218)
+.+||. .|+|||.+. ++.|+.++|||||||++|||+| |+.||.+.+ .+
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 223322 399999654 5569999999999999999998 999999874 34
Q ss_pred hHHHHHHHhccc
Q 041487 191 HLSLIVRYFTAL 202 (218)
Q Consensus 191 ~~~~~~~~~~~~ 202 (218)
.+...+.....+
T Consensus 296 ~~~~~i~~g~~~ 307 (353)
T 4ase_A 296 EFCRRLKEGTRM 307 (353)
T ss_dssp HHHHHHHHTCCC
T ss_pred HHHHHHHcCCCC
Confidence 455555543333
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=229.74 Aligned_cols=152 Identities=24% Similarity=0.434 Sum_probs=121.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHH---HHHHhhCCCCCeeeeeeeEEeC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAG---VSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.+..++|++++.||+|+||.||+|+++.+|+.||+|++++... .........+| +.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 3456889999999999999999999999999999999976432 22223344444 5667778999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc--------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~-------- 145 (218)
+.+|+|||||++ +|.+++...+.. |++|.+ .+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999997 999998765432 444433 233
Q ss_pred -------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 -------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 -------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
|++ |+|||.+..+..|+.++|||||||++|+|++|++||.+.+
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 333 9999976666679999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=224.55 Aligned_cols=156 Identities=21% Similarity=0.354 Sum_probs=126.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 478999999999999999999999999999999987532 233567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccC-----------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVG----------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g----------- 146 (218)
|||++ +|.+++...... |++|.+ .+||
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 99987 999988643211 333322 2333
Q ss_pred -----C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -----S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -----~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+ .|+|||. +.+..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 314 ~~~~GT~~y~APEv-~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~ 370 (573)
T 3uto_A 314 KVTTGTAEFAAPEV-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370 (573)
T ss_dssp EEECSSGGGCCHHH-HTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred eeeEECccccCHHH-hCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence 2 2999994 5566789999999999999999999999998865555544443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=210.89 Aligned_cols=142 Identities=25% Similarity=0.463 Sum_probs=112.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-------
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR------- 113 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 113 (218)
++|++++.||+|+||.||+|.++.+++.||||.++... .....+.+.+|+.++++++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 56999999999999999999999999999999997543 3334568899999999999999999999986443
Q ss_pred -----EEEEEEecCCC-ChHHHhhhcccC------------------------------Cccccc-----------ccc-
Q 041487 114 -----YVYLVFEYLDL-DLGSFIRKHTIT------------------------------SIRPHI-----------KEV- 145 (218)
Q Consensus 114 -----~~~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~~~-----------~~~- 145 (218)
.+|+|||||++ +|.+++...... |++|.+ .+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 47999999987 999988754321 344432 222
Q ss_pred ----------------------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ----------------------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ----------------------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+ .|+|||. ..+..|+.++|||||||++|||++ ||...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~-~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CC--------------------------CCCTTSCHHH-HTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHH-HcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 33 3999995 556679999999999999999996 88653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-30 Score=210.50 Aligned_cols=158 Identities=23% Similarity=0.407 Sum_probs=124.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
.+.|++.+.||+|+||.||+|+++ .+++.||+|.+... ....++.+|+.+++.+ +||||++++++|.+.+.+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 467999999999999999999875 35788999988532 3456788999999998 699999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC------------------------Cccccc------------ccc-------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT------------------------SIRPHI------------KEV------------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~------------------------~~~~~~------------~~~------------- 145 (218)
|+|||||++ +|.+++...... |++|.+ .+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 999999986 898887542221 444432 122
Q ss_pred --------------------------------CCc-ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--Ccc
Q 041487 146 --------------------------------GSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG--KKD 190 (218)
Q Consensus 146 --------------------------------g~~-y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~--~~~ 190 (218)
|++ |+|||.+.+...|+.++||||+||++|+|++|+.||... +.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~ 255 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 333 999997766667999999999999999999999999654 445
Q ss_pred hHHHHHHHhcc
Q 041487 191 HLSLIVRYFTA 201 (218)
Q Consensus 191 ~~~~~~~~~~~ 201 (218)
.+..+...++.
T Consensus 256 ~l~~I~~~~G~ 266 (361)
T 4f9c_A 256 ALAQIMTIRGS 266 (361)
T ss_dssp HHHHHHHHHCH
T ss_pred HHHHHHHhcCC
Confidence 56666655543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-29 Score=202.39 Aligned_cols=181 Identities=27% Similarity=0.387 Sum_probs=139.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
....++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34568899999999999999999999999999999999866555555678899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------- 146 (218)
+||||+++ +|.+++...... +++|.+ .++|
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 99999976 998888654321 333322 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhhccc
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSIMLL 217 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 217 (218)
..|+|||.+......+.++|||||||++|+|++|+.||.+.+...+...+.......+ +..+.+++..||+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence 2399999766555456899999999999999999999998876666655554322211 3334455555553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=196.75 Aligned_cols=169 Identities=40% Similarity=0.694 Sum_probs=131.8
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
...+...++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 344556789999999999999999999984 5899999999765555566788999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
..++||||++++|.+++...... +++|.+ .++|
T Consensus 93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999999998888877654321 333322 2222
Q ss_pred ----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 147 ----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 147 ----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+...++.+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence 23999997766667899999999999999999999999887 5566666666655543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-28 Score=197.99 Aligned_cols=179 Identities=20% Similarity=0.301 Sum_probs=135.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++++.||+|+||.||+|.++.+++.||+|++++.. ......+.+.+|+.+++.++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34678999999999999999999999999999999997543 23445678899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------- 146 (218)
+||||+++ +|.+++...... +++|.+ .++|
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999987 888887654321 333322 2222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc---Ccccchhhhhhhcc
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL---TNYLVLPCFLSIML 216 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 216 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||...+...+...+...... ..+..+.+++..||
T Consensus 162 ~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGG-GSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccChhhCChhh-hcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 23999995 45566899999999999999999999999887666555544432211 11333445555555
Q ss_pred c
Q 041487 217 L 217 (218)
Q Consensus 217 ~ 217 (218)
.
T Consensus 241 ~ 241 (337)
T 1o6l_A 241 K 241 (337)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-28 Score=196.69 Aligned_cols=168 Identities=38% Similarity=0.637 Sum_probs=128.4
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
......++|++.+.||+|+||.||+|.+..+++.||+|+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34456788999999999999999999999999999999997665555556778899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhhhcccC---------------------------Cccccc----------------cccC-----
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI----------------KEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~----------------~~~g----- 146 (218)
+++||||++++|.+++...... ++++.+ .++|
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9999999999999888764322 333322 2222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+....+.+
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 23999997766666899999999999999999999999887 444555555554443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=197.66 Aligned_cols=159 Identities=30% Similarity=0.489 Sum_probs=128.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|.++.++..||+|++..........+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35689999999999999999999999999999999986555555567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g---------- 146 (218)
|||+.+ +|.+++...... +++|. +.++|
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 999987 888877654321 22222 22222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+..
T Consensus 187 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp CCCSCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 239999954 555689999999999999999999999988765555554443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=191.98 Aligned_cols=160 Identities=44% Similarity=0.722 Sum_probs=127.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6799999999999999999998 678999999997654444556788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccccc-----------ccc----------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEV---------------- 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~---------------- 145 (218)
|++++|.+++...... +++|.+ .++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 9998888887653211 333322 122
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcc
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTA 201 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~ 201 (218)
...|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+.+..+.
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC
Confidence 223999997666566899999999999999999999999877 33445555554443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=190.57 Aligned_cols=162 Identities=38% Similarity=0.671 Sum_probs=128.1
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||+|.++.+++.||+|.+..........+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999998766666667889999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccccc-----------cccC---------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------------- 146 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------------- 146 (218)
|+++++.+++...... ++++.+ .++|
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 9998877766542211 333322 2222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCC-CcchHHHHHHHhccc
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPL-FPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~P-f~~~-~~~~~~~~~~~~~~~ 202 (218)
..|+|||.+.....++.++|||||||++|+|++|..| |.+. ..+.+..+.+..+.+
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 2399999766666689999999999999999998777 4444 334445555544443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=200.05 Aligned_cols=141 Identities=25% Similarity=0.382 Sum_probs=104.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC----EE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR----YV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 115 (218)
..+|.+.+.||+|+||.||+|+. +|+.||||+++... ........|+..+.+++|||||++++++...+ .+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 35689999999999999999987 68999999986421 11122334555667889999999999997543 68
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------------Ccccc-----------ccccCC--
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPH-----------IKEVGS-- 147 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~-----------~~~~g~-- 147 (218)
|+|||||++ +|.+++...... |++|. +.+||.
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999986 999988654322 22332 233332
Q ss_pred --------------------cccCcccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 148 --------------------PYKAPESRIRSS-----VYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 148 --------------------~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
.|+|||.+.... .++.++|||||||++|||+||++||.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 399999664331 36679999999999999999987664
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=195.68 Aligned_cols=161 Identities=42% Similarity=0.762 Sum_probs=114.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++++.||+|+||.||+|.++.+++.||+|.++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467999999999999999999999999999999997543 3344577889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhccc-------C--------------------------Cccccc-----------cccC---------
Q 041487 120 EYLDLDLGSFIRKHTI-------T--------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~-------~--------------------------~~~~~~-----------~~~g--------- 146 (218)
||++++|.+++..... . +++|.+ .++|
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 9999999988765421 0 233221 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHHhcc
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTA 201 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~~~~ 201 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+. +.+..+....+.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 2399999766556689999999999999999999999988743 344444444443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=194.70 Aligned_cols=157 Identities=25% Similarity=0.403 Sum_probs=126.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+.|++.+.||+|+||.||+|.++.++..||+|++++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999999999999999998654322 245789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc---------------ccccC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH---------------IKEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~---------------~~~~g----- 146 (218)
+++||||+++ +|.+++...... +++|. +.++|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999975 999988654321 22222 22232
Q ss_pred -----------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 -----------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -----------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
+ .|+|||. ..+..++.++|||||||++|+|++|..||.+.+...+...+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCccccCCCCccEECchH-HcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 2999995 45566899999999999999999999999887555444443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=201.24 Aligned_cols=165 Identities=34% Similarity=0.620 Sum_probs=122.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCC--E
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGR--Y 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 114 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|.+..........+++.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999999999999999998755444555678889999999996 999999999997543 7
Q ss_pred EEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccCC----------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVGS---------- 147 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g~---------- 147 (218)
+|+||||++++|.+++...... +++|.+ .+||.
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999998888887654222 333322 23331
Q ss_pred -----------------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHH
Q 041487 148 -----------------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVR 197 (218)
Q Consensus 148 -----------------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~ 197 (218)
.|+|||.+.....++.++|||||||++|+|++|++||.+. ..+.+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2899997766577999999999999999999999999987 4455555555
Q ss_pred Hhccc
Q 041487 198 YFTAL 202 (218)
Q Consensus 198 ~~~~~ 202 (218)
.++.|
T Consensus 246 ~~~~p 250 (388)
T 3oz6_A 246 VIDFP 250 (388)
T ss_dssp HHCCC
T ss_pred hcCCC
Confidence 54444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-27 Score=190.02 Aligned_cols=153 Identities=28% Similarity=0.522 Sum_probs=123.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 467999999999999999999999999999999987543 233577899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG--------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g--------------- 146 (218)
||+++ +|.+++...... +++|.+ .++|
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 99976 999887654322 333322 2232
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+.......
T Consensus 177 ~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 177 VGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp CSCGGGCCHHHH-HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cCCcCccChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 239999954 455689999999999999999999999987754443333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=193.53 Aligned_cols=179 Identities=18% Similarity=0.292 Sum_probs=135.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45688999999999999999999999999999999997543 22345678889999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------------ 145 (218)
+||||+++ +|.+++...... +++|.+ .++
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 99999987 999888654321 333322 222
Q ss_pred --C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc---Ccccchhhhhhhccc
Q 041487 146 --G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL---TNYLVLPCFLSIMLL 217 (218)
Q Consensus 146 --g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 217 (218)
| ..|+|||. ..+..++.++|||||||++|+|++|+.||...+.......+...... ..+..+.++++.||.
T Consensus 163 ~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 163 LCGTPDYIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCSCTTTCCHHH-HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCccccCHhH-hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 2 23999995 45566899999999999999999999999877554444433322111 123345556666653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=190.70 Aligned_cols=153 Identities=30% Similarity=0.460 Sum_probs=124.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 45678899999999999999999999999999999998654322 34457889999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g---------- 146 (218)
++||||+++ +|.+++...... +++|.+ .++|
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999987 999988764321 333322 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 167 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 218 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218 (294)
T ss_dssp --------CCSSCCHHHH-HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH
T ss_pred cccCccccCccccCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 239999954 4556899999999999999999999999876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=197.01 Aligned_cols=160 Identities=22% Similarity=0.337 Sum_probs=129.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++++.||+|+||.||+|+++.+++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999997543 23345678899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------- 146 (218)
+||||+++ +|.+++...... +++|.+ .++|
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence 99999976 999888764321 333332 2222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+..
T Consensus 198 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 252 (350)
T 1rdq_E 198 LCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCccccCHHHh-cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc
Confidence 239999954 455689999999999999999999999998765555544443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=196.99 Aligned_cols=163 Identities=23% Similarity=0.367 Sum_probs=126.5
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
...+..++|++++.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|..+++.+ +||||+++++++...
T Consensus 17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 34467789999999999999999999999999999999997542 2234467788999999988 799999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
..+|+||||+++ +|.+++...... +++|.+ .++|
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999987 888887654321 333332 2222
Q ss_pred ----------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 ----------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ----------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+ .|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+..
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp ---------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2 39999954 455589999999999999999999999998866655555443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=196.10 Aligned_cols=156 Identities=23% Similarity=0.374 Sum_probs=126.0
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+..++|++++.||+|+||.||+|.++.+++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4466789999999999999999999999999999999997543 234456789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC---------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--------- 146 (218)
+|+||||+.+ +|.+++...... +++|.+ .++|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999987 888887654321 333322 2222
Q ss_pred --------CcccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 147 --------SPYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 147 --------~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
..|+|||.+.. +..++.++|||||||++|+|++|+.||.......
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 23999997653 3458899999999999999999999998654333
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=200.61 Aligned_cols=159 Identities=26% Similarity=0.455 Sum_probs=127.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|.++.+++.+|+|++..........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35779999999999999999999999999999999986554445567889999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g---------- 146 (218)
|||+++ +|.+++...... +++|.+ .++|
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 999987 888877654321 333322 2222
Q ss_pred -------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+ .|+|||. ..+..++.++|||||||++|+|++|++||.+.+...+...+..
T Consensus 169 ~~~~~~gt~~Y~APE~-l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEV-LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp BCCCSCSCGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecccCCcccCCHHH-hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 2 3999995 4555689999999999999999999999988765555555544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-27 Score=192.30 Aligned_cols=165 Identities=33% Similarity=0.635 Sum_probs=128.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------- 111 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 111 (218)
..++|++.+.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3578999999999999999999999999999999997665555556788899999999999999999999976
Q ss_pred -CCEEEEEEecCCCChHHHhhhcccC----------------------------Cccccc-----------cccC-----
Q 041487 112 -GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----- 146 (218)
Q Consensus 112 -~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----- 146 (218)
.+.+++||||++++|.+++...... +++|.+ .++|
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 4579999999998777766543211 333322 2222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHHhcccC
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTALT 203 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~~~~~~ 203 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+... ..+..+.+..+.++
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 2299999766666689999999999999999999999998744 44444444444443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=199.89 Aligned_cols=160 Identities=24% Similarity=0.421 Sum_probs=126.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++++.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 356789999999999999999999999999999999997532 2233345688999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC--------------------------Cccccc-----------ccc------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~------------ 145 (218)
|+||||+++ +|.+++...... +++|.+ .++
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999977 898887654321 333322 222
Q ss_pred ------CC-cccCcccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 146 ------GS-PYKAPESRIRSS---VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 146 ------g~-~y~aPE~~~~~~---~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
|+ .|+|||.+.... .++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 285 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence 22 399999665433 2788999999999999999999999987555444433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-27 Score=193.24 Aligned_cols=162 Identities=23% Similarity=0.338 Sum_probs=126.9
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCC
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGR 113 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (218)
..+..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ......+.+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3467789999999999999999999999999999999997543 1234467788899988877 9999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc---------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV--------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~--------- 145 (218)
.+|+||||+++ +|.+++...... +++|.+ .++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999976 998888653221 233321 222
Q ss_pred --------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 --------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 --------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+..
T Consensus 172 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhh-cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 22 39999954 455689999999999999999999999998766665555544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-26 Score=187.59 Aligned_cols=157 Identities=27% Similarity=0.414 Sum_probs=125.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+.|++.+.||+|+||.||+|.++.++..||+|++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999999999999999998654322 246789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccc---------------cccccC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP---------------HIKEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~---------------~~~~~g----- 146 (218)
.++||||+++ +|.+++...... +++| .+.++|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999976 999988654321 2222 222222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||.+.........+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCccccccCCcCcCCcee-ecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 23999995 45566899999999999999999999999877544444333
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=202.26 Aligned_cols=163 Identities=29% Similarity=0.457 Sum_probs=128.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++++.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999999999999999999976544445567889999999999999999999999644
Q ss_pred CEEEEEEecCCCChHHHhhhccc-------------------------CCccccc-----------cccCC---------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTI-------------------------TSIRPHI-----------KEVGS--------- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~-------------------------~~~~~~~-----------~~~g~--------- 147 (218)
..+|+||||+++++.+.+..... .+++|.+ .+||.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 219 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc
Confidence 46899999999877666543211 1333332 23332
Q ss_pred --------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 148 --------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 148 --------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
.|+|||.+. +..++.++|||||||++|+|++|+.||.+. ..+.+..+++.++.+
T Consensus 220 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 220 MTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp C----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred cCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 299999554 456899999999999999999999999987 455666666666554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=194.69 Aligned_cols=157 Identities=32% Similarity=0.544 Sum_probs=123.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC---CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN---EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+.|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44578999999999999999999999999999999986432 222346789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhccc-----C--------------------------Cccccc--------------ccc---
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI-----T--------------------------SIRPHI--------------KEV--- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~-----~--------------------------~~~~~~--------------~~~--- 145 (218)
+|+||||+++ +|.+++..... . +++|.+ .++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999986 88877654321 0 222221 122
Q ss_pred --------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 146 --------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 146 --------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
| ..|+|||. ..+..++.++|||||||++|+|++|+.||.+........+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i 244 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI 244 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH
T ss_pred eEecCCCeeecCCcCCcCccCHHH-HcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH
Confidence 2 23999995 4455689999999999999999999999988644333333
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=196.91 Aligned_cols=165 Identities=32% Similarity=0.559 Sum_probs=124.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++.+.||+|+||.||+|.++.+++.||+|.+..........+++.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35789999999999999999999999999999999865444444567889999999999999999999999765
Q ss_pred CEEEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccCC--------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVGS-------- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g~-------- 147 (218)
..+|+||||++++|.+++...... +++|.+ .++|.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence 346999999977998887654322 333322 22322
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhcccC
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTALT 203 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~~~ 203 (218)
.|+|||.+.....++.++||||+||++|+|++|+.||.+.+ .+.+..+.+..+.++
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 39999977665779999999999999999999999999873 445555555555443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=203.06 Aligned_cols=150 Identities=30% Similarity=0.515 Sum_probs=110.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-----CC
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-----GR 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 113 (218)
..++|++.+.||+|+||.||+|.++.+++.||||.+..........+++.+|+.+++.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999999999999999987554444556789999999999999999999999843 35
Q ss_pred EEEEEEecCCCChHHHhhhcccC---------------------------Cccccc-----------cccC---------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--------- 146 (218)
.+|+|||+++++|.+++...... +++|.+ .+||
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 79999999998888887654321 333322 2222
Q ss_pred ------------------------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-----------
Q 041487 147 ------------------------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS----------- 179 (218)
Q Consensus 147 ------------------------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t----------- 179 (218)
..|+|||.+.....++.++|||||||++|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 229999976667779999999999999999999
Q ss_pred CCCCCCCCC
Q 041487 180 GKPLFPCGK 188 (218)
Q Consensus 180 g~~Pf~~~~ 188 (218)
|++||++..
T Consensus 291 ~~p~f~g~~ 299 (458)
T 3rp9_A 291 RGPLFPGSS 299 (458)
T ss_dssp CCCSCC---
T ss_pred ccccCCCCc
Confidence 788887753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=187.57 Aligned_cols=150 Identities=37% Similarity=0.650 Sum_probs=121.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999999999999999998755444445677889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccCC-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVGS------------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g~------------- 147 (218)
||+++ +|.++....... +++|.+ .++|.
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99997 555555432211 333322 22222
Q ss_pred -----cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 148 -----PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 148 -----~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.|+|||.+.....++.++||||||+++|+|++|+.||.+...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 289999776667789999999999999999999999988743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=193.06 Aligned_cols=161 Identities=40% Similarity=0.688 Sum_probs=124.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 679999999999999999999999999999999874432 1222245579999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccccc-----------cccC---------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------------- 146 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------------- 146 (218)
|++++|.+++...... +++|.+ .++|
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 9999998887654321 333322 2222
Q ss_pred ---CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHHhccc
Q 041487 147 ---SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRYFTAL 202 (218)
Q Consensus 147 ---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~~~~~ 202 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+. +.+..+.+.++.+
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 220 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP 220 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2399999776667789999999999999999999999998743 4444555544444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=194.53 Aligned_cols=151 Identities=20% Similarity=0.375 Sum_probs=119.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
...+..++|++++.||+|+||.||+|+++.+++.||+|++++... .....+.+.+|..++.++ +||||+++++++...
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 345677899999999999999999999999999999999986543 334456788899999887 899999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
..+|+||||+++ +|.+++...... +++|.+ .++|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999987 888887654321 333322 2222
Q ss_pred ----------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 ----------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 ----------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
+ .|+|||. ..+..++.++|||||||++|+|++|+.||..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~-l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCccccccCCcccCCchh-hcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2 3999995 4556689999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-27 Score=193.26 Aligned_cols=164 Identities=21% Similarity=0.314 Sum_probs=127.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT 111 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 111 (218)
....+..++|++++.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|..++..+ .||+|+++++++..
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 344567889999999999999999999999899999999997643 2334567888999999888 89999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc-------
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------- 145 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------- 145 (218)
...+|+||||+++ +|.+++...... +++|.+ .++
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999987 998888653321 333322 222
Q ss_pred ----------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 ----------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 ----------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCcccccccCCccccChhhh-cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 22 39999954 555689999999999999999999999998766555554443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=197.27 Aligned_cols=150 Identities=29% Similarity=0.415 Sum_probs=121.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4578999999999999999999999999999999997543 223345678999999999999999999999999999999
Q ss_pred EEecCCCChHHHhhhcccC---------------------------Cccccc-----------cccC-------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------------- 146 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------------- 146 (218)
||||++++|.+++...... +++|.+ .++|
T Consensus 87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 9999988998887654321 333322 2222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+......+.++|||||||++|+|++|+.||....
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 239999966544445789999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-26 Score=188.64 Aligned_cols=154 Identities=25% Similarity=0.437 Sum_probs=124.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.++..+|+|.+... ......+.+|+.+++.++||||+++++++.....+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 57899999999999999999999999999999998632 334567889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccCC----------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVGS---------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g~---------- 147 (218)
||+++ +|.+++...... +++|.+ .++|.
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99987 999988654311 333322 22222
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+.
T Consensus 161 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 161 RLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp EEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccCChhhcCcHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 29999954 45558999999999999999999999998875554444443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=200.36 Aligned_cols=159 Identities=22% Similarity=0.322 Sum_probs=125.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|..++..++||||++++++|.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 355688999999999999999999999999999999997532 1223345588999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~---------- 145 (218)
|+||||+++ +|.+++...... +++|.+ .++
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999976 999988663211 333322 222
Q ss_pred --------CC-cccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 041487 146 --------GS-PYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLI 195 (218)
Q Consensus 146 --------g~-~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~ 195 (218)
|+ .|+|||.+.. ...++.++|||||||++|||++|+.||.+.+.......
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 292 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence 22 3999997652 45589999999999999999999999998754444333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=193.88 Aligned_cols=151 Identities=20% Similarity=0.321 Sum_probs=125.3
Q ss_pred hhccceeEEEEeeec--CceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 38 VKDWNYKVVEKIGQG--VFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
...++|++.+.||+| +||.||+|.++.+++.||+|.+..........+.+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 456789999999999 999999999999999999999987655555677889999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV--------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~--------- 145 (218)
++||||+++ +|.+++...... +++|.+ .++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999986 898888654211 333332 111
Q ss_pred ----------------CCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------------GSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------------g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+..|+|||.+... ..++.++|||||||++|+|++|+.||.+.+
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1238999976553 568999999999999999999999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=190.93 Aligned_cols=149 Identities=21% Similarity=0.373 Sum_probs=121.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
.+..++|++++.||+|+||.||+|+++.+++.||+|++++.... ....+.+.+|..++..+ +||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35578899999999999999999999999999999999865433 34456788999999988 89999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc-----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE----------- 144 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~----------- 144 (218)
+|+||||+++ +|.+++...... +++|.+ .+
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999986 888887654321 233322 11
Q ss_pred ------cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 145 ------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 145 ------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCcccc-CCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 122 39999954 455689999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=187.89 Aligned_cols=183 Identities=23% Similarity=0.356 Sum_probs=127.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCC--CCCchHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNE--PEGVPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
....+..++|++.+.||+|+||.||+|.+. .+++.||+|++++... .......+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 344567889999999999999999999975 5789999999976532 22345678899999999999999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC---
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--- 146 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--- 146 (218)
+...+.+|+||||+++ +|.+++...... +++|.+ .++|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999986 888887654321 233322 2222
Q ss_pred ---------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhccc-C--cccch
Q 041487 147 ---------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTAL-T--NYLVL 208 (218)
Q Consensus 147 ---------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~-~--~~~~~ 208 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+.......+...... + .+..+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---------CTTSSCCTTSCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred ccccCCccccccCCCcCccCHhhC-cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 239999954 4555899999999999999999999999887554444333322111 1 13334
Q ss_pred hhhhhhccc
Q 041487 209 PCFLSIMLL 217 (218)
Q Consensus 209 ~~~~~~~l~ 217 (218)
.+++..||.
T Consensus 249 ~~li~~~L~ 257 (327)
T 3a62_A 249 RDLLKKLLK 257 (327)
T ss_dssp HHHHHHHSC
T ss_pred HHHHHHHHh
Confidence 455555553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=196.66 Aligned_cols=142 Identities=31% Similarity=0.523 Sum_probs=116.6
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----C
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----R 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 113 (218)
..++|++.+.||+|+||.||+|.++.+++.||||.+..........+++.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 46789999999999999999999999999999999975544445567899999999999999999999999765 5
Q ss_pred EEEEEEecCCCChHHHhhhcccC---------------------------Cccccc-----------cccC---------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--------- 146 (218)
.+|+||||++++|.+++...... +++|.+ .++|
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 79999999999998888764321 233322 1222
Q ss_pred -------------------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhC
Q 041487 147 -------------------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG 180 (218)
Q Consensus 147 -------------------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg 180 (218)
..|+|||.+.....++.++|||||||++|+|++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 2399999766777799999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=193.26 Aligned_cols=162 Identities=21% Similarity=0.381 Sum_probs=119.1
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHH-HhhCCCCCeeeeeeeEEeC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSL-LKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~ 112 (218)
...+..++|++++.||+|+||.||+|+++.++..||+|++++... .......+.+|..+ ++.++||||+++++++...
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 345677899999999999999999999999999999999986542 23344566777776 5678999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc--------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~-------- 145 (218)
..+|+||||+++ +|.+++...... +++|.+ .++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999987 888887653321 333322 122
Q ss_pred ---------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 ---------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ---------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
|+ .|+|||. ..+..++.++|||||||++|+|++|+.||.+.+...+...+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred CCCccccccCCccccCHHH-hCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 22 3999995 455668999999999999999999999998876555544443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=190.50 Aligned_cols=147 Identities=26% Similarity=0.327 Sum_probs=118.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 456789999999999999999999999999999999975432 23678899999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccc-------------cccccCC---------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRP-------------HIKEVGS--------- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~-------------~~~~~g~--------- 147 (218)
||||+++ +|.+++...... +++| ++.++|.
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999976 998887653321 2222 2233332
Q ss_pred --------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 --------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 --------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+|||.+......+.++|||||||++|+|++|+.||...
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 3999997665554445599999999999999999999876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=182.76 Aligned_cols=158 Identities=30% Similarity=0.493 Sum_probs=128.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.++..||+|++..........+.+.+|+.++++++||||+++++++......+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999999999999999999866555555678899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccCC----------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVGS---------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g~---------- 147 (218)
||+++ +|.+++...... +++|. +.++|.
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99987 887776554321 22222 222222
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 165 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp CCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCCCcCCcCchhh-cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 29999954 555689999999999999999999999988765555555444
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=198.08 Aligned_cols=157 Identities=26% Similarity=0.395 Sum_probs=125.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|..++..++||||+++++++.+...+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 356789999999999999999999999999999999997532 1223345688999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cc-----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KE----------- 144 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~----------- 144 (218)
|+||||+++ +|.+++...... +++|.+ .+
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999976 999998764311 333322 11
Q ss_pred -------cCC-cccCcccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 145 -------VGS-PYKAPESRIR------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 145 -------~g~-~y~aPE~~~~------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
.|+ .|+|||.+.. ...++.++|||||||++|+|++|+.||...+.....
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 222 3999997653 345899999999999999999999999887554443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=193.28 Aligned_cols=149 Identities=30% Similarity=0.500 Sum_probs=120.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-----
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR----- 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 113 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999999999999999999865444455677889999999999999999999997654
Q ss_pred -EEEEEEecCCCChHHHhhhcccC-------------------------Cccccc-----------cccC----------
Q 041487 114 -YVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 114 -~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~~-----------~~~g---------- 146 (218)
..++||||++++|.+++...... +++|.+ .++|
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 182 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccc
Confidence 79999999998887776432111 333322 2222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+. +..++.++|||||||++|+|++|+.||.+.+
T Consensus 183 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 183 MTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2399999554 5568999999999999999999999998874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=187.29 Aligned_cols=161 Identities=24% Similarity=0.337 Sum_probs=126.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.....+..++|++.+.||+|+||.||+|.+ .+..||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 444556788999999999999999999976 788999999976544445567889999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc--------------------------------CCccccc-----------cccC--
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI--------------------------------TSIRPHI-----------KEVG-- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~--------------------------------~~~~~~~-----------~~~g-- 146 (218)
...++||||+++ +|.+++..... .++++.+ .++|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999987 89888764321 0222221 2232
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEV-LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp ---------------CCTTSCHHH-HTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred ccccccccccccCCCCccccChhh-hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23999995 45556899999999999999999999999887555544443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=188.99 Aligned_cols=166 Identities=34% Similarity=0.554 Sum_probs=127.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.+......++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 44455567899999999999999999999999999999999876544444566788999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
...++||||+++ .|.++....... +++|.+ .++|
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999987 444443322111 233322 2222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRY 198 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~ 198 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||...+ .+.+..+...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 229999976655568999999999999999999999998873 3344444433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=196.18 Aligned_cols=158 Identities=32% Similarity=0.473 Sum_probs=122.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+.|++.+.||+|+||.||+|.++.++..+|+|++++........+.+.+|+.+++.++||||+++++++......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34579999999999999999999999999999999987655555568899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g---------- 146 (218)
||||.+ +|.+++...... +++|. +.++|
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 999987 888776543221 22222 22232
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ . +.++.++||||+||++|+|++|+.||.+.....+...+..
T Consensus 195 ~~~~~gt~~y~aPE~l-~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (494)
T 3lij_A 195 MKERLGTAYYIAPEVL-R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251 (494)
T ss_dssp BCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCCCcCeeCHHHH-c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 239999964 3 3489999999999999999999999998866655555554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=196.47 Aligned_cols=173 Identities=26% Similarity=0.379 Sum_probs=133.5
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+..++|.+.+.||+|+||.||+|.++.++..||+|.++.. ......+.+.+|+.+++.++||||+++++++.....
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4557788999999999999999999999889999999998743 222334568899999999999999999999999899
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
+++||||+++ +|.+++...... +++|.+ .++|
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999986 999988754321 333322 2222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
..|+|||.+. +..++.++|||||||++|||+| |+.||...........+.....++.+...|
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ceeecCCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 1299999554 4558999999999999999999 999999886666655555444443333333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-26 Score=182.71 Aligned_cols=148 Identities=23% Similarity=0.389 Sum_probs=121.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
.+..++|.+.+.||+|+||.||+|.+..++..||+|.+.. ......+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 3567899999999999999999999999999999998853 23445678999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccCC---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVGS--------- 147 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g~--------- 147 (218)
+||||+++ +|.+++...... ++++. +.++|.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999987 999988763211 22322 122222
Q ss_pred -----------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 -----------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 -----------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+|||. ..+..++.++||||||+++|+|++|..||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHH-hcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 2999995 45666899999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=182.03 Aligned_cols=185 Identities=26% Similarity=0.358 Sum_probs=134.6
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
.....+..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3444567789999999999999999999998899999999987542 233456789999999999999999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC------
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------ 146 (218)
.+..++||||+++ +|.+++...... ++++.+ .++|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999976 999988654321 222221 2222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhh
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFL 212 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 212 (218)
..|+|||.+......+.++||||||+++|+|++|+.||.......+...+.......+ +..+.+++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 2399999665544456899999999999999999999988765555544443221111 33344555
Q ss_pred hhccc
Q 041487 213 SIMLL 217 (218)
Q Consensus 213 ~~~l~ 217 (218)
..||+
T Consensus 243 ~~~l~ 247 (276)
T 2h6d_A 243 MHMLQ 247 (276)
T ss_dssp HHHTC
T ss_pred HHHcc
Confidence 55553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=196.06 Aligned_cols=159 Identities=31% Similarity=0.472 Sum_probs=127.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+........+.+.+|+.++++++||||+++++++.....+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34678999999999999999999999999999999997654444557889999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccC---------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVG--------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g--------- 146 (218)
||||+.+ +|.+++...... +++|. +.++|
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999987 888777543221 33332 22222
Q ss_pred -------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+ .|+|||.+. + .++.++|||||||++|+|++|++||.+.+...+...+..
T Consensus 179 ~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLR-G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (486)
T ss_dssp ---CCTTGGGGCCGGGGG-S-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhC-C-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1 299999654 3 389999999999999999999999998765555554444
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-26 Score=195.06 Aligned_cols=158 Identities=32% Similarity=0.490 Sum_probs=123.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-----------CCchHHHHHHHHHHhhCCCCCeeeeee
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-----------EGVPSYLIAGVSLLKELEHDNIVRLLD 107 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (218)
..++|.+.+.||+|+||.||+|.++.++..||+|++++.... ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467899999999999999999999999999999999764422 144678999999999999999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------cccc
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEV 145 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~ 145 (218)
++.....+++|||||++ +|.+++...... +++|. +.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999987 888877553321 22222 2223
Q ss_pred C-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 146 G-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 146 g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
| ..|+|||.+. + .++.++||||+||++|+|++|+.||.+.+...+...+..
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-K-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc-c-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2 2399999643 3 489999999999999999999999998866555555444
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=193.99 Aligned_cols=164 Identities=31% Similarity=0.571 Sum_probs=120.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------ 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (218)
..++|++++.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 45789999999999999999999999999999999875444444567888999999999999999999998653
Q ss_pred CEEEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccC---------
Q 041487 113 RYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g--------- 146 (218)
...++++|+++++|.+++...... +++|.+ .++|
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 186 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccC
Confidence 568999999987887776543221 333322 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhccc
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTAL 202 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~~ 202 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+ .+.+..+.+..+.+
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 238999976665679999999999999999999999999873 34555555555544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=190.09 Aligned_cols=149 Identities=23% Similarity=0.371 Sum_probs=120.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 459999999999999999999989999999999975432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Cccccc-----------cccCC-------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS------------- 147 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~------------- 147 (218)
||+.+++.+++...... +++|.+ .++|.
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt 213 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 213 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSC
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCC
Confidence 99999888877542211 333322 23332
Q ss_pred -cccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 148 -PYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 148 -~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.|+|||.+. ....++.++|||||||++|+|++|+.||...+.
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 399999764 355689999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=197.70 Aligned_cols=182 Identities=26% Similarity=0.346 Sum_probs=136.6
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456789999999999999999999999999999999997543 223446789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~---------- 145 (218)
+++||||+++ +|.+++...... +++|.+ .++
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999976 999988654321 333322 222
Q ss_pred ------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhhhhhc
Q 041487 146 ------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCFLSIM 215 (218)
Q Consensus 146 ------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 215 (218)
| ..|+|||.+......+.++|||||||++|+|++|+.||...+...+...+....... .+..+-+++..|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHH
Confidence 2 239999966555545789999999999999999999999876555544443322111 123344555555
Q ss_pred cc
Q 041487 216 LL 217 (218)
Q Consensus 216 l~ 217 (218)
|+
T Consensus 251 L~ 252 (476)
T 2y94_A 251 LQ 252 (476)
T ss_dssp TC
T ss_pred cC
Confidence 53
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=187.00 Aligned_cols=148 Identities=27% Similarity=0.488 Sum_probs=117.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4789999999999999999999999999999999975432 223467889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g-------------- 146 (218)
||+++ +|.+++...... ++++.+ .++|
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99987 888887654221 333322 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 239999976655555789999999999999999999998763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=188.66 Aligned_cols=156 Identities=22% Similarity=0.365 Sum_probs=122.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC--
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-- 113 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 113 (218)
....++|++.+.||+|+||.||+|.+..+++.||+|+++...... .....+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 345688999999999999999999999999999999997654322 34567889999999999999999999986543
Q ss_pred --EEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc-------
Q 041487 114 --YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------- 145 (218)
Q Consensus 114 --~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------- 145 (218)
..|+||||+++ +|.+++...... ++++.+ .++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 45999999986 999888654321 233322 222
Q ss_pred --------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 146 --------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 146 --------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
...|+|||.+ .+..++.++|||||||++|+|++|+.||.+.......
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 228 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228 (311)
T ss_dssp --------------CCTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccCcCcccCCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 2239999955 4556899999999999999999999999887554443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-25 Score=182.88 Aligned_cols=155 Identities=25% Similarity=0.404 Sum_probs=124.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+.|++.+.||+|+||.||+|.+..++..||+|.+....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3577999999999999999999999999999999998654322 236789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccc---------------cccccC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP---------------HIKEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~---------------~~~~~g----- 146 (218)
.++||||+++ +|.+++...... +++| .+.++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999976 999988654321 2222 222222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||.+........
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 228 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred CccccccccCCCCCccCccc-ccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 12999995 455668999999999999999999999998775444333
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=183.72 Aligned_cols=160 Identities=25% Similarity=0.409 Sum_probs=116.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC------------------------CCchHHHHHHHHH
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP------------------------EGVPSYLIAGVSL 93 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~e~~~ 93 (218)
+..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 5568899999999999999999999999999999999754321 1224678899999
Q ss_pred HhhCCCCCeeeeeeeEEe--CCEEEEEEecCCC-ChHHHhhhcccC--------------------------Cccccc--
Q 041487 94 LKELEHDNIVRLLDVLTT--GRYVYLVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-- 142 (218)
Q Consensus 94 l~~l~h~~iv~~~~~~~~--~~~~~lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-- 142 (218)
+++++||||+++++++.. ...+++||||+++ +|.++....... +++|.+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 999999999999999986 6789999999975 555543221111 233322
Q ss_pred ---------cccC------------------CcccCcccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 143 ---------KEVG------------------SPYKAPESRIRSSV--YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 143 ---------~~~g------------------~~y~aPE~~~~~~~--~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
.++| ..|+|||.+..... ++.++|||||||++|+|++|+.||...+...+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 2222 23999996554432 467899999999999999999999877555544
Q ss_pred HHHH
Q 041487 194 LIVR 197 (218)
Q Consensus 194 ~~~~ 197 (218)
..+.
T Consensus 250 ~~~~ 253 (298)
T 2zv2_A 250 SKIK 253 (298)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 4443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=195.80 Aligned_cols=180 Identities=19% Similarity=0.278 Sum_probs=127.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|.++.+++.||+|+++... ........+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 345688999999999999999999999999999999997543 2334456788999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------- 146 (218)
++||||+++ +|.+++...... +++|.+ .+||
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999987 887776543221 333322 2232
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhhhhh
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCFLSI 214 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 214 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...+...+...+....... .+..+.++++.
T Consensus 304 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382 (446)
T ss_dssp ---CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 239999954 55568999999999999999999999999876666655554432221 23334455666
Q ss_pred ccc
Q 041487 215 MLL 217 (218)
Q Consensus 215 ~l~ 217 (218)
||+
T Consensus 383 ~L~ 385 (446)
T 4ejn_A 383 LLK 385 (446)
T ss_dssp HTC
T ss_pred Hcc
Confidence 553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=189.55 Aligned_cols=159 Identities=30% Similarity=0.611 Sum_probs=121.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------ 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 111 (218)
....+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345789999999999999999999999999999999864321 12379999999999999999999843
Q ss_pred --------------------------------CCEEEEEEecCCCChHHHhhhc----ccC-------------------
Q 041487 112 --------------------------------GRYVYLVFEYLDLDLGSFIRKH----TIT------------------- 136 (218)
Q Consensus 112 --------------------------------~~~~~lv~E~~~~~L~~~~~~~----~~~------------------- 136 (218)
...+++||||++++|.+++... ...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3459999999998877766531 100
Q ss_pred --------Cccccc------------cccCC-----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh
Q 041487 137 --------SIRPHI------------KEVGS-----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS 179 (218)
Q Consensus 137 --------~~~~~~------------~~~g~-----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t 179 (218)
+++|.+ .++|. .|+|||.+.....++.++||||+||++|+|++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 333322 22222 29999976666668999999999999999999
Q ss_pred CCCCCCCC-CcchHHHHHHHhccc
Q 041487 180 GKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 180 g~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
|+.||.+. ..+.+..+++.++.+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p 261 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTP 261 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999987 556666776666554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-26 Score=189.02 Aligned_cols=156 Identities=24% Similarity=0.389 Sum_probs=124.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+.|++.+.||+|+||.||+|.++.+++.+|+|++.... ......+.+|+.+++.++||||+++++++.....+++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999999999999999987432 22345788999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Ccccc-------------ccccCC---------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPH-------------IKEVGS--------- 147 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-------------~~~~g~--------- 147 (218)
|||+++ +|.+++...... +++|. +.++|.
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999987 998888654211 23322 222322
Q ss_pred --------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 --------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 --------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 207 ~~~~~gt~~y~aPE~-~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 207 VKVTTATAEFAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp EEEECSSGGGCCHHH-HTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred eeeeccCCCccCchh-ccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2999995 455668999999999999999999999998875444433333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-25 Score=178.03 Aligned_cols=155 Identities=26% Similarity=0.428 Sum_probs=124.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.++...... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3567999999999999999999999999999999998654322 246789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccc---------------cccccC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRP---------------HIKEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~---------------~~~~~g----- 146 (218)
.++||||+++ +|.+++...... +++| .+.++|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999975 999988653221 2222 222222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++||||||+++|+|++|+.||.+........
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221 (283)
T ss_dssp C--------CCCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cCCCcccccCCCcCccCcce-ecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 23999995 455668999999999999999999999998875444333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-26 Score=188.03 Aligned_cols=163 Identities=28% Similarity=0.517 Sum_probs=128.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (218)
.++|++.+.||+|+||.||+|.+..++..||+|.+... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999999999999999998642 2233457788999999999999999999998654 46
Q ss_pred EEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------ccc------------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~------------ 145 (218)
.++|||+++++|.+++...... +++|.+ .++
T Consensus 105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 9999999999998887654322 333322 122
Q ss_pred --------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 146 --------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 146 --------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
| ..|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+....+.++
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 2 22899997777777899999999999999999999999887 4555556555555443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-26 Score=193.78 Aligned_cols=159 Identities=30% Similarity=0.445 Sum_probs=128.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+.++++++||||+++++++.....++
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4567899999999999999999999999999999999765433 455788999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccC--------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVG-------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g-------- 146 (218)
+||||+.+ +|.+++...... +++|.+ .++|
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999986 888877554321 333322 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+. + .++.++|||||||++|+|++|++||.+.+...+...+..
T Consensus 183 ~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLH-G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHH-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccCCCCccccCceeec-C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 2299999654 3 489999999999999999999999998765555554443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-25 Score=181.72 Aligned_cols=153 Identities=24% Similarity=0.459 Sum_probs=121.5
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
.|...+.||+|+||.||+|.++.+++.||||++... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478888999999999999999889999999998743 334467789999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC-----------------
Q 041487 122 LDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG----------------- 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g----------------- 146 (218)
+++ +|.+++...... +++|.+ .++|
T Consensus 124 ~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 124 LQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 987 888877643221 222221 2222
Q ss_pred -CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...........+.
T Consensus 204 t~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 204 TPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp CGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 239999954 55568999999999999999999999998765444443333
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=183.60 Aligned_cols=164 Identities=40% Similarity=0.676 Sum_probs=122.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC---CCCchHHHHHHHHHHhhCC---CCCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE---PEGVPSYLIAGVSLLKELE---HDNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 111 (218)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 456889999999999999999999999999999999975432 2233456778888777764 9999999999976
Q ss_pred CC-----EEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc-----------cccC
Q 041487 112 GR-----YVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 112 ~~-----~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g 146 (218)
.. ..+++||+++++|.+++...... +++|.+ .++|
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 54 68999999999999988765321 333322 2222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhccc
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTAL 202 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~~ 202 (218)
..|+|||.+. +..++.++|||||||++|+|++|+.||.+.+ .+.+..+....+.+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccCCCcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2399999654 4558999999999999999999999998873 44445555544433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=188.59 Aligned_cols=173 Identities=25% Similarity=0.375 Sum_probs=131.0
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
...+..++|++.+.||+|+||.||+|.+..++. .||+|.++.. ......+.+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 345678899999999999999999999875544 5999998743 233445678999999999999999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS---- 147 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~---- 147 (218)
....++||||+++ +|.+++...... +++|.+ .+||.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999977 999988644211 333322 22221
Q ss_pred -----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 148 -----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 148 -----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
.|+|||.+ .+..++.++|||||||++|+|++ |+.||.......+...+.....++.+...|
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 39999955 44558999999999999999999 999998876555555544433333333333
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=190.35 Aligned_cols=162 Identities=31% Similarity=0.543 Sum_probs=126.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE---
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV--- 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 115 (218)
..++|.+.+.||+|+||.||+|.++.+++.||+|.+..........+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 35789999999999999999999999999999999976544445567889999999999999999999999866654
Q ss_pred ---EEEEecCCCChHHHhhhcccC-------------------------Cccccc-----------cccC----------
Q 041487 116 ---YLVFEYLDLDLGSFIRKHTIT-------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 116 ---~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~~-----------~~~g---------- 146 (218)
++||||+.++|.+++...... +++|.+ .++|
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 199 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 199 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcC
Confidence 999999998887765432111 333332 2232
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhc
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFT 200 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~ 200 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+ .+.+..+.+..+
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 239999976665779999999999999999999999998873 344444444333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-26 Score=183.25 Aligned_cols=161 Identities=19% Similarity=0.327 Sum_probs=121.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
......++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3445578999999999999999999999989999999998754322 233578899999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g-------- 146 (218)
..+++|||+++ +|.+++...... ++++.+ .++|
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999987 999988764321 222221 2222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||...+...+...+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp ---------CCGGGCCGGGT-CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred ccccccccCCCcCccCHHHH-cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 239999954 4556899999999999999999999999887554444433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=189.97 Aligned_cols=164 Identities=24% Similarity=0.433 Sum_probs=127.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEc-------cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNL-------ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV 108 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (218)
.+..++|++.+.||+|+||.||+|.+. ..+..||+|+++.. ......+.+.+|+.+++.+ +||||++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 456789999999999999999999874 24567999998743 2333456789999999999 89999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhccc-----------------C--------------------------Cccccc--
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------------T--------------------------SIRPHI-- 142 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------------~--------------------------~~~~~~-- 142 (218)
+...+.+|+||||+++ +|.+++..... . ++++.+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 9999999999999987 99999876431 0 233322
Q ss_pred ---------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchH
Q 041487 143 ---------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHL 192 (218)
Q Consensus 143 ---------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~ 192 (218)
.+|| ..|+|||.+. +..++.++|||||||++|+|++ |+.||.+.....+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 2222 1399999654 5568999999999999999999 9999998876666
Q ss_pred HHHHHHhccc
Q 041487 193 SLIVRYFTAL 202 (218)
Q Consensus 193 ~~~~~~~~~~ 202 (218)
...+.....+
T Consensus 315 ~~~~~~~~~~ 324 (370)
T 2psq_A 315 FKLLKEGHRM 324 (370)
T ss_dssp HHHHHTTCCC
T ss_pred HHHHhcCCCC
Confidence 6655543333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-26 Score=180.33 Aligned_cols=180 Identities=24% Similarity=0.356 Sum_probs=135.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 456789999999999999999999999999999999986533 1223457789999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC----------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g---------- 146 (218)
++||||+++ +|.+++...... +++|.+ .++|
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 999999987 888887653221 333322 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhhccc
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSIMLL 217 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 217 (218)
..|+|||. ..+..++.++||||||+++|+|++|+.||...+.......+.......+ +..+-+++..||+
T Consensus 165 ~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 165 TDLCGTLDYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243 (279)
T ss_dssp ---CCCCTTCCHHH-HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCC
T ss_pred cccCCCCCccCHhH-hccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhc
Confidence 23899995 4566689999999999999999999999998765555554444332222 2233455555553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-26 Score=179.97 Aligned_cols=157 Identities=25% Similarity=0.373 Sum_probs=124.8
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 466789999999999999999999975 57789999987432 23467899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---------- 146 (218)
+||||+++ +|.+++...... +++|.+ .++|
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999987 899988654321 333322 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 222 (269)
T ss_dssp HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence 139999954 45558999999999999999999 9999998766555554443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=187.95 Aligned_cols=164 Identities=30% Similarity=0.589 Sum_probs=121.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+.+.+|+.+++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 457899999999999999999999889999999999754322 22345788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC----------------------------Cccccc-----------ccc-----------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEV----------- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~----------- 145 (218)
++||||++++|.+++...... ++++.+ .++
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 999999999888887654321 233222 122
Q ss_pred -------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 146 -------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 146 -------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
+..|+|||.+.....++.++|||||||++|+|++|.+||.+. ..+.+..+....+.+
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 123999997666666899999999999999999999999887 344455555554443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-25 Score=189.87 Aligned_cols=156 Identities=28% Similarity=0.484 Sum_probs=124.0
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC-E
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR-Y 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~ 114 (218)
..+..++|++.+.||+|+||.||+|.. .+..||||.++.. ...+.+.+|+.++++++||||+++++++.... .
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 346778999999999999999999987 4789999998743 24578999999999999999999999987654 7
Q ss_pred EEEEEecCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccCC------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVGS------ 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g~------ 147 (218)
+++||||+++ +|.+++...... ++++. +.++|.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999987 999998765321 23332 233332
Q ss_pred ---------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 148 ---------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 ---------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||.+ .+..++.++|||||||++|+|+| |+.||.......+...+..
T Consensus 342 ~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 401 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401 (450)
T ss_dssp -----CCCTTTSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT
T ss_pred cccCCCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 39999955 45568999999999999999999 9999998755555554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-26 Score=181.28 Aligned_cols=166 Identities=22% Similarity=0.380 Sum_probs=133.0
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+..++|++.+.||+|+||.||+|.++.++..||+|.+.. .....+.+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 445678899999999999999999999999999999999863 33456789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC-------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g------- 146 (218)
.++||||+++ +|.+++...... +++|.+ .++|
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999996 999998753321 333322 2222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCc
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTN 204 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 204 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |..||...+...+...+.....+..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CccccccCCccccCcCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC
Confidence 139999955 44558999999999999999999 9999998876666666554433333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-26 Score=195.25 Aligned_cols=149 Identities=23% Similarity=0.317 Sum_probs=122.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|.+.+.||+|+||.||+|+++.+++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45688999999999999999999999999999999997543 22345678899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhccc-----C--------------------------Cccccc-----------cc---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTI-----T--------------------------SIRPHI-----------KE--------- 144 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~-----~--------------------------~~~~~~-----------~~--------- 144 (218)
+||||+++ +|.+++..... . +++|.+ .+
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999987 89888765321 0 233321 11
Q ss_pred --------cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 145 --------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 145 --------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l-~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCcccccccCCccccChhhh-cCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 232 39999954 4566899999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=177.58 Aligned_cols=157 Identities=22% Similarity=0.423 Sum_probs=125.1
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3466999999999999999999999999999999997543 234567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC--------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG-------------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g-------------- 146 (218)
|||+++ +|.+++...... ++++.+ .++|
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 999987 888887653221 222221 1222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||...........+.
T Consensus 179 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 232 (303)
T 3a7i_A 179 FVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232 (303)
T ss_dssp CCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cCCCcCccCHHHH-hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence 238999954 45568899999999999999999999998775544444433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=175.92 Aligned_cols=155 Identities=23% Similarity=0.391 Sum_probs=124.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 5679999999999999999999999999999999875432 34678999999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccC-----------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVG----------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g----------- 146 (218)
||+++ +|.+++...... +++|.+ .++|
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99977 888877654321 222221 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+. ++.++||||||+++|+|++|+.||...+.......+..
T Consensus 166 ~~~~~t~~y~aPE~~-~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVL-EGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp CCCCSCTTTCCHHHH-TTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hccCCCCCccChHHh-ccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 239999954 343 89999999999999999999999998755554444443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=183.79 Aligned_cols=148 Identities=26% Similarity=0.403 Sum_probs=114.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
...+.|++.+.||+|+||.||+|.++.+++.||+|+++... ..+.+.+|+.++++++||||+++++++......++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 34577999999999999999999999999999999997532 23567889999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccC---------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVG--------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g--------- 146 (218)
||||+++ +|.+++...... +++|.+ .++|
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999986 998887654321 233322 2222
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||......
T Consensus 206 ~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEI-LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp -------CGGGSCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred ccccccCCCCccCHHH-hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 23999995 45556899999999999999999999999876433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=183.95 Aligned_cols=161 Identities=24% Similarity=0.466 Sum_probs=126.0
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-----CCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-----HDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~ 110 (218)
..+..++|++.+.||+|+||.||+|.+..+++.||+|+++. .....+.+..|+.+++.+. ||||+++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34567889999999999999999999999999999999863 2233466778999999986 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc-------------------
Q 041487 111 TGRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI------------------- 142 (218)
Q Consensus 111 ~~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~------------------- 142 (218)
..+..++|||++.++|.+++...... +++|.+
T Consensus 107 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999977999998765421 333322
Q ss_pred -----------------cccCC---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 143 -----------------KEVGS---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 143 -----------------~~~g~---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
.++|. .|+|||.+ .+..++.++|||||||++|+|++|+.||...+..
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHH-cCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 22222 39999955 4556899999999999999999999999887443
Q ss_pred -hHHHHHHHhc
Q 041487 191 -HLSLIVRYFT 200 (218)
Q Consensus 191 -~~~~~~~~~~ 200 (218)
.+..+....+
T Consensus 266 ~~~~~~~~~~~ 276 (360)
T 3llt_A 266 EHLAMMESIIQ 276 (360)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhcC
Confidence 3444444333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=184.46 Aligned_cols=164 Identities=20% Similarity=0.335 Sum_probs=117.4
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
..+..++|++.+.||+|+||.||+|.++.++. .||+|.++.........+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34567889999999999999999999876664 899999986555556678899999999999999999999999876
Q ss_pred CEE------EEEEecCCC-ChHHHhhhccc-------C--------------------------Cccccc----------
Q 041487 113 RYV------YLVFEYLDL-DLGSFIRKHTI-------T--------------------------SIRPHI---------- 142 (218)
Q Consensus 113 ~~~------~lv~E~~~~-~L~~~~~~~~~-------~--------------------------~~~~~~---------- 142 (218)
... +++|||+++ +|.+++..... . +++|.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 554 999999988 99888854321 0 333322
Q ss_pred -cccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhc
Q 041487 143 -KEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFT 200 (218)
Q Consensus 143 -~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~ 200 (218)
.++|. .|+|||.+ .+..++.++|||||||++|+|++ |+.||.+.+...+...+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 22321 39999954 45558999999999999999999 999999886666555544433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=196.45 Aligned_cols=161 Identities=23% Similarity=0.395 Sum_probs=130.0
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+...+|++.+.||+|+||.||+|.++.++..||+|.++.. ....+.+.+|+.++++++||||+++++++.....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3456778899999999999999999999988999999998643 2346789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC-------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g------- 146 (218)
+++||||+++ +|.+++...... ++++.+ .+||
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999986 999998753221 233321 2222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYF 199 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~ 199 (218)
..|+|||.+ .+..++.++|||||||++|+|+| |+.||.+.+...+...+...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 435 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred CceeecCCCcCCcceeCHhHH-hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 239999965 44558999999999999999999 99999988766666555543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=179.30 Aligned_cols=158 Identities=24% Similarity=0.391 Sum_probs=126.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
-..++|.+.+.||+|+||.||+|.++.++..+|+|.+.... .....+.+.+|+.+++.++||||+++++++......++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 34578999999999999999999999999999999997653 33446789999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcc-----cC--------------------------Ccccc--------------ccccCC----
Q 041487 118 VFEYLDL-DLGSFIRKHT-----IT--------------------------SIRPH--------------IKEVGS---- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~-----~~--------------------------~~~~~--------------~~~~g~---- 147 (218)
||||+++ +|.+++.... .. +++|. +.++|.
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999987 8888774321 10 22222 222322
Q ss_pred -------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 148 -------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 -------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||.+ . +.++.++|||||||++|+|++|+.||.+............
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~ 239 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVF-K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239 (285)
T ss_dssp ---------CTTGGGCCHHHH-T-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccCcCcccccCcCChHHh-c-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence 29999954 3 3478999999999999999999999998766665555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=179.91 Aligned_cols=178 Identities=29% Similarity=0.427 Sum_probs=132.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYVY 116 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 116 (218)
..++|++.+.||+|+||.||+|.++.+++.||+|.+..........+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 357899999999999999999999999999999999865555555678999999999999999999999875 467899
Q ss_pred EEEecCCC-ChHHHhhhccc------------------------------------CCccccc-----------ccc---
Q 041487 117 LVFEYLDL-DLGSFIRKHTI------------------------------------TSIRPHI-----------KEV--- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~------------------------------------~~~~~~~-----------~~~--- 145 (218)
+||||+++ +|.+++..... .++++.+ .++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999987 99888765321 0222221 122
Q ss_pred ---------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc----cc
Q 041487 146 ---------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN----YL 206 (218)
Q Consensus 146 ---------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~----~~ 206 (218)
...|+|||.+. +..++.++||||||+++|+|++|+.||...+...+...+.....+.. +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eeeccccccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence 12399999554 45589999999999999999999999998765555554444332222 23
Q ss_pred chhhhhhhccc
Q 041487 207 VLPCFLSIMLL 217 (218)
Q Consensus 207 ~~~~~~~~~l~ 217 (218)
.+-+++..||+
T Consensus 243 ~l~~li~~~l~ 253 (279)
T 2w5a_A 243 ELNEIITRMLN 253 (279)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHHcC
Confidence 34445555543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=176.75 Aligned_cols=161 Identities=32% Similarity=0.485 Sum_probs=128.6
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
......++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34456788999999999999999999998899999999998665555667889999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccCC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVGS----- 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g~----- 147 (218)
.+++||++.+ +|.+++...... ++++. +.++|.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999976 888877543221 22222 223331
Q ss_pred ------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 ------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 ------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||.+ .+. ++.++||||||+++|+|++|+.||.+.+...+...+.
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~-~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVL-RGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHH-TTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccccccCcccccChHHh-cCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 28999954 343 8999999999999999999999998875554444433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=178.37 Aligned_cols=158 Identities=25% Similarity=0.432 Sum_probs=125.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..+..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 3466789999999999999999999999899999999986543 123445788999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC---------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--------- 146 (218)
.+++|||+++ +|.+++...... ++++.+ .++|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999987 998887654321 222221 2222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++||||||+++|+|++|+.||..........
T Consensus 169 ~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 222 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEM-IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR 222 (284)
T ss_dssp BCCCCSCGGGCCHHH-HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cccccCCCCcCCHHH-hccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH
Confidence 23999995 445568999999999999999999999998765444433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=177.76 Aligned_cols=156 Identities=28% Similarity=0.411 Sum_probs=122.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|.+.+.||+|+||.||+|.+..+++.||+|.++.... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 35789999999999999999999999999999999975322 2245788999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g---------- 146 (218)
|||+++ +|.+++...... ++++.+ .++|
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 999976 998887653321 222221 2222
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.......+...+.
T Consensus 165 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (304)
T 2jam_A 165 STACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220 (304)
T ss_dssp HHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 239999954 45568999999999999999999999998875554444443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=181.82 Aligned_cols=149 Identities=23% Similarity=0.370 Sum_probs=119.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC--EE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR--YV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 115 (218)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 456789999999999999999999999999999999875332 233677889999999999999999999987654 78
Q ss_pred EEEEecCCC-ChHHHhhhcccC------------------------------Cccccc---------------cccC---
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT------------------------------SIRPHI---------------KEVG--- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~~~---------------~~~g--- 146 (218)
++||||+++ +|.+++...... +++|.+ .++|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999986 999888754321 333322 2222
Q ss_pred --------------CcccCcccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------SPYKAPESRIR-------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------~~y~aPE~~~~-------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.. +..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23999996542 456899999999999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=178.19 Aligned_cols=157 Identities=25% Similarity=0.358 Sum_probs=123.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
.+..++|++.+.||+|+||.||+|.++ ++..||+|.++... ...+.+.+|+.++++++||||+++++++......+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 466789999999999999999999764 56789999987433 23467899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---------- 146 (218)
+||||+++ +|.+++...... +++|.+ .++|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999976 899988664321 333322 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220 (268)
T ss_dssp EECCSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred hcccCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence 139999954 45558999999999999999999 9999987755554444443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=186.65 Aligned_cols=160 Identities=31% Similarity=0.552 Sum_probs=123.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE-----
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY----- 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 114 (218)
.++|.+.+.||+|+||.||+|.++.+++.||+|.+..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 578999999999999999999999999999999997554444456788899999999999999999999976543
Q ss_pred -EEEEEecCCCChHHHhhhccc-------------------------CCccccc-----------cccC-----------
Q 041487 115 -VYLVFEYLDLDLGSFIRKHTI-------------------------TSIRPHI-----------KEVG----------- 146 (218)
Q Consensus 115 -~~lv~E~~~~~L~~~~~~~~~-------------------------~~~~~~~-----------~~~g----------- 146 (218)
.+++|||++++|.+++..... .+++|.+ .++|
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 182 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCccc
Confidence 599999998877766543211 0333322 2222
Q ss_pred ----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHh
Q 041487 147 ----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYF 199 (218)
Q Consensus 147 ----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~ 199 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+ .+.+..+.+..
T Consensus 183 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 240 (353)
T 3coi_A 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240 (353)
T ss_dssp -CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred cccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 239999976665678999999999999999999999998764 33444444433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=182.00 Aligned_cols=151 Identities=22% Similarity=0.386 Sum_probs=114.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
++..++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.++...++.++||||+++++++...+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 35678999999999999999999999999999999999754333333444555555688889999999999999999999
Q ss_pred EEEecCCCChHHHhhhc----c-c---------------------------CCccccc-----------cccC-------
Q 041487 117 LVFEYLDLDLGSFIRKH----T-I---------------------------TSIRPHI-----------KEVG------- 146 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~----~-~---------------------------~~~~~~~-----------~~~g------- 146 (218)
+||||++++|.+++... . . .+++|.+ .++|
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99999998887776431 0 0 0222222 2222
Q ss_pred ----------CcccCcccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----------SPYKAPESR---IRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----------~~y~aPE~~---~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .....++.++|||||||++|+|++|+.||...
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 239999965 34566889999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=183.95 Aligned_cols=156 Identities=26% Similarity=0.396 Sum_probs=122.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC---CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN---EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 3577999999999999999999999999999999997542 2445678899999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcc------------------------------------------------------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHT------------------------------------------------------------ 134 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~------------------------------------------------------------ 134 (218)
++||||+++ +|.+++....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999976 8888774100
Q ss_pred -----c--CCccc-------------cccccC----------------------CcccCcccccC-CCCCCCcchHHHHH
Q 041487 135 -----I--TSIRP-------------HIKEVG----------------------SPYKAPESRIR-SSVYSTPHDVWAVG 171 (218)
Q Consensus 135 -----~--~~~~~-------------~~~~~g----------------------~~y~aPE~~~~-~~~~~~~~DiwSlG 171 (218)
. .+++| .+.++| ..|+|||.+.. ...++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 0 02222 222232 12999996654 35689999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchHHH
Q 041487 172 CIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 172 ~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
|++|+|++|+.||.+.+......
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~ 286 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTIS 286 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHH
Confidence 99999999999998874443333
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=180.23 Aligned_cols=155 Identities=14% Similarity=0.239 Sum_probs=121.7
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC--C
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG--R 113 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 113 (218)
..+..++|++.+.||+|+||.||+|.+ .+..+|+|++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 346678999999999999999999997 588999999986554555567899999999999999999999999876 7
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-------------------------------Cccccc-----------c--c----
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-------------------------------SIRPHI-----------K--E---- 144 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------~~~~~~-----------~--~---- 144 (218)
..+++|||+++ +|.+++...... +++|.+ . +
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 89999999986 999998765321 222221 0 0
Q ss_pred -------cCCcccCcccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 145 -------VGSPYKAPESRIRSSV--YSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 145 -------~g~~y~aPE~~~~~~~--~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
.+..|+|||.+..... ++.++|||||||++|+|++|+.||...+....
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 1223999996654332 23379999999999999999999987754444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=187.62 Aligned_cols=169 Identities=22% Similarity=0.379 Sum_probs=129.2
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEE-----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLN-----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
....+..++|++.+.||+|+||.||+|.. ..++..||+|.++.. ........+.+|+.+++.++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34456678999999999999999999994 456789999998632 233345678899999999999999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc-----------
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI----------- 142 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~----------- 142 (218)
+......++||||+++ +|.+++...... +++|.+
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 9999999999999977 999988764310 233322
Q ss_pred ---cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 143 ---KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 ---~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
.+|| ..|+|||.+. +..++.++|||||||++|+|++ |..||.......+...+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 1221 2399999554 4558999999999999999998 9999998866666665554
Q ss_pred hcccCc
Q 041487 199 FTALTN 204 (218)
Q Consensus 199 ~~~~~~ 204 (218)
...+..
T Consensus 302 ~~~~~~ 307 (367)
T 3l9p_A 302 GGRMDP 307 (367)
T ss_dssp TCCCCC
T ss_pred CCCCCC
Confidence 443333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=178.98 Aligned_cols=179 Identities=19% Similarity=0.338 Sum_probs=132.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCC-------cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETG-------KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
.+..++|++.+.||+|+||.||+|.++.++ ..||+|.+... .....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 466789999999999999999999988776 47999998643 334467899999999999999999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccc-------------------c
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRP-------------------H 141 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~-------------------~ 141 (218)
...+..++||||+++ +|.+++...... +++| .
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999986 999998765421 2222 2
Q ss_pred ccccCC--------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHHhccc--Cc
Q 041487 142 IKEVGS--------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCGKKDHLSLIVRYFTAL--TN 204 (218)
Q Consensus 142 ~~~~g~--------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~~~~~~~~~~~~~~~~--~~ 204 (218)
+.++|. .|+|||.+.....++.++|||||||++|+|++| .+||...+.............. ..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (289)
T 4fvq_A 162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK 241 (289)
T ss_dssp ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCS
T ss_pred eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCC
Confidence 233433 399999766546689999999999999999995 5666655444444333322211 22
Q ss_pred ccchhhhhhhccc
Q 041487 205 YLVLPCFLSIMLL 217 (218)
Q Consensus 205 ~~~~~~~~~~~l~ 217 (218)
+..+-+++..||+
T Consensus 242 ~~~l~~li~~~l~ 254 (289)
T 4fvq_A 242 AAELANLINNCMD 254 (289)
T ss_dssp SCTTHHHHHHHSC
T ss_pred CHHHHHHHHHHcC
Confidence 3344455555553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=188.66 Aligned_cols=158 Identities=30% Similarity=0.576 Sum_probs=119.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------C
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------G 112 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 112 (218)
...+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3457999999999999999999999999999999986432 123479999999999999999999853 2
Q ss_pred CEEEEEEecCCCChHHHhhhc----cc---------------------------CCcccc------------ccccCC--
Q 041487 113 RYVYLVFEYLDLDLGSFIRKH----TI---------------------------TSIRPH------------IKEVGS-- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~~L~~~~~~~----~~---------------------------~~~~~~------------~~~~g~-- 147 (218)
..+++||||+++++.+.+... .. .++++. +.+||.
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 347899999998776654321 00 022222 223332
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
.|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+++.++.+
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2999997666657999999999999999999999999987 345666666655544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=194.27 Aligned_cols=149 Identities=26% Similarity=0.438 Sum_probs=122.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 56788999999999999999999999999999999997543 22344677889999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------ccc----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~---------- 145 (218)
+||||+++ +|.+++...... +++|.+ .++
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999976 998887654321 333322 222
Q ss_pred ------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 341 ~~~~~~GT~~Y~APEvl-~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CEECCCSCGGGCCHHHH-TTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cccccCCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 22 39999955 4555899999999999999999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=190.68 Aligned_cols=166 Identities=23% Similarity=0.397 Sum_probs=127.2
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....+..++|++.+.||+|+||.||+|... .+..||||.++... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 345677889999999999999999999874 57789999987432 34678999999999999999999999986 56
Q ss_pred EEEEEEecCCC-ChHHHhhhccc---C--------------------------Cccccc-----------cccC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~~-----------~~~g------ 146 (218)
.+++||||+.+ +|.+++..... . ++++.+ .+||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 78999999986 99999864321 1 233322 2222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcc
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 205 (218)
..|+|||.+ ....++.++|||||||++|+|+| |+.||.+.+...+...+.....++.+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 407 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 407 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred CCceeccCCCcccccccCHHHh-ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 239999955 44558999999999999999999 99999987655555555443333333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=190.15 Aligned_cols=161 Identities=25% Similarity=0.421 Sum_probs=124.4
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.++...+|++.+.||+|+||.||+|.++ ..+..||+|.++... .....+.+.+|+.++++++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 4567789999999999999999999876 457789999987432 333456799999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------ 146 (218)
...++||||+++ +|.+++...... +++|.+ .++|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999976 999998654321 333322 2222
Q ss_pred ---------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 ---------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 ---------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++|||||||++|++++ |+.||.......+...+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ---------------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred cCCccceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 139999955 45558999999999999999998 9999987765555554443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=181.68 Aligned_cols=150 Identities=28% Similarity=0.365 Sum_probs=119.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 345789999999999999999999999999999999874422 24588999999999 9999999999999999999
Q ss_pred EEEecCCCChHHHhhhcccC----------------------------Cccc----------------ccccc-------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT----------------------------SIRP----------------HIKEV------- 145 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~----------------------------~~~~----------------~~~~~------- 145 (218)
+||||+.++|.+++...... +++| .+.+|
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999977999998753111 2222 11222
Q ss_pred -----------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 146 -----------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 146 -----------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
| ..|+|||. ..+..++.++|||||||++|+|++|+.||.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINT-HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred cCCCCccccccccCCcCCCccccChHH-HcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 1 34999995 4456689999999999999999999999998644433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=183.50 Aligned_cols=163 Identities=28% Similarity=0.431 Sum_probs=124.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC---------chHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG---------VPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
...++|++.+.||+|+||.||+|.+.. +..||+|.+........ ..+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456889999999999999999998754 89999999975443322 13788999999999999999999999
Q ss_pred EEe-----CCEEEEEEecCCCChHHHhhhcccC----------------------------Cccccc-----------cc
Q 041487 109 LTT-----GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KE 144 (218)
Q Consensus 109 ~~~-----~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~ 144 (218)
+.. ...+++||||++++|.+++...... +++|.+ .+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 843 3479999999999888887654211 333322 22
Q ss_pred cCC-----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhcc
Q 041487 145 VGS-----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTA 201 (218)
Q Consensus 145 ~g~-----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~ 201 (218)
+|. .|+|||.+.....++.++|||||||++|+|++|+.||.+.. .+.+..+....+.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 322 28999976665778999999999999999999999998873 3444444444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=175.45 Aligned_cols=148 Identities=27% Similarity=0.489 Sum_probs=120.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 468999999999999999999999899999999997543 2345678999999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC--------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG-------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g-------------- 146 (218)
||+++ +|.+++...... ++++.+ .++|
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99987 888887653221 222221 1121
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++||||||+++|+|++|+.||....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 239999966555545778999999999999999999998763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=183.19 Aligned_cols=158 Identities=23% Similarity=0.429 Sum_probs=127.5
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+..++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 34566789999999999999999999999999999999997542 33445788999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
.++||||+++ +|.+++...... +++|.+ .++|
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999987 998887653221 333322 2333
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||...+...+..
T Consensus 186 ~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 240 (360)
T 3eqc_A 186 MANSFVGTRSYMSPER-LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240 (360)
T ss_dssp C----CCCCTTCCHHH-HTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred cccCCCCCCCeECHHH-HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23999995 455568999999999999999999999998775554433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=187.12 Aligned_cols=162 Identities=28% Similarity=0.607 Sum_probs=127.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC------CCCCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL------EHDNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 111 (218)
....+|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.+++.+ +|+||+++++.+..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3456799999999999999999999999999999998632 23345677788877776 57799999999999
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccc-------------cccccCC--
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRP-------------HIKEVGS-- 147 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~-------------~~~~~g~-- 147 (218)
...++++|||++++|.+++...... +++| ++.+||.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999999999999888765321 2222 3334443
Q ss_pred -------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 148 -------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 148 -------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
.|+|||.+. +..++.++|||||||++|+|++|++||.+. ..+.+..+++.++.++
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCCcccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 299999654 455899999999999999999999999987 4455666666555544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-25 Score=175.88 Aligned_cols=154 Identities=20% Similarity=0.332 Sum_probs=123.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|.+.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 456789999999999999999999999999999999976543 2344678889999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------- 146 (218)
++|||+++ +|.+++...... ++++.+ .++|
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999986 888887654321 222221 1221
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||........
T Consensus 172 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp BCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 239999954 555689999999999999999999999987654433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-25 Score=179.92 Aligned_cols=156 Identities=21% Similarity=0.332 Sum_probs=124.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
....+|.+.+.||+|+||.||++.+..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 446789999999999999999999999999999999976543 2345678899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----------- 146 (218)
+||||+++ +|.+++...... ++++.+ .++|
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999986 888887653221 222221 2222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSL 194 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~ 194 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||..........
T Consensus 198 ~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 251 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251 (335)
T ss_dssp BCCCCSCCSSCCHHHH-HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ccccCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 239999955 45558999999999999999999999998765444333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=177.88 Aligned_cols=159 Identities=23% Similarity=0.346 Sum_probs=122.1
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
...+..++|++.+.||+|+||.||+|.+. .+..||+|.++... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 44577889999999999999999999875 67789999987432 234678999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
.++||||+++ +|.+++...... +++|.+ .++|
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999976 899988652211 333322 2222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+. +..++.++||||||+++|+|+| |+.||...+.......+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 236 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ccccccCCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc
Confidence 1399999554 4458999999999999999999 9999998765555554443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=184.53 Aligned_cols=149 Identities=30% Similarity=0.488 Sum_probs=113.0
Q ss_pred cceeE--EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 41 WNYKV--VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 41 ~~~~~--~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..|.+ .+.||+|+||.||+|.+..++..||+|+++... ....+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34555 678999999999999999999999999987432 23457889999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccC----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVG---------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g---------- 146 (218)
|||+++ +|.+++...... +++|.+ .++|
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999986 888877543211 333322 2222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 245 ~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 296 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296 (373)
T ss_dssp CCCCCSSCTTCCHHH-HTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccccCCCcEeChhh-ccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23999995 4556689999999999999999999999988754433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=184.15 Aligned_cols=142 Identities=28% Similarity=0.522 Sum_probs=114.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|.++.+++.||+|++++... ...+|+.++.++ +||||+++++++.+...+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 35779999999999999999999999999999999975432 134678888887 79999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Ccccc---------------ccccC--------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPH---------------IKEVG-------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~---------------~~~~g-------- 146 (218)
||||+++ +|.+++...... +++|. +.++|
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999986 888887654321 22222 12222
Q ss_pred ----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. +..++.++|||||||++|+|++|+.||...
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 2399999654 444788999999999999999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=199.04 Aligned_cols=162 Identities=22% Similarity=0.333 Sum_probs=126.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
...+..++|++++.||+|+||.||+|.++.+++.||+|++++.. ......+.+..|..++..+ .||+|+++++++.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34466789999999999999999999999999999999997542 2234457788899999888 799999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
..+|+||||+++ +|.+++...... +++|.+ .+||
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999987 898888654321 333332 2232
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||. ..+..++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 495 ~~~~~~~~~GT~~Y~APE~-l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHH-HTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccccccCCCcccCHhh-hcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 23999995 456668999999999999999999999999876555555444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=183.23 Aligned_cols=166 Identities=33% Similarity=0.481 Sum_probs=112.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
.......++|++.+.||+|+||.||+|.++.++..||+|.+.... .......+++..+..++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 334456789999999999999999999999999999999986432 22345677888889999999999999986432
Q ss_pred -------EEEEEEecCCCChHHHhhhc----c---------------------------c--CCccccc-----------
Q 041487 114 -------YVYLVFEYLDLDLGSFIRKH----T---------------------------I--TSIRPHI----------- 142 (218)
Q Consensus 114 -------~~~lv~E~~~~~L~~~~~~~----~---------------------------~--~~~~~~~----------- 142 (218)
.+++||||++++|.+.+... . . .+++|.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 38999999998765543320 0 0 0222221
Q ss_pred -cccCC-----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhccc
Q 041487 143 -KEVGS-----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTAL 202 (218)
Q Consensus 143 -~~~g~-----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~~ 202 (218)
.++|. .|+|||.+.....++.++|||||||++|+|++|+.||.+.+ ...+..+.+..+.+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 22222 29999977666668999999999999999999999999873 34445555444433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-25 Score=177.60 Aligned_cols=161 Identities=41% Similarity=0.702 Sum_probs=122.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEc-cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEE----
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNL-ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLT---- 110 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 110 (218)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999985 6788999999976544444445567787777766 8999999999987
Q ss_pred -eCCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc-----------cccC---
Q 041487 111 -TGRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG--- 146 (218)
Q Consensus 111 -~~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g--- 146 (218)
.....++||||++++|.+++...... ++++.+ .++|
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 56779999999999999988664321 222221 2222
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhc
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFT 200 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~ 200 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.+.. .+.+..+....+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCCCCccccccccceeCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 238999954 45558999999999999999999999998873 344445554443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=176.45 Aligned_cols=150 Identities=28% Similarity=0.531 Sum_probs=110.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3468999999999999999999998899999999997543 223446789999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----------- 146 (218)
+|||+++ +|.+++...... +++|.+ .++|
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999987 898887654211 233322 1222
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||.....
T Consensus 169 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 169 HYTLCGTPNYISPEIA-TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred ceeccCCCCcCCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 239999954 455588999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-25 Score=178.62 Aligned_cols=161 Identities=19% Similarity=0.348 Sum_probs=126.0
Q ss_pred hhhhccceeEE-EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCC
Q 041487 36 EKVKDWNYKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGR 113 (218)
Q Consensus 36 ~~~~~~~~~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (218)
.+...+.|.+. +.||+|+||.||+|.++.+++.||+|+++...........+.+|+.+++.+ .||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 33446678887 899999999999999999999999999986555555577899999999999 5699999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc--------------ccc----
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI--------------KEV---- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~--------------~~~---- 145 (218)
..++||||+.+ +|.+++...... +++|.+ .++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 99999999987 888877442111 233321 122
Q ss_pred ------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 146 ------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 146 ------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
| ..|+|||. ..+..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEI-LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp EC---------CCCGGGCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCccccccccCCcCccCCee-ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 2 23999995 455668999999999999999999999998875554444433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=179.82 Aligned_cols=162 Identities=21% Similarity=0.364 Sum_probs=123.8
Q ss_pred hhhhccceeEEE-EeeecCceEEEEEEE--ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 36 EKVKDWNYKVVE-KIGQGVFGEVYKCLN--LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 36 ~~~~~~~~~~~~-~ig~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
..+...+|++.+ .||+|+||.||+|.+ ...+..||+|+++.........+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345678899998 999999999999954 45678999999976544455577899999999999999999999999 56
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
...++||||+++ +|.+++...... ++++.+ .++|
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 678999999986 999988764321 333322 1221
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYF 199 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~ 199 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...+...+...+...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CCCcccccccCCCCceeeChHHh-ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 239999965 44457889999999999999999 99999987666655555543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=181.56 Aligned_cols=149 Identities=28% Similarity=0.554 Sum_probs=120.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----C
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----R 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 113 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 467899999999999999999999999999999998632 2223456788999999999999999999987653 6
Q ss_pred EEEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccC----------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g---------- 146 (218)
..+++|||++++|.+++...... ++++.+ .++|
T Consensus 88 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred eEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 79999999999888887653221 222221 1222
Q ss_pred ------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 ------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 ------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+.+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 239999977666778999999999999999999999998874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-24 Score=175.37 Aligned_cols=150 Identities=27% Similarity=0.473 Sum_probs=113.9
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.....+.|++.+.||+|+||.||+|.+..++..||+|.+... ...+.+.+|+.+++.++||||+++++++......
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 344567899999999999999999999989999999998743 2346789999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------- 146 (218)
++||||+++ +|.+++...... +++|.+ .++|
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999988 999888632211 222221 1221
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||......
T Consensus 180 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 231 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM 231 (314)
T ss_dssp SCBCCCCSCGGGCCHHHH-SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cccCccCCCCCccChhhc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Confidence 238999954 4556899999999999999999999999876443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=186.20 Aligned_cols=149 Identities=31% Similarity=0.534 Sum_probs=118.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC--CCCeeeeeeeEEeCCEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE--HDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 115 (218)
+....|++.+.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+++.+. ||||+++++++.....+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 345569999999999999999998754 899999999865555555678999999999996 59999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC---------------------------Cccccc----------ccc-------------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI----------KEV------------- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~----------~~~------------- 145 (218)
++|||+..++|.+++...... +++|.+ .+|
T Consensus 132 ~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccc
Confidence 999997777999888664321 333322 222
Q ss_pred ------CC-cccCcccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------GS-PYKAPESRIR----------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------g~-~y~aPE~~~~----------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+ .|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 22 3999996643 235889999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=181.11 Aligned_cols=164 Identities=23% Similarity=0.396 Sum_probs=129.1
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
...+..++|.+.+.||+|+||.||+|.+. .++..||+|.++.. ......+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 44566789999999999999999999873 34588999998743 2334457889999999999999999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc-------------------------C--------------------------C
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI-------------------------T--------------------------S 137 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~-------------------------~--------------------------~ 137 (218)
...+..++||||+++ +|.+++..... . +
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999985 99999876422 0 2
Q ss_pred ccccc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 041487 138 IRPHI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFP 185 (218)
Q Consensus 138 ~~~~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~ 185 (218)
++|.+ .++| ..|+|||.+. +..++.++|||||||++|+|++ |+.||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 33321 2222 1299999654 4558999999999999999999 999999
Q ss_pred CCCcchHHHHHHHhc
Q 041487 186 CGKKDHLSLIVRYFT 200 (218)
Q Consensus 186 ~~~~~~~~~~~~~~~ 200 (218)
+.....+...+....
T Consensus 255 ~~~~~~~~~~~~~~~ 269 (314)
T 2ivs_A 255 GIPPERLFNLLKTGH 269 (314)
T ss_dssp TCCGGGHHHHHHTTC
T ss_pred CCCHHHHHHHhhcCC
Confidence 887777766665443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=182.64 Aligned_cols=162 Identities=28% Similarity=0.459 Sum_probs=126.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
...+..++|++.+.||+|+||.||+|.+.. ++..||+|.++... .....+.+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345677899999999999999999999863 45889999987432 333467889999999999999999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc-------------------------C--------------------------C
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI-------------------------T--------------------------S 137 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~-------------------------~--------------------------~ 137 (218)
...+..++||||+++ +|.+++..... . +
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 999999999999987 99999876321 0 2
Q ss_pred ccccc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 041487 138 IRPHI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFP 185 (218)
Q Consensus 138 ~~~~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~ 185 (218)
++|.+ .++| ..|+|||.+. +..++.++|||||||++|+|++ |+.||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 22221 2222 1399999554 4558999999999999999999 999998
Q ss_pred CCCcchHHHHHHH
Q 041487 186 CGKKDHLSLIVRY 198 (218)
Q Consensus 186 ~~~~~~~~~~~~~ 198 (218)
+.....+...+..
T Consensus 279 ~~~~~~~~~~~~~ 291 (343)
T 1luf_A 279 GMAHEEVIYYVRD 291 (343)
T ss_dssp TSCHHHHHHHHHT
T ss_pred CCChHHHHHHHhC
Confidence 8765555544443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-25 Score=184.69 Aligned_cols=151 Identities=26% Similarity=0.436 Sum_probs=115.9
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------CCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------PEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
.....++|.+.+.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.++++++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34456889999999999999999999999999999999975421 122234688999999999999999999997
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccCC
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVGS 147 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g~ 147 (218)
. ....++||||+++ +|.+++...... +++|. +.++|.
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5 4558999999987 888877543221 22222 223322
Q ss_pred -----------------cccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 -----------------PYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 -----------------~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 3999997643 355788999999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-24 Score=179.43 Aligned_cols=157 Identities=24% Similarity=0.470 Sum_probs=122.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC------CchHHHHHHHHHHhhC-CCCCeeeeeeeEEeC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE------GVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTG 112 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (218)
.++|++.+.||+|+||.||+|.++.+|+.||||+++...... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 467999999999999999999998899999999997543221 1245778999999999 899999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------- 146 (218)
...++||||+++ +|.+++...... +++|.+ .++|
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999987 999888654221 333322 2222
Q ss_pred ----------CcccCcccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 041487 147 ----------SPYKAPESRIR-----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ----------~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||...+.......+
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 23999996542 234788999999999999999999999876544444433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-25 Score=177.85 Aligned_cols=145 Identities=28% Similarity=0.534 Sum_probs=117.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEe--CCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTT--GRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~ 114 (218)
...++|++.+.||+|+||.||+|.+..+++.||+|+++. ...+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 346789999999999999999999999999999999863 23577999999999996 9999999999987 678
Q ss_pred EEEEEecCCC-ChHHHhhhcccC------------------------Ccccc------------ccccCC----------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT------------------------SIRPH------------IKEVGS---------- 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~------------------------~~~~~------------~~~~g~---------- 147 (218)
.+++|||+++ +|.+++...... +++|. +.++|.
T Consensus 108 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred eEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 9999999986 777776432111 33332 223322
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+|||.+.....++.++|||||||++|+|++|+.||...
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2899997766577999999999999999999999999544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=174.61 Aligned_cols=156 Identities=25% Similarity=0.359 Sum_probs=123.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 356789999999999999999999975 67889999987433 23467899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---------- 146 (218)
++|||+++ +|.+++...... +++|.+ .++|
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999986 999998764321 222221 1221
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...........+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~ 219 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219 (267)
T ss_dssp HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 139999954 45558999999999999999999 899998875555444443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-25 Score=176.03 Aligned_cols=153 Identities=23% Similarity=0.391 Sum_probs=120.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 457799999999999999999999999999999998643 334567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc-------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~------------- 145 (218)
|||+++ +|.+++...... +++|.+ .++
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 999987 888876542211 233322 122
Q ss_pred ----C-CcccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 146 ----G-SPYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 146 ----g-~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
| ..|+|||.+. ....++.++||||||+++|+|++|+.||...+.....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 231 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 2 2399999653 4566889999999999999999999999876544433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-24 Score=173.62 Aligned_cols=147 Identities=25% Similarity=0.379 Sum_probs=118.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe----CCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT----GRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 114 (218)
....|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3455899999999999999999999999999999998655555567789999999999999999999999864 567
Q ss_pred EEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc------------cccC------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI------------KEVG------ 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~------------~~~g------ 146 (218)
+++||||+++ +|.+++...... +++|.+ .++|
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999976 998888653221 222222 1222
Q ss_pred ----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+ .++.++|||||||++|+|++|+.||...
T Consensus 184 ~~~~~~~~~t~~y~aPE~~-~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMY-EE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TTSBEESCSSCCCCCGGGG-GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCCcCcCCHHHH-hc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 239999954 33 4899999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=177.62 Aligned_cols=162 Identities=23% Similarity=0.390 Sum_probs=122.2
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (218)
.....+..++|++.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 344567788999999999999999999998643 457999987643 2234456789999999999999999999998
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--- 146 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--- 146 (218)
. .+..++||||+++ +|.+++...... +++|.+ .++|
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 4 4568999999997 999988754311 333322 2222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~ 231 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231 (281)
T ss_dssp --------------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred ccCcccccccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence 139999954 45568999999999999999997 999999875555444443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-25 Score=183.76 Aligned_cols=168 Identities=23% Similarity=0.411 Sum_probs=130.3
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccC-------CcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLET-------GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVR 104 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 104 (218)
.....+..++|.+.+.||+|+||.||+|.+... +..||+|+++.. ......+.+.+|+.+++++ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 334467778999999999999999999997532 357999998743 2334457789999999999 9999999
Q ss_pred eeeeEEeCCEEEEEEecCCC-ChHHHhhhccc-----------------C--------------------------Cccc
Q 041487 105 LLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------------T--------------------------SIRP 140 (218)
Q Consensus 105 ~~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------------~--------------------------~~~~ 140 (218)
+++++...+..++||||+++ +|.+++..... . +++|
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999987 99999876431 0 2333
Q ss_pred cc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 141 HI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 141 ~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
.+ .++| ..|+|||.+. +..++.++|||||||++|+|++ |+.||.+.+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22 2222 1399999554 5568999999999999999999 999999887
Q ss_pred cchHHHHHHHhccc
Q 041487 189 KDHLSLIVRYFTAL 202 (218)
Q Consensus 189 ~~~~~~~~~~~~~~ 202 (218)
...+...+.....+
T Consensus 299 ~~~~~~~~~~~~~~ 312 (382)
T 3tt0_A 299 VEELFKLLKEGHRM 312 (382)
T ss_dssp HHHHHHHHHTTCCC
T ss_pred HHHHHHHHHcCCCC
Confidence 66666655544333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=188.29 Aligned_cols=159 Identities=25% Similarity=0.455 Sum_probs=123.2
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....+..++|++.+.||+|+||.||+|.+.. +..||+|.++... ...+.+.+|+.++++++||||+++++++.. .
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 3455778899999999999999999999753 5679999987432 235789999999999999999999999866 6
Q ss_pred EEEEEEecCCC-ChHHHhhhccc---C--------------------------Ccccc-----------ccccC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPH-----------IKEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~-----------~~~~g------ 146 (218)
..++||||+++ +|.+++..... . ++++. +.++|
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 68999999986 99999875311 1 22222 12222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+. +..++.++|||||||++|+|++ |+.||.+.....+...+..
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 396 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396 (452)
T ss_dssp -----------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred CCceecccCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 2399999654 4558999999999999999999 9999998755554444443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-25 Score=179.88 Aligned_cols=166 Identities=23% Similarity=0.414 Sum_probs=121.6
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcE----EEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
...+..++|++.+.||+|+||.||+|.+..++.. ||+|.++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3446778899999999999999999998777665 577776532 23345678999999999999999999999998
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---- 146 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---- 146 (218)
... .++++|++.+ +|.+++...... +++|.+ .+||
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 765 6778888876 898888664321 333332 2222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccC
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALT 203 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 203 (218)
..|+|||.+. +..++.++|||||||++|+|+| |+.||.+.....+...+.....++
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccCCcccccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC
Confidence 1499999654 5568999999999999999999 999999887777776666544333
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-24 Score=174.84 Aligned_cols=149 Identities=23% Similarity=0.426 Sum_probs=117.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT------ 111 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------ 111 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 4678999999999999999999999999999999987432 3347788999999999 89999999999976
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc-----------cccC----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI-----------KEVG---- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~g---- 146 (218)
...+++||||+++ +|.+++...... +++|.+ .++|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 5689999999988 999988753211 222221 2222
Q ss_pred --------------CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 147 --------------SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 147 --------------~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 23999996542 455889999999999999999999999876443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-24 Score=172.58 Aligned_cols=160 Identities=25% Similarity=0.462 Sum_probs=124.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC-------CchHHHHHHHHHHhhCC-CCCeeeeeeeE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE-------GVPSYLIAGVSLLKELE-HDNIVRLLDVL 109 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 109 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|+++...... ...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34688999999999999999999999999999999997543221 22456789999999995 99999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC----
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG---- 146 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g---- 146 (218)
......++||||+++ +|.+++...... ++++.+ .++|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999986 999998764321 222221 1222
Q ss_pred -------------CcccCccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -------------SPYKAPESRI-----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------~~y~aPE~~~-----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+. ....++.++||||||+++|+|++|+.||...+.......+.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 2399999654 24457899999999999999999999998775554444443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=183.00 Aligned_cols=105 Identities=21% Similarity=0.345 Sum_probs=85.5
Q ss_pred cCCChhhhhhhhccceeEEEEeeecCceEEEEEE-----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCC
Q 041487 28 KTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDN 101 (218)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 101 (218)
..+.......+..++|++.+.||+|+||.||+|. +..+++.||+|.++.. ......+.+.+|+.++.++ .|||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcc
Confidence 3444456667788999999999999999999998 4456689999999743 2233456789999999999 7899
Q ss_pred eeeeeeeEEeC-CEEEEEEecCCC-ChHHHhhhc
Q 041487 102 IVRLLDVLTTG-RYVYLVFEYLDL-DLGSFIRKH 133 (218)
Q Consensus 102 iv~~~~~~~~~-~~~~lv~E~~~~-~L~~~~~~~ 133 (218)
|+++++++... ..+++||||+++ +|.+++...
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 121 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTT
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhc
Confidence 99999998764 459999999988 999988654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=182.99 Aligned_cols=149 Identities=32% Similarity=0.545 Sum_probs=119.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC--CCeeeeeeeEEeCCEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH--DNIVRLLDVLTTGRYV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~ 115 (218)
+....|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+.+|+.+++.++| +||+++++++.....+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4567899999999999999999987 468899999998655454556788999999999976 9999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC---------------------------Cccccc----------ccc-------------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI----------KEV------------- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~----------~~~------------- 145 (218)
++|||+..++|.+++...... +++|.+ .+|
T Consensus 85 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccc
Confidence 999998777999988764332 333322 122
Q ss_pred ------C-CcccCcccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------G-SPYKAPESRIR----------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------g-~~y~aPE~~~~----------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 2 23999996543 255889999999999999999999999865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-24 Score=174.55 Aligned_cols=152 Identities=28% Similarity=0.491 Sum_probs=118.1
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
.....++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3345678999999999999999999998899999999997543 233446778899999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhccc-----C--------------------------Cccccc-----------cccC-----
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI-----T--------------------------SIRPHI-----------KEVG----- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~-----~--------------------------~~~~~~-----------~~~g----- 146 (218)
.+++|||+++ +|.+++..... . ++++.+ .++|
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999987 99888764210 0 222221 2222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||.+ .+..++.++||||||+++|+|++|+.||.+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp ------------CCSSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCccccccCCCeeEeChHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 239999954 45568999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=180.65 Aligned_cols=162 Identities=28% Similarity=0.392 Sum_probs=126.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEE--EEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKV--AIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
...+.+..++|++.+.||+|+||.||+|.++.++..+ ++|.++.. ......+.+.+|+.+++++ +||||+++++++
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 4566678899999999999999999999998888865 99988743 2334456789999999999 899999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhcc-----------------cC--------------------------Cccccc---
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHT-----------------IT--------------------------SIRPHI--- 142 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~-----------------~~--------------------------~~~~~~--- 142 (218)
...+..++||||+++ +|.+++.... .. +++|.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence 999999999999977 9999987643 00 333322
Q ss_pred --------cccC-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 143 --------KEVG-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 143 --------~~~g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
.++| ..|+|||.+ .+..++.++|||||||++|+|++ |+.||.+.+...+...+
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 2222 239999954 45558999999999999999998 99999887655444433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=177.68 Aligned_cols=149 Identities=30% Similarity=0.597 Sum_probs=115.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--------
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-------- 110 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------- 110 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 357899999999999999999999999999999998743 2344577889999999999999999999873
Q ss_pred ------eCCEEEEEEecCCCChHHHhhhcccC--------------------------Ccccc------------ccccC
Q 041487 111 ------TGRYVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPH------------IKEVG 146 (218)
Q Consensus 111 ------~~~~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~------------~~~~g 146 (218)
.....++||||++++|.+++...... +++|. +.++|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 44789999999999998887653321 22222 12222
Q ss_pred ---------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 ---------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 ---------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 2399999776667789999999999999999999999988743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=175.82 Aligned_cols=149 Identities=26% Similarity=0.440 Sum_probs=114.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
...++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 345789999999999999999999999999999999875421 12234568899999999999999999999876
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccC---
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVG--- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g--- 146 (218)
.. .++||||+++ +|.+++...... ++++. +.++|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 8999999987 888877543221 22222 22333
Q ss_pred --------------CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. ....++.++|||||||++|+|++|+.||...
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 2399999653 3456889999999999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=177.51 Aligned_cols=163 Identities=21% Similarity=0.346 Sum_probs=120.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEcc---CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLE---TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
...+..++|.+.+.||+|+||.||+|.... ++..||+|.++.........+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334567889999999999999999998765 45689999997655455556789999999999999999999999875
Q ss_pred CC-----EEEEEEecCCC-ChHHHhhhccc------C---------------------------Cccccc----------
Q 041487 112 GR-----YVYLVFEYLDL-DLGSFIRKHTI------T---------------------------SIRPHI---------- 142 (218)
Q Consensus 112 ~~-----~~~lv~E~~~~-~L~~~~~~~~~------~---------------------------~~~~~~---------- 142 (218)
.. ..+++|||+++ +|.+++..... . +++|.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 44 35999999987 99988743211 0 222221
Q ss_pred -cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 143 -KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 -~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
.++| ..|+|||.+ .+..++.++||||||+++|+|++ |..||.......+...+..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhh-cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 2222 139999955 45568999999999999999999 8999998766555554443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=179.22 Aligned_cols=141 Identities=29% Similarity=0.501 Sum_probs=106.6
Q ss_pred cceeEE---EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEE
Q 041487 41 WNYKVV---EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 41 ~~~~~~---~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 116 (218)
++|.+. +.||+|+||.||+|.++.+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 456664 7899999999999999999999999998642 3467889999999996 999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------ccccC--------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEVG-------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~g-------- 146 (218)
+||||+++ +|.+++...... +++|. +.++|
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999987 999888764321 23332 22232
Q ss_pred ----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 163 ~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCcccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 239999954 5556899999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=180.83 Aligned_cols=164 Identities=23% Similarity=0.396 Sum_probs=124.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEE-----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLD 107 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (218)
.....+..++|++.+.||+|+||.||+|. +..++..||+|.+... ........+.+|+.++++++||||+++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 55666788999999999999999999998 4467889999998633 23344567889999999999999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc----------
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI---------- 142 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~---------- 142 (218)
++......++||||+++ +|.+++...... +++|.+
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 99999999999999976 999998764310 222221
Q ss_pred ----ccc--------------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 143 ----KEV--------------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 143 ----~~~--------------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
.++ ...|+|||.+. +..++.++|||||||++|+|+| |+.||.......+...+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 111 12399999554 4558999999999999999999 999998876555555444
Q ss_pred H
Q 041487 198 Y 198 (218)
Q Consensus 198 ~ 198 (218)
.
T Consensus 260 ~ 260 (327)
T 2yfx_A 260 S 260 (327)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=181.53 Aligned_cols=161 Identities=31% Similarity=0.499 Sum_probs=123.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CC-----CeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HD-----NIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~ 111 (218)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.+. |+ +++++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3467899999999999999999999999999999998632 223456777888888774 44 49999999999
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC-------------------------------Ccccc-------------ccccCC
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT-------------------------------SIRPH-------------IKEVGS 147 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~-------------------------------~~~~~-------------~~~~g~ 147 (218)
....++||||++++|.+++...... +++|. +.++|.
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999999999999887654211 22222 223332
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
.|+|||.+ .+..++.++|||||||++|+|++|+.||.+. ..+.+..+.+..+.+
T Consensus 208 a~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 208 SCQLGQRIYQYIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred ceecccccccccCCccccChHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 29999955 4556899999999999999999999999987 445555555554444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=179.38 Aligned_cols=160 Identities=22% Similarity=0.390 Sum_probs=123.6
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
.++...+|++.+.||+|+||.||+|..+.++ ..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 4567789999999999999999999876543 469999987432 23345678899999999999999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----- 146 (218)
.+..++||||+++ +|.+++...... ++++.+ .++|
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999988 999988654211 233322 2222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|+|++ |+.||.......+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp -------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccccccccCCCCccccccCchhc-ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 139999955 45558999999999999999999 999998775555444444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=173.53 Aligned_cols=157 Identities=21% Similarity=0.324 Sum_probs=121.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCc-----hHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV-----PSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
..+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+......... .+.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 34557788999999999999999999999999999999998754433322 2788999999999999999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhcccC------------------------------Cccc----------------c
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTIT------------------------------SIRP----------------H 141 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~----------------~ 141 (218)
+.... ++||||+++ +|.+++...... +++| .
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 97665 699999985 887776443211 2222 2
Q ss_pred ccccCC---------------cccCccccc-CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 142 IKEVGS---------------PYKAPESRI-RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 142 ~~~~g~---------------~y~aPE~~~-~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
+.++|. .|+|||.+. ....++.++|||||||++|+|++|+.||........
T Consensus 170 l~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp ECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred eCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 223332 399999653 344478899999999999999999999987754444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=182.40 Aligned_cols=159 Identities=28% Similarity=0.557 Sum_probs=116.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG----- 112 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 112 (218)
....+|++.+.||+|+||.||+|.+..++. +|+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 345679999999999999999999876655 88887753221 123799999999999999999998543
Q ss_pred -CEEEEEEecCCCChHHHhhhc----c-c--------------------------CCcccc------------ccccCC-
Q 041487 113 -RYVYLVFEYLDLDLGSFIRKH----T-I--------------------------TSIRPH------------IKEVGS- 147 (218)
Q Consensus 113 -~~~~lv~E~~~~~L~~~~~~~----~-~--------------------------~~~~~~------------~~~~g~- 147 (218)
..+++||||+++++.+.+... . . .+++|. +.+||.
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 348999999988665543321 0 0 033332 223332
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
.|+|||.+.....++.++|||||||++|+|++|+.||.+. ..+.+..+++.++.++
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 2999997666666999999999999999999999999987 4456666666655443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=184.58 Aligned_cols=160 Identities=33% Similarity=0.635 Sum_probs=116.8
Q ss_pred ccceeE-EEEeeecCceEEEEEEEc--cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCE
Q 041487 40 DWNYKV-VEKIGQGVFGEVYKCLNL--ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRY 114 (218)
Q Consensus 40 ~~~~~~-~~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 114 (218)
.+.|.+ .+.||+|+||.||+|.++ .++..||+|.+... .....+.+|+.+++.++||||+++++++. ....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345776 457999999999999976 46889999998633 23356889999999999999999999995 4778
Q ss_pred EEEEEecCCCChHHHhhhcc----------c--------------------------CCcccc---------------cc
Q 041487 115 VYLVFEYLDLDLGSFIRKHT----------I--------------------------TSIRPH---------------IK 143 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~----------~--------------------------~~~~~~---------------~~ 143 (218)
+++||||++++|.+++.... . .+++|. +.
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999999988887765321 0 022322 22
Q ss_pred ccCC---------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----------chH
Q 041487 144 EVGS---------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK----------DHL 192 (218)
Q Consensus 144 ~~g~---------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~----------~~~ 192 (218)
++|. .|+|||.+.....++.++|||||||++|+|++|++||.+... +.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 2321 299999766656689999999999999999999999986632 566
Q ss_pred HHHHHHhcccC
Q 041487 193 SLIVRYFTALT 203 (218)
Q Consensus 193 ~~~~~~~~~~~ 203 (218)
..+...++.++
T Consensus 255 ~~i~~~~g~p~ 265 (405)
T 3rgf_A 255 DRIFNVMGFPA 265 (405)
T ss_dssp HHHHHHHCCCC
T ss_pred HHHHHhhCCCC
Confidence 66666666554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=178.44 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=117.7
Q ss_pred hhhhccceeEEEEeeecCceEEEEEE----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCL----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
.++..++|++.+.||+|+||.||+|. +..+++.||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999998 4567899999998632 33445678999999999999999999999854
Q ss_pred --CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC--
Q 041487 112 --GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS-- 147 (218)
Q Consensus 112 --~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~-- 147 (218)
...+++||||+++ +|.+++...... +++|.+ .++|.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4568999999976 999998764321 333322 22221
Q ss_pred -------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 148 -------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 148 -------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.|+|||.+ .+..++.++||||||+++|+|+||..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHh-cCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 29999954 4555899999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=176.93 Aligned_cols=167 Identities=23% Similarity=0.400 Sum_probs=127.5
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEE----EEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKV----AIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
..+..++|++.+.||+|+||.||+|.+..++..+ ++|.+... ......+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 3466789999999999999999999988777655 66665432 344567889999999999999999999999987
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS---- 147 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~---- 147 (218)
.. .++++|++.+ +|.+++...... +++|.+ .+||.
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 6778888876 899888654321 333332 22222
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcc
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 205 (218)
.|+|||.+. +..++.++|||||||++|+|++ |+.||.+.....+...+.....++.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp ------------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cCccccccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 399999554 5568999999999999999999 99999988777777766654444333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=176.14 Aligned_cols=148 Identities=23% Similarity=0.292 Sum_probs=121.3
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+..+..+ +||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35789999999999999999999999999999999986655555667888999999999 99999999999999999999
Q ss_pred EEecCCC-ChHHHhhhccc-----C--------------------------Ccccc------------------------
Q 041487 118 VFEYLDL-DLGSFIRKHTI-----T--------------------------SIRPH------------------------ 141 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~-----~--------------------------~~~~~------------------------ 141 (218)
||||+++ +|.+++..... . +++|.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 9999987 99999875411 1 23322
Q ss_pred ------ccccC--------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 142 ------IKEVG--------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 142 ------~~~~g--------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
+.++| ..|+|||.+.....++.++|||||||++|+|++|.+|+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred CceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 22222 2399999766555677899999999999999999887754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=175.02 Aligned_cols=147 Identities=23% Similarity=0.325 Sum_probs=114.4
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++.+.||+|+||.||+|.++.+++.||+|.+...............|+..+.++ +||||+++++++...+.++
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 445789999999999999999999999999999999865443333344555566555555 9999999999999999999
Q ss_pred EEEecCCCChHHHhhhcccC----------------------------Cccccc-----------cccC-----------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----------- 146 (218)
+||||++++|.+++...... +++|.+ .+||
T Consensus 134 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 134 LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 99999998998887654321 333322 2333
Q ss_pred ------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 ------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 ------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+. + .++.++|||||||++|+|++|..|+..
T Consensus 214 ~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2399999654 4 589999999999999999999766654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=173.16 Aligned_cols=154 Identities=25% Similarity=0.385 Sum_probs=115.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC--CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP--EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
++..++|++.+.||+|+||.||+|.+ .+..+|+|+++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 35678999999999999999999987 5889999998754322 3446789999999999999999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhccc-----------------------------CCccccc-------------------ccc
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI-----------------------------TSIRPHI-------------------KEV 145 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~-----------------------------~~~~~~~-------------------~~~ 145 (218)
.++||||+++ +|.+++..... .+++|.+ .++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999976 77777643221 1222221 222
Q ss_pred CC----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 146 GS----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 146 g~----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
|. .|+|||.+ .+..++.++||||||+++|+|++|+.||...+.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp CC-------------CCGGGSCHHHH-HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred CcccccccccccCCCCccceeCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 22 38999954 4556899999999999999999999999876544433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-24 Score=178.55 Aligned_cols=142 Identities=30% Similarity=0.451 Sum_probs=112.1
Q ss_pred hccceeEE-EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh-CCCCCeeeeeeeEEe----C
Q 041487 39 KDWNYKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE-LEHDNIVRLLDVLTT----G 112 (218)
Q Consensus 39 ~~~~~~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~ 112 (218)
..++|.+. +.||+|+||.||+|.++.+++.||+|++.. ...+.+|+.++.+ .+||||+++++++.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 45678877 789999999999999999999999999862 2457788888754 489999999999875 6
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc---C--------------------------Ccccc--------------ccccCC-
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPH--------------IKEVGS- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~--------------~~~~g~- 147 (218)
..+|+||||+++ +|.+++..... . ++++. +.+||.
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 679999999987 99998876432 1 22222 223332
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||....
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC-----------CTTCCGGG-SCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCCCccccCCCCCCccCHhh-cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2999995 455668999999999999999999999998763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=189.78 Aligned_cols=158 Identities=25% Similarity=0.477 Sum_probs=123.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+++.++|+||+++++++.. .
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 3455778899999999999999999999753 5679999987432 235789999999999999999999999866 6
Q ss_pred EEEEEEecCCC-ChHHHhhhcc---cC--------------------------Ccccc-----------ccccC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHT---IT--------------------------SIRPH-----------IKEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~---~~--------------------------~~~~~-----------~~~~g------ 146 (218)
.+++||||+.+ +|.+++.... .. ++++. +.+||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 68999999987 9999987531 11 22222 22232
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+. +..++.++|||||||++|+|++ |+.||.+.....+...+.
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~ 478 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred CCceecccCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2399999654 4558999999999999999999 999999875555444444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=179.25 Aligned_cols=164 Identities=24% Similarity=0.417 Sum_probs=126.3
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEc-------cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-------ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRL 105 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (218)
....+..++|++.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 334567789999999999999999999975 356789999987432 333456788999999999 89999999
Q ss_pred eeeEEeCCEEEEEEecCCC-ChHHHhhhccc-----------------C--------------------------Ccccc
Q 041487 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------------T--------------------------SIRPH 141 (218)
Q Consensus 106 ~~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------------~--------------------------~~~~~ 141 (218)
++++...+..++||||+++ +|.+++..... . ++++.
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999987 99999875431 0 22222
Q ss_pred c-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 041487 142 I-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKK 189 (218)
Q Consensus 142 ~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~ 189 (218)
+ .++| ..|+|||.+. +..++.++|||||||++|+|++ |+.||.+...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 1 2222 2399999654 4558999999999999999999 9999998766
Q ss_pred chHHHHHHHh
Q 041487 190 DHLSLIVRYF 199 (218)
Q Consensus 190 ~~~~~~~~~~ 199 (218)
..+...+...
T Consensus 266 ~~~~~~~~~~ 275 (334)
T 2pvf_A 266 EELFKLLKEG 275 (334)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHhcC
Confidence 6665555543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=180.71 Aligned_cols=150 Identities=25% Similarity=0.409 Sum_probs=120.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC------CchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE------GVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
-..++|++.+.||+|+||.||+|.++.++..||+|+++...... ...+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34678999999999999999999999999999999998654322 134567889999999999999999999999
Q ss_pred CCEEEEEEecCCC--ChHHHhhhcccC---------------------------Cccccc-----------cccC-----
Q 041487 112 GRYVYLVFEYLDL--DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG----- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~--~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g----- 146 (218)
.+..++||||+.. +|.+++...... +++|.+ .++|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 9999999998854 788887654321 333322 2222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||...
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 24999996655554588999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=176.33 Aligned_cols=164 Identities=25% Similarity=0.386 Sum_probs=126.2
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEE-----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLN-----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLL 106 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (218)
.....+..++|++.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 444557778999999999999999999985 3467899999987432 223457889999999999 999999999
Q ss_pred eeEEeCCEEEEEEecCCC-ChHHHhhhccc-------------------C--------------------------Cccc
Q 041487 107 DVLTTGRYVYLVFEYLDL-DLGSFIRKHTI-------------------T--------------------------SIRP 140 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~-------------------~--------------------------~~~~ 140 (218)
+++...+..++||||+++ +|.+++..... . +++|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999987 99999876431 0 2222
Q ss_pred cc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 141 HI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 141 ~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
.+ .++| ..|+|||.+. +..++.++||||||+++|+|+| |+.||....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 21 1121 1399999554 4558999999999999999999 999998874
Q ss_pred c-chHHHHHHH
Q 041487 189 K-DHLSLIVRY 198 (218)
Q Consensus 189 ~-~~~~~~~~~ 198 (218)
. ......+..
T Consensus 253 ~~~~~~~~~~~ 263 (313)
T 1t46_A 253 VDSKFYKMIKE 263 (313)
T ss_dssp SSHHHHHHHHH
T ss_pred chhHHHHHhcc
Confidence 3 334444333
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=179.42 Aligned_cols=153 Identities=27% Similarity=0.460 Sum_probs=119.5
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV 108 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (218)
...+..++|++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34567789999999999999999999973 356789999997432 334457899999999999 89999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhccc------------------------C--------------------------C
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTI------------------------T--------------------------S 137 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~------------------------~--------------------------~ 137 (218)
+...+..++||||+++ +|.+++..... . +
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999987 99999865421 0 2
Q ss_pred ccccc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 041487 138 IRPHI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFP 185 (218)
Q Consensus 138 ~~~~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~ 185 (218)
++|.+ .++| ..|+|||.+. +..++.++|||||||++|+|+| |+.||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 33322 1221 1399999554 4558999999999999999998 999998
Q ss_pred CCCc
Q 041487 186 CGKK 189 (218)
Q Consensus 186 ~~~~ 189 (218)
+...
T Consensus 277 ~~~~ 280 (344)
T 1rjb_A 277 GIPV 280 (344)
T ss_dssp TCCC
T ss_pred cCCc
Confidence 8743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=174.81 Aligned_cols=159 Identities=22% Similarity=0.329 Sum_probs=121.7
Q ss_pred hhhccceeEEE-EeeecCceEEEEEEEc--cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 37 KVKDWNYKVVE-KIGQGVFGEVYKCLNL--ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 37 ~~~~~~~~~~~-~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
.+..++|.+.+ .||+|+||.||+|.++ ..+..||+|.++.. ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 35678898887 9999999999999864 46788999998753 2334567889999999999999999999999 556
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------- 146 (218)
..++||||+++ +|.+++...... +++|.+ .++|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 68999999988 999988543221 233321 1121
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...+...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred CcceeeccccccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 239999955 44558999999999999999999 9999988765555554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-24 Score=171.29 Aligned_cols=146 Identities=23% Similarity=0.284 Sum_probs=119.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (218)
.+..++|++.+.||+|+||.||+|.+..+++.||+|+++... ..+.+.+|+.+++.+ .|++++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 355788999999999999999999998999999999986432 224478899999999 899999999999999999
Q ss_pred EEEEecCCCChHHHhhhcccC----------------------------Cccc----------------cccccC-----
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT----------------------------SIRP----------------HIKEVG----- 146 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~----------------~~~~~g----- 146 (218)
++||||+.++|.+++...... +++| .+.++|
T Consensus 82 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 82 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999977999998754321 2222 122222
Q ss_pred --------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccCccCCCCCcccCCchh-hcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 23999995 45566899999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=178.91 Aligned_cols=162 Identities=25% Similarity=0.372 Sum_probs=123.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcE----EEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.+..++|++.+.||+|+||.||+|.+..++.. ||+|.+... ......+.+.+|+.+++.++||||+++++++. +
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 35678899999999999999999998877765 777776533 22333456788999999999999999999886 4
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------ 146 (218)
...++||||+.+ +|.+++...... +++|.+ .+||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 568899999986 998888654211 333322 2222
Q ss_pred -------------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcc
Q 041487 147 -------------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTA 201 (218)
Q Consensus 147 -------------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~ 201 (218)
+ .|+|||.+ .+..++.++|||||||++|+|+| |+.||.+.....+...+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 235 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred cccccccccCCCCcccccChHHh-ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence 1 49999955 44558999999999999999999 9999998876666666655433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=175.07 Aligned_cols=147 Identities=30% Similarity=0.527 Sum_probs=118.2
Q ss_pred hccceeEE-EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEE
Q 041487 39 KDWNYKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 39 ~~~~~~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (218)
..+.|++. +.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++.++ +||||+++++++...+.++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 35678885 7899999999999999899999999999754 334567899999999985 7999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Ccccc--------------cccc---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPH--------------IKEV--------- 145 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~--------------~~~~--------- 145 (218)
+||||+++ +|.+++...... +++|. +.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999985 999888654321 22221 2222
Q ss_pred ---------------C-CcccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---------------G-SPYKAPESRIR----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---------------g-~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 2 23999996543 244789999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=190.53 Aligned_cols=162 Identities=22% Similarity=0.318 Sum_probs=123.0
Q ss_pred hhccceeEEE-EeeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVE-KIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~-~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+..+++.+.+ .||+|+||.||+|..+. .+..||||+++.. ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 3445666666 89999999999998763 4567999999754 334457889999999999999999999999976 55
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
+++||||+++ +|.+++...... ++++.+ .+||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 8999999987 899988643221 333322 2222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhccc
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
..|+|||.+ .+..++.++|||||||++|||++ |+.||.+.+...+...+.....+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 558 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 558 (613)
T ss_dssp ------------CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC
T ss_pred CceeeeccCCCCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 249999955 45568999999999999999998 99999988666555555543333
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=179.61 Aligned_cols=159 Identities=21% Similarity=0.288 Sum_probs=105.3
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
+.....+..++|++.+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES
T ss_pred cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 344556778999999999999999999999888999999999864322 2335678899999999999999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhc--------c-cC--------------------------Cccccc-----------cc
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKH--------T-IT--------------------------SIRPHI-----------KE 144 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~--------~-~~--------------------------~~~~~~-----------~~ 144 (218)
.+..++||||+++ +|.+++... . .. ++++.+ .+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999976 998887631 0 00 222221 11
Q ss_pred c----------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch
Q 041487 145 V----------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191 (218)
Q Consensus 145 ~----------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~ 191 (218)
+ | ..|+|||.+.....++.++|||||||++|+|++|+.||.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 1 2 239999976554568999999999999999999999998764443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-26 Score=187.80 Aligned_cols=148 Identities=15% Similarity=0.235 Sum_probs=112.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHH---HHHhhCCCCCeeeee-------ee
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGV---SLLKELEHDNIVRLL-------DV 108 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~ 108 (218)
.++|++.+.||+|+||.||+|.++.+++.||||++.... ......+.+.+|+ ..++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 477999999999999999999998899999999998653 3445678899999 455566899999998 66
Q ss_pred EEeCC-----------------EEEEEEecCCCChHHHhhhcccC----------------------------------C
Q 041487 109 LTTGR-----------------YVYLVFEYLDLDLGSFIRKHTIT----------------------------------S 137 (218)
Q Consensus 109 ~~~~~-----------------~~~lv~E~~~~~L~~~~~~~~~~----------------------------------~ 137 (218)
+...+ ..|++|||++++|.+++...... +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 55443 38999999988999988753210 3
Q ss_pred ccccc-----------cc--------------cCCcccCcccccCC----------CCCCCcchHHHHHHHHHHHHhCCC
Q 041487 138 IRPHI-----------KE--------------VGSPYKAPESRIRS----------SVYSTPHDVWAVGCIFAEMVSGKP 182 (218)
Q Consensus 138 ~~~~~-----------~~--------------~g~~y~aPE~~~~~----------~~~~~~~DiwSlG~~l~~l~tg~~ 182 (218)
++|.+ .+ .|..|+|||.+... ..++.++|||||||++|+|++|+.
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 33332 12 23559999965544 258999999999999999999999
Q ss_pred CCCCC
Q 041487 183 LFPCG 187 (218)
Q Consensus 183 Pf~~~ 187 (218)
||...
T Consensus 312 Pf~~~ 316 (377)
T 3byv_A 312 PITKD 316 (377)
T ss_dssp CC---
T ss_pred CCccc
Confidence 99765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=177.71 Aligned_cols=163 Identities=25% Similarity=0.417 Sum_probs=125.9
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
....+..++|++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 344567789999999999999999999876 357889999986432 22335578899999999999999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhccc-----------C--------------------------Cccccc--------
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------T--------------------------SIRPHI-------- 142 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------~--------------------------~~~~~~-------- 142 (218)
+......++||||+++ +|.+++..... . +++|.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 9999999999999986 99998865320 0 222221
Q ss_pred ---cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 041487 143 ---KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 ---~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~ 198 (218)
.++| ..|+|||.+ .+..++.++|||||||++|+|++ |+.||.+.+...+...+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhh-ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 2222 239999954 45558999999999999999999 8999988765555554443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=174.91 Aligned_cols=144 Identities=24% Similarity=0.399 Sum_probs=113.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR------ 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (218)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... .....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467999999999999999999999999999999997543 3445678999999999999999999999985433
Q ss_pred ---------------------------------------------------EEEEEEecCCC-ChHHHhhhcccC-----
Q 041487 114 ---------------------------------------------------YVYLVFEYLDL-DLGSFIRKHTIT----- 136 (218)
Q Consensus 114 ---------------------------------------------------~~~lv~E~~~~-~L~~~~~~~~~~----- 136 (218)
..+++|||+++ +|.+++......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 48999999988 999887653221
Q ss_pred -------------------------Cccccc-----------ccc-----------------------------C-Cccc
Q 041487 137 -------------------------SIRPHI-----------KEV-----------------------------G-SPYK 150 (218)
Q Consensus 137 -------------------------~~~~~~-----------~~~-----------------------------g-~~y~ 150 (218)
+++|.+ .++ | ..|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 223221 112 2 2399
Q ss_pred CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 151 APESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 151 aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
|||.+ .+..++.++|||||||++|+|++|..|+.
T Consensus 244 aPE~~-~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 244 SPEQI-HGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CHHHH-HCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ChHHh-cCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99954 45568999999999999999999877653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=173.74 Aligned_cols=143 Identities=15% Similarity=0.181 Sum_probs=115.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 4567899999999999999999999889999999999755432 234578899999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC-------------------------CccccccccC--------C-cccCcccccCCCCC
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT-------------------------SIRPHIKEVG--------S-PYKAPESRIRSSVY 161 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~-------------------------~~~~~~~~~g--------~-~y~aPE~~~~~~~~ 161 (218)
+||||+++ +|.+++...... ++++.+..++ . .|++ .+
T Consensus 108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~--------~~ 179 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP--------DA 179 (286)
T ss_dssp EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT--------TC
T ss_pred EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC--------CC
Confidence 99999986 999988543211 4444432211 1 1222 37
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 162 STPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 162 ~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
+.++|||||||++|+|+||+.||.+.+
T Consensus 180 ~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 180 NPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp CHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 889999999999999999999998763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=177.82 Aligned_cols=152 Identities=23% Similarity=0.382 Sum_probs=109.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEE--
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLT-- 110 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-- 110 (218)
+...+...+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34445667899999999999999999999999999999998643 2334567889999999995 999999999983
Q ss_pred ------eCCEEEEEEecCCCChHHHhhhccc---C-----------------------------Ccccc-----------
Q 041487 111 ------TGRYVYLVFEYLDLDLGSFIRKHTI---T-----------------------------SIRPH----------- 141 (218)
Q Consensus 111 ------~~~~~~lv~E~~~~~L~~~~~~~~~---~-----------------------------~~~~~----------- 141 (218)
....++++|||++++|.+++..... . +++|.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 4556999999999998888754111 0 22222
Q ss_pred ccccC------------------------------CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 142 IKEVG------------------------------SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 142 ~~~~g------------------------------~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+.++| ..|+|||.+. .+..++.++|||||||++|+|++|+.||...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 12222 1299999653 4555888999999999999999999999865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=172.59 Aligned_cols=157 Identities=28% Similarity=0.512 Sum_probs=120.5
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
....+..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 345567789999999999999999999864 56789999986432 33578999999999999999999999986 44
Q ss_pred EEEEEEecCCC-ChHHHhhhcc---cC--------------------------Cccccc-----------cccC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHT---IT--------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~---~~--------------------------~~~~~~-----------~~~g------ 146 (218)
..++||||+++ +|.+++.... .. ++++.+ .++|
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 58999999976 9999886532 11 222221 1221
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...+...+...+
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CcccccccCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 239999955 44558899999999999999999 99999887554444433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=178.35 Aligned_cols=151 Identities=20% Similarity=0.344 Sum_probs=117.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCC--CCCchHHHHHHHHHHhhC-CCCCeeeeeeeEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNE--PEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLT 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (218)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|+++.... .....+.+.+|+.+++.+ .||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345689999999999999999999984 4789999999865321 223456677899999999 7999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc------
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------ 145 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------ 145 (218)
.....++||||+++ +|.+++...... +++|.+ .++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999987 998888654321 233322 122
Q ss_pred -------------CCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -------------GSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -------------g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+... ..++.++|||||||++|+|++|+.||...
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 2239999966543 34788999999999999999999999765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=179.35 Aligned_cols=163 Identities=30% Similarity=0.555 Sum_probs=123.4
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC--------CCCeeeeeee
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE--------HDNIVRLLDV 108 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~ 108 (218)
.+..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.+++.+. |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34568899999999999999999999999999999998632 234567889999999885 7889999999
Q ss_pred EE----eCCEEEEEEecCCCChHHHhhhcccC------------------------------Ccccc-------------
Q 041487 109 LT----TGRYVYLVFEYLDLDLGSFIRKHTIT------------------------------SIRPH------------- 141 (218)
Q Consensus 109 ~~----~~~~~~lv~E~~~~~L~~~~~~~~~~------------------------------~~~~~------------- 141 (218)
+. ....+++||||+.+++.+++...... +++|.
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 87 55689999999988887776543210 22221
Q ss_pred -----------------------------------------------ccccC---------------CcccCcccccCCC
Q 041487 142 -----------------------------------------------IKEVG---------------SPYKAPESRIRSS 159 (218)
Q Consensus 142 -----------------------------------------------~~~~g---------------~~y~aPE~~~~~~ 159 (218)
+.++| ..|+|||.+. +.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~-~~ 268 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI-GS 268 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH-TS
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc-CC
Confidence 22222 2399999654 45
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cchHHHHHHHhcccC
Q 041487 160 VYSTPHDVWAVGCIFAEMVSGKPLFPCGK-------KDHLSLIVRYFTALT 203 (218)
Q Consensus 160 ~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-------~~~~~~~~~~~~~~~ 203 (218)
.++.++|||||||++|+|++|+.||.... .+.+..+.+.++.++
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p 319 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCC
Confidence 58999999999999999999999998653 234455555555543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-25 Score=176.73 Aligned_cols=152 Identities=23% Similarity=0.383 Sum_probs=118.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-- 110 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-- 110 (218)
.....+..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 344556778999999999999999999999999999999998653 3344678899999999999999999999986
Q ss_pred --eCCEEEEEEecCCC-ChHHHhhhcc----cC---------------------------Cccccc-----------ccc
Q 041487 111 --TGRYVYLVFEYLDL-DLGSFIRKHT----IT---------------------------SIRPHI-----------KEV 145 (218)
Q Consensus 111 --~~~~~~lv~E~~~~-~L~~~~~~~~----~~---------------------------~~~~~~-----------~~~ 145 (218)
.....++||||+.+ +|.+++.... .. +++|.+ .++
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34579999999988 9998887521 10 333322 223
Q ss_pred C---------------------------CcccCcccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 146 G---------------------------SPYKAPESRIRSS--VYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 146 g---------------------------~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
| ..|+|||.+.... .++.++|||||||++|+|++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 3 2399999654332 268899999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=176.83 Aligned_cols=162 Identities=28% Similarity=0.461 Sum_probs=124.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCc-----EEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK-----KVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV 108 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (218)
...+..++|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 455677899999999999999999999876554 79999986432 223457789999999999 89999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhccc-----------------------------------------CCccccc----
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHTI-----------------------------------------TSIRPHI---- 142 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~~-----------------------------------------~~~~~~~---- 142 (218)
+...+..++||||+++ +|.+++..... .+++|.+
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999987 99998865321 0333322
Q ss_pred -------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc-chHH
Q 041487 143 -------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKK-DHLS 193 (218)
Q Consensus 143 -------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~-~~~~ 193 (218)
.++| ..|+|||.+. +..++.++|||||||++|+|+| |..||.+... ....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 1121 1399999554 4558999999999999999999 9999987633 3344
Q ss_pred HHHHH
Q 041487 194 LIVRY 198 (218)
Q Consensus 194 ~~~~~ 198 (218)
.....
T Consensus 278 ~~~~~ 282 (333)
T 2i1m_A 278 KLVKD 282 (333)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 44443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=182.56 Aligned_cols=149 Identities=23% Similarity=0.370 Sum_probs=118.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC--EE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR--YV 115 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 115 (218)
...++|++.+.||+|+||.||+|.++.+++.||+|+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 446789999999999999999999999999999999975332 234577889999999999999999999998654 78
Q ss_pred EEEEecCCC-ChHHHhhhcccC------------------------------Cccccc---------------cccC---
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT------------------------------SIRPHI---------------KEVG--- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~~~---------------~~~g--- 146 (218)
++||||+++ +|.+++...... +++|.+ .++|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999986 999888654321 333322 1221
Q ss_pred --------------CcccCcccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------SPYKAPESRIR-------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------~~y~aPE~~~~-------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 23999996543 144778999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=190.77 Aligned_cols=163 Identities=21% Similarity=0.355 Sum_probs=123.5
Q ss_pred cceeEE-EEeeecCceEEEEEEE--ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 41 WNYKVV-EKIGQGVFGEVYKCLN--LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 41 ~~~~~~-~~ig~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
..+.+. +.||+|+||.||+|.+ +..+..||||+++.........+.+.+|+.++++++||||+++++++.. ...++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 334443 4899999999999965 3567899999998655455557889999999999999999999999864 45889
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC------------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------------ 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------------ 146 (218)
||||+++ +|.+++...... ++++.+ .+||
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999987 899988654321 333322 2222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcc
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNY 205 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 205 (218)
..|+|||.+ .+..++.++|||||||++|+|++ |+.||.+.+...+...+.....+..+
T Consensus 527 ~~~~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 594 (635)
T ss_dssp --------CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 239999955 55568999999999999999999 99999988766666655544434333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=172.26 Aligned_cols=161 Identities=24% Similarity=0.340 Sum_probs=119.6
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
....++..++|++.+.||+|+||.||+|.+ ...+|+|.++.........+.+.+|+.+++.++||||+++++++ ..
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344567889999999999999999999975 34699999976555555567899999999999999999999965 55
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------ 146 (218)
...++||||+++ +|.+++...... ++++.+ .++|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 668999999986 888887543211 333322 2222
Q ss_pred --------------CcccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHH
Q 041487 147 --------------SPYKAPESRI--RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVR 197 (218)
Q Consensus 147 --------------~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~ 197 (218)
..|+|||.+. ....++.++||||||+++|+|++|+.||... ..+.+...+.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 2399999654 2455788999999999999999999999875 3334444433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=171.16 Aligned_cols=162 Identities=20% Similarity=0.362 Sum_probs=122.7
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
..+..++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 346678999999999999999999986543 3469999987432 233467889999999999999999999998654
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g------ 146 (218)
..+++|||+++ +|.+++...... +++|.+ .++|
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 46899999986 999988654321 333322 1222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhc
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFT 200 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~ 200 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~ 231 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231 (281)
T ss_dssp --------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred cccccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence 139999955 45568999999999999999999 999998775555555544433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=177.64 Aligned_cols=151 Identities=21% Similarity=0.291 Sum_probs=114.8
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
......+..++|++.+.||+|+||.||+|++ .++.||+|+++.. ........+|+.++++++||||+++++++..
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CccccccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3445557889999999999999999999987 4899999998643 2223455668888999999999999999976
Q ss_pred C----CEEEEEEecCCC-ChHHHhhhcccC------------------------------------Cccccc--------
Q 041487 112 G----RYVYLVFEYLDL-DLGSFIRKHTIT------------------------------------SIRPHI-------- 142 (218)
Q Consensus 112 ~----~~~~lv~E~~~~-~L~~~~~~~~~~------------------------------------~~~~~~-------- 142 (218)
. ..+++||||+++ +|.+++...... +++|.+
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 358999999987 999887653211 222221
Q ss_pred ---cccC--------------------CcccCcccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 143 ---KEVG--------------------SPYKAPESRIRS----SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 143 ---~~~g--------------------~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.+|| ..|+|||.+... ..++.++|||||||++|+|+||+.||.+.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 2222 239999965542 23556889999999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=171.98 Aligned_cols=155 Identities=28% Similarity=0.467 Sum_probs=119.5
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-CCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-GRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 114 (218)
..+..++|++.+.||+|+||.||+|.+ .+..||+|.++.. ...+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 346678999999999999999999987 5889999998632 345789999999999999999999998754 457
Q ss_pred EEEEEecCCC-ChHHHhhhccc---C--------------------------Cccccc-----------cccC-------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~~-----------~~~g------- 146 (218)
.++||||+++ +|.+++..... . +++|.+ .++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999988 99998865421 1 333322 2222
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++||||||+++|+|+| |+.||.......+...+.
T Consensus 170 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 228 (278)
T 1byg_A 170 TQDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228 (278)
T ss_dssp ------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred cccCCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 239999954 45568999999999999999999 999998876555544443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=173.44 Aligned_cols=161 Identities=28% Similarity=0.584 Sum_probs=123.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEE-ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC------eeeeeeeE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLN-LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN------IVRLLDVL 109 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~ 109 (218)
....++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.++|++ ++++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 34567899999999999999999998 557899999998632 234567888999988887654 99999999
Q ss_pred EeCCEEEEEEecCCCChHHHhhhcccC-----------------------------Ccccc-------------------
Q 041487 110 TTGRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPH------------------- 141 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~------------------- 141 (218)
...+.+++||||++++|.+++...... +++|.
T Consensus 87 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 87 EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999988999998765421 22222
Q ss_pred -----------ccccCC---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcch-HHH
Q 041487 142 -----------IKEVGS---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH-LSL 194 (218)
Q Consensus 142 -----------~~~~g~---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~-~~~ 194 (218)
+.++|. .|+|||.+ .+..++.++|||||||++|+|++|+.||...+... +..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccccccccCCccccChHHh-hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 222322 29999954 45568999999999999999999999999874433 333
Q ss_pred HHHHhcc
Q 041487 195 IVRYFTA 201 (218)
Q Consensus 195 ~~~~~~~ 201 (218)
+.+..++
T Consensus 246 ~~~~~~~ 252 (339)
T 1z57_A 246 MERILGP 252 (339)
T ss_dssp HHHHHCS
T ss_pred HHHHhCC
Confidence 4343333
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=173.77 Aligned_cols=178 Identities=21% Similarity=0.290 Sum_probs=126.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC--CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--eCCEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT--TGRYV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 115 (218)
.++|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999997542 12345678999999999999999999999984 45679
Q ss_pred EEEEecCCCChHHHhhhcccC-----------------------------Cccccc-----------ccc----------
Q 041487 116 YLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI-----------KEV---------- 145 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~---------- 145 (218)
++||||++++|.+++...... ++++.+ .++
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999998877776542211 222221 111
Q ss_pred ----------CCcccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhh
Q 041487 146 ----------GSPYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCF 211 (218)
Q Consensus 146 ----------g~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 211 (218)
...|+|||.+.... .++.++||||||+++|+|++|+.||.+.+...+...+....... .+..+.++
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 243 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL 243 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHH
Confidence 22399999654432 24779999999999999999999999875554444433321111 12334455
Q ss_pred hhhccc
Q 041487 212 LSIMLL 217 (218)
Q Consensus 212 ~~~~l~ 217 (218)
+..||+
T Consensus 244 i~~~l~ 249 (305)
T 2wtk_C 244 LKGMLE 249 (305)
T ss_dssp HHHHTC
T ss_pred HHHHcc
Confidence 555553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=172.72 Aligned_cols=155 Identities=24% Similarity=0.425 Sum_probs=120.3
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeee
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRL 105 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (218)
......+..++|++.+.||+|+||.||+|.+. .+++.||+|.++... .....+.+.+|+.+++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455677899999999999999999999853 466899999987432 223456788999999999 78999999
Q ss_pred eeeEEeC-CEEEEEEecCCC-ChHHHhhhccc----------------C---------------------------Cccc
Q 041487 106 LDVLTTG-RYVYLVFEYLDL-DLGSFIRKHTI----------------T---------------------------SIRP 140 (218)
Q Consensus 106 ~~~~~~~-~~~~lv~E~~~~-~L~~~~~~~~~----------------~---------------------------~~~~ 140 (218)
++++... ..++++|||+++ +|.+++..... . +++|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 9998754 459999999997 99999876432 0 2222
Q ss_pred cc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 141 HI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 141 ~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
.+ .++| ..|+|||.+. +..++.++|||||||++|+|+| |+.||....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 21 1111 1399999554 5558999999999999999998 999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=177.29 Aligned_cols=152 Identities=17% Similarity=0.336 Sum_probs=118.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCc---------------hHHHHHHHHHHhhCCCC
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGV---------------PSYLIAGVSLLKELEHD 100 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---------------~~~~~~e~~~l~~l~h~ 100 (218)
.....++|++.+.||+|+||.||+|.+ ++..||+|.+......... .+.+.+|+.++++++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345578999999999999999999998 8999999999754322211 17899999999999999
Q ss_pred CeeeeeeeEEeCCEEEEEEecCCC-ChHHH------hhhc--cc----------------------------CCccccc-
Q 041487 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSF------IRKH--TI----------------------------TSIRPHI- 142 (218)
Q Consensus 101 ~iv~~~~~~~~~~~~~lv~E~~~~-~L~~~------~~~~--~~----------------------------~~~~~~~- 142 (218)
||+++++++...+..++||||+++ +|.++ +... .. .++++.+
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999987 88887 4331 00 0222221
Q ss_pred ----------cccC----------------CcccCcccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 143 ----------KEVG----------------SPYKAPESRIRSSVYST-PHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 143 ----------~~~g----------------~~y~aPE~~~~~~~~~~-~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
.++| ..|+|||.+.....++. ++|||||||++|+|++|+.||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2222 23999996655535666 99999999999999999999987644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=171.36 Aligned_cols=153 Identities=20% Similarity=0.333 Sum_probs=106.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
......++|++.+.||+|+||.||+|.++.+++.||+|.+..........+.+.++..+++.++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34456788999999999999999999999999999999997554333333445555567888899999999999999999
Q ss_pred EEEEEecCCCChHHHhhhc---------------------------cc--CCccccc-----------cccC--------
Q 041487 115 VYLVFEYLDLDLGSFIRKH---------------------------TI--TSIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~---------------------------~~--~~~~~~~-----------~~~g-------- 146 (218)
.++||||++..+..+.... +. .++++.+ .++|
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999954444333221 11 0222221 2222
Q ss_pred ---------CcccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. ....++.++|||||||++|+|++|+.||...
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 2399999664 3455889999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=172.73 Aligned_cols=149 Identities=23% Similarity=0.386 Sum_probs=115.2
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEE----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCL----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
...+....|++.+.||+|+||.||+|. +..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 444667789999999999999999998 45688999999997543 3345678999999999999999999999997
Q ss_pred eC--CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC-
Q 041487 111 TG--RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS- 147 (218)
Q Consensus 111 ~~--~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~- 147 (218)
.. ..+++||||+++ +|.+++...... +++|.+ .++|.
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 66 669999999987 999998543221 333322 22221
Q ss_pred --------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 148 --------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 148 --------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
.|+|||.+. +..++.++||||||+++|+|++|+.|+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 299999554 4457899999999999999999998864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=173.79 Aligned_cols=155 Identities=30% Similarity=0.477 Sum_probs=122.1
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC--CCCeeeeeeeE
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE--HDNIVRLLDVL 109 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~ 109 (218)
..+...+...+|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+.+|+.+++++. |+||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34445567788999999999999999999875 5889999999765545555678899999999996 59999999999
Q ss_pred EeCCEEEEEEecCCCChHHHhhhcccC---------------------------Cccccc----------ccc-------
Q 041487 110 TTGRYVYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPHI----------KEV------- 145 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~~----------~~~------- 145 (218)
......+++||+..++|.+++...... ++++.+ .++
T Consensus 98 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 98 ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQ 177 (313)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--
T ss_pred ecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeecccccccc
Confidence 999999999997777999988764321 222221 122
Q ss_pred -------------CCcccCcccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 -------------GSPYKAPESRIR----------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 -------------g~~y~aPE~~~~----------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 223999996543 145888999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=175.25 Aligned_cols=155 Identities=23% Similarity=0.412 Sum_probs=109.2
Q ss_pred hhhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHH-HHhhCCCCCeeeeeeeEE
Q 041487 32 SEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVS-LLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~ 110 (218)
+.+...+..++|++.+.||+|+||.||+|.++.+++.||+|.++.... ......+..|+. +++.++||||+++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 344556778999999999999999999999999999999999975432 223344555555 677789999999999999
Q ss_pred eCCEEEEEEecCCCChHHHhhhc-----cc----------------------------CCccccc-----------cccC
Q 041487 111 TGRYVYLVFEYLDLDLGSFIRKH-----TI----------------------------TSIRPHI-----------KEVG 146 (218)
Q Consensus 111 ~~~~~~lv~E~~~~~L~~~~~~~-----~~----------------------------~~~~~~~-----------~~~g 146 (218)
..+..++||||++++|.+++... .. .++++.+ .++|
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 92 REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 99999999999998887776531 00 0222221 2222
Q ss_pred -----------------CcccCccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------------SPYKAPESRI---RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------------~~y~aPE~~~---~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. .+..++.++|||||||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 2399999653 3455899999999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-25 Score=180.55 Aligned_cols=145 Identities=17% Similarity=0.239 Sum_probs=112.9
Q ss_pred hhhccceeEEEEeeecCceEEEEEE-----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC---CCCeeeeeee
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCL-----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---HDNIVRLLDV 108 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~ 108 (218)
.+..++|.+.+.||+|+||.||+|. +..+++.||+|.++.. ....+.+|+.++..+. |++++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 4566789999999999999999994 5678899999998632 3456788888888886 9999999999
Q ss_pred EEeCCEEEEEEecCCC-ChHHHhhhcc------cC--------------------------Ccccc--------------
Q 041487 109 LTTGRYVYLVFEYLDL-DLGSFIRKHT------IT--------------------------SIRPH-------------- 141 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~~~~~~~------~~--------------------------~~~~~-------------- 141 (218)
+...+..++||||+++ +|.+++.... .. +++|.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999986 9999986421 10 22222
Q ss_pred --------ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 142 --------IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 142 --------~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+.+||. .|+|||.+ .+..++.++|||||||++|+|+||+.||...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-cCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 223332 29999954 5555899999999999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=170.25 Aligned_cols=145 Identities=28% Similarity=0.441 Sum_probs=113.1
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.|.....||+|+||.||+|.+..++..||+|.++.. .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3344455999999999999999999999999998753 33446789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC------------------------------Ccccc------------ccccC-----------
Q 041487 121 YLDL-DLGSFIRKHTIT------------------------------SIRPH------------IKEVG----------- 146 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~------------------------------~~~~~------------~~~~g----------- 146 (218)
|+++ +|.+++...... ++++. +.++|
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9976 888887654210 22221 11222
Q ss_pred -------CcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -------SPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -------~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+... ..++.++||||||+++|+|++|+.||...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 239999966543 23788999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=176.88 Aligned_cols=154 Identities=19% Similarity=0.266 Sum_probs=112.2
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEcc---CCcEEEEEEeecCCCCC---------CchHHHHHHHHHHhhCCCC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLE---TGKKVAIKMINIQNEPE---------GVPSYLIAGVSLLKELEHD 100 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ 100 (218)
.....+..++|++.+.||+|+||.||+|.+.. ++..+|+|.+....... .....+.+|+..++.++||
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (345)
T 2v62_A 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYL 108 (345)
T ss_dssp CEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCC
T ss_pred CeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccccc
Confidence 44455667899999999999999999999976 78899999987542110 0123466788889999999
Q ss_pred CeeeeeeeEEe----CCEEEEEEecCCCChHHHhhhcccC---------------------------Ccccc--------
Q 041487 101 NIVRLLDVLTT----GRYVYLVFEYLDLDLGSFIRKHTIT---------------------------SIRPH-------- 141 (218)
Q Consensus 101 ~iv~~~~~~~~----~~~~~lv~E~~~~~L~~~~~~~~~~---------------------------~~~~~-------- 141 (218)
||+++++++.. ....++||||+.++|.+++...... +++|.
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 99999999987 7899999999966999988754321 22221
Q ss_pred -----ccccC-------------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 142 -----IKEVG-------------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 142 -----~~~~g-------------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+.++| ..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-KGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 12222 239999954 4556899999999999999999999999653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=170.07 Aligned_cols=143 Identities=30% Similarity=0.409 Sum_probs=113.5
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
.+..++|++.+.||+|+||.||+|.. .+..||+|.+.. ....+.+.+|+.++++++||||+++++++.+. .+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 75 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VC 75 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cE
Confidence 35678899999999999999999987 578999999752 34567899999999999999999999988744 78
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------------Ccccc------------ccccC----
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------------SIRPH------------IKEVG---- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------------~~~~~------------~~~~g---- 146 (218)
+||||+++ +|.+++...... ++++. +.++|
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999986 888887643210 22221 22232
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
..|+|||. ..+..++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 156 IQTHMTNNKGSAAWMAPEV-FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------CCTTSSCHHH-HTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cccccccCCCCCceEChhh-hCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 23999995 455568999999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-24 Score=173.00 Aligned_cols=162 Identities=25% Similarity=0.524 Sum_probs=123.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCC-cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC------eeeeeeeE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETG-KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN------IVRLLDVL 109 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~ 109 (218)
....++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+.+|+.+++.+.|++ ++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 345789999999999999999999998776 68999998632 234567888999999887665 89999999
Q ss_pred EeCCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc------------------
Q 041487 110 TTGRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI------------------ 142 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~------------------ 142 (218)
...+..++||||+++++.+++...... +++|.+
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 92 NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999988888887654311 233222
Q ss_pred ------------cccCC---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHH
Q 041487 143 ------------KEVGS---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSL 194 (218)
Q Consensus 143 ------------~~~g~---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~ 194 (218)
.++|. .|+|||.+. +..++.++|||||||++|+|++|+.||...+. +.+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 22222 299999554 55689999999999999999999999998743 33444
Q ss_pred HHHHhccc
Q 041487 195 IVRYFTAL 202 (218)
Q Consensus 195 ~~~~~~~~ 202 (218)
+.+..+++
T Consensus 251 ~~~~~~~~ 258 (355)
T 2eu9_A 251 MEKILGPI 258 (355)
T ss_dssp HHHHHCCC
T ss_pred HHHHcCCC
Confidence 44444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=175.07 Aligned_cols=162 Identities=22% Similarity=0.282 Sum_probs=127.1
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
.....+..++|++.+.||+|+||.||+|.++. .+|+|.++.........+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 45556778999999999999999999998743 599999976555555566788999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc----------ccccC-------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH----------IKEVG------- 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~----------~~~~g------- 146 (218)
...+++|||+++ +|.+++...... ++++. +.++|
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGV 181 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccc
Confidence 999999999986 999988764311 23222 12333
Q ss_pred ----------------CcccCcccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 ----------------SPYKAPESRIR--------SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ----------------~~y~aPE~~~~--------~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+.. ...++.++|||||||++|+|++|+.||...........+.
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 23899996653 3447889999999999999999999998876555544443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=174.18 Aligned_cols=145 Identities=21% Similarity=0.346 Sum_probs=117.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++.+.||+|+||.||+|.+ .++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 457899999999999999999996 46899999987643 334567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC-------------------------------Cccccc-----------cccC---------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-------------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-------------------------------~~~~~~-----------~~~g--------- 146 (218)
|||+++ +|.+++...... +++|.+ .++|
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999986 888887543210 222221 2222
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. +..++.++|||||||++|+|++|+.||...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 2399999654 445899999999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=169.92 Aligned_cols=142 Identities=27% Similarity=0.399 Sum_probs=113.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------ 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 111 (218)
....+|++.+.||+|+||.||+|.+..+++.||+|.++... +.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 44678999999999999999999998899999999987431 457789999999999999999998854
Q ss_pred ----------CCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc---------
Q 041487 112 ----------GRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI--------- 142 (218)
Q Consensus 112 ----------~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~--------- 142 (218)
...++++|||+++ +|.+++...... +++|.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 4568999999997 999998654211 222221
Q ss_pred --cccC-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 143 --KEVG-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 143 --~~~g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.++| ..|+|||.+ .+..++.++||||||+++|+|++|..||..
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHH-HCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EECcchhheeccccccccccCCcccccChhhh-ccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 2222 239999954 455689999999999999999999988853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=176.01 Aligned_cols=142 Identities=13% Similarity=0.139 Sum_probs=110.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc--------CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeee-----
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE--------TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVR----- 104 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~----- 104 (218)
...++|++.+.||+|+||.||+|.+.. .++.||+|.+... +.+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 345899999999999999999999876 4889999998743 35889999999999999887
Q ss_pred ----------eeeeEEe-CCEEEEEEecCCCChHHHhhhc--ccC---------------------------Cccccc--
Q 041487 105 ----------LLDVLTT-GRYVYLVFEYLDLDLGSFIRKH--TIT---------------------------SIRPHI-- 142 (218)
Q Consensus 105 ----------~~~~~~~-~~~~~lv~E~~~~~L~~~~~~~--~~~---------------------------~~~~~~-- 142 (218)
+++++.. ....++||||+.++|.+++... ... +++|.+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5666665 7889999999966999998764 111 222211
Q ss_pred -----------ccc------------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 143 -----------KEV------------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 143 -----------~~~------------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
.++ | ..|+|||. ..+..++.++|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL-HKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH-HccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 111 2 24999995 4555689999999999999999999999987
Q ss_pred C
Q 041487 187 G 187 (218)
Q Consensus 187 ~ 187 (218)
.
T Consensus 271 ~ 271 (352)
T 2jii_A 271 C 271 (352)
T ss_dssp G
T ss_pred C
Confidence 5
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=176.71 Aligned_cols=155 Identities=26% Similarity=0.436 Sum_probs=116.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCC---cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE-eCCEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETG---KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-TGRYVY 116 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 116 (218)
..|++.+.||+|+||.||+|.....+ ..||+|.++.. ......+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35788999999999999999876543 46899988642 23345678999999999999999999999864 556889
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---------- 146 (218)
+||||+++ +|.+++...... +++|.+ .+||
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999987 999998653221 233221 2222
Q ss_pred ------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 ------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 ------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++|||||||++|+|+| |.+||...+...+...+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~ 310 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310 (373)
T ss_dssp ----------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH
T ss_pred ccccccCCCCCcccccChHHh-cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH
Confidence 139999954 45568999999999999999999 788998775544444443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=167.44 Aligned_cols=164 Identities=21% Similarity=0.320 Sum_probs=119.4
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE-EE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY-VY 116 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~ 116 (218)
-.|++.+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++.++||||+++++++..... .+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 346778999999999999999765544 7999998642 233345788899999999999999999999976554 49
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS--------- 147 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~--------- 147 (218)
++|||+.+ +|.+++...... +++|.+ .++|.
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999975 999888653221 233322 22221
Q ss_pred -------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCccc
Q 041487 148 -------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYL 206 (218)
Q Consensus 148 -------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 206 (218)
.|+|||. ..+..++.++||||||+++|+|++ |.+||...+...+...+.....++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALES-LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE 251 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHH-HTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred cccccCcCCCCCccccChhh-hccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence 3899995 455568999999999999999999 556676666666666555444443333
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=175.04 Aligned_cols=162 Identities=27% Similarity=0.519 Sum_probs=121.2
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-----------CCCeeeee
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-----------HDNIVRLL 106 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~ 106 (218)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+.+|+.+++++. |+||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 456889999999999999999999999999999999863 2223467888999888876 88999999
Q ss_pred eeEEeCC----EEEEEEecCCCChHHHhhhcccC------------------------------Ccccc-----------
Q 041487 107 DVLTTGR----YVYLVFEYLDLDLGSFIRKHTIT------------------------------SIRPH----------- 141 (218)
Q Consensus 107 ~~~~~~~----~~~lv~E~~~~~L~~~~~~~~~~------------------------------~~~~~----------- 141 (218)
+++...+ .++++||++.++|.+++...... +++|.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 9997544 79999999977888887653211 22222
Q ss_pred ------ccccCC---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cchHH
Q 041487 142 ------IKEVGS---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-------KDHLS 193 (218)
Q Consensus 142 ------~~~~g~---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-------~~~~~ 193 (218)
+.++|. .|+|||.+. +..++.++|||||||++|+|++|+.||...+ .+.+.
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred CcceEEEcccccccccCCCCCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 223332 299999654 5558999999999999999999999998653 33455
Q ss_pred HHHHHhcccC
Q 041487 194 LIVRYFTALT 203 (218)
Q Consensus 194 ~~~~~~~~~~ 203 (218)
.++..++.++
T Consensus 252 ~~~~~~~~~p 261 (373)
T 1q8y_A 252 QIIELLGELP 261 (373)
T ss_dssp HHHHHHCSCC
T ss_pred HHHHhcCCCC
Confidence 5555555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=169.38 Aligned_cols=156 Identities=26% Similarity=0.434 Sum_probs=115.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE-EeCCEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL-TTGRYV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 115 (218)
...|++.+.||+|+||.||+|.+..+ ...+|+|.+... ......+.+.+|+.++++++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 35689999999999999999987543 346899988642 2333457789999999999999999999985 456788
Q ss_pred EEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g--------- 146 (218)
+++|||+++ +|.+++...... +++|.+ .++|
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999988 999998653221 233322 1222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |.+||...+.......+.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH
T ss_pred hhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 139999954 45568999999999999999999 677887765544444443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=174.20 Aligned_cols=148 Identities=26% Similarity=0.392 Sum_probs=117.1
Q ss_pred hhhccceeEEEEeeecCceEEEEEE----EccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE--
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCL----NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT-- 110 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-- 110 (218)
.+..++|++.+.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 3667899999999999999999998 4567899999998643 2334567899999999999999999999886
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---- 146 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---- 146 (218)
.....++||||+++ +|.+++...... +++|.+ .++|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56779999999966 999988763221 333322 1111
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccCCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 128999954 4555789999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-23 Score=164.84 Aligned_cols=144 Identities=19% Similarity=0.278 Sum_probs=112.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE-EeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL-TTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+.|++++..+..+ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4678999999999999999999999999999999986432 224588999999999888766555554 67888999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------Cccccc--------------ccc----------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------SIRPHI--------------KEV---------- 145 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------~~~~~~--------------~~~---------- 145 (218)
+|||+.++|.+++...... +++|.+ .++
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999977999988732211 222221 111
Q ss_pred ---------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ---------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ---------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||. ..+..++.++|||||||++|+|++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccCChhh-hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 123999995 45555899999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-23 Score=164.07 Aligned_cols=145 Identities=19% Similarity=0.278 Sum_probs=108.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeE-EeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVL-TTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~ 116 (218)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... +.+.+|+.+++.++|++++..+..+ ......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3457899999999999999999999999999999987643322 3478899999999887766665554 6888999
Q ss_pred EEEecCCCChHHHhhhcccC----------------------------Cccccc--------------ccc---------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI--------------KEV--------- 145 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~--------------~~~--------- 145 (218)
++|||+.++|.+++...... +++|.+ .++
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999977999988642211 222221 111
Q ss_pred ----------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ----------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ----------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||. ..+..++.++|||||||++|+|++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCccCCCCcccccCCCccccchHH-hcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 123899995 45556899999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=185.11 Aligned_cols=164 Identities=23% Similarity=0.376 Sum_probs=124.1
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
....+..++|++.+.||+|+||.||+|.+... +..||+|.++.. ......+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34456678899999999999999999998643 457999987642 23334578899999999999999999999985
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---- 146 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---- 146 (218)
.+..++||||+++ +|.+++...... +++|.+ .++|
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4568999999986 999988754321 333322 2222
Q ss_pred ---------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhc
Q 041487 147 ---------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFT 200 (218)
Q Consensus 147 ---------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~ 200 (218)
..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609 (656)
T ss_dssp CCC----------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC
T ss_pred cCCCcceeccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 249999955 45568999999999999999997 999999875555444444433
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=177.48 Aligned_cols=150 Identities=23% Similarity=0.392 Sum_probs=113.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (218)
..+...+|.+.+.||+|+||.|+. ....+++.||||.+.... .+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 334556799999999999999764 334688999999986422 23366899999999 89999999999999999
Q ss_pred EEEEEecCCCChHHHhhhcccC----------------------------Ccccc----------------ccccC----
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPH----------------IKEVG---- 146 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~----------------~~~~g---- 146 (218)
.|+|||||+++|.+++...... +++|. +.++|
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9999999999999888654321 22222 22222
Q ss_pred -----------------CcccCcccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcch
Q 041487 147 -----------------SPYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDH 191 (218)
Q Consensus 147 -----------------~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~ 191 (218)
..|+|||.+.. ...++.++|||||||++|+|++ |..||.......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 23999996654 3457789999999999999999 999997654333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=172.39 Aligned_cols=147 Identities=23% Similarity=0.376 Sum_probs=113.5
Q ss_pred hccce-eEEEEeeecCceEEEEEEE----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--
Q 041487 39 KDWNY-KVVEKIGQGVFGEVYKCLN----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-- 111 (218)
Q Consensus 39 ~~~~~-~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 111 (218)
...+| ++++.||+|+||.||++.. ..+++.||+|+++.. ......+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34444 9999999999999988754 357889999999753 223446778999999999999999999999987
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC--------------------------Cccccc-----------cccC-------
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEVG------- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g------- 146 (218)
...+++||||+++ +|.+++...... ++++.+ .++|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 4689999999987 999988764332 333322 1221
Q ss_pred --------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 --------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 --------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECL-KEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 128999955 4445789999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-23 Score=165.62 Aligned_cols=141 Identities=27% Similarity=0.430 Sum_probs=111.9
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-------- 111 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 111 (218)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 46799999999999999999999999999999998642 2345678899999999999999999998854
Q ss_pred -----CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC
Q 041487 112 -----GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 112 -----~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g 146 (218)
....++||||+++ +|.+++...... ++++.+ .++|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 4679999999986 999988643221 222221 1222
Q ss_pred --------------------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 --------------------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 --------------------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+.....++.++|||||||++|+|++ ||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 239999976655568999999999999999998 5643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=171.24 Aligned_cols=154 Identities=25% Similarity=0.383 Sum_probs=119.2
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCC--CCCeeeeee
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELE--HDNIVRLLD 107 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~ 107 (218)
.......++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++++. |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 334456788999999999999999999999999999999997654322 23356778999999995 599999999
Q ss_pred eEEeCCEEEEEEecCC--CChHHHhhhcccC---------------------------Ccccc------------ccccC
Q 041487 108 VLTTGRYVYLVFEYLD--LDLGSFIRKHTIT---------------------------SIRPH------------IKEVG 146 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~--~~L~~~~~~~~~~---------------------------~~~~~------------~~~~g 146 (218)
++...+..+++||++. ++|.+++...... ++++. +.++|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999999997 4888887654321 22222 22232
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.....++.++|||||||++|+|++|+.||...
T Consensus 196 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 23999996655554578899999999999999999999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-24 Score=172.67 Aligned_cols=150 Identities=24% Similarity=0.352 Sum_probs=116.3
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
........++|++.+.||+|+||.||+|.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 344556788999999999999999999975 46899999998754322 2234689999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc-----------cccC
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~-----------~~~g 146 (218)
...++||||+++ +|.+++...... +++|.+ .++|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 999999999987 888887653211 222221 2222
Q ss_pred -------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 147 -------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 147 -------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
..|+|||.+ .+..++.++|||||||++|+|++|+.||.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHH-HHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccCcccccccccccCCcCccCHHHh-ccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 239999955 44458999999999999999999999995
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=170.72 Aligned_cols=152 Identities=15% Similarity=0.193 Sum_probs=110.4
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccC-----CcEEEEEEeecCCCCC---------CchHHHHHHHHHHhhCCCC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLET-----GKKVAIKMINIQNEPE---------GVPSYLIAGVSLLKELEHD 100 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ 100 (218)
...+..++|++.+.||+|+||.||+|.++.+ ++.||+|++....... ........|+..++.++||
T Consensus 29 i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp EECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred eeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3345567999999999999999999998654 5789999987432100 0012233455566777899
Q ss_pred CeeeeeeeEEeC----CEEEEEEecCCCChHHHhhhcccC----------------------------Cccccc------
Q 041487 101 NIVRLLDVLTTG----RYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI------ 142 (218)
Q Consensus 101 ~iv~~~~~~~~~----~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~------ 142 (218)
||+++++++... ...++||||+.++|.+++...... +++|.+
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 999999998754 569999999966999988664211 233221
Q ss_pred -------ccc------------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 143 -------KEV------------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 143 -------~~~------------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.+| | ..|+|||. ..+..++.++|||||||++|+|+||+.||.+.
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA-HNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH-hCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 122 2 24999995 45556899999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=167.93 Aligned_cols=150 Identities=25% Similarity=0.426 Sum_probs=102.5
Q ss_pred hhhhhhhhccceeEEE-EeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHH-HHHhhCCCCCeeeeeeeE
Q 041487 32 SEQMEKVKDWNYKVVE-KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGV-SLLKELEHDNIVRLLDVL 109 (218)
Q Consensus 32 ~~~~~~~~~~~~~~~~-~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~ 109 (218)
.........++|.+.+ .||+|+||.||+|.++.+++.||+|++... ....+|+ ..++.++||||+++++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHH
Confidence 3444445678899966 599999999999999999999999998632 1223333 345667999999999998
Q ss_pred Ee----CCEEEEEEecCCC-ChHHHhhhcccC-----------------------------Ccccc--------------
Q 041487 110 TT----GRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPH-------------- 141 (218)
Q Consensus 110 ~~----~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-------------- 141 (218)
.. ...+++||||+++ +|.+++...... ++++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 75 5569999999988 999998765321 22222
Q ss_pred ccccCC----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 142 IKEVGS----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 142 ~~~~g~----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
+.++|. .|+|||.+ .+..++.++|||||||++|+|++|+.||.....
T Consensus 172 l~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp ECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EeccccceeccccccccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 223332 29999954 455588899999999999999999999987643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.9e-24 Score=168.94 Aligned_cols=159 Identities=25% Similarity=0.358 Sum_probs=113.2
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEcc-CC--cEEEEEEeecCCC-CCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLE-TG--KKVAIKMINIQNE-PEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT 111 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (218)
..+..++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34567889999999999999999998643 33 3689999875442 33456788999999999999999999999976
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----- 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----- 146 (218)
.. .+++|||+++ +|.+++...... +++|.+ .++|
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 8899999986 999888654211 333322 1222
Q ss_pred ----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 147 ----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 147 ----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
..|+|||.+ .+..++.++||||||+++|+|++ |+.||...+...+...+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccchhhhccCCCCceeeCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 139999955 44557899999999999999999 99999887554444433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=170.41 Aligned_cols=151 Identities=28% Similarity=0.454 Sum_probs=116.0
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEE----ccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLN----LETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
.....+...+|++.+.||+|+||.||+|.. ..+++.||+|.+... .....+.+.+|+.++++++||||++++++
T Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 334557788899999999999999999984 567899999998642 34446789999999999999999999999
Q ss_pred EEeC--CEEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC
Q 041487 109 LTTG--RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG 146 (218)
Q Consensus 109 ~~~~--~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g 146 (218)
+... ..+++||||+++ +|.+++...... +++|.+ .++|
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 8654 378999999987 999998764321 233322 1121
Q ss_pred ---------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 ---------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 ---------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+. +..++.++||||||+++|+|+||..||..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred chhhccccccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 1299999654 44578999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=173.69 Aligned_cols=148 Identities=17% Similarity=0.175 Sum_probs=103.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhC--CCCCeeeee-------eeE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKEL--EHDNIVRLL-------DVL 109 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 109 (218)
...|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999986543 234456777885544444 699988755 444
Q ss_pred EeC-----------------CEEEEEEecCCCChHHHhhhcccC----------------------------------Cc
Q 041487 110 TTG-----------------RYVYLVFEYLDLDLGSFIRKHTIT----------------------------------SI 138 (218)
Q Consensus 110 ~~~-----------------~~~~lv~E~~~~~L~~~~~~~~~~----------------------------------~~ 138 (218)
... ..+|+||||++++|.+++...... ++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 322 348999999999999988753110 33
Q ss_pred cccc-----------ccc---------------CCcccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 139 RPHI-----------KEV---------------GSPYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 139 ~~~~-----------~~~---------------g~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+|.+ .+| +..|+|||.+... ..++.++|||||||++|+|++|+.||...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 3322 122 3449999966431 55899999999999999999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=169.88 Aligned_cols=152 Identities=28% Similarity=0.391 Sum_probs=107.3
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhC----CCCCeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKEL----EHDNIVRLL 106 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~iv~~~ 106 (218)
..+...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556788999999999999999999998999999999997543221 2234566788888888 899999999
Q ss_pred eeEEeCCEEEEEEec-CCC-ChHHHhhhcccC---------------------------Ccccc------------cccc
Q 041487 107 DVLTTGRYVYLVFEY-LDL-DLGSFIRKHTIT---------------------------SIRPH------------IKEV 145 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~-~~~-~L~~~~~~~~~~---------------------------~~~~~------------~~~~ 145 (218)
+++...+..+++||+ +.+ +|.+++...... ++++. +.++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 554 888888654321 22222 1222
Q ss_pred C----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 146 G----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 146 g----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
| ..|+|||.+......+.++|||||||++|+|++|+.||..
T Consensus 185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 2 2399999665555455689999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.7e-22 Score=158.37 Aligned_cols=144 Identities=23% Similarity=0.414 Sum_probs=108.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh--CCCCCeeeeeeeEEe---
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE--LEHDNIVRLLDVLTT--- 111 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~--- 111 (218)
....++|++.+.||+|+||.||+|.+ ++..||+|++... ....+.+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 45678999999999999999999987 7899999998632 34556667777666 799999999998653
Q ss_pred -CCEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc-----------cc
Q 041487 112 -GRYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI-----------KE 144 (218)
Q Consensus 112 -~~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~-----------~~ 144 (218)
...+++||||+++ +|.+++...... +++|.+ .+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 3569999999987 998887542211 222221 22
Q ss_pred cC----------------------CcccCcccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 041487 145 VG----------------------SPYKAPESRIRSS-----VYSTPHDVWAVGCIFAEMVSG----------KPLFPCG 187 (218)
Q Consensus 145 ~g----------------------~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~~l~tg----------~~Pf~~~ 187 (218)
+| ..|+|||.+.... .++.++|||||||++|+|++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 22 2399999655443 234689999999999999999 8999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=171.08 Aligned_cols=147 Identities=22% Similarity=0.331 Sum_probs=115.0
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC-CCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-DNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 116 (218)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| +++..+..++......+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3467899999999999999999999999999999988754322 347889999999976 56666666778889999
Q ss_pred EEEecCCCChHHHhhhcccC----------------------------Cccccc--------------cccC--------
Q 041487 117 LVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI--------------KEVG-------- 146 (218)
Q Consensus 117 lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~--------------~~~g-------- 146 (218)
+||||+.++|.+++...... ++++.+ .+||
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999977999988642211 333322 1222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK 189 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~ 189 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~-~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNT-HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccCCCccccCHHH-hcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 23899995 5555689999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=162.26 Aligned_cols=140 Identities=25% Similarity=0.412 Sum_probs=110.8
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC--CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
...+.||+|+||.||+|.. ++..||+|.+.... ......+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 3448999999999999986 68899999987543 2345577899999999999999999999999999999999999
Q ss_pred CCC-ChHHHhhhcccC------------------------------Cccccc-----------cccC-------------
Q 041487 122 LDL-DLGSFIRKHTIT------------------------------SIRPHI-----------KEVG------------- 146 (218)
Q Consensus 122 ~~~-~L~~~~~~~~~~------------------------------~~~~~~-----------~~~g------------- 146 (218)
+++ +|.+++...... +++|.+ .++|
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 976 998887642210 222221 1221
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+ .+. ++.++||||||+++|+|++|+.||...
T Consensus 192 ~~~~~g~~~y~aPE~~-~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 192 TSRIVGTTAYMAPEAL-RGE-ITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp CSSCCSCGGGCCHHHH-TTE-ECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred ccccCCCcCcCChHHh-cCC-CCccchhHHHHHHHHHHHHCCCCcccC
Confidence 239999954 333 789999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-22 Score=169.40 Aligned_cols=144 Identities=26% Similarity=0.421 Sum_probs=111.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (218)
..+.|.+.+.||+|+||+||.+. ..+++.||||.+... ..+.+.+|+.+++.+ +||||+++++++.....+++
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 34556778999999999998753 467999999998642 245678999999886 89999999999999999999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------------Ccccc----------------------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------------SIRPH---------------------- 141 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------------~~~~~---------------------- 141 (218)
|||||+++|.+++...... +++|.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999998998887653211 22221
Q ss_pred --ccccC----------------------CcccCcccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 142 --IKEVG----------------------SPYKAPESRIR------SSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 142 --~~~~g----------------------~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
+.++| ..|+|||.+.. ...++.++|||||||++|+|+| |+.||....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 22222 23999996644 2558999999999999999999 999997653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-21 Score=155.36 Aligned_cols=146 Identities=21% Similarity=0.382 Sum_probs=107.8
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC--CCCCeeeeeeeEEe
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL--EHDNIVRLLDVLTT 111 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~ 111 (218)
.......++|++.+.||+|+||.||+|.+ .+..||+|++... ......+|.+++... +||||+++++++..
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 34455678999999999999999999987 4899999998632 223445555555554 89999999999987
Q ss_pred C----CEEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc----------
Q 041487 112 G----RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI---------- 142 (218)
Q Consensus 112 ~----~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~---------- 142 (218)
. ..+++||||+++ +|.+++...... +++|.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7 789999999987 998887543211 222221
Q ss_pred -cccC----------------------CcccCcccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCC
Q 041487 143 -KEVG----------------------SPYKAPESRIRSSVYSTP------HDVWAVGCIFAEMVSG----------KPL 183 (218)
Q Consensus 143 -~~~g----------------------~~y~aPE~~~~~~~~~~~------~DiwSlG~~l~~l~tg----------~~P 183 (218)
.+|| ..|+|||.+... ..... +|||||||++|+|+|| +.|
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 1222 239999965443 34444 9999999999999999 777
Q ss_pred CCCC
Q 041487 184 FPCG 187 (218)
Q Consensus 184 f~~~ 187 (218)
|...
T Consensus 262 ~~~~ 265 (337)
T 3mdy_A 262 YHDL 265 (337)
T ss_dssp TTTT
T ss_pred Hhhh
Confidence 7654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.2e-21 Score=155.41 Aligned_cols=146 Identities=23% Similarity=0.378 Sum_probs=111.9
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhh--CCCCCeeeeeeeEEeC
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE--LEHDNIVRLLDVLTTG 112 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~ 112 (218)
......++|++.+.||+|+||.||+|.+ +++.||+|++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3445678899999999999999999987 6899999998532 34567888888887 6899999999999876
Q ss_pred C----EEEEEEecCCC-ChHHHhhhcccC----------------------------------Cccccc-----------
Q 041487 113 R----YVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPHI----------- 142 (218)
Q Consensus 113 ~----~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~~----------- 142 (218)
. .+++||||+++ +|.+++...... +++|.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 5 89999999987 999887653211 222221
Q ss_pred cccC----------------------CcccCcccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCC
Q 041487 143 KEVG----------------------SPYKAPESRIRSSV-----YSTPHDVWAVGCIFAEMVSG----------KPLFP 185 (218)
Q Consensus 143 ~~~g----------------------~~y~aPE~~~~~~~-----~~~~~DiwSlG~~l~~l~tg----------~~Pf~ 185 (218)
.++| ..|+|||.+..... ++.++|||||||++|+|+|| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 1222 23999996554322 23689999999999999999 78997
Q ss_pred CC
Q 041487 186 CG 187 (218)
Q Consensus 186 ~~ 187 (218)
..
T Consensus 269 ~~ 270 (342)
T 1b6c_B 269 DL 270 (342)
T ss_dssp TT
T ss_pred cc
Confidence 65
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.7e-23 Score=180.88 Aligned_cols=147 Identities=25% Similarity=0.429 Sum_probs=114.0
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------ 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 111 (218)
...++|++.+.||+|+||.||+|.+..++..||+|.++.. ......+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3458899999999999999999999889999999998643 233446778999999999999999999998754
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC------------------------------Ccccc--------------ccccC
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT------------------------------SIRPH--------------IKEVG 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~------------------------------~~~~~--------------~~~~g 146 (218)
....++||||+++ +|.+++...... +++|. +.++|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 6778999999976 999988764310 22222 12222
Q ss_pred -----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 -----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 -----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||. ..+..++.++|||||||++|+|++|+.||..
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~-l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPEL-LEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCS-SCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccccccCCcccCChHH-hccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23899995 4556689999999999999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-22 Score=176.78 Aligned_cols=147 Identities=21% Similarity=0.337 Sum_probs=111.9
Q ss_pred hhccceeEEEEeeecCceEEEEEEEcc-CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE--
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLE-TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY-- 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 114 (218)
+..++|++.+.||+|+||.||+|.+.. +++.||+|.+... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 456889999999999999999999976 7899999998642 223345678899999999999999999999976544
Q ss_pred ---EEEEEecCCC-ChHHHhhhccc-------------------------CCccccc----------cccC---------
Q 041487 115 ---VYLVFEYLDL-DLGSFIRKHTI-------------------------TSIRPHI----------KEVG--------- 146 (218)
Q Consensus 115 ---~~lv~E~~~~-~L~~~~~~~~~-------------------------~~~~~~~----------~~~g--------- 146 (218)
.|+||||+++ +|.+++..... .+++|.+ .+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~ 235 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG 235 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCCS
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccCC
Confidence 7999999987 77766543111 1344432 2232
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+. +. ++.++|||||||++|+|++|.+||.+.
T Consensus 236 ~~~gt~~y~aPE~~~-~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVR-TG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CCCCCTTTSCTTHHH-HC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ccCCCccccCHHHHc-CC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 2399999654 33 488999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-22 Score=163.44 Aligned_cols=145 Identities=26% Similarity=0.330 Sum_probs=103.7
Q ss_pred hhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHH--HhhCCCCCeeeeeeeEE-
Q 041487 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSL--LKELEHDNIVRLLDVLT- 110 (218)
Q Consensus 34 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~- 110 (218)
....+..++|++.+.||+|+||.||+|.. +++.||+|++... ..+.+..|.++ +..++||||+++++.+.
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 34557789999999999999999999976 7899999998643 22344445544 44579999999998653
Q ss_pred ----eCCEEEEEEecCCC-ChHHHhhhcccC-----------------------------------Cccccc--------
Q 041487 111 ----TGRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------------SIRPHI-------- 142 (218)
Q Consensus 111 ----~~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------------~~~~~~-------- 142 (218)
....+++||||+++ +|.+++...... +++|.+
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 33468999999976 998887543221 222221
Q ss_pred ---cccC--------------------------CcccCcccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 143 ---KEVG--------------------------SPYKAPESRIRS------SVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 143 ---~~~g--------------------------~~y~aPE~~~~~------~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
.+|| ..|+|||.+... ..++.++|||||||++|+|++|+.||.
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 2222 249999965442 345678999999999999999976653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-20 Score=151.84 Aligned_cols=142 Identities=26% Similarity=0.381 Sum_probs=108.3
Q ss_pred hhccceeEE-EEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHH-hhCCCCCeeeeeeeEEe----
Q 041487 38 VKDWNYKVV-EKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLL-KELEHDNIVRLLDVLTT---- 111 (218)
Q Consensus 38 ~~~~~~~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~---- 111 (218)
...++|.+. +.||+|+||.||+|.++.+++.||+|+++. ...+.+|+.++ +..+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 346778887 789999999999999999999999999863 24577888887 55599999999999976
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC-----------------------------CccccccccCC----------cccC
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHIKEVGS----------PYKA 151 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~~~~g~----------~y~a 151 (218)
...+++||||+++ +|.+++...... +++|.+..+.. .|-.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 7789999999987 999998765321 33443322111 0111
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 152 PESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 152 PE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
.+ ...+..++.++|||||||++|+|++|+.||...
T Consensus 167 a~-~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 167 AK-ETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CE-ECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cc-ccccccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 12 223445889999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=158.17 Aligned_cols=147 Identities=15% Similarity=0.164 Sum_probs=104.3
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCC-CCeeee---------e---
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEH-DNIVRL---------L--- 106 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~~iv~~---------~--- 106 (218)
..|...+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.+.| .+...+ .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45888999999999999999999999999999987433 333456789999999999977 221111 1
Q ss_pred ---------eeEEe-----CCEEEEEEecCCCChHHHhhhcc------c----------------------------CCc
Q 041487 107 ---------DVLTT-----GRYVYLVFEYLDLDLGSFIRKHT------I----------------------------TSI 138 (218)
Q Consensus 107 ---------~~~~~-----~~~~~lv~E~~~~~L~~~~~~~~------~----------------------------~~~ 138 (218)
..+.. ....+++|+.+.++|.+++.... . .|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111 23478999999889988874210 0 044
Q ss_pred cccc-----------ccc--------------CCcccCccccc---------CCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 041487 139 RPHI-----------KEV--------------GSPYKAPESRI---------RSSVYSTPHDVWAVGCIFAEMVSGKPLF 184 (218)
Q Consensus 139 ~~~~-----------~~~--------------g~~y~aPE~~~---------~~~~~~~~~DiwSlG~~l~~l~tg~~Pf 184 (218)
+|.+ .+| |..|+|||.+. ....++.++|||||||++|+|++|+.||
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 4432 222 34599999663 4445788999999999999999999999
Q ss_pred CCC
Q 041487 185 PCG 187 (218)
Q Consensus 185 ~~~ 187 (218)
...
T Consensus 318 ~~~ 320 (413)
T 3dzo_A 318 TDD 320 (413)
T ss_dssp CTT
T ss_pred CCc
Confidence 876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6e-21 Score=155.93 Aligned_cols=146 Identities=18% Similarity=0.206 Sum_probs=105.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC------CCCchHHHHHHHHHHhhCC---------CCC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE------PEGVPSYLIAGVSLLKELE---------HDN 101 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~ 101 (218)
.+..++|++.+.||+|+||.||+|++ +++.||+|+++.... .....+.+.+|+.+++.++ |||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 45578899999999999999999987 789999999986542 2334578899999998886 666
Q ss_pred eeeeeee-----------------EEe-------------CCEEEEEEecCCC-ChHHHhhhcccC--------------
Q 041487 102 IVRLLDV-----------------LTT-------------GRYVYLVFEYLDL-DLGSFIRKHTIT-------------- 136 (218)
Q Consensus 102 iv~~~~~-----------------~~~-------------~~~~~lv~E~~~~-~L~~~~~~~~~~-------------- 136 (218)
++++.++ +.. ...+|+||||+++ ++.+.+......
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 6666554 332 6789999999965 344443221111
Q ss_pred -------------Cc-------------------------------cccccccCCc-------------ccCcccccCCC
Q 041487 137 -------------SI-------------------------------RPHIKEVGSP-------------YKAPESRIRSS 159 (218)
Q Consensus 137 -------------~~-------------------------------~~~~~~~g~~-------------y~aPE~~~~~~ 159 (218)
++ ..++.+||.+ |+|||.+. +.
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~-g~ 252 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT-GD 252 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC-CC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc-CC
Confidence 22 2333444432 99999554 44
Q ss_pred CCCCcchHHHHHHH-HHHHHhCCCCCCC
Q 041487 160 VYSTPHDVWAVGCI-FAEMVSGKPLFPC 186 (218)
Q Consensus 160 ~~~~~~DiwSlG~~-l~~l~tg~~Pf~~ 186 (218)
. +.++||||++++ .+++++|..||..
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCcc
Confidence 3 889999998877 7778889999954
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-15 Score=132.22 Aligned_cols=133 Identities=13% Similarity=-0.037 Sum_probs=81.9
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC--------CCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP--------EGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (218)
....+.|++|....+...-.|+.+++|++.+.... ....+.+.+|+++|+++ .|+||+++++++.++..+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34456677776666666667899999999865321 12345689999999999 7999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC------------------------Cccccc-----------cccCCc------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT------------------------SIRPHI-----------KEVGSP------------ 148 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~------------------------~~~~~~-----------~~~g~~------------ 148 (218)
|||||++| +|.+++...+.. |++|.+ .+||.+
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t 398 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN 398 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred EEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence 99999999 999999876543 555543 456543
Q ss_pred ------ccCcccccCCCCCCCcchHHHHHHHHHHHHhC
Q 041487 149 ------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG 180 (218)
Q Consensus 149 ------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg 180 (218)
|+|||.+ .+. +...+|+||+|++++.+.++
T Consensus 399 ~vGTp~YmAPE~l-~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 399 LVQSFFVFVNELF-AEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ceechhhccHHHh-CCC-CCCcccccccccchhhhccc
Confidence 9999955 333 67789999999987776444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=113.33 Aligned_cols=138 Identities=14% Similarity=0.042 Sum_probs=93.6
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC------CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE------GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.+.||+|+||.||+|. ..+..+++|......... ...+++.+|+.++++++||||+++..++......|+||
T Consensus 341 ~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 5689999999999994 467889999875432221 11355899999999999999996666666677789999
Q ss_pred ecCCC-ChHHHhhhccc-------------------CCccc---------cccccCC-----------------------
Q 041487 120 EYLDL-DLGSFIRKHTI-------------------TSIRP---------HIKEVGS----------------------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~-------------------~~~~~---------~~~~~g~----------------------- 147 (218)
||+++ +|.+++..... .|++| ++.+||.
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~G 498 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKAVDLIVFKKAVLS 498 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECCeEEEEECccCEECCCccccccchhhhhhhhcC
Confidence 99985 99888764100 13333 3334443
Q ss_pred --cccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 041487 148 --PYKAPESRIRS-SVYSTPHDVWAVGCIFAEMVSGKPLFP 185 (218)
Q Consensus 148 --~y~aPE~~~~~-~~~~~~~DiwSlG~~l~~l~tg~~Pf~ 185 (218)
.|+|||.+... ..|+...|+||..+-..+-..++.+|.
T Consensus 499 T~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 499 THHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 27899965441 337788999999998888888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=4e-09 Score=83.97 Aligned_cols=79 Identities=15% Similarity=0.199 Sum_probs=60.3
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----------------CchHHHHHHHHHHhhCCCCCeeeeeee
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----------------GVPSYLIAGVSLLKELEHDNIVRLLDV 108 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (218)
+.+.||+|+||.||+|.+ .+++.||+|+++...... .....+.+|+.++++++ | ++++++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 449999999999999998 889999999996432211 12456889999999998 4 666665
Q ss_pred EEeCCEEEEEEecCCC-ChHH
Q 041487 109 LTTGRYVYLVFEYLDL-DLGS 128 (218)
Q Consensus 109 ~~~~~~~~lv~E~~~~-~L~~ 128 (218)
+.. +..++||||+++ +|.+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~ 189 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR 189 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG
T ss_pred Eec-cceEEEEEecCCCcHHH
Confidence 533 456999999987 8876
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.3e-07 Score=74.15 Aligned_cols=84 Identities=15% Similarity=0.128 Sum_probs=60.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcE--EEEEEeecCCCCCC----------------------chHHHHHHHHHHhhCC
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKK--VAIKMINIQNEPEG----------------------VPSYLIAGVSLLKELE 98 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 98 (218)
|.+.+.||+|+||.||+|.+..+|.. ||||+++.....-. ....+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999998778988 99999764321100 0136788999999998
Q ss_pred CCCe--eeeeeeEEeCCEEEEEEecCCC------ChHHHh
Q 041487 99 HDNI--VRLLDVLTTGRYVYLVFEYLDL------DLGSFI 130 (218)
Q Consensus 99 h~~i--v~~~~~~~~~~~~~lv~E~~~~------~L~~~~ 130 (218)
|+++ +.+++. ...++||||++. .|.++.
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~ 164 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELG 164 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHG
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHh
Confidence 7754 333332 346899999952 566554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.23 E-value=5e-07 Score=74.83 Aligned_cols=83 Identities=17% Similarity=0.256 Sum_probs=51.7
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC------------CCchHH--------HHHHHHHHhhCCCCCe
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP------------EGVPSY--------LIAGVSLLKELEHDNI 102 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~--------~~~e~~~l~~l~h~~i 102 (218)
|.+.+.||.|++|.||+|.+ .+|+.||||+++..... ...... ..+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999987 46999999998643211 000111 1245555666644333
Q ss_pred eeeeeeEEeCCEEEEEEecCCC-ChHH
Q 041487 103 VRLLDVLTTGRYVYLVFEYLDL-DLGS 128 (218)
Q Consensus 103 v~~~~~~~~~~~~~lv~E~~~~-~L~~ 128 (218)
.-...+.... .++||||+++ .|.+
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~ 200 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQ 200 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGG
T ss_pred CCCeeeeccC--ceEEEEecCCccHhh
Confidence 2222122222 3799999987 5544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=9.3e-05 Score=57.46 Aligned_cols=86 Identities=13% Similarity=0.076 Sum_probs=69.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 118 (218)
..+|++...++.|+.+.||++.. .+..+++|..+..... ....+.+|+.+++.+ .+..++++++++...+..|+|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 35799999999999999999974 4789999998743211 124588999999988 467788999999999999999
Q ss_pred EecCCC-ChHHH
Q 041487 119 FEYLDL-DLGSF 129 (218)
Q Consensus 119 ~E~~~~-~L~~~ 129 (218)
||+++| ++.+.
T Consensus 89 ~e~i~G~~l~~~ 100 (263)
T 3tm0_A 89 MSEADGVLCSEE 100 (263)
T ss_dssp EECCSSEEHHHH
T ss_pred EEecCCeehhhc
Confidence 999998 77664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0022 Score=49.17 Aligned_cols=81 Identities=16% Similarity=0.087 Sum_probs=59.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC--eeeeeeeEEeCCEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN--IVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv 118 (218)
.++.+....+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.+.+ +++++++....+..++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 4466655545667799999964 45778999997532 1245788999888884433 66788888877889999
Q ss_pred EecCCC-ChH
Q 041487 119 FEYLDL-DLG 127 (218)
Q Consensus 119 ~E~~~~-~L~ 127 (218)
|||+++ ++.
T Consensus 94 ~e~i~G~~l~ 103 (264)
T 1nd4_A 94 LGEVPGQDLL 103 (264)
T ss_dssp EECCSSEETT
T ss_pred EEecCCcccC
Confidence 999998 663
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.014 Score=47.31 Aligned_cols=81 Identities=10% Similarity=0.151 Sum_probs=56.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEee--cCCCCCCchHHHHHHHHHHhhCC--CCCeeeeeeeEEeC---CEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN--IQNEPEGVPSYLIAGVSLLKELE--HDNIVRLLDVLTTG---RYV 115 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~ 115 (218)
...++.++.|.++.||+... .+..+++|..+ ..... .....+.+|..+++.+. +..+++++..+.+. +..
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34578899999999999875 45788888765 32211 12346788999999886 45578888888765 458
Q ss_pred EEEEecCCC-Ch
Q 041487 116 YLVFEYLDL-DL 126 (218)
Q Consensus 116 ~lv~E~~~~-~L 126 (218)
|+||||+++ .+
T Consensus 117 ~~vme~v~G~~l 128 (359)
T 3dxp_A 117 FYIMEFVSGRVL 128 (359)
T ss_dssp EEEEECCCCBCC
T ss_pred EEEEEecCCeec
Confidence 999999987 44
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.65 E-value=0.099 Score=40.21 Aligned_cols=83 Identities=11% Similarity=0.086 Sum_probs=59.4
Q ss_pred cceeEEEEeeecCc-eEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-CCCeeeeeeeEEeCCEEEEE
Q 041487 41 WNYKVVEKIGQGVF-GEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-HDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 118 (218)
.+|++. .+..|.. +.||+......+..+++|..+.. ....+.+|..+++.+. +--+.+++.++.+.+..++|
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 345443 3444544 46898877667788999986532 2456788999888873 44578888888899999999
Q ss_pred EecCCC-ChHHH
Q 041487 119 FEYLDL-DLGSF 129 (218)
Q Consensus 119 ~E~~~~-~L~~~ 129 (218)
||++++ ++.+.
T Consensus 99 me~l~G~~~~~~ 110 (272)
T 4gkh_A 99 TTAIPGKTAFQV 110 (272)
T ss_dssp EECCCSEEHHHH
T ss_pred EEeeCCcccccc
Confidence 999988 65543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.58 E-value=0.07 Score=42.62 Aligned_cols=74 Identities=20% Similarity=0.193 Sum_probs=59.4
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC---CCCeeeeeeeEEeCCEEEEEEe
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE---HDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.-.+.|+.|..+.+|+... .+..+++|..+.. ....+..|...++.+. ...+++++......+..++|||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 3467899999999999875 5778999987632 2567889998888873 3568888888887889999999
Q ss_pred cCCC
Q 041487 121 YLDL 124 (218)
Q Consensus 121 ~~~~ 124 (218)
++++
T Consensus 112 ~l~G 115 (312)
T 3jr1_A 112 ALNK 115 (312)
T ss_dssp CCCC
T ss_pred eccC
Confidence 9987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.09 E-value=0.043 Score=45.06 Aligned_cols=78 Identities=18% Similarity=0.122 Sum_probs=50.8
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-----CCCchHHHHHHHHHHhhCC-C-C-CeeeeeeeEEeCCEEE
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-----PEGVPSYLIAGVSLLKELE-H-D-NIVRLLDVLTTGRYVY 116 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~ 116 (218)
..+.+|.|..+.||++.....+..+++|..+.... .....+++..|..+++.+. + + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997655678899998753211 0123456788888888773 2 3 34556543 344467
Q ss_pred EEEecCCC
Q 041487 117 LVFEYLDL 124 (218)
Q Consensus 117 lv~E~~~~ 124 (218)
+|||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.33 Score=37.81 Aligned_cols=80 Identities=14% Similarity=0.135 Sum_probs=55.7
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCC---CeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD---NIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~ 114 (218)
+.-....-...+|.|..+.||+.+. .+|+.+.+|..+... ......+..|+..|+.+... -+++++.. ..
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~-- 84 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD-- 84 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence 3445567788999999999999985 578899999876432 22234578899998888422 24444443 33
Q ss_pred EEEEEecCCC
Q 041487 115 VYLVFEYLDL 124 (218)
Q Consensus 115 ~~lv~E~~~~ 124 (218)
-+++||+++.
T Consensus 85 ~~lv~e~l~~ 94 (288)
T 3f7w_A 85 RTLAMEWVDE 94 (288)
T ss_dssp TEEEEECCCC
T ss_pred ceEEEEeecc
Confidence 3689999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=92.52 E-value=0.38 Score=37.92 Aligned_cols=74 Identities=16% Similarity=0.154 Sum_probs=53.5
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCC---CeeeeeeeEE-eCCEEEEEEec
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHD---NIVRLLDVLT-TGRYVYLVFEY 121 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~E~ 121 (218)
++.++.|....||+. +..+++|+.+ .......+.+|..+++.+.+. .+++++.+.. ..+..+++||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788988899987 5778889843 122356788999999998642 3556666654 44567899999
Q ss_pred CCC-ChHH
Q 041487 122 LDL-DLGS 128 (218)
Q Consensus 122 ~~~-~L~~ 128 (218)
++| .+.+
T Consensus 95 i~G~~l~~ 102 (306)
T 3tdw_A 95 VQGQILGE 102 (306)
T ss_dssp CCSEECHH
T ss_pred cCCeECch
Confidence 998 6654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.18 E-value=0.0096 Score=50.38 Aligned_cols=64 Identities=9% Similarity=0.098 Sum_probs=17.4
Q ss_pred eEEEEeeecCceEEEEEEEccCCcEEEE------EEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETGKKVAI------KMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
.+.+.|| ||.||++.......+||+ |..+......+....+.+|..+++.++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3344555 999999988665678888 665543344444566888889999999999999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=87.84 E-value=1.1 Score=35.79 Aligned_cols=85 Identities=13% Similarity=0.130 Sum_probs=55.6
Q ss_pred eEEEEe-eecCceEEEEEEEc--c----CCcEEEEEEeecCCC-CCCchHHHHHHHHHHhhCC-C--CCeeeeeeeEEeC
Q 041487 44 KVVEKI-GQGVFGEVYKCLNL--E----TGKKVAIKMINIQNE-PEGVPSYLIAGVSLLKELE-H--DNIVRLLDVLTTG 112 (218)
Q Consensus 44 ~~~~~i-g~G~~g~v~~~~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~ 112 (218)
...+.| +.|..+.+|+.... . ++..+++|..+.... .......+.+|+.+++.+. + ..+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445677 88989999988653 1 256889998653220 0001134778888888773 3 3577787776554
Q ss_pred ---CEEEEEEecCCC-ChHH
Q 041487 113 ---RYVYLVFEYLDL-DLGS 128 (218)
Q Consensus 113 ---~~~~lv~E~~~~-~L~~ 128 (218)
+..++|||++++ .+.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 357899999988 5543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=85.54 E-value=4.1 Score=31.90 Aligned_cols=71 Identities=17% Similarity=0.323 Sum_probs=41.1
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC--CCeeeeee------eEEeCCEEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH--DNIVRLLD------VLTTGRYVYL 117 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~l 117 (218)
++.|+.|..+.||++.. .+..+++|.... . ...+..|..+++.+.. -.+++++. +....+..++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR---P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS---C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC---C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666677889999875 345689998763 1 2344455555554421 12344443 1235678899
Q ss_pred EEecCCC
Q 041487 118 VFEYLDL 124 (218)
Q Consensus 118 v~E~~~~ 124 (218)
+|||+++
T Consensus 109 l~~~i~G 115 (346)
T 2q83_A 109 VYDWIEG 115 (346)
T ss_dssp EEECCCC
T ss_pred EEEeecC
Confidence 9999987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=85.52 E-value=0.49 Score=37.08 Aligned_cols=73 Identities=16% Similarity=0.152 Sum_probs=49.2
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCC--eeeeeeeEEeCC---EEEEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDN--IVRLLDVLTTGR---YVYLVF 119 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~ 119 (218)
++.++.|..+.||+.. ..+++|+.+.. .....+.+|..+++.+ .+.. +++++....... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3468999999999763 56889985421 3356788999999887 4333 344444433332 458899
Q ss_pred ecCCC-ChH
Q 041487 120 EYLDL-DLG 127 (218)
Q Consensus 120 E~~~~-~L~ 127 (218)
|+++| ++.
T Consensus 96 ~~i~G~~l~ 104 (304)
T 3sg8_A 96 TKIKGVPLT 104 (304)
T ss_dssp ECCCCEECC
T ss_pred cccCCeECC
Confidence 99987 554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 218 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-27 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-22 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-21 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-07 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-06 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-04 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-19 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-19 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-05 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-06 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-17 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 0.001 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-17 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-16 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-05 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-16 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-16 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-07 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-15 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-15 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-15 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-14 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-14 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-14 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-04 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-14 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-14 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-13 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-04 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-13 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 0.003 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 0.002 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-11 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-11 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-06 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-29
Identities = 42/216 (19%), Positives = 80/216 (37%), Gaps = 58/216 (26%)
Query: 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL 97
+KD +++ + ++G G G V+K + +G +A K+I+++ +P + + +I + +L E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHEC 61
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRK-----------------------H 133
IV + + + E++D L ++K
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 134 TITSI--------------RPHIK-----------------EVGSP-YKAPESRIRSSVY 161
I R IK VG+ Y +PE R++ + Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHY 180
Query: 162 STPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197
S D+W++G EM G+ P L L+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 2e-27
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 57/199 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y EKIGQG G VY +++ TG++VAI+ +N+Q +P+ +I + +++E ++ N
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78
Query: 102 IVRLLDVLTTGRYVYLVFEYL---DLDLGSFIRKHTITSIRPHIKEV------------- 145
IV LD G +++V EYL L I +E
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 146 ---------------------------------------GSPYKAPESRIRSSVYSTPHD 166
G+PY + Y D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 167 VWAVGCIFAEMVSGKPLFP 185
+W++G + EM+ G+P +
Sbjct: 199 IWSLGIMAIEMIEGEPPYL 217
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-27
Identities = 72/215 (33%), Positives = 98/215 (45%), Gaps = 59/215 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
N++ VEKIG+G +G VYK N TG+ VA+K I + E EGVPS I +SLLKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITS------------------------ 137
IV+LLDV+ T +YLVFE+L DL F+ +T
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 138 -----IRPHI-----------------KEVGSPYKAPESRIRSSVYSTPH---------- 165
++P + G P + + + Y P
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 166 --DVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
D+W++GCIFAEMV+ + LFP + D L I R
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (243), Expect = 2e-25
Identities = 43/200 (21%), Positives = 70/200 (35%), Gaps = 57/200 (28%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
++++ +G+G FG VY ++ +A+K++ E GV L V + L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRK-----------------------HTIT 136
NI+RL VYL+ EY L + ++K H+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 137 SIRPHIK------------------------------EVGSP-YKAPESRIRSSVYSTPH 165
I IK G+ Y PE I ++
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKV 185
Query: 166 DVWAVGCIFAEMVSGKPLFP 185
D+W++G + E + GKP F
Sbjct: 186 DLWSLGVLCYEFLVGKPPFE 205
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.6 bits (240), Expect = 1e-24
Identities = 38/199 (19%), Positives = 62/199 (31%), Gaps = 56/199 (28%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDN 101
+ + +IG G FG VY ++ + VAIK ++ + +I V L++L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRK------------------------HTITS 137
++ +LV EY + H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 138 IRPHIK----------------------------EVGSP-YKAPES--RIRSSVYSTPHD 166
I +K VG+P + APE + Y D
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 167 VWAVGCIFAEMVSGKPLFP 185
VW++G E+ KP
Sbjct: 197 VWSLGITCIELAERKPPLF 215
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.7 bits (235), Expect = 6e-24
Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 3/102 (2%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVS 92
+Q E ++D Y + +G G F EV + T K VAIK I + EG + ++
Sbjct: 2 KQAEDIRD-IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIA 59
Query: 93 LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L +++H NIV L D+ +G ++YL+ + + +L I +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK 101
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 4e-22
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 61/212 (28%)
Query: 47 EKIGQGVFGEVYKCLNLETGKKVAIKMIN---IQNEPEGVPSYLIAGVSLLKELEHDNIV 103
+ +G+G F VYK + T + VAIK I +G+ + + LL+EL H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 104 RLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHI--------------------- 142
LLD + LVF++++ DL I+ +++ HI
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 143 ------------------------KEVGSPYKAPESRIRSSVYSTPH------------D 166
K GSP +A ++ + Y P D
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183
Query: 167 VWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVR 197
+WAVGCI AE++ P P D L+ I
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 90.1 bits (223), Expect = 4e-22
Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y ++E++G G FG V++C+ TG+ K IN + + +S++ +L H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87
Query: 102 IVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++ L D + L+ E+L +L I
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 90.1 bits (223), Expect = 5e-22
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 3/93 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y + E++G G FG V++ TG A K + +E + + + + L H
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPT 84
Query: 102 IVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
+V L D + +++E++ +L +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 9e-22
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+Y+V+ IG G +G K GK + K ++ + E L++ V+LL+EL+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 102 IVRLLDVLT--TGRYVYLVFEYLDL-DLGSFIRKHT 134
IVR D + T +Y+V EY + DL S I K T
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT 100
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 2e-05
Identities = 11/39 (28%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186
Y +PE + Y+ D+W++GC+ E+ + P F
Sbjct: 179 YYMSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 2e-21
Identities = 24/102 (23%), Positives = 44/102 (43%), Gaps = 2/102 (1%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVS 92
Q K + ++K + +G+G F V L T ++ AIK++ ++ E Y+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 93 LLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++ L+H V+L +Y Y +L +IRK
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 102
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (107), Expect = 1e-06
Identities = 18/69 (26%), Positives = 30/69 (43%), Gaps = 2/69 (2%)
Query: 125 DLGSFIRKHTITSIRPHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPL 183
D G+ + VG+ Y +PE + D+WA+GCI ++V+G P
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 184 FPCGKKDHL 192
F G + +
Sbjct: 210 FRAGNEYLI 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 2e-21
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 59/215 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + +G G +G V + +TG +VA+K ++ + + LLK ++H+N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 102 IVRLLDVLTTGR------YVYLVFEYLDLDLGSFI--RKHTITSIRPHIKEV-------- 145
++ LLDV T R VYLV + DL + + +K T ++ I ++
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 146 ------------------------------------------GSPYKAPESRIRSSVYST 163
Y+APE + Y+
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 164 PHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVR 197
D+W+VGCI AE+++G+ LFP D L LI+R
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.0 bits (215), Expect = 5e-21
Identities = 21/93 (22%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y + E +G+G FG V++C+ + K K + ++ + + +S+L H N
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLD-LDLGSFIRKH 133
I+ L + + + ++FE++ LD+ I
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTS 95
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 5e-21
Identities = 38/112 (33%), Positives = 64/112 (57%), Gaps = 8/112 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ + KIGQG FGEV+K + +TG+KVA+K + ++NE EG P + + +L+ L+H+N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 102 IVRLLDVLTTG--------RYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEV 145
+V L+++ T +YLVF++ + DL + + IK V
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (111), Expect = 4e-07
Identities = 20/77 (25%), Positives = 32/77 (41%), Gaps = 2/77 (2%)
Query: 123 DLDLGSFIRKHTITSIRPHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK 181
D L + + V + Y+ PE + Y P D+W GCI AEM +
Sbjct: 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
Query: 182 PLFPC-GKKDHLSLIVR 197
P+ ++ L+LI +
Sbjct: 220 PIMQGNTEQHQLALISQ 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (212), Expect = 6e-21
Identities = 23/93 (24%), Positives = 45/93 (48%), Gaps = 2/93 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++ +V+ +G+G +GEV +N T + VA+K+++++ + P + + + K L H+N
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHEN 64
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLG-SFIRKH 133
+V+ G YL EY I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (210), Expect = 2e-20
Identities = 26/198 (13%), Positives = 64/198 (32%), Gaps = 54/198 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
+++++ +G G FG V+ + G+ A+K++ + + +L + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 101 NIVRLLDVLTTGRYVYLVFEYLD----LDLGSFIRKHTITSIRPHIKEV----------- 145
I+R+ + ++++ +Y++ L ++ + + EV
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 146 --------------------------------------GSPYKAPESRIRSSVYSTPHDV 167
G+P + + Y+ D
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 168 WAVGCIFAEMVSGKPLFP 185
W+ G + EM++G F
Sbjct: 185 WSFGILIYEMLAGYTPFY 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 2e-20
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 5/94 (5%)
Query: 34 QMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIA 89
+ E V D Y E++G G F V KC TG + A K I + +
Sbjct: 4 RQENVDD-YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 90 GVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123
VS+LKE++H N++ L +V V L+ E +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-05
Identities = 14/61 (22%), Positives = 23/61 (37%), Gaps = 2/61 (3%)
Query: 126 LGSFIRKHTITSIRPHIKEVGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLF 184
+ F H I G+ + APE + D+W++G I ++SG F
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 185 P 185
Sbjct: 217 L 217
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 2e-20
Identities = 48/215 (22%), Positives = 74/215 (34%), Gaps = 59/215 (27%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ ++ IG G G V + + VAIK ++ + + + L+K + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 102 IVRLLDVLTT------GRYVYLVFEYLDLDLGSFIRK---------------------HT 134
I+ LL+V T + VYLV E +D +L I+ H+
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 135 ITSIRPHIK-------------------------------EVGSPYKAPESRIRSSVYST 163
I +K V + Y I Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 164 PHDVWAVGCIFAEMVSGKPLFPC-GKKDHLSLIVR 197
D+W+VGCI EMV K LFP D + ++
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 84.6 bits (208), Expect = 2e-20
Identities = 42/92 (45%), Positives = 59/92 (64%), Gaps = 1/92 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y +EKIG+G +G VYK N G+ A+K I ++ E EG+PS I +S+LKEL+H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
IV+L DV+ T + + LVFE+LD DL +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 43.3 bits (101), Expect = 7e-06
Identities = 27/50 (54%), Positives = 34/50 (68%), Gaps = 1/50 (2%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
Y+AP+ + S YST D+W+VGCIFAEMV+G PLFP + D L I R
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.3 bits (208), Expect = 3e-20
Identities = 24/85 (28%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
++++ ++G G FG+VYK N ET A K+I+ ++E E + + +L +H N
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPN 70
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDL 126
IV+LLD ++++ E+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGA 95
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 4e-20
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y+ ++ +G G +G V ++ TG KVAIK + + E + LLK + H+N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 103 VRLLDVLTTGR------YVYLVFEYLDLDLGSFIRKHTIT 136
+ LLDV T YLV ++ DLG ++ +
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 119
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 4e-04
Identities = 18/38 (47%), Positives = 25/38 (65%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPC 186
Y+APE + Y+ D+W+VGCI AEM++GK LF
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 5e-20
Identities = 36/203 (17%), Positives = 65/203 (32%), Gaps = 60/203 (29%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
K +IG+G F VYK L+ ET +VA + + + +LK L+H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 103 VRLLDVLTT----GRYVYLVFEYLDL-DLGSFIRKHTITS---IRPHIKEVGSPY----- 149
VR D + + + LV E + L +++++ + +R +++
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 150 --------------------------------KAPESRIRSSVYSTPH------------ 165
+ +V TP
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYD 190
Query: 166 ---DVWAVGCIFAEMVSGKPLFP 185
DV+A G EM + + +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYS 213
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 83.4 bits (205), Expect = 1e-19
Identities = 44/215 (20%), Positives = 83/215 (38%), Gaps = 64/215 (29%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHD 100
+Y++V K+G+G + EV++ +N+ +KV +K++ + + + + +L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 90
Query: 101 NIVRLLDVLT--TGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEV------------ 145
NI+ L D++ R LVFE+++ D + T IR ++ E+
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGI 150
Query: 146 ----------------------------------------GSP-YKAPESRIRSSVYSTP 164
S +K PE + +Y
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 210
Query: 165 HDVWAVGCIFAEMVSGKPLFPCGK--KDHLSLIVR 197
D+W++GC+ A M+ K F G D L I +
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.6 bits (206), Expect = 1e-19
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 5/97 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQ----NEPEGVPSYLIAGVSLLKEL 97
++ V IG+G FGEVY C +TGK A+K ++ + + E + +SL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ IV + T + + + ++ DL + +H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 101
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 6e-19
Identities = 42/104 (40%), Positives = 62/104 (59%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
Y+ +EKIG+G +G V+K N ET + VA+K + + ++ EGVPS + + LLKEL+H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKHTITSIRPHIKEV 145
IVRL DVL + + + LVFE+ D DL + +K
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.9 bits (199), Expect = 6e-19
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 3/95 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN--EPEGVPSYLIAGVSLLKELEH 99
++ + + +G+G FG+V+ +T + AIK + + V ++ L EH
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 100 DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ + T ++ V EYL+ DL I+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC 97
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 80.6 bits (198), Expect = 7e-19
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 6/97 (6%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDN 101
Y++ E +G G EV+ +L + VA+K++ L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 102 IVRLLDVLTT----GRYVYLVFEYLD-LDLGSFIRKH 133
IV + D G Y+V EY+D + L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE 105
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 7e-19
Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y + IG+G +G V + +VAIK I+ + + + +L H+NI
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENI 68
Query: 103 VRLLDVLTTG-----RYVYLVFEYLDLDLGSFIRKHTIT 136
+ + D++ + VYLV + DL ++ ++
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS 107
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 1e-05
Identities = 21/65 (32%), Positives = 30/65 (46%)
Query: 122 LDLDLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK 181
D L + Y+APE + S Y+ D+W+VGCI AEM+S +
Sbjct: 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
Query: 182 PLFPC 186
P+FP
Sbjct: 211 PIFPG 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 77.8 bits (191), Expect = 7e-18
Identities = 26/101 (25%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-------EPEGVPSYLIAGVSLL 94
NY+ E +G+GV V +C++ T K+ A+K+I++ E + + + V +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 95 KEL-EHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+++ H NI++L D T + +LVF+ + +L ++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 104
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 3e-17
Identities = 25/104 (24%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
++ ++ +Y + IG G FG VY+ ++G+ VAIK + + + +++
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMR 68
Query: 96 ELEHDNIVRLLDVLTTG------RYVYLVFEYLDLDLGSFIRKH 133
+L+H NIVRL + Y+ LV +Y+ + R +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY 112
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 1e-06
Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 148 PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-CGKKDHLSLIVR 197
Y+APE ++ Y++ DVW+ GC+ AE++ G+P+FP D L I++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 75.3 bits (184), Expect = 6e-17
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 13/154 (8%)
Query: 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYL 87
+E ++ N + V IG+G FG V++ L E VA+KM+ + + +
Sbjct: 6 LSLEYPRN-NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADF 63
Query: 88 IAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVG 146
+L+ E ++ NIV+LL V G+ + L+FEY+ DL F+R PH
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM-----SPHTVCSL 118
Query: 147 SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG 180
S SS P CI ++ +G
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.7 bits (84), Expect = 0.001
Identities = 16/74 (21%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 125 DLGSFIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPL 183
D G ++ + + P I + Y+T DVWA G + E+ S G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 184 FPCGKKDHLSLIVR 197
+ + + VR
Sbjct: 243 YYGMAHEEVIYYVR 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 6e-17
Identities = 32/146 (21%), Positives = 60/146 (41%), Gaps = 14/146 (9%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGK-----KVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
N + + +G G FG+V K +VA+KM+ + + + L++ + ++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQ 96
Query: 97 LE-HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKAPES 154
L H+NIV LL T +YL+FEY DL +++R I+ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY------ENQK 150
Query: 155 RIRSSVYSTPHDVWAVGCIFAEMVSG 180
R+ + C ++ G
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKG 176
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 8e-17
Identities = 38/201 (18%), Positives = 67/201 (33%), Gaps = 63/201 (31%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
K+++ IG+G FG+V G KVA+K I + +A S++ +L H N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSN 61
Query: 102 IVRLLDVLTTGR-YVYLVFEYLDL-DLGSFIRKHTITSIRP------------------- 140
+V+LL V+ + +Y+V EY+ L ++R + +
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 141 -------------------HIKEVGSPYKAPESRIRSSVYSTPH---------------- 165
K S + +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 166 DVWAVGCIFAEMVS-GKPLFP 185
DVW+ G + E+ S G+ +P
Sbjct: 182 DVWSFGILLWEIYSFGRVPYP 202
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 1e-16
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ +G G FG+V + + + VA+KM+ + L++ + +L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSY 82
Query: 97 LE-HDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
L H NIV LL T G ++ EY DL +F+R+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 2e-16
Identities = 22/82 (26%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ ++++G G FG V VAIKMI + E I ++ L H+
Sbjct: 5 DLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+L V T R ++++ EY+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMA 82
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 2e-16
Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKEL- 97
Y+V +G G FG VY + + VAIK + + + V LLK++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 98 -EHDNIVRLLDVLTTGRYVYLVFEYLD--LDLGSFIRKH 133
++RLLD L+ E + DL FI +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 104
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (98), Expect = 2e-05
Identities = 14/64 (21%), Positives = 23/64 (35%), Gaps = 7/64 (10%)
Query: 123 DLDLGSFIRKHTITSIRPHIKEVGSP-YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK 181
D G+ ++ T G+ Y PE + VW++G + +MV G
Sbjct: 154 DFGSGALLKDTVYTDF------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 182 PLFP 185
F
Sbjct: 208 IPFE 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 2e-16
Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
V++IG G FG V+ KVAIK I E I ++ +L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 61
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+L V + LVFE+++
Sbjct: 62 LVQLYGVCLEQAPICLVFEFME 83
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (179), Expect = 3e-16
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
K+VE++G G FGEV+ KVA+K + + P +A +L+K+L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQR 69
Query: 102 IVRLLDVLTTGRYVYLVFEYLDLDL 126
+VRL V+T +Y++ EY++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGS 93
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (179), Expect = 3e-16
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 10/100 (10%)
Query: 40 DW-----NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLL 94
DW V ++IG G FG VYK + VA+KM+N+ V +L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 95 KELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++ H NI+ + +T + +V ++ + L +
Sbjct: 59 RKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHII 97
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 4e-16
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 20/102 (19%)
Query: 42 NYKVVEK-IGQGVFGEVYKCLNLETGKKVAIKMIN----IQNEPEGVPSYLIAGVSLLKE 96
+YKV + +G G+ G+V + N T +K A+KM+ + E E +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE----------LHWRA 61
Query: 97 LEHDNIVRLLDVLTT----GRYVYLVFEYLDL-DLGSFIRKH 133
+ +IVR++DV + + +V E LD +L S I+
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 103
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.4 bits (177), Expect = 5e-16
Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ + K+G G +GEVY+ + + VA+K + + +++KE++H N
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 74
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+LL V T Y++ E++
Sbjct: 75 LVQLLGVCTREPPFYIITEFMT 96
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 72.6 bits (177), Expect = 7e-16
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNI 102
Y++ KIG G FG++Y ++ G++VAIK+ ++ + L + K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVG 64
Query: 103 VRLL-DVLTTGRYVYLVFEYLDLDLGSFIRKH 133
+ + G Y +V E L L
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 7e-16
Identities = 39/101 (38%), Positives = 62/101 (61%), Gaps = 9/101 (8%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKK-VAIKMINIQNEPEGVPSYLIAGVSLLKEL--- 97
Y+ V +IG+G +G+V+K +L+ G + VA+K + +Q EG+P I V++L+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 98 EHDNIVRLLDVLTTGR-----YVYLVFEYLDLDLGSFIRKH 133
EH N+VRL DV T R + LVFE++D DL +++ K
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV 108
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 6e-07
Identities = 23/71 (32%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 129 FIRKHTITSIRPHIKEVGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188
F + V + + + S Y+TP D+W+VGCIFAEM KPLF
Sbjct: 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219
Query: 189 -KDHLSLIVRY 198
D L I+
Sbjct: 220 DVDQLGKILDV 230
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.0 bits (173), Expect = 2e-15
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-D 100
+YKV +IG+G FG +++ NL ++VAIK +++ L K L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCT 61
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
I + G + LV + L L +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (93), Expect = 1e-04
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 97 LEHDNIVRLLDVLTTGRYVYLV-FEYLDLDLGSFIRKHTITSIRPHIKEVGSP-YKAPES 154
++ DN + +Y+V F + ++H + ++ G+ Y +
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL--SGTARYMSIN- 183
Query: 155 RIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP 185
S D+ A+G +F + G +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 2e-15
Identities = 33/116 (28%), Positives = 46/116 (39%), Gaps = 4/116 (3%)
Query: 40 DWN-YKVVEKIGQGVFGEVYKCLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKE 96
DWN K + IG+G FG+V K + G + AIK + + + L K
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYKA 151
H NI+ LL Y+YL EY +L F+RK + P S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 3e-15
Identities = 23/103 (22%), Positives = 48/103 (46%), Gaps = 5/103 (4%)
Query: 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAG 90
+ +K+ +K ++ +G G FG VYK L + G+ VAIK + P+ ++
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDE 61
Query: 91 VSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLDLGSFIRKH 133
++ +++ ++ RLL + T + L ++R+H
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 104
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 3e-15
Identities = 17/98 (17%), Positives = 42/98 (42%), Gaps = 2/98 (2%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
++ ++ +G+G FG+V TG+ A+K++ + + ++ + +L+ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 101 NIVRLLDVLTTGRYVYLVFEYLDLD-LGSFIRKHTITS 137
+ L T + V EY + L + + + +
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT 103
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 4e-15
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 6/100 (6%)
Query: 38 VKDWNYKVVE-KIGQGVFGEVYKCLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLL 94
+K N + + ++G G FG V + + K+ VAIK++ E ++ ++
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIM 63
Query: 95 KELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+L++ IVRL+ V + LV E L F+
Sbjct: 64 HQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGK 102
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.0 bits (168), Expect = 1e-14
Identities = 22/91 (24%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVS 92
+++ K+ + IG G FGEV GK+ VAIK + + ++ S
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEAS 79
Query: 93 LLKELEHDNIVRLLDVLTTGRYVYLVFEYLD 123
++ + +H N++ L V+T V ++ E+++
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.6 bits (167), Expect = 1e-14
Identities = 21/89 (23%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 48 KIGQGVFGEVYKCL--NLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRL 105
++G G FG V K + K VA+K++ + + L+A +++++L++ IVR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 106 LDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ + + LV E +L L +++++
Sbjct: 74 IGICEAESW-MLVMEMAELGPLNKYLQQN 101
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 21/94 (22%), Positives = 43/94 (45%), Gaps = 10/94 (10%)
Query: 40 DW-----NYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNEPEGVPSYLIAGV 91
D+ ++ IG+G FG+V++ + + VAIK + V +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEA 59
Query: 92 SLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDLD 125
+++ +H +IV+L+ V+T V+++ E L
Sbjct: 60 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLG 92
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 3e-14
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKC-LNLETGK--KVAIKMINIQ--NEPEGVPSYLIAGVSLLKE 96
+ +++EK+G G FG V + + +GK VA+K + ++PE + I V+ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHS 67
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDL 124
L+H N++RL V+ T + +V E L
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPL 94
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 4e-04
Identities = 7/42 (16%), Positives = 14/42 (33%), Gaps = 1/42 (2%)
Query: 145 VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFP 185
+++ +S D W G EM + G+ +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 7e-14
Identities = 22/117 (18%), Positives = 46/117 (39%), Gaps = 8/117 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGK-------KVAIKMINIQNEPEGVPSYLIAGVSLL 94
+ + +G+G FG+V + K KVA+KM+ + + + +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 95 KELEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKHTITSIRPHIKEVGSPYK 150
+H NI+ LL T +Y++ EY +L +++ + +P +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 8e-14
Identities = 25/100 (25%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ E IG+G FGEV++ G++VA+K+ + + E + A + L H+N
Sbjct: 4 TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW---FREAEIYQTVMLRHEN 58
Query: 102 IVRLLDVLT----TGRYVYLVFEYLDL-DLGSFIRKHTIT 136
I+ + T ++LV +Y + L ++ ++T+T
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 98
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 8e-14
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
+ ++GQG FG VY+ + E +VAIK +N + S++KE
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKE 79
Query: 97 LEHDNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
++VRLL V++ G+ ++ E + DL S++R
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 117
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 1e-13
Identities = 21/115 (18%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 26 VKKTNGSEQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQN--EP 80
++ N + EKV N+++++ +G G +G+V+ + +TGK A+K++ +
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 81 EGVPSYLIAGVSLLKELEH-DNIVRLLDVLTTGRYVYLVFEYLDL-DLGSFIRKH 133
+ +L+ + +V L T ++L+ +Y++ +L + + +
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 6e-04
Identities = 25/145 (17%), Positives = 52/145 (35%), Gaps = 2/145 (1%)
Query: 55 GEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114
+++ L+ G ++ + + E + + L E H + D+
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161
Query: 115 VYLVFEYLDLDLGSFIRKHTITSIRPHIKEVGSPYKAPES-RIRSSVYSTPHDVWAVGCI 173
+ + D G + R + Y AP+ R S + D W++G +
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221
Query: 174 FAEMVSGKPLFPC-GKKDHLSLIVR 197
E+++G F G+K+ + I R
Sbjct: 222 MYELLTGASPFTVDGEKNSQAEISR 246
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 2e-13
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN 101
+ ++ K+GQG FGEV+ +VAIK + P + ++K+L H+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEK 73
Query: 102 IVRLLDVLTTGRYVYLVFEYLD 123
+V+L V++ Y+V EY+
Sbjct: 74 LVQLYAVVSEEPI-YIVTEYMS 94
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.5 bits (81), Expect = 0.003
Identities = 6/47 (12%), Positives = 14/47 (29%)
Query: 145 VGSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDH 191
++ DVW+ G + E+ + + G +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 65.6 bits (159), Expect = 2e-13
Identities = 17/81 (20%), Positives = 36/81 (44%), Gaps = 1/81 (1%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHD 100
+ ++ +G G FG V + E+G A+K+++ Q + + +L+ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 101 NIVRLLDVLTTGRYVYLVFEY 121
+V+L +Y+V EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEY 122
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.4 bits (145), Expect = 1e-11
Identities = 15/73 (20%), Positives = 30/73 (41%), Gaps = 3/73 (4%)
Query: 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLK 95
E KD Y +V K+G G F V+ ++ VA+K++ + + LL+
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQ 64
Query: 96 ELEHDNIVRLLDV 108
+ + + +
Sbjct: 65 RVNDADNTKEDSM 77
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 36.6 bits (83), Expect = 0.002
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 8/66 (12%)
Query: 149 YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFP-------CGKKDHLSLIVRYFTA 201
Y++PE + + + D+W+ C+ E+++G LF DH++ I+
Sbjct: 195 YRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 202 LTNYLV 207
L +YL+
Sbjct: 254 LPSYLL 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.8 bits (144), Expect = 2e-11
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 5/84 (5%)
Query: 42 NYKVVEKIGQGVFGEVYKCLNLETGKK----VAIKMINIQNEPEGVPSYLIAGVSLLKEL 97
+ IG G FGEVYK + + K VAIK + E + ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQF 66
Query: 98 EHDNIVRLLDVLTTGRYVYLVFEY 121
H NI+RL V++ + + ++ EY
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEY 90
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (143), Expect = 3e-11
Identities = 23/81 (28%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 47 EKIGQGVFGEVYKCLNLETGKK---VAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIV 103
E IG+G FG VY L+ K A+K +N + V S + ++K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNVL 91
Query: 104 RLLDV-LTTGRYVYLVFEYLD 123
LL + L + +V Y+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMK 112
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 3e-11
Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 7/99 (7%)
Query: 42 NYKVVEKIGQGVFGEVYKC-----LNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKE 96
K+ + +G+G FG+V + T + VA+KM+ + + L+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 97 LEHDNIVRLLDVLT-TGRYVYLVFEYLDL-DLGSFIRKH 133
H N+V LL T G + ++ E+ +L +++R
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 112
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 42.8 bits (100), Expect = 6e-06
Identities = 12/108 (11%), Positives = 33/108 (30%), Gaps = 13/108 (12%)
Query: 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMI--------NIQNEPEGVPSYLIAGVSLL 94
+ + +G+G V+ C + E + +K ++ + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 95 KELEHDNIVRLLDVLTTGRY----VYLVFEYLDLDLGSFIRKHTITSI 138
E + +L + Y ++ E +D +R +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 218 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.98 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.93 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.03 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 95.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.8 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=227.54 Aligned_cols=159 Identities=26% Similarity=0.425 Sum_probs=130.9
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ......+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999987543 234556789999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccCC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVGS----------- 147 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g~----------- 147 (218)
|||||++ +|.+++...... |++|.+ .+||.
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 163 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence 9999987 999988765432 444433 23332
Q ss_pred -----cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 148 -----PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 -----~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.+...+...+..
T Consensus 164 ~~Gt~~Y~APE~-~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 164 LCGTLDYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp TTEEGGGCCHHH-HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cCCCCcccCHHH-HcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 3999995 4556689999999999999999999999998766655554443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=230.30 Aligned_cols=159 Identities=25% Similarity=0.446 Sum_probs=130.0
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
...++|++.+.||+|+||.||+|+++.+++.||||++.+.. ......+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 44578999999999999999999999999999999997543 23455688999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc-------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE------------- 144 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~------------- 144 (218)
+|||||++ +|.+++...... +++|.+ .+
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999997 898887765432 333332 12
Q ss_pred ------cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 145 ------VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 145 ------~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+ .|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+...+...+.
T Consensus 165 ~~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp -----CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccCCccccCceee-ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 233 39999954 55568999999999999999999999999876555554444
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-34 Score=226.50 Aligned_cols=176 Identities=30% Similarity=0.458 Sum_probs=133.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--CCEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT--GRYVYL 117 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 117 (218)
.++|++++.||+|+||.||+|+++.+|+.||+|.+......+...+.+.+|+.++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 578999999999999999999999999999999998665555556789999999999999999999999864 456899
Q ss_pred EEecCCC-ChHHHhhhcc-----cC-------------------------------Cccccc-----------c------
Q 041487 118 VFEYLDL-DLGSFIRKHT-----IT-------------------------------SIRPHI-----------K------ 143 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~-----~~-------------------------------~~~~~~-----------~------ 143 (218)
|||||++ +|.+++.... .. +++|.+ .
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999987 9988875421 10 333332 1
Q ss_pred -----------ccCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCcccc----
Q 041487 144 -----------EVGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTNYLV---- 207 (218)
Q Consensus 144 -----------~~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---- 207 (218)
..|+ .|+|||.+ .+..++.++|||||||++|+|+||+.||.+.+...+...+.....+..+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 1233 39999954 556689999999999999999999999998766666555554433333333
Q ss_pred hhhhhhhcc
Q 041487 208 LPCFLSIML 216 (218)
Q Consensus 208 ~~~~~~~~l 216 (218)
+-+++..||
T Consensus 242 l~~li~~~L 250 (269)
T d2java1 242 LNEIITRML 250 (269)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHc
Confidence 344455554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-33 Score=223.87 Aligned_cols=157 Identities=27% Similarity=0.397 Sum_probs=127.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.+.|++++.||+|+||.||+|.++.+|+.||+|++++..... ...+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999999999999999997654322 3467899999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC---------------------------Cccccc---------------cccCC-----
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI---------------KEVGS----- 147 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~---------------~~~g~----- 147 (218)
|+|||||++ +|.+++...... +++|.+ .++|.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999987 999998765432 233222 22222
Q ss_pred ------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 ------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 ------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 169 ~~~~~~~~~~t~~y~APE~-~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCccccccCCCCcccCHHH-HcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 3999995 455668999999999999999999999999875555444443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-34 Score=224.26 Aligned_cols=147 Identities=27% Similarity=0.499 Sum_probs=119.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++++.||+|+||.||+|+++.+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3679999999999999999999999999999999975432 233467899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc---------------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV--------------- 145 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~--------------- 145 (218)
|||++ +|.+++...... |++|.+ .+|
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99987 999998654332 333332 222
Q ss_pred ----CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ----GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ----g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
|+ .|+|||.+.....++.++|||||||++|+|+||+.||...
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 33 3999997665554577899999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-33 Score=222.44 Aligned_cols=155 Identities=24% Similarity=0.399 Sum_probs=125.6
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
+.|++++.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4589999999999999999999999999999999754 33446789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhccc--C--------------------------Cccccc-----------cccCC-------------
Q 041487 121 YLDL-DLGSFIRKHTI--T--------------------------SIRPHI-----------KEVGS------------- 147 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~--~--------------------------~~~~~~-----------~~~g~------------- 147 (218)
||++ +|.+++..... . +++|.+ .+||.
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9987 88888765322 1 444432 33332
Q ss_pred -----cccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 -----PYKAPESRI----RSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 -----~y~aPE~~~----~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||.+. ....|+.++|||||||++|+|+||+.||.+.+.......+.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~ 228 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 299999653 34558999999999999999999999998875544444333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-33 Score=223.04 Aligned_cols=147 Identities=29% Similarity=0.544 Sum_probs=122.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.+|++++.||+|+||.||+|.++.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 469999999999999999999999999999999975432 335789999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC--------------------------Cccccc-----------ccc-----------------
Q 041487 121 YLDL-DLGSFIRKHTIT--------------------------SIRPHI-----------KEV----------------- 145 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~--------------------------~~~~~~-----------~~~----------------- 145 (218)
||++ +|.+++...... |++|.+ .+|
T Consensus 98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 177 (293)
T d1yhwa1 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (293)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccc
Confidence 9987 888887654432 344432 222
Q ss_pred CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 146 GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 146 g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
|+ .|+|||.+ .++.++.++|||||||++|+|+||+.||.+.+..
T Consensus 178 gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 222 (293)
T d1yhwa1 178 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (293)
T ss_dssp SCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCCCccChhhh-cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH
Confidence 32 29999954 5566899999999999999999999999876433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-33 Score=226.53 Aligned_cols=156 Identities=26% Similarity=0.388 Sum_probs=121.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.+.|++.+.||+|+||.||+|.++.+++.||+|++.+..... ..+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 466999999999999999999999999999999998654332 3456889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC---------------------------Cccccc--------------cccCC----------
Q 041487 120 EYLDL-DLGSFIRKHTIT---------------------------SIRPHI--------------KEVGS---------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~---------------------------~~~~~~--------------~~~g~---------- 147 (218)
|||++ +|.+++...... +++|.+ .+||.
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 99986 999998765332 333332 23322
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.....+...+.
T Consensus 167 ~~~~GT~~y~APE~-~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 222 (307)
T d1a06a_ 167 STACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222 (307)
T ss_dssp ------CTTSCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeeeCccccCcHH-HcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3999995 555668999999999999999999999999875555444443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-33 Score=226.36 Aligned_cols=160 Identities=21% Similarity=0.355 Sum_probs=132.6
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
+..++|++++.||+|+||.||+|+++.+++.||+|++++.. ......+.+.+|+.++++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45678999999999999999999999999999999997643 23455788999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc-------------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE------------- 144 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~------------- 144 (218)
+|||||++ +|.+++...... +++|.+ .+
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999997 888888765432 333332 22
Q ss_pred ----cCC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 145 ----VGS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 145 ----~g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
+|+ .|+|||. ..+..|+.++|||||||++|+|++|++||.+.+...+...+..
T Consensus 162 ~~~~~GT~~Y~aPE~-~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~ 219 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp BCCCEECGGGCCGGG-GSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccceeCHHHhhhhh-ccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc
Confidence 232 3999994 5566689999999999999999999999999877777666655
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-33 Score=225.33 Aligned_cols=152 Identities=22% Similarity=0.405 Sum_probs=127.2
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
++..++|++++.||+|+||.||+|.++.+++.||+|+++.. ......+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35678999999999999999999999999999999999754 34455678999999999999999999999999999999
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC---------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS--------- 147 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~--------- 147 (218)
+||||+++ +|.+++.+.... |++|.+ .+||.
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 99999997 898888654332 444443 33333
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
.|+|||.+. +..|+.++||||+||++|||++|+.||.+.+..
T Consensus 161 ~~~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ---CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ccccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 299999654 556999999999999999999999999876443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-33 Score=223.74 Aligned_cols=177 Identities=19% Similarity=0.299 Sum_probs=136.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.++|++++.||+|+||.||+|+++.+|+.||+|++++.. ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 468999999999999999999999999999999997543 2345578899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc--------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV-------------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~-------------- 145 (218)
||||++ +|..++...... +++|.+ .+|
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 162 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccccc
Confidence 999987 666666554332 444433 222
Q ss_pred CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccC---cccchhhhhhhccc
Q 041487 146 GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALT---NYLVLPCFLSIMLL 217 (218)
Q Consensus 146 g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 217 (218)
|+ .|+|||. ..+..++.++|||||||++|+|+||+.||.+.+...+...+....... .+..+.+++..||.
T Consensus 163 Gt~~Y~APE~-l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 163 GTPDYIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp SCTTTCCHHH-HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CcccccCHHH-HcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 32 3999995 556668999999999999999999999999876655555444322221 13344555666653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-32 Score=223.08 Aligned_cols=156 Identities=21% Similarity=0.346 Sum_probs=126.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999986432 233577899999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccCC----------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVGS---------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g~---------- 147 (218)
|||++ +|.+++...... +++|.+ .+||.
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99987 999988543221 333332 23332
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.+...+...+..
T Consensus 183 ~~~~gT~~Y~aPEv-~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 239 (350)
T d1koaa2 183 KVTTGTAEFAAPEV-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239 (350)
T ss_dssp EEECSCTTTCCHHH-HHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ceecCcccccCHHH-HcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3999995 4556689999999999999999999999998755555444443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-32 Score=217.89 Aligned_cols=154 Identities=23% Similarity=0.383 Sum_probs=123.5
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC----C
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG----R 113 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~ 113 (218)
..++|++.+.||+|+||.||+|+++.+++.||+|++++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999999999999999999865433 34466899999999999999999999998753 3
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC---------------------------Ccccccc-----------c----------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHIK-----------E---------- 144 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~~-----------~---------- 144 (218)
.+|+||||+++ +|.+++...... +++|.+. +
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 58999999997 888887665432 4445431 1
Q ss_pred ----------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHH
Q 041487 145 ----------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLS 193 (218)
Q Consensus 145 ----------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~ 193 (218)
.| ..|+|||. ..+..++.++|||||||++|+|+||++||.+.+...+.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~-~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 223 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQ-ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223 (277)
T ss_dssp --------------TTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccccccccCcccccCHHH-HcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH
Confidence 12 23999995 45666899999999999999999999999987544443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-32 Score=222.71 Aligned_cols=157 Identities=24% Similarity=0.370 Sum_probs=126.8
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
..++|++++.||+|+||.||+|.++.+|+.||+|+++... ....+.+.+|+.++++++||||++++++|.+++.+|+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3567999999999999999999999999999999987532 22346788999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccCCc--------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVGSP-------- 148 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g~~-------- 148 (218)
||||++ +|.+++...... +++|.+ .+||.+
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 999997 898887654321 344432 334332
Q ss_pred ---------ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 149 ---------YKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 149 ---------y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
|+|||. ..+..++.++|||||||++|+|+||+.||.+.+...+...+..
T Consensus 185 ~~~~~gt~~y~aPE~-~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 185 VKVTTATAEFAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp EEEECSSGGGCCHHH-HTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred eeeccCcccccCHHH-HcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 899995 5566699999999999999999999999998755554444443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.9e-32 Score=214.64 Aligned_cols=152 Identities=25% Similarity=0.380 Sum_probs=120.2
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe----CCEEEEE
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT----GRYVYLV 118 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 118 (218)
|++.++||+|+||.||+|+++.+++.||+|.+..........+.+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 377889999999999999999999999999998655555556789999999999999999999999864 4679999
Q ss_pred EecCCC-ChHHHhhhcccC-----------------------------Cccccc------------ccc-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI------------KEV----------- 145 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~------------~~~----------- 145 (218)
||||++ +|.+++...... |++|.+ .+|
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 999987 998888664322 333332 222
Q ss_pred ----CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHH
Q 041487 146 ----GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIV 196 (218)
Q Consensus 146 ----g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~ 196 (218)
|+ .|+|||.+ .+ .++.++|||||||++|+|++|+.||... +...+...+
T Consensus 171 ~~~~GT~~Y~aPE~~-~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i 225 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMY-EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225 (270)
T ss_dssp EESCSSCCCCCGGGG-GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred CCcccCccccCHHHh-CC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH
Confidence 22 39999965 44 4899999999999999999999999865 333333333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=1.3e-32 Score=224.95 Aligned_cols=177 Identities=22% Similarity=0.291 Sum_probs=137.7
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+++.++||||+++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 478999999999999999999999999999999997543 2345567899999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccCC------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVGS------------ 147 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g~------------ 147 (218)
|||+.+ +|.+++...... +++|.+ .+||.
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 199 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccccc
Confidence 999987 888887664332 444433 33333
Q ss_pred ---cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHhcccCc---ccchhhhhhhccc
Q 041487 148 ---PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYFTALTN---YLVLPCFLSIMLL 217 (218)
Q Consensus 148 ---~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 217 (218)
.|+|||. ..+..++.++|||||||++|+|+||+.||.+.+...+...+.......+ +..+.+++..||.
T Consensus 200 Gt~~Y~APE~-~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 200 GTPEALAPEI-ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp ECGGGCCHHH-HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred CccccCCHHH-HcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhh
Confidence 2999995 4566689999999999999999999999998765555554444322221 3345556666553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=1.5e-32 Score=220.86 Aligned_cols=149 Identities=22% Similarity=0.329 Sum_probs=118.8
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
.|+.++.||+|+||.||+|+++.+++.||||+++..... ....+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999999999999999999754432 3445678999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC-------------C-
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG-------------S- 147 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g-------------~- 147 (218)
||.+ +|..+....... +++|.+ .+|| +
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~ 175 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 175 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCG
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccCc
Confidence 9987 444444332221 444433 2333 2
Q ss_pred cccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 148 PYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 148 ~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
.|+|||.+.. .+.|+.++|||||||++|+|++|+.||.+.+..
T Consensus 176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~ 220 (309)
T d1u5ra_ 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (309)
T ss_dssp GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 3999997643 345899999999999999999999999876433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-32 Score=219.88 Aligned_cols=158 Identities=22% Similarity=0.338 Sum_probs=126.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCC-CCCCchHHHHHHHHHHh-hCCCCCeeeeeeeEEeCCEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-EPEGVPSYLIAGVSLLK-ELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
++|.+++.||+|+||.||+|+++.+++.||||++++.. ......+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999997543 22344566667766655 68999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cc---------------
Q 041487 119 FEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KE--------------- 144 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~--------------- 144 (218)
|||+++ +|.+++...... +++|.+ .+
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 999987 999988765432 333322 11
Q ss_pred --cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 041487 145 --VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRYF 199 (218)
Q Consensus 145 --~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~~ 199 (218)
.| ..|+|||.+ .+..++.++|||||||++|+|+||+.||.+.+...+...+...
T Consensus 162 ~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 218 (320)
T d1xjda_ 162 TFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 218 (320)
T ss_dssp CCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccCCCCCcCCHHHH-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 22 239999954 5566899999999999999999999999988777766666543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.9e-32 Score=216.51 Aligned_cols=163 Identities=46% Similarity=0.747 Sum_probs=128.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++++.||+|+||.||+|+++.+++.||+|+++.....+...+.+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999997655555567889999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC-----------------------------Cccccc-----------ccc---------------
Q 041487 121 YLDLDLGSFIRKHTIT-----------------------------SIRPHI-----------KEV--------------- 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~-----------------------------~~~~~~-----------~~~--------------- 145 (218)
|+.+++.+++...... |++|.+ .++
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 9988766665433211 444443 122
Q ss_pred ---CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 146 ---GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 146 ---g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
+..|+|||.+.....++.++||||+||++|+|++|+.||.+. ..+.+..+.+..+.+.
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~ 223 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 234999997777777889999999999999999999999877 3455666666555443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.4e-32 Score=219.35 Aligned_cols=154 Identities=25% Similarity=0.431 Sum_probs=126.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
.++|++.+.||+|+||.||+|.++.+++.||+|+++.. ......+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999999753 223457889999999999999999999999999999999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Cccccc-------------cccCC----------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPHI-------------KEVGS---------- 147 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-------------~~~g~---------- 147 (218)
|||++ +|.+++...... +++|.+ .+||.
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 99997 999998765321 344432 22322
Q ss_pred -------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 148 -------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 148 -------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
.|+|||. ..+..++.++|||||||++|+|++|+.||.+.+...+...+.
T Consensus 161 ~~~~~t~~y~ape~-~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 161 RLLFTAPEYYAPEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp EEEESCGGGSCHHH-HTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccccccccccchh-ccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3899994 555668999999999999999999999999876555444443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.98 E-value=4.3e-32 Score=222.82 Aligned_cols=160 Identities=24% Similarity=0.401 Sum_probs=125.2
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCC-CCCchHHHHH---HHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNE-PEGVPSYLIA---GVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+ ++.+++.++||||+++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 35789999999999999999999999999999999875431 1122233334 4667778899999999999999999
Q ss_pred EEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC---------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG--------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g--------- 146 (218)
+|+|||||++ +|.+++...... +++|.+ .+||
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999986 999988765432 344432 2333
Q ss_pred -------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 041487 147 -------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 147 -------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~~ 198 (218)
..|+|||.+..+..++.++|||||||++|+|+||+.||...+......+.+.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 220 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2399999776677799999999999999999999999988755544444443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.9e-32 Score=212.15 Aligned_cols=160 Identities=26% Similarity=0.361 Sum_probs=124.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEE
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (218)
++.++|++++.||+|+||.||+|.++ ++..||||.++.. ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 45678999999999999999999875 5678999998643 2334779999999999999999999999999999999
Q ss_pred EEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC-----------
Q 041487 118 VFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG----------- 146 (218)
Q Consensus 118 v~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g----------- 146 (218)
||||+++ +|.+++...... +++|.+ .+||
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999987 899987654322 333322 2232
Q ss_pred --------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhccc
Q 041487 147 --------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 --------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~ 202 (218)
..|+|||.+ .+..++.++|||||||++|||+| |++||.......+...+.....+
T Consensus 158 ~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221 (263)
T ss_dssp -------CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC
T ss_pred eecceecCcccCChHHh-cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 239999954 55568999999999999999999 57777766655555555544333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-32 Score=213.14 Aligned_cols=166 Identities=22% Similarity=0.328 Sum_probs=127.7
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLV 118 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (218)
+.++|+++++||+|+||.||+|+++ +++.||||.++... ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 4678999999999999999999974 77899999998543 2347799999999999999999999999999999999
Q ss_pred EecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccCC-----------
Q 041487 119 FEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVGS----------- 147 (218)
Q Consensus 119 ~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g~----------- 147 (218)
|||+++ +|.+++...... ++++. +.++|.
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999986 778775543221 22221 222222
Q ss_pred --------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 148 --------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 148 --------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
.|+|||. ..++.++.++|||||||++|||+| |+.||.+.+...+...+.....++.+...|
T Consensus 158 ~~~~~~t~~y~aPE~-~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 227 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEV-LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227 (258)
T ss_dssp CCCSCCCGGGCCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ecccCCCCCcCCcHH-hcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 2899995 445568999999999999999998 899999887666666655543443333333
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=3.2e-32 Score=216.96 Aligned_cols=164 Identities=22% Similarity=0.375 Sum_probs=129.1
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYV 115 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (218)
.++..++|++.+.||+|+||.||+|.++.+++.||||.++.. ....+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 457788999999999999999999999999999999998643 33457899999999999999999999999999999
Q ss_pred EEEEecCCC-ChHHHhhhcccC-----------------------------Ccccc-----------ccccCC-------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPH-----------IKEVGS------- 147 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~-----------~~~~g~------- 147 (218)
+++||||++ +|.+++...... +++|. +.+||.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999986 888887653221 33332 233332
Q ss_pred ------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCcchHHHHHHHhcccC
Q 041487 148 ------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKP-LFPCGKKDHLSLIVRYFTALT 203 (218)
Q Consensus 148 ------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~-Pf~~~~~~~~~~~~~~~~~~~ 203 (218)
.|+|||.+. ++.++.++|||||||++|||++|.. ||.+.+...+...+.....++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CceeeccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 399999654 4558999999999999999999655 555556666666555433333
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=5.7e-32 Score=216.68 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=130.1
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCc---EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGK---KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
++..++|++.+.||+|+||.||+|.++.++. .||||.+.... .....+.+.+|+.++++++|||||++++++...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3567889999999999999999999876654 58888876432 3334568999999999999999999999999999
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccCC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVGS------ 147 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g~------ 147 (218)
.+++|||||++ +|.+++...... +++|. +.+||.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999997 888887664321 33332 233332
Q ss_pred -----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 148 -----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 148 -----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
.|+|||.+ .++.++.++|||||||++|||+| |+.||.......+...+.....++.+...|
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHH-hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 39999954 45568999999999999999998 899998876665555555444444444444
Q ss_pred hhhh
Q 041487 210 CFLS 213 (218)
Q Consensus 210 ~~~~ 213 (218)
..+.
T Consensus 260 ~~l~ 263 (299)
T d1jpaa_ 260 SALH 263 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=8.2e-31 Score=207.69 Aligned_cols=158 Identities=25% Similarity=0.468 Sum_probs=126.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCC-------chHHHHHHHHHHhhCC-CCCeeeeeeeEEe
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEG-------VPSYLIAGVSLLKELE-HDNIVRLLDVLTT 111 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 111 (218)
.++|++.+.||+|+||+||+|+++.+++.||+|++++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999986553322 2346889999999996 9999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccC------
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVG------ 146 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g------ 146 (218)
.+.+|+|||||++ +|.+++...... +++|.+ .++|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999987 999999765442 333322 2222
Q ss_pred -----------CcccCcccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 041487 147 -----------SPYKAPESRIR-----SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHLSLIVR 197 (218)
Q Consensus 147 -----------~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~~~~~~ 197 (218)
..|+|||.+.. ...++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 23899996542 3447889999999999999999999999886555444443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=212.22 Aligned_cols=170 Identities=21% Similarity=0.284 Sum_probs=125.9
Q ss_pred hhccceeEEEE-eeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 38 VKDWNYKVVEK-IGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 38 ~~~~~~~~~~~-ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
+..++|.+.+. ||+|+||.||+|.++. .+..||||.++.. ......+.+.+|+.++++++||||+++++++.. +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 45678888885 9999999999998764 4558999998743 233446789999999999999999999999865 45
Q ss_pred EEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC--------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG-------- 146 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g-------- 146 (218)
+|+|||||++ +|.+++...... +++|.+ .+||
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999997 999987553221 333322 2222
Q ss_pred -------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhh
Q 041487 147 -------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPC 210 (218)
Q Consensus 147 -------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (218)
..|+|||.+ ..+.++.++|||||||++|||+| |+.||...+...+...+.....++.+...|.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccCccccChHHH-hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 239999965 44558999999999999999998 9999998766555555554333433333443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=212.18 Aligned_cols=158 Identities=24% Similarity=0.356 Sum_probs=123.3
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVY 116 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (218)
++..++|++.+.||+|+||.||+|+. +..||||+++.........+.+.+|+.++++++||||+++++++. .+.++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 46678999999999999999999974 346999999876666667889999999999999999999999875 45689
Q ss_pred EEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccC----------
Q 041487 117 LVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 117 lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g---------- 146 (218)
+|||||++ +|.+++...... +++|.+ .+||
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999996 999998654321 333322 2332
Q ss_pred ---------C-cccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHH
Q 041487 147 ---------S-PYKAPESRIR--SSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRY 198 (218)
Q Consensus 147 ---------~-~y~aPE~~~~--~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~ 198 (218)
+ .|+|||.+.. ...++.++|||||||++|||+||+.||.+.+. ..+...+..
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 224 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 2 3999997643 24488999999999999999999999987643 344444443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-31 Score=211.90 Aligned_cols=159 Identities=32% Similarity=0.598 Sum_probs=120.9
Q ss_pred EEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC---CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEec
Q 041487 45 VVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP---EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEY 121 (218)
Q Consensus 45 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~ 121 (218)
-++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999999999999999999754322 23356789999999999999999999999999999999999
Q ss_pred CCCChHHHhhhcccC----------------------------Cccccc-----------cc-----------------c
Q 041487 122 LDLDLGSFIRKHTIT----------------------------SIRPHI-----------KE-----------------V 145 (218)
Q Consensus 122 ~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~-----------------~ 145 (218)
+.+++..++...... |++|.+ .+ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 987554444332211 333332 11 2
Q ss_pred C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhcccC
Q 041487 146 G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTALT 203 (218)
Q Consensus 146 g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~~ 203 (218)
| ..|+|||.+.....++.++|||||||++|+|+||++||.+. +.+.+..+.+..+.+.
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC
Confidence 2 33999997777777899999999999999999999999877 5556666666655543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=211.34 Aligned_cols=164 Identities=21% Similarity=0.330 Sum_probs=121.2
Q ss_pred EEeeecCceEEEEEEEcc--CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 47 EKIGQGVFGEVYKCLNLE--TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 47 ~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
++||+|+||.||+|..+. +++.||||+++.........+.+.+|+.++++++||||+++++++..+ ..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 479999999999998653 457899999976555555567899999999999999999999998654 57899999987
Q ss_pred -ChHHHhhhcccC---------------------------Cccccc-----------ccc--------------------
Q 041487 125 -DLGSFIRKHTIT---------------------------SIRPHI-----------KEV-------------------- 145 (218)
Q Consensus 125 -~L~~~~~~~~~~---------------------------~~~~~~-----------~~~-------------------- 145 (218)
+|.+++...... +++|.+ .++
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 999998765432 333332 122
Q ss_pred CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhhhh
Q 041487 146 GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPCFL 212 (218)
Q Consensus 146 g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (218)
|+ .|+|||.+. +..++.++|||||||++|||+| |+.||.+.+...+...+.....++.+...|..+
T Consensus 172 gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 172 WPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239 (277)
T ss_dssp CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 22 399999654 4558999999999999999998 899999886666666665444444444444433
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-31 Score=208.79 Aligned_cols=165 Identities=27% Similarity=0.459 Sum_probs=122.2
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
....++..++|++.+.||+|+||.||+|.++ ++..||||.++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 3445577789999999999999999999974 5788999998643 2345789999999999999999999998754
Q ss_pred CEEEEEEecCCC-ChHHHhhhccc---C--------------------------Ccccc-----------ccccCC----
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPH-----------IKEVGS---- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~-----------~~~~g~---- 147 (218)
+.+++||||+++ +|.+++..... . +++|. +.+||.
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 557999999987 88877654321 1 33332 223332
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHHhcccC
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCGKKDHLSLIVRYFTALT 203 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~~~~~~~~~~~~~~~~~ 203 (218)
.|+|||.+. .+.++.++|||||||++|||+|| .+||.......+...+.....++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cCCccccccccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 399999654 45589999999999999999995 56666655555544444433333
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.7e-30 Score=206.78 Aligned_cols=161 Identities=43% Similarity=0.705 Sum_probs=129.9
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++++.||+|+||.||+|+++ +++.||||+++.........+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999985 78999999997665555667889999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhcccC----------------------------Cccccc-----------ccc----------------
Q 041487 121 YLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEV---------------- 145 (218)
Q Consensus 121 ~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~---------------- 145 (218)
++.+++...+...... +++|.+ .++
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 9988665555432221 444433 122
Q ss_pred --CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 146 --GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 146 --g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
+..|+|||.+.....++.++||||+||++|+|++|+.||.+. +.+.+.++.+..+.+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 234999998777777899999999999999999999999876 445566666655544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9e-31 Score=211.98 Aligned_cols=172 Identities=24% Similarity=0.410 Sum_probs=127.6
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCCc-----EEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETGK-----KVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVL 109 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (218)
.++..++|++.+.||+|+||.||+|+++..++ .||+|.+.... .....+.+.+|+.++.++ +|||||++++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 34667899999999999999999999875543 69999886433 334457789999999998 899999999999
Q ss_pred EeCCEEEEEEecCCC-ChHHHhhhccc--------------------------------------------------CCc
Q 041487 110 TTGRYVYLVFEYLDL-DLGSFIRKHTI--------------------------------------------------TSI 138 (218)
Q Consensus 110 ~~~~~~~lv~E~~~~-~L~~~~~~~~~--------------------------------------------------~~~ 138 (218)
...+.+++|||||++ +|.+++..... .|+
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 999999999999987 99999865421 033
Q ss_pred cccc-----------cccC--------------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 041487 139 RPHI-----------KEVG--------------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPC 186 (218)
Q Consensus 139 ~~~~-----------~~~g--------------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~ 186 (218)
+|.+ .+|| ..|+|||.+. ++.++.++|||||||++|||+| |+.||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 3332 2222 2399999554 5558999999999999999998 8999988
Q ss_pred CCc-chHHHHHHHhcccCcccchh
Q 041487 187 GKK-DHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 187 ~~~-~~~~~~~~~~~~~~~~~~~~ 209 (218)
.+. ..+..+++....++.+...|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~ 293 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYAT 293 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCC
Confidence 643 44555555433443333333
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.5e-31 Score=206.01 Aligned_cols=167 Identities=26% Similarity=0.387 Sum_probs=125.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-CCEE
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-GRYV 115 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 115 (218)
.+..++|++++.||+|+||.||+|.. .|..||||.++. ....+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 46678899999999999999999987 578999999863 2345779999999999999999999999854 4568
Q ss_pred EEEEecCCC-ChHHHhhhccc---C--------------------------Cccccc-----------ccc---------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPHI-----------KEV--------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~~-----------~~~--------- 145 (218)
++||||+++ +|.+++..... . ++++.+ .++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999987 99999865431 1 333322 122
Q ss_pred ------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhh
Q 041487 146 ------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPC 210 (218)
Q Consensus 146 ------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (218)
...|+|||.+.+ +.++.++|||||||++|||+| |++||...+...+...+.....++.+...|.
T Consensus 157 ~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227 (262)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 224999996554 558999999999999999998 7999988876666666554344443333333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=212.50 Aligned_cols=159 Identities=33% Similarity=0.605 Sum_probs=121.2
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR------ 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (218)
.++|++++.||+|+||.||+|.++.+++.||||++++........+.+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 67899999999999999999999999999999999865555555778999999999999999999999997554
Q ss_pred EEEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccC----------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVG---------- 146 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g---------- 146 (218)
.+|+||||++.+|..+....... +++|.+ .++|
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~ 176 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCccc
Confidence 57999999976777766544332 444433 2222
Q ss_pred -----CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHH
Q 041487 147 -----SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKK-DHLSLIVRY 198 (218)
Q Consensus 147 -----~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~-~~~~~~~~~ 198 (218)
..|+|||.+.....++.++||||+||++|+|++|+.||.+.+. +.+......
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 2399999877777789999999999999999999999988743 333333333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-30 Score=205.58 Aligned_cols=174 Identities=21% Similarity=0.344 Sum_probs=126.1
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccCC----cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLETG----KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG 112 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (218)
++..++|++.+.||+|+||.||+|..+.++ ..||||.++... .......+.+|+.++++++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 466788999999999999999999987554 479999986432 233455789999999999999999999999999
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC------
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------ 146 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------ 146 (218)
...+++|||+.+ ++.+++...... +++|. +.+||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999987 666665543221 33332 22232
Q ss_pred --------------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHHhcccCcccchhh
Q 041487 147 --------------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPCGKKDHLSLIVRYFTALTNYLVLPC 210 (218)
Q Consensus 147 --------------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (218)
+ .|+|||.+ .++.++.++|||||||++|||++|. +||.......+...+.....++.+...|.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 2 39999955 4556899999999999999999954 55555555555555554444444444443
Q ss_pred hh
Q 041487 211 FL 212 (218)
Q Consensus 211 ~~ 212 (218)
.+
T Consensus 241 ~l 242 (283)
T d1mqba_ 241 AI 242 (283)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-30 Score=205.38 Aligned_cols=164 Identities=32% Similarity=0.617 Sum_probs=123.4
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe--------
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-------- 111 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 111 (218)
.++|++++.||+|+||+||+|+++.+|+.||||++......+...+.+.+|+.++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 588999999999999999999999999999999997666666667889999999999999999999999854
Q ss_pred CCEEEEEEecCCCChHHHhhhcccC----------------------------Cccccc-----------ccc-------
Q 041487 112 GRYVYLVFEYLDLDLGSFIRKHTIT----------------------------SIRPHI-----------KEV------- 145 (218)
Q Consensus 112 ~~~~~lv~E~~~~~L~~~~~~~~~~----------------------------~~~~~~-----------~~~------- 145 (218)
...+|++||++..++.......... +++|.+ .++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 3468999999986554443322111 333322 111
Q ss_pred --------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhcccC
Q 041487 146 --------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFTALT 203 (218)
Q Consensus 146 --------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~~~~ 203 (218)
| ..|+|||++.....++.++||||+||++|+|++|+.||.+.+ ...+..+.+..+.+.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 2 239999987777779999999999999999999999998774 344444555555443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-30 Score=204.54 Aligned_cols=171 Identities=22% Similarity=0.341 Sum_probs=126.6
Q ss_pred hhhccceeEEEEeeecCceEEEEEEEccC---CcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 37 KVKDWNYKVVEKIGQGVFGEVYKCLNLET---GKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 37 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
++..++|++.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++++. .+
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45678999999999999999999998654 346888887532 23344578999999999999999999999985 46
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~-------- 145 (218)
.+++||||+++ +|.+++...... +++|.+ .+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999987 777776543221 333332 222
Q ss_pred ----------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchhh
Q 041487 146 ----------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLPC 210 (218)
Q Consensus 146 ----------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (218)
|+ .|+|||.+ .+..++.++|||||||++|||+| |.+||...+...+...+.....++.+...|.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp ----------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CcceeccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 22 38999954 45568999999999999999998 8999998866666665555444444444443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-30 Score=208.39 Aligned_cols=144 Identities=28% Similarity=0.413 Sum_probs=115.3
Q ss_pred hccceeEEE-EeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe----C
Q 041487 39 KDWNYKVVE-KIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT----G 112 (218)
Q Consensus 39 ~~~~~~~~~-~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~ 112 (218)
..++|.+++ .||+|+||.||+|.++.+++.||||+++. ...+.+|+.++.++ +||||++++++|.+ +
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 357899886 59999999999999999999999999863 25678899887655 89999999999875 4
Q ss_pred CEEEEEEecCCC-ChHHHhhhcccC-----------------------------Cccccc--------------cccCC-
Q 041487 113 RYVYLVFEYLDL-DLGSFIRKHTIT-----------------------------SIRPHI--------------KEVGS- 147 (218)
Q Consensus 113 ~~~~lv~E~~~~-~L~~~~~~~~~~-----------------------------~~~~~~--------------~~~g~- 147 (218)
..+|+|||||++ +|.+++...... +++|.+ .++|.
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 679999999987 999999764321 333332 22222
Q ss_pred ----------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 041487 148 ----------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKD 190 (218)
Q Consensus 148 ----------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~ 190 (218)
.|+|||. ..+..|+.++|||||||++|+|+||+.||.+.+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~-~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCC-CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred eeccCCCccccccCCcccCCcHH-HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 2999995 55666899999999999999999999999876433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.6e-30 Score=203.99 Aligned_cols=162 Identities=41% Similarity=0.693 Sum_probs=120.0
Q ss_pred ccceeEEEEeeecCceEEEEEEEccC-CcEEEEEEeecCCCCCCchHHHHHHHHHHhhC---CCCCeeeeeeeEEe----
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLET-GKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL---EHDNIVRLLDVLTT---- 111 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 111 (218)
.++|++++.||+|+||.||+|++..+ ++.||||+++...........+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 66799999976554444455567788777665 79999999999852
Q ss_pred -CCEEEEEEecCCCChHHHhhhcccC-----------------------------Cccccc-----------cc------
Q 041487 112 -GRYVYLVFEYLDLDLGSFIRKHTIT-----------------------------SIRPHI-----------KE------ 144 (218)
Q Consensus 112 -~~~~~lv~E~~~~~L~~~~~~~~~~-----------------------------~~~~~~-----------~~------ 144 (218)
...++++||++++++..+....... |++|.+ .+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3579999999988655443322111 444433 11
Q ss_pred ----------cC-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 145 ----------VG-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 145 ----------~g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
.| ..|+|||. ..+..|+.++||||+||++|+|++|++||.+. ..+.+..+.+..+.+
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~-~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEV-LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHH-HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hcccccCCCcccChhhcCcch-hcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 22 23999995 45566999999999999999999999999987 445556666655443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=204.97 Aligned_cols=169 Identities=22% Similarity=0.375 Sum_probs=123.3
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccCCc----EEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLETGK----KVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+..++|++++.||+|+||.||+|.++.+|+ .||+|.++.. ......+.+.+|+.++++++||||+++++++.++.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 84 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 84 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345679999999999999999999887765 5788877643 33345678999999999999999999999998765
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------ccc--------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEV-------- 145 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~-------- 145 (218)
.++++|++.+ +|.+++...... +++|.+ .+|
T Consensus 85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 4556666654 888877654332 333322 122
Q ss_pred ------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHHhcccCcccchh
Q 041487 146 ------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIVRYFTALTNYLVLP 209 (218)
Q Consensus 146 ------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (218)
+..|+|||.+. ++.++.++|||||||++|||+| |++||.+.+...+...+.....++.+...|
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239 (317)
T ss_dssp TCC--------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred ccccccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 23499999654 4568999999999999999999 899999887777777776655444443333
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6e-30 Score=202.36 Aligned_cols=148 Identities=26% Similarity=0.393 Sum_probs=117.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCC----CchHHHHHHHHHHhhCC--CCCeeeeeeeEEeCC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPE----GVPSYLIAGVSLLKELE--HDNIVRLLDVLTTGR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 113 (218)
.++|++.+.||+|+||.||+|+++.+++.||||++++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999999999999999997643222 22345778999999986 899999999999999
Q ss_pred EEEEEEecCCC--ChHHHhhhcccC---------------------------Cccccc------------cccC------
Q 041487 114 YVYLVFEYLDL--DLGSFIRKHTIT---------------------------SIRPHI------------KEVG------ 146 (218)
Q Consensus 114 ~~~lv~E~~~~--~L~~~~~~~~~~---------------------------~~~~~~------------~~~g------ 146 (218)
..++||||+.+ ++.+++...... |++|.+ .+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999975 666776554322 333332 2222
Q ss_pred ---------C-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------S-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+ .|+|||.+.....++.++|||||||++|+|+||+.||...
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 2 3999997665555677899999999999999999999763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=201.38 Aligned_cols=170 Identities=24% Similarity=0.387 Sum_probs=122.8
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCE
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRY 114 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (218)
..++..++|++.+.||+|+||.||+|.++.+ ..||||+++... ...+.+.+|+.++++++|||||++++++.+ +.
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 3457788999999999999999999998644 679999986432 234789999999999999999999999854 55
Q ss_pred EEEEEecCCC-ChHHHhhhccc---C--------------------------Ccccc-----------ccccCC------
Q 041487 115 VYLVFEYLDL-DLGSFIRKHTI---T--------------------------SIRPH-----------IKEVGS------ 147 (218)
Q Consensus 115 ~~lv~E~~~~-~L~~~~~~~~~---~--------------------------~~~~~-----------~~~~g~------ 147 (218)
+++||||+++ +|.+++..... . +++|. +.++|.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 7999999997 77777654321 1 33332 233332
Q ss_pred -------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHHhcccCcccchhh
Q 041487 148 -------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPCGKKDHLSLIVRYFTALTNYLVLPC 210 (218)
Q Consensus 148 -------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (218)
.|+|||.+. .+.++.++|||||||++|||+||. +|+.......+...+.....++.+...|.
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp ----------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred CCceeeccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence 299999655 455899999999999999999965 55555554444444443333333333333
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.7e-30 Score=204.80 Aligned_cols=162 Identities=27% Similarity=0.356 Sum_probs=123.2
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEccCCcE--EEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLETGKK--VAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT 111 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 111 (218)
.+.++.++|++.+.||+|+||.||+|+++.++.. ||||.++.. ......+.+.+|+.+++++ +||||+++++++..
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 4456778999999999999999999999888764 677776533 2334457799999999998 79999999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhccc-------------------------------------------CCccccc-----
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTI-------------------------------------------TSIRPHI----- 142 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~-------------------------------------------~~~~~~~----- 142 (218)
.+.+++||||+++ +|.+++..... .++++.+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 9999999999997 99999865321 0333322
Q ss_pred ------cccC-----------------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHH
Q 041487 143 ------KEVG-----------------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPCGKKDHLSLIVRY 198 (218)
Q Consensus 143 ------~~~g-----------------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~~~~~~~~~~~~~~ 198 (218)
.++| ..|+|||.+. ++.++.++|||||||++|||++|. +||.+.+...+...+..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 2222 3499999665 455899999999999999999965 67887766665555443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-28 Score=196.11 Aligned_cols=161 Identities=37% Similarity=0.610 Sum_probs=124.5
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCCEEEEEEe
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGRYVYLVFE 120 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~E 120 (218)
++|++++.||+|+||+||+|+++.+++.||||+++.........+.+.+|+.+++.++||||+++++++......++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999998766666778899999999999999999999999999999999999
Q ss_pred cCCC-ChHHHhhhcccC---------------------------Cccccc-----------cccCC--------------
Q 041487 121 YLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEVGS-------------- 147 (218)
Q Consensus 121 ~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~g~-------------- 147 (218)
++.+ .+..+....... |++|.+ .++|.
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 9987 444444333221 444433 22222
Q ss_pred ----cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-Cc-chHHHHHHHhcc
Q 041487 148 ----PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KK-DHLSLIVRYFTA 201 (218)
Q Consensus 148 ----~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~-~~~~~~~~~~~~ 201 (218)
.|+|||.+.....++.++||||+||++|+|++|+.||... +. +.+..+....+.
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 2677775555666899999999999999999999886433 33 334444443333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-30 Score=204.22 Aligned_cols=157 Identities=25% Similarity=0.359 Sum_probs=112.1
Q ss_pred hhccceeEEEEeeecCceEEEEEEEccC-C--cEEEEEEeecCCCC-CCchHHHHHHHHHHhhCCCCCeeeeeeeEEeCC
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNLET-G--KKVAIKMINIQNEP-EGVPSYLIAGVSLLKELEHDNIVRLLDVLTTGR 113 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~-~--~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (218)
+..++|++++.||+|+||.||+|+.... + ..||||++++.... ....+.+.+|+.++++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999986533 2 46899998765433 3446789999999999999999999999965 4
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------Cccccc-----------cccCC------
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------SIRPHI-----------KEVGS------ 147 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------~~~~~~-----------~~~g~------ 147 (218)
..++||||+++ ++.+++..+... +++|.+ .++|.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999986 888776554321 333322 22221
Q ss_pred ---------------cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 041487 148 ---------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDHLSLIV 196 (218)
Q Consensus 148 ---------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~~~~~~ 196 (218)
.|+|||.+. +..++.++|||||||++|||+| |+.||.+.+...+...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i 227 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CCCcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence 389999554 5568999999999999999998 89999887555544443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-29 Score=202.96 Aligned_cols=155 Identities=30% Similarity=0.566 Sum_probs=119.6
Q ss_pred ceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------CCEE
Q 041487 42 NYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------GRYV 115 (218)
Q Consensus 42 ~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~ 115 (218)
+|+.+++||+|+||+||+|+++.+++.||||++..... ...+|+.++++++||||++++++|.. ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975321 23479999999999999999999853 3468
Q ss_pred EEEEecCCCChHHHhhhc----ccC---------------------------Cccccc------------cccC------
Q 041487 116 YLVFEYLDLDLGSFIRKH----TIT---------------------------SIRPHI------------KEVG------ 146 (218)
Q Consensus 116 ~lv~E~~~~~L~~~~~~~----~~~---------------------------~~~~~~------------~~~g------ 146 (218)
++|||||++++.+.+... ... |++|.+ .+||
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999988665554321 110 333332 2333
Q ss_pred -----------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHHhccc
Q 041487 147 -----------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG-KKDHLSLIVRYFTAL 202 (218)
Q Consensus 147 -----------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~-~~~~~~~~~~~~~~~ 202 (218)
..|+|||++.....++.++||||+||++|+|++|+.||... ..+.+..+.+.++.+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 23999998777777999999999999999999999999876 445556665554443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.9e-29 Score=201.04 Aligned_cols=166 Identities=28% Similarity=0.444 Sum_probs=127.1
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
.++-.++|++++.||+|+||.||+|+.+. ++..||||.++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33445789999999999999999998753 4578999998643 23344678999999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC---------------------------------------------------Cc
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------------------SI 138 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------------------~~ 138 (218)
.....+++|||+++ +|.+++...... ++
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 99999999999986 899888543210 33
Q ss_pred ccc-----------ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCC
Q 041487 139 RPH-----------IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGK-PLFPC 186 (218)
Q Consensus 139 ~~~-----------~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~-~Pf~~ 186 (218)
++. +.+||. .|+|||. ..+..++.++|||||||++|||++|. +||..
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH-HccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 322 233332 3889995 45666999999999999999999985 78888
Q ss_pred CCcchHHHHHHHhcccC
Q 041487 187 GKKDHLSLIVRYFTALT 203 (218)
Q Consensus 187 ~~~~~~~~~~~~~~~~~ 203 (218)
.+...+...++....++
T Consensus 246 ~~~~e~~~~v~~~~~~~ 262 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILA 262 (301)
T ss_dssp SCHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHcCCCCC
Confidence 76666666655444333
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-29 Score=203.63 Aligned_cols=160 Identities=29% Similarity=0.446 Sum_probs=123.1
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe------CC
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT------GR 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 113 (218)
.++|++++.||+|+||+||+|.++.+|+.||||+++.........+++.+|+.+++.++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999999999999999998765555556789999999999999999999999963 46
Q ss_pred EEEEEEecCCCChHHHhhhcccC-------------------------Cccccc-----------ccc------------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT-------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~-------------------------~~~~~~-----------~~~------------ 145 (218)
.+|+|||||.+++.+.+...... +++|.+ .++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~ 175 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccccc
Confidence 89999999988766655432211 444433 111
Q ss_pred -----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHHhc
Q 041487 146 -----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-KDHLSLIVRYFT 200 (218)
Q Consensus 146 -----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-~~~~~~~~~~~~ 200 (218)
+..|+|||.+ .+..++.++||||+||++|+|++|+.||.+.+ ...+..+.....
T Consensus 176 ~~~~~t~~y~aPE~l-~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp -----CCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccChhhh-cCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 2349999965 45668999999999999999999999998773 333344444333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-29 Score=201.71 Aligned_cols=150 Identities=19% Similarity=0.336 Sum_probs=119.8
Q ss_pred hhccceeEEEEeeecCceEEEEEEEc---cCCcEEEEEEeecCCC--CCCchHHHHHHHHHHhhCCC-CCeeeeeeeEEe
Q 041487 38 VKDWNYKVVEKIGQGVFGEVYKCLNL---ETGKKVAIKMINIQNE--PEGVPSYLIAGVSLLKELEH-DNIVRLLDVLTT 111 (218)
Q Consensus 38 ~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~ 111 (218)
+..++|++++.||+|+||.||+|.+. .+|+.||+|++++... .....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45688999999999999999999873 4689999999875432 23446778899999999976 899999999999
Q ss_pred CCEEEEEEecCCC-ChHHHhhhcccC---------------------------Cccccc-----------ccc-------
Q 041487 112 GRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------SIRPHI-----------KEV------- 145 (218)
Q Consensus 112 ~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------~~~~~~-----------~~~------- 145 (218)
...++++|||+.+ +|.+++...... +++|.+ .+|
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999987 898888765432 333332 222
Q ss_pred ------------CCcccCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------------GSPYKAPESRIRSS-VYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------------g~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
...|+|||.+.... .++.++|||||||++|+|++|+.||.+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 22399999765543 4788999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=201.02 Aligned_cols=153 Identities=30% Similarity=0.559 Sum_probs=120.5
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC------C
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG------R 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (218)
.++|++++.||+|+||+||+|+++.+|+.||||++++........+.+.+|+.++++++|||++++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999999999999999999986554445567889999999999999999999998632 2
Q ss_pred EEEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------cccCC---------
Q 041487 114 YVYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEVGS--------- 147 (218)
Q Consensus 114 ~~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~g~--------- 147 (218)
..+++++++.++|.+++...... +++|.+ .++|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~ 176 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGS
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcccc
Confidence 35555555555999988654432 444443 12221
Q ss_pred ------cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcchH
Q 041487 148 ------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGKKDHL 192 (218)
Q Consensus 148 ------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~~~~~ 192 (218)
.|+|||.......++.++|||||||++|+|++|+.||.+.+....
T Consensus 177 ~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~ 227 (348)
T d2gfsa1 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227 (348)
T ss_dssp SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 299999877777789999999999999999999999988744333
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=197.06 Aligned_cols=178 Identities=23% Similarity=0.329 Sum_probs=131.4
Q ss_pred hhhhhhhccceeEEEEeeecCceEEEEEEEc-----cCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeee
Q 041487 33 EQMEKVKDWNYKVVEKIGQGVFGEVYKCLNL-----ETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLL 106 (218)
Q Consensus 33 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (218)
....++..++|++.+.||+|+||.||+|+.+ .++..||||.++... .......+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3455677899999999999999999999864 356789999997543 233456788999999999 799999999
Q ss_pred eeEEeCCEEEEEEecCCC-ChHHHhhhcccC---------------------------------------------Cccc
Q 041487 107 DVLTTGRYVYLVFEYLDL-DLGSFIRKHTIT---------------------------------------------SIRP 140 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~---------------------------------------------~~~~ 140 (218)
+++.....++++||||++ +|.+++...... +++|
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 999999999999999987 888888654311 3333
Q ss_pred cc-----------ccc--------------------CCcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 041487 141 HI-----------KEV--------------------GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGK 188 (218)
Q Consensus 141 ~~-----------~~~--------------------g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~ 188 (218)
.+ .++ +..|+|||.+ .+..++.++|||||||++|||+| |.+||....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh-cCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 22 111 1239999955 45568999999999999999999 667776663
Q ss_pred -cchHHHHHHHhcccCcccchhhhh
Q 041487 189 -KDHLSLIVRYFTALTNYLVLPCFL 212 (218)
Q Consensus 189 -~~~~~~~~~~~~~~~~~~~~~~~~ 212 (218)
.+.+..+++....+..+..+|..+
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l 277 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEM 277 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHH
Confidence 345566666544444433343333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.1e-29 Score=199.32 Aligned_cols=173 Identities=24% Similarity=0.362 Sum_probs=129.8
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEE
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLT 110 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (218)
.++..++|++.+.||+|+||.||+|.++. .+..||||.++.. ........+.+|+.++++++||||+++++++.
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45778999999999999999999998753 3578999998643 23334567899999999999999999999999
Q ss_pred eCCEEEEEEecCCC-ChHHHhhhcccC-------------------------------------Cccc-----------c
Q 041487 111 TGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------SIRP-----------H 141 (218)
Q Consensus 111 ~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------~~~~-----------~ 141 (218)
.....++||||+++ +|.+++...... ++++ +
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 99999999999986 888887543210 2222 2
Q ss_pred ccccCC--------------------cccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHHhc
Q 041487 142 IKEVGS--------------------PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCGKKDHLSLIVRYFT 200 (218)
Q Consensus 142 ~~~~g~--------------------~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~~~~~~~~~~~~~~ 200 (218)
+.++|. .|+|||.+. +..++.++|||||||++|||+|| ++||.+.+...+...+....
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 233333 299999654 55588999999999999999997 58898876666555554434
Q ss_pred ccCcccchhh
Q 041487 201 ALTNYLVLPC 210 (218)
Q Consensus 201 ~~~~~~~~~~ 210 (218)
.++.+...|.
T Consensus 253 ~~~~p~~~~~ 262 (308)
T d1p4oa_ 253 LLDKPDNCPD 262 (308)
T ss_dssp CCCCCTTCCH
T ss_pred CCCCcccchH
Confidence 3433333333
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=196.69 Aligned_cols=175 Identities=22% Similarity=0.357 Sum_probs=127.4
Q ss_pred hhhhccceeEEEEeeecCceEEEEEEEccCC-------cEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeee
Q 041487 36 EKVKDWNYKVVEKIGQGVFGEVYKCLNLETG-------KKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLD 107 (218)
Q Consensus 36 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (218)
..+..++|++++.||+|+||.||+|++..++ ..||||.+++.. .......+.+|...+.++ +||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 4467889999999999999999999876543 479999987533 333456788888888888 8999999999
Q ss_pred eEEeCCEEEEEEecCCC-ChHHHhhhcccC-------------------------------------------Cccccc-
Q 041487 108 VLTTGRYVYLVFEYLDL-DLGSFIRKHTIT-------------------------------------------SIRPHI- 142 (218)
Q Consensus 108 ~~~~~~~~~lv~E~~~~-~L~~~~~~~~~~-------------------------------------------~~~~~~- 142 (218)
++.+++.+++||||+++ +|.+++...... +++|.+
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 99999999999999987 999998654310 333332
Q ss_pred ----------ccc-------------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcch
Q 041487 143 ----------KEV-------------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVS-GKPLFPCGKKDH 191 (218)
Q Consensus 143 ----------~~~-------------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~t-g~~Pf~~~~~~~ 191 (218)
.++ | ..|+|||.+. ++.|+.++|||||||++|||++ |.+||.+.+...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 111 2 2399999654 4569999999999999999998 799999887777
Q ss_pred HHHHHHHhcccCcccchhhhh
Q 041487 192 LSLIVRYFTALTNYLVLPCFL 212 (218)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~ 212 (218)
+...+.....++.+...|..+
T Consensus 246 ~~~~i~~~~~~~~p~~~~~~l 266 (299)
T d1fgka_ 246 LFKLLKEGHRMDKPSNCTNEL 266 (299)
T ss_dssp HHHHHHTTCCCCCCSSCCHHH
T ss_pred HHHHHHcCCCCCCCccchHHH
Confidence 777766554444444443333
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=1.6e-27 Score=190.09 Aligned_cols=145 Identities=23% Similarity=0.291 Sum_probs=117.4
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCC-CCeeeeeeeEEeCCEEEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEH-DNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 117 (218)
..++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+|+++++.+.| +|++.+++++......++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 35789999999999999999999999999999999864322 2346788888999965 899999999999999999
Q ss_pred EEecCCCChHHHhhhcccC----------------------------Cccccc----------------ccc--------
Q 041487 118 VFEYLDLDLGSFIRKHTIT----------------------------SIRPHI----------------KEV-------- 145 (218)
Q Consensus 118 v~E~~~~~L~~~~~~~~~~----------------------------~~~~~~----------------~~~-------- 145 (218)
||||++++|.+++...... |++|.+ .+|
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999988998887654322 333332 111
Q ss_pred ----------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 ----------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 ----------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
| ..|+|||. ..+..++.++|||||||++|+|+||+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~-~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHH-HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccccceeecccCceEEchhhcCHHH-hcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 2 23999995 455668999999999999999999999998663
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.6e-28 Score=196.14 Aligned_cols=148 Identities=28% Similarity=0.541 Sum_probs=116.3
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEeC-----CE
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTTG-----RY 114 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (218)
.++|++++.||+|+||+||+|.++.+++.||||++++.. .....+.+.+|+.++++++|||++++++++... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 357999999999999999999999999999999987432 233456788999999999999999999998654 34
Q ss_pred EEEEEecCCCChHHHhhhcccC--------------------------Cccccc-----------ccc------------
Q 041487 115 VYLVFEYLDLDLGSFIRKHTIT--------------------------SIRPHI-----------KEV------------ 145 (218)
Q Consensus 115 ~~lv~E~~~~~L~~~~~~~~~~--------------------------~~~~~~-----------~~~------------ 145 (218)
.+++++++.++|.+++...... |++|.+ .++
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 6777777766999998765443 444433 122
Q ss_pred --------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 041487 146 --------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK 188 (218)
Q Consensus 146 --------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~ 188 (218)
|+ .|+|||.+.....++.++||||+||++|+|++|+.||.+.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 22 39999977677778999999999999999999999998763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.3e-27 Score=190.70 Aligned_cols=142 Identities=26% Similarity=0.406 Sum_probs=106.8
Q ss_pred eEEEEeeecCceEEEEEEEccCC---cEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCCeeeeeeeEEe-CCEEEEEE
Q 041487 44 KVVEKIGQGVFGEVYKCLNLETG---KKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDNIVRLLDVLTT-GRYVYLVF 119 (218)
Q Consensus 44 ~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 119 (218)
++.++||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34678999999999999986543 36899998642 233446789999999999999999999999765 56899999
Q ss_pred ecCCC-ChHHHhhhcccC----------------------------Ccccc-----------ccccC-------------
Q 041487 120 EYLDL-DLGSFIRKHTIT----------------------------SIRPH-----------IKEVG------------- 146 (218)
Q Consensus 120 E~~~~-~L~~~~~~~~~~----------------------------~~~~~-----------~~~~g------------- 146 (218)
|||++ +|.+++...... ++++. +.+||
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99997 887777644322 22222 12222
Q ss_pred ---------CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 147 ---------SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 147 ---------~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
..|+|||.+.. ..++.++||||||+++|||+||+.||...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred eecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 23999996554 45899999999999999999977777544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=4.2e-27 Score=190.38 Aligned_cols=144 Identities=27% Similarity=0.524 Sum_probs=115.0
Q ss_pred hccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEe--CCEE
Q 041487 39 KDWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTT--GRYV 115 (218)
Q Consensus 39 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 115 (218)
..++|++++.||+|+||+||+|+++.+++.||+|+++.. ..+.+.+|+.+++.+ .||||++++++|.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 456899999999999999999999999999999998632 356789999999999 49999999999974 4569
Q ss_pred EEEEecCCC-ChHHHhhhcccC------------------------Cccccc------------ccc-------------
Q 041487 116 YLVFEYLDL-DLGSFIRKHTIT------------------------SIRPHI------------KEV------------- 145 (218)
Q Consensus 116 ~lv~E~~~~-~L~~~~~~~~~~------------------------~~~~~~------------~~~------------- 145 (218)
++|||||++ +|.++....... +++|.+ .++
T Consensus 108 ~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred eEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 999999987 565543321111 344432 122
Q ss_pred ----CCcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ----GSPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ----g~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
+..|+|||.+.....++.++||||+||++|++++|+.||...
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 223999997777777899999999999999999999999765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1e-26 Score=185.83 Aligned_cols=142 Identities=20% Similarity=0.306 Sum_probs=111.8
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCCCCC-eeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELEHDN-IVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 119 (218)
++|++.+.||+|+||.||+|+++.+++.||||++..... .+.+.+|+++++.++|++ |+.+.+++......++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 569999999999999999999999999999999875322 234788999999997766 555566678889999999
Q ss_pred ecCCCChHHHhhhcccC----------------------------Cccccc--------------ccc------------
Q 041487 120 EYLDLDLGSFIRKHTIT----------------------------SIRPHI--------------KEV------------ 145 (218)
Q Consensus 120 E~~~~~L~~~~~~~~~~----------------------------~~~~~~--------------~~~------------ 145 (218)
||+++++.+.+...... |++|.+ .+|
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99988887766543221 344432 122
Q ss_pred ------------C-CcccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 041487 146 ------------G-SPYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCG 187 (218)
Q Consensus 146 ------------g-~~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~ 187 (218)
| ..|+|||. ..+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHH-HTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cceeccccCCcCCCccccCHHH-HhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 2 23999994 55666899999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.5e-27 Score=186.59 Aligned_cols=167 Identities=22% Similarity=0.375 Sum_probs=119.0
Q ss_pred hhhhhccceeEEEEeeecCceEEEEEEEcc-----CCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeee
Q 041487 35 MEKVKDWNYKVVEKIGQGVFGEVYKCLNLE-----TGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDV 108 (218)
Q Consensus 35 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (218)
..++..++|++.+.||+|+||.||+|++.. +++.||+|.++... .....+.+.+|..++.++ .|+||+.++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344667899999999999999999999764 34689999986432 233356677788777777 68899999998
Q ss_pred EEe-CCEEEEEEecCCC-ChHHHhhhccc-------------------------------------------CCccccc-
Q 041487 109 LTT-GRYVYLVFEYLDL-DLGSFIRKHTI-------------------------------------------TSIRPHI- 142 (218)
Q Consensus 109 ~~~-~~~~~lv~E~~~~-~L~~~~~~~~~-------------------------------------------~~~~~~~- 142 (218)
+.. ...+++|||||++ +|.+++..... .|++|.+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 764 5579999999986 99999864321 0333332
Q ss_pred ----------ccc-------------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCC-cc
Q 041487 143 ----------KEV-------------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSG-KPLFPCGK-KD 190 (218)
Q Consensus 143 ----------~~~-------------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg-~~Pf~~~~-~~ 190 (218)
.+| |+ .|+|||.+. +..++.++|||||||++|||+|| .+||...+ .+
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 222 22 399999654 55689999999999999999996 57888763 34
Q ss_pred hHHHHHHHhcccC
Q 041487 191 HLSLIVRYFTALT 203 (218)
Q Consensus 191 ~~~~~~~~~~~~~ 203 (218)
.+...+.....++
T Consensus 245 ~~~~~~~~~~~~~ 257 (299)
T d1ywna1 245 EFCRRLKEGTRMR 257 (299)
T ss_dssp HHHHHHHHTCCCC
T ss_pred HHHHHHhcCCCCC
Confidence 4444444433333
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.7e-26 Score=184.98 Aligned_cols=140 Identities=24% Similarity=0.381 Sum_probs=104.6
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHH--HHHHHhhCCCCCeeeeeeeEEeCC----
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIA--GVSLLKELEHDNIVRLLDVLTTGR---- 113 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~~iv~~~~~~~~~~---- 113 (218)
+.+|.+.+.||+|+||.||+|+. +|+.||||.++.. ..+.+.+ |+..+..++||||+++++++...+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 46789999999999999999986 7899999998632 1233444 444556789999999999987543
Q ss_pred EEEEEEecCCC-ChHHHhhhcccC----------------------------------Ccccc-----------ccccC-
Q 041487 114 YVYLVFEYLDL-DLGSFIRKHTIT----------------------------------SIRPH-----------IKEVG- 146 (218)
Q Consensus 114 ~~~lv~E~~~~-~L~~~~~~~~~~----------------------------------~~~~~-----------~~~~g- 146 (218)
.+++|||||++ +|.+++.+.... +++|. +.+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999987 999998764432 22222 22333
Q ss_pred ---------------------CcccCcccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 041487 147 ---------------------SPYKAPESRIRSS-----VYSTPHDVWAVGCIFAEMVSGKPLFPC 186 (218)
Q Consensus 147 ---------------------~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~~l~tg~~Pf~~ 186 (218)
..|+|||.+.... .++.++|||||||++|||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 2399999654432 256689999999999999999988743
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=6.1e-22 Score=161.51 Aligned_cols=159 Identities=25% Similarity=0.490 Sum_probs=107.8
Q ss_pred ccceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC-----------CCCeeeeeee
Q 041487 40 DWNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE-----------HDNIVRLLDV 108 (218)
Q Consensus 40 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~ 108 (218)
.++|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.+. |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 45699999999999999999999999999999998643 223456778888887764 5789999998
Q ss_pred EE--eCCEEEEEEecCCC--ChHH---------------------------Hhhh-ccc--CCccccc------------
Q 041487 109 LT--TGRYVYLVFEYLDL--DLGS---------------------------FIRK-HTI--TSIRPHI------------ 142 (218)
Q Consensus 109 ~~--~~~~~~lv~E~~~~--~L~~---------------------------~~~~-~~~--~~~~~~~------------ 142 (218)
+. .....+++++++.. .... ++.. .+. .|++|.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 85 34566666666532 1111 1111 101 1334432
Q ss_pred -----ccc--------------CC-cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cchHHHH
Q 041487 143 -----KEV--------------GS-PYKAPESRIRSSVYSTPHDVWAVGCIFAEMVSGKPLFPCGK-------KDHLSLI 195 (218)
Q Consensus 143 -----~~~--------------g~-~y~aPE~~~~~~~~~~~~DiwSlG~~l~~l~tg~~Pf~~~~-------~~~~~~~ 195 (218)
.++ |+ .|+|||.+. ...++.++||||+||++++|++|+.||...+ .+.+...
T Consensus 169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred ceeeEeecccccccccccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 112 22 399999655 5558999999999999999999999997552 2344555
Q ss_pred HHHhccc
Q 041487 196 VRYFTAL 202 (218)
Q Consensus 196 ~~~~~~~ 202 (218)
+..++.+
T Consensus 248 ~~~lg~~ 254 (362)
T d1q8ya_ 248 IELLGEL 254 (362)
T ss_dssp HHHHCSC
T ss_pred HHHhCCC
Confidence 5555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.03 E-value=2.7e-10 Score=83.64 Aligned_cols=77 Identities=14% Similarity=0.213 Sum_probs=56.0
Q ss_pred eeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCC----C------------CchHHHHHHHHHHhhCCCCCeeeee
Q 041487 43 YKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEP----E------------GVPSYLIAGVSLLKELEHDNIVRLL 106 (218)
Q Consensus 43 ~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~------------~~~~~~~~e~~~l~~l~h~~iv~~~ 106 (218)
+.+.+.||+|+||.||+|.+ .+|+.||||+++..... . .......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999987 47899999987643211 0 0122344677888999999998887
Q ss_pred eeEEeCCEEEEEEecCCC
Q 041487 107 DVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 107 ~~~~~~~~~~lv~E~~~~ 124 (218)
+.. . .+++|||+++
T Consensus 81 ~~~--~--~~lvme~~~~ 94 (191)
T d1zara2 81 AWE--G--NAVLMELIDA 94 (191)
T ss_dssp EEE--T--TEEEEECCCC
T ss_pred Eec--C--CEEEEEeecc
Confidence 653 2 2699999975
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=95.43 E-value=0.035 Score=40.73 Aligned_cols=83 Identities=14% Similarity=0.142 Sum_probs=59.2
Q ss_pred cceeEEEEeeecCceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhC-CCCCeeeeeeeEEeCCEEEEEE
Q 041487 41 WNYKVVEKIGQGVFGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKEL-EHDNIVRLLDVLTTGRYVYLVF 119 (218)
Q Consensus 41 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (218)
..|++.+..+.++.+.||+... .+..+++|...... ......+.+|...+..+ .+--+.+++.+....+..++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 5677777766666678998763 67778888875432 22233567788887776 3444678888888889999999
Q ss_pred ecCCC-ChH
Q 041487 120 EYLDL-DLG 127 (218)
Q Consensus 120 E~~~~-~L~ 127 (218)
+++++ .+.
T Consensus 90 ~~l~G~~~~ 98 (263)
T d1j7la_ 90 SEADGVLCS 98 (263)
T ss_dssp ECCSSEEHH
T ss_pred Eeccccccc
Confidence 99987 543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.19 E-value=0.13 Score=40.43 Aligned_cols=77 Identities=19% Similarity=0.143 Sum_probs=50.2
Q ss_pred EEEeeecCceEEEEEEEccCCcEEEEEEeecCC-----CCCCchHHHHHHHHHHhhC-CC--CCeeeeeeeEEeCCEEEE
Q 041487 46 VEKIGQGVFGEVYKCLNLETGKKVAIKMINIQN-----EPEGVPSYLIAGVSLLKEL-EH--DNIVRLLDVLTTGRYVYL 117 (218)
Q Consensus 46 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h--~~iv~~~~~~~~~~~~~l 117 (218)
.+.||.|....||++.....+..+++|...... ......++...|..+++.+ .+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999877778899999865321 1122345677788887766 33 345666544 3444578
Q ss_pred EEecCCC
Q 041487 118 VFEYLDL 124 (218)
Q Consensus 118 v~E~~~~ 124 (218)
+||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.80 E-value=0.34 Score=34.84 Aligned_cols=71 Identities=15% Similarity=0.049 Sum_probs=48.6
Q ss_pred EeeecC-ceEEEEEEEccCCcEEEEEEeecCCCCCCchHHHHHHHHHHhhCC--CCCeeeeeeeEEeCCEEEEEEecCCC
Q 041487 48 KIGQGV-FGEVYKCLNLETGKKVAIKMINIQNEPEGVPSYLIAGVSLLKELE--HDNIVRLLDVLTTGRYVYLVFEYLDL 124 (218)
Q Consensus 48 ~ig~G~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~E~~~~ 124 (218)
.+..|. .+.||+... ..+..+++|..+... ...+..|...++.+. .-.+++++......+..++||+++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 344444 467888864 456678889865432 223677888777763 23367778877888889999999976
|